The	DT	det	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
in	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
:	:	punct	O
analysis	NN	dep	O
of	IN	case	O
microsatellite	NN	compound	O
regions	NNS	nmod	O
and	CC	cc	O
gene	NN	compound	O
expression	NN	conj	O
.	.	punct	O

Genomic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
one	CD	nummod	O
mechanism	NN	ROOT	O
proposed	VBN	acl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
disease	NN	compound	O
progression	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
CML	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Microsatellite	NN	compound	O
regions	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
type	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
transforming	VBG	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	intj	I-Gene_or_gene_product
RII	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nmod	O
appear	VBP	ROOT	O
to	TO	mark	O
be	VB	cop	O
targets	NNS	xcomp	O
for	IN	case	O
mutation	NN	nmod	O
in	IN	case	O
some	DT	det	O
cancers	NNS	nmod	B-Cancer
displaying	VBG	acl	O
microsatellite	NN	compound	O
instability	NN	dobj	O
(	-LRB-	punct	O
replication	NN	compound	O
error	NN	compound	O
phenotype	NN	dep	O
,	,	punct	O
RER	NN	appos	O
+	CC	cc	O
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	compound	I-Gene_or_gene_product
mutations	NNS	nsubjpass	O
in	IN	case	O
RER	NN	nmod	B-Cancer
+	CC	cc	I-Cancer
tumors	NNS	conj	I-Cancer
have	VBP	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	compound	I-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

As	IN	mark	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
negative	JJ	amod	O
growth	NN	compound	O
regulator	NN	nmod	O
of	IN	case	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
investigations	NNS	nsubjpass	O
were	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
inactivation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
by	IN	case	O
microsatellite	NN	compound	O
alteration	NN	nmod	O
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-Cancer
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	compound	I-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
RNase	NN	compound	B-Gene_or_gene_product
protection	NN	nmod	O
,	,	punct	O
with	IN	case	O
comparison	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
from	IN	case	O
the	DT	det	O
chronic	JJ	nmod	O
,	,	punct	O
accelerated	VBN	conj	O
and	CC	cc	O
blast	NN	conj	O
phases	NNS	dep	O
of	IN	case	O
CML	NN	nmod	B-Cancer
,	,	punct	O
showed	VBD	ROOT	O
no	DT	neg	O
change	NN	dobj	O
in	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	compound	I-Gene_or_gene_product
transcript	NN	compound	O
levels	NNS	nmod	O
during	IN	case	O
disease	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
during	IN	case	O
each	DT	det	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
,	,	punct	O
low	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
detected	VBN	ROOT	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
normal	JJ	amod	O
donors	NNS	nmod	B-Organism
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
this	DT	det	O
decreased	VBN	amod	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
myeloproliferative	JJ	amod	O
disorders	NNS	nmod	O
,	,	punct	O
polycythemia	NN	nsubj	O
rubra	NN	compound	O
vera	NN	nmod	O
(	-LRB-	punct	O
PRV	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
essential	JJ	amod	O
thrombocythemia	NN	conj	O
(	-LRB-	punct	O
ET	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
leukemia	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
K562	NN	dep	I-Cell
and	CC	cc	O
HL	NN	compound	B-Cell
-	:	punct	I-Cell
60	CD	conj	I-Cell
had	VBD	ROOT	O
no	DT	neg	O
detectable	JJ	amod	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	compound	I-Gene_or_gene_product
mRNA	NN	dobj	O
.	.	punct	O

Two	CD	nummod	O
microsatellite	NN	compound	O
regions	NNS	nsubjpass	O
found	VBN	acl	O
altered	VBN	xcomp	O
in	IN	case	O
RER	NN	nmod	B-Cancer
+	CC	cc	I-Cancer
colon	NN	compound	I-Cancer
cancers	NNS	conj	I-Cancer
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
to	TO	mark	O
establish	VB	xcomp	O
if	IN	mark	O
these	DT	det	O
sequences	NNS	nsubj	O
were	VBD	cop	O
aberrant	JJ	ccomp	O
in	IN	case	O
CML	NN	nmod	B-Cancer
.	.	punct	O

No	DT	neg	O
alteration	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
either	DT	nmod	O
of	IN	case	O
these	DT	det	O
regions	NNS	nmod	O
in	IN	case	O
any	DT	det	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
alterations	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
microsatellite	NN	compound	O
regions	NNS	nmod	O
in	IN	case	O
the	DT	det	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-Cancer
.	.	punct	O

Decreased	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
RII	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
CML	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
leukemia	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
raises	VBZ	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
altered	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
maintenance	NN	conj	O
of	IN	case	O
the	DT	det	O
disease	NN	compound	O
state	NN	nmod	O
.	.	punct	O

N	NN	compound	O
-	HYPH	punct	O
glycosylation	NN	nsubjpass	O
of	IN	case	O
glucose	NN	compound	B-Gene_or_gene_product
transporter	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Glut	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
increased	VBN	amod	O
transporter	NN	compound	O
affinity	NN	nmod	O
for	IN	case	O
glucose	NN	nmod	B-Simple_chemical
in	IN	case	O
human	JJ	amod	B-Organism
leukemic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
N	NN	compound	O
-	HYPH	punct	O
glycosylation	NN	nmod	O
in	IN	case	O
the	DT	det	O
functional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
universal	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	nmod	O
,	,	punct	O
Glut	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
effects	NNS	dobj	O
of	IN	case	O
the	DT	det	O
N	NN	compound	O
-	HYPH	punct	O
glycosylation	NN	compound	O
inhibitor	NN	nmod	O
,	,	punct	O
tunicamycin	NN	appos	B-Simple_chemical
,	,	punct	O
on	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
by	IN	case	O
human	JJ	amod	B-Organism
leukemic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
K562	NN	dep	I-Cell
,	,	punct	O
U937	NN	conj	B-Cell
and	CC	cc	O
HL60	NN	conj	B-Cell
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
tunicamycin	NN	nmod	B-Simple_chemical
produced	VBD	ROOT	O
a	DT	det	O
40	CD	compound	O
-	HYPH	punct	O
50	CD	nummod	O
%	NN	amod	O
inhibition	NN	dobj	O
of	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyglucose	NN	compound	I-Simple_chemical
uptake	NN	nmod	O
and	CC	cc	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
a	DT	det	O
2	CD	compound	O
-	SYM	punct	O
2	CD	nummod	O
.	.	punct	O
5	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
decrease	NN	nmod	O
in	IN	case	O
transporter	NN	compound	O
affinity	NN	nmod	O
for	IN	case	O
glucose	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Km	NN	appos	O
)	-RRB-	punct	O
without	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
Vmax	NN	nmod	O
.	.	punct	O

Leukemic	JJ	amod	B-Cell
K562	NN	nsubj	I-Cell
,	,	punct	O
U937	NN	conj	B-Cell
and	CC	cc	O
HL60	NN	conj	B-Cell
cells	NNS	conj	I-Cell
expressed	VBD	ROOT	O
Glut	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
transporter	NN	compound	O
protein	NN	dobj	O
.	.	punct	O

With	IN	case	O
K562	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
Glut	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
appeared	VBD	ROOT	O
as	IN	prep	O
a	DT	det	O
broad	JJ	amod	O
band	NN	pobj	O
of	IN	prep	O
50	CD	compound	O
-	HYPH	punct	O
60	CD	nummod	O
kDa	NN	pobj	O
,	,	punct	O
whereas	IN	dep	O
with	IN	case	O
U937	NN	nmod	B-Cell
and	CC	cc	O
HL60	NN	conj	B-Cell
cells	NNS	nmod	I-Cell
a	DT	det	O
diffuse	JJ	amod	O
band	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	conj	O
at	IN	case	O
approximately	RB	advmod	O
55	CD	nummod	O
kDa	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
K562	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
tunicamycin	NN	nmod	B-Simple_chemical
for	IN	case	O
18	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
extensive	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
the	DT	det	O
50	CD	compound	O
-	HYPH	punct	O
60	CD	nummod	O
kDa	NN	compound	O
glycoprotein	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
appearance	NN	xcomp	O
of	IN	case	O
a	DT	det	O
30	CD	compound	O
-	HYPH	punct	O
40	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
.	.	punct	O

With	IN	case	O
U937	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
tunicamycin	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
a	DT	det	O
30	CD	compound	O
-	HYPH	punct	O
40	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
.	.	punct	O

With	IN	case	O
HL60	NN	compound	B-Cell
cells	NNS	compound	I-Cell
loss	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
55	CD	nummod	O
kDa	NN	compound	O
Glut	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
band	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
and	CC	cc	O
a	DT	det	O
band	NN	nsubj	O
of	IN	case	O
45	CD	nummod	O
kDa	NN	nmod	O
appeared	VBD	conj	O
.	.	punct	O

Tunicamycin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
75	CD	compound	O
-	SYM	punct	O
90	CD	nummod	O
%	NN	compound	O
inhibition	NN	nmod	O
in	IN	case	O
[	-LRB-	punct	B-Simple_chemical
3H	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
mannose	NN	compound	I-Simple_chemical
incorporation	NN	nmod	O
but	CC	cc	O
only	RB	advmod	O
20	CD	compound	O
-	SYM	punct	O
25	CD	nummod	O
%	NN	compound	O
inhibition	NN	conj	O
in	IN	case	O
[	-LRB-	punct	B-Simple_chemical
3H	NN	pobj	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
thymidine	NN	nmod	I-Simple_chemical
and	CC	cc	O
[	-LRB-	punct	B-Simple_chemical
3H	NN	conj	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
leucine	NN	compound	I-Simple_chemical
incorporation	NN	dep	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
tunicamycin	NN	nsubj	B-Simple_chemical
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
viability	NN	nmod	O
and	CC	cc	O
MTT	NN	compound	B-Simple_chemical
responses	NNS	conj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
used	VBN	acl	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
leukemic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
N	NN	compound	O
-	:	punct	O
glycosylation	NN	nsubj	O
of	IN	prep	O
Glut	NNP	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	pobj	I-Gene_or_gene_product
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
maintaining	VBG	advcl	O
its	PRP$	nmod:poss	O
structure	NN	dobj	O
and	CC	cc	O
functional	JJ	amod	O
integration	NN	conj	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
node	NN	compound	B-Multi-tissue_structure
-	HYPH	punct	O
positive	JJ	amod	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
considered	VBN	ROOT	O
as	IN	case	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
protein	NN	nmod	O
and	CC	cc	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
its	PRP$	nmod:poss	O
expression	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	conj	O
to	TO	mark	O
correlate	VB	xcomp	O
inversely	RB	advmod	O
with	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
in	IN	case	O
some	DT	det	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
sites	NNS	nmod	B-Multi-tissue_structure
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
detail	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
surgically	RB	advmod	O
resected	VBN	amod	O
46	CD	nummod	O
pairs	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
metastatic	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

The	DT	det	O
positive	JJ	amod	O
staining	NN	nsubjpass	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
metastatic	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
56	CD	nmod	O
.	.	punct	O
5	CD	ROOT	O
and	CC	cc	O
67	CD	conj	O
.	.	punct	O
4	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
heterogeneity	NN	nsubjpass	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
between	IN	case	O
primary	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
metastatic	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
41	CD	nmod	O
.	.	punct	O
3	CD	nummod	O
%	NN	ROOT	O
.	.	punct	O

No	DT	det	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
lung	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
the	DT	det	O
patients	NNS	compound	B-Organism
survival	NN	conj	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
between	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
the	DT	det	O
patients	NNS	compound	B-Organism
survival	NN	conj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
,	,	punct	O
furthermore	RB	advmod	O
,	,	punct	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
heterogeneity	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
patients	NNS	compound	B-Organism
survival	NN	conj	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
does	VBZ	aux	O
not	RB	neg	O
significantly	RB	advmod	O
reveal	VB	ROOT	O
prognostic	JJ	amod	O
value	NN	dobj	O
in	IN	case	O
node	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
positive	JJ	amod	I-Cancer
lung	NN	compound	I-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
metastatic	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
was	VBD	auxpass	O
also	RB	advmod	O
unrelated	JJ	ROOT	O
to	TO	case	O
patients	NNS	compound	B-Organism
survival	NN	nmod	O
.	.	punct	O

Bradycardia	NNP	advmod	O
-	HYPH	punct	O
induced	VBN	amod	O
coronary	JJ	amod	B-Multi-tissue_structure
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

A	DT	det	O
marked	JJ	amod	O
coronary	JJ	amod	B-Multi-tissue_structure
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
with	IN	case	O
chronic	JJ	amod	O
bradycardia	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
mitogen	NN	appos	O
and	CC	cc	O
a	DT	det	O
major	JJ	amod	O
regulator	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
upregulated	VBN	ccomp	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
low	JJ	amod	O
heart	NN	compound	B-Organ
rate	NN	nmod	O
and	CC	cc	O
consequential	JJ	amod	O
increased	VBD	amod	O
stroke	NN	compound	O
volume	NN	conj	O
.	.	punct	O

Bradycardia	NNP	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
rats	NNS	nmod	B-Organism
by	IN	mark	O
administering	VBG	advcl	O
the	DT	det	O
bradycardic	JJ	amod	O
drug	NN	compound	O
alinidine	NN	dobj	B-Simple_chemical
(	-LRB-	punct	O
3	CD	nummod	O
mg	NN	nummod	O
/	:	punct	O
kg	NN	compound	O
body	NN	compound	B-Organism_subdivision
weight	NN	appos	O
)	-RRB-	punct	O
twice	RB	advmod	O
daily	RB	advmod	O
.	.	punct	O

Heart	NN	compound	B-Organ
rate	NN	nsubj	O
decreased	VBD	ROOT	O
by	IN	prep	O
32	CD	nummod	O
%	NN	pobj	O
for	IN	case	O
20	CD	compound	O
to	TO	dep	O
40	CD	nummod	O
minutes	NNS	nmod	O
after	IN	case	O
injection	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
chronically	RB	advmod	O
reduced	VBN	conj	O
by	IN	agent	O
10	CD	nummod	O
%	NN	pobj	O
,	,	punct	O
14	CD	nummod	O
%	NN	appos	O
,	,	punct	O
and	CC	cc	O
18	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
after	IN	case	O
1	CD	dep	O
,	,	punct	O
2	CD	conj	O
,	,	punct	O
and	CC	cc	O
3	CD	nummod	O
weeks	NNS	appos	O
of	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Arterial	JJ	amod	B-Multi-tissue_structure
pressure	NN	nsubj	O
and	CC	cc	O
cardiac	JJ	amod	B-Organ
output	NN	conj	O
were	VBD	ROOT	O
unchanged	JJ	acomp	O
.	.	punct	O

Left	JJ	amod	B-Tissue
ventricular	JJ	amod	I-Tissue
capillary	JJ	compound	I-Tissue
length	NN	compound	O
density	NN	nsubj	O
(	-LRB-	punct	O
mm	NN	compound	O
/	SYM	punct	O
mm	NN	dep	O
(	-LRB-	punct	O
3	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
increased	VBD	ROOT	O
gradually	RB	advmod	O
with	IN	case	O
alinidine	NN	compound	B-Simple_chemical
administration	NN	nmod	O
;	:	punct	O
a	DT	det	O
15	CD	nummod	O
%	NN	compound	O
increase	NN	nsubjpass	O
after	IN	case	O
2	CD	nummod	O
weeks	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
40	CD	nummod	O
%	NN	compound	O
increase	NN	nsubjpass	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
alinidine	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
were	VBD	auxpass	O
documented	VBN	parataxis	O
.	.	punct	O

Left	JJ	amod	B-Multi-tissue_structure
ventricular	JJ	amod	I-Multi-tissue_structure
weight	NN	ROOT	O
,	,	punct	O
body	NN	compound	B-Organism_subdivision
weight	NN	conj	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
ratio	NN	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
altered	VBN	conj	O
by	IN	case	O
alinidine	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

After	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
of	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
before	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
capillary	JJ	amod	B-Tissue
length	NN	compound	O
density	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubj	O
increased	VBD	ROOT	O
greater	JJR	advmod	O
than	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
fold	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
declined	VBD	conj	O
to	TO	mark	O
control	VB	xcomp	O
levels	NNS	dobj	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
was	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
alinidine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
than	IN	case	O
in	IN	case	O
controls	NNS	nmod	O
after	IN	case	O
2	CD	nummod	O
weeks	NNS	nmod	O
and	CC	cc	O
increased	VBN	conj	O
further	RB	advmod	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
over	IN	case	O
a	DT	det	O
2	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
period	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
alinidine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
bFGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
by	IN	case	O
alinidine	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
VEGF	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
response	NN	nmod	O
that	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
with	IN	case	O
chronic	JJ	amod	O
bradycardia	NN	nmod	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
underlying	VBG	acl	O
this	DT	det	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	dobj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
increase	NN	ROOT	O
in	IN	case	O
stretch	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
enhanced	VBN	amod	O
diastolic	JJ	amod	O
filling	NN	nmod	O
.	.	punct	O

External	JJ	amod	O
beam	NN	compound	O
radiotherapy	NN	nsubj	O
for	IN	case	O
subretinal	JJ	amod	B-Immaterial_anatomical_entity
neovascularization	NN	nmod	O
in	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
:	:	punct	O
is	VBZ	ROOT	O
this	DT	det	O
treatment	NN	nsubj	O
efficient	JJ	acomp	O
?	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Control	NN	nsubj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
course	NN	nmod	O
of	IN	case	O
subretinal	JJ	amod	B-Immaterial_anatomical_entity
neovascularization	NN	nmod	O
(	-LRB-	punct	O
SRNV	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
difficult	JJ	appos	O
.	.	punct	O

Only	RB	advmod	O
a	DT	det	O
subset	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
is	VBZ	cop	O
suitable	JJ	ROOT	O
for	IN	case	O
laser	NN	compound	O
coagulation	NN	nmod	O
.	.	punct	O

This	DT	det	O
prospective	JJ	amod	O
study	NN	ROOT	O
aimed	VBN	acl	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
efficacy	NN	dobj	O
and	CC	cc	O
individual	JJ	amod	O
benefit	NN	conj	O
of	IN	case	O
external	JJ	amod	O
beam	NN	compound	O
radiotherapy	NN	nmod	O
(	-LRB-	punct	O
EBRT	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	nsubj	O
AND	CC	cc	O
MATERIALS	NNS	conj	O
:	:	punct	O
The	DT	det	O
prospective	JJ	amod	O
trial	NN	nsubj	O
included	VBD	ROOT	O
287	CD	nummod	O
patients	NNS	dobj	B-Organism
with	IN	case	O
subfoveal	JJ	amod	O
neovascularization	NN	nmod	O
due	JJ	case	O
to	TO	case	O
AMD	NN	nmod	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
verified	VBN	acl:relcl	O
by	IN	case	O
fluorescein	NN	compound	B-Simple_chemical
angiography	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubjpass	B-Organism
have	VBP	aux	O
been	VBN	auxpass	O
treated	VBN	ROOT	O
between	IN	prep	O
January	NNP	pobj	O
1996	CD	nummod	O
and	CC	cc	O
October	NNP	conj	O
1997	CD	nummod	O
.	.	punct	O

All	DT	det	O
patients	NNS	nsubj	B-Organism
received	VBD	ROOT	O
a	DT	det	O
total	JJ	amod	O
dose	NN	dobj	O
of	IN	case	O
16	CD	nummod	O
Gy	NN	nmod	O
in	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
Gy	NN	compound	O
daily	RB	amod	O
fractions	NNS	nmod	O
with	IN	case	O
5	CD	compound	O
-	SYM	punct	O
6	CD	nummod	O
MeV	NN	compound	O
photons	NNS	nmod	O
based	VBN	case	O
on	IN	case	O
computerized	VBN	amod	O
treatment	NN	nmod	O
planning	NN	acl	O
in	IN	prep	O
individual	JJ	amod	O
head	NN	compound	B-Organism_subdivision
mask	JJ	compound	O
fixation	NN	pobj	O
.	.	punct	O

This	DT	det	O
first	JJ	amod	O
analysis	NN	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
73	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
50	CD	nummod	O
women	NNS	dep	B-Organism
,	,	punct	O
23	CD	nummod	O
men	NNS	appos	B-Organism
,	,	punct	O
median	JJ	amod	O
age	NN	appos	O
74	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
years	NNS	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	prep	O
a	DT	det	O
median	JJ	amod	O
follow	NN	compound	O
-	HYPH	punct	O
up	NN	pobj	O
of	IN	prep	O
13	CD	pobj	O
.	.	punct	O
3	CD	nummod	O
months	NNS	ROOT	O
and	CC	cc	O
a	DT	det	O
minimum	JJ	amod	O
follow	NN	amod	O
-	HYPH	punct	O
up	NN	conj	O
of	IN	prep	O
11	CD	nummod	O
months	NNS	pobj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
All	DT	det	O
patients	NNS	nsubj	B-Organism
completed	VBD	dep	O
therapy	NN	dobj	O
and	CC	cc	O
tolerability	NN	conj	O
was	VBD	ROOT	O
good	JJ	acomp	O
.	.	punct	O

First	JJ	advmod	O
clinical	JJ	amod	O
control	NN	nsubjpass	O
with	IN	case	O
second	JJ	amod	O
angiography	NN	nmod	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
6	CD	nummod	O
weeks	NNS	npadvmod	O
after	IN	case	O
irradiation	NN	dep	O
,	,	punct	O
then	RB	advmod	O
in	IN	prep	O
3	CD	nummod	O
-	HYPH	punct	O
month	NN	compound	O
intervals	NNS	pobj	O
.	.	punct	O

Eighteen	CD	nummod	O
patients	NNS	nsubjpass	B-Organism
with	IN	case	O
SRNV	NN	nmod	O
refusing	VBG	acl	O
radiotherapy	NN	dobj	O
served	VBD	acl	O
as	IN	case	O
a	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
and	CC	cc	O
were	VBD	auxpass	O
matched	VBN	ROOT	O
with	IN	case	O
18	CD	nummod	O
irradiated	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

After	IN	case	O
7	CD	nummod	O
months	NNS	nmod	O
median	JJ	amod	O
visual	JJ	amod	O
acuity	NN	dobj	O
(	-LRB-	punct	O
VA	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
20	CD	nummod	O
/	SYM	punct	O
160	CD	ROOT	O
for	IN	case	O
the	DT	det	O
irradiated	JJ	nmod	O
and	CC	cc	O
20	CD	conj	O
/	SYM	punct	O
400	CD	dep	O
for	IN	case	O
the	DT	det	O
untreated	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

One	CD	nummod	O
year	NN	npadvmod	O
after	IN	mark	O
radiotherapy	NN	compound	O
final	JJ	amod	O
median	JJ	amod	O
VA	NN	nsubj	O
was	VBD	cop	O
20	CD	nummod	O
/	SYM	punct	O
400	CD	ROOT	O
in	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
16	CD	nummod	O
Gy	NN	nsubj	O
of	IN	prep	O
conventionally	RB	advmod	O
fractionated	VBN	amod	O
external	JJ	amod	O
beam	NN	compound	O
irradiation	NN	pobj	O
slows	VBZ	ccomp	O
down	IN	prt	O
the	DT	det	O
visual	JJ	amod	O
loss	NN	dobj	O
in	IN	case	O
exudative	JJ	amod	O
AMD	NN	nmod	O
for	IN	case	O
only	RB	advmod	O
a	DT	det	O
few	JJ	amod	O
months	NNS	nmod	O
.	.	punct	O

Patients	NNS	poss	B-Organism
'	POS	case	O
reading	VBG	compound	O
vision	NN	nsubjpass	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
saved	VBN	ROOT	O
for	IN	prep	O
a	DT	det	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
run	NN	pobj	O
.	.	punct	O

Increased	VBN	amod	O
serum	NN	compound	B-Organism_substance
levels	NNS	ROOT	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Neovascularization	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
event	NN	appos	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

One	CD	nummod	O
such	JJ	amod	O
factor	NN	nsubjpass	O
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
considered	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
a	DT	det	O
potent	JJ	amod	O
angiogenic	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
as	IN	mark	O
indicated	VBN	advcl	O
by	IN	case	O
immunohistochemical	JJ	amod	O
and	CC	cc	O
molecular	JJ	conj	O
evidence	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
serum	NN	compound	B-Organism_substance
VEGF	NN	compound	B-Gene_or_gene_product
level	NN	compound	O
(	-LRB-	punct	O
s	NNS	compound	O
-	:	punct	O
VEGF	NN	dobj	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
RCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

s	NNS	compound	O
-	HYPH	punct	O
VEGF	NN	nsubjpass	B-Gene_or_gene_product
in	IN	case	O
peripheral	JJ	amod	B-Organism_substance
blood	NN	compound	I-Organism_substance
samples	NNS	nmod	I-Organism_substance
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
40	CD	nummod	O
RCC	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
and	CC	cc	O
40	CD	nummod	O
patients	NNS	conj	B-Organism
without	IN	case	O
cancer	NN	nmod	B-Cancer
(	-LRB-	punct	O
controls	NNS	appos	O
)	-RRB-	punct	O
using	VBG	xcomp	O
a	DT	det	O
sandwich	JJ	amod	O
enzyme	NN	npadvmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunoassay	NN	dobj	O
.	.	punct	O

In	IN	case	O
20	CD	nummod	O
RCC	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
serum	NN	compound	B-Organism_substance
samples	NNS	nsubjpass	I-Organism_substance
were	VBD	auxpass	O
obtained	VBN	ROOT	O
separately	RB	advmod	O
from	IN	case	O
the	DT	det	O
bilateral	JJ	amod	B-Multi-tissue_structure
renal	JJ	amod	I-Multi-tissue_structure
veins	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
also	RB	advmod	O
measured	VBN	ROOT	O
before	RB	case	O
,	,	punct	O
4	CD	nummod	O
and	CC	cc	O
8	CD	conj	O
weeks	NNS	nmod	O
after	IN	case	O
nephrectomy	NN	nmod	O
in	IN	case	O
11	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
significant	JJ	amod	O
differences	NNS	nsubj	O
in	IN	case	O
s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nmod	B-Gene_or_gene_product
between	IN	case	O
the	DT	det	O
RCC	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
and	CC	cc	O
the	DT	det	O
controls	NNS	conj	O
(	-LRB-	punct	O
207	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
32	CD	nummod	O
.	.	punct	O
9	CD	npadvmod	O
vs	CC	cc	O
.	.	punct	O
71	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	ROOT	O
.	.	punct	O
1	CD	nummod	O
pg	TO	compound	O
/	SYM	punct	O
ml	NN	ROOT	O
,	,	punct	O
mean	NN	appos	O
+	CC	cc	O
/	SYM	punct	O
-	HYPH	punct	O
SE	NN	conj	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
005	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
tumor	NN	npadvmod	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
renal	JJ	amod	B-Multi-tissue_structure
veins	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
the	DT	det	O
contralateral	JJ	amod	O
ones	NNS	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
pre	JJ	compound	O
-	HYPH	punct	O
and	CC	cc	O
post	JJ	amod	O
-	HYPH	punct	O
nephrectomy	NN	conj	O
situations	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
among	IN	case	O
the	DT	det	O
various	JJ	amod	O
parameters	NNS	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
status	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	B-Cancer
extent	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
existence	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nsubj	B-Gene_or_gene_product
significantly	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
volume	NN	nmod	O
obtained	VBN	acl	O
by	IN	case	O
a	DT	det	O
three	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
measurement	NN	nmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
802	CD	dobj	O
,	,	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
0001	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
sensitivity	NN	nsubj	O
and	CC	cc	O
specificity	NN	conj	O
of	IN	case	O
s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nmod	B-Gene_or_gene_product
at	IN	prep	O
the	DT	det	O
cut	NN	pobj	O
-	HYPH	punct	O
off	RP	prep	O
level	NN	conj	O
of	IN	case	O
100	CD	nummod	O
pg	CC	compound	O
/	SYM	punct	O
ml	NN	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	acl	O
by	IN	case	O
the	DT	det	O
receiver	NN	compound	O
-	HYPH	punct	O
operating	NN	compound	O
-	HYPH	punct	O
characteristics	NNS	compound	O
curve	NN	nmod	O
,	,	punct	O
were	VBD	ROOT	O
80	CD	attr	O
.	.	punct	O
0	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
72	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
tumor	NN	compound	B-Tissue
tissue	NN	nsubj	I-Tissue
of	IN	case	O
RCC	NN	nmod	B-Cancer
liberates	VBZ	ccomp	O
VEGF	NN	dobj	B-Gene_or_gene_product
into	IN	case	O
the	DT	det	O
systemic	JJ	amod	O
blood	NN	compound	B-Organism_substance
flow	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
s	VBZ	compound	O
-	HYPH	punct	O
VEGF	NNP	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
possible	JJ	amod	O
marker	NN	conj	O
for	IN	case	O
RCC	NN	nmod	B-Cancer
.	.	punct	O

Insulin	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
expression	NN	ROOT	O
in	IN	case	O
retina	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
Clinical	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
intensive	JJ	amod	O
insulin	NN	compound	B-Gene_or_gene_product
therapy	NN	nsubj	O
causes	VBZ	ccomp	O
a	DT	det	O
transient	JJ	amod	O
worsening	NN	dobj	O
of	IN	prep	O
retinopathy	NN	pobj	O
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubj	O
underlying	VBG	acl	O
the	DT	det	O
initial	JJ	amod	O
insulin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
deterioration	NN	dobj	O
of	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
status	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
diabetes	NNS	nmod	O
remain	VBP	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
operative	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
diabetic	JJ	amod	O
retinopathy	NN	nmod	O
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
conducted	VBN	ROOT	O
to	TO	mark	O
characterize	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
VEGF	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
studies	NNS	nmod	O
of	IN	case	O
rat	NN	compound	B-Organism
retinal	JJ	amod	B-Multi-tissue_structure
VEGF	NN	compound	B-Gene_or_gene_product
transcripts	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
insulin	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	acl:relcl	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
human	JJ	amod	B-Organism
retinal	JJ	amod	B-Cell
pigment	NN	amod	I-Cell
epithelial	JJ	amod	I-Cell
(	-LRB-	punct	I-Cell
RPE	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
exposed	VBN	ROOT	O
to	TO	case	O
insulin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
quantified	VBN	conj	O
with	IN	case	O
RNase	NN	compound	B-Gene_or_gene_product
protection	NN	compound	O
assays	NNS	nmod	O
(	-LRB-	punct	O
RPAs	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Conditioned	JJ	amod	O
media	NNS	nsubjpass	O
from	IN	case	O
insulin	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
treated	VBN	amod	O
RPE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
assayed	VBN	ROOT	O
for	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
and	CC	cc	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	conj	O
.	.	punct	O

The	DT	det	O
capacity	NN	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
stimulate	VB	acl	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	dobj	O
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
luciferase	NN	compound	B-Gene_or_gene_product
reporter	NN	compound	O
gene	NN	nmod	O
was	VBD	auxpass	O
characterized	VBN	ROOT	O
in	IN	case	O
transient	JJ	amod	O
transfection	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Insulin	NN	nsubj	B-Gene_or_gene_product
increased	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
the	DT	det	O
ganglion	NN	nmod	B-Tissue
,	,	punct	O
inner	JJ	amod	B-Tissue
nuclear	JJ	conj	I-Tissue
,	,	punct	O
and	CC	cc	O
RPE	NN	compound	B-Tissue
cell	NN	compound	I-Tissue
layers	NNS	conj	I-Tissue
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
insulin	NN	nsubj	B-Gene_or_gene_product
increased	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
RPE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
enhanced	VBN	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
without	IN	mark	O
affecting	VBG	advcl	O
transcript	NN	compound	O
stability	NN	dobj	O
.	.	punct	O

Insulin	NN	compound	B-Gene_or_gene_product
treatment	NN	nsubj	O
also	RB	advmod	O
increased	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
conditioned	JJ	amod	O
RPE	NN	compound	B-Cell
cell	NN	compound	I-Cell
media	NNS	nmod	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
with	IN	case	O
a	DT	det	O
median	JJ	amod	O
effective	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
5	CD	nummod	O
nM	NN	nmod	O
.	.	punct	O

The	DT	det	O
insulin	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
conditioned	VBN	amod	O
RPE	NN	compound	B-Cell
cell	NN	compound	I-Cell
media	NNS	nsubj	O
stimulated	VBD	amod	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	ROOT	O
,	,	punct	O
an	DT	det	O
effect	NN	appos	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
completely	RB	advmod	O
blocked	VBN	acl:relcl	O
by	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
neutralizing	VBG	compound	O
antibody	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Insulin	NN	nsubj	B-Gene_or_gene_product
increases	VBZ	appos	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	dobj	O
and	CC	cc	O
secreted	VBN	amod	O
protein	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
RPE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
enhanced	VBN	amod	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Intensive	JJ	amod	O
insulin	NN	compound	B-Gene_or_gene_product
therapy	NN	nsubj	O
may	MD	aux	O
cause	VB	ROOT	O
a	DT	det	O
transient	JJ	amod	O
worsening	NN	dobj	O
of	IN	case	O
retinopathy	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
diabetes	NNS	nmod	O
through	IN	case	O
increased	VBN	amod	O
retinal	JJ	amod	B-Multi-tissue_structure
VEGF	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
antiangiogenic	JJ	amod	O
agent	NN	compound	O
linomide	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
the	DT	det	O
growth	NN	compound	O
rate	NN	dobj	O
of	IN	prep	O
von	NN	compound	B-Cancer
Hippel	NNP	compound	I-Cancer
-	HYPH	punct	I-Cancer
Lindau	NN	compound	I-Cancer
paraganglioma	NN	pobj	I-Cancer
xenografts	NNS	conj	I-Cancer
to	TO	prep	O
mice	NNS	pobj	B-Organism
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
ascertain	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
usefulness	NN	dobj	O
of	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
compound	NN	compound	O
linomide	NN	nmod	B-Simple_chemical
for	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
von	NN	compound	B-Cancer
Hippel	NNP	compound	I-Cancer
-	HYPH	punct	I-Cancer
Lindau	NNP	nmod:npmod	I-Cancer
(	-LRB-	punct	I-Cancer
VHL	NN	appos	I-Cancer
)	-RRB-	punct	I-Cancer
-	:	punct	I-Cancer
related	JJ	amod	I-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Paraganglioma	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
fragments	NNS	nsubj	I-Tissue
obtained	VBN	acl	O
at	IN	case	O
surgery	NN	nmod	O
from	IN	case	O
a	DT	det	O
VHL	NN	compound	O
type	NN	compound	O
2a	NN	compound	O
patient	NN	nmod	B-Organism
were	VBD	cop	O
transplanted	VBN	amod	O
s	NNS	ROOT	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
to	TO	case	O
male	JJ	amod	O
BALB	NN	compound	B-Organism
/	:	punct	I-Organism
c	NN	dep	I-Organism
nu	CC	dep	I-Organism
/	SYM	punct	I-Organism
nu	PRP	dep	I-Organism
(	-LRB-	punct	I-Organism
nude	JJ	appos	I-Organism
)	-RRB-	punct	I-Organism
mice	NNS	ROOT	I-Organism
:	:	punct	O
(	-LRB-	punct	O
a	LS	det	O
)	-RRB-	punct	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	nummod	O
-	HYPH	punct	O
mm	NN	amod	O
fragments	NNS	dep	O
for	IN	prep	O
"	``	punct	O
prevention	NN	nmod	O
"	''	punct	O
experiments	NNS	pobj	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
b	LS	conj	O
)	-RRB-	punct	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	nummod	O
-	HYPH	punct	O
mm	NN	dep	O
fragments	NNS	nsubj	O
allowed	VBN	acl:relcl	O
to	TO	mark	O
grow	VB	xcomp	O
to	IN	prep	O
1	CD	pobj	O
cm	NN	acl	O
for	IN	case	O
"	``	punct	O
intervention	NN	compound	O
"	''	punct	O
studies	NNS	nmod	O
.	.	punct	O

Both	DT	det	O
groups	NNS	nsubj	O
received	VBD	ROOT	O
either	CC	cc:preconj	O
0	CD	dobj	O
.	.	punct	O
5	CD	nummod	O
mg	NN	nummod	O
/	:	punct	O
ml	NN	compound	O
linomide	NN	nsubjpass	B-Simple_chemical
in	IN	prep	O
drinking	VBG	pcomp	O
water	NN	dobj	O
or	CC	cc	O
acidified	VBD	amod	O
water	NN	conj	O
and	CC	cc	O
were	VBD	auxpass	O
followed	VBN	ROOT	O
until	IN	case	O
tumor	NN	compound	B-Cancer
diameter	NN	nsubj	O
reached	VBD	ccomp	O
3	CD	nummod	O
cm	NN	dobj	O
or	CC	cc	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	conj	O
.	.	punct	O

In	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
prevention	NN	pobj	O
and	CC	cc	O
intervention	NN	conj	O
experiments	NNS	nmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
diminution	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cancer
size	NN	nmod	O
and	CC	cc	O
weight	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
drug	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
blood	NN	compound	B-Organism_substance
flow	NN	nmod	O
in	IN	case	O
linomide	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
showed	VBD	ROOT	O
localization	NN	dobj	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
almost	RB	advmod	O
exclusively	RB	advmod	O
to	TO	case	O
the	DT	det	O
periphery	NN	nmod	O
of	IN	case	O
the	DT	det	O
poorly	RB	advmod	O
vascularized	VBN	amod	O
tumors	NNS	nmod	B-Cancer
with	IN	case	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
vascular	JJ	amod	B-Multi-tissue_structure
functionality	NN	nmod	O
and	CC	cc	O
vasodilation	NN	conj	O
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
linomide	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
revealed	VBD	ROOT	O
marked	JJ	amod	O
avascularity	NN	dobj	O
.	.	punct	O

Treated	VBN	amod	O
animals	NNS	nsubj	O
also	RB	advmod	O
displayed	VBD	ROOT	O
a	DT	det	O
2	CD	nummod	O
.	.	punct	O
4	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
reduction	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
VHL	NN	compound	O
disease	NN	nmod	O
,	,	punct	O
therapy	NN	nsubj	O
directed	VBN	acl	O
at	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
constitutively	RB	advmod	O
expressed	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
induction	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	case	O
VHL	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
may	MD	aux	O
constitute	VB	ccomp	O
an	DT	det	O
effective	JJ	amod	O
medical	JJ	amod	O
treatment	NN	dobj	O
.	.	punct	O

LMP1	NN	nsubj	B-Gene_or_gene_product
of	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	nmod	I-Organism
induces	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
and	CC	cc	O
cooperatively	RB	advmod	O
transforms	VBZ	conj	O
the	DT	det	O
cells	NNS	dobj	B-Cell
with	IN	case	O
a	DT	det	O
p16	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
insensitive	JJ	amod	O
CDK4	NN	compound	B-Gene_or_gene_product
oncogene	NN	nmod	O
.	.	punct	O

The	DT	det	O
latent	JJ	amod	O
membrane	NN	compound	O
protein	NN	nsubj	O
LMP1	NN	dep	B-Gene_or_gene_product
of	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	nmod	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
is	VBZ	cop	O
often	RB	advmod	O
present	JJ	ROOT	O
in	IN	case	O
EBV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
associated	VBN	amod	O
malignancies	NNS	nmod	B-Cancer
including	VBG	case	O
nasopharyngeal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
Hodgkin	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	conj	I-Cancer
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
gene	NN	nsubj	O
of	IN	case	O
EBV	NN	nmod	B-Organism
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
transform	VB	xcomp	O
certain	JJ	amod	O
established	JJ	amod	O
rodent	JJ	amod	O
fibroblast	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
the	DT	det	O
tumorigenicity	NN	dobj	O
of	IN	case	O
some	DT	det	O
human	JJ	amod	B-Organism
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
LMP1	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ROOT	O
pleiotropic	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	compound	O
arrest	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
background	NN	advcl	O
of	IN	case	O
the	DT	det	O
target	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
LMP1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
growth	NN	compound	O
regulation	NN	conj	O
in	IN	case	O
primary	JJ	amod	B-Cell
culture	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
a	DT	det	O
recombinant	JJ	amod	O
retrovirus	NN	dobj	B-Organism
containing	VBG	acl	O
an	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
gene	NN	dobj	O
.	.	punct	O

With	IN	case	O
this	DT	det	O
retrovirus	NN	nmod	B-Organism
,	,	punct	O
LMP1	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
MEF	NN	compound	B-Cell
cells	NNS	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubj	O
has	VBZ	ROOT	O
a	DT	det	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
for	IN	case	O
MEF	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	IN	mark	O
demonstrated	VBN	advcl	O
by	IN	case	O
an	DT	det	O
immediate	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
doubling	VBG	compound	O
time	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
significantly	RB	advmod	O
extends	VBZ	ROOT	O
the	DT	det	O
passage	NN	compound	O
number	NN	dobj	O
of	IN	case	O
MEF	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
more	JJR	advmod	O
than	IN	mwe	O
30	CD	nmod	O
after	IN	case	O
retroviral	JJ	amod	B-Organism
infection	NN	nmod	O
,	,	punct	O
compared	VBN	advcl	O
with	IN	case	O
less	JJR	advmod	O
than	IN	mwe	O
5	CD	nmod	O
for	IN	case	O
uninfected	JJ	amod	O
MEF	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
LMP1	NN	nsubj	B-Gene_or_gene_product
cooperates	VBZ	ROOT	O
with	IN	case	O
a	DT	det	O
p16	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
insensitive	JJ	amod	O
CDK4	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
R24C	NN	compound	O
)	-RRB-	punct	O
oncogene	NN	nmod	O
in	IN	case	O
transforming	VBG	amod	O
MEF	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
evidence	NN	dobj	O
of	IN	case	O
the	DT	det	O
abilities	NNS	nmod	O
of	IN	case	O
the	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
acting	VBG	acl	O
alone	RB	advmod	O
,	,	punct	O
to	TO	mark	O
effectively	RB	advmod	O
induce	VB	advcl	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
MEF	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
of	IN	case	O
its	PRP$	nmod:poss	O
cooperativity	NN	conj	O
with	IN	case	O
another	DT	det	O
cellular	JJ	amod	B-Cell
oncogene	NN	nmod	O
in	IN	case	O
transforming	VBG	amod	O
primary	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Autotaxin	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
ATX	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
tumor	NN	compound	B-Cancer
motogen	NN	appos	O
,	,	punct	O
augments	VBZ	ROOT	O
invasive	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
potential	NN	dobj	O
of	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Autotaxin	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	O
ATX	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
exo	NN	compound	O
-	HYPH	punct	O
nucleotide	NN	compound	O
pyrophosphatase	NN	appos	O
and	CC	cc	O
phosphodiesterase	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
originally	RB	advmod	O
isolated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
stimulator	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
motility	NN	nmod	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
study	VB	advcl	O
whether	IN	mark	O
ATX	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
affects	VBZ	ccomp	O
motility	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
processes	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
stably	RB	advmod	O
transfected	VBD	ROOT	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
ATX	NN	compound	B-Gene_or_gene_product
cDNA	NN	dobj	O
into	IN	case	O
two	CD	nummod	O
non	JJ	amod	O
-	HYPH	punct	O
expressing	VBG	dep	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
parental	JJ	amod	O
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	dep	O
NIH3T3	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
clone7	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	appos	I-Cell
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
ATX	NN	compound	B-Gene_or_gene_product
secretion	NN	nmod	O
on	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	B-Cell
motility	NN	nmod	O
was	VBD	cop	O
variable	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
ras	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	dep	O
,	,	punct	O
ATX	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
secreting	NN	compound	O
subclones	NNS	conj	B-Cell
had	VBD	aux	O
enhanced	VBN	ROOT	O
motility	NN	dobj	O
to	TO	case	O
ATX	NN	nmod	B-Gene_or_gene_product
as	IN	case	O
chemoattractant	NN	nmod	O
,	,	punct	O
but	CC	cc	O
there	EX	expl	O
was	VBD	conj	O
little	JJ	amod	O
difference	NN	nsubj	O
in	IN	case	O
the	DT	det	O
motility	NN	compound	O
responses	NNS	nmod	O
of	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transfected	VBN	acl	O
with	IN	case	O
atx	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
inactive	JJ	amod	O
mutant	JJ	amod	O
gene	NN	appos	O
,	,	punct	O
or	CC	cc	O
empty	JJ	amod	O
vector	NN	conj	O
.	.	punct	O

In	IN	case	O
MatrigelTM	NN	compound	O
invasion	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
all	DT	det	O
subclones	NNS	nsubj	B-Cell
,	,	punct	O
which	WDT	nsubj	O
secreted	VBD	acl:relcl	O
enzymatically	RB	advmod	O
active	JJ	amod	O
ATX	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
demonstrated	VBD	ROOT	O
greater	JJR	amod	O
spontaneous	JJ	dep	O
and	CC	cc	O
ATX	NNP	conj	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
invasion	NN	dobj	O
than	IN	case	O
appropriate	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

This	DT	det	O
difference	NN	nsubjpass	O
in	IN	case	O
invasiveness	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
caused	VBN	ROOT	O
by	IN	case	O
differences	NNS	nmod	O
in	IN	case	O
gelatinase	NN	compound	B-Gene_or_gene_product
production	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
constant	JJ	acl:relcl	O
within	IN	case	O
each	DT	det	O
group	NN	nmod	O
of	IN	case	O
transfectants	NNS	nmod	B-Cell
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
with	IN	case	O
athymic	JJ	amod	B-Organism
nude	JJ	compound	I-Organism
mice	NNS	nmod	I-Organism
demonstrated	VBD	ROOT	O
that	IN	mark	O
injection	NN	nsubj	O
of	IN	case	O
atx	NN	advmod	B-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
resulted	VBD	ccomp	O
in	IN	case	O
a	DT	det	O
weak	JJ	amod	O
tumorigenic	JJ	amod	O
capacity	NN	nmod	O
with	IN	case	O
few	JJ	amod	O
experimental	JJ	amod	O
metastases	NNS	nmod	O
.	.	punct	O

Combination	NN	nsubj	O
of	IN	case	O
ATX	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
with	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
transformation	NN	nmod	O
produced	VBD	ROOT	O
cells	NNS	dobj	B-Cell
with	IN	case	O
greatly	RB	advmod	O
amplified	VBN	amod	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
potential	NN	conj	O
compared	VBN	case	O
to	TO	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
controls	NNS	advcl	B-Cell
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
ATX	NNP	nsubj	B-Gene_or_gene_product
appears	VBZ	ROOT	O
to	TO	mark	O
augment	VB	xcomp	O
cellular	JJ	amod	B-Cell
characteristics	NNS	dobj	O
necessary	JJ	amod	O
for	IN	case	O
tumor	NN	compound	B-Cancer
aggressiveness	NN	nmod	O
.	.	punct	O

Oncogenic	JJ	amod	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
mutants	NNS	ROOT	O
with	IN	case	O
tandem	JJ	amod	O
duplication	NN	nmod	O
:	:	punct	O
gene	NN	compound	O
structure	NN	dep	O
and	CC	cc	O
effects	NNS	conj	O
on	IN	case	O
receptor	NN	compound	O
function	NN	nmod	O
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
deletion	NN	compound	O
mutants	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
EGFR	NN	compound	B-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
amplified	VBN	parataxis	O
and	CC	cc	O
rearranged	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
characterized	VBN	ROOT	O
the	DT	det	O
structure	NN	dobj	O
of	IN	case	O
a	DT	det	O
gene	NN	nmod	O
in	IN	case	O
A	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
172	CD	nummod	I-Cell
human	JJ	amod	I-Cell
glioma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
a	DT	det	O
190	CD	compound	O
-	HYPH	punct	O
kDa	NN	compound	O
EGFR	NN	compound	B-Gene_or_gene_product
mutant	NN	dobj	O
with	IN	case	O
tandem	JJ	amod	O
duplication	NN	nmod	O
of	IN	case	O
the	DT	det	O
tyrosine	NN	compound	O
kinase	NN	nmod	O
(	-LRB-	punct	O
TK	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
calcium	NN	compound	B-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
internalization	NN	compound	O
(	-LRB-	punct	O
CAIN	NN	appos	O
)	-RRB-	punct	O
domains	NNS	conj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
185	CD	nummod	O
-	HYPH	punct	O
kDa	NN	amod	O
tandem	JJ	amod	O
duplication	NN	compound	O
mutant	NN	dobj	O
(	-LRB-	punct	O
TDM	NN	appos	O
)	-RRB-	punct	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
in	IN	case	O
KE	NN	nmod	B-Cell
and	CC	cc	O
A	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
1235	CD	nummod	I-Cell
glioma	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
along	IN	case	O
with	IN	case	O
certain	JJ	amod	O
functional	JJ	amod	O
characteristics	NNS	nmod	O
of	IN	case	O
the	DT	det	O
mutants	NNS	nmod	O
.	.	punct	O

The	DT	det	O
corresponding	JJ	amod	O
transcripts	NNS	nsubj	O
in	IN	case	O
KE	NN	nmod	B-Cell
and	CC	cc	O
A	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
1235	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
contain	VBP	ROOT	O
1053	CD	nummod	O
additional	JJ	amod	O
nucleotides	NNS	dobj	O
representing	VBG	acl	O
an	DT	det	O
in	IN	amod	O
-	HYPH	punct	O
frame	NN	compound	O
duplication	NN	dobj	O
of	IN	case	O
exons	NNS	nmod	O
18	CD	nummod	O
through	IN	case	O
25	CD	nmod	O
which	WDT	nsubj	O
encode	VBP	acl:relcl	O
the	DT	det	O
entire	JJ	amod	O
TK	NN	compound	O
region	NN	dobj	O
and	CC	cc	O
a	DT	det	O
portion	NN	conj	O
of	IN	case	O
the	DT	det	O
CAIN	NN	compound	O
domain	NN	nmod	O
.	.	punct	O

As	IN	case	O
with	IN	case	O
duplication	NN	nmod	O
of	IN	case	O
the	DT	det	O
entire	JJ	amod	O
TK	NN	nmod	O
/	:	punct	O
CAIN	NN	compound	O
region	NN	conj	O
(	-LRB-	punct	O
exons	NNS	dep	O
18	CD	nummod	O
-	SYM	punct	O
26	CD	nummod	O
)	-RRB-	punct	O
in	IN	case	O
A	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
172	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
duplication	NN	nsubjpass	O
of	IN	case	O
exons	NNS	nmod	O
18	CD	nummod	O
-	SYM	punct	O
25	CD	dep	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
genomic	JJ	amod	O
rearrangement	NN	nmod	O
between	IN	case	O
flanking	JJ	amod	O
introns	NNS	nmod	O
.	.	punct	O

Involved	JJ	amod	O
introns	NNS	nsubj	O
contain	VBP	ROOT	O
homology	NN	dobj	O
to	TO	case	O
recombination	NN	compound	O
signal	NN	compound	O
sequence	NN	compound	O
(	-LRB-	punct	O
RSS	NN	appos	O
)	-RRB-	punct	O
heptamers	NNS	nmod	O
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
V	NN	compound	O
(	-LRB-	punct	O
D	NN	compound	O
)	-RRB-	punct	O
J	NN	compound	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-Gene_or_gene_product
lymphocyte	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

In	IN	case	O
defined	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
both	DT	cc:preconj	O
oncogenic	JJ	amod	O
TDM	NNS	nsubjpass	O
are	VBP	auxpass	O
constitutively	RB	advmod	O
autophosphorylated	VBN	ROOT	O
and	CC	cc	O
inefficiently	RB	advmod	O
downregulated	VBN	conj	O
.	.	punct	O

High	NNP	amod	O
-	HYPH	punct	O
affinity	NN	compound	O
binding	NN	nsubjpass	O
is	VBZ	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
.	.	punct	O
TDM	NNS	ROOT	O
/	:	punct	O
18	CD	nummod	O
-	SYM	punct	O
26	CD	appos	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
t1	NN	nsubj	O
/	:	punct	O
2	CD	appos	O
of	IN	case	O
receptor	NN	compound	O
internalization	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
prolonged	JJ	advcl	O
.	.	punct	O

Ciprofloxacin	NN	nsubj	B-Simple_chemical
mediated	VBD	ROOT	O
cell	NN	compound	B-Cell
growth	NN	compound	O
inhibition	NN	dobj	O
,	,	punct	O
S	NN	compound	O
/	:	punct	O
G2	NN	compound	O
-	:	punct	O
M	NN	compound	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
transitional	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
bladder	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
.	.	punct	O

The	DT	det	O
second	JJ	amod	O
most	RBS	advmod	O
prevalent	JJ	amod	O
urological	JJ	amod	B-Cancer
malignancy	NN	nsubj	I-Cancer
in	IN	prep	O
middle	JJ	amod	O
aged	JJ	amod	O
and	CC	cc	O
elderly	JJ	conj	O
men	NNS	pobj	B-Organism
is	VBZ	ROOT	O
bladder	NN	compound	B-Cancer
cancer	NN	attr	I-Cancer
,	,	punct	O
with	IN	prep	O
90	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cases	NNS	nmod	O
being	VBG	cop	O
transitional	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	pobj	I-Cancer
.	.	punct	O

The	DT	det	O
success	NN	nsubjpass	O
of	IN	prep	O
current	JJ	amod	O
systemic	JJ	amod	O
and	CC	cc	O
intravesical	JJ	conj	O
therapeutic	JJ	amod	O
agents	NNS	pobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
cisplatin	NN	nmod	B-Simple_chemical
,	,	punct	O
thiotepa	NN	conj	B-Simple_chemical
,	,	punct	O
Adriamycin	NN	conj	B-Simple_chemical
,	,	punct	O
mitomycin	NN	compound	B-Simple_chemical
C	NN	conj	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
bacillus	NN	compound	B-Organism
Calmette	NNP	compound	I-Organism
-	HYPH	punct	I-Organism
Guerin	NNP	conj	I-Organism
,	,	punct	O
is	VBZ	auxpass	O
limited	VBN	ROOT	O
with	IN	prep	O
recurrence	NN	compound	O
rates	NNS	pobj	O
reduced	VBD	acl	O
to	IN	prep	O
17	CD	compound	O
-	HYPH	punct	O
44	CD	nummod	O
%	NN	pobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
most	JJS	nsubj	O
of	IN	case	O
these	DT	det	O
agents	NNS	nmod	O
require	VBP	ROOT	O
instrumentation	NN	dobj	O
of	IN	case	O
the	DT	det	O
urinary	JJ	amod	B-Organism_subdivision
tract	NN	nmod	I-Organism_subdivision
and	CC	cc	O
are	VBP	auxpass	O
delivered	VBN	conj	O
at	IN	case	O
a	DT	det	O
significant	JJ	amod	O
cost	NN	nmod	O
and	CC	cc	O
potential	JJ	amod	O
morbidity	NN	conj	O
to	TO	case	O
the	DT	det	O
patient	NN	nmod	B-Organism
.	.	punct	O

Fluroquinolone	NN	compound	B-Simple_chemical
antibiotics	NNS	ROOT	O
such	JJ	case	O
as	IN	mwe	O
ciprofloxacin	NN	nmod	B-Simple_chemical
,	,	punct	O
which	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
administered	VBN	acl:relcl	O
p	NN	dobj	O
.	.	punct	O
o	NN	nsubj	O
.	.	punct	O
,	,	punct	O
may	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
profound	JJ	amod	O
effect	NN	dobj	O
in	IN	case	O
bladder	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
management	NN	nmod	O
.	.	punct	O

This	DT	nsubjpass	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
based	VBN	ROOT	O
on	IN	case	O
limited	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
studies	NNS	nmod	O
on	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
derived	VBN	acl	O
from	IN	case	O
transitional	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
bladder	NN	nmod	B-Organ
that	WDT	nsubj	O
revealed	VBD	acl:relcl	O
a	DT	det	O
dose	NN	compound	O
-	HYPH	punct	O
and	CC	cc	O
time	NN	npadvmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
inhibition	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
by	IN	case	O
ciprofloxacin	NN	nmod	B-Simple_chemical
at	IN	case	O
concentrations	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
easily	RB	advmod	O
attainable	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
urine	NN	nmod	B-Organism_substance
of	IN	case	O
patients	NNS	nmod	B-Organism
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
ciprofloxacin	NN	nsubj	B-Simple_chemical
elicits	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
biological	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
bladder	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
not	RB	neg	O
well	RB	advmod	O
documented	VBN	ROOT	O
.	.	punct	O

Our	PRP$	nmod:poss	O
experimental	JJ	amod	O
data	NNS	nsubj	O
confirm	VBP	ROOT	O
previous	JJ	amod	O
studies	NNS	dobj	O
showing	VBG	acl	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	B-Cell
growth	NN	compound	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
transitional	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
bladder	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
HTB9	NN	nmod	I-Cell
and	CC	cc	O
further	RB	advmod	O
showed	VBD	conj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
at	IN	case	O
the	DT	det	O
S	NN	compound	O
/	:	punct	O
G2	NN	compound	O
-	:	punct	O
M	NN	nmod	O
checkpoints	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
down	RB	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
cyclin	NN	compound	B-Gene_or_gene_product
E	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
dephosphorylation	NN	conj	O
of	IN	case	O
cdk2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
ciprofloxacin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
bladder	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
also	RB	advmod	O
an	DT	det	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	attr	O
of	IN	prep	O
Bax	NN	pobj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
altered	VBD	relcl	O
the	DT	det	O
Bax	NN	dobj	B-Gene_or_gene_product
:	:	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
ratio	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
responsible	JJ	relcl	O
for	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
depolarization	NN	nmod	O
reported	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
prior	RB	case	O
to	TO	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
cyclin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
inhibitor	NN	compound	O
p21WAF1	JJ	compound	B-Gene_or_gene_product
level	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
decreased	VBN	xcomp	O
within	IN	case	O
12	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
ciprofloxacin	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
and	CC	cc	O
disappeared	VBD	conj	O
completely	RB	advmod	O
when	WRB	advmod	O
HTB9	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
200	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
ml	NN	compound	O
ciprofloxacin	NN	nmod	B-Simple_chemical
for	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

The	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
p21WAF1	JJ	nmod	B-Gene_or_gene_product
closely	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
poly	NN	amod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ADP	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ribose	NN	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
polymerase	NN	compound	I-Gene_or_gene_product
cleavage	NN	nmod	O
and	CC	cc	O
CPP32	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
p21WAF1	JJ	nsubj	B-Gene_or_gene_product
protects	VBZ	ccomp	O
cells	NNS	dobj	B-Cell
from	IN	case	O
apoptosis	NN	nmod	O
by	IN	mark	O
arresting	VBG	advcl	O
them	PRP	dobj	O
in	IN	case	O
G1	NN	nmod	O
and	CC	cc	O
further	RB	advmod	O
binds	VBZ	conj	O
to	TO	case	O
pro	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
caspase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
preventing	VBG	advcl	O
its	PRP$	nmod:poss	O
activation	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
,	,	punct	O
inhibiting	VBG	advcl	O
the	DT	det	O
apoptotic	JJ	amod	O
cascade	NN	dobj	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
the	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
p21WAF1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
alterations	NNS	nmod	O
in	IN	case	O
Bax	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
cdk2	NN	conj	B-Gene_or_gene_product
as	IN	mark	O
observed	VBN	acl	O
in	IN	case	O
our	PRP$	nmod:poss	O
studies	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
define	VB	ROOT	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ciprofloxacin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	acl:relcl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
our	PRP$	nmod:poss	O
current	JJ	amod	O
studies	NNS	nmod	O
provide	VBP	ROOT	O
strong	JJ	amod	O
experimental	JJ	amod	O
evidence	NN	dobj	O
for	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
ciprofloxacin	NN	nmod	B-Simple_chemical
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
preventive	JJ	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
therapeutic	JJ	conj	O
agent	NN	dep	O
for	IN	case	O
the	DT	det	O
management	NN	nmod	O
of	IN	case	O
transitional	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	prep	O
the	DT	det	O
bladder	NN	pobj	B-Organ
.	.	punct	O

Vascular	JJ	amod	B-Multi-tissue_structure
proliferation	NN	ROOT	O
and	CC	cc	O
enhanced	VBN	amod	O
expression	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Gene_or_gene_product
nitric	JJ	amod	I-Gene_or_gene_product
oxide	NN	compound	I-Gene_or_gene_product
synthase	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
peritoneum	NN	nmod	B-Multi-tissue_structure
exposed	VBN	acl	O
to	IN	prep	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
peritoneal	JJ	compound	B-Multi-tissue_structure
dialysis	NN	pobj	O
.	.	punct	O

Long	JJ	compound	O
-	HYPH	punct	O
term	NN	compound	O
peritoneal	NN	compound	B-Multi-tissue_structure
dialysis	NN	nsubjpass	O
(	-LRB-	punct	O
PD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
permeability	NN	nmod	O
and	CC	cc	O
loss	NN	conj	O
of	IN	prep	O
ultrafiltration	NN	pobj	O
.	.	punct	O

These	DT	det	O
changes	NNS	nsubj	O
originate	VBP	ROOT	O
from	IN	prep	O
increased	VBN	amod	O
peritoneal	JJ	amod	B-Immaterial_anatomical_entity
surface	NN	compound	I-Immaterial_anatomical_entity
area	NN	pobj	I-Immaterial_anatomical_entity
,	,	punct	O
but	CC	cc	O
the	DT	det	O
morphologic	JJ	amod	O
and	CC	cc	O
molecular	JJ	conj	O
mechanisms	NNS	nsubj	O
involved	VBN	acl	O
remain	VBP	conj	O
unknown	JJ	xcomp	O
.	.	punct	O

The	DT	det	O
hypothesis	NN	nsubjpass	O
that	IN	mark	O
modifications	NNS	nsubj	O
of	IN	case	O
activity	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
expression	NN	conj	O
of	IN	case	O
nitric	JJ	amod	B-Gene_or_gene_product
oxide	NN	compound	I-Gene_or_gene_product
synthase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
NOS	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
isozymes	NNS	nmod	O
might	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
these	DT	det	O
modifications	NNS	nmod	O
,	,	punct	O
via	IN	case	O
enhanced	VBN	amod	O
local	JJ	amod	O
production	NN	nmod	O
of	IN	case	O
nitric	JJ	amod	B-Simple_chemical
oxide	NN	nmod	I-Simple_chemical
,	,	punct	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
.	.	punct	O

NOS	NN	compound	B-Gene_or_gene_product
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
L	NNP	compound	O
-	HYPH	punct	O
citrulline	NN	compound	O
assay	NN	nmod	O
in	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
biopsies	NNS	nmod	I-Multi-tissue_structure
from	IN	case	O
seven	CD	nummod	O
control	JJ	amod	O
subjects	NNS	nmod	O
,	,	punct	O
eight	CD	nummod	O
uremic	JJ	amod	O
patients	NNS	nsubj	B-Organism
immediately	RB	advmod	O
before	IN	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
PD	NN	nmod	O
,	,	punct	O
and	CC	cc	O
13	CD	nummod	O
uremic	JJ	amod	O
patients	NNS	conj	B-Organism
on	IN	case	O
short	JJ	amod	O
-	HYPH	punct	O
term	NN	nmod	O
(	-LRB-	punct	O
less	JJR	advmod	O
than	IN	quantmod	O
18	CD	nummod	O
mo	NN	dep	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	parataxis	O
6	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	conj	O
(	-LRB-	punct	O
greater	JJR	advmod	O
than	IN	quantmod	O
18	CD	nummod	O
mo	NN	appos	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	dep	O
7	CD	dep	O
)	-RRB-	punct	O
PD	NN	dobj	O
.	.	punct	O

Peritoneal	JJ	amod	B-Multi-tissue_structure
NOS	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	ROOT	O
fivefold	RB	advmod	O
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	compound	O
patients	NNS	nmod	B-Organism
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
subjects	NNS	advcl	O
.	.	punct	O

In	IN	case	O
uremic	JJ	amod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
NOS	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
positively	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
duration	NN	nmod	O
of	IN	case	O
PD	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
NOS	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
solely	RB	advmod	O
by	IN	case	O
Ca	NN	nmod	O
(	-LRB-	punct	O
2	CD	nummod	O
+	CC	cc	O
)	-RRB-	punct	O
-	:	punct	O
dependent	JJ	amod	O
NOS	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
immunoblotting	NN	nmod	O
,	,	punct	O
an	DT	det	O
upregulation	NN	appos	O
of	IN	case	O
endothelial	JJ	amod	B-Gene_or_gene_product
NOS	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
biologic	JJ	amod	O
relevance	NN	nsubjpass	O
of	IN	case	O
increased	VBN	amod	O
NOS	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	nmod	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
enhanced	VBN	amod	O
nitrotyrosine	NN	compound	B-Simple_chemical
immunoreactivity	NN	nmod	O
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
density	NN	nmod	O
and	CC	cc	O
endothelial	JJ	amod	B-Tissue
area	NN	conj	I-Tissue
in	IN	prep	O
the	DT	det	O
peritoneum	NN	pobj	B-Multi-tissue_structure
.	.	punct	O

Immunoblotting	NN	amod	O
and	CC	cc	O
immunostaining	JJ	conj	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
an	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
mostly	RB	advmod	O
along	IN	case	O
the	DT	det	O
endothelium	NN	compound	B-Tissue
lining	JJ	compound	O
peritoneal	JJ	amod	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	compound	O
patients	NNS	nmod	B-Organism
.	.	punct	O

In	IN	case	O
the	DT	det	O
latter	JJ	nmod	O
,	,	punct	O
VEGF	NNP	nsubj	B-Gene_or_gene_product
colocalized	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
advanced	JJ	amod	O
glycation	NN	compound	O
end	NN	compound	O
product	NN	compound	O
pentosidine	NN	compound	B-Simple_chemical
deposits	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
a	DT	det	O
morphologic	JJ	amod	O
(	-LRB-	punct	O
angiogenesis	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
endothelial	JJ	amod	B-Tissue
area	NN	conj	I-Tissue
)	-RRB-	punct	O
and	CC	cc	O
molecular	JJ	amod	O
(	-LRB-	punct	O
enhanced	VBN	amod	O
NOS	NN	compound	B-Gene_or_gene_product
activity	NN	conj	O
and	CC	cc	O
endothelial	JJ	amod	B-Gene_or_gene_product
NOS	NN	compound	I-Gene_or_gene_product
upregulation	NN	conj	O
)	-RRB-	punct	O
basis	NN	dobj	O
for	IN	mark	O
explaining	VBG	acl	O
the	DT	det	O
permeability	NN	compound	O
changes	NNS	dobj	O
observed	VBN	acl	O
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	nmod	O
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
support	VBP	ROOT	O
the	DT	det	O
implication	NN	dobj	O
of	IN	case	O
local	JJ	amod	O
advanced	JJ	amod	O
glycation	NN	compound	O
end	NN	compound	O
product	NN	compound	O
deposits	NNS	nmod	O
and	CC	cc	O
liberation	NN	conj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
that	DT	det	O
process	NN	nmod	O
.	.	punct	O

Active	JJ	amod	O
hair	NN	compound	B-Multi-tissue_structure
growth	NN	nsubjpass	O
(	-LRB-	punct	O
anagen	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

After	IN	ROOT	O
the	DT	det	O
completion	NN	pobj	O
of	IN	prep	O
skin	NN	compound	B-Organ
development	NN	pobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
i	LS	intj	O
.	.	punct	O
e	LS	npadvmod	O
.	.	punct	O
,	,	punct	O
the	DT	det	O
growth	NN	nsubjpass	O
of	IN	prep	O
new	JJ	amod	O
capillaries	NNS	pobj	B-Tissue
from	IN	prep	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
existing	VBG	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	pobj	I-Multi-tissue_structure
,	,	punct	O
is	VBZ	auxpass	O
held	VBN	ROOT	O
to	TO	aux	O
occur	VB	xcomp	O
in	IN	prep	O
the	DT	det	O
skin	NN	pobj	B-Organ
only	RB	advmod	O
under	IN	prep	O
pathologic	JJ	amod	O
conditions	NNS	pobj	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
long	RB	advmod	O
been	VBN	auxpass	O
noted	VBN	ROOT	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
that	IN	mark	O
hair	NN	compound	B-Multi-tissue_structure
follicle	NN	compound	I-Multi-tissue_structure
cycling	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
prominent	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
skin	NN	compound	B-Organ
perfusion	NN	nmod	O
,	,	punct	O
that	IN	mark	O
the	DT	det	O
epithelial	JJ	amod	B-Tissue
hair	NN	compound	I-Tissue
bulbs	NN	nsubj	I-Tissue
of	IN	case	O
anagen	NN	compound	B-Multi-tissue_structure
follicles	NNS	nmod	I-Multi-tissue_structure
display	VBP	ccomp	O
angiogenic	JJ	amod	O
properties	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
follicular	JJ	amod	B-Tissue
dermal	JJ	amod	I-Tissue
papilla	NN	nsubj	I-Tissue
can	MD	aux	O
produce	VB	conj	O
angiogenic	JJ	amod	O
factors	NNS	dobj	O
.	.	punct	O

Despite	IN	case	O
these	DT	det	O
suggestive	JJ	amod	O
observations	NNS	nmod	O
,	,	punct	O
no	DT	neg	O
formal	JJ	amod	O
proof	NN	nsubj	O
is	VBZ	cop	O
as	RB	advmod	O
yet	RB	advmod	O
available	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
concept	NN	nmod	O
that	IN	mark	O
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
physiologic	JJ	amod	O
event	NN	ccomp	O
that	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
all	DT	advmod	O
over	IN	case	O
the	DT	det	O
mature	JJ	amod	O
mammalian	JJ	amod	O
integument	NN	nmod	O
whenever	WRB	advmod	O
hair	NN	compound	B-Multi-tissue_structure
follicles	NNS	compound	I-Multi-tissue_structure
switch	VBP	dep	O
from	IN	case	O
resting	VBG	amod	O
(	-LRB-	punct	O
telogen	NN	nmod	O
)	-RRB-	punct	O
to	TO	case	O
active	JJ	amod	O
growth	NN	nmod	O
(	-LRB-	punct	O
anagen	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
uses	VBZ	ROOT	O
quantitative	JJ	amod	O
histomorphometry	NN	dobj	O
and	CC	cc	O
double	JJ	amod	O
-	HYPH	punct	O
immunohistologic	JJ	amod	O
detection	NN	compound	O
techniques	NNS	conj	O
for	IN	case	O
the	DT	det	O
demarcation	NN	nmod	O
of	IN	case	O
proliferating	VBG	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
to	TO	mark	O
show	VB	advcl	O
that	IN	mark	O
synchronized	VBN	amod	O
hair	NN	compound	B-Multi-tissue_structure
follicle	NN	compound	I-Multi-tissue_structure
cycling	NN	nsubjpass	O
in	IN	case	O
adolescent	JJ	amod	O
C57BL	NN	nmod	B-Organism
/	SYM	punct	I-Organism
6	CD	nummod	I-Organism
mice	NNS	nsubjpass	I-Organism
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
substantial	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	nsubj	O
inhibiting	VBG	acl	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	case	O
the	DT	det	O
intraperitoneal	JJ	amod	B-Immaterial_anatomical_entity
application	NN	nmod	O
of	IN	case	O
a	DT	det	O
fumagillin	NN	compound	B-Simple_chemical
derivative	JJ	amod	I-Simple_chemical
retards	NNS	nmod	O
experimentally	RB	advmod	O
induced	VBD	conj	O
anagen	NN	compound	B-Multi-tissue_structure
development	NN	dobj	O
in	IN	case	O
these	DT	det	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
physiologic	JJ	amod	O
event	NN	advcl	O
in	IN	case	O
normal	JJ	amod	O
postnatal	JJ	amod	O
murine	JJ	amod	B-Organism
skin	NN	nmod	B-Organ
,	,	punct	O
apparently	RB	advmod	O
is	VBZ	auxpass	O
dictated	VBN	ROOT	O
by	IN	agent	O
the	DT	det	O
hair	NN	compound	B-Multi-tissue_structure
follicle	NN	pobj	I-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
appears	VBZ	conj	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
normal	JJ	amod	O
anagen	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Anagen	NNP	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	nsubj	O
offers	VBZ	ROOT	O
an	DT	det	O
attractive	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
identifying	VBG	acl	O
the	DT	det	O
physiologic	JJ	amod	O
controls	NNS	dobj	O
of	IN	case	O
cutaneous	JJ	amod	B-Organism_subdivision
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
interesting	JJ	amod	O
system	NN	conj	O
for	IN	mark	O
screening	VBG	acl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
potential	JJ	amod	O
antiangiogenic	JJ	amod	O
drugs	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Neuroblastoma	NN	nmod	B-Cancer
and	CC	cc	O
hepatocyte	NN	conj	B-Cell
coculture	NN	nsubj	O
conditioned	VBD	ROOT	O
media	NNS	compound	O
alter	VBP	compound	O
apoptosis	NN	dobj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Neuroblastoma	NN	nsubj	B-Cancer
is	VBZ	cop	O
a	DT	det	O
childhood	NN	compound	O
tumor	NN	appos	B-Cancer
that	WDT	nsubj	O
often	RB	advmod	O
displays	VBZ	acl:relcl	O
unusual	JJ	amod	O
biological	JJ	amod	O
behavior	NN	dobj	O
.	.	punct	O

The	DT	det	O
tumor	NN	nsubj	B-Cancer
may	MD	aux	O
present	VB	ROOT	O
with	IN	case	O
widespread	JJ	amod	O
metastases	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
unresponsive	JJ	acl:relcl	O
to	TO	case	O
aggressive	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O

At	IN	prep	O
other	JJ	amod	O
times	NNS	pobj	O
,	,	punct	O
both	CC	preconj	O
the	DT	det	O
metastases	NNS	nsubj	O
and	CC	cc	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	conj	B-Cancer
may	MD	aux	O
spontaneously	RB	advmod	O
regress	VB	ROOT	O
without	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
,	,	punct	O
or	CC	cc	O
programmed	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
,	,	punct	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
dichotomous	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
neuroblastoma	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
hypothesize	VBP	ROOT	O
that	IN	mark	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
will	MD	aux	O
interact	VB	ccomp	O
with	IN	case	O
host	NN	compound	O
tissues	NNS	nmod	B-Tissue
to	TO	mark	O
release	VB	xcomp	O
mediators	NNS	dobj	O
that	WDT	nsubj	O
affect	VBP	acl:relcl	O
apoptosis	NN	dobj	O
.	.	punct	O

MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Human	JJ	amod	B-Organism
neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
and	CC	cc	O
human	JJ	amod	B-Organism
Chang	NN	compound	B-Cell
hepatocytes	NNS	conj	I-Cell
are	VBP	auxpass	O
grown	VBN	appos	O
in	IN	prep	O
a	DT	det	O
noncontact	NN	pobj	O
,	,	punct	O
coculture	NN	compound	O
system	NN	pobj	O
.	.	punct	O

After	IN	case	O
incubation	NN	nmod	O
for	IN	case	O
4	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
the	DT	det	O
medium	NN	nsubjpass	O
from	IN	prep	O
the	DT	det	O
coculture	NN	compound	O
system	NN	pobj	O
is	VBZ	auxpass	O
collected	VBN	ROOT	O
.	.	punct	O

Neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
and	CC	cc	O
Chang	NN	compound	B-Cell
hepatocytes	NNS	conj	I-Cell
are	VBP	auxpass	O
then	RB	advmod	O
plated	VBN	ROOT	O
separately	RB	advmod	O
with	IN	case	O
the	DT	det	O
conditioned	JJ	amod	O
medium	NN	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
own	JJ	amod	O
standard	JJ	amod	O
growth	NN	compound	O
medium	NN	conj	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

After	IN	case	O
4	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
these	DT	det	O
cells	NNS	nsubj	B-Cell
are	VBP	cop	O
harvested	VBN	ROOT	O
and	CC	cc	O
cytospins	NNS	conj	O
made	VBN	acl	O
for	IN	prep	O
immunostaining	NN	pobj	O
.	.	punct	O

Tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
are	VBP	auxpass	O
measured	VBN	ROOT	O
with	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
is	VBZ	auxpass	O
detected	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
TUNEL	NN	compound	O
method	NN	nmod	O
.	.	punct	O

Immunostaining	NN	amod	O
data	NNS	nsubjpass	O
are	VBP	auxpass	O
interpreted	VBN	ROOT	O
with	IN	case	O
computer	NN	compound	O
image	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
reported	VBN	conj	O
as	IN	case	O
stain	NN	compound	O
index	NN	nmod	O
.	.	punct	O

TUNEL	NN	compound	O
data	NNS	nsubjpass	O
are	VBP	auxpass	O
reported	VBN	ROOT	O
as	IN	case	O
percentage	NN	compound	O
apoptotic	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

All	DT	det	O
data	NNS	nsubjpass	O
are	VBP	auxpass	O
reported	VBN	ROOT	O
as	IN	case	O
means	NNS	compound	O
+	CC	cc	O
/	SYM	punct	O
-	HYPH	punct	O
SEM	NNP	nmod	O
.	.	punct	O

Statistical	JJ	amod	O
analysis	NN	nsubjpass	O
is	VBZ	auxpass	O
performed	VBN	ROOT	O
and	CC	cc	O
P	NN	compound	O
<	ADD	conj	O
0	CD	nummod	O
.	.	punct	O
05	CD	nsubj	O
considered	VBN	ROOT	O
significant	JJ	xcomp	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Chang	NN	compound	B-Cell
hepatocytes	NNS	nsubj	I-Cell
grown	VBN	acl	O
in	IN	prep	O
the	DT	det	O
coculture	NN	pobj	O
conditioned	JJ	amod	O
media	NNS	npadvmod	O
have	VBP	appos	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
have	VBP	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
apoptotic	JJ	amod	O
hepatocytes	NNS	nmod	B-Cell
when	WRB	advmod	O
they	PRP	nsubjpass	O
are	VBP	auxpass	O
cultured	VBN	advcl	O
in	IN	prep	O
the	DT	det	O
conditioned	JJ	amod	O
media	NNS	pobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
grown	VBN	acl	O
in	IN	case	O
the	DT	det	O
coculture	NN	nmod	O
conditioned	JJ	amod	O
media	NNS	dep	O
show	VBP	ROOT	O
no	DT	neg	O
increase	NN	dobj	O
in	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
cultured	VBN	acl	O
in	IN	case	O
the	DT	det	O
conditioned	JJ	amod	O
media	NNS	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Neuroblastoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
grown	VBN	acl	O
in	IN	case	O
coculture	NN	compound	O
conditioned	JJ	amod	O
media	NNS	nmod	O
show	VBP	appos	O
increased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
Bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
decreased	VBN	amod	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	compound	I-Gene_or_gene_product
levels	NNS	dobj	O
.	.	punct	O

These	DT	det	O
changes	NNS	nsubj	O
should	MD	aux	O
diminish	VB	ROOT	O
apoptosis	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
conditioned	JJ	amod	O
media	NNS	nsubj	O
induce	VBP	ROOT	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
proapoptotic	JJ	amod	O
mediators	NNS	nmod	O
in	IN	case	O
the	DT	det	O
Chang	NNP	compound	O
hepatocytes	NNS	nmod	B-Cell
.	.	punct	O

A	DT	det	O
tumor	NN	compound	B-Cancer
'	POS	punct	O
s	NNS	compound	O
ability	NN	nsubj	O
to	TO	case	O
successfully	RB	advmod	O
metastasize	VB	acl	O
may	MD	aux	O
be	VB	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
mediators	NNS	nmod	O
generated	VBN	acl	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
host	NN	compound	O
interaction	NN	nmod	O
,	,	punct	O
and	CC	cc	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
just	RB	advmod	O
an	DT	det	O
independent	JJ	amod	O
characteristic	NN	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
itself	PRP	dep	O
.	.	punct	O

Neoplastic	JJ	amod	O
transformation	NN	nsubj	O
by	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
requires	VBZ	ROOT	O
nuclear	JJ	amod	B-Cellular_component
localization	NN	dobj	O
.	.	punct	O

Notch	NN	compound	B-Gene_or_gene_product
proteins	NNS	nsubj	O
are	VBP	cop	O
plasma	NN	compound	B-Cellular_component
membrane	NN	nmod:npmod	I-Cellular_component
-	HYPH	punct	O
spanning	VBG	amod	O
receptors	NNS	ROOT	O
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
important	JJ	amod	O
cell	NN	compound	B-Cell
fate	NN	compound	O
decisions	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
differentiation	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
remains	VBZ	ROOT	O
poorly	RB	advmod	O
understood	VBN	xcomp	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
clear	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nsubj	O
mediates	VBZ	ccomp	O
its	PRP$	nmod:poss	O
effects	NNS	dobj	O
through	IN	case	O
intercellular	JJ	amod	O
contact	NN	nmod	O
between	IN	case	O
neighboring	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
prevailing	VBG	amod	O
model	NN	nsubj	O
for	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
ligand	NN	nsubj	O
,	,	punct	O
presented	VBN	acl	O
on	IN	case	O
a	DT	det	O
neighboring	JJ	amod	O
cell	NN	nmod	B-Cell
,	,	punct	O
triggers	VBZ	ccomp	O
proteolytic	JJ	amod	O
processing	NN	dobj	O
of	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Following	VBG	case	O
proteolysis	NN	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
portion	NN	nsubj	O
of	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
N	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
)	-RRB-	punct	O
translocates	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
,	,	punct	O
where	WRB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	mark	O
regulating	VBG	advcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
considerable	JJ	amod	O
debate	NN	attr	O
concerning	VBG	acl	O
where	WRB	pcomp	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
Notch	NN	compound	B-Gene_or_gene_product
functions	NNS	nmod	O
and	CC	cc	O
what	WP	dobj	O
proteins	NNS	nsubj	O
serve	VBP	conj	O
as	IN	prep	O
effectors	NNS	pobj	O
of	IN	case	O
the	DT	det	O
Notch	NN	compound	B-Gene_or_gene_product
signal	NN	nmod	O
.	.	punct	O

Several	JJ	amod	O
Notch	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubjpass	O
have	VBP	aux	O
clearly	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
proto	JJ	compound	O
-	HYPH	punct	O
oncogenes	NNS	xcomp	O
in	IN	case	O
mammalian	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	HYPH	punct	O
oncogenes	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
tumorigenesis	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
human	JJ	nmod	B-Organism
and	CC	cc	O
other	JJ	amod	O
mammalian	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

Transforming	VBG	amod	O
alleles	NNS	nsubj	O
of	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
direct	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
truncated	VBN	amod	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
primarily	RB	advmod	O
consist	VBP	acl:relcl	O
of	IN	case	O
N	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
are	VBP	auxpass	O
not	RB	neg	O
tethered	VBN	conj	O
to	TO	case	O
the	DT	det	O
plasma	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubjpass	O
by	IN	case	O
which	WDT	nmod	O
Notch	NN	compound	B-Gene_or_gene_product
oncoproteins	NNS	nsubj	O
(	-LRB-	punct	O
generically	RB	advmod	O
termed	VBN	acl	O
here	RB	advmod	O
as	IN	case	O
N	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
)	-RRB-	punct	O
induce	VBP	acl:relcl	O
neoplastic	JJ	amod	O
transformation	NN	dobj	O
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

Previously	RB	advmod	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
N1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
N2	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
could	MD	aux	O
transform	VB	ccomp	O
E1A	NN	compound	B-Gene_or_gene_product
immortalized	JJ	amod	O
baby	NN	compound	O
rat	NN	compound	B-Organism
kidney	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
(	-LRB-	punct	O
RKE	NN	appos	B-Cell
)	-RRB-	punct	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
report	VBP	ROOT	O
direct	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
N1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
must	MD	aux	O
accumulate	VB	ccomp	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
to	TO	mark	O
induce	VB	xcomp	O
transformation	NN	dobj	O
of	IN	case	O
RKE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
define	VBP	ROOT	O
the	DT	det	O
minimal	JJ	amod	O
domain	NN	dobj	O
of	IN	case	O
N1	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
required	VBN	acl	O
to	TO	mark	O
induce	VB	xcomp	O
transformation	NN	dobj	O
and	CC	cc	O
present	JJ	amod	O
evidence	NN	conj	O
that	IN	mark	O
transformation	NN	nsubj	O
of	IN	case	O
RKE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
N1	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
is	VBZ	cop	O
likely	JJ	ccomp	O
to	TO	mark	O
be	VB	cop	O
through	IN	case	O
a	DT	det	O
CBF1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
independent	JJ	amod	O
pathway	NN	xcomp	O
.	.	punct	O

Alpha	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
melanocyte	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	VBG	amod	I-Gene_or_gene_product
hormone	NN	nsubj	I-Gene_or_gene_product
modulates	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
AP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
dermal	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

Alpha	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
melanocyte	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	VBG	amod	I-Gene_or_gene_product
hormone	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
evolved	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
mediator	NN	nmod	O
of	IN	case	O
diverse	JJ	amod	O
biological	JJ	amod	O
activities	NNS	nmod	O
in	IN	case	O
an	DT	det	O
ever	RB	advmod	O
-	HYPH	punct	O
growing	VBG	amod	O
number	NN	nmod	O
of	IN	prep	O
non	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
melanocytic	JJ	amod	I-Cell
cell	NN	compound	I-Cell
types	NNS	pobj	O
.	.	punct	O

One	CD	nummod	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nsubj	I-Gene_or_gene_product
exerts	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
effects	NNS	dobj	O
is	VBZ	cop	O
modulation	NN	ROOT	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
two	CD	nummod	O
transcription	NN	compound	O
factors	NNS	nsubj	O
also	RB	advmod	O
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
,	,	punct	O
in	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
composition	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
cytokine	NN	compound	O
expression	NN	conj	O
.	.	punct	O

By	IN	case	O
use	NN	nmod	O
of	IN	case	O
electric	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	appos	O
)	-RRB-	punct	O
to	TO	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	:	punct	O
14	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
)	-RRB-	punct	O
activates	VBZ	ccomp	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dobj	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
dermal	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
results	VBZ	parataxis	O
in	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
activation	NN	nmod	O
.	.	punct	O

alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nsubj	I-Gene_or_gene_product
also	RB	advmod	O
induces	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
but	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
modulate	VB	conj	O
DNA	NN	compound	B-Cellular_component
binding	NN	dobj	O
on	IN	case	O
costimulation	NN	nmod	O
with	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Since	IN	mark	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nsubj	I-Gene_or_gene_product
are	VBP	cop	O
key	JJ	amod	O
elements	NNS	advcl	O
in	IN	mark	O
controlling	VBG	acl	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dobj	I-Gene_or_gene_product
)	-RRB-	punct	O
transcription	NN	dobj	O
,	,	punct	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	conj	I-Gene_or_gene_product
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
cytokine	NN	compound	O
levels	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
supernatants	NNS	nmod	O
were	VBD	auxpass	O
measured	VBN	conj	O
by	IN	case	O
ELISA	NN	nmod	O
.	.	punct	O

alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nsubj	I-Gene_or_gene_product
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nsubj	I-Gene_or_gene_product
exerts	VBZ	ccomp	O
modulatory	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
AP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
can	MD	aux	O
regulate	VB	conj	O
chemokine	NN	compound	O
secretion	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
dermal	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nmod	I-Gene_or_gene_product
may	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
regulatory	JJ	amod	O
functions	NNS	dobj	O
in	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
composition	NN	nmod	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	dobj	O
,	,	punct	O
or	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

CD40	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
on	IN	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
correlates	VBZ	ROOT	O
with	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
poor	JJ	amod	O
prognosis	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
related	JJ	appos	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
regional	JJ	amod	O
and	CC	cc	O
distant	JJ	conj	O
metastasis	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
need	NN	attr	O
to	TO	aux	O
identify	VB	acl	O
parameters	NNS	dobj	O
that	WDT	nsubj	O
can	MD	aux	O
predict	VB	relcl	O
a	DT	det	O
tendancy	NN	dobj	O
to	TO	case	O
metastatic	JJ	acl	O
spread	NN	acl	O
to	TO	mark	O
allow	VB	xcomp	O
better	JJR	amod	O
prognostic	JJ	amod	O
evaluation	NN	dobj	O
and	CC	cc	O
therapeutic	JJ	amod	O
approach	NN	conj	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
Using	VBG	dep	O
flow	NN	compound	O
cytometry	NN	dobj	O
we	PRP	nsubj	O
evaluated	VBD	conj	O
18	CD	nummod	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
surface	NN	compound	O
markers	NNS	nmod	O
on	IN	case	O
lung	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
suggested	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
possible	JJ	amod	O
prognostic	JJ	amod	O
parameters	NNS	xcomp	O
,	,	punct	O
including	VBG	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
Fas	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
CD40	NN	conj	B-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	dep	O
between	IN	case	O
tumor	NN	compound	B-Cancer
prognosis	NN	nmod	O
and	CC	cc	O
EGFR	NN	conj	B-Gene_or_gene_product
,	,	punct	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
or	CC	cc	O
Fas	NN	conj	B-Gene_or_gene_product
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
surface	NN	compound	B-Cellular_component
expression	NN	nmod	O
of	IN	case	O
CD40	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
metastatic	JJ	amod	O
spread	NN	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
14	CD	compound	O
of	IN	case	O
18	CD	nummod	O
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
expressed	VBD	ROOT	O
CD40	NN	dobj	B-Gene_or_gene_product
on	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	nmod	B-Cellular_component
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
the	DT	det	O
4	CD	nummod	O
tumors	NNS	nmod	B-Cancer
that	WDT	nsubj	O
were	VBD	cop	O
CD40	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
negative	JJ	acl:relcl	O
,	,	punct	O
were	VBD	cop	O
stage	NN	ROOT	O
I	CD	compound	O
tumors	NNS	dobj	B-Cancer
,	,	punct	O
without	IN	case	O
any	DT	det	O
evidence	NN	nmod	O
of	IN	case	O
regional	JJ	amod	O
or	CC	cc	O
distant	JJ	conj	O
metastasis	NN	nmod	O
.	.	punct	O

Of	IN	case	O
the	DT	det	O
14	CD	nummod	O
tumors	NNS	nsubj	B-Cancer
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
CD40	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
all	DT	appos	O
but	CC	cc	O
1	CD	conj	O
(	-LRB-	punct	O
93	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
either	CC	cc:preconj	O
nodal	JJ	dobj	B-Multi-tissue_structure
or	CC	cc	O
systemic	JJ	conj	O
metastasis	NN	dep	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
diagnosis	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
whose	WP$	nmod:poss	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
CD40	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
negative	NN	dep	O
showed	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
better	JJR	amod	O
N	NN	compound	O
stage	NN	dobj	O
,	,	punct	O
overall	JJ	amod	O
stage	NN	appos	O
at	IN	case	O
presentation	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
than	IN	case	O
those	DT	det	O
patients	NNS	nmod	B-Organism
with	IN	case	O
CD40	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cancer
size	NN	nmod	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
age	NN	conj	O
,	,	punct	O
histology	NN	conj	O
,	,	punct	O
differentiation	NN	conj	O
or	CC	cc	O
preoperative	JJ	amod	O
therapy	NN	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	dep	O
that	IN	mark	O
CD40	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
on	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
,	,	punct	O
and	CC	cc	O
also	RB	advmod	O
may	MD	aux	O
serve	VB	conj	O
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
marker	NN	nmod	O
and	CC	cc	O
an	DT	det	O
indicator	NN	conj	O
of	IN	case	O
advanced	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O

The	DT	det	O
value	NN	ROOT	O
of	IN	case	O
serum	NN	compound	B-Organism_substance
S	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
100beta	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
interleukins	NNS	conj	B-Gene_or_gene_product
as	IN	case	O
tumour	NN	compound	B-Cancer
markers	NNS	nmod	O
in	IN	case	O
advanced	JJ	amod	O
melanoma	NN	nmod	B-Cancer
.	.	punct	O

Recently	RB	advmod	O
serum	NN	compound	B-Organism_substance
S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	nsubj	I-Gene_or_gene_product
has	VBZ	aux	O
shown	VBN	ROOT	O
promise	NN	dobj	O
as	IN	case	O
a	DT	det	O
tumour	NN	compound	B-Cancer
marker	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
use	NN	nsubj	O
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
marker	NN	nmod	O
in	IN	case	O
the	DT	det	O
advanced	JJ	amod	O
stage	NN	nmod	O
needs	VBZ	parataxis	O
to	TO	aux	O
be	VB	auxpass	O
confirmed	VBN	xcomp	O
.	.	punct	O

Interleukins	NNS	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
ILs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
study	VB	advcl	O
their	PRP$	nmod:poss	O
relation	NN	dobj	O
to	TO	case	O
the	DT	det	O
metastatic	JJ	amod	O
profile	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
pretreatment	NN	amod	O
serum	NN	compound	B-Organism_substance
levels	NNS	nmod	O
of	IN	prep	O
S	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	intj	I-Gene_or_gene_product
,	,	punct	O
IL	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	intj	I-Gene_or_gene_product
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
metastatic	JJ	conj	O
site	NN	dep	O
and	CC	cc	O
survival	NN	conj	O
in	IN	case	O
50	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
advanced	JJ	amod	O
melanoma	NN	nmod	B-Cancer
who	WP	nsubj	O
were	VBD	acl:relcl	O
to	TO	aux	O
receive	VB	xcomp	O
chemoimmunotherapy	NN	dobj	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
with	IN	case	O
liver	NN	nmod	B-Organ
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
bone	NN	compound	B-Organ
metastases	NNS	conj	O
had	VBD	ROOT	O
significantly	RB	advmod	O
higher	JJR	amod	O
median	JJ	amod	O
concentrations	NNS	dobj	O
of	IN	case	O
S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	intj	I-Gene_or_gene_product
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	nmod	I-Gene_or_gene_product
than	IN	case	O
those	DT	nmod	O
with	IN	case	O
only	JJ	advmod	O
skin	NN	nmod	B-Organ
,	,	punct	O
nodal	NN	conj	B-Multi-tissue_structure
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
lung	NN	compound	B-Organ
involvement	NN	conj	O
.	.	punct	O

The	DT	det	O
differences	NNS	nsubj	O
in	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
were	VBD	cop	O
unremarkable	JJ	ROOT	O
.	.	punct	O

Using	VBG	ROOT	O
univariate	JJ	amod	O
analysis	NN	dobj	O
,	,	punct	O
the	DT	det	O
S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	compound	I-Gene_or_gene_product
level	NN	nsubjpass	O
and	CC	cc	O
metastatic	JJ	amod	O
profile	NN	conj	O
were	VBD	auxpass	O
found	VBN	parataxis	O
to	TO	mark	O
be	VB	cop	O
statistically	RB	advmod	O
significant	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	xcomp	O
for	IN	case	O
survival	NN	nmod	O
.	.	punct	O

Using	VBG	ROOT	O
multivariate	JJ	amod	O
analysis	NN	dobj	O
the	DT	det	O
S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	nummod	I-Gene_or_gene_product
level	NN	nsubj	O
was	VBD	cop	O
the	DT	det	O
most	RBS	advmod	O
powerful	JJ	amod	O
prognostic	JJ	amod	O
indicator	NN	dobj	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
metastatic	JJ	amod	O
profile	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
significant	JJ	xcomp	O
after	IN	case	O
exclusion	NN	nmod	O
of	IN	case	O
S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
elevated	JJ	amod	O
serum	NN	compound	B-Organism_substance
levels	NNS	nsubj	O
of	IN	case	O
S	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	intj	I-Gene_or_gene_product
,	,	punct	O
IL	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	conj	I-Gene_or_gene_product
reflect	NN	ccomp	O
concurrent	JJ	amod	O
liver	NN	dobj	B-Organ
or	CC	cc	O
bone	NN	compound	B-Organ
metastases	NNS	conj	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
.	.	punct	O

S	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
100beta	CD	nsubj	I-Gene_or_gene_product
is	VBZ	ROOT	O
also	RB	advmod	O
an	DT	det	O
independent	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	attr	O
.	.	punct	O

Pretreatment	NN	amod	O
IL	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
outcome	NN	nmod	O
.	.	punct	O

TEL	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
putative	JJ	amod	O
tumor	NN	compound	B-Cancer
suppressor	NN	appos	O
,	,	punct	O
modulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
and	CC	cc	O
cell	NN	compound	B-Cell
morphology	NN	conj	O
of	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
while	IN	mark	O
repressing	VBG	advcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
stromelysin	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

TEL	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
ETS	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
the	DT	dep	O
mSin3	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
SMRT	NN	conj	B-Gene_or_gene_product
corepressors	NNS	dep	O
to	TO	mark	O
regulate	VB	xcomp	O
transcription	NN	dobj	O
.	.	punct	O

TEL	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
biallelically	RB	advmod	O
disrupted	VBN	ROOT	O
in	IN	case	O
acute	JJ	amod	B-Cancer
leukemia	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
loss	NN	nsubjpass	O
of	IN	case	O
heterozygosity	NN	nmod	O
at	IN	case	O
the	DT	det	O
TEL	NN	compound	B-Gene_or_gene_product
locus	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
observed	VBN	conj	O
in	IN	case	O
various	JJ	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
TEL	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
Ras	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
inhibits	VBZ	ccomp	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
and	CC	cc	O
in	IN	case	O
normal	JJ	amod	O
cultures	NNS	conj	O
.	.	punct	O

Unexpectedly	RB	advmod	O
,	,	punct	O
cells	NNS	nsubj	B-Cell
expressing	VBG	acl	O
both	CC	cc:preconj	O
Ras	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
TEL	NN	conj	B-Gene_or_gene_product
grew	VBD	ROOT	O
as	IN	case	O
aggregates	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
begin	VB	advcl	O
to	TO	mark	O
explain	VB	xcomp	O
the	DT	det	O
morphology	NN	dobj	O
of	IN	case	O
Ras	NN	nmod	B-Gene_or_gene_product
-	:	punct	O
plus	CC	cc	O
TEL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	conj	B-Cell
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
endogenous	JJ	amod	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
stromelysin	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
repressed	VBN	ccomp	O
by	IN	case	O
TEL	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

TEL	NN	nsubj	B-Gene_or_gene_product
bound	VBD	ROOT	O
sequences	NNS	dobj	O
in	IN	case	O
the	DT	det	O
stromelysin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
and	CC	cc	O
repressed	VBD	conj	O
the	DT	det	O
promoter	NN	dobj	O
in	IN	case	O
transient	JJ	amod	O
-	HYPH	punct	O
expression	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
direct	JJ	amod	O
target	NN	ccomp	O
for	IN	case	O
TEL	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
regulation	NN	nmod	O
.	.	punct	O

Mutants	NNS	nsubj	O
of	IN	case	O
TEL	NN	nmod	B-Gene_or_gene_product
that	WDT	nsubj	O
removed	VBD	acl:relcl	O
a	DT	det	O
binding	VBG	amod	O
site	NN	dobj	O
for	IN	case	O
the	DT	det	O
mSin3A	NN	amod	B-Gene_or_gene_product
corepressor	NN	nmod	O
but	CC	cc	O
retained	VBD	conj	O
the	DT	det	O
ETS	NN	compound	O
domain	NN	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
repress	VB	xcomp	O
stromelysin	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

When	WRB	advmod	O
BB	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
94	CD	nsubjpass	I-Simple_chemical
,	,	punct	O
a	DT	det	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
inhibitor	NN	appos	O
,	,	punct	O
was	VBD	auxpass	O
added	VBN	advcl	O
to	TO	case	O
the	DT	det	O
culture	NN	compound	O
medium	NN	nmod	O
of	IN	case	O
Ras	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
it	PRP	nsubj	O
caused	VBD	ROOT	O
a	DT	det	O
cell	NN	compound	B-Cell
aggregation	NN	compound	O
phenotype	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
caused	VBN	acl	O
by	IN	case	O
TEL	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TEL	NN	nsubj	B-Gene_or_gene_product
inhibited	VBD	ROOT	O
the	DT	det	O
invasiveness	NN	dobj	O
of	IN	case	O
Ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
TEL	NN	nsubj	B-Gene_or_gene_product
acts	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
of	IN	case	O
stromelysin	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Caspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
procaspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
processing	NN	nmod	O
and	CC	cc	O
cisplatin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	conj	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	aux	O
investigate	VB	xcomp	O
in	IN	case	O
more	JJR	advmod	O
detail	NN	nmod	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
apoptotic	JJ	amod	O
processes	NNS	nmod	O
in	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
in	IN	case	O
cell	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
free	JJ	amod	O
extracts	NNS	conj	B-Organism_substance
of	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
apoptosis	NN	compound	O
of	IN	case	O
caspase	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
MCF	NNP	compound	O
-	HYPH	punct	O
7	CD	nummod	O
breast	NN	compound	O
cancer	NN	compound	O
cells	NNS	nsubj	O
is	VBZ	cop	O
defective	JJ	ccomp	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
cisplatin	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
chromatin	NN	compound	B-Cellular_component
condensation	NN	nmod	O
,	,	punct	O
nuclear	JJ	amod	B-Cellular_component
fragmentation	NN	conj	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	conj	O
,	,	punct	O
and	CC	cc	O
release	NN	conj	O
of	IN	case	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	nmod	I-Gene_or_gene_product
from	IN	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
.	.	punct	O

Reconstitution	NN	nsubj	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
stable	JJ	amod	O
transfection	NN	nmod	O
of	IN	case	O
CASP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
cDNA	NN	nmod	O
restores	VBZ	ROOT	O
all	PDT	det:predet	O
these	DT	det	O
defects	NNS	dobj	O
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
an	DT	det	O
extensive	JJ	amod	O
apoptosis	NN	nmod	O
after	IN	case	O
cisplatin	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
extracts	NNS	nmod	B-Organism_substance
from	IN	case	O
caspase	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
MCF	NNP	compound	O
-	HYPH	punct	O
7	CD	nummod	O
cells	NNS	nmod	O
,	,	punct	O
procaspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
processing	NN	appos	O
is	VBZ	cop	O
strongly	RB	advmod	O
impaired	JJ	ccomp	O
after	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
recombinant	JJ	amod	O
caspase	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Reconstitution	NN	nsubj	O
of	IN	case	O
MCF	NNP	compound	B-Organism_substance
-	HYPH	punct	I-Organism_substance
7	CD	nummod	I-Organism_substance
cell	NN	compound	I-Organism_substance
extracts	NNS	nmod	I-Organism_substance
with	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
corrects	VBZ	ROOT	O
this	DT	det	O
defect	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
an	DT	det	O
efficient	JJ	amod	O
and	CC	cc	O
complete	JJ	conj	O
processing	NN	nmod	O
of	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
define	NN	ROOT	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dobj	I-Gene_or_gene_product
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
integrator	NN	nmod	O
of	IN	case	O
the	DT	det	O
apoptotic	JJ	amod	O
process	NN	nmod	O
in	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
reveal	VBP	conj	O
an	DT	det	O
essential	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
for	IN	case	O
procaspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
processing	NN	nmod	O
.	.	punct	O

Vasodilator	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulated	VBN	amod	I-Gene_or_gene_product
phosphoprotein	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
stress	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
fiber	NN	intj	I-Cellular_component
and	CC	cc	O
membrane	NN	compound	B-Cellular_component
ruffle	JJ	compound	I-Cellular_component
formation	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Vasodilator	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulated	VBN	amod	I-Gene_or_gene_product
phosphoprotein	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
VASP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
where	WRB	advmod	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
cellular	JJ	amod	B-Cell
reorganization	NN	nmod	O
during	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
retraction	NN	conj	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
permeability	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
cellular	JJ	amod	B-Cell
functions	NNS	nsubjpass	O
of	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
are	VBP	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
expressed	VBN	ROOT	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
and	CC	cc	O
mutant	JJ	amod	O
forms	NNS	dobj	O
of	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
determine	VB	xcomp	O
in	IN	mark	O
what	WDT	det	O
aspects	NNS	nsubj	O
of	IN	prep	O
cytoskeletal	JJ	amod	B-Cellular_component
behavior	NN	pobj	O
this	DT	det	O
protein	NN	nsubj	O
participates	VBZ	advcl	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
VASP	NN	nmod	B-Gene_or_gene_product
induces	VBZ	ROOT	O
marked	JJ	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
and	CC	cc	O
formation	NN	conj	O
of	IN	case	O
prominent	JJ	amod	O
stress	NN	compound	B-Cellular_component
fibers	NNS	nmod	I-Cellular_component
in	IN	case	O
bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proline	NN	nmod:npmod	O
-	HYPH	punct	O
rich	JJ	amod	O
domain	NN	nmod	O
of	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
abolishes	VBZ	ROOT	O
its	PRP$	nmod:poss	O
ability	NN	dobj	O
to	TO	mark	O
bind	VB	acl	O
profilin	NN	dobj	B-Gene_or_gene_product
but	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
affect	VB	conj	O
ruffling	NN	dobj	O
or	CC	cc	O
stress	NN	conj	B-Cellular_component
fiber	NN	compound	I-Cellular_component
formation	NN	dep	O
.	.	punct	O

Further	JJ	amod	O
deletions	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
sequence	NN	dobj	O
within	IN	case	O
the	DT	det	O
carboxy	NN	compound	O
-	HYPH	punct	O
terminal	JJ	amod	O
domain	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
responsible	JJ	acl:relcl	O
for	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
bundle	NN	compound	O
formation	NN	nmod	O
.	.	punct	O

Ruffling	NN	nsubj	O
occurs	VBZ	ROOT	O
only	RB	advmod	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
forms	NNS	nmod	O
of	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
that	WDT	nsubj	O
possess	VBP	acl:relcl	O
bundling	NN	amod	O
activity	NN	dobj	O
and	CC	cc	O
the	DT	det	O
capacity	NN	conj	O
to	TO	mark	O
bind	VB	acl	O
zyxin	NN	compound	B-Gene_or_gene_product
/	:	punct	O
vinculin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
derived	VBN	amod	O
peptide	NN	dobj	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
distinct	JJ	amod	O
subdomains	NNS	nmod	O
within	IN	case	O
VASP	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
bind	VB	acl	O
adhesion	NN	compound	O
proteins	NNS	dobj	O
and	CC	cc	O
induce	VBP	conj	O
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
bundling	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
protein	NN	nsubj	O
could	MD	aux	O
function	VB	ccomp	O
in	IN	case	O
the	DT	det	O
aggregation	NN	nmod	O
and	CC	cc	O
tethering	NN	conj	O
of	IN	case	O
actin	NN	compound	B-Gene_or_gene_product
filaments	NNS	nmod	O
during	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cellular_component
cell	NN	compound	I-Cellular_component
-	HYPH	punct	I-Cellular_component
substrate	NN	nmod	I-Cellular_component
and	CC	cc	O
cell	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
cell	NN	compound	I-Cellular_component
contacts	NNS	conj	I-Cellular_component
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
whereby	IN	advmod	O
VASP	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
influence	VB	acl:relcl	O
endothelial	JJ	amod	B-Cell
migration	NN	dobj	O
and	CC	cc	O
organization	NN	conj	O
during	IN	case	O
capillary	JJ	amod	B-Tissue
formation	NN	nmod	O
and	CC	cc	O
modulate	VBP	conj	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	dobj	O
via	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
contractility	NN	nmod	O
.	.	punct	O

Urokinase	NN	compound	B-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
molecular	JJ	amod	O
organizer	NN	dep	O
in	IN	case	O
cellular	JJ	amod	B-Cell
communication	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
types	NNS	nmod	O
,	,	punct	O
the	DT	det	O
glycolipid	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
anchored	VBN	amod	I-Gene_or_gene_product
urokinase	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
uPAR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
colocalized	VBN	ROOT	O
pericellularly	RB	advmod	O
with	IN	case	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
plasminogen	NN	compound	B-Gene_or_gene_product
activation	NN	compound	O
system	NN	nmod	O
and	CC	cc	O
endocytosis	NN	compound	O
receptors	NNS	conj	O
.	.	punct	O

uPAR	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
also	RB	advmod	O
coexpressed	VBN	ROOT	O
with	IN	case	O
caveolin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
members	NNS	conj	O
of	IN	case	O
the	DT	det	O
integrin	NN	compound	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
superfamily	NN	nmod	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
functional	JJ	amod	O
units	NNS	nmod	O
with	IN	case	O
these	DT	det	O
various	JJ	amod	O
proteins	NNS	nmod	O
allows	VBZ	ROOT	O
the	DT	det	O
uPAR	NN	dobj	B-Gene_or_gene_product
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
focused	JJ	amod	O
proteolysis	NN	dobj	O
required	VBN	acl	O
for	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
and	CC	cc	O
to	TO	mark	O
contribute	VB	conj	O
both	CC	cc:preconj	O
directly	RB	advmod	O
and	CC	advmod	O
indirectly	RB	advmod	O
to	TO	case	O
cell	NN	compound	B-Cell
adhesive	JJ	amod	O
processes	NNS	nmod	O
in	IN	case	O
a	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
proteolytic	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

This	DT	det	O
dual	JJ	amod	O
activity	NN	nsubjpass	O
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
initiation	NN	nsubjpass	O
of	IN	case	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
by	IN	case	O
uPAR	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
cellular	JJ	amod	B-Cell
behaviour	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
inflammation	NN	conj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
repair	NN	conj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
/	:	punct	O
metastasis	NN	conj	O
and	CC	cc	O
open	VB	conj	O
up	RP	prt	O
the	DT	det	O
way	NN	dobj	O
for	IN	prep	O
uPAR	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
based	VBN	amod	O
therapeutic	JJ	amod	O
approaches	NNS	pobj	O
.	.	punct	O

p75	NN	nsubj	B-Gene_or_gene_product
mediated	VBD	nsubjpass	O
apoptosis	NN	dobj	O
in	IN	case	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
expression	NN	nmod	O
of	IN	case	O
TrkA	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Neurotrophins	NNS	nsubj	B-Gene_or_gene_product
mediate	VBP	appos	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Trk	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
affinity	NN	compound	O
nerve	NN	compound	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	compound	O
p75	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Nerve	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
NGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
support	VB	xcomp	O
survival	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
neuroblastoma	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
NB	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
TrkA	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	O
.	.	punct	O

The	DT	det	O
p75	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubj	O
belongs	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TNF	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
family	NN	nmod	O
of	IN	case	O
death	NN	compound	O
receptors	NNS	nmod	O
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	conj	O
as	IN	case	O
a	DT	det	O
receptor	NN	nmod	O
that	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
apoptosis	NN	dobj	O
in	IN	case	O
neuronal	JJ	amod	B-Cell
and	CC	cc	O
NB	NN	conj	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

PROCEDURE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
p75	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
NB	NN	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
transfected	VBD	parataxis	O
the	DT	det	O
p75	NN	compound	B-Gene_or_gene_product
cDNA	NN	dobj	O
into	IN	case	O
SH	NN	compound	B-Cell
-	HYPH	punct	I-Cell
SY5Y	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
an	DT	det	O
NB	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	appos	I-Cell
lacking	VBG	acl	O
expression	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
p75	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TrkA	NN	conj	B-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Cell	NN	compound	B-Cell
clones	NNS	nsubj	I-Cell
expressing	VBG	acl	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
p75	NN	nmod	B-Gene_or_gene_product
showed	VBD	dep	O
a	DT	det	O
high	JJ	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
even	RB	advmod	O
in	IN	case	O
10	CD	compound	O
%	NN	amod	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
supplemented	VBN	amod	O
medium	NN	nmod	O
.	.	punct	O

Apoptotic	JJ	amod	O
signaling	NN	nsubj	O
by	IN	case	O
p75	NN	nmod	B-Gene_or_gene_product
was	VBD	cop	O
ligand	NN	compound	O
-	HYPH	punct	O
independent	JJ	ROOT	O
and	CC	cc	O
only	RB	advmod	O
partly	RB	advmod	O
caspase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	conj	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
correlated	VBD	ROOT	O
directly	RB	advmod	O
with	IN	case	O
the	DT	det	O
expression	NN	compound	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
p75	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
activate	VB	ccomp	O
the	DT	det	O
cell	NN	compound	B-Cell
death	NN	compound	O
program	NN	dobj	O
directly	RB	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
additional	JJ	amod	O
transfection	NN	nsubj	O
of	IN	case	O
TrkA	NN	nmod	B-Gene_or_gene_product
into	IN	case	O
SY5Y	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
p75	NN	compound	B-Gene_or_gene_product
cells	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significantly	RB	advmod	O
reduced	VBN	amod	O
rate	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
NGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Thus	RB	advmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TrkA	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	O
itself	PRP	dep	O
inhibits	VBZ	dep	O
p75	NN	compound	B-Gene_or_gene_product
mediated	JJ	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
NB	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

RNA	NN	compound	O
damage	NN	ROOT	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
neoplastic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
growth	NN	nmod	O
:	:	punct	O
effects	NNS	dep	O
of	IN	case	O
human	JJ	amod	B-Organism
and	CC	cc	O
amphibian	JJ	conj	O
ribonucleases	NNS	nmod	B-Gene_or_gene_product
.	.	punct	O

Angiogenesis	NN	nsubj	O
defines	VBZ	ROOT	O
the	DT	det	O
many	JJ	amod	O
steps	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	,	punct	O
derived	VBN	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

This	DT	det	O
process	NN	nsubj	O
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
considerable	JJ	amod	O
effort	NN	nsubjpass	O
is	VBZ	aux	O
being	VBG	auxpass	O
expended	VBN	conj	O
to	TO	mark	O
find	VB	xcomp	O
inhibitors	NNS	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
usually	RB	advmod	O
involves	VBZ	ROOT	O
screening	NN	dobj	O
of	IN	case	O
potential	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
compounds	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

To	IN	case	O
this	DT	det	O
end	NN	nmod	O
,	,	punct	O
two	CD	nummod	O
candidate	NN	compound	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
RNA	NN	compound	O
-	HYPH	punct	O
damaging	NN	compound	O
agents	NNS	nsubjpass	O
,	,	punct	O
onconase	NN	conj	B-Simple_chemical
and	CC	cc	O
(	-LRB-	punct	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
4	LS	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
rhEDN	NN	conj	I-Simple_chemical
,	,	punct	O
were	VBD	auxpass	O
screened	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
effects	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
using	VBG	xcomp	O
three	CD	nummod	O
distinct	JJ	amod	O
types	NNS	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
culture	NN	nmod	O
:	:	punct	O
HPV	NN	compound	B-Organism
-	:	punct	I-Organism
16	CD	nummod	I-Organism
E6	NN	compound	I-Organism
/	:	punct	O
E7	NN	nmod:npmod	B-Organism
-	:	punct	O
immortalized	VBN	amod	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	dep	I-Cell
(	-LRB-	punct	O
HUVECs	NNS	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
Kras	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
HPV	NNP	compound	B-Organism
-	:	punct	I-Organism
16	CD	nummod	I-Organism
E6	NN	compound	I-Organism
/	:	punct	O
E7	NN	compound	B-Organism
HUVEC	NN	appos	B-Cell
(	-LRB-	punct	O
Rhim	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
Carcinogenesis	NN	appos	O
4	CD	nummod	O
,	,	punct	O
673	CD	nummod	O
-	SYM	punct	O
681	CD	nummod	O
,	,	punct	O
1998	CD	amod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
primary	JJ	amod	O
HUVECs	NNS	conj	B-Cell
.	.	punct	O

Onconase	RB	nsubj	B-Simple_chemical
similarly	RB	advmod	O
inhibited	VBD	ROOT	O
proliferation	NN	dobj	O
in	IN	case	O
all	DT	det	O
three	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
3	CD	nummod	O
-	SYM	punct	O
1	CD	ROOT	O
.	.	punct	O
0	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
while	IN	mark	O
(	-LRB-	punct	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
4	LS	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
rhEDN	NN	nsubj	I-Simple_chemical
was	VBD	cop	O
more	RBR	advmod	O
effective	JJ	dep	O
on	IN	case	O
immortalized	VBN	amod	O
HUVEC	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
02	CD	compound	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
06	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
than	IN	case	O
on	IN	case	O
primary	JJ	amod	O
HUVECs	NNS	nmod	B-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
>	NN	dep	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Differential	JJ	amod	O
sensitivity	NN	nsubj	O
to	TO	case	O
these	DT	det	O
agents	NNS	nmod	O
implies	VBZ	ROOT	O
that	IN	mark	O
more	JJR	advmod	O
than	IN	mwe	O
one	CD	nummod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
type	NN	nsubjpass	I-Cell
must	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
in	IN	case	O
proliferation	NN	compound	O
assays	NNS	nmod	O
to	TO	mark	O
screen	VB	xcomp	O
for	IN	case	O
novel	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
compounds	NNS	nmod	O
.	.	punct	O

TRADD	NN	compound	B-Gene_or_gene_product
domain	NN	nsubj	O
of	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
transforming	NN	amod	O
protein	NN	nmod	O
LMP1	NN	dep	B-Gene_or_gene_product
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	mark	O
inducing	VBG	advcl	O
immortalization	NN	dobj	O
and	CC	cc	O
suppressing	VBG	conj	O
senescence	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
rodent	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Mutation	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	nmod:npmod	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
immortalization	NN	nmod	O
revealed	VBD	ROOT	O
two	CD	nummod	O
transformation	NN	compound	O
effector	NN	compound	O
sites	NNS	dobj	O
,	,	punct	O
TES1	NN	appos	O
and	CC	cc	O
TES2	NN	conj	O
.	.	punct	O

TES2	NN	nsubj	O
mediates	VBZ	ROOT	O
the	DT	det	O
interaction	NN	dobj	O
with	IN	case	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
associated	VBN	amod	I-Gene_or_gene_product
death	NN	compound	I-Gene_or_gene_product
domain	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
plays	VBZ	conj	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
transactivating	VBG	advcl	O
NF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
AP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Recombinant	JJ	amod	O
EBV	NN	nsubj	B-Organism
containing	VBG	acl	O
LMP1	NN	dobj	B-Gene_or_gene_product
with	IN	case	O
TES2	NN	nmod	O
deleted	VBN	nsubj	O
induces	VBZ	ROOT	O
a	DT	det	O
limited	JJ	amod	O
proliferation	NN	dobj	O
of	IN	case	O
B	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
mutant	NN	nsubj	O
with	IN	case	O
an	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
site	NN	compound	O
-	:	punct	O
specific	JJ	amod	O
mutation	NN	nmod	O
at	IN	case	O
TES2	NN	nmod	O
,	,	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
initially	RB	advmod	O
stimulates	VBZ	ccomp	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
and	CC	cc	O
significantly	RB	advmod	O
extends	VBZ	conj	O
the	DT	det	O
life	NN	compound	O
span	NN	dobj	O
of	IN	case	O
MEF	NNP	nmod	B-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
sufficient	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
immortalization	NN	nmod	O
of	IN	case	O
MEF	NN	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
MEF	NNP	compound	O
-	HYPH	punct	O
LMP1	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
cells	NNS	nsubj	O
eventually	RB	advmod	O
enter	VBP	conj	O
growth	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O

Further	JJ	amod	O
analysis	NN	nsubj	O
reveals	VBZ	ROOT	O
that	IN	mark	O
although	IN	mark	O
LMP1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
promotes	VBZ	advcl	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
,	,	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
prevent	VB	ccomp	O
the	DT	det	O
eventual	JJ	amod	O
onset	NN	dobj	O
of	IN	case	O
senescence	NN	nmod	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
p16	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4a	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
inhibition	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
functions	NNS	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
depends	VBZ	ROOT	O
on	IN	case	O
lymphocyte	NN	compound	B-Cell
-	HYPH	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
tumor	NN	compound	B-Cancer
inhibition	NN	compound	O
rests	VBZ	nsubj	O
on	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	nmod	I-Gene_or_gene_product
to	TO	mark	O
activate	VB	acl	O
a	DT	det	O
CD8	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
cytotoxicity	NN	dobj	O
,	,	punct	O
inhibit	VB	ROOT	O
angiogenesis	NN	dobj	O
,	,	punct	O
and	CC	cc	O
cause	VB	conj	O
vascular	JJ	amod	B-Multi-tissue_structure
injury	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	advcl	O
that	IN	mark	O
such	JJ	amod	O
inhibition	NN	nsubj	O
stems	VBZ	ccomp	O
from	IN	case	O
complex	JJ	amod	O
interactions	NNS	nmod	O
of	IN	case	O
immune	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
the	DT	det	O
production	NN	conj	O
of	IN	case	O
IFN	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
gamma	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
other	JJ	amod	O
downstream	JJ	amod	O
angiostatic	JJ	amod	O
chemokines	NNS	conj	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
involved	VBN	acl	O
are	VBP	auxpass	O
still	RB	advmod	O
poorly	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
IL	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
activates	VBZ	ccomp	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
program	NN	dobj	O
in	IN	case	O
Con	NN	compound	B-Simple_chemical
A	NNP	compound	I-Simple_chemical
-	HYPH	punct	O
activated	VBN	amod	O
mouse	NN	compound	B-Organism
spleen	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
activated	VBN	dep	O
spc	NN	dep	B-Cell
)	-RRB-	punct	O
or	CC	cc	O
human	JJ	amod	B-Organism
PBMC	NN	conj	B-Cell
(	-LRB-	punct	O
activated	VBN	amod	O
PBMC	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
soluble	JJ	amod	O
factors	NNS	nsubj	O
they	PRP	nsubj	O
release	VBP	ROOT	O
in	IN	case	O
its	PRP$	nmod:poss	O
presence	NN	compound	O
arrest	VBP	ccomp	O
the	DT	det	O
cycle	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
inhibit	VBP	conj	O
in	FW	amod	O
vitro	FW	dep	O
angiogenesis	NN	dobj	O
,	,	punct	O
negatively	RB	advmod	O
modulate	VB	parataxis	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ability	NN	conj	O
of	IN	case	O
EC	NN	nmod	B-Cell
to	TO	mark	O
adhere	VB	acl	O
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
up	RB	advmod	O
-	HYPH	punct	O
regulate	VB	conj	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
VCAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
expression	NN	dep	O
.	.	punct	O

These	DT	det	O
effects	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
require	VB	ROOT	O
direct	JJ	amod	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
contact	NN	dobj	O
,	,	punct	O
yet	RB	advmod	O
result	VBP	advcl	O
from	IN	case	O
continuous	JJ	amod	O
interaction	NN	nmod	O
between	IN	case	O
activated	VBN	amod	O
lymphoid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
EC	NN	conj	B-Cell
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
neutralizing	VBG	amod	O
Abs	NNS	dobj	O
to	TO	mark	O
show	VB	xcomp	O
that	IN	mark	O
the	DT	det	O
IFN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
monokine	NN	conj	O
-	,	punct	O
induced	VBN	acl	O
by	IN	case	O
IFN	NN	compound	O
-	HYPH	punct	O
gamma	NN	compound	O
chemokines	NNS	nmod	O
are	VBP	cop	O
pivotal	JJ	ccomp	O
in	IN	mark	O
inducing	VBG	advcl	O
these	DT	det	O
effects	NNS	dobj	O
.	.	punct	O

Experiments	NNS	nsubj	O
with	IN	prep	O
nu	CC	advmod	B-Organism
/	SYM	punct	I-Organism
nu	PRP	amod	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
nonobese	JJ	amod	B-Organism
diabetic	JJ	amod	I-Organism
-	HYPH	punct	I-Organism
SCID	NN	compound	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
or	CC	cc	O
activated	VBN	ROOT	O
spc	NN	advmod	B-Cell
enriched	VBN	dobj	O
in	IN	case	O
specific	JJ	amod	O
cell	NN	compound	B-Cell
subpopulations	NNS	nmod	O
demonstrated	VBD	conj	O
that	IN	mark	O
CD4	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
CD8	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
NK	NN	compound	B-Cell
cells	NNS	conj	I-Cell
are	VBP	auxpass	O
all	DT	advmod	O
needed	VBN	ccomp	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
full	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenetic	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

[	-LRB-	punct	O
Study	NN	nsubj	O
of	IN	prep	O
fungus	NN	pobj	B-Simple_chemical
polysaccharides	NNS	ROOT	I-Simple_chemical
compounds	NNS	dobj	I-Simple_chemical
(	-LRB-	punct	O
FPC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
in	IN	mark	O
inducing	VBG	advcl	O
the	DT	det	O
apoptosis	NN	dobj	O
of	IN	case	O
liver	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
Bel	NN	nmod	I-Cell
-	HYPH	punct	I-Cell
7402	CD	nummod	I-Cell
]	-RRB-	punct	I-Cell
.	.	punct	O

To	TO	mark	O
observe	VB	advcl	O
the	DT	det	O
influence	NN	dobj	O
of	IN	prep	O
fungus	NN	pobj	B-Simple_chemical
polysaccharides	NNS	ROOT	I-Simple_chemical
compounds	NNS	dobj	I-Simple_chemical
(	-LRB-	punct	O
FPC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
in	IN	mark	O
inducing	VBG	advcl	O
human	JJ	amod	B-Organism
liver	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
Bel	NN	compound	I-Cell
-	HYPH	punct	I-Cell
7402	CD	nummod	I-Cell
apoptosis	NN	dobj	O
in	IN	case	O
cell	NN	nmod	B-Cell
cultivating	VBG	acl	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
the	DT	det	O
authors	NNS	nsubj	O
analyzed	VBD	parataxis	O
tumor	NN	compound	B-Cancer
inhibitive	JJ	amod	O
gene	NN	compound	O
P53	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
Bel	NN	compound	B-Cell
-	HYPH	punct	I-Cell
7402	CD	nummod	I-Cell
apoptosis	NN	nmod	O
by	IN	mark	O
applying	VBG	advcl	O
double	JJ	amod	O
immuno	NN	amod	O
-	HYPH	punct	O
marker	NN	dobj	O
.	.	punct	O

The	DT	det	O
result	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
multilevel	NN	nsubj	O
of	IN	case	O
FPC	NN	nmod	B-Simple_chemical
could	MD	aux	O
all	RB	advmod	O
apparently	RB	advmod	O
induce	VBP	ccomp	O
Bel	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7402	CD	nummod	I-Cell
apoptosis	NN	dobj	O
.	.	punct	O

With	IN	case	O
the	DT	det	O
enhancement	NN	nmod	O
of	IN	case	O
FPC	NN	compound	B-Simple_chemical
concentration	NN	nmod	O
,	,	punct	O
the	DT	det	O
authors	NNS	nsubj	O
observed	VBD	ROOT	O
chromatin	NN	compound	B-Cellular_component
condensation	NN	dobj	O
in	IN	case	O
some	DT	det	O
phases	NNS	nmod	O
companying	VBG	acl	O
with	IN	case	O
the	DT	det	O
characteristic	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

In	IN	prep	O
the	DT	det	O
meantime	NN	pobj	O
,	,	punct	O
it	PRP	nsubj	O
could	MD	aux	O
also	RB	advmod	O
greatly	RB	advmod	O
reduce	VB	ROOT	O
the	DT	det	O
G1	NN	dobj	O
and	CC	cc	O
S	NN	conj	O
,	,	punct	O
with	IN	case	O
obviously	RB	advmod	O
dose	NN	compound	O
-	HYPH	punct	O
response	NN	compound	O
relationship	NN	nmod	O
.	.	punct	O

The	DT	det	O
percentage	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-Cell
apoptosis	NN	nmod	O
increased	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
enhancing	NN	nmod	O
of	IN	case	O
concentration	NN	nmod	O
.	.	punct	O

In	IN	prep	O
the	DT	det	O
high	JJ	amod	O
-	HYPH	punct	O
level	NN	compound	O
group	NN	pobj	O
the	DT	det	O
authors	NNS	nsubj	O
found	VBD	ROOT	O
typical	JJ	amod	O
DNA	NN	compound	B-Cellular_component
ladder	NN	compound	O
eletrophoresis	NN	compound	O
stripe	NN	ccomp	O
.	.	punct	O

The	DT	det	O
result	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
the	DT	det	O
FPC	NN	compound	B-Simple_chemical
antineoplastic	JJ	amod	O
effect	NN	nmod	O
had	VBD	ccomp	O
an	DT	det	O
intimate	JJ	amod	O
relation	NN	dobj	O
with	IN	case	O
its	PRP$	nmod:poss	O
induction	NN	nmod	O
to	TO	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
result	NN	nsubj	O
of	IN	case	O
FPC	NN	nmod	B-Simple_chemical
inducing	VBG	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
had	VBD	conj	O
the	DT	det	O
character	NN	dobj	O
of	IN	case	O
P53	NN	compound	B-Gene_or_gene_product
independence	NN	nmod	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
morphological	JJ	amod	O
patterning	NN	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

The	DT	det	O
migration	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
morphology	NN	nmod	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
ECs	NNS	nmod	I-Cell
by	IN	mark	O
culturing	VBG	advcl	O
cells	NNS	dobj	B-Cell
on	IN	case	O
micropatterned	VBN	amod	O
strips	NNS	nmod	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
matrix	NN	nmod	B-Cellular_component
(	-LRB-	punct	O
60	CD	nummod	O
-	HYPH	punct	O
,	,	punct	O
30	CD	conj	O
-	HYPH	punct	O
,	,	punct	O
and	CC	cc	O
15	CD	nummod	O
-	HYPH	punct	O
microm	NN	dep	O
wide	JJ	amod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
spreading	VBG	amod	O
areas	NNS	nsubj	O
of	IN	prep	O
the	DT	det	O
cells	NNS	pobj	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
and	CC	cc	O
30	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
were	VBD	ROOT	O
30	CD	nummod	O
%	NN	npadvmod	O
lower	JJR	acomp	O
than	IN	prep	O
those	DT	pobj	O
on	IN	prep	O
60	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
and	CC	cc	O
unpatterned	JJ	amod	O
collagen	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
cells	NNS	nsubj	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
completely	RB	advmod	O
aligned	VBN	ROOT	O
in	IN	prep	O
the	DT	det	O
direction	NN	pobj	O
of	IN	prep	O
the	DT	det	O
strip	NN	pobj	O
,	,	punct	O
and	CC	cc	O
had	VBD	conj	O
significantly	RB	advmod	O
lower	JJR	amod	O
shape	NN	compound	O
index	NN	dobj	O
than	IN	prep	O
those	DT	pobj	O
in	IN	prep	O
all	DT	det	O
other	JJ	amod	O
groups	NNS	pobj	O
.	.	punct	O

On	IN	prep	O
strips	NNS	pobj	O
of	IN	prep	O
all	DT	det	O
widths	NNS	pobj	O
,	,	punct	O
ECs	NNS	nsubj	B-Cell
tended	VBD	ROOT	O
to	TO	aux	O
migrate	VB	xcomp	O
in	IN	prep	O
the	DT	det	O
direction	NN	pobj	O
of	IN	prep	O
strips	NNS	pobj	O
.	.	punct	O

ECs	NNS	nsubj	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
had	VBD	ROOT	O
highest	JJS	amod	O
speed	NN	dobj	O
,	,	punct	O
particularly	RB	advmod	O
in	IN	prep	O
the	DT	det	O
direction	NN	pobj	O
of	IN	prep	O
the	DT	det	O
strip	NN	pobj	O
.	.	punct	O

Vinculin	NN	compound	B-Gene_or_gene_product
staining	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
leading	JJ	amod	O
edge	NN	nsubj	O
of	IN	case	O
ECs	NNS	nmod	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
had	VBD	ccomp	O
focal	JJ	amod	O
adhesions	NNS	dobj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
oriented	VBN	acl:relcl	O
with	IN	case	O
their	PRP$	nmod:poss	O
lamellipodial	JJ	amod	O
protrusion	NN	nmod	O
and	CC	cc	O
the	DT	det	O
direction	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
;	:	punct	O
this	DT	det	O
arrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
focal	JJ	amod	O
adhesions	NNS	nmod	O
may	MD	aux	O
promote	VB	parataxis	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
provides	VBZ	ROOT	O
direct	JJ	amod	O
evidence	NN	dobj	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
morphology	NN	nmod	O
in	IN	case	O
EC	NN	compound	B-Cell
migration	NN	nmod	O
,	,	punct	O
and	CC	cc	O
will	MD	aux	O
help	VB	conj	O
us	PRP	dobj	O
to	TO	aux	O
understand	VB	xcomp	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
EC	NN	compound	B-Cell
migration	NN	nmod	O
during	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
.	.	punct	O

Thrombospondin	NNP	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
plays	VBZ	ROOT	O
a	DT	det	O
protective	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
multistep	NN	compound	O
carcinogenesis	NN	nmod	O
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
host	NN	compound	O
anti	NN	compound	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
defense	NN	compound	O
mechanism	NN	dep	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubjpass	O
during	IN	case	O
tumorigenesis	NN	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
factors	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	compound	O
thrombospondin	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TSP	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
during	IN	case	O
multistep	NN	compound	O
carcinogenesis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
subjected	VBD	ROOT	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
and	CC	cc	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	conj	O
mice	NNS	dobj	B-Organism
to	IN	case	O
a	DT	det	O
chemical	JJ	amod	O
skin	NN	compound	B-Organ
carcinogenesis	NN	compound	O
regimen	NNS	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
strongly	RB	advmod	O
upregulated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
mesenchymal	JJ	amod	B-Tissue
stroma	NN	nmod	I-Tissue
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
mice	NNS	nmod	B-Organism
throughout	IN	case	O
the	DT	det	O
consecutive	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
tumorigenesis	NN	nmod	O
whereas	IN	mark	O
the	DT	det	O
angiogenesis	NN	compound	O
factor	NN	nsubjpass	O
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
,	,	punct	O
was	VBD	auxpass	O
induced	VBN	advcl	O
predominantly	RB	advmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
deficiency	NN	nsubj	O
dramatically	RB	advmod	O
enhanced	VBD	ROOT	O
susceptibility	NN	dobj	O
to	TO	case	O
skin	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
accelerated	VBN	amod	O
and	CC	cc	O
increased	VBN	conj	O
tumor	NN	compound	B-Cancer
formation	NN	nmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
malignant	JJ	amod	I-Pathological_formation
tumor	NN	compound	I-Pathological_formation
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

While	IN	mark	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
deficiency	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
tumor	NN	compound	B-Cancer
differentiation	NN	dobj	O
or	CC	cc	O
proliferation	NN	conj	O
,	,	punct	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
upregulation	NN	dobj	O
of	IN	case	O
an	DT	det	O
endogenous	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
during	IN	case	O
multi	NN	amod	O
step	NN	compound	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
identify	VB	conj	O
enhanced	VBN	amod	O
stromal	JJ	amod	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
host	NN	compound	O
anti	NN	compound	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
defense	NN	compound	O
mechanism	NN	nmod	O
.	.	punct	O

Relationship	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
Helicobacter	NNP	conj	B-Organism
pylori	NNS	nmod	I-Organism
to	TO	case	O
clinicopathological	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
remnant	JJ	amod	B-Cancer
stomach	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
after	IN	case	O
gastric	JJ	amod	B-Organ
surgery	NN	nmod	O
for	IN	case	O
primary	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
biological	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
remnant	JJ	amod	B-Organ
stomach	NN	nmod	I-Organ
(	-LRB-	punct	O
RSC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Twenty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
patients	NNS	nsubj	B-Organism
underwent	VBD	ROOT	O
resection	NN	dobj	O
of	IN	case	O
the	DT	det	O
remnant	JJ	amod	B-Organ
stomach	NN	nmod	I-Organ
for	IN	case	O
RSC	NN	nmod	B-Cancer
and	CC	cc	O
were	VBD	auxpass	O
divided	VBN	conj	O
into	IN	case	O
two	CD	nummod	O
groups	NNS	nmod	O
:	:	punct	O
the	DT	det	O
RSCB	NN	compound	B-Cancer
group	NN	nsubj	O
consisted	VBD	parataxis	O
of	IN	case	O
11	CD	nummod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
underwent	VBD	acl:relcl	O
distal	JJ	amod	O
gastrectomy	NN	dobj	O
for	IN	case	O
benign	JJ	amod	O
disease	NN	nmod	O
and	CC	cc	O
the	DT	det	O
RSCM	NN	compound	B-Cancer
group	NN	conj	O
consisted	VBD	acl	O
of	IN	case	O
10	CD	nummod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
underwent	VBD	acl:relcl	O
gastrectomy	NN	dobj	O
for	IN	case	O
primary	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
interval	NN	nsubj	O
between	IN	case	O
primary	JJ	amod	O
surgery	NN	nmod	O
and	CC	cc	O
the	DT	det	O
appearance	NN	conj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	IN	case	O
the	DT	det	O
remnant	JJ	amod	B-Organ
stomach	NN	nmod	I-Organ
was	VBD	cop	O
significantly	RB	advmod	O
shorter	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
RSCM	NN	compound	B-Cancer
group	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
RSCB	NN	compound	B-Cancer
group	NN	advcl	O
.	.	punct	O

Invasion	NN	nsubj	O
of	IN	prep	O
adjacent	JJ	amod	O
organs	NNS	pobj	B-Organ
was	VBD	cop	O
more	RBR	advmod	O
frequent	JJ	acomp	O
in	IN	case	O
the	DT	det	O
RSCM	NN	compound	B-Cancer
group	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
RSCB	NN	compound	B-Cancer
group	NN	advcl	O
and	CC	cc	O
the	DT	det	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
labeling	VBG	compound	O
index	NN	conj	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
former	JJ	amod	O
group	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
p53	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
by	IN	case	O
tumors	NNS	nmod	B-Cancer
was	VBD	cop	O
almost	RB	advmod	O
twice	RB	advmod	O
as	IN	advmod	O
common	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
RSCM	NN	compound	B-Cancer
group	NN	nmod	O
as	IN	case	O
in	IN	case	O
the	DT	det	O
RSCB	NN	compound	B-Cancer
group	NN	advcl	O
.	.	punct	O

Although	IN	mark	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubj	O
of	IN	case	O
the	DT	det	O
H	NN	nmod	B-Organism
.	.	punct	I-Organism
pylori	NNS	compound	I-Organism
positivity	NN	nsubj	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
,	,	punct	O
the	DT	det	O
rate	NN	nsubj	O
for	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	mark	O
reported	VBN	advcl	O
in	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
high	JJ	amod	O
proliferative	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
RSCM	NN	compound	B-Cancer
group	NN	nmod	O
and	CC	cc	O
H	NN	conj	B-Organism
.	.	punct	I-Organism
pylori	NNS	compound	I-Organism
infection	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
closely	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
carcinogenesis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
RSC	NN	nmod	B-Cancer
.	.	punct	O

Current	JJ	amod	O
prospects	NNS	ROOT	O
for	IN	prep	O
controlling	VBG	pcomp	O
cancer	NN	compound	B-Cancer
growth	NN	dobj	O
with	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
cytotoxic	JJ	amod	O
agents	NNS	compound	O
-	:	punct	O
-	HYPH	punct	O
nutrients	NNS	pobj	O
,	,	punct	O
phytochemicals	NNS	conj	O
,	,	punct	O
herbal	JJ	amod	O
extracts	NNS	conj	O
,	,	punct	O
and	CC	cc	O
available	JJ	amod	O
drugs	NNS	conj	O
.	.	punct	O

In	IN	case	O
animal	NN	nmod	O
or	CC	cc	O
cell	NN	compound	B-Cell
culture	NN	compound	O
studies	NNS	conj	O
,	,	punct	O
the	DT	det	O
growth	NN	nsubjpass	O
and	CC	cc	O
spread	NN	conj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
can	MD	aux	O
be	VB	auxpass	O
slowed	VBN	ROOT	O
by	IN	case	O
many	JJ	amod	O
nutrients	NNS	nmod	O
,	,	punct	O
food	NN	compound	O
factors	NNS	appos	O
,	,	punct	O
herbal	JJ	amod	O
extracts	NNS	conj	O
,	,	punct	O
and	CC	cc	O
well	RB	advmod	O
-	HYPH	punct	O
tolerated	VBN	conj	O
,	,	punct	O
available	JJ	amod	O
drugs	NNS	appos	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
still	RB	advmod	O
rarely	RB	advmod	O
used	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
clinical	JJ	amod	O
management	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
because	IN	mark	O
they	PRP	nsubj	O
seem	VBP	advcl	O
unlikely	JJ	advmod	O
to	TO	aux	O
constitute	VB	xcomp	O
definitive	JJ	amod	O
therapies	NNS	dobj	O
in	IN	prep	O
themselves	PRP	pobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
reasonable	JJ	ROOT	O
to	TO	mark	O
expect	VB	xcomp	O
that	IN	mark	O
mechanistically	RB	advmod	O
complementary	JJ	amod	O
combinations	NNS	nsubj	O
of	IN	prep	O
these	DT	det	O
measures	NNS	pobj	O
could	MD	aux	O
have	VB	ccomp	O
a	DT	det	O
worthwhile	JJ	amod	O
impact	NN	dobj	O
on	IN	prep	O
survival	NN	compound	O
times	NNS	pobj	O
and	CC	cc	O
,	,	punct	O
when	WRB	advmod	O
used	VBN	advcl	O
as	IN	prep	O
adjuvants	NNS	pobj	O
,	,	punct	O
could	MD	aux	O
improve	VB	advcl	O
the	DT	det	O
cure	NN	compound	O
rates	NNS	dobj	O
achievable	JJ	amod	O
with	IN	prep	O
standard	JJ	amod	O
therapies	NNS	pobj	O
.	.	punct	O

The	DT	det	O
therapeutic	JJ	amod	O
options	NNS	nsubj	O
available	JJ	amod	O
in	IN	case	O
this	DT	det	O
regard	NN	nmod	O
include	VBP	ROOT	O
measures	NNS	dobj	O
that	WDT	mark	O
:	:	punct	O
down	RB	advmod	O
-	HYPH	punct	O
regulate	VB	amod	O
serum	NN	compound	B-Organism_substance
free	JJ	amod	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	PRP	nsubj	I-Gene_or_gene_product
;	:	punct	O
suppress	VBP	ccomp	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
mevalonic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
certain	JJ	amod	O
derivatives	NNS	conj	O
thereof	RB	advmod	O
;	:	punct	O
modulate	VB	conj	O
arachidonate	NN	compound	B-Simple_chemical
metabolism	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
5	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
lipoxygenase	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
12	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
lipoxygenase	NN	conj	I-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
COX	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
;	:	punct	O
antagonize	VB	conj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
transcription	NN	compound	O
factors	NNS	nmod	O
;	:	punct	O
promote	VBP	conj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
PPAR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
gamma	NN	compound	I-Gene_or_gene_product
transcription	NN	compound	O
factors	NNS	nmod	O
;	:	punct	O
and	CC	cc	O
that	IN	nsubj	O
suppress	VBP	conj	O
angiogenesis	NN	dobj	O
by	IN	case	O
additional	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

Many	JJ	nsubj	O
of	IN	prep	O
these	DT	det	O
measures	NNS	pobj	O
appear	VBP	ROOT	O
suitable	JJ	xcomp	O
for	IN	case	O
use	NN	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cancer
prevention	NN	nmod	O
.	.	punct	O

Oncogenic	JJ	amod	O
mechanisms	NNS	ROOT	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
Evi	NNP	nsubjpass	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	auxpass	O
thought	VBN	advcl	O
to	TO	mark	O
promote	VB	xcomp	O
growth	NN	dobj	O
or	CC	cc	O
block	VB	conj	O
differentiation	NN	dobj	O
in	IN	case	O
some	DT	det	O
cell	NN	compound	B-Cell
types	NNS	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
biological	JJ	amod	O
functions	NNS	nsubjpass	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
elucidated	VBN	ROOT	O
.	.	punct	O

To	TO	mark	O
explore	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
Evi	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
oncogenesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
Evi	NNP	nsubj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
affects	VBZ	ccomp	O
the	DT	det	O
signaling	NN	dobj	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
proliferation	NN	dobj	O
of	IN	case	O
a	DT	det	O
wide	JJ	amod	O
range	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
types	NNS	nmod	I-Cell
and	CC	cc	O
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
studied	VBN	amod	O
growth	NN	compound	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
Evi	NNP	nsubj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
represses	VBZ	ccomp	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	dobj	O
and	CC	cc	O
antagonizes	VBZ	conj	O
its	PRP$	nmod:poss	O
growth	NN	nmod:npmod	O
-	HYPH	punct	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

Two	CD	nummod	O
separate	JJ	amod	O
regions	NNS	nsubj	O
of	IN	prep	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	pobj	I-Gene_or_gene_product
are	VBP	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
this	DT	det	O
repression	NN	nmod	O
,	,	punct	O
one	CD	nsubj	O
of	IN	case	O
which	WDT	nmod	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
zinc	NN	compound	O
-	HYPH	punct	O
finger	NN	compound	O
domain	NN	conj	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
domain	NN	nmod	O
,	,	punct	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
physically	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
mediator	NN	appos	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suppressing	VBG	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
define	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
repressor	NN	nmod	O
of	IN	case	O
signaling	VBG	compound	O
components	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
Evi	NNP	nsubj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
represses	VBZ	ccomp	O
Smad	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
by	IN	mark	O
recruiting	VBG	advcl	O
CtBP	NN	dobj	B-Gene_or_gene_product
as	IN	prep	O
a	DT	det	O
corepressor	NN	pobj	O
.	.	punct	O

Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
associates	VBZ	ROOT	O
with	IN	case	O
CtBP1	NN	nmod	B-Gene_or_gene_product
through	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
CtBP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
consensus	NN	compound	O
motifs	NNS	nmod	O
within	IN	case	O
the	DT	det	O
region	NN	nmod	O
from	IN	case	O
amino	NN	compound	B-Amino_acid
acid	NN	nmod	I-Amino_acid
544	CD	nummod	I-Amino_acid
to	TO	dep	O
607	CD	nummod	B-Amino_acid
,	,	punct	O
and	CC	cc	O
this	DT	det	O
association	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
the	DT	det	O
efficient	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
HDAc	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	B-Simple_chemical
A	NN	appos	I-Simple_chemical
(	-LRB-	punct	O
TSA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

This	DT	nsubj	O
identifies	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
member	NN	nmod	O
of	IN	case	O
corepressor	NN	compound	O
complexes	NNS	nmod	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
aberrant	JJ	amod	O
recruitment	NN	nsubj	O
of	IN	case	O
corepressors	NNS	nmod	O
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
Evi	NNP	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
specific	JJ	amod	O
HDAc	NNS	compound	B-Gene_or_gene_product
inhibitors	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
Evi	NNP	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
neoplastic	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
including	VBG	case	O
myeloid	JJ	amod	B-Cancer
leukemias	NNS	nmod	I-Cancer
.	.	punct	O

Antibodies	NNS	nsubj	O
to	TO	case	O
PAI	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
alter	VBP	ROOT	O
the	DT	det	O
invasive	JJ	amod	O
and	CC	cc	O
migratory	JJ	conj	O
properties	NNS	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
tumour	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Recent	JJ	amod	O
reports	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
elevated	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
plasminogen	NN	compound	B-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
tumour	VB	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

The	DT	det	O
studies	NNS	nsubjpass	O
reported	VBN	acl	O
here	RB	advmod	O
were	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
help	VB	xcomp	O
elucidate	VB	xcomp	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
'	''	punct	O
s	NNS	compound	O
contribution	NN	dobj	O
to	TO	prep	O
the	DT	det	O
invasive	JJ	amod	O
and	CC	cc	O
migratory	JJ	conj	O
phenotype	NN	pobj	O
.	.	punct	O

Antibodies	NNS	nsubj	O
to	TO	case	O
PA	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
dose	NN	nmod	O
-	HYPH	punct	O
dependently	RB	advmod	O
,	,	punct	O
and	CC	cc	O
significantly	RB	advmod	O
,	,	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
invasive	JJ	amod	O
and	CC	cc	O
migratory	JJ	conj	O
potential	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
HT1080	NN	compound	B-Cell
fibrosarcoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	IN	mark	O
did	VBD	advcl	O
an	DT	det	O
antibody	NN	dobj	O
to	TO	case	O
uPA	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
plasmin	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
aprotinin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Invasion	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
BLM	NN	appos	B-Cell
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
attenuated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
PAI	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
monoclonal	JJ	amod	O
antibody	NN	compound	O
MAI	NNP	nmod	O
-	:	punct	O
12	CD	nummod	O
.	.	punct	O

The	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
invasive	JJ	amod	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nsubj	I-Cell
,	,	punct	O
IF6	NN	appos	B-Cell
,	,	punct	O
which	WDT	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
express	VB	acl:relcl	O
uPA	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
provided	VBD	ROOT	O
further	JJ	amod	O
confirmation	NN	dobj	O
of	IN	case	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
uPA	NN	conj	B-Gene_or_gene_product
'	''	punct	O
s	VBZ	compound	O
role	NN	nmod	O
as	IN	advmod	O
,	,	punct	O
upon	IN	case	O
transfection	NN	nmod	O
with	IN	case	O
uPA	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
this	DT	det	O
cell	NN	compound	B-Cell
line	NN	nsubj	I-Cell
attained	VBD	conj	O
an	DT	det	O
invasive	JJ	amod	O
phenotype	NN	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
again	RB	advmod	O
attenuated	VBN	acl:relcl	O
by	IN	case	O
MAI	NNP	nmod	O
-	:	punct	O
12	CD	nummod	O
.	.	punct	O

Although	IN	mark	O
antibodies	NNS	nsubj	O
to	TO	case	O
PAI	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
the	DT	det	O
adhesion	NN	dobj	O
of	IN	case	O
HT1080	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
antibody	NN	nsubj	O
to	TO	case	O
uPA	NN	nmod	B-Gene_or_gene_product
reduced	VBD	ROOT	O
their	PRP$	nmod:poss	O
attachment	NN	dobj	O
.	.	punct	O

Addition	NN	nsubj	O
of	IN	case	O
exogenous	JJ	amod	O
PAI	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
prevented	VBD	ROOT	O
HT1080	NN	compound	B-Cell
cell	NN	compound	I-Cell
adhesion	NN	dobj	O
(	-LRB-	punct	O
IC50	NN	dep	O
180	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
promoted	VBD	conj	O
cell	NN	compound	B-Cell
detachment	NN	dobj	O
from	IN	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Furthermore	RB	advmod	O
melanoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
uPA	NN	amod	B-Gene_or_gene_product
variant	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
had	VBD	acl:relcl	O
an	DT	det	O
impaired	JJ	amod	O
interaction	NN	dobj	O
with	IN	case	O
PAI	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
were	VBD	cop	O
not	RB	neg	O
invasive	JJ	ROOT	O
and	CC	cc	O
had	VBD	conj	O
impaired	JJ	amod	O
binding	NN	dobj	O
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
highlight	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
a	DT	det	O
balanced	JJ	amod	O
proteolysis	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
an	DT	det	O
additional	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
PAI	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
distinct	JJ	amod	O
from	IN	case	O
its	PRP$	nmod:poss	O
role	NN	nmod	O
in	IN	case	O
proteolysis	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
uPA	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
PAI	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
co	VB	compound	O
-	HYPH	punct	O
operate	NN	ccomp	O
in	IN	case	O
the	DT	det	O
migratory	JJ	amod	O
process	NN	nmod	O
by	IN	mark	O
respectively	RB	advmod	O
facilitating	VBG	advcl	O
the	DT	det	O
attachment	NN	dobj	O
to	TO	prep	O
,	,	punct	O
and	CC	cc	O
subsequent	JJ	amod	O
detachment	NN	conj	O
from	IN	case	O
,	,	punct	O
vitronectin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
clinical	JJ	amod	O
findings	NNS	dobj	O
and	CC	cc	O
indicate	VBP	conj	O
that	IN	mark	O
modulation	NN	nsubj	O
of	IN	case	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
therapeutic	JJ	amod	O
benefit	NN	ccomp	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
PDGF	NN	compound	B-Gene_or_gene_product
-	:	punct	O
stimulated	VBN	amod	O
and	CC	cc	O
matrix	NN	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
mediated	VBN	conj	O
proliferation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
vascular	JJ	amod	B-Cell
smooth	NN	amod	I-Cell
muscle	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
independent	JJ	ROOT	O
of	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
cell	NN	compound	B-Cell
shape	NN	nmod	O
or	CC	cc	O
cyclin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dependent	JJ	amod	I-Simple_chemical
kinase	NN	compound	I-Simple_chemical
inhibitors	NNS	conj	I-Simple_chemical
.	.	punct	O

Interactions	NNS	nsubj	O
among	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
,	,	punct	O
cells	NNS	conj	B-Cell
,	,	punct	O
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	conj	I-Cellular_component
regulate	VBP	ROOT	O
proliferation	NN	dobj	O
during	IN	case	O
normal	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
in	IN	case	O
pathologies	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
atherosclerosis	NN	nmod	O
.	.	punct	O

SPARC	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
secreted	VBN	amod	B-Gene_or_gene_product
protein	NN	dep	I-Gene_or_gene_product
,	,	punct	I-Gene_or_gene_product
acidic	JJ	conj	I-Gene_or_gene_product
,	,	punct	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
rich	JJ	conj	I-Gene_or_gene_product
in	IN	case	I-Gene_or_gene_product
cysteine	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
matrix	NN	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
associated	VBN	amod	O
glycoprotein	NN	ROOT	O
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
the	DT	det	O
adhesion	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
SPARC	NN	nsubj	B-Gene_or_gene_product
inhibits	VBZ	ccomp	O
human	JJ	amod	B-Organism
arterial	JJ	amod	B-Cell
smooth	NN	amod	I-Cell
muscle	NN	compound	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
stimulated	VBN	acl	O
by	IN	case	O
platelet	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
by	IN	case	O
adhesion	NN	conj	O
to	TO	case	O
monomeric	JJ	amod	B-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
collagen	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Binding	NN	amod	O
studies	NNS	nsubj	O
with	IN	case	O
SPARC	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
SPARC	NN	conj	B-Gene_or_gene_product
peptides	NNS	nmod	I-Gene_or_gene_product
indicate	VBP	ROOT	O
specific	JJ	amod	O
and	CC	cc	O
saturable	JJ	conj	O
interaction	NN	dobj	O
with	IN	case	O
smooth	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
involves	VBZ	acl:relcl	O
the	DT	det	O
C	NN	compound	O
-	HYPH	punct	O
terminal	JJ	amod	O
Ca2	NN	nmod	O
+	CC	cc	O
-	:	punct	O
binding	NN	compound	O
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
SPARC	NN	nsubj	B-Gene_or_gene_product
arrests	NNS	ccomp	O
monomeric	JJ	amod	O
collagen	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
supported	VBN	dep	O
smooth	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
in	IN	case	O
the	DT	det	O
late	JJ	amod	O
G1	NN	compound	O
-	HYPH	punct	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
an	DT	det	O
effect	NN	nmod	O
on	IN	case	O
cell	NN	compound	B-Cell
shape	NN	nmod	O
or	CC	cc	O
on	IN	case	O
levels	NNS	conj	O
of	IN	case	O
cyclin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dependent	JJ	amod	I-Simple_chemical
kinase	NN	compound	I-Simple_chemical
inhibitors	NNS	nmod	I-Simple_chemical
.	.	punct	O

Cyclin	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activity	NN	nsubjpass	O
,	,	punct	O
p107	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
cyclin	NN	compound	B-Gene_or_gene_product
A	NN	conj	I-Gene_or_gene_product
levels	NNS	conj	O
,	,	punct	O
and	CC	cc	O
retinoblastoma	NN	compound	B-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
phosphorylation	NN	nsubjpass	O
are	VBP	auxpass	O
markedly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	O
SPARC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
peptides	NNS	conj	O
derived	VBN	acl	O
from	IN	case	O
specific	JJ	amod	O
domains	NNS	nmod	O
of	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
SPARC	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
previously	RB	advmod	O
characterized	VBN	advcl	O
as	IN	case	O
an	DT	det	O
inhibitor	NN	nmod	O
of	IN	case	O
platelet	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
binding	VBG	acl	O
to	TO	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
,	,	punct	O
also	RB	advmod	O
antagonizes	VBZ	ROOT	O
smooth	VB	amod	B-Cell
muscle	NN	compound	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
mediated	VBN	acl	O
by	IN	case	O
monomeric	JJ	amod	O
collagen	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

Prognostic	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
heat	NN	compound	B-Gene_or_gene_product
shock	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
27	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
HSP27	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Heat	NN	compound	B-Gene_or_gene_product
shock	NN	compound	I-Gene_or_gene_product
proteins	NNS	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
HSPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
defined	VBN	ROOT	O
as	IN	case	O
proteins	NNS	nmod	O
induced	VBN	acl	O
by	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
environmental	JJ	amod	O
and	CC	cc	O
pathophysiologic	JJ	conj	O
stress	NN	conj	O
.	.	punct	O

Heat	NN	compound	B-Gene_or_gene_product
shock	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
27	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
HSP27	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
small	JJ	amod	B-Gene_or_gene_product
heat	NN	compound	I-Gene_or_gene_product
shock	NN	compound	I-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

HSP27	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
protein	NN	compound	O
-	HYPH	punct	O
protein	NN	compound	O
interactions	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
folding	VBG	nmod	O
,	,	punct	O
translocation	NN	conj	O
,	,	punct	O
and	CC	cc	O
prevention	NN	conj	O
of	IN	case	O
inappropriate	JJ	amod	O
protein	NN	compound	O
aggregation	NN	nmod	O
.	.	punct	O

Many	JJ	nsubj	O
of	IN	prep	O
their	PRP$	poss	O
functions	NNS	pobj	O
suggest	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
play	VBP	ccomp	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Archival	NN	compound	B-Tissue
tissues	NNS	nsubjpass	I-Tissue
from	IN	case	O
40	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
who	WP	nsubj	O
received	VBD	acl:relcl	O
primary	JJ	amod	O
surgical	JJ	amod	O
resection	NN	dobj	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
HSP27	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
immunohistochemistry	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
clinical	JJ	amod	O
stage	NN	nmod	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
,	,	punct	O
histological	JJ	amod	O
grade	NN	compound	O
and	CC	cc	O
survival	NN	conj	O
period	NN	appos	O
.	.	punct	O

HSP27	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
positive	JJ	amod	O
staining	NN	ROOT	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
in	IN	case	O
20	CD	nummod	O
(	-LRB-	punct	O
50	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
weak	JJ	amod	O
or	CC	cc	O
negative	JJ	conj	O
staining	NN	conj	O
(	-LRB-	punct	O
-	:	punct	O
)	-RRB-	punct	O
in	IN	case	O
20	CD	nmod	O
(	-LRB-	punct	O
50	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
total	JJ	amod	O
40	CD	nummod	O
cases	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
HSP27	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
stage	NN	conj	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
and	CC	cc	O
histological	JJ	amod	O
grade	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
clinicopathological	JJ	amod	O
features	NNS	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
HSP27	NN	nmod	B-Gene_or_gene_product
correlated	VBD	ROOT	O
inversely	RB	advmod	O
with	IN	case	O
survival	NN	compound	O
period	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
HSP27	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
frequently	RB	advmod	O
promoted	VBN	ccomp	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
should	MD	aux	O
be	VB	auxpass	O
considered	VBN	conj	O
an	DT	det	O
independent	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	xcomp	O
of	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

Upregulation	NN	nsubjpass	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
advanced	JJ	amod	O
neuroblastoma	NN	nmod	B-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptors	NNS	nmod	O
Flt	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	conj	O
at	IN	case	O
gene	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
levels	NNS	nmod	O
in	IN	case	O
neuroblastoma	NN	nmod	B-Cancer
remains	VBZ	ROOT	O
widely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Tumor	NN	compound	B-Cancer
biopsy	NN	compound	I-Cancer
specimens	NNS	nsubjpass	I-Cancer
and	CC	cc	O
serum	NN	conj	B-Organism_substance
were	VBD	auxpass	O
obtained	VBN	dep	O
from	IN	case	O
37	CD	nummod	O
neuroblastoma	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
;	:	punct	O
adrenal	JJ	amod	B-Multi-tissue_structure
biopsy	NN	compound	I-Multi-tissue_structure
sections	NNS	dep	I-Multi-tissue_structure
and	CC	cc	O
sera	NNS	conj	B-Organism_substance
of	IN	case	O
7	CD	nummod	O
normal	JJ	amod	O
children	NNS	nmod	B-Organism
served	VBN	acl	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

Biopsy	NN	compound	B-Cancer
specimens	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
reverse	JJ	amod	O
transcription	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
(	-LRB-	punct	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
Western	NN	compound	O
blotting	NN	conj	O
;	:	punct	O
serum	NN	nsubjpass	B-Organism_substance
was	VBD	auxpass	O
analyzed	VBN	parataxis	O
by	IN	case	O
enzyme	NN	nmod:npmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
(	-LRB-	punct	O
ELISA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
165	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
,	,	punct	O
B	NN	conj	B-Gene_or_gene_product
,	,	punct	O
C	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Flt	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nsubjpass	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod:poss	O
'	POS	case	O
mRNA	NN	conj	O
were	VBD	auxpass	O
expressed	VBN	dep	O
in	IN	case	O
neuroblastoma	NN	nmod	B-Cancer
and	CC	cc	O
control	NN	conj	O
tissues	NNS	dep	B-Tissue
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
ligands	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	advcl	O
in	IN	case	O
stages	NNS	nmod	O
III	CD	nummod	O
and	CC	cc	O
IV	CD	conj	O
,	,	punct	O
the	DT	det	O
receptors	NNS	nsubjpass	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
stage	NN	nmod	O
III	CD	nummod	O
only	RB	advmod	O
.	.	punct	O

At	IN	case	O
protein	NN	compound	O
level	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
B	NN	intj	I-Gene_or_gene_product
and	CC	cc	O
C	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Flt	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
were	VBD	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
in	IN	case	O
tissue	NN	compound	B-Organism_substance
lysates	NNS	nmod	I-Organism_substance
,	,	punct	O
whereas	IN	dep	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
increased	VBN	parataxis	O
in	IN	case	O
stages	NNS	nmod	O
III	CD	nummod	O
and	CC	cc	O
IV	CD	conj	O
.	.	punct	O

Serum	NN	compound	B-Organism_substance
VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
stage	NN	nmod	O
III	CD	nummod	O
.	.	punct	O

CONCLUSIONS	NNS	nsubj	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
165	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
is	VBZ	cop	O
one	CD	dep	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
angiogenesis	NN	compound	O
regulators	NNS	nmod	O
among	IN	case	O
the	DT	det	O
ligands	NNS	nmod:poss	O
'	POS	case	O
family	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
whereas	IN	punct	O
its	PRP$	nmod:poss	O
receptors	NNS	appos	O
KDR	NN	dep	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
most	RBS	advmod	O
probably	RB	advmod	O
Flt	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	compound	O
(	-LRB-	punct	O
angiogenic	JJ	amod	O
)	-RRB-	punct	O
phenotype	NN	nmod	O
,	,	punct	O
as	IN	mark	O
indicated	VBN	advcl	O
by	IN	case	O
their	PRP$	nmod:poss	O
upregulated	VBN	amod	O
MRNA	NN	compound	O
levels	NNS	nmod	O
in	IN	case	O
stage	NN	compound	B-Cancer
III	CD	nummod	I-Cancer
neuroblastoma	NN	nmod	I-Cancer
.	.	punct	O

VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
165	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
mainly	RB	advmod	O
contributes	VBZ	ROOT	O
to	TO	case	O
increased	VBN	amod	O
serum	NN	compound	B-Organism_substance
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
serve	VB	conj	O
as	IN	case	O
a	DT	det	O
diagnostic	JJ	amod	O
tool	NN	nmod	O
in	IN	case	O
advanced	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
stage	NN	compound	I-Cancer
neuroblastoma	NN	nmod	I-Cancer
.	.	punct	O

Hypoxia	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activation	NN	nsubj	O
by	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
implicates	VBZ	ROOT	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	dobj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

Cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
display	VBP	ROOT	O
high	JJ	amod	O
rates	NNS	dobj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
,	,	punct	O
a	DT	det	O
phenomenon	NN	appos	O
known	VBN	acl	O
historically	RB	advmod	O
as	IN	case	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	nmod	O
.	.	punct	O

Lactate	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
pyruvate	NN	conj	B-Simple_chemical
,	,	punct	O
the	DT	det	O
end	NN	compound	O
products	NNS	appos	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
are	VBP	auxpass	O
highly	RB	advmod	O
produced	VBN	ROOT	O
by	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
.	.	punct	O

Hypoxia	NN	nsubj	O
-	HYPH	punct	O
induced	VBN	amod	O
gene	NN	compound	O
expression	NN	nsubjpass	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
has	VBZ	aux	O
been	VBN	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
lactate	NN	nsubj	B-Simple_chemical
and	CC	cc	O
pyruvate	VB	conj	B-Simple_chemical
regulate	NN	ccomp	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
independently	RB	advmod	O
of	IN	case	O
hypoxia	NN	nmod	O
by	IN	mark	O
stimulating	VBG	advcl	O
the	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
Factor	NN	compound	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-Organism
gliomas	NNS	nmod	B-Cancer
and	CC	cc	O
other	JJ	amod	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
,	,	punct	O
the	DT	det	O
accumulation	NN	nsubj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
under	IN	case	O
aerobic	JJ	amod	O
conditions	NNS	nmod	O
requires	VBZ	ROOT	O
the	DT	det	O
metabolism	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
to	TO	mark	O
pyruvate	VB	advcl	B-Simple_chemical
that	WDT	nsubj	O
prevents	VBZ	ccomp	O
the	DT	det	O
aerobic	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
activates	VBZ	conj	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
enhances	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
HIF	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
activated	VBN	amod	O
genes	NNS	nmod	O
including	VBG	case	O
erythropoietin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
glucose	NN	compound	B-Gene_or_gene_product
transporter	NN	conj	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
aldolase	NN	compound	B-Gene_or_gene_product
A	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
pyruvate	NN	nmod	B-Simple_chemical
in	IN	case	O
metabolic	JJ	amod	O
signaling	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
high	JJ	amod	O
rates	NNS	nsubj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
can	MD	aux	O
promote	VB	acl:relcl	O
the	DT	det	O
malignant	JJ	amod	O
transformation	NN	dobj	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Risk	NN	ROOT	O
of	IN	case	O
myelodysplastic	JJ	amod	O
syndrome	NN	nmod	O
and	CC	cc	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	conj	I-Cancer
in	IN	case	O
congenital	JJ	amod	O
neutropenias	NNS	nmod	O
.	.	punct	O

Granulocyte	NN	compound	B-Gene_or_gene_product
colony	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
had	VBN	ROOT	O
a	DT	det	O
major	JJ	amod	O
impact	NN	dobj	O
on	IN	prep	O
the	DT	det	O
management	NN	pobj	O
of	IN	prep	O
"	``	punct	O
severe	JJ	amod	O
chronic	JJ	amod	O
neutropenia	NN	pobj	O
"	''	punct	O
(	-LRB-	punct	O
SCN	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
collective	JJ	amod	O
term	NN	appos	O
referring	VBG	acl	O
to	TO	prep	O
congenital	JJ	amod	O
,	,	punct	O
idiopathic	JJ	conj	O
,	,	punct	O
or	CC	cc	O
cyclic	JJ	conj	O
neutropenia	NN	pobj	O
.	.	punct	O

Almost	RB	advmod	O
all	DT	det	O
patients	NNS	nsubj	B-Organism
respond	VBP	ROOT	O
to	TO	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
with	IN	case	O
increased	VBN	amod	O
neutrophils	NNS	nmod	B-Cell
,	,	punct	O
reduced	VBN	amod	O
infections	NNS	conj	O
,	,	punct	O
and	CC	cc	O
improved	VBD	conj	O
survival	NN	dobj	O
.	.	punct	O

Some	DT	det	O
responders	NNS	nsubj	O
with	IN	prep	O
congenital	JJ	amod	O
neutropenia	NN	pobj	O
and	CC	cc	O
Shwachman	NNP	compound	O
-	HYPH	punct	O
Diamond	NN	compound	O
syndrome	NN	conj	O
(	-LRB-	punct	O
SDS	NN	appos	O
)	-RRB-	punct	O
have	VBP	aux	O
developed	VBN	ROOT	O
myelodysplastic	JJ	amod	O
syndrome	NN	dobj	O
and	CC	cc	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	conj	I-Cancer
(	-LRB-	punct	O
MDS	NN	appos	O
/	:	punct	O
AML	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
raises	VBZ	acl:relcl	O
the	DT	det	O
question	NN	dobj	O
of	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
pathogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
issue	NN	nsubjpass	O
is	VBZ	auxpass	O
complicated	VBN	ROOT	O
because	IN	mark	O
both	DT	det	O
disorders	NNS	nsubj	O
have	VBP	advcl	O
a	DT	det	O
propensity	NN	dobj	O
for	IN	case	O
MDS	NN	nmod	O
or	CC	cc	O
AML	NN	conj	B-Cancer
as	IN	case	O
part	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
natural	JJ	amod	O
history	NN	nmod	O
.	.	punct	O

To	TO	aux	O
address	VB	advcl	O
this	DT	dobj	O
,	,	punct	O
the	DT	nsubj	O
Severe	NNP	compound	O
Chronic	NNP	compound	O
Neutropenia	NNP	compound	O
International	NNP	compound	O
Registry	NNP	prep	O
(	-LRB-	punct	O
SCNIR	NN	appos	O
)	-RRB-	punct	O
used	VBD	ROOT	O
its	PRP$	nmod:poss	O
large	JJ	amod	O
database	NN	dobj	O
of	IN	case	O
chronic	JJ	amod	O
neutropenia	NN	amod	O
patients	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
incidence	NN	dobj	O
of	IN	case	O
malignant	JJ	amod	B-Cell
myeloid	JJ	amod	I-Cell
transformation	NN	nmod	O
in	IN	case	O
the	DT	det	O
two	CD	nummod	O
disorders	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
relationship	NN	conj	O
to	TO	case	O
treatment	NN	nmod	O
and	CC	cc	O
to	TO	case	O
other	JJ	amod	O
patient	NN	compound	B-Organism
characteristics	NNS	conj	O
.	.	punct	O

No	DT	neg	O
statistically	RB	advmod	O
significant	JJ	amod	O
relationships	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
age	NN	nmod	O
at	IN	case	O
onset	NN	nmod	O
of	IN	case	O
MDS	NN	nmod	O
or	CC	cc	O
AML	NN	conj	B-Cancer
and	CC	cc	O
patient	NN	conj	B-Organism
gender	NN	conj	O
,	,	punct	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
dose	NN	conj	O
,	,	punct	O
or	CC	cc	O
duration	NN	conj	O
of	IN	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
therapy	NN	nmod	O
.	.	punct	O

What	WP	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	case	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
was	VBD	cop	O
the	DT	det	O
multistep	NN	compound	O
acquisition	NN	ROOT	O
of	IN	case	O
aberrant	JJ	amod	O
cellular	JJ	amod	B-Cell
genetic	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
marrow	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
transformed	VBD	acl:relcl	O
,	,	punct	O
including	VBG	case	O
activating	VBG	amod	O
ras	NN	compound	B-Gene_or_gene_product
oncogene	NN	compound	O
mutations	NNS	nmod	O
,	,	punct	O
clonal	JJ	amod	O
cytogenetic	JJ	amod	O
abnormalities	NNS	conj	O
,	,	punct	O
and	CC	cc	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
mutations	NNS	conj	O
.	.	punct	O

In	IN	case	O
murine	JJ	amod	B-Organism
models	NNS	nmod	O
,	,	punct	O
the	DT	det	O
latter	JJ	nsubj	O
produces	VBZ	ROOT	O
a	DT	det	O
hyperproliferative	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
confers	VBZ	conj	O
resistance	NN	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
enhances	VBZ	conj	O
cell	NN	compound	B-Cell
survival	NN	dobj	O
.	.	punct	O

Since	IN	mark	O
congenital	JJ	amod	O
neutropenia	NN	nsubjpass	O
and	CC	cc	O
SDS	NN	conj	O
are	VBP	auxpass	O
inherited	VBN	advcl	O
forms	NNS	dobj	O
of	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
failure	NN	nmod	O
,	,	punct	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
accelerate	VB	ROOT	O
the	DT	det	O
propensity	NN	dobj	O
for	IN	case	O
MDS	NN	compound	O
/	:	punct	O
AML	NN	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
genetically	RB	advmod	O
altered	JJ	amod	O
stem	NN	compound	B-Cell
and	CC	cc	O
progenitor	NN	conj	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
those	DT	nmod	O
with	IN	case	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
ras	NN	compound	B-Gene_or_gene_product
mutations	NNS	conj	O
(	-LRB-	punct	O
82	CD	nummod	O
%	NN	conj	O
and	CC	cc	O
50	CD	nummod	O
%	NN	conj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
transform	VBP	acl:relcl	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Alternatively	RB	advmod	O
,	,	punct	O
and	CC	cc	O
equally	RB	advmod	O
plausible	JJ	conj	O
,	,	punct	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
simply	RB	advmod	O
be	VB	ROOT	O
an	DT	det	O
"	``	punct	O
innocent	JJ	amod	O
bystander	NN	attr	O
"	''	punct	O
that	WDT	nsubj	O
corrects	VBZ	relcl	O
neutropenia	NN	dobj	O
,	,	punct	O
prolongs	NNS	advcl	O
patient	VBP	compound	B-Organism
survival	NN	dobj	O
,	,	punct	O
and	CC	cc	O
allows	VBZ	conj	O
time	NN	dobj	O
for	IN	mark	O
the	DT	det	O
malignant	JJ	amod	O
predisposition	NN	nsubj	O
to	TO	aux	O
declare	VB	advcl	O
itself	PRP	dobj	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
transform	VBP	acl:relcl	O
to	TO	mark	O
overt	VB	xcomp	O
MDS	NN	dobj	O
or	CC	cc	O
AML	NN	conj	B-Cancer
,	,	punct	O
hematopoietic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
transplantation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
chance	NN	ROOT	O
for	IN	prep	O
cure	NN	pobj	O
.	.	punct	O

In	IN	prep	O
those	DT	pobj	O
with	IN	prep	O
"	``	punct	O
soft	JJ	amod	O
"	''	punct	O
signs	NNS	pobj	O
of	IN	prep	O
MDS	NN	pobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
an	DT	det	O
isolated	VBN	amod	O
clonal	JJ	amod	O
cytogenetic	JJ	amod	O
change	NN	nmod	O
but	CC	cc	O
without	IN	case	O
other	JJ	amod	O
evidence	NN	conj	O
of	IN	case	O
MDS	NN	nmod	O
,	,	punct	O
or	CC	cc	O
with	IN	case	O
an	DT	det	O
isolated	VBN	amod	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
mutation	NN	conj	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
room	NN	attr	O
for	IN	prep	O
conservative	JJ	amod	O
management	NN	pobj	O
.	.	punct	O

One	CD	nummod	O
option	NN	nsubj	O
is	VBZ	ROOT	O
to	TO	aux	O
reduce	VB	xcomp	O
the	DT	det	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
dosage	NN	dobj	O
as	RB	advmod	O
much	JJ	advmod	O
as	IN	prep	O
possible	JJ	amod	O
,	,	punct	O
and	CC	cc	O
observe	VB	conj	O
the	DT	det	O
tempo	NN	dobj	O
of	IN	prep	O
progression	NN	pobj	O
,	,	punct	O
if	IN	mark	O
any	DT	advcl	O
,	,	punct	O
to	TO	prep	O
more	RBR	advmod	O
overt	JJ	amod	O
signs	NNS	pobj	O
of	IN	prep	O
malignancy	NN	pobj	B-Cancer
.	.	punct	O

Hypoxic	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
head	NN	amod	B-Cell
and	CC	cc	I-Cell
neck	NN	conj	I-Cell
squamous	JJ	amod	I-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
stress	NN	compound	O
activated	JJ	amod	O
protein	NN	compound	O
kinases	NNS	nmod	O
.	.	punct	O

Solid	JJ	amod	B-Cancer
tumors	NNS	nsubj	I-Cancer
must	MD	aux	O
establish	VB	ROOT	O
a	DT	det	O
blood	NN	compound	B-Organism_substance
supply	NN	dobj	O
in	IN	mark	O
order	NN	pobj	O
to	TO	aux	O
proliferate	VB	advcl	O
and	CC	cc	O
grow	VB	conj	O
.	.	punct	O

Cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Among	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	nsubj	O
of	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
is	VBZ	cop	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	ROOT	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Increased	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
by	IN	case	O
malignant	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
high	JJ	amod	O
vascularity	NN	nmod	O
,	,	punct	O
increased	VBN	amod	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	conj	O
,	,	punct	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
.	.	punct	O

Reduced	VBN	amod	O
oxygen	NN	compound	B-Simple_chemical
tension	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
increase	VB	xcomp	O
VEGF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
by	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
hypoxia	NN	compound	B-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
hypoxic	JJ	amod	O
tumor	NN	compound	B-Cancer
environments	NNS	nsubj	O
induce	VBP	acl:relcl	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
are	VBP	cop	O
largely	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

Jun	NN	compound	B-Gene_or_gene_product
N	NN	compound	I-Gene_or_gene_product
terminal	JJ	amod	I-Gene_or_gene_product
kinase	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
JNK1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p38	NN	compound	B-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
are	VBP	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
stress	NN	compound	O
stimuli	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
if	IN	mark	O
hypoxic	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
stress	NN	compound	O
activated	VBD	amod	O
protein	NN	compound	O
kinases	NNS	nmod	O
regulated	VBD	ccomp	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
assayed	VBD	ROOT	O
JNK1	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
squamous	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
SCC	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
lines	NNS	nmod	I-Cell
grown	VBN	acl	O
under	IN	case	O
normoxic	JJ	amod	O
or	CC	cc	O
hypoxic	JJ	conj	O
conditions	NNS	nmod	O
.	.	punct	O

Hypoxia	NN	nsubj	O
rapidly	RB	advmod	O
induced	VBD	ROOT	O
both	CC	cc:preconj	O
JNK1	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

This	DT	det	O
activation	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
activity	NN	conj	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
p38	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
SB203580	NN	nmod	B-Simple_chemical
.	.	punct	O

Hypoxia	NN	nsubj	O
also	RB	advmod	O
increased	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
by	IN	case	O
SCC	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	acl:relcl	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
SB203580	NN	nmod	B-Simple_chemical
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
JNK1	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
induction	NN	nsubj	O
of	IN	case	O
SAPKs	NNS	nmod	B-Gene_or_gene_product
by	IN	case	O
hypoxia	NN	nmod	O
regulates	VBZ	ccomp	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
head	NN	compound	B-Cell
and	CC	cc	I-Cell
neck	NN	conj	I-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
two	CD	nummod	O
independent	JJ	amod	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
segments	NNS	nsubj	O
sensitize	VBP	ROOT	O
cells	NNS	dobj	B-Cell
to	TO	case	O
apoptosis	NN	nmod	O
following	VBG	case	O
genotoxic	JJ	amod	O
damage	NN	nmod	O
.	.	punct	O

The	DT	det	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
(	-LRB-	punct	O
SV40	NN	appos	B-Organism
)	-RRB-	punct	O
large	JJ	amod	B-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
antigen	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
transform	VB	xcomp	O
cells	NNS	dobj	B-Cell
in	IN	case	O
cultures	NNS	nmod	O
and	CC	cc	O
induce	VB	conj	O
tumors	NNS	dobj	B-Cancer
in	IN	case	O
experimental	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

Transformation	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	O
cells	NNS	nmod	B-Cell
in	IN	case	O
cultures	NNS	nmod	O
requires	VBZ	ROOT	O
both	CC	det	O
overcoming	VBG	amod	O
growth	NN	compound	O
arrest	NN	dobj	O
by	IN	mark	O
stimulating	VBG	advcl	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	dobj	O
and	CC	cc	O
blocking	VBG	conj	O
cell	NN	compound	B-Cell
death	NN	compound	O
activities	NNS	dobj	O
presumably	RB	advmod	O
activated	VBN	acl	O
by	IN	case	O
oncogene	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
hyperproliferation	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
study	NN	nsubj	O
presented	VBN	acl	O
here	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
regions	NNS	nmod	O
and	CC	cc	O
activities	NNS	conj	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
modulate	VB	acl	O
apoptosis	NN	dobj	O
in	IN	case	O
cells	NNS	nmod	B-Cell
treated	VBN	acl	O
with	IN	case	O
the	DT	det	O
genotoxic	JJ	amod	O
agent	NN	nmod	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
rendered	JJ	ccomp	O
rat	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	dobj	I-Cell
(	-LRB-	punct	O
REF	NN	appos	B-Cell
)	-RRB-	punct	O
sensitive	JJ	amod	O
to	TO	case	O
5	CD	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
neither	CC	cc:preconj	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
binding	NN	compound	O
region	NN	nsubj	O
nor	CC	cc	O
the	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
homology	NN	compound	O
region	NN	conj	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
prevent	VB	xcomp	O
cell	NN	compound	B-Cell
death	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	NN	amod	O
agent	NN	nmod	O
.	.	punct	O

T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
sensitization	NN	nsubj	O
occurred	VBD	ROOT	O
independently	RB	advmod	O
of	IN	case	O
retinoblastoma	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
p300	NN	conj	B-Gene_or_gene_product
binding	NN	conj	O
.	.	punct	O

An	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
segment	NN	nsubj	O
containing	VBG	acl	O
the	DT	det	O
first	JJ	amod	O
127	CD	nummod	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
amino	NN	compound	B-Amino_acid
acids	NNS	dobj	I-Amino_acid
(	-LRB-	punct	O
T1	NN	compound	O
-	:	punct	O
127	CD	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
sensitize	VB	xcomp	O
cells	NNS	dobj	B-Cell
.	.	punct	O

A	DT	det	O
C	NNP	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
segment	NN	nsubj	O
consisting	VBG	acl	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
amino	NN	compound	B-Amino_acid
acids	NNS	nmod	I-Amino_acid
251	CD	compound	O
to	TO	dep	O
708	CD	nummod	O
(	-LRB-	punct	O
T251	NN	compound	O
-	:	punct	O
708	CD	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
sensitized	VBD	ROOT	O
cells	NNS	dobj	B-Cell
to	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

This	DT	det	O
sensitization	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
occur	VB	ROOT	O
when	WRB	advmod	O
T251	NN	compound	O
-	:	punct	O
708	CD	nsubjpass	O
was	VBD	auxpass	O
targeted	VBN	advcl	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
by	IN	case	O
inclusion	NN	nmod	O
of	IN	case	O
the	DT	det	O
SV40	NN	compound	B-Organism
nuclear	JJ	amod	O
localization	NN	compound	O
signal	NN	nmod	O
.	.	punct	O

The	DT	det	O
introduction	NN	nsubj	O
of	IN	case	O
mutations	NNS	nmod	O
into	IN	case	O
the	DT	det	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
J	NN	compound	O
domain	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
mutation	NN	compound	O
-	HYPH	punct	O
specific	JJ	amod	O
and	CC	cc	O
variable	JJ	conj	O
inhibition	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
either	CC	cc:preconj	O
the	DT	det	O
structural	JJ	nsubjpass	O
or	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
integrity	NN	conj	O
of	IN	case	O
the	DT	det	O
J	NN	compound	O
domain	NN	nmod	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
to	TO	mark	O
sensitize	VB	xcomp	O
cells	NNS	dobj	B-Cell
to	TO	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
REF	NN	nmod	B-Cell
or	CC	cc	O
REF	NN	conj	B-Cell
expressing	VBG	acl	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
segment	NN	appos	O
,	,	punct	O
or	CC	cc	O
T251	NN	compound	O
-	:	punct	O
708	CD	conj	O
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
responsive	JJ	amod	O
MDM2	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
;	:	punct	O
apoptosis	NN	nsubj	O
occurred	VBD	parataxis	O
through	IN	case	O
a	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
pathway	NN	nmod	O
,	,	punct	O
as	IN	mark	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
null	NN	amod	O
cells	NNS	nsubj	O
expressing	VBG	acl	O
these	DT	det	O
T	NN	compound	B-Gene_or_gene_product
antigens	NNS	dobj	I-Gene_or_gene_product
were	VBD	cop	O
resistant	JJ	advcl	O
to	TO	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Possible	JJ	amod	O
mechanisms	NNS	nsubjpass	O
involved	VBN	acl	O
in	IN	case	O
sensitizing	VBG	amod	O
cells	NNS	nmod	B-Cell
to	TO	case	O
a	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
spite	NN	nmod	O
of	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
bind	VB	acl	O
and	CC	cc	O
inactivate	VB	conj	O
the	DT	det	O
transcriptional	JJ	amod	O
transactivating	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
are	VBP	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Optimizing	VBG	amod	O
treatment	NN	ROOT	O
of	IN	case	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	compound	O
feeder	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
associated	VBN	acl	O
with	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
optimize	VB	dep	O
the	DT	det	O
method	NN	dobj	O
of	IN	mark	O
treating	VBG	acl	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	dobj	O
(	-LRB-	punct	O
CNV	NN	appos	O
)	-RRB-	punct	O
associated	VBN	acl	O
with	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

DESIGN	NN	ROOT	O
:	:	punct	O
Experimental	JJ	amod	O
study	NN	appos	O
and	CC	cc	O
interventional	JJ	amod	O
case	NN	compound	O
series	NN	conj	O
.	.	punct	O

METHODS	NNS	nsubjpass	O
:	:	punct	O
The	DT	det	O
parameters	NNS	nsubj	O
associated	VBN	acl	O
with	IN	prep	O
locating	VBG	pobj	O
and	CC	cc	O
then	RB	advmod	O
photocoagulating	VBG	dep	O
CNV	NN	compound	O
feeder	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
were	VBD	auxpass	O
identified	VBN	ROOT	O
and	CC	cc	O
optimized	VBN	conj	O
using	VBG	xcomp	O
published	VBN	amod	O
data	NNS	dobj	O
and	CC	cc	O
data	NNS	conj	O
derived	VBN	acl	O
from	IN	mark	O
modeling	VBG	advcl	O
the	DT	det	O
choroidal	JJ	amod	B-Multi-tissue_structure
vasculature	NN	dobj	I-Multi-tissue_structure
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
optimized	VBN	amod	O
parameters	NNS	nmod	O
,	,	punct	O
a	DT	det	O
prototype	NN	compound	O
diagnostic	JJ	amod	O
/	:	punct	O
treatment	NN	compound	O
system	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
that	IN	nsubj	O
captures	NNS	ccomp	O
high	JJ	amod	O
-	HYPH	punct	O
speed	NN	compound	O
indocyanine	NN	amod	B-Simple_chemical
green	NN	amod	I-Simple_chemical
(	-LRB-	punct	O
ICG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
angiogram	NN	amod	O
images	NNS	dobj	O
and	CC	cc	O
facilitates	NNS	conj	O
analysis	NN	dobj	O
of	IN	prep	O
the	DT	det	O
images	NNS	pobj	O
by	IN	prep	O
enhancing	VBG	pcomp	O
visualization	NN	dobj	O
of	IN	prep	O
dye	NN	compound	O
movement	NN	pobj	O
through	IN	case	O
CNV	NN	compound	O
feeder	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
FVs	NNS	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
system	NN	nsubj	O
also	RB	advmod	O
permits	VBZ	ROOT	O
precise	JJ	amod	O
aiming	NN	dobj	O
and	CC	cc	O
delivery	NN	conj	O
of	IN	prep	O
810	CD	nummod	O
-	HYPH	punct	O
nm	NN	pobj	O
wavelength	JJ	amod	O
photocoagulation	NN	nsubj	O
laser	NN	conj	O
energy	NN	dobj	O
to	TO	aux	O
target	VB	advcl	O
FVs	NN	dobj	B-Multi-tissue_structure
on	IN	prep	O
a	DT	det	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
ICG	NN	compound	B-Simple_chemical
angiogram	NN	amod	O
image	NN	pobj	O
of	IN	prep	O
the	DT	det	O
choroidal	JJ	amod	B-Multi-tissue_structure
vasculature	NN	pobj	I-Multi-tissue_structure
.	.	punct	O

Target	NN	compound	O
FVs	NNS	nsubjpass	B-Multi-tissue_structure
are	VBP	auxpass	O
tracked	VBN	ROOT	O
by	IN	agent	O
a	DT	det	O
joy	NN	nmod	O
-	HYPH	punct	O
stick	NN	amod	O
controlled	JJ	amod	O
laser	NN	pobj	O
aiming	NN	acl	O
beam	NN	dobj	O
until	IN	mark	O
an	DT	det	O
intravenously	RB	advmod	B-Immaterial_anatomical_entity
-	HYPH	punct	O
injected	VBN	amod	O
high	JJ	amod	O
-	HYPH	punct	O
concentration	NN	compound	O
ICG	NN	compound	B-Simple_chemical
dye	NN	compound	I-Simple_chemical
bolus	NN	nsubjpass	O
is	VBZ	auxpass	O
observed	VBN	advcl	O
to	TO	mark	O
enter	VB	xcomp	O
the	DT	det	O
target	NN	compound	O
vessel	NN	dobj	B-Multi-tissue_structure
,	,	punct	O
at	IN	case	O
which	WDT	det	O
time	VBP	dep	O
the	DT	det	O
laser	NN	nsubjpass	O
is	VBZ	auxpass	O
fired	VBN	acl:relcl	O
.	.	punct	O

Proof	NN	nsubj	O
of	IN	case	O
principle	NN	nmod	O
of	IN	case	O
the	DT	det	O
combined	JJ	amod	O
diagnosis	NN	compound	O
/	:	punct	O
treatment	NN	compound	O
system	NN	compound	O
design	NN	nsubjpass	O
for	IN	prep	O
performing	VBG	pcomp	O
dye	NN	npadvmod	O
-	HYPH	punct	O
enhanced	VBN	amod	O
photocoagulation	NN	dobj	O
(	-LRB-	punct	O
DEP	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
clinical	JJ	amod	O
setting	NN	nmod	O
and	CC	cc	O
determination	NN	conj	O
of	IN	case	O
the	DT	det	O
minimum	JJ	amod	O
DEP	NN	compound	O
laser	NN	compound	O
energy	NN	nmod	O
needed	VBD	acl	O
to	TO	case	O
close	VB	amod	O
CNV	NN	compound	O
FVs	NNS	nmod	B-Multi-tissue_structure
was	VBD	auxpass	O
made	VBN	ROOT	O
in	IN	case	O
11	CD	nummod	O
AMD	NN	compound	O
patients	NNS	nmod	B-Organism
requiring	VBG	acl	O
treatment	NN	dobj	O
of	IN	case	O
CNV	NN	nmod	O
,	,	punct	O
but	CC	cc	O
for	IN	case	O
whom	WP	nmod	O
other	JJ	amod	O
treatment	NN	nsubj	O
was	VBD	conj	O
not	RB	neg	O
appropriate	JJ	acomp	O
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
Using	VBG	dep	O
ICG	NN	compound	B-Simple_chemical
-	HYPH	punct	O
DEP	NN	dobj	O
,	,	punct	O
CNV	NN	compound	O
feeder	NN	compound	B-Multi-tissue_structure
vessels	NNS	nsubjpass	I-Multi-tissue_structure
were	VBD	auxpass	O
closed	VBN	ROOT	O
with	IN	prep	O
single	JJ	amod	O
pulse	NN	compound	O
laser	NN	compound	O
energy	NN	pobj	O
,	,	punct	O
delivering	VBG	advcl	O
as	RB	advmod	O
little	JJ	amod	O
as	IN	quantmod	O
0	CD	dobj	O
.	.	punct	O
6	CD	compound	O
to	TO	dep	O
1	CD	ROOT	O
.	.	punct	O
8	CD	nummod	O
J	NN	ROOT	O
of	IN	case	O
energy	NN	nmod	O
to	IN	prep	O
the	DT	det	O
fundus	NN	pobj	B-Multi-tissue_structure
,	,	punct	O
producing	VBG	acl	O
no	DT	neg	O
visible	JJ	amod	O
change	NN	dobj	O
in	IN	case	O
the	DT	det	O
fundus	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

Successful	JJ	amod	O
FV	NN	compound	B-Multi-tissue_structure
closure	NN	nsubjpass	O
was	VBD	auxpass	O
usually	RB	advmod	O
indicated	VBN	ROOT	O
immediately	RB	advmod	O
by	IN	case	O
presence	NN	nmod	O
of	IN	case	O
incarcerated	VBN	amod	O
ICG	NN	compound	B-Simple_chemical
dye	NN	nmod	I-Simple_chemical
in	IN	case	O
the	DT	det	O
vessel	NN	nmod	B-Multi-tissue_structure
adjacent	JJ	amod	O
to	IN	case	O
the	DT	det	O
burn	NN	compound	O
site	NN	nmod	O
.	.	punct	O

The	DT	det	O
prototype	NN	compound	O
system	NN	nsubj	O
proved	VBD	ROOT	O
relatively	RB	advmod	O
easy	JJ	advmod	O
to	TO	aux	O
operate	VB	xcomp	O
.	.	punct	O

After	IN	case	O
acquiring	VBG	amod	O
and	CC	cc	O
interpreting	JJ	conj	O
diagnostic	JJ	amod	O
angiograms	NNS	nsubj	O
and	CC	cc	O
repositioning	VBG	conj	O
a	DT	det	O
patient	NN	dobj	B-Organism
in	IN	case	O
front	NN	nmod	O
of	IN	case	O
the	DT	det	O
device	NN	nmod	O
,	,	punct	O
feeder	NN	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
DEP	NN	conj	O
and	CC	cc	O
treatment	NN	compound	O
evaluation	NN	conj	O
required	VBD	ROOT	O
15	CD	compound	O
to	TO	dep	O
20	CD	nummod	O
minutes	NNS	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	nsubj	O
:	:	punct	O
Indocyanine	NN	compound	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
dye	NN	npadvmod	I-Simple_chemical
-	HYPH	punct	O
enhanced	VBN	amod	O
photocoagulation	NN	appos	O
of	IN	case	O
CNV	NN	compound	O
feeder	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
facilitated	VBN	acl	O
by	IN	case	O
use	NN	nmod	O
of	IN	prep	O
a	DT	det	O
device	NN	pobj	O
that	WDT	nsubj	O
permits	VBZ	relcl	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
visualization	NN	dobj	O
of	IN	prep	O
the	DT	det	O
choroidal	JJ	amod	B-Multi-tissue_structure
circulation	NN	pobj	O
while	IN	mark	O
aiming	VBG	advcl	O
the	DT	det	O
treatment	NN	compound	O
laser	NN	compound	O
beam	NN	dobj	O
,	,	punct	O
appears	VBZ	ROOT	O
to	TO	aux	O
minimize	VB	xcomp	O
the	DT	det	O
amount	NN	dobj	O
of	IN	prep	O
energy	NN	pobj	O
applied	VBN	acl	O
to	TO	prep	O
the	DT	det	O
fundus	NN	pobj	B-Multi-tissue_structure
and	CC	cc	O
the	DT	det	O
volume	NN	conj	O
of	IN	case	O
fundus	JJ	compound	B-Tissue
tissue	NN	nmod	I-Tissue
affected	VBN	acl	O
by	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
compared	VBN	prep	O
with	IN	prep	O
other	JJ	amod	O
treatment	NN	compound	O
modalities	NNS	pobj	O
.	.	punct	O

The	DT	det	O
combination	NN	compound	O
diagnosis	NN	compound	O
/	:	punct	O
treatment	NN	compound	O
device	NN	nsubj	O
should	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
in	IN	mark	O
optimizing	VBG	advcl	O
FV	NN	compound	B-Multi-tissue_structure
treatment	NN	dobj	O
and	CC	cc	O
in	IN	case	O
refining	VBG	conj	O
and	CC	cc	O
evaluating	VBG	conj	O
the	DT	det	O
efficacy	NN	dobj	O
of	IN	case	O
DEP	NN	nmod	O
in	IN	case	O
future	JJ	amod	O
clinical	JJ	amod	O
trials	NNS	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	case	O
the	DT	det	O
cancer	NN	compound	B-Cancer
chemopreventive	JJ	amod	O
agent	NN	nmod	O
conjugated	VBD	ROOT	B-Simple_chemical
linoleic	JJ	amod	I-Simple_chemical
acid	NN	dobj	I-Simple_chemical
.	.	punct	O

Dietary	NNP	nsubj	O
conjugated	VBD	ROOT	B-Simple_chemical
linoleic	JJ	amod	I-Simple_chemical
acid	NN	nsubjpass	I-Simple_chemical
(	-LRB-	punct	O
CLA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	dep	O
previously	RB	advmod	O
to	TO	mark	O
inhibit	VB	xcomp	O
rat	NN	compound	B-Organism
mammary	JJ	amod	B-Organ
carcinogenesis	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	dep	O
to	TO	case	O
direct	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
including	VBG	case	O
decreased	VBN	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
CLA	NN	nsubj	B-Simple_chemical
may	MD	aux	O
exert	VB	ROOT	O
its	PRP$	nmod:poss	O
effects	NNS	dobj	O
indirectly	RB	advmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
mammary	JJ	amod	B-Cell
stromal	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
an	DT	det	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
type	NN	nmod	I-Cell
.	.	punct	O

Specifically	RB	advmod	O
,	,	punct	O
CLA	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
decrease	VB	xcomp	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
mammary	JJ	amod	B-Cell
stromal	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
form	VB	acl	O
complex	NN	dobj	O
anastomosing	VBG	acl	O
microcapillary	JJ	amod	B-Multi-tissue_structure
networks	NNS	dobj	I-Multi-tissue_structure
in	FW	compound	O
vitro	FW	advmod	O
on	IN	prep	O
Engelbreth	NNP	compound	O
-	HYPH	punct	O
Holm	NNP	compound	O
-	HYPH	punct	O
Swarm	NNP	compound	O
-	HYPH	punct	O
derived	VBN	pobj	O
reconstituted	VBN	xcomp	O
basement	NN	compound	B-Cellular_component
membrane	NN	dobj	I-Cellular_component
.	.	punct	O

This	DT	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
CLA	NN	nsubj	B-Simple_chemical
might	MD	aux	O
inhibit	VB	ccomp	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
possibility	NN	dobj	O
,	,	punct	O
CD2	NN	compound	O
/	:	punct	O
F	NN	compound	O
(	-LRB-	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
placed	VBN	ROOT	O
on	IN	case	O
synthetic	JJ	amod	O
diets	NNS	nmod	O
containing	VBG	acl	O
0	CD	nummod	O
,	,	punct	O
1	CD	conj	O
,	,	punct	O
or	CC	cc	O
2	CD	compound	O
%	NN	compound	O
CLA	NN	dobj	B-Simple_chemical
for	IN	case	O
6	CD	nummod	O
weeks	NNS	nmod	O
,	,	punct	O
before	IN	case	O
angiogenic	JJ	amod	O
challenge	NN	nmod	O
by	IN	case	O
s	NNS	nmod	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
injection	NN	ROOT	O
with	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
gel	NN	compound	O
substrate	NN	nmod	O
(	-LRB-	punct	O
Matrigel	NN	compound	O
pellet	NN	compound	O
assay	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

After	IN	prep	O
7	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
the	DT	det	O
pellets	NNS	nsubj	O
from	IN	prep	O
animals	NNS	pobj	O
fed	VBD	advcl	O
the	DT	det	O
control	JJ	compound	O
diet	NN	nsubjpass	O
were	VBD	auxpass	O
infiltrated	VBN	ROOT	O
by	IN	case	O
abundant	JJ	amod	O
branching	VBG	compound	O
networks	NNS	nmod	B-Multi-tissue_structure
of	IN	case	I-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
with	IN	case	O
patent	JJ	compound	O
lumen	NN	nmod	B-Immaterial_anatomical_entity
-	:	punct	O
containing	VBG	acl	O
RBCs	NNS	dobj	B-Cell
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
pellets	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
CLA	NNP	npadvmod	B-Simple_chemical
-	HYPH	punct	O
fed	JJ	amod	O
animals	NNS	nmod	O
contained	VBD	advcl	O
fewer	JJR	amod	O
infiltrating	JJ	amod	O
cells	NNS	dobj	B-Cell
,	,	punct	O
which	WDT	nsubj	O
formed	VBD	acl:relcl	O
limited	JJ	amod	O
branching	VBG	amod	O
cellular	JJ	amod	B-Multi-tissue_structure
networks	NNS	dobj	I-Multi-tissue_structure
,	,	punct	O
the	DT	det	O
majority	NN	nsubj	O
of	IN	prep	O
which	WDT	pobj	O
had	VBD	aux	O
collapsed	VBN	ROOT	O
lumen	NN	dobj	B-Immaterial_anatomical_entity
and	CC	cc	O
no	DT	neg	O
RBCs	NNS	conj	B-Cell
.	.	punct	O

Both	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
dietary	JJ	amod	O
CLA	NN	nmod	B-Simple_chemical
showed	VBD	ROOT	O
similar	JJ	amod	O
effects	NNS	dobj	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
RBC	NN	compound	B-Cell
-	:	punct	O
containing	VBG	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
per	IN	case	O
20x	NN	compound	O
field	NN	nmod	O
decreased	VBD	advcl	O
to	IN	case	O
a	DT	det	O
third	NN	nmod	O
of	IN	case	O
that	DT	nmod	O
seen	VBN	acl	O
in	IN	case	O
control	NN	nmod	O
.	.	punct	O

Dietary	NNP	amod	O
CLA	NNP	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
serum	NN	compound	B-Organism_substance
levels	NNS	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
whole	JJ	amod	O
mammary	JJ	amod	B-Organ
gland	NN	compound	I-Organ
levels	NNS	conj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
receptor	NN	compound	O
Flk	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Both	DT	det	O
cis	NN	nsubj	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
9	CD	dep	I-Simple_chemical
,	,	punct	O
trans	JJ	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	conj	I-Simple_chemical
and	CC	cc	O
trans	JJ	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
10	CD	conj	I-Simple_chemical
,	,	punct	O
cis	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
12	CD	nummod	I-Simple_chemical
CLA	NNP	compound	I-Simple_chemical
isomers	NNS	nsubj	I-Simple_chemical
were	VBD	cop	O
effective	JJ	ROOT	O
in	IN	mark	O
inhibiting	VBG	advcl	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
CLA	NN	nmod	B-Simple_chemical
to	TO	mark	O
inhibit	VB	acl	O
angiogenesis	NN	dobj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
its	PRP$	nmod:poss	O
efficacy	NN	nmod	O
as	IN	case	O
a	DT	det	O
chemopreventive	JJ	amod	O
agent	NN	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
characterization	NN	ROOT	O
of	IN	case	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
oral	JJ	amod	B-Cell
squamous	JJ	amod	I-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
specificity	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
the	DT	det	O
possible	JJ	amod	O
mechanisms	NNS	conj	O
.	.	punct	O

Stimulatory	JJ	amod	O
effects	NNS	nsubj	O
on	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
HUVEC	NN	appos	B-Cell
)	-RRB-	punct	O
characterized	VBD	ROOT	O
the	DT	det	O
angiogenic	JJ	amod	O
properties	NNS	dobj	O
of	IN	case	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
but	CC	cc	O
not	RB	cc	O
normal	JJ	amod	B-Cell
oral	JJ	amod	I-Cell
keratinocytes	NNS	conj	I-Cell
(	-LRB-	punct	O
NOK	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

ELISA	NN	nsubj	O
found	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
tested	VBN	amod	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
NOK	NN	conj	B-Cell
.	.	punct	O

Attenuation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
effects	NNS	nmod	O
by	IN	mark	O
neutralizing	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
antibodies	NNS	dobj	I-Gene_or_gene_product
suggests	VBZ	ROOT	O
VEGF	NNP	nsubj	B-Gene_or_gene_product
play	VBP	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
phenotype	NN	nmod	O
in	IN	case	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Western	NN	compound	O
blotting	NN	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
murine	JJ	amod	B-Gene_or_gene_product
double	JJ	amod	I-Gene_or_gene_product
mutant	JJ	conj	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Mdm2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
together	RB	advmod	O
with	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
sequencing	NN	compound	O
analysis	NN	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
p53	NN	compound	B-Gene_or_gene_product
function	NN	compound	O
loss	NN	nsubj	O
by	IN	case	O
mutation	NN	nmod	O
or	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
Mdm2	NN	nmod	B-Gene_or_gene_product
occurred	VBD	ccomp	O
in	IN	case	O
all	DT	det	O
tested	VBN	amod	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
regardless	RB	advmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
etiology	NN	nmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
the	DT	det	O
angiogenic	JJ	amod	O
property	NN	nsubjpass	O
of	IN	case	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
many	JJ	amod	O
factors	NNS	nmod	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
status	NN	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Enforced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	nmod	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
matrix	NN	compound	I-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
affects	VBZ	ROOT	O
functional	JJ	amod	O
capillary	JJ	amod	B-Tissue
morphogenesis	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
in	IN	case	O
a	DT	det	O
murine	JJ	amod	B-Organism
tumor	NN	compound	B-Cancer
model	NN	nmod	O
.	.	punct	O

Homeostasis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
is	VBZ	cop	O
a	DT	det	O
delicate	JJ	amod	O
balance	NN	ROOT	O
between	IN	case	O
degradation	NN	nmod	O
and	CC	cc	O
remodeling	NN	conj	O
,	,	punct	O
the	DT	det	O
balance	NN	nsubjpass	O
being	VBG	auxpass	O
maintained	VBN	parataxis	O
by	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
activated	VBN	amod	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinases	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MMPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
specific	JJ	amod	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	conj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
matrix	NN	compound	I-Gene_or_gene_product
metalloproteinases	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TIMPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Up	IN	compound	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
,	,	punct	O
favoring	VBG	acl	O
proteolytic	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
the	DT	det	O
basement	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	conj	I-Cellular_component
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	conj	O
,	,	punct	O
whereas	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
appears	VBZ	advcl	O
to	TO	mark	O
restrict	VB	xcomp	O
these	DT	det	O
processes	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
retroviral	JJ	amod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
delivery	NN	dobj	O
to	TO	mark	O
effect	VB	advcl	O
sustained	JJ	amod	O
autocrine	JJ	compound	O
expression	NN	dobj	O
of	IN	case	O
TIMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
murine	JJ	amod	B-Organism
neuroblastoma	NN	nmod	B-Cell
and	CC	cc	O
melanoma	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
further	RB	advmod	O
examine	VB	advcl	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
TIMPs	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
inhibit	VB	acl	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Growth	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
histologic	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
gene	NN	nmod:npmod	O
-	HYPH	punct	O
modified	VBN	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	compound	O
(	-LRB-	punct	O
SCID	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	B-Organism
was	VBD	auxpass	O
significantly	RB	advmod	O
restricted	JJ	ROOT	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

Grossly	RB	advmod	O
,	,	punct	O
these	DT	det	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
small	JJ	ROOT	O
and	CC	cc	O
had	VBD	conj	O
few	JJ	amod	O
feeding	VBG	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
.	.	punct	O

Histologic	JJ	amod	O
evaluation	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
although	IN	mark	O
tumors	NNS	nsubj	B-Cancer
overexpressing	VBG	acl	O
TIMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
had	VBD	advcl	O
an	DT	det	O
increased	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
CD31	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
endothelial	JJ	amod	O
cells	NNS	dobj	O
,	,	punct	O
these	DT	det	O
endothelial	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
had	VBD	aux	O
not	RB	neg	O
formed	VBN	ccomp	O
functional	JJ	amod	O
tubules	NNS	dobj	B-Tissue
,	,	punct	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
decreased	VBN	amod	O
vessel	NN	compound	B-Multi-tissue_structure
continuity	NN	nmod	O
and	CC	cc	O
minimal	JJ	amod	O
pericyte	NN	compound	B-Cell
recruitment	NN	conj	O
.	.	punct	O

This	DT	det	O
effect	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
decreased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
VE	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
TIMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
as	IN	mark	O
seen	VBN	advcl	O
both	CC	cc:preconj	O
in	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
assay	NN	nmod	O
and	CC	cc	O
in	IN	case	O
TIMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
TIMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
can	MD	aux	O
inhibit	VB	ccomp	O
angiogenesis	NN	dobj	O
and	CC	cc	O
associated	VBN	amod	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
antiangiogenic	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
TIMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
appear	VBP	conj	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
through	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
capillary	JJ	amod	B-Tissue
morphogenesis	NN	nmod	O
.	.	punct	O

Brn	RB	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	ROOT	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
neuronal	JJ	amod	B-Cell
transcription	NN	compound	O
factor	NN	appos	O
of	IN	case	O
the	DT	det	O
POU	NN	compound	O
gene	NN	compound	O
family	NN	nmod	O
:	:	punct	O
indications	NNS	dep	O
for	IN	case	O
its	PRP$	nmod:poss	O
involvement	NN	nmod	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Brn	RB	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	nsubjpass	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
POU	NN	compound	O
gene	NN	compound	O
family	NN	nmod	O
(	-LRB-	punct	O
so	RB	advmod	O
-	HYPH	punct	O
called	VBN	dep	O
because	IN	prep	O
of	IN	pcomp	O
the	DT	det	O
similarity	NN	pobj	O
with	IN	case	O
the	DT	det	O
group	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
Pit	VBP	dep	B-Gene_or_gene_product
,	,	punct	O
Oct	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Unc	NNP	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
neuronal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
engaged	VBN	acl	O
in	IN	case	O
the	DT	det	O
transcription	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
p1	NN	compound	O
and	CC	cc	O
p2	NN	conj	O
promoters	NNS	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
powerful	JJ	amod	O
antiapoptotic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
Bcl	NN	npadvmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
alternative	JJ	amod	O
splicing	NN	nsubj	O
of	IN	case	O
Brn	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
produces	VBZ	ROOT	O
two	CD	nummod	O
molecular	JJ	amod	O
forms	NNS	dobj	O
:	:	punct	O
a	DT	det	O
longer	RBR	amod	O
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
transactivating	NN	compound	O
form	NN	dep	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
shorter	JJR	amod	O
inactive	JJ	amod	O
form	NN	conj	O
,	,	punct	O
lacking	VBG	acl	O
84	CD	nummod	O
AA	NN	dobj	O
in	IN	prep	O
the	DT	det	O
aminoterminus	NN	pobj	O
.	.	punct	O

In	IN	case	O
neuronal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
following	VBG	case	O
Brn	RB	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
transfection	NN	nmod	O
and	CC	cc	O
superexpression	NN	conj	O
,	,	punct	O
an	DT	det	O
increase	NN	nsubj	O
of	IN	case	O
30	CD	nummod	O
fold	NN	nmod	O
of	IN	case	O
the	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
protein	NN	nmod	O
occurs	VBZ	ROOT	O
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
apoptosis	NN	compound	O
protection	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
recent	JJ	amod	O
works	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Brn	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	compound	I-Gene_or_gene_product
expression	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
restricted	JJ	ccomp	O
to	TO	case	O
neuronal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	IN	mark	O
its	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	advcl	O
also	RB	advmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
neuronal	JJ	amod	B-Cell
nature	NN	nmod	O
.	.	punct	O

Looking	VBG	advcl	O
for	IN	case	O
mechanisms	NNS	nmod	O
linking	VBG	acl	O
Brn	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	dobj	I-Gene_or_gene_product
to	TO	case	O
carcinogenesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
discuss	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
this	DT	det	O
transcription	NN	compound	O
factor	NN	nmod	O
in	IN	mark	O
influencing	VBG	acl	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
/	:	punct	O
p53	NN	dep	B-Gene_or_gene_product
antagonism	NN	dobj	O
and	CC	cc	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
induction	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
,	,	punct	O
concluding	VBG	advcl	O
this	DT	det	O
review	NN	dobj	O
with	IN	case	O
a	DT	det	O
proposal	NN	nmod	O
for	IN	case	O
the	DT	det	O
oncogenic	JJ	amod	O
nature	NN	nmod	O
of	IN	case	O
Brn	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3a	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Roles	NNS	ROOT	O
of	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	compound	O
molecules	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
cotransplantation	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
to	TO	mark	O
nude	VB	acl	B-Organism
rats	NNS	dobj	I-Organism
.	.	punct	O

Roles	NNS	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	compound	O
molecules	NNS	nmod	O
mediating	VBG	acl	O
the	DT	det	O
interaction	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
using	VBG	xcomp	O
new	JJ	amod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
model	NN	compound	O
systems	NNS	dobj	O
with	IN	case	O
a	DT	det	O
cultured	VBN	amod	O
murine	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
(	-LRB-	punct	O
F	NN	dep	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
)	-RRB-	punct	O
and	CC	cc	O
human	JJ	amod	B-Organism
cultured	VBN	amod	O
epidermoid	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
A431	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
A431	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
exhibited	VBD	ROOT	O
typical	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	B-Cell
adhesion	NN	dobj	O
to	TO	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
F	NN	compound	I-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
initial	JJ	amod	O
step	NN	nsubjpass	O
of	IN	case	O
adhesion	NN	nmod	O
was	VBD	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
sialyl	JJ	compound	B-Simple_chemical
Lewis	NNP	nmod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
x	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
(	-LRB-	punct	O
Le	NN	dep	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
x	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
sialyl	VBD	compound	B-Simple_chemical
Le	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
a	DT	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
,	,	punct	O
the	DT	det	O
carbohydrate	NN	amod	O
determinants	NNS	appos	O
expressed	VBN	acl	O
on	IN	case	O
the	DT	det	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
selectin	NN	conj	I-Gene_or_gene_product
expressed	VBN	acl	O
constitutively	RB	advmod	O
on	IN	case	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Prolonged	JJ	amod	O
culture	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
implantation	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
into	IN	case	O
the	DT	det	O
monolayer	NN	nmod	B-Cell
of	IN	case	O
the	DT	det	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	acl:relcl	O
mainly	RB	advmod	O
by	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
cultured	VBN	acl	O
on	IN	case	O
Matrigel	NNP	nmod	O
showed	VBD	ROOT	O
evident	JJ	amod	O
tube	NN	compound	B-Tissue
formation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
coculture	NN	nsubj	O
of	IN	case	O
F	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
A431	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
led	VBD	conj	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
A431	NN	compound	B-Cell
cell	NN	compound	I-Cell
nests	NNS	nmod	O
constantly	RB	advmod	O
surrounded	VBN	acl	O
by	IN	agent	O
tube	NN	pobj	B-Tissue
-	HYPH	punct	O
like	IN	case	O
networks	NNS	nmod	O
consisting	VBG	acl	O
of	IN	prep	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	pobj	I-Cell
.	.	punct	O

This	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
morphogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
sialyl	JJ	compound	B-Simple_chemical
Le	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
x	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
/	:	punct	O
Le	NN	nmod	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
a	DT	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
or	CC	cc	O
anti	JJ	compound	O
-	HYPH	punct	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
integrin	NN	compound	I-Gene_or_gene_product
antibodies	NNS	conj	O
,	,	punct	O
which	WDT	nsubj	O
led	VBD	acl:relcl	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
aggregates	NNS	nmod	I-Cell
that	WDT	nsubj	O
were	VBD	cop	O
independent	JJ	acl:relcl	O
from	IN	case	O
the	DT	det	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cell	NN	compound	I-Cell
networks	NNS	nmod	O
.	.	punct	O

This	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
morphological	JJ	amod	O
appearance	NN	nsubjpass	O
was	VBD	auxpass	O
exactly	RB	advmod	O
reproduced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
formed	VBN	acl:relcl	O
when	WRB	advmod	O
the	DT	det	O
mixture	NN	nsubj	O
of	IN	case	O
A431	NN	nmod	B-Cell
and	CC	cc	O
F	NN	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
at	IN	case	O
the	DT	det	O
ratio	NN	nmod	O
of	IN	case	O
10	CD	nmod	O
:	SYM	punct	O
1	CD	dep	O
were	VBD	cop	O
cotransplanted	VBN	amod	O
s	NNS	nmod	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
into	IN	case	O
the	DT	det	O
back	NN	ROOT	B-Organism_subdivision
of	IN	prep	O
nude	JJ	amod	B-Organism
rats	NNS	pobj	I-Organism
.	.	punct	O

The	DT	det	O
tumors	NNS	nsubjpass	B-Cancer
of	IN	case	O
A431	NN	nmod	B-Cell
supplemented	VBN	acl	O
with	IN	case	O
F	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
profoundly	RB	advmod	O
vascularized	VBN	ROOT	O
throughout	IN	case	O
by	IN	case	O
the	DT	det	O
tubular	JJ	amod	B-Tissue
structures	NNS	nmod	I-Tissue
formed	VBN	acl	O
by	IN	case	O
F	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
the	DT	det	O
lumen	NN	nsubj	B-Immaterial_anatomical_entity
of	IN	case	O
which	WDT	nmod	O
contained	VBD	parataxis	O
the	DT	det	O
host	NN	compound	O
rat	NN	compound	B-Organism
blood	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

The	DT	det	O
tumor	NN	compound	B-Cancer
mass	NN	nsubj	O
thus	RB	advmod	O
formed	VBN	acl	O
was	VBD	cop	O
an	DT	det	O
average	JJ	amod	O
5	CD	ROOT	O
.	.	punct	O
8	CD	nummod	O
-	HYPH	punct	O
fold	JJ	ROOT	O
as	RB	advmod	O
large	JJ	amod	O
as	IN	prep	O
control	JJ	amod	O
A431	NN	compound	B-Cancer
tumors	NNS	pobj	I-Cancer
that	WDT	nsubjpass	O
were	VBD	auxpass	O
grown	VBN	acl:relcl	O
without	IN	case	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
co	NN	compound	O
-	HYPH	punct	O
injection	NN	nsubj	O
of	IN	case	O
anti	JJ	compound	O
-	HYPH	punct	O
Le	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
x	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
/	:	punct	O
Le	NN	nmod	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
a	DT	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
or	CC	cc	O
anti	JJ	compound	O
-	HYPH	punct	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
integrin	NN	compound	I-Gene_or_gene_product
antibodies	NNS	conj	O
produced	VBD	ROOT	O
a	DT	det	O
marked	JJ	amod	O
reduction	NN	dobj	O
in	IN	case	O
the	DT	det	O
size	NN	nmod	O
of	IN	case	O
A431	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
vascularized	VBN	acl:relcl	O
and	CC	cc	O
accompanied	VBD	conj	O
an	DT	det	O
independent	JJ	amod	O
tiny	JJ	amod	O
remnant	JJ	amod	O
clump	NN	dobj	O
of	IN	case	O
F	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
size	NN	nsubj	O
of	IN	case	O
these	DT	det	O
A431	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
did	VBD	aux	O
not	RB	neg	O
differ	VB	ROOT	O
significantly	RB	advmod	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
control	JJ	amod	O
A431	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
raised	VBN	acl	O
without	IN	case	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
in	IN	case	O
orderly	JJ	amod	O
tumor	NN	compound	B-Cancer
angiomorphogenesis	NN	nmod	O
is	VBZ	cop	O
highly	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
the	DT	det	O
action	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	compound	O
molecules	NNS	nmod	O
mediating	VBG	acl	O
the	DT	det	O
adhesion	NN	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
which	WDT	nmod	O
remarkably	RB	advmod	O
retards	VBZ	ccomp	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
Dss1	NN	nmod	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
12	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
O	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
tetradecanoylphorbol	NN	nmod:npmod	I-Simple_chemical
-	:	punct	I-Simple_chemical
13	CD	nmod:npmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetate	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
responsive	JJ	amod	O
gene	NN	nmod	O
expressed	VBN	acl	O
in	IN	case	O
keratinocyte	NN	compound	B-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
with	IN	case	O
possible	JJ	amod	O
involvement	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
skin	NN	compound	B-Organ
tumorigenesis	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
identifies	VBZ	ROOT	O
genes	NNS	nsubj	O
expressed	VBD	ccomp	O
early	RB	advmod	O
in	IN	case	O
12	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
O	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
tetradecanoylphorbol	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
13	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetate	NN	nmod:npmod	I-Simple_chemical
(	-LRB-	punct	O
TPA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
skin	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
in	IN	case	O
genetically	RB	advmod	O
initiated	VBN	amod	O
Tg	NN	nmod	O
.	.	punct	O
AC	NN	compound	O
v	CD	dep	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	ROOT	O
.	.	punct	O

Keratinocyte	NN	compound	B-Cell
progenitor	NN	compound	I-Cell
cells	NNS	ROOT	I-Cell
from	IN	case	O
TPA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
Tg	NN	nmod	B-Organism
.	.	punct	I-Organism
AC	NN	compound	I-Organism
mice	NNS	nsubjpass	I-Organism
were	VBD	auxpass	O
isolated	VBN	ROOT	O
with	IN	case	O
fluorescence	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
cell	NN	compound	B-Cell
sorting	NN	nmod	O
and	CC	cc	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
analyzed	VBN	conj	O
using	VBG	xcomp	O
cDNA	NN	compound	O
microarray	NN	compound	O
technology	NN	dobj	O
.	.	punct	O

Eleven	CD	amod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
whose	WP$	nmod:poss	O
expression	NN	nsubj	O
changed	VBD	ccomp	O
significantly	RB	advmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
carcinogen	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Deleted	VBN	ROOT	B-Gene_or_gene_product
in	IN	case	I-Gene_or_gene_product
split	JJ	amod	I-Gene_or_gene_product
hand	NN	nmod	I-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
split	VBD	amod	I-Gene_or_gene_product
foot	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Dss1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
gene	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
a	DT	det	O
heterogeneous	JJ	amod	O
limb	NN	compound	B-Organism_subdivision
developmental	JJ	amod	O
disorder	NN	nmod	O
called	VBN	acl	O
split	JJ	amod	O
hand	NN	dobj	B-Organism_subdivision
/	SYM	punct	O
split	VBD	amod	O
foot	NN	compound	B-Organism_subdivision
malformation	NN	nmod	O
.	.	punct	O

cDNA	NN	compound	O
microarray	NN	compound	O
expression	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
mouse	NN	compound	B-Organism
homologue	NN	nsubjpass	O
of	IN	case	O
Dss1	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
induced	VBN	ccomp	O
by	IN	case	O
TPA	NN	nmod	B-Simple_chemical
.	.	punct	O

Dss1	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
TPA	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
treated	VBN	amod	O
hyperplastic	JJ	amod	O
skins	NNS	nmod	B-Organ
and	CC	cc	O
in	IN	case	O
JB6	NN	compound	B-Cell
Cl	NN	compound	I-Cell
41	CD	nummod	I-Cell
-	HYPH	punct	I-Cell
5a	NN	dep	I-Cell
epidermal	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
Dss1	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
elevated	JJ	xcomp	O
in	IN	case	O
skin	NN	compound	B-Organ
papillomas	NNS	nmod	I-Organ
relative	JJ	case	O
to	TO	case	O
normal	JJ	amod	O
skins	NNS	nmod	B-Organ
,	,	punct	O
and	CC	cc	O
further	RB	advmod	O
increased	VBN	conj	O
in	IN	case	O
squamous	JJ	amod	B-Cell
cell	NN	compound	I-Cell
malignancies	NNS	nmod	I-Cell
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
by	IN	case	O
ectopically	RB	advmod	O
constitutive	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Dss1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
JB6	NN	compound	B-Cell
Cl	NN	compound	I-Cell
41	CD	nummod	I-Cell
-	HYPH	punct	I-Cell
5a	NN	compound	I-Cell
preneoplastic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
strongly	RB	advmod	O
increased	VBD	ROOT	O
focus	NN	compound	O
formation	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
enhanced	VBN	amod	O
efficiency	NN	conj	O
of	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
Dss1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
TPA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
inducible	JJ	amod	O
gene	NN	ccomp	O
that	WDT	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
skin	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
.	.	punct	O

Downregulation	NN	ROOT	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
FLIP	NN	intj	I-Gene_or_gene_product
sensitizes	VBZ	amod	O
DU145	NN	compound	B-Cell
prostate	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
DU145	NN	compound	B-Cell
prostate	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
are	VBP	cop	O
resistant	JJ	advcl	O
to	TO	mark	O
exogenously	RB	advmod	O
applied	VBN	amod	O
Fas	NN	compound	B-Gene_or_gene_product
agonist	NN	compound	O
CH	NN	compound	O
-	:	punct	O
11	CD	nummod	O
(	-LRB-	punct	O
anti	JJ	amod	O
-	HYPH	punct	O
Fas	NN	compound	B-Gene_or_gene_product
monoclonal	JJ	amod	O
antibody	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
Fas	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
resistance	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
overcome	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
FasL	NN	compound	B-Gene_or_gene_product
expressing	NN	compound	O
adenovirus	NN	dobj	B-Organism
(	-LRB-	punct	O
AdGFPFasL	NN	dep	B-Organism
(	-LRB-	punct	I-Organism
TET	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
)	-RRB-	punct	O
[	-LRB-	punct	O
Hyer	NNP	dep	O
et	FW	dep	O
al	FW	dep	O
.	NNP	punct	O
,	,	punct	O
Molecular	NNP	amod	O
Therapy	NNP	appos	O
,	,	punct	O
2000	CD	appos	O
;	:	punct	O
2	CD	nummod	O
:	:	punct	O
348	CD	compound	O
-	SYM	punct	O
58	CD	dep	O
(	-LRB-	punct	O
ref	NN	appos	O
.	.	punct	O
12	CD	ROOT	O
)	-RRB-	punct	O
]	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	aux	O
try	VB	xcomp	O
to	TO	mark	O
understand	VB	xcomp	O
why	WRB	advmod	O
DU145	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
are	VBP	cop	O
resistant	JJ	ccomp	O
to	TO	case	O
CH	NN	nmod	O
-	:	punct	O
11	CD	nummod	O
and	CC	cc	O
determine	VB	conj	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	dobj	O
utilized	VBN	acl	O
by	IN	case	O
AdGFPFasL	NN	nmod	B-Organism
(	-LRB-	punct	I-Organism
TET	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
to	TO	mark	O
induce	VB	advcl	O
apoptosis	NN	dobj	O
in	IN	case	O
these	DT	det	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
resistant	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Using	VBG	advcl	O
immunoblot	NN	compound	O
analysis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
AdGFPFasL	NN	nsubj	B-Organism
(	-LRB-	punct	I-Organism
TET	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
initiating	VBG	advcl	O
the	DT	det	O
classic	JJ	amod	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptotic	JJ	amod	O
pathway	NN	dobj	O
in	IN	case	O
DU145	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
includes	VBZ	acl:relcl	O
activation	NN	dobj	O
of	IN	case	O
caspases	NNS	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	dep	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
7	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
,	,	punct	O
BID	NN	compound	B-Gene_or_gene_product
cleavage	NN	conj	O
,	,	punct	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	compound	I-Gene_or_gene_product
release	NN	conj	O
from	IN	case	O
mitochondria	NN	nmod	B-Cellular_component
,	,	punct	O
and	CC	cc	O
PARP	NN	compound	B-Gene_or_gene_product
cleavage	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
CH	NN	compound	O
-	:	punct	O
11	CD	nsubj	O
binds	VBZ	ROOT	O
to	TO	case	O
Fas	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
is	VBZ	cop	O
unable	JJ	conj	O
to	TO	mark	O
transmit	VB	xcomp	O
the	DT	det	O
death	NN	compound	O
signal	NN	dobj	O
beyond	IN	case	O
the	DT	det	O
plasma	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
suggesting	VBG	acl	O
a	DT	det	O
block	NN	dobj	O
at	IN	case	O
the	DT	det	O
DISC	NNP	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
death	NN	dep	B-Gene_or_gene_product
inducing	VBG	acl	I-Gene_or_gene_product
signaling	NN	compound	I-Gene_or_gene_product
complex	NN	dobj	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
protein	NN	compound	O
c	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
FLIP	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
cellular	JJ	dep	B-Gene_or_gene_product
Flice	NNP	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
inhibitory	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubjpass	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
inhibit	VB	xcomp	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	dobj	O
at	IN	case	O
the	DT	det	O
DISC	NNP	nmod	B-Gene_or_gene_product
,	,	punct	O
was	VBD	cop	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
following	VBG	case	O
AdGFPFasL	NN	compound	B-Organism
(	-LRB-	punct	I-Organism
TET	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
treatment	NN	nmod	O
prompting	VBG	acl	O
us	PRP	dobj	O
to	TO	mark	O
investigate	VB	xcomp	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	mark	O
inhibiting	VBG	advcl	O
CH	NN	compound	O
-	:	punct	O
11	CD	nummod	O
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

Using	VBG	ROOT	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
FLIP	NN	amod	I-Gene_or_gene_product
anti	RB	amod	O
-	HYPH	punct	O
sense	NN	compound	O
oligonucleotides	NNS	dobj	O
to	IN	mark	O
down	RB	advmod	O
-	HYPH	punct	O
regulate	VB	advcl	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
FLIP	NN	dep	I-Gene_or_gene_product
we	PRP	nsubj	O
sensitized	VBD	parataxis	O
DU145	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
to	TO	case	O
CH	NN	nmod:npmod	O
-	HYPH	punct	O
11	CD	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
FLIP	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
that	IN	mark	O
modulation	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
FLIP	NN	nmod	I-Gene_or_gene_product
may	MD	aux	O
enhance	VB	conj	O
Fas	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
based	JJ	amod	O
therapies	NNS	dobj	O
.	.	punct	O

Topoisomerase	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	ROOT	O
in	IN	case	O
primary	JJ	amod	B-Cancer
colorectal	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
lymph	NN	compound	B-Cancer
node	NN	compound	I-Cancer
metastases	NNS	conj	I-Cancer
.	.	punct	O

Topoisomerase	NN	nsubj	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
topo	IN	appos	B-Gene_or_gene_product
I	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
target	NN	ROOT	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
disease	NN	nmod	I-Cancer
,	,	punct	O
especially	RB	advmod	O
colorectal	JJ	amod	B-Cancer
cancer	NN	appos	I-Cancer
.	.	punct	O

Because	IN	mark	O
there	EX	expl	O
is	VBZ	advcl	O
little	JJ	amod	O
information	NN	nsubj	O
on	IN	prep	O
the	DT	det	O
expression	NN	pobj	O
of	IN	prep	O
topo	NN	compound	B-Gene_or_gene_product
I	PRP	pobj	I-Gene_or_gene_product
in	IN	case	O
colorectal	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
evaluated	VBD	ROOT	O
and	CC	cc	O
characterized	VBN	conj	O
topo	NN	compound	B-Gene_or_gene_product
I	NN	nummod	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
lymph	NN	compound	B-Cancer
node	NN	compound	I-Cancer
metastases	NNS	conj	I-Cancer
and	CC	cc	O
studied	VBD	conj	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
clinicopathologic	JJ	amod	O
data	NNS	conj	O
,	,	punct	O
p53	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
proliferating	VBG	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
nuclear	JJ	amod	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PCNA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
status	NN	conj	O
.	.	punct	O

Immunohistochemistry	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
for	IN	case	O
topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
249	CD	nummod	O
primary	JJ	amod	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
42	CD	nummod	O
paired	JJ	amod	O
lymph	NN	compound	B-Cancer
node	NN	compound	I-Cancer
metastasis	NN	compound	I-Cancer
samples	NNS	conj	I-Cancer
.	.	punct	O

Topo	IN	compound	B-Gene_or_gene_product
I	PRP	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
described	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
percentage	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
staining	VBG	acl	O
positive	JJ	amod	O
for	IN	prep	O
topo	NN	compound	B-Gene_or_gene_product
I	PRP	pobj	I-Gene_or_gene_product
,	,	punct	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
intensity	NN	nmod	O
and	CC	cc	O
localization	NN	conj	O
of	IN	case	O
the	DT	det	O
staining	NN	nmod	O
.	.	punct	O

Clinicopathologic	JJ	amod	O
data	NNS	nsubjpass	O
(	-LRB-	punct	O
sex	NN	dep	O
,	,	punct	O
age	NN	conj	O
,	,	punct	O
Dukes	NNP	nmod:poss	O
'	POS	case	O
stage	NN	conj	O
,	,	punct	O
differentiation	NN	compound	O
grade	NN	conj	O
,	,	punct	O
survival	NN	compound	O
status	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
p53	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
PCNA	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
were	VBD	auxpass	O
statistically	RB	advmod	O
analyzed	VBN	ROOT	O
for	IN	case	O
association	NN	nmod	O
with	IN	case	O
topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Topo	IN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
in	IN	case	O
paired	JJ	amod	O
primary	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
for	IN	case	O
concordance	NN	nmod	O
.	.	punct	O

Topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
127	CD	nummod	O
(	-LRB-	punct	O
51	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
samples	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
24	CD	nmod	O
.	.	punct	O
4	CD	nummod	O
%	NN	ROOT	O
with	IN	case	O
>	NN	amod	O
50	CD	nummod	O
%	NN	amod	O
positive	JJ	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
majority	NN	nsubj	O
had	VBD	ROOT	O
nuclear	JJ	dobj	B-Cellular_component
(	-LRB-	punct	O
70	CD	dep	O
.	.	punct	O
1	CD	nummod	O
%	NN	ROOT	O
)	-RRB-	punct	O
or	CC	cc	O
nuclear	JJ	amod	B-Cellular_component
and	CC	cc	O
cytoplasmic	JJ	conj	B-Organism_substance
staining	NN	conj	O
(	-LRB-	punct	O
17	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
higher	JJR	amod	O
percentage	NN	nsubjpass	O
of	IN	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
topo	IN	dobj	B-Gene_or_gene_product
I	PRP	dep	I-Gene_or_gene_product
in	IN	case	O
primary	JJ	amod	B-Cancer
colorectal	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
advanced	JJ	amod	O
age	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.	.	punct	O
040	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
with	IN	case	O
rectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
had	VBD	ROOT	O
greater	JJR	amod	O
topo	IN	compound	B-Gene_or_gene_product
I	PRP	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
than	IN	case	O
those	DT	nmod	O
with	IN	case	O
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.	.	punct	O
029	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
topo	NN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
sex	NN	conj	O
,	,	punct	O
Dukes	NNP	nmod:poss	O
'	POS	case	O
stage	NN	conj	O
,	,	punct	O
differentiation	NN	compound	O
grade	NN	conj	O
,	,	punct	O
survival	NN	compound	O
status	NN	conj	O
,	,	punct	O
p53	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
PCNA	NN	compound	B-Gene_or_gene_product
status	NN	conj	O
.	.	punct	O

Concordance	NN	nsubjpass	O
in	IN	prep	O
topo	IN	pobj	B-Gene_or_gene_product
I	PRP	compound	I-Gene_or_gene_product
staining	VBG	nmod	O
between	IN	case	O
primary	JJ	amod	B-Cancer
and	CC	cc	O
lymph	NN	conj	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
33	CD	compound	O
of	IN	advmod	O
42	CD	nummod	O
cases	NNS	nmod	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	acl:relcl	O
.	.	punct	O
029	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
activity	NN	nsubj	O
of	IN	case	O
topo	NN	compound	B-Gene_or_gene_product
I	PRP	nummod	I-Gene_or_gene_product
inhibitors	NNS	nmod	O
will	MD	aux	O
not	RB	neg	O
differ	VB	ccomp	O
across	IN	case	O
various	JJ	amod	O
tumor	NN	compound	B-Cancer
stages	NNS	nmod	O
,	,	punct	O
pathology	NN	conj	O
,	,	punct	O
and	CC	cc	O
patient	NN	compound	B-Organism
gender	NN	conj	O
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
PCNA	NN	conj	B-Gene_or_gene_product
status	NN	dep	O
do	VBP	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
topo	IN	compound	B-Gene_or_gene_product
I	NN	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
topo	NN	nsubj	B-Gene_or_gene_product
I	PRP	nsubj	I-Gene_or_gene_product
has	VBZ	conj	O
no	DT	neg	O
apparent	JJ	amod	O
association	NN	dobj	O
with	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
a	DT	det	O
metastatic	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

Topo	IN	compound	B-Gene_or_gene_product
I	PRP	compound	I-Gene_or_gene_product
expression	NN	nsubj	O
now	RB	advmod	O
needs	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
evaluated	VBN	xcomp	O
in	IN	case	O
patients	NNS	nmod	B-Organism
undergoing	VBG	acl	O
topo	IN	compound	B-Gene_or_gene_product
I	PRP	compound	I-Gene_or_gene_product
-	HYPH	punct	O
inhibitor	NN	compound	O
therapy	NN	dobj	O
,	,	punct	O
to	TO	mark	O
better	RBR	advmod	O
define	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
as	IN	case	O
a	DT	det	O
predictive	JJ	amod	O
marker	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
diseases	NNS	conj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Members	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
superfamily	NN	nmod	O
play	VBP	dep	O
critical	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
cellular	JJ	amod	B-Cell
functions	NNS	nmod	O
.	.	punct	O

Dysregulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
signaling	NN	compound	O
mechanisms	NNS	nmod	O
of	IN	case	O
the	DT	det	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
superfamily	NN	compound	O
proteins	NNS	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
clinical	JJ	amod	O
diseases	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
fibrotic	JJ	amod	O
diseases	NNS	conj	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
disorders	NNS	conj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
understanding	VBG	csubj	O
these	DT	det	O
signaling	NN	compound	O
mechanisms	NNS	dobj	O
may	MD	aux	O
provide	VB	ROOT	O
us	PRP	dobj	O
with	IN	case	O
novel	JJ	amod	O
ways	NNS	nmod	O
to	TO	mark	O
develop	VB	acl	O
strategies	NNS	dobj	O
for	IN	mark	O
treating	VBG	advcl	O
clinical	JJ	amod	O
diseases	NNS	dobj	O
induced	VBN	acl	O
by	IN	case	O
these	DT	det	O
cytokines	NNS	nmod	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
This	DT	det	O
review	NN	nsubj	O
discusses	VBZ	ROOT	O
our	PRP$	nmod:poss	O
current	JJ	amod	O
understanding	NN	dobj	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
focusing	VBG	advcl	O
on	IN	case	O
the	DT	det	O
roles	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Cell
wall	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
on	IN	case	O
the	DT	det	O
regulation	NN	conj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
superfamily	NN	compound	O
signals	NNS	nmod	O
by	IN	case	O
inhibitory	JJ	amod	O
Smads	NNP	nmod	B-Gene_or_gene_product
.	.	punct	O

[	-LRB-	punct	O
Expression	NN	ROOT	O
and	CC	cc	O
mutation	NN	conj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
gastrointestinal	JJ	amod	B-Cancer
stromal	JJ	amod	I-Cancer
tumor	NN	nmod	I-Cancer
]	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
and	CC	cc	O
mutation	NN	conj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
relationship	NN	conj	O
with	IN	case	O
clinical	JJ	amod	O
pathology	NN	nmod	O
and	CC	cc	O
prognosis	NN	conj	O
of	IN	case	O
gastrointestinal	JJ	amod	B-Cancer
stromal	JJ	amod	I-Cancer
tumor	NN	nmod	I-Cancer
(	-LRB-	punct	O
GIST	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Immunohistochemical	JJ	amod	O
and	CC	cc	O
PCR	NN	compound	O
-	:	punct	O
SSCP	NN	conj	O
techniques	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
detect	VB	xcomp	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
exon	NN	compound	O
11	CD	nummod	O
mutation	NN	conj	O
in	IN	case	O
82	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
GIST	NN	nmod	B-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
positive	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nsubj	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
mutation	NN	compound	O
rates	NNS	conj	O
were	VBD	cop	O
97	CD	appos	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
80	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
41	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
34	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Correlating	VBG	csubj	O
the	DT	det	O
results	NNS	dobj	O
of	IN	case	O
these	DT	det	O
two	CD	nummod	O
methods	NNS	nmod	O
and	CC	cc	O
clinicopathological	JJ	amod	O
factors	NNS	conj	O
,	,	punct	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
mutation	NN	compound	O
rates	NNS	conj	O
were	VBD	cop	O
95	CD	ROOT	O
.	.	punct	O
0	CD	nummod	O
%	NN	nsubj	O
(	-LRB-	punct	O
19	CD	nummod	O
/	SYM	punct	O
20	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
0	CD	conj	O
in	IN	case	O
benign	JJ	amod	B-Cancer
GIST	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
were	VBD	conj	O
98	CD	ROOT	O
.	.	punct	O
4	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
61	CD	nummod	O
/	SYM	punct	O
62	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
54	CD	appos	O
.	.	punct	O
8	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
34	CD	nummod	O
/	SYM	punct	O
62	CD	appos	O
)	-RRB-	punct	O
in	IN	case	O
malignant	JJ	amod	B-Cancer
GIST	NN	nmod	I-Cancer
.	.	punct	O

Mutation	NN	compound	O
positive	JJ	amod	O
GIST	NN	nsubj	B-Cancer
showed	VBD	ROOT	O
higher	JJR	amod	O
frequency	NN	dobj	O
of	IN	case	O
adjacent	JJ	amod	O
tissue	NN	compound	B-Tissue
invasion	NN	nmod	O
,	,	punct	O
metastasis	NN	conj	O
and	CC	cc	O
recurrence	NN	conj	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
mutation	NN	compound	O
negative	JJ	amod	O
ones	NNS	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
diagnostic	JJ	amod	O
marker	NN	dep	O
of	IN	case	O
gastrointestinal	JJ	amod	B-Cancer
stromal	JJ	amod	I-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kit	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
mutation	NN	nsubj	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
GIST	NN	nmod	B-Cancer
and	CC	cc	O
also	RB	advmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
prognostic	JJ	amod	O
marker	NN	conj	O
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	compound	O
sensitizes	VBZ	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
death	NN	compound	O
receptor	NN	nmod:npmod	O
-	:	punct	O
triggered	VBN	amod	O
apoptosis	NN	nmod	O
through	IN	case	O
enhancement	NN	nmod	O
of	IN	case	O
death	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducing	VBG	amod	I-Gene_or_gene_product
signaling	NN	compound	I-Gene_or_gene_product
complex	NN	compound	I-Gene_or_gene_product
formation	NN	nmod	O
and	CC	cc	O
apical	JJ	amod	O
procaspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
processing	NN	conj	O
.	.	punct	O

Tumors	NNS	nsubj	B-Cancer
display	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	O
rate	NN	dobj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
and	CC	cc	O
glycolysis	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
how	WRB	advmod	O
inhibition	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
could	MD	aux	O
affect	VB	ccomp	O
death	NN	nmod:npmod	O
receptor	NN	nmod:npmod	O
-	:	punct	O
mediated	VBN	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
diverse	JJ	amod	O
origin	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	dobj	O
both	CC	det	O
substitution	NN	dep	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
for	IN	case	O
pyruvate	NN	nmod	B-Simple_chemical
and	CC	cc	O
treatment	NN	conj	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyglucose	NN	amod	I-Simple_chemical
enhanced	VBN	amod	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TNF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
CD95	NN	compound	B-Gene_or_gene_product
agonistic	JJ	amod	O
antibody	NN	conj	O
,	,	punct	O
and	CC	cc	O
TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
apoptosis	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducing	VBG	amod	I-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
TRAIL	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
enhanced	VBD	ROOT	O
killing	NN	dobj	O
of	IN	case	O
myeloid	JJ	amod	B-Cell
leukemia	NN	compound	I-Cell
U937	NN	nmod	I-Cell
,	,	punct	O
cervical	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
HeLa	NN	conj	I-Cell
,	,	punct	O
and	CC	cc	O
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
MCF	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
upon	IN	case	O
death	NN	compound	O
receptor	NN	compound	O
ligation	NN	nmod	O
.	.	punct	O

Caspase	NN	compound	B-Gene_or_gene_product
activation	NN	nsubjpass	O
,	,	punct	O
mitochondrial	JJ	amod	B-Cellular_component
depolarization	NN	conj	O
,	,	punct	O
and	CC	cc	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	compound	I-Gene_or_gene_product
release	NN	conj	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
deprivation	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
sensitization	NN	nsubjpass	O
to	TO	case	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
prevented	VBN	ROOT	O
in	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
overexpressing	VBG	acl	O
BCL	NN	dobj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Interestingly	RB	ROOT	O
,	,	punct	O
the	DT	det	O
human	JJ	amod	B-Organism
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
lymphoblastoid	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
SKW6	NN	intj	I-Cell
.	.	punct	I-Cell
4	LS	nsubjpass	I-Cell
,	,	punct	O
a	DT	det	O
prototype	NN	appos	O
for	IN	case	O
mitochondria	NN	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
independent	JJ	amod	O
death	NN	compound	O
receptor	NN	nmod:npmod	O
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
sensitized	VBN	ROOT	O
to	TO	case	O
anti	VB	compound	O
-	HYPH	punct	O
CD95	NN	nmod:npmod	B-Gene_or_gene_product
and	CC	cc	O
TRAIL	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
under	IN	case	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
free	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

Changes	NNS	nsubjpass	O
in	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
FLIP	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
cFLIPs	NN	conj	B-Gene_or_gene_product
levels	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
some	DT	intj	O
but	CC	cc	O
not	RB	cc	O
all	PDT	det:predet	O
the	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
studied	VBN	acl	O
following	VBG	case	O
glucose	NN	compound	B-Simple_chemical
deprivation	NN	nmod	O
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
deprivation	NN	nsubj	O
enhanced	VBD	ROOT	O
death	NN	compound	O
receptor	NN	npadvmod	O
-	HYPH	punct	O
triggered	VBN	amod	O
formation	NN	dobj	O
of	IN	case	O
death	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducing	VBG	amod	I-Gene_or_gene_product
signaling	NN	compound	I-Gene_or_gene_product
complex	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
early	JJ	amod	O
processing	NN	conj	O
of	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Altogether	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
glycolytic	JJ	amod	O
pathway	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
target	NN	ccomp	O
for	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
to	TO	mark	O
sensitize	VB	advcl	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
to	TO	case	O
selectively	RB	advmod	O
toxic	JJ	amod	O
soluble	JJ	amod	O
death	NN	compound	O
ligands	NNS	nmod	O
or	CC	cc	O
death	NN	compound	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	conj	B-Cell
of	IN	case	O
the	DT	det	O
immune	JJ	amod	B-Anatomical_system
system	NN	nmod	I-Anatomical_system
by	IN	mark	O
facilitating	VBG	advcl	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
initiator	NN	compound	O
caspase	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Arteriogenesis	NN	ROOT	O
:	:	punct	O
the	DT	det	O
development	NN	appos	O
and	CC	cc	O
growth	NN	conj	O
of	IN	case	O
collateral	JJ	amod	B-Multi-tissue_structure
arteries	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
atherosclerotic	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
diseases	NNS	nmod	O
,	,	punct	O
collateral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nsubjpass	I-Multi-tissue_structure
bypassing	VBG	acl	O
major	JJ	amod	O
arterial	JJ	amod	B-Pathological_formation
obstructions	NNS	dobj	I-Pathological_formation
have	VBP	aux	O
frequently	RB	advmod	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

This	DT	nsubj	O
may	MD	aux	O
explain	VB	ROOT	O
why	WRB	advmod	O
some	DT	det	O
patients	NNS	nsubj	B-Organism
remain	VBP	ccomp	O
without	IN	case	O
symptoms	NNS	nmod	O
or	CC	cc	O
signs	NNS	conj	O
of	IN	case	O
ischemia	NN	nmod	O
.	.	punct	O

The	DT	det	O
term	NN	nmod	O
"	``	punct	O
arteriogenesis	NN	nsubjpass	O
"	''	punct	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
to	TO	mark	O
differentiate	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
collateral	JJ	amod	B-Multi-tissue_structure
arteries	NNS	nmod	I-Multi-tissue_structure
from	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
mainly	RB	advmod	O
occurs	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
ischemic	JJ	amod	O
,	,	punct	O
collateral	JJ	dep	O
flow	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	dep	O
tissue	NN	nmod	B-Tissue
.	.	punct	O

Many	JJ	amod	O
observations	NNS	nsubj	O
in	IN	case	O
various	JJ	amod	O
animal	NN	compound	O
models	NNS	nmod	O
and	CC	cc	O
humans	NNS	conj	B-Organism
support	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
remodeling	NN	nsubj	O
of	IN	prep	O
preexisting	VBG	pcomp	O
collateral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
is	VBZ	cop	O
the	DT	det	O
mechanism	NN	ccomp	O
of	IN	case	O
collateral	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
.	.	punct	O

This	DT	det	O
remodeling	JJ	amod	O
process	NN	nsubj	O
seems	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mainly	RB	advmod	O
flow	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	xcomp	O
.	.	punct	O

It	PRP	nsubj	O
involves	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	dobj	O
,	,	punct	O
basal	JJ	amod	B-Cellular_component
membrane	NN	compound	I-Cellular_component
degradation	NN	conj	O
,	,	punct	O
leukocyte	NN	compound	B-Cell
invasion	NN	conj	O
,	,	punct	O
proliferation	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
neointima	NN	compound	B-Tissue
formation	NN	appos	O
(	-LRB-	punct	O
in	IN	case	O
most	JJS	amod	O
species	NNS	nmod	O
studied	VBN	acl	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
changes	NNS	conj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
.	.	punct	O

The	DT	det	O
contribution	NN	nsubj	O
of	IN	case	O
ischemia	NN	nmod	O
to	TO	case	O
arteriogenesis	NN	nmod	O
is	VBZ	cop	O
still	RB	advmod	O
unclear	JJ	ROOT	O
,	,	punct	O
but	CC	cc	O
arteriogenesis	NN	nsubj	O
clearly	RB	advmod	O
can	MD	aux	O
occur	VB	conj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
any	DT	det	O
significant	JJ	amod	O
ischemia	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
questionable	JJ	acomp	O
,	,	punct	O
whether	IN	mark	O
collateral	JJ	amod	B-Multi-tissue_structure
arteries	NNS	nsubj	I-Multi-tissue_structure
also	RB	advmod	O
form	VBP	advcl	O
de	FW	amod	O
novo	FW	dobj	O
in	IN	case	O
ischemic	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
diseases	NNS	nmod	O
.	.	punct	O

A	DT	det	O
better	JJR	amod	O
understanding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
arteriogenesis	NN	nmod	O
will	MD	aux	O
be	VB	cop	O
important	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
design	NN	nmod	O
of	IN	case	O
more	RBR	advmod	O
effective	JJ	amod	O
strategies	NNS	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
ischemic	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
diseases	NNS	nmod	O
.	.	punct	O

Bee	NN	compound	B-Organism
venom	NN	nsubj	B-Organism_substance
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
expression	NN	dobj	O
of	IN	case	O
cyclooxygenase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
NCI	NN	compound	I-Cell
-	:	punct	I-Cell
H1299	NN	nmod	I-Cell
.	.	punct	O

To	TO	mark	O
investigate	VB	ROOT	O
whether	IN	mark	O
bee	NN	compound	B-Organism
venom	NN	nsubj	B-Organism_substance
(	-LRB-	punct	O
BV	NN	appos	B-Organism_substance
)	-RRB-	punct	O
induces	VBZ	ccomp	O
apoptosis	NN	dobj	O
,	,	punct	O
the	DT	det	O
3	CD	nummod	B-Simple_chemical
-	CD	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethylthiazol	NN	conj	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
yl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
diphenyltetrazolium	NN	compound	I-Simple_chemical
bromide	NN	compound	I-Simple_chemical
assay	NN	conj	O
,	,	punct	O
terminal	JJ	amod	B-Gene_or_gene_product
deoxynucleotidyl	NN	compound	I-Gene_or_gene_product
transferase	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
dUTP	NN	compound	B-Simple_chemical
nick	NNS	compound	O
end	NN	compound	O
-	HYPH	punct	O
labeling	NN	compound	O
assay	NN	conj	O
,	,	punct	O
4	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
diamidino	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phenylindole	NN	amod	I-Simple_chemical
staining	NN	appos	O
,	,	punct	O
flow	NN	compound	O
cytometric	JJ	amod	O
analysis	NN	conj	O
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	compound	O
assay	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	parataxis	O
on	IN	case	O
NCI	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
H1299	NN	compound	I-Cell
lung	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
treated	VBN	acl	O
with	IN	case	O
BV	NN	nmod	B-Organism_substance
.	.	punct	O

Through	IN	case	O
morphological	JJ	amod	O
and	CC	cc	O
biochemical	JJ	conj	O
analyses	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
NCI	NN	compound	B-Cell
-	HYPH	punct	I-Cell
H1299	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
treated	VBN	acl	O
with	IN	case	O
BV	NN	nmod	B-Organism_substance
exhibit	VBP	ccomp	O
several	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
reverse	JJ	amod	O
transcription	NN	compound	O
-	HYPH	punct	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubjpass	O
and	CC	cc	O
prostaglandin	NN	compound	B-Simple_chemical
E	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
(	-LRB-	punct	O
PGE	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
immunoassay	NN	conj	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
verify	VB	xcomp	O
whether	IN	mark	O
BV	NN	nsubj	B-Organism_substance
possesses	VBZ	ccomp	O
an	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
cyclooxygenase	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
COX	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
PGE	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	LS	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
synthesis	NN	conj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	B-Organism_substance
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
BV	NN	nsubj	B-Organism_substance
may	MD	aux	O
exert	VB	ccomp	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
effect	NN	dobj	O
on	IN	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Possible	JJ	amod	O
role	NN	ROOT	O
of	IN	case	O
cyclooxygenase	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
ovarian	JJ	amod	B-Multi-tissue_structure
luteal	JJ	amod	I-Multi-tissue_structure
function	NN	nmod	O
in	IN	case	O
rodents	NNS	nmod	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
the	DT	det	O
corpus	NN	amod	B-Multi-tissue_structure
luteum	NN	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
CL	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
involves	VBZ	acl:relcl	O
angiogenesis	NN	dobj	O
,	,	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
establishment	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
pregnancy	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
the	DT	det	O
prostaglandin	NN	compound	B-Simple_chemical
synthases	NNS	compound	O
cyclooxygenase	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
COX	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
I	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
II	CD	conj	I-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
progesterone	NN	compound	B-Simple_chemical
production	NN	conj	O
in	IN	case	O
the	DT	det	O
newly	RB	advmod	O
formed	VBN	amod	O
CL	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
using	VBG	advcl	O
inhibitors	NNS	dobj	O
of	IN	case	O
the	DT	det	O
COX	NN	compound	B-Gene_or_gene_product
enzymes	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
gonadotropin	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
pseudopregnant	JJ	amod	O
rat	NN	conj	B-Organism
as	IN	case	O
a	DT	det	O
model	NN	nmod	O
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
indomethacin	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
nonselective	JJ	amod	O
COX	NN	compound	B-Gene_or_gene_product
inhibitor	NN	appos	O
,	,	punct	O
on	IN	prep	O
the	DT	det	O
day	NN	pobj	O
of	IN	prep	O
ovulation	NN	pobj	O
and	CC	cc	O
the	DT	det	O
following	VBG	amod	O
day	NN	conj	O
decreased	VBD	ROOT	O
serum	NN	compound	B-Organism_substance
levels	NNS	dobj	O
of	IN	case	O
progesterone	NN	nmod	B-Simple_chemical
,	,	punct	O
as	IN	mark	O
did	VBD	advcl	O
injection	NN	dobj	O
of	IN	case	O
the	DT	det	O
selective	JJ	amod	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
II	CD	dep	I-Gene_or_gene_product
inhibitor	NN	compound	O
NS	NN	nmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
398	CD	nummod	I-Simple_chemical
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
a	DT	det	O
selective	JJ	amod	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nsubj	O
,	,	punct	O
SC	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
560	CD	appos	I-Simple_chemical
,	,	punct	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
serum	NN	compound	B-Organism_substance
progesterone	NN	compound	B-Simple_chemical
concentrations	NNS	nmod	O
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
inhibitors	NNS	nmod	O
had	VBD	ROOT	O
any	DT	det	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
weight	NN	nmod	O
of	IN	prep	O
the	DT	det	O
superovulated	VBN	amod	B-Organ
ovaries	NNS	pobj	I-Organ
or	CC	cc	O
on	IN	case	O
the	DT	det	O
synthesis	NN	conj	O
of	IN	case	O
progesterone	NN	nmod	B-Simple_chemical
by	IN	case	O
cultured	VBN	amod	B-Cell
luteal	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
angiogenesis	NN	nmod	O
are	VBP	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
progesterone	NN	compound	B-Simple_chemical
synthesis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
measured	VBD	ROOT	O
hemoglobin	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
CD34	NN	conj	B-Gene_or_gene_product
levels	NNS	dep	O
in	IN	case	O
luteinized	JJ	amod	O
ovaries	NNS	nmod	B-Organ
following	VBG	case	O
injection	NN	nmod	O
of	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nmod	O
and	CC	cc	O
measured	VBD	conj	O
the	DT	det	O
relative	JJ	amod	O
frequency	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
positive	JJ	amod	O
for	IN	case	O
platelet	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
specific	JJ	amod	O
marker	NN	nmod	O
for	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

All	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
parameters	NNS	nmod	O
were	VBD	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
COX	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
inhibitors	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Multi-tissue_structure
are	VBP	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
progesterone	NN	nmod	B-Simple_chemical
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
of	IN	case	O
ovarian	JJ	amod	B-Organ
corrosion	NN	compound	O
casts	NNS	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
NS	NN	nsubj	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
398	CD	nummod	I-Simple_chemical
inhibited	VBD	ccomp	O
the	DT	det	O
establishment	NN	dobj	O
of	IN	case	O
luteal	JJ	amod	B-Multi-tissue_structure
capillary	JJ	amod	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
following	VBG	case	O
the	DT	det	O
injection	NN	nmod	O
of	IN	case	O
hCG	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
the	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
II	CD	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
CL	NN	nmod	B-Multi-tissue_structure
via	IN	case	O
its	PRP$	nmod:poss	O
stimulation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	B-Cancer
angiogenesis	NN	nsubj	O
modulates	VBZ	ROOT	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
endothelial	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
endothelial	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
EC	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecules	NNS	nmod	I-Gene_or_gene_product
involved	VBN	acl	O
in	IN	case	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nmod	O
is	VBZ	auxpass	O
suppressed	VBN	ROOT	O
in	IN	case	O
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nmod	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

By	IN	case	O
means	NNS	nmod	O
of	IN	case	O
intravital	JJ	amod	O
microscopy	NN	nmod	O
,	,	punct	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
stimulated	VBN	amod	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nsubjpass	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
ear	NN	amod	B-Tissue
skin	NN	compound	I-Tissue
microvessels	NNS	nmod	I-Tissue
of	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
bearing	VBG	acl	O
small	JJ	amod	O
human	JJ	amod	B-Organism
LS174T	NN	compound	B-Cancer
colon	NN	compound	I-Cancer
carcinomas	NNS	dobj	I-Cancer
and	CC	cc	O
in	IN	case	O
C57Bl	NN	compound	B-Organism
/	SYM	punct	I-Organism
6	CD	nummod	I-Organism
mice	NNS	conj	I-Organism
bearing	VBG	acl	O
murine	JJ	amod	B-Organism
B16F10	NN	compound	B-Cancer
melanomas	NNS	dobj	I-Cancer
.	.	punct	O

Leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nsubjpass	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
both	CC	cc:preconj	O
within	IN	nmod	O
and	CC	cc	O
outside	IN	conj	O
small	JJ	amod	O
tumors	NNS	nmod	B-Cancer
growing	VBG	acl	O
in	IN	prep	O
the	DT	det	O
ear	NN	pobj	B-Organ
,	,	punct	O
and	CC	cc	O
in	IN	case	O
ear	NN	amod	B-Tissue
microvessels	NNS	conj	I-Tissue
of	IN	case	O
mice	NNS	nmod	B-Organism
with	IN	case	O
a	DT	det	O
large	JJ	amod	O
tumor	NN	nmod	B-Cancer
growing	VBG	acl	O
on	IN	prep	O
their	PRP$	poss	O
flank	NN	pobj	B-Organism_subdivision
.	.	punct	O

Tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
free	JJ	amod	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
values	NNS	nmod	O
measured	VBN	acl	O
at	IN	prep	O
the	DT	det	O
edge	NN	pobj	O
of	IN	prep	O
the	DT	det	O
ear	NN	pobj	B-Organ
and	CC	cc	O
in	IN	case	O
the	DT	det	O
contralateral	JJ	amod	O
ear	NN	conj	B-Organ
,	,	punct	O
leukocyte	NN	compound	B-Cell
adhesion	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
diminished	VBN	xcomp	O
significantly	RB	advmod	O
in	IN	case	O
vessels	NNS	nmod	B-Tissue
inside	IN	case	O
the	DT	det	O
ear	NN	amod	B-Cancer
tumor	NN	nmod	I-Cancer
in	IN	case	O
both	CC	det	O
mouse	NN	compound	B-Organism
models	NNS	nmod	O
.	.	punct	O

This	DT	det	O
reduction	NN	nsubj	O
disappeared	VBD	ROOT	O
with	IN	prep	O
increasing	VBG	amod	O
distance	NN	pobj	O
from	IN	prep	O
the	DT	det	O
tumor	NN	pobj	B-Cancer
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
leukocyte	NN	compound	B-Cell
adhesion	NN	nmod	O
in	IN	case	O
ear	NN	amod	B-Multi-tissue_structure
venules	NNS	nmod	I-Multi-tissue_structure
of	IN	case	O
mice	NNS	nmod	B-Organism
with	IN	case	O
a	DT	det	O
large	JJ	amod	O
flank	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
was	VBD	auxpass	O
also	RB	advmod	O
reduced	VBN	ROOT	O
significantly	RB	advmod	O
.	.	punct	O

Leukocyte	NN	compound	B-Cell
rolling	NN	ROOT	O
,	,	punct	O
i	LS	appos	O
.	.	punct	O
e	LS	npadvmod	O
.	.	punct	O
,	,	punct	O
the	DT	det	O
step	NN	compound	O
preceding	VBG	compound	O
adhesion	NN	nsubjpass	O
,	,	punct	O
was	VBD	auxpass	O
not	RB	neg	O
influenced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
tumor	NN	nmod	B-Cancer
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
in	IN	case	O
immune	JJ	amod	O
-	HYPH	punct	O
competent	JJ	amod	O
C57Bl	NN	nmod	B-Organism
/	SYM	punct	I-Organism
6	CD	nummod	I-Organism
mice	NNS	dep	I-Organism
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
a	DT	det	O
small	JJ	amod	O
ear	NN	amod	B-Cancer
tumor	NN	dobj	I-Cancer
with	IN	case	O
a	DT	det	O
humanized	JJ	amod	O
antivascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
prevented	VBD	ROOT	O
the	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nmod	O
inside	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
nontreated	JJ	amod	O
group	NN	advcl	O
.	.	punct	O

Fluorescence	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
cell	NN	compound	B-Cell
sorter	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
isolated	VBN	amod	O
tumor	NN	compound	B-Cell
ECs	NNS	nsubj	I-Cell
have	VBP	aux	O
suppressed	VBN	ccomp	O
levels	NNS	dobj	O
of	IN	case	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
ECs	NNS	nmod	B-Cell
from	IN	case	O
normal	JJ	amod	O
mouse	NN	compound	B-Organism
tissues	NNS	nmod	B-Tissue
.	.	punct	O

In	IN	case	O
cultured	VBN	amod	O
b	NN	ROOT	B-Cell
.	.	punct	I-Cell
END5	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
the	DT	det	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	nsubj	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	ROOT	O
up	RP	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	conj	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
that	WDT	nsubjpass	O
were	VBD	auxpass	O
preincubated	VBN	acl:relcl	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
results	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
an	DT	det	O
impact	NN	dobj	O
on	IN	case	O
the	DT	det	O
effectiveness	NN	nmod	O
of	IN	case	O
clinical	JJ	amod	O
immunotherapeutic	JJ	amod	O
treatment	NN	compound	O
protocols	NNS	nmod	O
,	,	punct	O
because	IN	mark	O
immune	JJ	amod	B-Cell
effector	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
able	JJ	advcl	O
to	TO	mark	O
enter	VB	xcomp	O
tumor	NN	compound	B-Tissue
tissue	NN	dobj	I-Tissue
.	.	punct	O

[	-LRB-	punct	O
Effects	NNS	ROOT	O
of	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
EBV	NN	compound	B-Organism
-	:	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
on	IN	case	O
related	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
of	IN	case	O
nasopharyngeal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
CNE1	NN	nmod	I-Cell
]	-RRB-	punct	O
.	.	punct	O

BACKGROUND	NN	nsubjpass	O
&	CC	cc	O
#	$	advmod	O
38	CD	conj	O
;	:	punct	O
OBJECTIVE	NN	appos	O
:	:	punct	O
It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
proved	VBN	ROOT	O
that	IN	mark	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
EBV	NN	compound	B-Organism
-	:	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
EBV	NN	compound	B-Organism
-	:	punct	O
LMP1	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
related	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
of	IN	case	O
nasopharyngeal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
CNE1	NN	nmod	I-Cell
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Expression	NN	nsubjpass	O
of	IN	case	O
MMP	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
NPC	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
cultured	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
:	:	punct	O
CNE1	NN	dep	B-Cell
(	-LRB-	punct	O
well	RB	advmod	O
differentiated	VBN	amod	O
cell	NN	compound	B-Cell
line	NN	dep	I-Cell
of	IN	case	O
NPC	NN	nmod	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
CNE1	NN	compound	B-Cell
-	:	punct	I-Cell
GL	NN	compound	I-Cell
(	-LRB-	punct	O
CNE1	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	conj	I-Cell
transfected	VBN	acl	O
with	IN	case	O
an	DT	det	O
eukaryotic	JJ	amod	O
LMP1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
expression	NN	compound	O
plasmid	NN	nmod	O
)	-RRB-	punct	O
by	IN	case	O
SP	NN	compound	O
immunohistochemistry	NN	nmod	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

Cell	NNP	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	B-Cellular_component
adhesion	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
adhesive	JJ	amod	O
ability	NN	dobj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
-	HYPH	punct	I-Cell
GL	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
LMP1	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
invasion	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	case	O
transwell	NN	compound	O
methods	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
expressed	VBN	appos	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
but	CC	cc	O
the	DT	det	O
intensity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
staining	NN	nmod	O
was	VBD	cop	O
different	JJ	conj	O
.	.	punct	O

The	DT	det	O
positive	JJ	amod	O
rates	NNS	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
CNE1	NN	compound	B-Cell
and	CC	cc	O
CNE1	NN	compound	B-Cell
-	HYPH	punct	I-Cell
GL	NN	conj	I-Cell
cells	NNS	nmod	I-Cell
were	VBD	cop	O
30	CD	ROOT	O
.	.	punct	O
2	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
98	CD	conj	O
.	.	punct	O
2	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
MMP	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
was	VBD	auxpass	O
also	RB	advmod	O
shown	VBN	ROOT	O
in	IN	case	O
CNE1	NN	compound	B-Cell
-	HYPH	punct	I-Cell
GL	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Cell	NNP	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	B-Cellular_component
adhesion	NN	compound	O
assay	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	dobj	O
the	DT	det	O
adhesive	JJ	amod	O
ability	NN	intj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
-	:	punct	I-Cell
GL	NN	nmod	I-Cell
with	IN	case	O
the	DT	det	O
matrix	NN	nmod	B-Cellular_component
(	-LRB-	punct	O
mean	NN	amod	O
A	NN	compound	O
value	NN	dep	O
:	:	punct	O
1	CD	dep	O
.	.	punct	O
2508	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
0711	CD	nsubj	O
)	-RRB-	punct	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
CNE1	NN	compound	B-Cell
cell	NN	nmod	I-Cell
(	-LRB-	punct	O
mean	NN	amod	O
A	NN	compound	O
value	NN	dep	O
:	:	punct	O
0	CD	dep	O
.	.	punct	O
9519	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
068	CD	dep	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Invasion	NN	compound	O
assay	NN	nsubj	O
and	CC	cc	O
migration	NN	compound	O
assay	NN	conj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
invasion	NN	nsubj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
-	HYPH	punct	I-Cell
GL	NN	compound	I-Cell
cell	NN	nmod	I-Cell
were	VBD	cop	O
higher	JJR	ccomp	O
than	IN	case	O
those	DT	nmod	O
of	IN	case	O
CNE1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	dep	O
0	CD	nummod	O
.	.	punct	O
01	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
transfection	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	B-Gene_or_gene_product
can	MD	aux	O
increase	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
CNE1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Abilities	NNS	nsubjpass	O
of	IN	case	O
adhesion	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
CNE1	NN	compound	B-Cell
cell	NN	nmod	I-Cell
were	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
LMP1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
MMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
have	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
LMP1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
acceleration	NN	nmod	O
of	IN	case	O
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
NPC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Truncated	VBN	amod	O
galectin	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
orthotopic	JJ	amod	O
nude	JJ	amod	B-Organism
mouse	NN	compound	I-Organism
model	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
goal	NN	nsubj	O
of	IN	prep	O
this	DT	det	O
research	NN	pobj	O
was	VBD	appos	O
to	TO	mark	O
evaluate	VB	xcomp	O
a	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
agent	NN	dobj	O
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
based	VBN	case	O
on	IN	case	O
galectin	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
tumorigenicity	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
hypothesis	NN	nsubj	O
was	VBD	ROOT	O
that	IN	mark	O
therapy	NN	nsubj	O
with	IN	case	O
NH	NN	nmod	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
-	:	punct	O
terminally	RB	advmod	O
truncated	VBN	amod	O
form	NN	conj	O
of	IN	prep	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
will	MD	aux	O
be	VB	cop	O
efficacious	JJ	ccomp	O
for	IN	case	O
reduction	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
for	IN	case	O
inhibition	NN	conj	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
Recombinant	JJ	amod	O
human	JJ	amod	B-Organism
galectin	NN	nsubjpass	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
produced	VBN	dep	O
in	IN	case	O
Escherichia	FW	compound	B-Organism
coli	FW	nmod	I-Organism
from	IN	case	O
which	WDT	nmod	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
derived	VBN	acl:relcl	O
by	IN	case	O
collagenase	NN	compound	B-Gene_or_gene_product
enzyme	NN	compound	O
digestion	NN	nmod	O
.	.	punct	O

Toxicity	NN	nsubjpass	O
,	,	punct	O
pharmacokinetic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
organ	NN	compound	B-Organ
biodistribution	NN	compound	O
studies	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

For	IN	case	O
efficacy	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
nude	JJ	amod	B-Organism
mice	NNS	nsubjpass	I-Organism
bearing	VBG	acl	O
orthotopically	RB	advmod	O
implanted	VBN	amod	O
tumors	NNS	dobj	B-Cancer
derived	VBN	acl	O
from	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
MDA	NN	compound	I-Cell
-	:	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
435	CD	dep	I-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	prep	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	pobj	I-Gene_or_gene_product
or	CC	cc	O
a	DT	det	O
vehicle	NN	conj	O
control	NN	conj	O
i	LS	dobj	O
.	.	punct	O
m	LS	ROOT	O
.	.	punct	O
twice	RB	advmod	O
daily	RB	ROOT	O
for	IN	prep	O
90	CD	nummod	O
days	NNS	pobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
maximum	NN	amod	O
tolerated	JJ	amod	O
dose	NN	nsubjpass	O
of	IN	case	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
was	VBD	auxpass	O
determined	VBN	dep	O
to	TO	mark	O
be	VB	cop	O
>	NN	advmod	O
125	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	xcomp	O
without	IN	case	O
overt	JJ	amod	O
adverse	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

The	DT	det	O
elimination	NN	compound	O
half	NN	nummod	O
-	HYPH	punct	O
life	NN	nsubj	O
when	WRB	advmod	O
administered	VBN	ROOT	O
i	NN	dobj	O
.	.	punct	O
m	NN	nsubjpass	O
.	.	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
3	CD	xcomp	O
.	.	punct	O
0	CD	nummod	O
h	NN	ROOT	O
in	IN	case	O
the	DT	det	O
serum	NN	nmod	B-Organism_substance
and	CC	cc	O
4	CD	conj	O
.	.	punct	O
3	CD	nummod	O
h	NN	ROOT	O
in	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
fraction	NN	nmod	O
of	IN	case	O
the	DT	det	O
blood	NN	nmod	B-Organism_substance
.	.	punct	O

Organ	JJ	compound	O
biodistribution	NN	compound	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	ccomp	I-Gene_or_gene_product
localized	JJ	acl	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	B-Organ
,	,	punct	O
kidneys	NNS	conj	B-Organ
,	,	punct	O
and	CC	cc	O
spleen	NN	conj	B-Organ
but	CC	cc	O
not	RB	conj	O
in	IN	conj	O
the	DT	det	O
heart	NN	pobj	B-Organ
or	CC	cc	O
lungs	NNS	conj	B-Organ
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
mean	JJ	amod	O
tumor	NN	compound	B-Cancer
volumes	NNS	nsubj	O
and	CC	cc	O
weights	NNS	conj	O
were	VBD	cop	O
statistically	RB	advmod	O
significantly	RB	advmod	O
less	JJR	ccomp	O
in	IN	case	O
mice	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	nmod	I-Gene_or_gene_product
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
mice	NNS	advcl	B-Organism
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
fewer	JJR	amod	O
numbers	NNS	nsubj	O
of	IN	case	O
mice	NNS	nmod	B-Organism
exhibited	VBD	conj	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	dobj	O
in	IN	case	O
the	DT	det	O
treated	VBN	amod	O
group	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	advcl	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Galectin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3C	NN	nsubj	I-Gene_or_gene_product
is	VBZ	appos	O
not	RB	neg	O
overtly	RB	advmod	O
toxic	JJ	acomp	O
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
efficacious	JJ	conj	O
in	IN	prep	O
reducing	VBG	pcomp	O
metastases	NNS	dobj	O
and	CC	cc	O
tumor	NN	conj	B-Cancer
volumes	NNS	conj	O
and	CC	cc	O
weights	NNS	conj	O
in	IN	case	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
an	DT	det	O
orthotopic	JJ	amod	O
nude	JJ	amod	B-Organism
mouse	NN	compound	I-Organism
model	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Prognostic	JJ	amod	O
value	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
resected	JJ	amod	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	B-Organ
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
are	VBP	cop	O
p53	NN	compound	B-Gene_or_gene_product
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	xcomp	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
genetic	JJ	amod	O
stability	NN	nmod	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
process	NN	ROOT	O
in	IN	case	O
solid	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
recently	RB	advmod	O
identified	VBN	amod	O
growth	NN	compound	O
factor	NN	appos	O
with	IN	case	O
significant	JJ	amod	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
major	JJ	amod	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	compound	O
regulator	NN	ROOT	O
.	.	punct	O

Few	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expressions	NNS	dep	O
and	CC	cc	O
prognosis	NN	conj	O
in	IN	case	O
esophageal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Forty	CD	compound	O
-	HYPH	punct	O
seven	CD	nummod	O
specimens	NNS	nsubjpass	O
resected	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
(	-LRB-	punct	O
SCC	NN	appos	B-Cancer
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	B-Organ
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
immunohistochemical	JJ	amod	O
staining	NN	dobj	O
.	.	punct	O

VEGF	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
expressions	NNS	conj	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
40	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
53	CD	nummod	O
%	NN	conj	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
staining	NN	compound	O
statuses	NNS	nsubj	O
were	VBD	cop	O
coincident	JJ	ROOT	O
in	IN	case	O
only	RB	advmod	O
21	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	conj	O
between	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
statuses	NNS	dep	O
.	.	punct	O

No	DT	neg	O
clinicopathologic	JJ	amod	O
factors	NNS	nsubjpass	O
were	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dep	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
between	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expressions	NNS	dep	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	B-Cancer
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	B-Organ
.	.	punct	O

Therapeutic	JJ	amod	O
targeting	NN	ROOT	O
of	IN	case	O
the	DT	det	O
survivin	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
:	:	punct	O
initiation	NN	dep	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
apoptosis	NN	nmod	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Molecular	JJ	amod	O
antagonists	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
inhibitor	NN	nmod	O
of	IN	case	O
apoptosis	NN	compound	O
protein	NN	compound	O
survivin	NN	nmod	B-Gene_or_gene_product
have	VBP	aux	O
shown	VBN	dep	O
promise	NN	dobj	O
as	IN	case	O
novel	JJ	amod	O
anticancer	NN	compound	B-Cancer
strategies	NNS	nmod	O
for	IN	mark	O
triggering	VBG	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
,	,	punct	O
dysregulating	VBG	advcl	O
mitotic	JJ	amod	O
progression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
inhibiting	VBG	conj	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
in	IN	case	O
preclinical	JJ	amod	O
models	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
survivin	NN	amod	B-Gene_or_gene_product
couples	NNS	nsubj	O
to	TO	prep	O
the	DT	det	O
cell	NN	compound	B-Cell
death	NN	compound	O
machinery	NN	pobj	O
has	VBZ	aux	O
remained	VBN	ROOT	O
elusive	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
relevant	JJ	amod	O
cellular	JJ	amod	B-Cell
targets	NNS	nsubjpass	O
of	IN	case	O
survivin	NN	compound	B-Gene_or_gene_product
antagonists	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
completely	RB	advmod	O
elucidated	VBN	conj	O
.	.	punct	O

Experimental	JJ	compound	O
Design	NN	nsubjpass	O
:	:	punct	O
Human	JJ	amod	B-Organism
umbilical	JJ	amod	B-Cell
vein	NN	nsubjpass	I-Cell
and	CC	cc	O
dermal	JJ	amod	B-Cell
microvascular	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
were	VBD	auxpass	O
infected	VBN	ROOT	O
with	IN	case	O
replication	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
adenoviruses	NNS	nmod	B-Organism
encoding	VBG	acl	O
survivin	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
Survivin	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
green	JJ	amod	B-Gene_or_gene_product
fluorescent	NN	amod	I-Gene_or_gene_product
protein	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
GFP	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
a	DT	det	O
phosphorylation	NN	nmod:npmod	O
-	HYPH	punct	O
defective	JJ	amod	O
survivin	NN	compound	B-Gene_or_gene_product
Thr	NN	compound	O
(	-LRB-	punct	O
34	CD	nummod	O
)	-RRB-	punct	O
-	:	punct	O
-	:	punct	O
>	NN	amod	O
Ala	NN	compound	O
(	-LRB-	punct	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
T34A	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutant	NN	conj	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nmod	O
or	CC	cc	O
mutant	JJ	amod	O
survivin	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
investigated	VBN	ROOT	O
on	IN	case	O
capillary	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
stability	NN	nmod	O
,	,	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
viability	NN	conj	O
,	,	punct	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
on	IN	case	O
kinetics	NNS	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
a	DT	det	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
model	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
cell	NN	compound	B-Cell
death	NN	compound	O
pathway	NN	nsubjpass	O
initiated	VBN	acl	O
by	IN	case	O
survivin	NN	compound	B-Gene_or_gene_product
targeting	NN	nmod	O
was	VBD	auxpass	O
mapped	VBN	ROOT	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	compound	I-Gene_or_gene_product
release	NN	nmod	O
,	,	punct	O
changes	NNS	conj	O
in	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
transmembrane	JJ	compound	O
potential	NN	nmod	O
,	,	punct	O
and	CC	cc	O
apoptosome	NN	compound	O
requirements	NNS	conj	O
using	VBG	acl	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	dobj	I-Cell
deficient	JJ	amod	O
in	IN	case	O
Apaf	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	compound	I-Gene_or_gene_product
or	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Adenoviral	JJ	amod	B-Organism
transduction	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
Survivin	NNP	nmod	I-Gene_or_gene_product
inhibited	VBD	appos	O
growth	NN	compound	O
factor	NN	compound	O
deprivation	NN	dobj	O
-	:	punct	O
or	CC	cc	O
ceramide	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	conj	O
,	,	punct	O
reduced	VBN	amod	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
7	CD	conj	I-Gene_or_gene_product
generation	NN	conj	O
,	,	punct	O
and	CC	cc	O
stabilized	VBD	conj	O
three	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
capillary	JJ	compound	B-Multi-tissue_structure
networks	NNS	dobj	I-Multi-tissue_structure
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
T34A	NN	nmod	I-Gene_or_gene_product
caused	VBD	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
umbilical	JJ	amod	B-Cell
vein	NN	nmod	I-Cell
and	CC	cc	O
dermal	JJ	amod	B-Cell
microvascular	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

Cell	NN	compound	B-Cell
death	NN	nsubj	O
induced	VBN	acl	O
by	IN	agent	O
survivin	NN	compound	B-Gene_or_gene_product
targeting	NN	pobj	O
exhibited	VBD	ROOT	O
the	DT	det	O
hallmarks	NNS	dobj	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
with	IN	case	O
release	NN	nmod	O
of	IN	case	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
transmembrane	JJ	compound	O
potential	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
suppressed	VBN	conj	O
in	IN	case	O
Apaf	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
or	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
knockout	JJ	amod	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

When	WRB	advmod	O
injected	VBN	advcl	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenografts	NNS	dep	I-Cancer
,	,	punct	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
T34A	NN	nsubj	I-Gene_or_gene_product
inhibited	VBD	ROOT	O
growth	NN	dobj	O
of	IN	case	O
established	JJ	amod	O
tumors	NNS	nmod	B-Cancer
and	CC	cc	O
triggered	VBD	conj	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
approximately	RB	advmod	O
60	CD	nummod	O
%	NN	amod	O
reduction	NN	nmod	O
in	IN	case	O
tumor	NN	npadvmod	B-Cancer
-	HYPH	punct	O
derived	VBN	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
by	IN	case	O
quantitative	JJ	amod	O
morphometry	NN	nmod	O
of	IN	case	O
CD31	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
stained	JJ	amod	O
tumor	NN	compound	B-Cancer
areas	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
appearance	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	nmod	O
by	IN	case	O
internucleosomal	JJ	amod	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Survivin	NN	nsubj	B-Gene_or_gene_product
functions	VBZ	nsubj	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
upstream	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
molecular	JJ	amod	O
targeting	NN	conj	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
results	VBZ	appos	O
in	IN	case	O
anticancer	NN	compound	B-Cancer
activity	NN	nmod	O
via	IN	case	O
a	DT	det	O
dual	JJ	amod	O
mechanism	NN	nmod	O
of	IN	case	O
induction	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	nmod	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
organ	NN	compound	B-Organ
vascularization	NN	nmod	O
and	CC	cc	O
lipoplex	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
serum	NN	nmod:npmod	B-Organism_substance
initial	JJ	amod	O
contact	NN	conj	O
in	IN	case	O
intravenous	JJ	amod	B-Immaterial_anatomical_entity
murine	JJ	amod	B-Organism
lipofection	NN	nmod	O
.	.	punct	O

Following	VBG	case	O
intravenous	JJ	amod	B-Immaterial_anatomical_entity
administration	NN	nmod	O
of	IN	case	O
cationic	JJ	amod	O
lipid	NN	compound	O
-	HYPH	punct	O
DNA	NN	compound	B-Cellular_component
complexes	NNS	nmod	O
(	-LRB-	punct	O
lipoplexes	NNS	appos	B-Simple_chemical
)	-RRB-	punct	O
into	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
transfection	NN	nsubj	O
(	-LRB-	punct	O
lipofection	NN	appos	O
)	-RRB-	punct	O
occurs	VBZ	ROOT	O
predominantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
lungs	NNS	nmod	B-Organ
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
high	JJ	amod	O
entrapment	NN	nmod	O
of	IN	case	O
lipoplexes	NNS	nmod	B-Simple_chemical
in	IN	case	O
the	DT	det	O
extended	VBN	amod	O
lung	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
tree	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
lipofection	NN	nsubjpass	O
in	IN	case	O
other	JJ	amod	O
organs	NNS	nmod	B-Organ
could	MD	aux	O
be	VB	auxpass	O
enhanced	VBN	ccomp	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
degree	NN	dobj	O
of	IN	case	O
vascularization	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
transgenic	JJ	amod	O
mouse	NN	compound	B-Organism
model	NN	dobj	O
with	IN	case	O
tissue	NN	nmod:npmod	B-Tissue
-	HYPH	punct	O
specific	JJ	amod	O
angiogenesis	NN	nmod	O
in	IN	case	O
liver	NN	nmod	B-Organ
.	.	punct	O

Tail	NN	compound	B-Multi-tissue_structure
vein	NN	compound	I-Multi-tissue_structure
injection	NN	nsubj	O
of	IN	case	O
N	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
1	CD	dep	I-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	conj	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dioleoyloxy	NN	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
propyl	NN	nmod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
N	NN	compound	I-Simple_chemical
,	,	punct	I-Simple_chemical
N	NN	compound	I-Simple_chemical
,	,	punct	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trimethylammonium	NN	compound	I-Simple_chemical
chloride	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
DOTAP	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
/	:	punct	I-Simple_chemical
cholesterol	NN	compound	I-Simple_chemical
lipoplexes	NNS	nsubj	I-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
lipoplex	JJ	compound	B-Simple_chemical
entrapment	NN	nmod	O
in	IN	case	O
hypervascularized	VBN	amod	O
liver	NN	nmod	B-Organ
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
boost	VB	conj	O
luciferase	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
lipoplex	JJ	compound	B-Simple_chemical
delivery	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
sufficient	JJ	amod	O
condition	NN	ccomp	O
for	IN	case	O
efficient	JJ	amod	O
organ	NN	compound	B-Organ
lipofection	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
intravenously	RB	advmod	B-Immaterial_anatomical_entity
injected	JJ	amod	O
lipoplexes	NNS	nsubj	B-Simple_chemical
migrated	VBD	advcl	O
within	IN	case	O
seconds	NNS	nmod	O
to	IN	case	O
lungs	NNS	xcomp	B-Organ
,	,	punct	O
we	PRP	nsubj	O
checked	VBD	ROOT	O
whether	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
immediate	JJ	amod	O
contact	NN	nmod	O
with	IN	case	O
serum	NN	nmod	B-Organism_substance
correlate	VBP	ccomp	O
with	IN	case	O
lung	NN	compound	B-Organ
lipofection	NN	compound	O
efficiency	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
DOTAP	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
based	VBN	amod	O
formulations	NNS	nmod	O
.	.	punct	O

Under	IN	case	O
conditions	NNS	nmod	O
mimicking	VBG	acl	O
the	DT	det	O
injection	NN	compound	O
environment	NN	dobj	O
,	,	punct	O
the	DT	det	O
lipoplex	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
serum	NN	compound	B-Organism_substance
interaction	NN	nsubj	O
was	VBD	cop	O
strongly	RB	advmod	O
dependent	JJ	ROOT	O
on	IN	case	O
helper	NN	compound	O
lipid	NN	nmod	B-Simple_chemical
and	CC	cc	O
ionic	JJ	amod	O
strength	NN	conj	O
:	:	punct	O
lipoplexes	NNS	nsubjpass	B-Simple_chemical
prepared	VBN	acl	O
in	IN	case	O
150	CD	compound	O
mM	NN	amod	O
NaCl	NN	nmod	O
or	CC	cc	O
lipoplexes	NNS	conj	B-Simple_chemical
with	IN	case	O
high	JJ	amod	O
(	-LRB-	punct	O
greater	JJR	dep	O
than	IN	case	O
33	CD	nummod	O
mol	NN	compound	O
%	NN	nmod	O
)	-RRB-	punct	O
cholesterol	NN	nmod	B-Simple_chemical
were	VBD	auxpass	O
found	VBN	parataxis	O
to	TO	mark	O
aggregate	VB	xcomp	O
immediately	RB	advmod	O
.	.	punct	O

This	DT	det	O
aggregation	NN	compound	O
process	NN	nsubj	O
was	VBD	cop	O
irreversible	JJ	ROOT	O
and	CC	cc	O
was	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	conj	O
with	IN	case	O
the	DT	det	O
percentage	NN	nmod	O
of	IN	case	O
lung	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
took	VBD	acl:relcl	O
up	RP	advmod	O
lipoplexes	NNS	dobj	B-Simple_chemical
and	CC	cc	O
with	IN	case	O
the	DT	det	O
efficiency	NN	conj	O
of	IN	case	O
lipofection	NN	nmod	O
.	.	punct	O

No	DT	neg	O
other	JJ	amod	O
structural	JJ	amod	O
changes	NNS	nsubjpass	O
in	IN	case	O
serum	NN	nmod	B-Organism_substance
were	VBD	auxpass	O
observed	VBN	ROOT	O
for	IN	case	O
cholesterol	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
based	VBN	amod	I-Simple_chemical
lipoplexes	NNS	nmod	I-Simple_chemical
.	.	punct	O

Dioleoyl	NN	compound	B-Simple_chemical
phosphatidylethanolamine	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
based	VBN	amod	I-Simple_chemical
lipoplexes	NNS	nsubjpass	I-Simple_chemical
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
give	VB	xcomp	O
low	JJ	amod	O
expression	NN	dobj	O
,	,	punct	O
apparently	RB	advmod	O
because	IN	case	O
of	IN	mwe	O
an	DT	det	O
immediate	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
integrity	NN	nmod	O
in	IN	case	O
serum	NN	nmod	B-Organism_substance
,	,	punct	O
without	IN	case	O
lipid	NN	compound	O
-	HYPH	punct	O
DNA	NN	compound	B-Cellular_component
dissociation	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
efficient	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
lipofection	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
result	NN	ccomp	O
of	IN	case	O
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	nmod	O
between	IN	prep	O
lipoplex	JJ	amod	B-Simple_chemical
composition	NN	pobj	O
,	,	punct	O
interaction	NN	appos	O
with	IN	case	O
serum	NN	nmod	B-Organism_substance
,	,	punct	O
hemodynamics	NNS	conj	O
,	,	punct	O
and	CC	cc	O
target	NN	compound	O
tissue	NN	compound	B-Tissue
"	''	punct	O
susceptibility	NN	conj	O
"	''	punct	O
to	TO	prep	O
transfection	NN	pobj	O
.	.	punct	O

Proliferative	JJ	amod	O
diabetic	JJ	amod	O
retinopathy	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
ocular	JJ	amod	B-Organ
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
agent	NN	compound	O
pigment	NN	compound	B-Gene_or_gene_product
epithelium	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
PEDF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
aqueous	JJ	amod	B-Organism_substance
humor	NN	nmod	I-Organism_substance
.	.	punct	O

a	DT	det	O
pilot	NN	compound	O
study	NN	ROOT	O
.	.	punct	O

Retinopathy	NNP	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
microvascular	JJ	amod	B-Tissue
diabetes	NNS	compound	O
complication	NN	attr	O
and	CC	cc	O
represents	VBZ	conj	O
a	DT	det	O
major	JJ	amod	O
threat	NN	dobj	O
to	IN	prep	O
the	DT	det	O
eyesight	NN	pobj	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
address	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
molecules	NNS	nmod	O
in	IN	case	O
diabetic	JJ	amod	O
retinopathy	NN	nmod	O
in	IN	case	O
the	DT	det	O
aqueous	JJ	amod	B-Organism_substance
humor	NN	nmod	I-Organism_substance
of	IN	prep	O
the	DT	det	O
eye	NN	pobj	B-Organ
.	.	punct	O

Aqueous	JJ	amod	B-Organism_substance
humor	NN	nsubjpass	I-Organism_substance
was	VBD	auxpass	O
collected	VBN	ROOT	O
at	IN	case	O
cataract	JJ	amod	O
surgery	NN	nmod	O
from	IN	case	O
19	CD	nummod	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
and	CC	cc	O
from	IN	case	O
13	CD	nummod	O
age	NN	npadvmod	O
-	:	punct	O
and	CC	cc	O
sex	NN	conj	O
-	HYPH	punct	O
matched	VBN	amod	O
normoglycemic	JJ	amod	O
controls	NNS	conj	B-Organism
.	.	punct	O

Levels	NNS	nsubjpass	O
of	IN	case	O
pro	NN	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
angiogenic	JJ	amod	O
inhibitor	NN	compound	O
pigment	NN	compound	B-Gene_or_gene_product
epithelium	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
PEDF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O

Angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
aqueous	JJ	amod	B-Organism_substance
humor	NN	nmod	I-Organism_substance
was	VBD	auxpass	O
quantified	VBN	ROOT	O
by	IN	mark	O
measuring	VBG	advcl	O
its	PRP$	nmod:poss	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
the	DT	det	O
aqueous	JJ	amod	B-Organism_substance
fluid	NN	nmod	I-Organism_substance
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
diabetics	NNS	nmod	O
(	-LRB-	punct	O
mean	JJ	amod	O
values	NNS	dep	O
:	:	punct	O
501	CD	dep	O
vs	CC	cc	O
.	.	punct	O
367	CD	nummod	O
pg	CC	compound	O
/	SYM	punct	O
ml	NN	ROOT	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
05	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
compared	VBN	case	O
to	TO	case	O
controls	NNS	advcl	O
.	.	punct	O

PEDF	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
decreased	VBN	xcomp	O
in	IN	case	O
diabetics	NNS	nmod	O
(	-LRB-	punct	O
mean	JJ	amod	O
values	NNS	dep	O
:	:	punct	O
2080	CD	dep	O
vs	CC	cc	O
.	.	punct	O
5780	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	ROOT	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
04	CD	dobj	O
)	-RRB-	punct	O
compared	VBN	case	O
to	TO	case	O
controls	NNS	nmod	O
.	.	punct	O

In	IN	case	O
seven	CD	nummod	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
proliferative	JJ	amod	O
retinopathy	NN	nmod	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
profound	JJ	amod	O
finding	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	ROOT	O
of	IN	case	O
the	DT	det	O
PEDF	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	dep	O
:	:	punct	O
237	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubj	O
were	VBD	cop	O
comparable	JJ	parataxis	O
to	TO	case	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
without	IN	case	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	nmod	O
:	:	punct	O
3153	CD	dep	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Angiogenic	JJ	compound	O
activity	NN	nsubj	O
in	IN	case	O
samples	NNS	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
from	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
was	VBD	cop	O
generally	RB	advmod	O
inhibitory	JJ	ROOT	O
due	JJ	case	O
to	TO	case	O
PEDF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Likewise	RB	advmod	O
,	,	punct	O
in	IN	case	O
diabetics	NNS	nmod	O
without	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
will	MD	aux	O
demonstrate	VB	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
ocular	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
agent	NN	compound	O
PEDF	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
inversely	RB	advmod	O
associated	VBN	ccomp	O
with	IN	case	O
proliferative	JJ	amod	O
retinopathy	NN	nmod	O
.	.	punct	O

PEDF	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
negative	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
aqueous	JJ	amod	B-Organism_substance
humor	NN	nmod	I-Organism_substance
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
implications	NNS	dobj	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
novel	JJ	amod	O
regimens	NNS	nmod	O
for	IN	case	O
diabetic	JJ	amod	O
retinopathy	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
osteoprotegerin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
RANK	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
bone	NN	compound	B-Tissue
metastasis	NN	nmod	O
.	.	punct	O

Bone	NN	compound	B-Tissue
destruction	NN	nsubjpass	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
mediated	VBN	ROOT	O
by	IN	case	O
osteoclastic	JJ	amod	B-Cell
bone	NN	compound	B-Tissue
resorption	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
stimulate	VBP	conj	O
the	DT	det	O
formation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
osteoclasts	NNS	nmod	B-Cell
next	RB	case	O
to	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	B-Cell
.	.	punct	O

Accumulating	NN	amod	O
evidences	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
receptor	NN	compound	B-Gene_or_gene_product
activator	NN	nsubj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
NF	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kB	NN	compound	I-Gene_or_gene_product
ligand	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
RANKL	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
ultimate	JJ	amod	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
mediator	NN	ccomp	O
that	WDT	nsubj	O
stimulates	VBZ	acl:relcl	O
osteoclast	JJ	compound	B-Cell
differentiation	NN	dobj	O
into	IN	case	O
mature	JJ	amod	O
osteoclasts	NNS	nmod	B-Cell
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
osteoprotegerin	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
OPG	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
osteoclast	JJ	compound	B-Cell
development	NN	dobj	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
elucidate	VB	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	case	O
cancer	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
induced	VBN	amod	O
osteoclastogenesis	NN	nmod	O
,	,	punct	O
cells	NNS	conj	B-Cell
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
line	NN	nmod	O
,	,	punct	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	appos	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
,	,	punct	O
were	VBD	auxpass	O
directly	RB	advmod	O
co	NN	advmod	O
-	HYPH	punct	O
cultured	VBN	ROOT	O
with	IN	case	O
ST2	NN	nmod	B-Cell
,	,	punct	O
MC3T3	NN	compound	B-Cell
-	HYPH	punct	I-Cell
E1	NN	conj	I-Cell
,	,	punct	O
or	CC	cc	O
with	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
calvarial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Osteoclast	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
like	JJ	case	I-Cell
cells	NNS	nsubjpass	I-Cell
and	CC	cc	O
tartarate	VBP	conj	B-Gene_or_gene_product
resistant	JJ	amod	I-Gene_or_gene_product
acid	NN	compound	I-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TRAP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
then	RB	advmod	O
quantitated	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
these	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	dobj	I-Cell
and	CC	cc	O
samples	NNS	conj	B-Tissue
from	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	dobj	O
for	IN	case	O
the	DT	det	O
expressions	NNS	nmod	O
of	IN	case	O
OPG	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
RANKL	NN	conj	B-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

Compared	VBN	case	O
to	IN	case	O
controls	NNS	nmod	O
,	,	punct	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	nsubj	O
of	IN	case	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
stromal	JJ	nmod	B-Cell
or	CC	cc	O
osteoblastic	JJ	conj	B-Cell
cells	NNS	dep	I-Cell
induced	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
number	NN	nmod	O
of	IN	case	O
osteoclasts	NNS	nmod	B-Cell
and	CC	cc	O
TRAP	NN	conj	B-Gene_or_gene_product
activities	NNS	dep	O
.	.	punct	O

MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
alone	RB	advmod	O
or	CC	cc	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
samples	NNS	conj	O
did	VBD	aux	O
not	RB	neg	O
express	VB	ROOT	O
RANKL	NN	compound	B-Gene_or_gene_product
mRNA	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
stromal	JJ	nmod	B-Cell
or	CC	cc	O
osteoblastic	JJ	conj	B-Cell
cells	NNS	dep	I-Cell
induced	VBD	ROOT	O
RANKL	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
decreased	VBD	conj	O
OPG	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

These	DT	det	O
experiments	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
direct	JJ	amod	O
interactions	NNS	nsubj	O
between	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
stromal	JJ	amod	B-Cell
or	CC	cc	O
osteoblastic	JJ	conj	B-Cell
cells	NNS	conj	I-Cell
induce	VBP	ccomp	O
osteoclastogenesis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
through	IN	mark	O
modulating	VBG	advcl	O
RANKL	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
antagonist	NN	nsubj	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
ischaemic	JJ	amod	O
and	CC	cc	O
excitotoxic	JJ	conj	O
neuronal	JJ	amod	B-Cell
damage	NN	dobj	O
in	IN	case	O
the	DT	det	O
rat	NN	nmod	B-Organism
.	.	punct	O

Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
synthesis	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
brain	NN	nmod	B-Organ
is	VBZ	auxpass	O
stimulated	VBN	ROOT	O
by	IN	case	O
mechanical	JJ	amod	O
injury	NN	nmod	O
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
mimics	VBZ	conj	O
some	DT	det	O
effects	NNS	dobj	O
of	IN	prep	O
injury	NN	pobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
gliosis	NN	nmod	O
and	CC	cc	O
neovascularization	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
neuronal	JJ	amod	B-Cell
death	NN	nsubjpass	O
resulting	VBG	acl	O
from	IN	case	O
focal	JJ	amod	O
cerebral	JJ	amod	B-Organ
ischaemia	NN	nmod	O
(	-LRB-	punct	O
middle	JJ	amod	O
cerebral	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
occlusion	NN	dep	O
,	,	punct	O
24	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
inhibited	VBN	ccomp	O
(	-LRB-	punct	O
by	IN	case	O
50	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
in	IN	case	O
rats	NNS	nmod	B-Organism
injected	VBN	acl	O
with	IN	case	O
a	DT	det	O
recombinant	JJ	amod	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
antagonist	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1ra	NN	dep	I-Gene_or_gene_product
,	,	punct	O
10	CD	nummod	O
micrograms	NNS	conj	O
,	,	punct	O
icv	DT	compound	O
30	CD	nummod	O
min	NN	conj	O
before	IN	dep	O
and	CC	cc	O
10	CD	nummod	O
min	NN	conj	O
after	IN	case	O
ischaemia	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Excitotoxic	JJ	amod	O
damage	NN	nsubjpass	O
due	JJ	case	O
to	TO	mwe	O
striatal	JJ	amod	B-Multi-tissue_structure
infusion	NN	nmod	O
of	IN	case	O
an	DT	det	O
NMDA	NN	compound	B-Simple_chemical
-	HYPH	punct	O
receptor	NN	compound	O
agonist	NN	nmod	O
(	-LRB-	punct	O
cis	NN	appos	B-Simple_chemical
-	,	punct	I-Simple_chemical
2	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methanoglutamate	NN	conj	I-Simple_chemical
)	-RRB-	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
markedly	RB	advmod	O
inhibited	VBN	ROOT	O
(	-LRB-	punct	O
71	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
by	IN	case	O
injection	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1ra	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
endogenous	JJ	amod	O
IL	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
mediator	NN	ccomp	O
of	IN	case	O
ischaemic	JJ	amod	O
and	CC	cc	O
excitotoxic	JJ	conj	O
brain	NN	compound	B-Organ
damage	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
inhibitors	NNS	nsubj	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
action	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
therapeutic	JJ	amod	O
value	NN	conj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
acute	JJ	amod	O
or	CC	cc	O
chronic	JJ	conj	O
neuronal	JJ	amod	B-Cell
death	NN	nmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
and	CC	cc	O
post	JJ	conj	O
-	HYPH	punct	O
translation	NN	dep	O
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Tie1	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
fluid	NN	compound	O
shear	NN	compound	O
stress	NN	compound	O
changes	NNS	nmod	O
in	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
between	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Tissue
endothelium	NN	nmod	I-Tissue
and	CC	cc	O
hemodynamic	JJ	amod	O
forces	NNS	conj	O
(	-LRB-	punct	O
and	CC	cc	O
more	RBR	advmod	O
specifically	RB	advmod	O
,	,	punct	O
fluid	NN	compound	O
shear	NN	compound	O
stress	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
flow	NN	nmod	O
of	IN	case	O
blood	NN	nmod	B-Organism_substance
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	nmod	O
and	CC	cc	O
in	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	compound	I-Multi-tissue_structure
formation	NN	conj	O
via	IN	case	O
a	DT	det	O
process	NN	nmod	O
termed	VBN	acl	O
arteriogenesis	NN	xcomp	O
.	.	punct	O

Tie1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
orphan	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptor	NN	ROOT	O
expressed	VBN	acl	O
almost	RB	advmod	O
exclusively	RB	advmod	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
normal	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nmod	O
and	CC	cc	O
maintenance	NN	conj	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
Tie1	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ccomp	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
exposed	VBN	acl	O
to	TO	case	O
shear	VB	compound	O
stress	NN	nmod	O
,	,	punct	O
and	CC	cc	O
more	RBR	advmod	O
so	RB	advmod	O
to	TO	mark	O
shear	VB	conj	O
stress	NN	compound	O
changes	NNS	dobj	O
.	.	punct	O

This	DT	det	O
down	RB	compound	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
rapid	JJ	amod	O
cleavage	NN	nmod	O
of	IN	case	O
Tie1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
binding	NN	conj	O
of	IN	case	O
the	DT	det	O
cleaved	VBN	amod	O
Tie1	NN	compound	B-Gene_or_gene_product
45	CD	nummod	O
kDa	NN	compound	O
endodomain	NN	nmod	O
to	TO	case	O
Tie2	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
rapid	JJ	amod	O
cleavage	NN	nsubjpass	O
of	IN	case	O
Tie1	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
shear	VB	compound	O
stress	NN	nmod	O
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Tie1	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
is	VBZ	auxpass	O
suppressed	VBN	ROOT	O
by	IN	case	O
shear	NN	compound	O
stress	NN	nmod	O
and	CC	cc	O
by	IN	case	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Shear	NN	compound	O
stress	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transcriptional	JJ	amod	O
suppression	NN	nsubjpass	O
of	IN	case	O
Tie1	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
negative	JJ	amod	O
shear	NN	compound	O
stress	NN	compound	O
response	NN	compound	O
element	NN	nmod	O
,	,	punct	O
localized	JJ	acl	O
in	IN	case	O
a	DT	det	O
region	NN	nmod	O
of	IN	case	O
250	CD	nummod	O
bp	NN	nmod	O
within	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
.	.	punct	O

The	DT	det	O
rapid	JJ	amod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
Tie1	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
shear	NN	compound	O
stress	NN	compound	O
changes	NNS	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
rapid	JJ	amod	O
binding	NN	conj	O
to	TO	case	O
Tie2	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
destabilization	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
initiate	VB	advcl	O
the	DT	det	O
process	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
restructuring	NN	nmod	O
.	.	punct	O

Therapeutic	JJ	amod	O
angiogenesis	NN	ROOT	O
:	:	punct	O
a	DT	det	O
complex	JJ	amod	O
problem	NN	dep	O
requiring	VBG	acl	O
a	DT	det	O
sophisticated	JJ	amod	O
approach	NN	dobj	O
.	.	punct	O

Blood	NN	nsubj	B-Organism_substance
and	CC	cc	O
vascular	JJ	conj	B-Multi-tissue_structure
disorders	NNS	conj	O
underlie	VBP	ROOT	O
a	DT	det	O
plethora	NN	dobj	O
of	IN	case	O
pathologic	JJ	amod	O
conditions	NNS	nmod	O
and	CC	cc	O
are	VBP	cop	O
the	DT	det	O
single	JJ	amod	O
most	RBS	advmod	O
frequent	JJ	amod	O
cause	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
disease	NN	nmod	O
.	.	punct	O

Ischemia	NN	nsubj	O
,	,	punct	O
involving	VBG	acl	O
restricted	JJ	amod	O
blood	NN	compound	B-Organism_substance
flow	NN	dobj	O
to	TO	case	O
tissues	NNS	nmod	B-Tissue
is	VBZ	cop	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
consequence	NN	ROOT	O
of	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
dysfunction	NN	nmod	O
resulting	VBG	acl	O
in	IN	case	O
the	DT	det	O
disruption	NN	nmod	O
of	IN	case	O
oxygen	NN	compound	B-Simple_chemical
and	CC	cc	O
nutrient	JJ	conj	O
delivery	NN	nmod	O
and	CC	cc	O
the	DT	det	O
accumulation	NN	conj	O
of	IN	case	O
waste	JJ	compound	O
metabolites	NNS	nmod	O
.	.	punct	O

Cells	NNS	nsubj	B-Cell
cannot	NN	advmod	O
survive	NN	ROOT	O
extended	VBD	xcomp	O
severe	JJ	amod	O
ischemia	NN	dobj	O
but	CC	cc	O
may	MD	aux	O
be	VB	cop	O
able	JJ	conj	O
to	TO	mark	O
adapt	VB	xcomp	O
to	IN	case	O
a	DT	det	O
moderate	JJ	amod	O
condition	NN	nmod	O
where	WRB	advmod	O
diffusion	NN	nsubj	O
to	TO	dep	O
and	CC	cc	O
from	IN	mark	O
bordering	VBG	conj	O
nonischemic	JJ	amod	O
regions	NNS	compound	O
sustains	VBZ	acl:relcl	O
vital	JJ	amod	O
functions	NNS	dobj	O
.	.	punct	O

Under	IN	prep	O
this	DT	det	O
condition	NN	pobj	O
,	,	punct	O
the	DT	det	O
secondary	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
effected	JJ	amod	O
cells	NNS	nmod	B-Cell
are	VBP	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	cop	O
impaired	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
new	JJ	amod	O
metabolic	JJ	amod	O
equilibrium	NN	nsubjpass	O
is	VBZ	auxpass	O
established	VBN	conj	O
,	,	punct	O
determined	VBN	conj	O
by	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
cross	NN	compound	O
-	HYPH	punct	O
diffusion	NN	nmod	O
and	CC	cc	O
degree	NN	conj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

In	IN	case	O
tissues	NNS	nmod	B-Tissue
with	IN	case	O
a	DT	det	O
normally	RB	advmod	O
high	JJ	amod	O
metabolic	JJ	amod	O
turnover	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
skeletal	JJ	amod	B-Tissue
and	CC	cc	O
cardiac	JJ	conj	B-Tissue
muscle	NN	nmod	I-Tissue
,	,	punct	O
even	RB	advmod	O
mild	JJ	amod	O
ischemia	NN	nsubj	O
causes	VBZ	ROOT	O
hypoxia	NN	dobj	O
,	,	punct	O
acidosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
depressed	JJ	amod	O
function	NN	conj	O
(	-LRB-	punct	O
contractility	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
eventually	RB	advmod	O
threatens	VBZ	conj	O
myocyte	NN	amod	B-Cell
viability	NN	dobj	O
and	CC	cc	O
organ	NN	compound	B-Organ
function	NN	conj	O
.	.	punct	O

Ischemic	JJ	amod	O
cardiac	JJ	amod	B-Tissue
muscle	NN	nsubj	I-Tissue
is	VBZ	ROOT	O
additionally	RB	advmod	O
vulnerable	JJ	acomp	O
because	IN	mark	O
reperfusion	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	advcl	O
for	IN	case	O
survival	NN	nmod	O
but	CC	cc	O
reperfusion	NN	conj	O
itself	PRP	nsubj	O
poses	VBZ	advcl	O
additional	JJ	amod	O
stress	NN	dobj	O
principally	RB	advmod	O
from	IN	case	O
increased	VBN	amod	O
production	NN	nmod	O
of	IN	case	O
free	JJ	amod	O
radicals	NNS	nmod	O
during	IN	case	O
reoxygenation	NN	nmod	O
.	.	punct	O

The	DT	det	O
latter	JJ	amod	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
called	VBN	ROOT	O
reperfusion	NN	compound	O
injury	NN	oprd	O
and	CC	cc	O
can	MD	aux	O
cause	VB	conj	O
as	RB	advmod	O
much	JJ	amod	O
damage	NN	nmod	O
as	IN	prep	O
the	DT	det	O
ischemia	NN	pobj	O
.	.	punct	O

The	DT	det	O
treatment	NN	compound	O
possibilities	VBZ	nsubjpass	O
for	IN	case	O
ischemia	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
disease	NN	nmod	O
are	VBP	auxpass	O
limited	JJ	ROOT	O
.	.	punct	O

Lipid	NN	compound	B-Simple_chemical
/	SYM	punct	O
cholesterol	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
lowering	VBG	amod	O
agents	NNS	nsubj	O
,	,	punct	O
diet	NN	compound	O
and	CC	cc	O
antiplatelet	JJ	conj	B-Cell
adherence	NN	compound	O
(	-LRB-	punct	O
aspirin	NN	compound	B-Simple_chemical
)	-RRB-	punct	O
therapy	NN	conj	O
may	MD	aux	O
help	VB	ROOT	O
slow	VB	xcomp	O
the	DT	det	O
progression	NN	dobj	O
of	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
disease	NN	nmod	O
in	IN	case	O
some	DT	det	O
instances	NNS	nmod	O
;	:	punct	O
but	CC	cc	O
surgical	JJ	amod	O
reconstruction	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
the	DT	det	O
only	JJ	amod	O
option	NN	conj	O
in	IN	case	O
advanced	JJ	amod	O
stages	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
even	RB	advmod	O
this	DT	nsubj	O
is	VBZ	conj	O
not	RB	neg	O
always	RB	advmod	O
an	DT	det	O
option	NN	attr	O
.	.	punct	O

An	DT	det	O
alternative	NN	amod	O
and	CC	cc	O
rather	RB	conj	O
obvious	JJ	conj	O
strategy	NN	nsubj	O
to	TO	case	O
treat	VB	compound	O
ischemia	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
endogenous	JJ	amod	O
angiogenic	JJ	dep	O
or	CC	cc	O
arteriogenic	JJ	conj	O
pathways	NNS	dobj	O
to	TO	mark	O
stimulate	VB	advcl	O
revascularization	NN	dobj	O
of	IN	case	O
the	DT	det	O
tissue	NN	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
feasibility	NN	nsubjpass	O
of	IN	prep	O
such	PDT	predet	O
a	DT	det	O
strategy	NN	pobj	O
has	VBZ	aux	O
now	RB	advmod	O
been	VBN	auxpass	O
established	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
results	NNS	nmod	O
of	IN	case	O
studies	NNS	nmod	O
over	IN	case	O
the	DT	det	O
past	JJ	amod	O
decade	NN	nmod	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
new	JJ	amod	O
discipline	NN	nsubj	O
called	VBN	conj	O
therapeutic	JJ	amod	O
angiogenesis	NN	dobj	O
has	VBZ	aux	O
emerged	VBN	conj	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
application	NN	nmod	O
of	IN	case	O
therapeutic	JJ	amod	O
angiogenesis	NN	nmod	O
for	IN	mark	O
treating	VBG	acl	O
ischemic	JJ	amod	O
muscle	NN	compound	B-Organ
disease	NN	dobj	O
and	CC	cc	O
includes	VBZ	conj	O
a	DT	det	O
critical	JJ	amod	O
evaluation	NN	dobj	O
of	IN	case	O
the	DT	det	O
parameters	NNS	nmod	O
and	CC	cc	O
limitations	NNS	conj	O
of	IN	prep	O
current	JJ	amod	O
procedures	NNS	pobj	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
this	DT	det	O
technology	NN	nmod	O
has	VBZ	aux	O
benefited	VBN	ROOT	O
from	IN	case	O
its	PRP$	nmod:poss	O
application	NN	nmod	O
to	TO	case	O
both	CC	cc:preconj	O
peripheral	JJ	amod	B-Tissue
and	CC	cc	O
coronary	JJ	conj	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
disease	NN	nmod	O
and	CC	cc	O
results	VBZ	nsubjpass	O
from	IN	case	O
both	DT	nsubjpass	O
are	VBP	auxpass	O
reviewed	VBN	conj	O
here	RB	advmod	O
.	.	punct	O

Expression	NN	ROOT	O
,	,	punct	O
regulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
function	NN	conj	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1R	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
proteins	NNS	conj	I-Gene_or_gene_product
in	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
insulin	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
like	IN	mark	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
IGF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
system	NN	nsubj	O
includes	VBZ	ROOT	O
the	DT	det	O
IGFs	NNS	dobj	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1R	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
multiple	JJ	amod	O
binding	NN	compound	O
proteins	NNS	conj	O
.	.	punct	O

This	DT	det	O
growth	NN	compound	O
factor	NN	compound	O
system	NN	nsubj	O
exerts	VBZ	ROOT	O
multiple	JJ	amod	O
physiologic	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Anatomical_system
through	IN	case	O
both	CC	cc:preconj	O
endocrine	JJ	amod	O
and	CC	cc	O
autocrine	JJ	conj	O
/	:	punct	O
paracrine	JJ	dep	O
mechanisms	NNS	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IGF	NNP	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
are	VBP	auxpass	O
mediated	VBN	ROOT	O
principally	RB	advmod	O
through	IN	case	O
the	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1R	NN	nmod	I-Gene_or_gene_product
but	CC	cc	O
are	VBP	auxpass	O
modulated	VBN	conj	O
by	IN	case	O
complex	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
multiple	JJ	amod	O
IGF	NN	compound	B-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
that	WDT	mark	O
themselves	PRP	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
phosphorylation	NN	nmod	O
,	,	punct	O
proteolysis	NN	conj	O
,	,	punct	O
polymerization	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	B-Cell
or	CC	cc	O
matrix	NN	conj	B-Cellular_component
association	NN	conj	O
.	.	punct	O

During	IN	prep	O
the	DT	det	O
last	JJ	amod	O
decade	NN	pobj	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
body	NN	nsubj	O
of	IN	case	O
evidence	NN	nmod	O
has	VBZ	aux	O
accumulated	VBN	ROOT	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
IGF	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
are	VBP	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
multiple	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
growth	NN	compound	O
factors	NNS	nmod	O
,	,	punct	O
cytokines	NNS	conj	O
,	,	punct	O
lipoproteins	NNS	conj	O
,	,	punct	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	conj	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
hemodynamic	JJ	amod	O
forces	NNS	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
IGF	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
growth	NN	compound	O
factors	NNS	conj	O
and	CC	cc	O
integrin	NN	compound	B-Gene_or_gene_product
receptors	NNS	conj	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
accumulating	VBG	amod	O
evidence	NN	nsubj	O
of	IN	case	O
a	DT	det	O
role	NN	nmod	O
for	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
multiple	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
pathologies	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
atherosclerosis	NN	nmod	O
,	,	punct	O
hypertension	NN	conj	O
,	,	punct	O
restenosis	NN	conj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
diabetic	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
disease	NN	conj	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1R	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
IGF	NN	compound	B-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
proteins	NNS	conj	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Anatomical_system
and	CC	cc	O
summarize	VB	conj	O
evidence	NN	dep	O
implicating	VBG	acl	O
involvement	NN	dobj	O
of	IN	case	O
this	DT	det	O
system	NN	nmod	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
diseases	NNS	nmod	O
.	.	punct	O

Microvascular	JJ	amod	B-Tissue
density	NN	ROOT	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
immunoreactivity	NN	conj	O
as	IN	case	O
predictors	NNS	nmod	O
of	IN	case	O
regional	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
from	IN	case	O
betel	NN	nmod:npmod	B-Organism_subdivision
-	HYPH	punct	O
associated	VBN	amod	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Neovascularization	NN	nsubj	O
has	VBZ	dep	O
profound	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
mitogen	NN	ROOT	O
that	WDT	nsubj	O
acts	VBZ	acl:relcl	O
exclusively	RB	advmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
roles	NNS	nsubj	O
of	IN	case	O
miscrovascularity	NN	compound	B-Tissue
density	NN	nmod	O
(	-LRB-	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
OSCC	NN	appos	B-Cancer
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	cop	O
controversial	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
MVD	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
cohort	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
betel	NN	nmod:npmod	B-Organism_subdivision
-	HYPH	punct	O
associated	VBN	amod	O
OSCC	NN	nmod	B-Cancer
and	CC	cc	O
to	TO	mark	O
evaluate	VB	conj	O
for	IN	case	O
possible	JJ	amod	O
clinicopathologic	JJ	amod	O
correlations	NNS	nmod	O
.	.	punct	O

PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
paraffin	NN	amod	B-Cancer
sections	NNS	nsubjpass	I-Cancer
from	IN	case	O
49	CD	nummod	O
subjects	NNS	nmod	B-Organism
with	IN	case	O
OSCC	NN	nmod	B-Cancer
were	VBD	auxpass	O
subjected	VBN	dep	O
to	TO	case	O
immunohistochemical	JJ	amod	O
studies	NNS	nmod	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
highest	JJS	amod	O
MVD	NN	dobj	O
(	-LRB-	punct	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cytoplasmic	JJ	amod	B-Organism_substance
immunoreactivity	NN	conj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
findings	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
tissue	NN	compound	B-Cancer
samples	NNS	nmod	I-Cancer
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
the	DT	det	O
patients	NNS	nmod:poss	B-Organism
'	POS	case	O
risk	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
course	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
OSCC	NN	compound	B-Cancer
samples	NNS	nsubj	I-Cancer
had	VBD	dep	O
an	DT	det	O
average	JJ	amod	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
score	NN	dobj	O
of	IN	case	O
27	CD	nmod	O
.	.	punct	O
7	CD	nummod	O
/	SYM	punct	O
mm	NN	ROOT	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

VEGF	NN	compound	B-Gene_or_gene_product
immunoreactivity	NN	nsubj	O
was	VBD	cop	O
positive	JJ	ROOT	O
in	IN	case	O
75	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
samples	NNS	nmod	B-Cancer
.	.	punct	O

Both	CC	cc:preconj	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
immunoreactivity	NN	nsubjpass	O
were	VBD	auxpass	O
statistically	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.	.	punct	O
012	CD	ROOT	O
and	CC	cc	O
.	.	punct	O
037	CD	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
marginally	RB	advmod	O
significant	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
noted	VBN	ROOT	O
between	IN	case	O
the	DT	dep	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	nmod	O
and	CC	cc	O
patient	NN	compound	B-Organism
survival	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.	.	punct	O
056	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
age	NN	nsubj	O
and	CC	cc	O
oral	JJ	amod	B-Organism_subdivision
habits	NNS	conj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
tumor	NN	compound	B-Cancer
site	NN	conj	O
and	CC	cc	O
size	NN	conj	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
correlated	VBN	xcomp	O
with	IN	case	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
or	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
immunoreactivity	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
immunoreactivity	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	amod	O
predictors	NNS	ccomp	O
for	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
OSCC	NN	nmod	B-Cancer
associated	VBN	acl	O
mostly	RB	advmod	O
with	IN	case	O
betel	NN	compound	B-Organism_subdivision
use	NN	nmod	O
.	.	punct	O

Antiangiogenesis	NN	compound	O
therapy	NN	nsubj	O
might	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
reducing	VBG	advcl	O
regional	JJ	amod	O
metastasis	NN	dobj	O
.	.	punct	O

Promotion	NN	ROOT	O
of	IN	case	O
tumorigenesis	NN	nmod	O
by	IN	case	O
heterozygous	JJ	amod	O
disruption	NN	nmod	O
of	IN	case	O
the	DT	det	O
beclin	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
autophagy	NN	compound	O
gene	NN	nmod	O
.	.	punct	O

Malignant	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
often	RB	advmod	O
display	VBP	ROOT	O
defects	NNS	dobj	O
in	IN	case	O
autophagy	NN	nmod	O
,	,	punct	O
an	DT	det	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
pathway	NN	appos	O
for	IN	mark	O
degrading	VBG	acl	O
long	RB	advmod	O
-	HYPH	punct	O
lived	VBN	amod	O
proteins	NNS	dobj	O
and	CC	cc	O
cytoplasmic	JJ	amod	B-Cellular_component
organelles	NNS	conj	I-Cellular_component
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
as	IN	advmod	O
yet	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
no	DT	neg	O
genetic	JJ	amod	O
evidence	NN	nsubj	O
for	IN	case	O
a	DT	det	O
role	NN	nmod	O
of	IN	case	O
autophagy	JJ	compound	O
genes	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
suppression	NN	nmod	O
.	.	punct	O

The	DT	det	O
beclin	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
autophagy	NN	compound	O
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
monoallelically	RB	advmod	O
deleted	VBN	ROOT	O
in	IN	case	O
40	CD	compound	O
-	SYM	punct	O
75	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
cases	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
sporadic	JJ	amod	O
breast	NN	nmod	B-Cancer
,	,	punct	O
ovarian	JJ	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
prostate	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
targeted	VBN	amod	O
mutant	JJ	amod	O
mouse	NN	compound	B-Organism
model	NN	dobj	O
to	TO	mark	O
test	VB	xcomp	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
monoallelic	JJ	amod	O
deletion	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promotes	VBZ	ccomp	O
tumorigenesis	NN	dobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
heterozygous	JJ	amod	O
disruption	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
increases	VBZ	ccomp	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
spontaneous	JJ	amod	O
malignancies	NNS	nmod	B-Cancer
and	CC	cc	O
accelerates	VBZ	conj	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
hepatitis	NN	compound	B-Organism
B	NN	compound	I-Organism
virus	NN	npadvmod	I-Organism
-	:	punct	O
induced	VBN	amod	O
premalignant	JJ	amod	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
.	.	punct	O

Molecular	JJ	amod	O
analyses	NNS	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
beclin	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
heterozygous	JJ	amod	O
mice	NNS	nmod	B-Organism
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
remaining	VBG	amod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
allele	NN	nsubj	O
is	VBZ	cop	O
neither	CC	cc:preconj	O
mutated	VBN	ccomp	O
nor	CC	cc	O
silenced	VBN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
beclin	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
heterozygous	JJ	amod	O
disruption	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
increased	VBN	amod	O
cellular	JJ	amod	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
reduced	VBD	amod	O
autophagy	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
beclin	NN	nsubj	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
haplo	JJ	amod	O
-	HYPH	punct	O
insufficient	JJ	amod	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
suppressor	NN	compound	O
gene	NN	ccomp	O
and	CC	cc	O
provide	VB	conj	O
genetic	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
autophagy	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	ccomp	O
of	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
growth	NN	compound	O
control	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
suppression	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
mutation	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
other	JJ	amod	O
autophagy	NN	compound	O
genes	NNS	conj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
dietary	JJ	amod	O
folate	NN	nmod	B-Simple_chemical
on	IN	case	O
ulcerative	JJ	amod	B-Pathological_formation
colitis	NN	nmod:npmod	I-Pathological_formation
-	HYPH	punct	O
associated	VBN	amod	O
colorectal	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
interleukin	NN	compound	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	:	punct	O
and	CC	cc	O
beta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
microglobulin	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Folate	JJ	compound	B-Simple_chemical
supplementation	NN	nsubj	O
may	MD	aux	O
reduce	VB	ROOT	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	B-Pathological_formation
dysplasia	NN	nmod	I-Pathological_formation
and	CC	cc	O
cancer	NN	conj	B-Cancer
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
ulcerative	JJ	amod	B-Pathological_formation
colitis	NN	nmod	I-Pathological_formation
(	-LRB-	punct	O
UC	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
interleukin	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
IL	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	:	punct	O
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
microglobulin	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
m	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
deficient	JJ	dep	O
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	amod	O
)	-RRB-	punct	O
x	NN	nummod	O
beta	NN	dep	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
m	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	dep	O
)	-RRB-	punct	O
)	-RRB-	punct	O
mice	NNS	nsubj	B-Organism
spontaneously	RB	advmod	O
develop	VBP	ROOT	O
colon	NN	compound	B-Cancer
cancer	NN	dobj	I-Cancer
in	IN	case	O
the	DT	det	O
setting	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
UC	NN	nmod	B-Pathological_formation
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
dietary	JJ	amod	O
folate	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
UC	NN	nmod:npmod	B-Pathological_formation
-	HYPH	punct	O
associated	VBN	amod	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
in	IN	case	O
the	DT	det	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	amod	O
)	-RRB-	punct	O
x	NN	nummod	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
m	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	dep	O
)	-RRB-	punct	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Weaning	VBG	nsubjpass	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	amod	O
)	-RRB-	punct	O
x	NN	nummod	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
m	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	dep	O
)	-RRB-	punct	O
mice	NNS	dobj	B-Organism
were	VBD	auxpass	O
randomized	VBN	ROOT	O
to	TO	mark	O
receive	VB	xcomp	O
0	CD	dobj	O
(	-LRB-	punct	O
deficient	JJ	dep	O
;	:	punct	O
n	NN	nsubj	O
=	JJ	dep	O
40	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
2	CD	nummod	O
(	-LRB-	punct	O
basal	JJ	amod	O
requirement	NN	conj	O
;	:	punct	O
control	NN	dep	O
;	:	punct	O
n	NN	nsubj	O
=	JJ	dep	O
46	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
8	CD	nummod	O
(	-LRB-	punct	O
supplemented	VBN	conj	O
;	:	punct	O
n	NN	nsubj	O
=	JJ	dep	O
36	CD	dep	O
)	-RRB-	punct	O
mg	NN	compound	O
folate	NN	compound	B-Simple_chemical
/	:	punct	O
kg	NN	compound	O
diet	NN	dep	O
for	IN	prep	O
32	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

At	IN	case	O
necropsy	NN	nmod	O
,	,	punct	O
all	DT	det	O
macroscopic	JJ	amod	O
colonic	JJ	amod	B-Cancer
tumors	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
identified	VBN	ROOT	O
and	CC	cc	O
histologically	RB	advmod	O
classified	VBN	conj	O
as	IN	case	O
dysplasia	NN	nmod	B-Pathological_formation
or	CC	cc	O
adenocarcinoma	NN	conj	B-Cancer
.	.	punct	O

The	DT	det	O
incidence	NN	nsubj	O
of	IN	case	O
high	JJ	amod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
grade	NN	compound	I-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
(	-LRB-	punct	O
high	JJ	amod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
grade	NN	compound	I-Pathological_formation
dysplasia	NN	dep	I-Pathological_formation
/	:	punct	O
carcinoma	NN	conj	B-Cancer
in	FW	compound	O
situ	FW	punct	O
and	CC	cc	O
invasive	JJ	amod	O
adenocarcinoma	NN	conj	B-Cancer
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
folate	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
supplemented	VBN	amod	O
group	NN	nmod	O
was	VBD	ROOT	O
46	CD	nummod	O
%	NN	nmod:npmod	O
lower	JJR	acomp	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
35	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
%	NN	dep	O
versus	CC	cc	O
65	CD	conj	O
.	.	punct	O
1	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
009	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
incidence	NN	nsubj	O
of	IN	prep	O
high	JJ	amod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
grade	NN	compound	I-Pathological_formation
lesions	NNS	pobj	I-Pathological_formation
in	IN	prep	O
the	DT	det	O
folate	JJ	npadvmod	B-Simple_chemical
-	HYPH	punct	O
deficient	JJ	amod	O
group	NN	pobj	O
was	VBD	ROOT	O
also	RB	advmod	O
49	CD	nummod	O
%	NN	nmod:npmod	O
lower	JJR	acomp	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
33	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
%	NN	dep	O
versus	CC	cc	O
65	CD	conj	O
.	.	punct	O
1	CD	nummod	O
%	NN	npadvmod	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
007	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
higher	JJR	amod	O
mortality	NN	compound	O
rate	NN	ROOT	O
in	IN	case	O
the	DT	det	O
folate	JJ	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
deficient	JJ	amod	O
group	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
other	JJ	amod	O
two	CD	nummod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
25	CD	nummod	O
%	NN	dep	O
versus	CC	cc	O
6	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
5	CD	conj	O
.	.	punct	O
6	CD	nummod	O
%	NN	nsubj	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0	CD	nummod	O
.	.	punct	O
02	CD	appos	O
)	-RRB-	punct	O
partially	RB	advmod	O
accounted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
low	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
high	JJ	amod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
grade	NN	compound	I-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
in	IN	case	O
this	DT	det	O
group	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
dietary	JJ	amod	O
folate	NN	compound	B-Simple_chemical
supplementation	NN	nsubj	O
at	IN	case	O
4x	NN	nmod	O
the	DT	det	O
basal	JJ	amod	O
dietary	NN	amod	O
requirement	NN	nmod	O
significantly	RB	advmod	O
suppresses	VBZ	ccomp	O
UC	NN	nmod:npmod	B-Pathological_formation
-	HYPH	punct	O
associated	VBN	amod	O
colorectal	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	dobj	O
in	IN	case	O
the	DT	det	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	amod	O
)	-RRB-	punct	O
x	NN	nummod	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
m	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
null	NN	dep	O
)	-RRB-	punct	O
mice	NNS	nmod	B-Organism
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
folate	JJ	amod	B-Simple_chemical
deficiency	NN	nsubj	O
may	MD	aux	O
inhibit	VB	ccomp	O
colorectal	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	dobj	O
in	IN	case	O
chronic	JJ	amod	O
UC	NN	nmod	B-Pathological_formation
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
mortality	NN	nsubj	O
observed	VBN	acl	O
in	IN	case	O
the	DT	det	O
folate	JJ	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
deficient	JJ	amod	O
group	NN	nmod	O
precludes	VBZ	ROOT	O
a	DT	det	O
definitive	JJ	amod	O
conclusion	NN	dobj	O
concerning	VBG	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
folate	JJ	compound	B-Simple_chemical
deficiency	NN	nmod	O
on	IN	case	O
UC	NNP	nmod:npmod	B-Pathological_formation
-	HYPH	punct	O
associated	VBN	amod	O
colorectal	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	nmod	O
in	IN	case	O
this	DT	det	O
model	NN	nmod	O
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
antitumor	JJ	compound	B-Cancer
agents	NNS	nmod	O
on	IN	case	O
cytotoxicity	NN	compound	O
induction	NN	nmod	O
by	IN	case	O
sodium	NN	compound	B-Simple_chemical
fluoride	NN	nmod	I-Simple_chemical
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
found	VBN	ROOT	O
that	IN	mark	O
sodium	NN	compound	B-Simple_chemical
fluoride	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
NaF	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
induced	VBD	ccomp	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
here	RB	advmod	O
whether	IN	mark	O
6	CD	nummod	O
popular	JJ	amod	O
antitumor	NN	compound	B-Cancer
compounds	NNS	nsubj	O
modify	VBP	ccomp	O
the	DT	det	O
cytotoxic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
NaF	NN	nmod	B-Simple_chemical
against	IN	case	O
human	JJ	amod	B-Organism
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
HSC	NN	compound	B-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
)	-RRB-	punct	I-Cell
and	CC	cc	O
human	JJ	amod	B-Organism
promyelocytic	JJ	amod	B-Cancer
leukemia	NN	compound	I-Cancer
(	-LRB-	punct	O
HL	NN	compound	B-Cell
-	:	punct	I-Cell
60	CD	nummod	I-Cell
)	-RRB-	punct	I-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
.	.	punct	O

Cytotoxic	JJ	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
cisplatin	NN	nmod	B-Simple_chemical
,	,	punct	O
etoposide	NN	conj	B-Simple_chemical
,	,	punct	O
doxorubicin	NN	conj	B-Simple_chemical
or	CC	cc	O
peplomycin	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
tentatively	RB	advmod	O
termed	VBN	acl	O
as	IN	prep	O
Group	NN	compound	O
I	CD	nummod	O
compounds	NNS	pobj	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
methotrexate	JJ	conj	B-Simple_chemical
and	CC	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	conj	I-Simple_chemical
(	-LRB-	punct	O
tentatively	RB	advmod	O
termed	VBN	acl	O
as	IN	case	O
Group	NN	compound	O
II	CD	nummod	O
compounds	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
enhanced	VBD	ROOT	O
the	DT	det	O
cytotoxic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
NaF	NN	nmod	B-Simple_chemical
.	.	punct	O

NaF	NN	compound	B-Simple_chemical
and	CC	cc	O
Group	NN	conj	O
I	CD	nummod	O
compounds	NNS	nsubj	O
induced	VBD	ROOT	O
internucleosomal	JJ	amod	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	dobj	O
in	IN	case	O
HL	NN	compound	B-Cell
-	:	punct	I-Cell
60	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
whereas	IN	dep	O
Group	NN	compound	O
II	CD	nummod	O
compounds	NNS	nsubj	O
were	VBD	cop	O
inactive	JJ	parataxis	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
NaF	NN	nmod	B-Simple_chemical
.	.	punct	O

Most	JJS	amod	O
Group	NNP	compound	O
I	CD	nummod	O
compounds	VBZ	ROOT	O
except	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
which	WDT	nsubj	O
induced	VBD	acl:relcl	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	dobj	O
less	RBR	advmod	O
effectively	RB	advmod	O
than	IN	case	O
others	NNS	nmod	O
)	-RRB-	punct	O
activated	VBN	amod	O
caspase	NN	appos	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
more	RBR	advmod	O
efficiently	RB	advmod	O
than	IN	case	O
Group	NN	compound	O
II	CD	nummod	O
compounds	NNS	nmod	O
.	.	punct	O

Caspase	NN	nsubjpass	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
mitochondrial	JJ	amod	B-Cellular_component
extrinsic	JJ	amod	O
pathway	NN	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
intrinsic	JJ	amod	O
pathway	NN	nmod	O
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
activated	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
to	IN	case	O
a	DT	det	O
much	RB	advmod	O
lesser	JJR	amod	O
extent	NN	conj	O
.	.	punct	O

NaF	NN	nsubj	B-Simple_chemical
reduced	VBD	ROOT	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	dobj	O
at	IN	case	O
early	JJ	amod	O
stage	NN	nmod	O
,	,	punct	O
possibly	RB	advmod	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
cisplatin	NN	nsubj	B-Simple_chemical
and	CC	cc	O
etoposide	NN	conj	B-Simple_chemical
reduced	VBD	parataxis	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	dobj	O
at	IN	case	O
later	JJR	amod	O
stage	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
early	JJ	amod	O
decline	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	nmod	O
is	VBZ	cop	O
rather	RB	advmod	O
specific	JJ	ccomp	O
to	TO	case	O
NaF	NN	nmod	B-Simple_chemical
.	.	punct	O

Morphogenesis	NN	ROOT	O
of	IN	case	O
embryonic	JJ	amod	B-Multi-tissue_structure
CNS	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

This	DT	det	O
chapter	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
morphology	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
in	IN	prep	O
and	CC	cc	O
around	IN	case	O
the	DT	det	O
early	JJ	amod	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	conj	I-Anatomical_system
(	-LRB-	punct	O
CNS	NN	appos	B-Anatomical_system
,	,	punct	O
i	LS	appos	O
.	.	punct	O
e	LS	ccomp	O
.	.	punct	O
,	,	punct	O
brain	NN	ROOT	B-Organ
and	CC	cc	O
spinal	JJ	amod	B-Organ
cord	NN	conj	I-Organ
)	-RRB-	punct	O
of	IN	prep	O
avian	JJ	amod	B-Organism
embryos	NNS	pobj	B-Developing_anatomical_structure
.	.	punct	O

We	PRP	nsubj	O
discuss	VBP	ROOT	O
cell	NN	compound	B-Cell
lineages	NNS	dobj	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
interactions	NNS	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
pericytes	NNS	conj	B-Cell
and	CC	cc	O
smooth	VB	amod	B-Cell
muscle	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
macrophages	NNS	conj	B-Cell
.	.	punct	O

Due	JJ	case	O
to	TO	aux	O
space	NN	advcl	O
limitations	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
can	MD	aux	O
not	RB	neg	O
review	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
CNS	NN	compound	B-Anatomical_system
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
refer	VBP	conj	O
the	DT	det	O
reader	NN	dobj	O
to	IN	prep	O
other	JJ	amod	O
chapters	NNS	pobj	O
in	IN	prep	O
this	DT	det	O
book	NN	pobj	O
and	CC	cc	O
to	TO	conj	O
recent	JJ	amod	O
publications	NNS	pobj	O
on	IN	prep	O
the	DT	det	O
assembly	NN	pobj	O
of	IN	prep	O
the	DT	det	O
vasculature	NN	pobj	B-Multi-tissue_structure
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
2	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
candidate	NN	compound	O
tumour	NN	compound	B-Cancer
suppressor	NN	compound	O
protein	NN	compound	O
ING4	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	ROOT	O
brain	NN	compound	B-Cancer
tumour	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Gliomas	NNS	nsubj	B-Cancer
are	VBP	ROOT	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
primary	JJ	amod	O
tumours	NNS	attr	B-Cancer
of	IN	prep	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	pobj	I-Anatomical_system
,	,	punct	O
with	IN	prep	O
nearly	RB	advmod	O
15	CD	nummod	O
,	,	punct	O
000	CD	nsubj	O
diagnosed	VBN	pcomp	O
annually	RB	advmod	O
in	IN	prep	O
the	DT	det	O
United	NNP	compound	O
States	NNP	pobj	O
and	CC	cc	O
a	DT	det	O
lethality	NN	conj	O
approaching	VBG	acl	O
80	CD	nummod	O
%	NN	dobj	O
within	IN	case	O
the	DT	det	O
first	JJ	amod	O
year	NN	nmod	O
of	IN	case	O
glioblastoma	NN	compound	B-Cancer
diagnosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
marked	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
glioblastomas	NNS	nmod	B-Cancer
suggests	VBZ	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
necessary	JJ	amod	O
part	NN	ccomp	O
of	IN	case	O
malignant	JJ	amod	O
progression	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
precise	JJ	amod	O
molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
underlying	VBG	acl	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
brain	NN	compound	B-Cancer
tumour	NN	compound	I-Cancer
growth	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
remain	VBP	parataxis	O
unresolved	JJ	xcomp	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
candidate	NN	compound	O
tumour	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nsubjpass	O
,	,	punct	O
ING4	NN	appos	B-Gene_or_gene_product
,	,	punct	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	mark	O
regulating	VBG	advcl	O
brain	NN	compound	B-Cancer
tumour	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
ING4	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
brain	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
,	,	punct	O
and	CC	cc	O
the	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
reduction	NN	nmod	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
from	IN	case	O
lower	JJR	nmod	O
to	IN	case	O
higher	JJR	amod	O
grades	NNS	nmod	O
of	IN	prep	O
tumours	NNS	pobj	B-Cancer
.	.	punct	O

In	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
xenografts	NNS	nsubj	B-Cancer
of	IN	case	O
human	JJ	amod	B-Organism
glioblastoma	NN	compound	B-Cancer
U87MG	NN	nmod	I-Cancer
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	aux	O
decreased	VBN	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
ING4	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
grow	VBP	ROOT	O
significantly	RB	advmod	O
faster	RBR	acomp	O
and	CC	cc	O
have	VBP	conj	O
higher	JJR	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
volume	NN	compound	O
fractions	NNS	dobj	O
than	IN	prep	O
control	NN	compound	O
tumours	NNS	pobj	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
ING4	NN	nsubj	B-Gene_or_gene_product
physically	RB	advmod	O
interacts	VBZ	ccomp	O
with	IN	case	O
p65	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
RelA	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
subunit	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	O
factor	NN	compound	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
ING4	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	conj	O
brain	NN	compound	B-Cancer
tumour	NN	compound	I-Cancer
angiogenesis	NN	dobj	O
through	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
of	IN	case	O
NF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
responsive	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
ING4	NN	nsubj	B-Gene_or_gene_product
has	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
brain	NN	compound	B-Cancer
tumour	NN	compound	I-Cancer
pathogenesis	NN	nmod	O
.	.	punct	O

TGFbeta1	NNP	ROOT	B-Gene_or_gene_product
,	,	punct	O
back	RB	advmod	O
to	IN	prep	O
the	DT	det	O
future	NN	pobj	O
:	:	punct	O
revisiting	VBG	dep	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
as	IN	case	O
a	DT	det	O
transforming	VBG	amod	O
growth	NN	compound	O
factor	NN	nmod	O
.	.	punct	O

TGFbeta1	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
initially	RB	advmod	O
identified	VBN	ROOT	O
in	IN	case	O
culture	NN	compound	O
media	NNS	nmod	O
from	IN	case	O
transformed	VBN	amod	B-Cell
cells	NNS	nmod	I-Cell
as	IN	case	O
part	NN	nmod	O
of	IN	case	O
a	DT	det	O
factor	NN	nmod	O
that	WDT	nsubj	O
could	MD	aux	O
produce	VB	acl:relcl	O
a	DT	det	O
transformed	VBN	amod	O
phenotype	NN	dobj	O
in	IN	case	O
a	DT	det	O
nontransformed	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	O
.	.	punct	O

Subsequently	RB	advmod	O
this	DT	det	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
separated	VBN	ROOT	O
into	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TGFalpha	NN	conj	B-Gene_or_gene_product
an	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	O
ligand	NN	dep	O
.	.	punct	O

With	IN	prep	O
the	DT	det	O
discovery	NN	pobj	O
that	IN	mark	O
TGFbeta1	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
a	DT	det	O
potent	JJ	amod	O
growth	NN	compound	O
inhibitor	NN	relcl	O
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
the	DT	det	O
identification	NN	pobj	O
of	IN	case	O
inactivating	VBG	amod	O
mutations	NNS	nmod	O
within	IN	case	O
the	DT	det	O
TGFbeta1	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
cancers	NNS	nmod	B-Cancer
it	PRP	nsubj	O
became	VBD	ROOT	O
clear	JJ	acomp	O
that	IN	mark	O
TGFbeta1	JJ	amod	B-Gene_or_gene_product
signaling	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
pathway	NN	ccomp	O
for	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

However	RB	advmod	O
many	JJ	amod	O
human	JJ	amod	B-Organism
carcinomas	NNS	nsubj	B-Cancer
overexpress	VBP	ROOT	O
TGFbeta1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
this	DT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
poor	JJ	amod	O
patient	NN	compound	B-Organism
prognosis	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
frequency	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
experimental	JJ	amod	O
animal	NN	compound	O
models	NNS	conj	O
.	.	punct	O

Thus	RB	advmod	O
stage	NN	ROOT	O
specific	JJ	amod	O
duality	NN	nsubj	O
of	IN	case	O
function	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
emerging	VBG	amod	O
paradigm	NN	dobj	O
for	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
TGFbeta1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
focus	VB	ROOT	O
on	IN	case	O
the	DT	det	O
evidence	NN	nmod	O
for	IN	case	O
TGFbeta1	NN	nmod	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
tumor	NN	nmod	B-Cancer
promoting	VBG	acl	O
and	CC	cc	O
metastasis	NN	compound	O
factor	NN	conj	O
and	CC	cc	O
examine	VB	conj	O
the	DT	det	O
biological	JJ	amod	O
and	CC	cc	O
molecular	JJ	conj	O
basis	NN	dobj	O
for	IN	case	O
these	DT	det	O
effects	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
switch	NN	nsubj	O
from	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
to	IN	case	O
oncogene	NN	nmod	O
reflects	VBZ	ccomp	O
genetic	JJ	amod	O
or	CC	cc	O
epigenetic	JJ	conj	O
alterations	NNS	dobj	O
in	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
alter	VBP	acl:relcl	O
the	DT	det	O
readout	NN	dobj	O
from	IN	case	O
the	DT	det	O
TGFbeta1	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
.	.	punct	O

Clinical	JJ	amod	O
,	,	punct	O
laboratory	NN	conj	O
,	,	punct	O
histopathological	JJ	conj	O
,	,	punct	O
and	CC	cc	O
pharmacological	JJ	conj	O
evidence	NN	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
notion	NN	dobj	O
that	IN	mark	O
the	DT	det	O
coagulation	NN	compound	O
system	NN	nsubj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	acl:relcl	O
in	IN	case	O
most	JJS	amod	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
biology	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
laboratory	NN	nsubj	O
has	VBZ	aux	O
provided	VBN	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
thrombin	NN	nsubj	B-Gene_or_gene_product
activates	VBZ	ccomp	O
angiogenesis	NN	dobj	O
,	,	punct	O
a	DT	det	O
process	NN	dobj	O
which	WDT	nsubj	O
is	VBZ	cop	O
essential	JJ	acl:relcl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

This	DT	det	O
event	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	ROOT	O
of	IN	case	O
fibrin	NN	compound	B-Gene_or_gene_product
formation	NN	nmod	O
.	.	punct	O

At	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
level	NN	compound	O
many	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
can	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
.	.	punct	O

Thrombin	NN	nsubj	B-Gene_or_gene_product
decreases	VBZ	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
attach	VB	acl	O
to	TO	mark	O
basement	NN	xcomp	B-Cellular_component
membrane	NN	compound	I-Cellular_component
proteins	NNS	dobj	O
.	.	punct	O

(	-LRB-	punct	O
2	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Thrombin	NN	nsubj	B-Gene_or_gene_product
greatly	RB	advmod	O
potentiates	VBZ	ROOT	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
-	:	punct	O
)	-RRB-	punct	O
induced	VBD	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
.	.	punct	O

This	DT	det	O
potentiation	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	O
(	-LRB-	punct	O
kinase	NN	compound	B-Gene_or_gene_product
insert	NN	compound	I-Gene_or_gene_product
domain	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
containing	VBG	amod	I-Gene_or_gene_product
receptor	NN	dep	I-Gene_or_gene_product
[	-LRB-	punct	O
KDR	NN	appos	B-Gene_or_gene_product
]	-RRB-	punct	O
and	CC	cc	O
fms	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	prep	I-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	pobj	I-Gene_or_gene_product
[	-LRB-	punct	O
Flt	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
]	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O

(	-LRB-	punct	O
3	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Thrombin	NN	nsubj	B-Gene_or_gene_product
increases	VBZ	ROOT	O
the	DT	det	O
mRNA	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
levels	NNS	dobj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
serves	VBZ	conj	O
as	IN	case	O
a	DT	det	O
ligand	NN	nmod	O
to	TO	case	O
this	DT	det	O
receptor	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
thrombin	NN	nsubj	B-Gene_or_gene_product
increases	VBZ	ROOT	O
the	DT	det	O
secretion	NN	dobj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
enhances	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
protein	NN	compound	O
synthesis	NN	conj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloprotease	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
PC	NN	compound	I-Cell
-	:	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
could	MD	aux	O
explain	VB	ROOT	O
the	DT	dep	O
angiogenic	JJ	dobj	O
and	CC	cc	O
tumor	NN	conj	B-Cancer
-	HYPH	punct	O
promoting	VBG	dep	O
effect	NN	dep	O
of	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
provide	VBP	conj	O
the	DT	det	O
basis	NN	dobj	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
mimetics	NNS	nmod	O
or	CC	cc	O
antagonists	NNS	conj	O
for	IN	case	O
therapeutic	JJ	amod	O
application	NN	nmod	O
.	.	punct	O

NIH3T3	NN	compound	B-Cell
transfectant	NN	nsubj	I-Cell
containing	VBG	acl	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	dobj	O
shows	VBZ	ROOT	O
enhanced	VBN	amod	O
metastatic	JJ	amod	O
activity	NN	dobj	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
or	CC	cc	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	conj	O
with	IN	case	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

A	DT	det	O
clone	NN	nsubj	B-Cell
of	IN	prep	O
NIH3T3	NN	compound	B-Cell
transformant	NN	intj	I-Cell
(	-LRB-	punct	O
H	NN	compound	B-Cell
-	:	punct	I-Cell
3	CD	appos	I-Cell
)	-RRB-	punct	O
,	,	punct	O
obtained	VBN	acl	O
by	IN	mark	O
transfecting	VBG	advcl	O
genomic	JJ	amod	O
DNA	NN	dobj	B-Cellular_component
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
contains	VBZ	ROOT	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	dobj	O
and	CC	cc	O
yields	VBZ	conj	O
metastatic	JJ	amod	O
pulmonary	JJ	amod	B-Pathological_formation
nodules	NNS	dobj	I-Pathological_formation
after	IN	case	O
intravenous	JJ	amod	B-Immaterial_anatomical_entity
injection	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
into	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

This	DT	det	O
metastatic	JJ	amod	O
ability	NN	nsubjpass	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
remarkably	RB	advmod	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
(	-LRB-	punct	O
subcutaneous	JJ	amod	O
tumor	NN	compound	B-Cancer
formation	NN	dep	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
)	-RRB-	punct	O
accompanied	VBN	acl	O
by	IN	case	O
increased	VBN	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
gene	NN	compound	O
amplification	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
-	HYPH	punct	O
derived	VBN	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
,	,	punct	O
while	IN	mark	O
it	PRP	nsubj	O
declined	VBD	advcl	O
gradually	RB	advmod	O
as	IN	mark	O
the	DT	det	O
passage	NN	compound	O
number	NN	nsubj	O
increased	VBD	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
with	IN	case	O
corresponding	JJ	amod	O
decreases	NNS	nmod	O
of	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
and	CC	cc	O
mRNA	NN	compound	O
expression	NN	conj	O
.	.	punct	O

Six	CD	nummod	O
subclones	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
randomly	RB	advmod	O
selected	VBN	ROOT	O
from	IN	case	O
H	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
subcultured	VBN	acl:relcl	O
to	TO	aux	O
passage	VB	xcomp	O
22	CD	nummod	O
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
the	DT	det	O
clones	NNS	nmod	B-Cell
in	IN	case	O
culture	NN	nmod	O
showed	VBD	ROOT	O
almost	RB	advmod	O
the	DT	det	O
same	JJ	amod	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
ability	NN	nmod	O
and	CC	cc	O
exhibited	VBD	conj	O
little	JJ	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	compound	O
amplification	NN	dobj	O
with	IN	case	O
correspondingly	RB	advmod	O
low	JJ	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
after	IN	mark	O
they	PRP	nsubj	O
formed	VBD	advcl	O
tumors	NNS	dobj	B-Cancer
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
every	DT	det	O
clone	NN	nsubj	B-Cell
acquired	VBD	ROOT	O
high	JJ	amod	O
metastatic	JJ	amod	O
ability	NN	dobj	O
and	CC	cc	O
the	DT	det	O
gene	NN	compound	O
amplification	NN	conj	O
increased	VBD	conj	O
,	,	punct	O
with	IN	case	O
elevated	JJ	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

These	DT	det	O
experimental	JJ	amod	O
facts	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
acquisition	NN	nsubj	O
of	IN	case	O
metastatic	JJ	amod	O
ability	NN	nmod	O
coupled	VBN	acl	O
with	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
was	VBD	cop	O
conditional	JJ	ccomp	O
in	IN	case	O
nature	NN	nmod	O
,	,	punct	O
being	VBG	auxpass	O
strongly	RB	advmod	O
affected	VBN	advcl	O
by	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
circumstances	NNS	nmod	O
.	.	punct	O

The	DT	det	O
low	JJ	amod	O
metastatic	JJ	amod	O
and	CC	cc	O
G	NN	conj	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
418	CD	dep	I-Simple_chemical
-	HYPH	punct	O
resistant	JJ	amod	O
H	NN	compound	B-Cell
-	:	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
co	NN	advmod	O
-	HYPH	punct	O
cultured	VBN	ROOT	O
with	IN	case	O
BALB	NN	compound	B-Cell
/	SYM	punct	I-Cell
c3T3	VBZ	compound	I-Cell
fibroblasts	NNS	nmod	I-Cell
for	IN	case	O
2	CD	compound	O
-	SYM	punct	O
4	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

After	IN	case	O
removal	NN	nmod	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
by	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
G	NN	nmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
418	CD	nummod	I-Simple_chemical
,	,	punct	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
exhibited	VBD	ROOT	O
increased	VBN	amod	O
metastatic	JJ	amod	O
ability	NN	dobj	O
and	CC	cc	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	compound	O
mRNA	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
intimate	JJ	amod	O
interaction	NN	dobj	O
between	IN	case	O
H	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
influencing	VBG	acl	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
transfected	VBN	amod	O
human	JJ	amod	B-Organism
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
.	.	punct	O

Fibroblasts	NNS	nsubj	B-Cell
of	IN	case	O
the	DT	det	O
host	NN	compound	O
animal	NN	nmod	B-Organism
may	MD	aux	O
thus	RB	advmod	O
have	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
generating	VBG	advcl	O
enhanced	VBN	amod	O
metastatic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
H	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Lactoferrin	NN	nsubj	B-Gene_or_gene_product
enhances	VBZ	ROOT	O
Fas	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
the	DT	det	O
colon	NN	compound	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
azoxymethane	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

Bovine	JJ	amod	B-Organism
lactoferrin	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
multifunctional	JJ	amod	O
glycoprotein	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
strongly	RB	advmod	O
inhibit	VB	xcomp	O
development	NN	dobj	O
of	IN	case	O
azoxymethane	NN	nmod:npmod	B-Simple_chemical
(	-LRB-	punct	O
AOM	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
rat	NN	compound	B-Organism
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Little	JJ	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
recently	RB	advmod	O
that	IN	mark	O
lactoferrin	NN	nsubj	B-Gene_or_gene_product
enhances	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
member	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
family	NN	nmod	O
,	,	punct	O
Fas	NN	appos	B-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
the	DT	det	O
colon	NN	compound	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
during	IN	case	O
both	CC	cc:preconj	O
early	JJ	amod	O
and	CC	cc	O
late	JJ	conj	O
stages	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
Fas	NN	nsubjpass	B-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
bovine	JJ	amod	B-Organism
lactoferrin	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
inhibition	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
this	DT	det	O
possibility	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
influence	NN	dobj	O
of	IN	case	O
bovine	JJ	amod	B-Organism
lactoferrin	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
expression	NN	nmod	O
of	IN	case	O
Fas	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
activation	NN	appos	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	conj	O
in	IN	case	O
the	DT	det	O
colon	NN	compound	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
AOM	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
>	NN	dobj	O
2	CD	dep	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	ROOT	O
in	IN	case	O
Fas	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
elevation	NN	conj	O
of	IN	case	O
the	DT	det	O
active	JJ	amod	O
forms	NNS	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

Immunohistochemical	JJ	amod	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
cells	NNS	dobj	O
and	CC	cc	O
apoptotic	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
preferentially	RB	advmod	O
within	IN	case	O
the	DT	det	O
proximal	JJ	amod	O
colon	NN	compound	B-Organ
region	NN	nmod	O
,	,	punct	O
clearly	RB	advmod	O
at	IN	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
bovine	JJ	amod	B-Organism
lactoferrin	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
tumor	NN	compound	B-Cancer
inhibition	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
apoptosis	NN	nsubjpass	O
caused	VBN	acl	O
by	IN	case	O
elevated	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Fas	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
chemoprevention	NN	nmod	O
by	IN	case	O
lactoferrin	NN	nmod	B-Gene_or_gene_product
of	IN	case	O
colon	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
.	.	punct	O

Dynein	NN	compound	B-Gene_or_gene_product
light	JJ	amod	I-Gene_or_gene_product
chain	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
p21	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
interacting	VBG	amod	O
substrate	NN	appos	O
,	,	punct	O
promotes	VBZ	ROOT	O
cancerous	JJ	amod	B-Cancer
phenotypes	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
dynein	NN	compound	B-Gene_or_gene_product
light	JJ	amod	I-Gene_or_gene_product
chain	NN	dobj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
DLC1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
as	IN	case	O
a	DT	det	O
physiologic	JJ	amod	O
substrate	NN	nmod	O
of	IN	case	O
p21	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Pak1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Pak1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
DLC1	NN	compound	B-Gene_or_gene_product
interaction	NN	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
cell	NN	compound	B-Cell
survival	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
depends	VBZ	acl:relcl	O
on	IN	case	O
Pak1	NN	nmod:poss	B-Gene_or_gene_product
'	POS	case	O
s	VBZ	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
DLC1	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
Ser88	NN	nmod	B-Amino_acid
.	.	punct	O

Pak1	NN	nsubj	B-Gene_or_gene_product
associates	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
complex	NN	nmod	O
of	IN	case	O
DLC1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
BimL	NN	conj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
proapoptotic	JJ	amod	O
BH3	NN	compound	O
-	:	punct	O
only	JJ	amod	O
protein	NN	conj	O
,	,	punct	O
and	CC	cc	O
phosphorylates	VBZ	conj	O
both	DT	det	O
proteins	NNS	dobj	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
BimL	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
Pak1	NN	nmod	B-Gene_or_gene_product
prevents	VBZ	ROOT	O
it	PRP	dobj	O
from	IN	prep	O
interacting	VBG	pcomp	O
with	IN	prep	O
and	CC	cc	O
inactivation	NN	dobj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
antiapoptotic	JJ	amod	O
protein	NN	appos	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
DLC1	NN	nmod	B-Gene_or_gene_product
but	CC	cc	O
not	RB	cc	O
DLC1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Ser88Ala	NN	compound	B-Amino_acid
mutant	NN	conj	O
promotes	VBZ	ROOT	O
cancerous	JJ	amod	B-Cancer
properties	NNS	dobj	O
of	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

DLC1	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
level	NN	nsubj	O
is	VBZ	aux	O
elevated	JJ	ROOT	O
in	IN	case	O
more	JJR	advmod	O
than	IN	quantmod	O
90	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
regulation	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-Cell
survival	NN	compound	O
functions	VBZ	nmod	O
by	IN	case	O
Pak1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
DLC1	NN	compound	B-Gene_or_gene_product
interaction	NN	nmod	O
represents	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
a	DT	det	O
signaling	NN	compound	O
kinase	NN	nsubj	O
might	MD	aux	O
regulate	VB	acl:relcl	O
the	DT	det	O
cancerous	JJ	amod	B-Cancer
phenotypes	NNS	dobj	O
.	.	punct	O

Matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
activity	NN	ROOT	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
profile	NN	conj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	intj	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	conj	B-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	nmod	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
during	IN	case	O
human	JJ	amod	B-Organism
dermal	JJ	amod	B-Pathological_formation
wound	NN	compound	I-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
during	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

Matrix	NN	compound	B-Gene_or_gene_product
metalloproteinases	NNS	nsubj	I-Gene_or_gene_product
can	MD	aux	O
collectively	RB	advmod	O
cleave	VB	ROOT	O
all	DT	det	O
components	NNS	dobj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
,	,	punct	O
with	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	nmod	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
regulating	VBG	acl	O
their	PRP$	nmod:poss	O
activity	NN	dobj	O
.	.	punct	O

Breast	NN	compound	B-Tissue
tissue	NN	nsubjpass	I-Tissue
taken	VBN	acl	O
at	IN	case	O
varying	VBG	amod	O
postoperative	JJ	amod	O
times	NNS	nmod	O
(	-LRB-	punct	O
n	NN	nsubjpass	O
=	JJ	amod	O
92	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
during	IN	case	O
surgery	NN	conj	O
(	-LRB-	punct	O
controls	NNS	dep	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	amod	O
17	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
temporal	JJ	amod	O
and	CC	cc	O
spatial	JJ	conj	O
activity	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	conj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
during	IN	case	O
human	JJ	amod	B-Organism
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

Matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
activity	NN	nsubj	O
,	,	punct	O
determined	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
quenched	JJ	amod	O
fluorescence	NN	compound	O
substrate	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
increased	VBD	xcomp	O
during	IN	case	O
early	JJ	amod	O
healing	NN	nmod	O
(	-LRB-	punct	O
3	CD	compound	O
-	SYM	punct	O
8	CD	nummod	O
weeks	NNS	appos	O
)	-RRB-	punct	O
compared	VBN	case	O
to	TO	case	O
controls	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
then	RB	advmod	O
decreased	VBD	conj	O
between	IN	case	O
24	CD	nummod	O
and	CC	cc	O
36	CD	conj	O
weeks	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
05	CD	nummod	O
until	IN	case	O
24	CD	nummod	O
weeks	NNS	dep	O
,	,	punct	O
Mann	NNP	compound	O
-	HYPH	punct	O
Whitney	NNP	compound	O
U	NNP	compound	O
-	HYPH	punct	O
test	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Immunohistochemistry	NN	compound	O
scores	NNS	nsubjpass	O
for	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
were	VBD	auxpass	O
significantly	RB	advmod	O
elevated	JJ	ROOT	O
compared	VBN	case	O
to	TO	case	O
controls	NNS	advcl	O
in	IN	case	O
scar	JJ	compound	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
from	IN	case	O
2	CD	nmod	O
until	IN	case	O
12	CD	nummod	O
and	CC	cc	O
20	CD	conj	O
weeks	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
staining	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
exclusively	RB	advmod	O
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
,	,	punct	O
reaching	VBG	advcl	O
maximum	NN	amod	O
levels	NNS	dobj	O
8	CD	compound	O
-	SYM	punct	O
12	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
surgery	NN	dep	O
,	,	punct	O
decreasing	VBG	advcl	O
by	IN	prep	O
1	CD	pobj	O
.	.	punct	O
5	CD	nummod	O
years	NNS	nsubj	O
but	CC	cc	O
remaining	VBG	conj	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
.	.	punct	O

Tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	nsubj	I-Gene_or_gene_product
of	IN	prep	I-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
staining	NN	pobj	O
was	VBD	ROOT	O
relatively	RB	advmod	O
sparse	JJ	acomp	O
but	CC	cc	O
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	conj	O
until	IN	case	O
8	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinases	NNS	nsubj	I-Gene_or_gene_product
are	VBP	cop	O
present	JJ	ccomp	O
at	IN	case	O
elevated	JJ	amod	O
levels	NNS	nmod	O
during	IN	case	O
early	JJ	amod	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
angiogenesis	NN	nsubj	O
occurs	VBZ	advcl	O
,	,	punct	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
significant	JJ	amod	O
role	NN	dobj	O
.	.	punct	O

The	DT	det	O
later	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
suggests	VBZ	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
remodeling	NN	nmod	O
.	.	punct	O

Convergence	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	conj	I-Gene_or_gene_product
signaling	NN	compound	O
networks	NNS	nmod	O
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
protein	NN	ROOT	O
with	IN	prep	O
many	JJ	amod	O
talents	NNS	pobj	O
.	.	punct	O

One	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
most	RBS	amod	O
fundamental	JJ	pobj	O
is	VBZ	ROOT	O
the	DT	det	O
ability	NN	attr	O
to	TO	aux	O
act	VB	acl	O
as	IN	case	O
essential	JJ	amod	O
growth	NN	compound	O
checkpoint	NN	nmod	O
that	WDT	nsubj	O
protects	VBZ	acl:relcl	O
cells	NNS	dobj	B-Cell
against	IN	case	O
cellular	JJ	amod	B-Cell
transformation	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

Most	JJS	nsubjpass	O
of	IN	case	O
the	DT	det	O
studies	NNS	nmod	O
focusing	VBG	acl	O
on	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	B-Cell
upon	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
established	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
activating	VBG	compound	O
inputs	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
high	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
radiations	NNS	nmod	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	JJ	amod	O
drugs	NNS	conj	O
and	CC	cc	O
activated	VBN	amod	O
oncogenes	NNS	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressive	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
become	VBP	advcl	O
concerted	VBN	xcomp	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
cues	NNS	nmod	O
arriving	VBG	acl	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
during	IN	case	O
tissue	NN	compound	B-Tissue
homeostasis	NN	nmod	O
,	,	punct	O
remains	VBZ	ROOT	O
largely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O

Intriguingly	RB	advmod	O
,	,	punct	O
two	CD	nummod	O
recent	JJ	amod	O
papers	NNS	nsubj	O
have	VBP	aux	O
shed	VBN	ROOT	O
new	JJ	amod	O
light	NN	dobj	O
into	IN	prep	O
this	DT	det	O
unexplored	JJ	amod	O
field	NN	pobj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
growth	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
,	,	punct	O
unexpectedly	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
developmental	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
early	JJ	amod	O
embryos	NNS	nmod	B-Developing_anatomical_structure
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
review	VBP	ROOT	O
and	CC	cc	O
comment	VB	conj	O
on	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
and	CC	cc	O
on	IN	case	O
their	PRP$	nmod:poss	O
implications	NNS	conj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
biology	NN	nmod	O
.	.	punct	O

Enhanced	VBN	amod	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
improves	VBZ	ROOT	O
smooth	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
cell	NN	dobj	I-Cell
engraftment	NN	amod	O
after	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
benefit	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
after	IN	case	O
a	DT	det	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
is	VBZ	auxpass	O
diminished	VBN	ROOT	O
by	IN	case	O
early	JJ	amod	O
cell	NN	compound	B-Cell
losses	NNS	nmod	O
.	.	punct	O

IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
enhances	VBZ	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
IGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
smooth	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
(	-LRB-	punct	O
SMCs	NNS	appos	B-Cell
)	-RRB-	punct	O
would	MD	aux	O
enhance	VB	ccomp	O
cell	NN	compound	B-Cell
survival	NN	dobj	O
and	CC	cc	O
improve	VB	conj	O
engraftment	NN	dobj	O
after	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
.	.	punct	O

The	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
gene	NN	nsubjpass	O
was	VBD	auxpass	O
transfected	VBN	ROOT	O
into	IN	case	O
male	JJ	amod	O
SMCs	NNS	nmod	B-Cell
and	CC	cc	O
compared	VBN	conj	O
with	IN	case	O
SMCs	NNS	nmod	B-Cell
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
plasmid	NN	compound	O
vector	NN	nmod	O
(	-LRB-	punct	O
vector	NN	compound	O
control	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
nontransfected	JJ	amod	O
SMCs	NNS	conj	B-Cell
(	-LRB-	punct	O
cell	NN	compound	B-Cell
control	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nsubj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
10	CD	nummod	O
/	SYM	punct	O
group	NN	dep	O
)	-RRB-	punct	O
and	CC	cc	O
protein	NN	compound	O
levels	NNS	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
6	CD	nummod	O
/	:	punct	O
group	NN	dep	O
)	-RRB-	punct	O
were	VBD	cop	O
higher	JJR	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
for	IN	case	O
all	DT	det	O
groups	NNS	nmod	O
)	-RRB-	punct	O
at	IN	case	O
3	CD	nummod	O
,	,	punct	O
7	CD	conj	O
,	,	punct	O
and	CC	cc	O
14	CD	conj	O
days	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
controls	NNS	advcl	O
.	.	punct	O

VEGF	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
also	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
parallel	NN	nmod	O
to	TO	case	O
enhanced	VBN	amod	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
cells	NNS	nsubj	B-Cell
demonstrated	VBD	ROOT	O
greater	JJR	amod	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
stimulated	VBN	amod	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
decreased	VBN	amod	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activity	NN	conj	O
after	IN	case	O
simulated	JJ	amod	O
ischemia	NN	nmod	O
and	CC	cc	O
reperfusion	NN	conj	O
(	-LRB-	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
for	IN	case	O
all	DT	det	O
groups	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
vector	NN	nmod	O
or	CC	cc	O
cell	NN	compound	B-Cell
controls	NNS	conj	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
uniform	NN	nsubj	O
left	VBD	ROOT	B-Multi-tissue_structure
ventricular	JJ	amod	I-Multi-tissue_structure
injury	NN	nsubjpass	O
was	VBD	auxpass	O
produced	VBN	ccomp	O
in	IN	case	O
female	JJ	amod	O
rats	NNS	nmod	B-Organism
using	VBG	acl	O
a	DT	det	O
cryoprobe	NN	dobj	O
.	.	punct	O

Three	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
6	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	nsubjpass	B-Cell
from	IN	case	O
three	CD	nummod	O
groups	NNS	nmod	O
were	VBD	auxpass	O
implanted	VBN	ROOT	O
into	IN	prep	O
the	DT	det	O
scar	NN	pobj	B-Pathological_formation
.	.	punct	O

One	CD	nummod	O
week	NN	npadvmod	O
later	RB	advmod	O
,	,	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
SMCs	NNS	nsubj	B-Cell
had	VBD	aux	O
increased	VBN	ROOT	O
myocardial	JJ	amod	B-Multi-tissue_structure
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
levels	NNS	dobj	O
,	,	punct	O
increased	VBN	amod	O
Bcl2	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
,	,	punct	O
limited	JJ	amod	O
cell	NN	compound	B-Cell
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
enhanced	VBD	amod	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	conj	O
in	IN	case	O
the	DT	det	O
myocardial	JJ	amod	B-Pathological_formation
scar	NN	nmod	I-Pathological_formation
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
two	CD	nummod	O
control	NN	compound	O
groups	NNS	advcl	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
for	IN	case	O
all	DT	det	O
groups	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
proportion	NN	nsubj	O
of	IN	case	O
SMCs	NNS	nmod	B-Cell
surviving	VBG	acl	O
in	IN	case	O
the	DT	det	O
implanted	VBN	amod	O
region	NN	nmod	O
was	VBD	cop	O
greater	JJR	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
group	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
vector	NN	nmod	O
or	CC	cc	O
cell	NN	compound	B-Cell
controls	NNS	conj	O
.	.	punct	O

Gene	NN	compound	O
enhancement	NN	nsubj	O
with	IN	case	O
IGF	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
improved	VBD	ROOT	O
donor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
survival	NN	conj	O
,	,	punct	O
and	CC	cc	O
engraftment	JJ	conj	O
after	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
,	,	punct	O
perhaps	RB	advmod	O
mediated	VBN	advcl	O
by	IN	case	O
enhanced	VBN	amod	O
angiogenesis	NN	nmod	O
and	CC	cc	O
reduced	VBN	amod	O
apoptosis	NN	conj	O
.	.	punct	O

[	-LRB-	punct	O
Altered	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
LOH	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
]	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
PTEN	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
heterozygosity	NN	nmod	O
(	-LRB-	punct	O
LOH	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
explore	VBP	conj	O
their	PRP$	nmod:poss	O
roles	NNS	dobj	O
in	IN	case	O
progression	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
LOH	NN	nsubjpass	O
of	IN	case	O
epigenetic	JJ	amod	O
microsatellites	NNS	nmod	O
of	IN	case	O
PTEN	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
D10S541	NN	appos	O
,	,	punct	O
D10S583	NN	conj	O
and	CC	cc	O
D10S1687	NN	conj	O
)	-RRB-	punct	O
in	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
was	VBD	auxpass	O
detected	VBN	dep	O
by	IN	case	O
PCR	NN	compound	O
-	HYPH	punct	O
SSCP	NNP	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
in	IN	case	O
normal	JJ	amod	O
gastric	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
gastric	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
and	CC	cc	O
SABC	NN	compound	O
immunohistochemistry	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
relationship	NN	nsubjpass	O
between	IN	case	O
expression	NN	nmod	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
or	CC	cc	O
LOH	NN	conj	O
of	IN	case	O
microsatellites	NNS	nmod	O
was	VBD	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
LOH	NN	nsubjpass	O
of	IN	case	O
D10S541	NN	nmod	O
,	,	punct	O
D10S583	NN	conj	O
and	CC	cc	O
D10S1687	NN	conj	O
was	VBD	auxpass	O
found	VBN	dep	O
in	IN	case	O
37	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
21	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
positive	JJ	amod	O
rates	NNS	nsubj	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	nmod	O
were	VBD	cop	O
80	CD	ROOT	O
.	.	punct	O
4	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
45	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
45	CD	appos	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
5	CD	nummod	O
/	SYM	punct	O
11	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
32	CD	conj	O
.	.	punct	O
1	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
18	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
in	IN	case	O
normal	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
early	JJ	amod	O
and	CC	cc	O
advanced	JJ	conj	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	appos	I-Cancer
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
while	IN	prep	O
78	CD	pobj	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
44	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
44	CD	appos	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
5	CD	nummod	O
/	SYM	punct	O
11	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
28	CD	conj	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
16	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
at	IN	case	O
the	DT	det	O
protein	NN	compound	O
level	NN	nmod	O
.	.	punct	O

PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubjpass	O
and	CC	cc	O
protein	NN	conj	O
were	VBD	auxpass	O
less	RBR	advmod	O
frequently	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
early	JJ	amod	O
and	CC	cc	O
advanced	JJ	conj	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
normal	JJ	amod	O
gastric	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
positive	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
LOH	NN	conj	O
of	IN	case	O
microsatellites	NNS	nmod	O
in	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

PTEN	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	ROOT	O
paralleled	VBD	acl	O
with	IN	case	O
its	PRP$	nmod:poss	O
mRNA	NN	compound	O
expression	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
was	VBD	auxpass	O
negatively	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
Down	NN	npadvmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
is	VBZ	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
closely	RB	advmod	O
correlated	VBN	conj	O
with	IN	case	O
LOH	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellites	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
probably	RB	advmod	O
is	VBZ	cop	O
its	PRP$	nmod:poss	O
underlying	VBG	amod	O
molecular	JJ	amod	O
mechanisms	NNS	acl:relcl	O
.	.	punct	O

It	PRP	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
altered	JJ	amod	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

Granulocyte	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
macrophage	NN	compound	I-Gene_or_gene_product
colony	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
interleukin	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
enhance	VBP	ROOT	O
the	DT	det	O
incorporation	NN	dobj	O
of	IN	case	O
cytosine	NN	nmod	B-Simple_chemical
arabinoside	RB	advmod	I-Simple_chemical
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
of	IN	case	O
leukemic	JJ	amod	B-Cell
blasts	NNS	nmod	I-Cell
and	CC	cc	O
the	DT	det	O
cytotoxic	JJ	amod	O
effect	NN	conj	O
on	IN	case	O
clonogenic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
the	DT	det	O
48	CD	nummod	O
-	HYPH	punct	O
hour	NN	compound	O
administration	NN	nmod	O
of	IN	case	O
granulocyte	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
macrophage	NN	compound	I-Gene_or_gene_product
colony	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
GM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
(	-LRB-	punct	O
100	CD	nummod	O
U	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
interleukin	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
(	-LRB-	punct	O
100	CD	nummod	O
U	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
leukemic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
on	IN	case	O
the	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
metabolism	NN	conj	O
and	CC	cc	O
cytotoxic	JJ	amod	O
efficacy	NN	conj	O
of	IN	case	O
a	DT	det	O
subsequent	JJ	amod	O
12	CD	nummod	O
-	HYPH	punct	O
hour	NN	compound	O
application	NN	nmod	O
of	IN	case	O
cytosine	NN	compound	B-Simple_chemical
arabinoside	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
at	IN	case	O
doses	NNS	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
1	CD	ROOT	O
,	,	punct	O
1	CD	conj	O
.	.	punct	O
0	CD	dep	O
,	,	punct	O
10	CD	conj	O
.	.	punct	O
0	CD	dep	O
,	,	punct	O
and	CC	cc	O
100	CD	conj	O
.	.	punct	O
0	CD	nummod	O
mumol	NN	compound	O
/	:	punct	O
L	NN	nsubjpass	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
on	IN	case	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
17	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
.	.	punct	O

After	IN	ROOT	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	pobj	I-Gene_or_gene_product
or	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
1	CD	appos	O
.	.	punct	O
2	CD	nummod	O
-	:	punct	O
to	TO	prep	O
2	CD	pobj	O
.	.	punct	O
4	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
increase	NN	nsubjpass	O
in	IN	case	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
cells	NNS	nmod	B-Cell
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
nine	CD	nmod	O
of	IN	case	O
14	CD	nummod	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
seven	CD	nummod	O
of	IN	case	O
11	CD	nummod	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
cases	NNS	conj	O
.	.	punct	O

3H	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Cytosine	NN	compound	I-Simple_chemical
arabinoside	NN	amod	I-Simple_chemical
incorporation	NN	nsubjpass	O
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
1	CD	dobj	O
.	.	punct	O
33	CD	compound	O
-	HYPH	punct	O
to	TO	quantmod	O
18	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
-	HYPH	punct	O
fold	JJ	ROOT	O
over	RP	prep	O
respective	JJ	amod	O
controls	NNS	pobj	O
in	IN	case	O
14	CD	compound	O
of	IN	advmod	O
17	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

While	IN	mark	O
in	IN	prep	O
control	JJ	compound	O
specimens	NNS	pobj	B-Cell
are	VBP	cop	O
ara	JJ	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NNP	nmod:npmod	I-Simple_chemical
dose	NN	npadvmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
3H	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
ara	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	compound	I-Simple_chemical
uptake	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	advcl	O
by	IN	case	O
a	DT	det	O
corresponding	JJ	amod	O
rise	NN	nmod	O
in	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
ara	IN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
'	''	punct	I-Simple_chemical
triphosphate	NN	intj	I-Simple_chemical
(	-LRB-	punct	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
CTP	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
levels	NNS	nmod	O
,	,	punct	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
CTP	NN	compound	I-Simple_chemical
concentrations	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
increased	VBN	ROOT	O
after	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
or	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
exposure	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
a	DT	det	O
higher	JJR	amod	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NNP	nmod	I-Simple_chemical
to	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
CTP	NNP	compound	I-Simple_chemical
ratio	NN	nmod	O
over	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

This	DT	det	O
finding	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
stimulatory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
on	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	compound	I-Simple_chemical
phosphorylating	NN	compound	O
enzymes	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
more	RBR	advmod	O
rapid	JJ	amod	O
incorporation	NN	conj	O
of	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
CTP	NNP	nmod	I-Simple_chemical
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
of	IN	case	O
leukemic	JJ	amod	B-Cell
blasts	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
effects	NNS	ROOT	O
translated	VBN	acl	O
into	IN	case	O
a	DT	det	O
2	CD	nmod	O
.	.	punct	O
2	CD	nummod	O
-	:	punct	O
to	TO	prep	O
229	CD	pobj	O
.	.	punct	O
0	CD	meta	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	ROOT	O
in	IN	case	O
the	DT	det	O
cytotoxic	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	nmod	I-Simple_chemical
against	IN	case	O
clonogenic	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
after	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	intj	I-Gene_or_gene_product
or	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
pretreatment	NN	nmod	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
enhance	VBP	ROOT	O
the	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
metabolism	NN	dobj	O
of	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	nmod	I-Simple_chemical
and	CC	cc	O
its	PRP$	nmod:poss	O
incorporation	NN	conj	O
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
of	IN	case	O
leukemic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
leading	VBG	acl	O
to	TO	case	O
a	DT	det	O
higher	JJR	amod	O
antileukemic	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
ara	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
C	NN	nmod	I-Simple_chemical
on	IN	case	O
clonogenic	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
CFU	NN	compound	B-Cell
-	HYPH	punct	I-Cell
L	NN	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

Silencing	NN	nsubj	O
of	IN	case	O
monocarboxylate	JJ	amod	B-Gene_or_gene_product
transporters	NNS	nmod	I-Gene_or_gene_product
via	IN	case	O
small	JJ	amod	O
interfering	VBG	amod	O
ribonucleic	JJ	amod	O
acid	NN	nmod	O
inhibits	VBZ	ROOT	O
glycolysis	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
cell	NN	compound	B-Cell
death	NN	dobj	O
in	IN	case	O
malignant	JJ	amod	B-Cancer
glioma	NN	nmod	I-Cancer
:	:	punct	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
study	NN	dobj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Dependence	NN	nsubj	O
on	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	appos	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

As	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
,	,	punct	O
these	DT	det	O
tumors	NNS	nsubj	B-Cancer
generate	VBP	ROOT	O
more	JJR	amod	O
lactate	NN	dobj	B-Simple_chemical
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
effluxed	VBN	acl:relcl	O
from	IN	case	O
cells	NNS	nmod	B-Cell
by	IN	case	O
monocarboxylate	JJ	amod	B-Gene_or_gene_product
transporters	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MCTs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
1	LS	dep	O
)	-RRB-	punct	O
MCT	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
in	IN	case	O
malignant	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
may	MD	aux	O
differ	VB	ccomp	O
from	IN	case	O
normal	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
in	IN	case	O
quantity	NN	nmod	O
,	,	punct	O
isoform	NN	conj	O
,	,	punct	O
or	CC	cc	O
both	DT	conj	O
;	:	punct	O
and	CC	cc	O
2	LS	conj	O
)	-RRB-	punct	O
silencing	NN	conj	O
MCT	NN	compound	B-Gene_or_gene_product
expression	NN	dep	O
would	MD	aux	O
induce	VB	ccomp	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
acidification	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
decreased	VBN	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
increased	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
quantified	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
MCT	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
glioblastoma	NN	compound	B-Cell
multiforme	NN	nmod	I-Cell
and	CC	cc	O
glioma	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
cells	NNS	compound	I-Cell
lines	NNS	conj	I-Cell
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

MCTs	NNS	nsubjpass	B-Gene_or_gene_product
that	WDT	nsubj	O
were	VBD	cop	O
abundant	JJ	acl:relcl	O
or	CC	cc	O
specific	JJ	conj	O
to	TO	case	O
glioma	NN	nmod	B-Cancer
then	RB	advmod	O
were	VBD	auxpass	O
targeted	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
model	NN	compound	O
U	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
87	CD	nummod	I-Cell
MG	NN	compound	I-Cell
glioma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
via	IN	case	O
small	JJ	amod	O
interfering	VBG	amod	O
ribonucleic	JJ	amod	O
acid	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
silencing	NN	nmod	O
and	CC	cc	O
tested	VBN	conj	O
for	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
lactate	NN	amod	B-Simple_chemical
efflux	NN	nmod	O
,	,	punct	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
pH	NN	compound	O
changes	NNS	conj	O
,	,	punct	O
reduced	VBD	amod	O
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
induction	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
death	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
MCT	NN	nsubj	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
2	CD	conj	B-Gene_or_gene_product
were	VBD	cop	O
the	DT	det	O
primary	JJ	amod	O
isoforms	NNS	dep	O
expressed	VBN	acl	O
in	IN	case	O
human	JJ	amod	B-Organism
glioblastoma	NN	compound	B-Cell
multiforme	NN	amod	I-Cell
and	CC	cc	O
glioma	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
MCT	NN	nsubj	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
was	VBD	cop	O
the	DT	det	O
predominantly	RB	advmod	O
expressed	VBN	amod	O
isoform	NN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
brain	NN	nmod	B-Organ
.	.	punct	O

Small	JJ	nsubj	O
interfering	VBG	dep	O
ribonucleic	JJ	amod	O
acid	NN	dobj	O
specific	JJ	amod	O
for	IN	case	O
MCT	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
2	CD	conj	B-Gene_or_gene_product
reduced	VBD	amod	O
expression	NN	ROOT	O
of	IN	case	O
these	DT	det	O
isoforms	NNS	nmod	O
in	IN	case	O
U	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
87	CD	nummod	I-Cell
MG	NNP	compound	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
barely	RB	advmod	O
detectable	JJ	amod	O
levels	NNS	nmod	O
and	CC	cc	O
reduced	VBN	amod	O
lactate	NN	amod	B-Simple_chemical
efflux	NN	conj	O
by	IN	case	O
30	CD	nummod	O
%	NN	nmod	O
individually	RB	advmod	O
and	CC	cc	O
85	CD	nummod	O
%	NN	conj	O
in	IN	case	O
combination	NN	nmod	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
concomitant	JJ	amod	O
decrease	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
pH	NN	nmod	O
by	IN	case	O
0	CD	nmod	O
.	.	punct	O
6	CD	nummod	O
units	NNS	ROOT	O
(	-LRB-	punct	O
a	DT	det	O
fourfold	JJ	amod	O
increase	NN	dep	O
in	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
H	NN	nmod	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O

Prolonged	JJ	amod	O
silencing	NN	nsubj	O
of	IN	case	O
both	DT	det	O
MCTs	NNS	nmod	B-Gene_or_gene_product
reduced	VBD	ROOT	O
viability	NN	dobj	O
by	IN	case	O
75	CD	nummod	O
%	NN	nmod	O
individually	RB	advmod	O
and	CC	cc	O
92	CD	nummod	O
%	NN	conj	O
in	IN	case	O
combination	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
both	CC	cc:preconj	O
phenotypic	JJ	intj	O
and	CC	cc	O
flow	NN	compound	O
cytometric	JJ	amod	O
analyses	NNS	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
MCT	NN	nsubj	B-Gene_or_gene_product
targeting	NN	acl	O
significantly	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
viability	NN	dobj	O
of	IN	case	O
U	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
87	CD	nummod	I-Cell
MG	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
mediated	VBN	acl	O
by	IN	case	O
both	CC	cc:preconj	O
apoptosis	NN	nmod	O
and	CC	cc	O
necrosis	NN	conj	O
.	.	punct	O

This	DT	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
strategy	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
therapeutic	JJ	dep	O
avenue	NN	ccomp	O
for	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
malignant	JJ	amod	B-Cancer
glioma	NN	nmod	I-Cancer
.	.	punct	O

Hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
responsive	JJ	amod	O
element	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
soluble	JJ	amod	O
Tie2	NN	compound	B-Gene_or_gene_product
vector	NN	nsubj	O
exhibits	VBZ	ROOT	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
activity	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
under	IN	case	O
hypoxic	JJ	amod	O
condition	NN	nmod	O
.	.	punct	O

Hypoxia	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
key	JJ	amod	O
mammalian	JJ	amod	O
transcription	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
shows	VBZ	conj	O
increased	VBN	amod	O
levels	NNS	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
protein	NN	compound	O
stability	NN	nmod	O
and	CC	cc	O
intrinsic	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	conj	O
during	IN	case	O
low	JJ	amod	O
oxygen	NN	compound	B-Simple_chemical
tension	NN	nmod	O
.	.	punct	O

Hypoxia	NN	npadvmod	O
-	HYPH	punct	O
activated	VBN	amod	O
functional	JJ	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nsubj	O
binds	VBZ	ROOT	O
to	TO	case	O
hypoxia	NN	compound	O
-	HYPH	punct	O
responsive	JJ	amod	O
elements	NNS	nmod	O
(	-LRB-	punct	O
HRE	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
enhancers	NNS	nmod	O
of	IN	case	O
several	JJ	amod	O
genes	NNS	nmod	O
including	VBG	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
player	NN	appos	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
initiates	VBZ	conj	O
their	PRP$	nmod:poss	O
mRNA	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
regulating	VBG	acl	O
the	DT	det	O
gene	NN	compound	O
expression	NN	dobj	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
could	MD	aux	O
increase	VB	ROOT	O
the	DT	det	O
therapeutic	JJ	amod	O
window	NN	dobj	O
of	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
delivery	NN	compound	O
systems	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
to	TO	mark	O
examine	VB	advcl	O
hypoxia	NN	compound	O
-	HYPH	punct	O
specific	JJ	amod	O
production	NN	dobj	O
of	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
therapeutic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
5	CD	nummod	O
copies	NNS	dobj	O
of	IN	case	O
HRE	NN	nmod	O
(	-LRB-	punct	O
5xHRE	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
human	JJ	amod	B-Organism
VEGF	NN	nmod	B-Gene_or_gene_product
linked	VBN	acl	O
to	TO	case	O
soluble	JJ	amod	O
Tie2	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
sTie2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
driven	VBN	acl	O
by	IN	case	O
minimal	JJ	amod	O
SV40	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
(	-LRB-	punct	O
5xHRE	NN	dep	O
/	SYM	punct	O
SV40	NN	dep	B-Gene_or_gene_product
/	:	punct	O
sTie2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
under	IN	case	O
hypoxia	NN	nmod	O
the	DT	det	O
secreted	VBN	amod	O
sTie2	NN	nsubj	B-Gene_or_gene_product
selectively	RB	advmod	O
inhibited	VBD	ccomp	O
tube	NN	compound	B-Tissue
formation	NN	dobj	O
and	CC	cc	O
migration	NN	compound	O
capacities	NNS	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
vector	NN	compound	O
system	NN	nsubj	O
,	,	punct	O
5xHRE	NN	compound	O
/	SYM	punct	O
SV40	NN	appos	B-Gene_or_gene_product
/	:	punct	O
sTie2	NN	appos	B-Gene_or_gene_product
,	,	punct	O
might	MD	aux	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
tool	NN	ccomp	O
for	IN	case	O
down	RB	advmod	O
-	HYPH	punct	O
regulating	VBG	amod	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
under	IN	case	O
hypoxic	JJ	amod	O
condition	NN	nmod	O
.	.	punct	O

Proteome	NN	compound	O
analysis	NN	ROOT	O
of	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
activated	VBN	amod	O
Galpha12	NN	nmod	B-Gene_or_gene_product
:	:	punct	O
regulation	NN	dep	O
of	IN	case	O
leukemia	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
protein	NN	compound	O
SET	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Galpha	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
alpha	NN	compound	O
-	HYPH	punct	O
subunit	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
G12	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
of	IN	case	O
heterotrimeric	JJ	amod	B-Gene_or_gene_product
G	NN	compound	I-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
neoplastic	JJ	amod	O
transformation	NN	conj	O
.	.	punct	O

GTPase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	nsubj	O
,	,	punct	O
constitutively	RB	advmod	O
activated	VBN	amod	O
mutant	NN	nsubjpass	O
of	IN	case	O
Galpha	NNP	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
(	-LRB-	punct	O
Galpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
Q229L	NN	dep	I-Gene_or_gene_product
or	CC	cc	O
Galpha	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
previously	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
oncogenic	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
promoting	VBG	acl	O
serum	NN	dobj	B-Organism_substance
-	:	punct	O
and	CC	cc	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	conj	O
.	.	punct	O

Reduced	VBN	amod	O
growth	NN	compound	O
-	HYPH	punct	O
factor	NN	nmod:npmod	O
dependent	JJ	nmod	O
,	,	punct	O
autonomous	JJ	amod	O
cell	NN	compound	B-Cell
growth	NN	nsubj	O
forms	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
defining	VBG	compound	O
point	NN	dobj	O
at	IN	case	O
which	WDT	nmod	O
a	DT	det	O
normal	JJ	amod	O
cell	NN	compound	B-Cell
turns	VBZ	acl:relcl	O
into	IN	case	O
an	DT	det	O
oncogenic	JJ	amod	O
one	NN	nmod	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
the	DT	det	O
underlying	VBG	amod	O
mechanism	NN	dobj	O
involved	VBN	acl	O
in	IN	case	O
such	JJ	amod	O
growth	NN	compound	O
-	HYPH	punct	O
factor	NN	nmod:npmod	O
/	:	punct	O
serum	NN	nmod:npmod	B-Organism_substance
independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH3T3	NN	nmod	B-Cell
,	,	punct	O
we	PRP	nsubj	O
carried	VBD	ROOT	O
out	RP	prt	O
a	DT	det	O
two	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
differential	JJ	amod	O
proteome	NN	compound	O
analysis	NN	dobj	O
of	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
cells	NNS	conj	B-Cell
expressing	VBG	acl	O
vector	NN	compound	O
control	NN	dobj	O
.	.	punct	O

This	DT	det	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
total	NN	dobj	O
of	IN	case	O
22	CD	nummod	O
protein	NN	compound	O
-	:	punct	O
spots	NNS	nmod	O
whose	WP$	nmod:poss	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
altered	VBN	acl:relcl	O
by	IN	case	O
more	JJR	advmod	O
than	IN	mwe	O
3	CD	nummod	O
-	HYPH	punct	O
folds	NNS	nmod	O
.	.	punct	O

Two	CD	nsubjpass	O
of	IN	case	O
these	DT	det	O
spots	NNS	nmod	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
MALDI	NN	compound	O
-	:	punct	O
MS	NN	compound	O
analysis	NN	nmod	O
as	IN	case	O
proliferating	VBG	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
nuclear	JJ	amod	I-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
PCNA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
myeloid	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
leukemia	NN	nmod:npmod	I-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
SET	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
expressions	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
in	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	compound	I-Gene_or_gene_product
cells	NNS	nmod	O
were	VBD	auxpass	O
validated	VBN	ROOT	O
by	IN	case	O
immunoblot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
transient	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
with	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
activated	VBN	amod	O
Galpha	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
readily	RB	advmod	O
increased	VBD	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
SET	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

As	IN	mark	O
SET	NNP	nsubjpass	B-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
previously	RB	advmod	O
reported	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
inhibitor	NN	xcomp	O
of	IN	case	O
phosphatase	NN	nmod	O
PP2A	NN	dep	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
nuclear	JJ	amod	B-Cellular_component
phosphatase	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
monitored	VBN	ROOT	O
in	IN	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
activated	VBN	amod	O
Galpha	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
nuclear	JJ	amod	B-Cellular_component
phosphatase	NN	compound	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
inhibited	VBN	ccomp	O
by	IN	case	O
greater	JJR	amod	O
than	IN	quantmod	O
50	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
Galpha	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
QL	NN	compound	I-Gene_or_gene_product
cells	NNS	nmod	O
compared	VBN	case	O
to	TO	case	O
vector	NN	compound	O
control	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	ROOT	O
from	IN	case	O
differential	JJ	amod	O
proteome	NN	compound	O
analysis	NN	nmod	O
presented	VBN	acl	O
here	RB	advmod	O
report	VBP	dobj	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
SET	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
Galpha	NNP	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
signaling	NN	compound	O
pathways	NNS	dep	O
and	CC	cc	O
a	DT	det	O
role	NN	conj	O
for	IN	case	O
Galpha	NNP	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
12	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
leukemia	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
SET	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
protein	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Matrix	NN	compound	O
metalloproteinase	NN	compound	O
/	:	punct	O
tissue	NN	compound	O
inhibitors	NNS	nsubj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
phenotype	NN	nmod	O
identifies	VBZ	ROOT	O
poor	JJ	amod	O
prognosis	NN	compound	O
colorectal	JJ	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
The	DT	det	O
matrix	NN	compound	O
metalloproteinases	NNS	nsubj	O
(	-LRB-	punct	O
MMPs	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
a	DT	det	O
family	NN	dep	O
of	IN	case	O
proteolytic	JJ	amod	O
enzymes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
invasion	NN	nmod	O
;	:	punct	O
several	JJ	amod	O
individual	JJ	amod	O
members	NNS	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cancer
prognosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
enzymes	NNS	nsubj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
physiologic	JJ	amod	O
inhibitors	NNS	conj	O
,	,	punct	O
the	DT	det	O
tissue	NN	compound	O
inhibitors	NNS	appos	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinases	NNS	nmod	O
(	-LRB-	punct	O
TIMPs	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
act	VBP	ROOT	O
in	IN	case	O
a	DT	det	O
coordinated	VBN	amod	O
manner	NN	nmod	O
to	TO	mark	O
form	VB	xcomp	O
an	DT	det	O
integrated	JJ	amod	O
system	NN	dobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
to	TO	mark	O
understand	VB	advcl	O
their	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
invasion	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
necessary	JJ	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
them	PRP	dobj	O
collectively	RB	advmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
all	DT	nsubjpass	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
matrix	NN	compound	O
metalloproteinase	NN	nmod	O
(	-LRB-	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
7	CD	conj	I-Gene_or_gene_product
,	,	punct	O
MMP	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
13	CD	conj	I-Gene_or_gene_product
,	,	punct	O
MT1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
MMP	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
MT2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
MMP	NN	conj	I-Gene_or_gene_product
)	-RRB-	punct	O
/	:	punct	O
tissue	NN	compound	O
inhibitor	NN	nmod	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
(	-LRB-	punct	O
TIMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
TIMP	NNP	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
TIMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
)	-RRB-	punct	O
system	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
investigated	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
in	IN	case	O
a	DT	det	O
series	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
90	CD	dep	O
)	-RRB-	punct	O
of	IN	case	O
stage	NN	nmod	B-Cancer
III	CD	nummod	I-Cancer
(	-LRB-	punct	I-Cancer
Dukes	NN	compound	I-Cancer
'	POS	case	I-Cancer
C	NN	intj	I-Cancer
)	-RRB-	punct	I-Cancer
colorectal	JJ	amod	I-Cancer
cancers	NNS	dep	I-Cancer
.	.	punct	O

An	DT	det	O
immunohistochemical	JJ	amod	O
score	NN	nsubjpass	O
based	VBN	case	O
on	IN	case	O
the	DT	det	O
intensity	NN	nmod	O
of	IN	case	O
immunoreactivity	NN	nmod	O
and	CC	cc	O
proportion	NN	conj	O
of	IN	case	O
immunoreactive	JJ	amod	O
cells	NNS	nmod	B-Cell
was	VBD	auxpass	O
established	VBN	ROOT	O
for	IN	case	O
each	DT	det	O
MMP	NN	nmod	O
and	CC	cc	O
TIMP	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
MMP	NN	compound	O
/	:	punct	O
TIMP	NN	compound	O
profile	NN	nsubj	O
defined	VBN	acl	O
by	IN	case	O
hierarchical	JJ	amod	O
cluster	NN	compound	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunohistochemical	JJ	amod	O
score	NN	nmod	O
identifies	VBZ	appos	O
a	DT	det	O
distinct	JJ	amod	O
group	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
(	-LRB-	punct	O
log	NN	compound	O
-	HYPH	punct	O
rank	NN	compound	O
test	NN	dep	O
,	,	punct	O
12	CD	appos	O
.	.	punct	O
22	CD	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0005	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
survival	NN	compound	O
time	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
in	IN	case	O
this	DT	det	O
survival	NN	compound	O
group	NN	nmod	O
was	VBD	cop	O
18	CD	nummod	O
months	NNS	ROOT	O
compared	VBN	case	O
with	IN	case	O
a	DT	det	O
median	JJ	amod	O
survival	NN	nmod	O
of	IN	case	O
49	CD	nummod	O
months	NNS	nmod	O
in	IN	prep	O
the	DT	det	O
"	``	punct	O
good	JJ	amod	O
"	``	punct	O
survival	NN	compound	O
group	NN	pobj	O
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
profile	NN	nsubj	O
was	VBD	cop	O
independently	RB	advmod	O
the	DT	det	O
most	RBS	advmod	O
significant	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	ccomp	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
001	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubj	O
has	VBZ	aux	O
identified	VBN	appos	O
that	IN	mark	O
the	DT	det	O
MMP	NN	compound	O
/	:	punct	O
TIMP	NN	compound	O
profile	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
independent	JJ	amod	O
indicator	NN	ccomp	O
of	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methoxyestradiol	NN	nsubj	I-Simple_chemical
inhibits	VBZ	ROOT	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1alpha	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
,	,	punct	O
and	CC	cc	O
angiogenesis	NN	conj	O
and	CC	cc	O
augments	VBZ	conj	O
paclitaxel	NN	compound	B-Simple_chemical
efficacy	NN	dobj	O
in	IN	prep	O
head	NN	nmod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	pobj	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Head	NNP	nsubjpass	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	conj	I-Cancer
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	dep	O
to	TO	mark	O
overexpress	VB	xcomp	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
HIF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	appos	O
that	WDT	nsubj	O
promotes	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
angiogenesis	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	case	O
programmed	VBN	intj	O
and	CC	cc	O
therapy	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	nmod	O
.	.	punct	O

2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Methoxyestradiol	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
2ME2	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
natural	JJ	amod	O
compound	NN	ROOT	O
with	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
inhibitory	JJ	amod	O
activity	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
being	VBG	auxpass	O
evaluated	VBN	acl:relcl	O
in	IN	case	O
phase	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
2	CD	nummod	O
clinical	JJ	amod	O
trials	NNS	conj	O
for	IN	case	O
advanced	JJ	amod	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
multiple	JJ	amod	O
myeloma	NN	conj	B-Cancer
.	.	punct	O

To	TO	prep	O
our	PRP$	poss	O
knowledge	NN	pobj	O
,	,	punct	O
this	DT	nsubj	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
study	NN	ROOT	O
to	TO	mark	O
evaluate	VB	acl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
2ME2	NN	nmod	B-Simple_chemical
in	IN	case	O
head	NN	nmod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	dep	I-Cancer
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
2ME2	NN	nmod	B-Simple_chemical
alone	RB	advmod	O
and	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
,	,	punct	O
an	DT	det	O
active	JJ	amod	O
agent	NN	appos	O
in	IN	case	O
recurrent	JJ	amod	O
or	CC	cc	O
advanced	JJ	conj	O
head	NN	nmod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
2ME2	NN	nsubj	B-Simple_chemical
exhibited	VBD	ROOT	O
antiproliferative	JJ	amod	O
and	CC	cc	O
cytotoxic	JJ	conj	O
effects	NNS	dobj	O
in	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
five	CD	nummod	O
head	NN	nmod	B-Cell
and	CC	cc	I-Cell
neck	NN	conj	I-Cell
squamous	JJ	amod	I-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
in	IN	case	O
the	DT	det	O
0	CD	nmod	O
.	.	punct	O
5	CD	compound	O
to	TO	dep	O
10	CD	nummod	O
micromol	NN	compound	O
/	:	punct	O
L	NN	compound	O
range	NN	ROOT	O
,	,	punct	O
including	VBG	case	O
induction	NN	nmod	O
of	IN	case	O
G2	NN	compound	O
-	HYPH	punct	O
M	NN	compound	O
blockade	NN	nmod	O
,	,	punct	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
7	CD	nummod	B-Gene_or_gene_product
activation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
at	IN	case	O
48	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

2ME2	NN	nsubj	B-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
decreased	VBN	amod	O
nuclear	JJ	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
affected	VBD	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
downstream	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
bid	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
proapoptotic	JJ	amod	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
family	NN	compound	O
member	NN	conj	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
proangiogenic	JJ	amod	O
cytokine	NN	appos	O
.	.	punct	O

The	DT	det	O
up	RP	amod	O
-	HYPH	punct	O
regulation	NN	ROOT	O
of	IN	prep	O
Bid	NN	pobj	B-Gene_or_gene_product
(	-LRB-	punct	O
57	CD	dep	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
at	IN	case	O
12	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
0006	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
secretion	NN	nmod	O
(	-LRB-	punct	O
57	CD	dep	O
.	.	punct	O
7	CD	nummod	O
%	NN	npadvmod	O
at	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
P	NN	nsubj	O
less	JJR	advmod	O
than	IN	case	O
0	CD	nummod	O
.	.	punct	O
015	CD	ROOT	O
;	:	punct	O
and	CC	cc	O
50	CD	conj	O
.	.	punct	O
3	CD	nummod	O
%	NN	ROOT	O
at	IN	case	O
48	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
0006	CD	dep	O
)	-RRB-	punct	O
could	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
attributed	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
effects	NNS	nmod	O
on	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
because	IN	mark	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
small	JJ	amod	O
interfering	VBG	amod	O
RNAs	NNS	nsubj	O
produced	VBD	advcl	O
similar	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	B-Cancer
model	NN	nmod	O
of	IN	case	O
head	NN	amod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
using	VBG	acl	O
UM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
SCC	NN	compound	I-Cell
-	:	punct	I-Cell
11A	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
2ME2	NN	nsubj	B-Simple_chemical
exhibited	VBD	ROOT	O
antitumor	NN	dobj	B-Cancer
and	CC	cc	O
antiangiogenic	JJ	conj	O
activity	NN	dep	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
CD31	NN	compound	B-Gene_or_gene_product
immunostaining	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
provide	VBP	appos	O
support	NN	dobj	O
for	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
2ME2	NN	nmod	B-Simple_chemical
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
recurrent	JJ	amod	O
or	CC	cc	O
advanced	JJ	conj	O
head	NN	nmod	B-Cancer
and	CC	cc	I-Cancer
neck	NN	conj	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	dep	I-Cancer
.	.	punct	O

HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	compound	I-Gene_or_gene_product
expression	NN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
fetal	JJ	amod	B-Cell
paraganglia	NN	nmod	I-Cell
and	CC	cc	O
neuroblastoma	NN	conj	B-Cancer
:	:	punct	O
relation	NN	dep	O
to	TO	case	O
sympathetic	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
glucose	NN	compound	B-Simple_chemical
deficiency	NN	conj	O
,	,	punct	O
and	CC	cc	O
hypoxia	NN	conj	O
.	.	punct	O

Solid	JJ	amod	B-Cancer
tumors	NNS	nsubj	I-Cancer
are	VBP	cop	O
frequently	RB	advmod	O
necrotic	JJ	ROOT	O
and	CC	cc	O
hypoxic	RB	conj	O
due	JJ	case	O
to	TO	mwe	O
poor	JJ	amod	O
vascularization	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
adapt	VBP	ROOT	O
to	TO	case	O
hypoxia	NN	nmod	O
by	IN	mark	O
modulating	VBG	advcl	O
their	PRP$	nmod:poss	O
phenotype	NN	dobj	O
.	.	punct	O

Key	JJ	amod	O
players	NNS	nsubj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
are	VBP	cop	O
the	DT	det	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factors	NNS	ROOT	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
to	TO	case	O
3alpha	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

HIFs	NNS	nsubjpass	B-Gene_or_gene_product
are	VBP	auxpass	O
also	RB	advmod	O
expressed	VBN	ROOT	O
during	IN	case	O
normal	JJ	amod	O
development	NN	nmod	O
;	:	punct	O
for	IN	case	O
example	NN	nmod	O
,	,	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
specifically	RB	advmod	O
expressed	VBN	parataxis	O
and	CC	cc	O
appears	VBZ	conj	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-Organism
sympathetic	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
(	-LRB-	punct	O
SNS	NN	appos	B-Anatomical_system
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	O
is	VBZ	cop	O
selectively	RB	advmod	O
present	JJ	ccomp	O
in	IN	case	O
human	JJ	amod	B-Organism
fetal	JJ	amod	B-Developing_anatomical_structure
week	NN	nmod	O
8	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
SNS	NN	compound	B-Cell
paraganglia	NN	ROOT	I-Cell
.	.	punct	O

Neuroblastoma	NN	nsubjpass	B-Cancer
is	VBZ	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
SNS	NN	compound	B-Developing_anatomical_structure
precursors	NNS	nmod	I-Developing_anatomical_structure
.	.	punct	O

In	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
neuroblastomas	NNS	nmod	B-Cancer
,	,	punct	O
a	DT	det	O
spontaneous	JJ	amod	O
neuronal	JJ	appos	B-Cell
to	TO	case	O
neuroendocrine	JJ	compound	B-Cell
differentiation	NN	nmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
areas	NNS	nmod	O
adjacent	JJ	amod	O
to	TO	case	O
necrotic	JJ	amod	B-Tissue
zones	NNS	nmod	I-Tissue
.	.	punct	O

As	IN	mark	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	compound	I-Gene_or_gene_product
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	advcl	O
not	RB	neg	O
only	RB	cc:preconj	O
with	IN	case	O
hypoxic	JJ	nmod	O
but	CC	cc	O
also	RB	advmod	O
with	IN	case	O
hypoglycemic	JJ	amod	O
conditions	NNS	conj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
putative	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
,	,	punct	O
glucose	NN	compound	B-Simple_chemical
depletion	NN	conj	O
,	,	punct	O
and	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	conj	I-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
neuroblastoma	NN	compound	B-Cancer
phenotype	NN	nmod	O
.	.	punct	O

HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
hypoxic	JJ	nmod	O
and	CC	cc	O
in	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
oxygenized	VBN	amod	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	conj	I-Cell
and	CC	cc	O
tissue	NN	conj	B-Tissue
,	,	punct	O
presumably	RB	advmod	O
reflecting	VBG	advcl	O
their	PRP$	nmod:poss	O
embryonic	JJ	amod	B-Developing_anatomical_structure
features	NNS	dobj	O
.	.	punct	O

With	IN	case	O
regard	NN	dep	O
to	TO	case	O
differentiation	NN	nmod	O
,	,	punct	O
hypoxic	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
lost	VBD	ROOT	O
their	PRP$	nmod:poss	O
neuronal	JJ	amod	B-Cell
/	SYM	punct	O
neuroendocrine	JJ	dep	B-Cell
features	NNS	dobj	O
and	CC	cc	O
gained	VBD	conj	O
marker	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
an	DT	det	O
immature	JJ	amod	O
,	,	punct	O
neural	JJ	dep	O
crest	NN	dep	O
-	HYPH	punct	O
like	IN	dep	O
phenotype	NN	nmod	O
.	.	punct	O

Low	JJ	amod	O
glucose	NN	nsubj	B-Simple_chemical
potentiated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
poorly	RB	advmod	O
vascularized	VBN	amod	O
neuroblastomas	NNS	nsubj	B-Cancer
become	VBP	ccomp	O
immature	JJ	acomp	O
and	CC	cc	O
maintain	VB	conj	O
a	DT	det	O
more	RBR	advmod	O
aggressive	JJ	amod	O
phenotype	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
possibly	RB	advmod	O
could	MD	aux	O
involve	VB	acl:relcl	O
a	DT	det	O
sustained	JJ	amod	O
stabilization	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Expression	NN	ROOT	O
and	CC	cc	O
purification	NN	conj	O
of	IN	case	O
the	DT	det	O
catalytic	JJ	amod	O
domain	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
for	IN	case	O
inhibitor	NN	compound	O
screening	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
endothelial	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
specific	JJ	amod	O
mitogen	NN	appos	O
,	,	punct	O
can	MD	aux	O
act	VB	ROOT	O
in	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
specific	JJ	amod	O
receptors	NNS	nmod	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	B-Cellular_component
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

One	CD	nummod	O
such	JJ	amod	O
receptor	NN	nsubj	O
,	,	punct	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
KDR	NN	appos	B-Gene_or_gene_product
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
expressed	VBD	ROOT	O
the	DT	det	O
catalytic	JJ	amod	O
domain	NN	dobj	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
active	JJ	amod	O
kinase	NN	nmod	O
using	VBG	acl	O
Bac	NN	compound	O
-	HYPH	punct	O
to	IN	dep	O
-	HYPH	punct	O
Bac	NN	compound	O
expression	NN	compound	O
system	NN	dobj	O
,	,	punct	O
and	CC	cc	O
investigated	VBN	conj	O
correlations	NNS	dobj	O
between	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
and	CC	cc	O
enzyme	NN	compound	O
concentration	NN	conj	O
,	,	punct	O
ATP	NN	compound	B-Simple_chemical
concentration	NN	conj	O
,	,	punct	O
substrate	JJ	compound	O
concentration	NN	conj	O
and	CC	cc	O
divalent	JJ	amod	O
cation	NN	compound	O
type	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
these	DT	det	O
data	NNS	dobj	O
to	TO	mark	O
establish	VB	xcomp	O
a	DT	det	O
convenient	JJ	amod	O
,	,	punct	O
effective	JJ	conj	O
and	CC	cc	O
non	JJ	conj	O
-	HYPH	punct	O
radioactive	JJ	dep	O
ELISA	NN	compound	O
screening	NN	compound	O
technique	NN	dobj	O
for	IN	case	O
the	DT	dep	O
identification	NN	nmod	O
and	CC	cc	O
evaluation	NN	conj	O
of	IN	case	O
potential	JJ	amod	O
inhibitors	NNS	nmod	O
for	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
kinase	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
screened	VBD	ROOT	O
200	CD	nummod	O
RTK	NN	compound	O
target	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
compounds	NNS	dobj	O
and	CC	cc	O
identified	VBD	conj	O
one	CD	dobj	O
(	-LRB-	punct	O
TKI	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
31	CD	appos	I-Simple_chemical
)	-RRB-	punct	O
that	WDT	nsubj	O
potently	RB	advmod	O
inhibited	VBD	ccomp	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
kinase	NN	compound	O
activity	NN	dobj	O
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	advcl	O
0	CD	dobj	O
.	.	punct	O
596	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
NIH3T3	NN	compound	B-Cell
/	:	punct	I-Cell
KDR	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
TKI	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
31	CD	nmod	I-Simple_chemical
blocked	VBD	ROOT	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
KDR	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
TKI	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
31	CD	nummod	I-Simple_chemical
dose	NN	nsubj	O
-	:	punct	O
dependently	RB	advmod	O
suppressed	VBD	ROOT	O
HUVEC	NN	compound	B-Tissue
tube	NN	compound	I-Tissue
formation	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
herein	RB	advmod	O
report	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
,	,	punct	O
efficient	JJ	dep	O
method	NN	dobj	O
for	IN	mark	O
identifying	VBG	acl	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
kinase	NN	compound	O
inhibitors	NNS	dobj	O
and	CC	cc	O
introduce	VB	conj	O
one	CD	dobj	O
,	,	punct	O
TKI	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
31	CD	conj	I-Simple_chemical
,	,	punct	O
that	WDT	nsubj	O
may	MD	aux	O
prove	VB	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
new	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	xcomp	O
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
thrombogenic	JJ	amod	B-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
atherosclerosis	NN	nmod	O
.	.	punct	O

Hemostatic	JJ	amod	B-Gene_or_gene_product
factors	NNS	nsubj	I-Gene_or_gene_product
play	VBP	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
generating	VBG	advcl	O
thrombotic	JJ	amod	B-Pathological_formation
plugs	NNS	dobj	I-Pathological_formation
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
damage	NN	nmod	O
(	-LRB-	punct	O
atherothrombosis	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
whether	IN	mark	O
hemostatic	JJ	amod	B-Gene_or_gene_product
factors	NNS	nsubj	I-Gene_or_gene_product
contribute	VBP	csubj	O
directly	RB	advmod	O
or	CC	advmod	O
indirectly	RB	advmod	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
atherosclerosis	NN	nmod	O
remains	VBZ	ROOT	O
uncertain	JJ	xcomp	O
.	.	punct	O

Autopsy	NN	compound	O
studies	NNS	nsubj	O
have	VBP	aux	O
revealed	VBN	ROOT	O
that	IN	mark	O
intimal	JJ	amod	B-Tissue
thickening	NN	nsubj	O
represents	VBZ	ccomp	O
the	DT	det	O
first	JJ	amod	O
stage	NN	dobj	O
of	IN	case	O
atherosclerosis	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
lipid	NN	nmod:npmod	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
rich	JJ	amod	I-Pathological_formation
plaque	NN	nsubj	I-Pathological_formation
arises	VBZ	conj	O
from	IN	prep	O
such	JJ	amod	O
lesions	NNS	pobj	B-Pathological_formation
.	.	punct	O

Several	JJ	amod	O
factors	NNS	nsubj	O
contribute	VBP	ROOT	O
to	TO	case	O
the	DT	det	O
start	NN	nmod	O
of	IN	prep	O
intimal	JJ	amod	B-Tissue
thickening	NN	pobj	O
.	.	punct	O

Platelets	NNS	nsubj	B-Cell
release	VBP	ROOT	O
several	JJ	amod	O
growth	NN	compound	O
factors	NNS	dobj	O
and	CC	cc	O
bioactive	JJ	amod	O
agents	NNS	conj	O
that	WDT	nsubj	O
play	VBP	acl:relcl	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
development	NN	nmod	O
of	IN	case	O
not	RB	neg	O
only	RB	cc:preconj	O
thrombus	NN	nmod	B-Pathological_formation
but	CC	cc	O
also	RB	conj	O
of	IN	case	O
intimal	JJ	amod	B-Tissue
thickening	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
been	VBN	aux	O
investigating	VBG	ROOT	O
which	WDT	dobj	O
coagulation	NN	compound	O
factors	NNS	nsubj	O
simultaneously	RB	advmod	O
,	,	punct	O
or	CC	cc	O
subsequently	RB	advmod	O
with	IN	case	O
platelet	NN	compound	B-Cell
aggregation	NN	conj	O
,	,	punct	O
participate	VBP	ccomp	O
in	IN	prep	O
thrombus	NN	compound	B-Pathological_formation
formation	NN	pobj	O
.	.	punct	O

Tissue	NN	compound	B-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
TF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
initiator	NN	ROOT	O
of	IN	case	O
blood	NN	compound	B-Organism_substance
coagulation	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
in	IN	case	O
various	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
atherosclerotic	JJ	amod	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
in	IN	case	O
humans	NNS	nmod	B-Organism
and	CC	cc	O
other	JJ	amod	O
animals	NNS	conj	O
.	.	punct	O

Factors	NNS	nsubj	O
including	VBG	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
fibrin	NN	conj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
downstream	JJ	acl:relcl	O
of	IN	case	O
the	DT	det	O
coagulation	NN	compound	O
cascade	NN	nmod	O
activated	VBN	acl	O
by	IN	case	O
TF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
also	RB	advmod	O
contribute	VBP	ROOT	O
to	TO	case	O
atherosclerosis	NN	nmod	O
.	.	punct	O

TF	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
,	,	punct	O
embryogenesis	NN	conj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
TF	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
factors	NNS	nmod	O
downstream	RB	amod	O
of	IN	case	O
the	DT	det	O
coagulation	NN	compound	O
cascade	NN	nmod	O
and	CC	cc	O
the	DT	det	O
protease	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activation	NN	compound	O
system	NN	conj	O
,	,	punct	O
would	MD	aux	O
be	VB	cop	O
a	DT	det	O
multifactorial	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
atherogenesis	NN	nmod	O
.	.	punct	O

Angiogenin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	acomp	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
and	CC	cc	O
cytoplasm	NN	conj	B-Organism_substance
in	IN	case	O
human	JJ	amod	B-Organism
primary	JJ	amod	O
breast	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
markers	NNS	nmod	O
of	IN	case	O
hypoxia	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
survival	NN	conj	O
.	.	punct	O

Angiogenin	NN	ROOT	B-Gene_or_gene_product
,	,	punct	O
a	DT	quantmod	O
14	CD	appos	O
.	.	punct	O
2	CD	nummod	O
kD	NN	compound	O
polypeptide	NN	nsubjpass	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
originally	RB	advmod	O
noted	VBN	acl:relcl	O
for	IN	case	O
its	PRP$	nmod:poss	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
now	RB	advmod	O
increasingly	RB	advmod	O
recognized	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
multiplicity	NN	dobj	O
of	IN	case	O
biological	JJ	amod	O
roles	NNS	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
physiological	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
conditions	NNS	dobj	O
.	.	punct	O

In	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
there	EX	expl	O
are	VBP	ROOT	O
conflicting	VBG	amod	O
studies	NNS	nsubj	O
questioning	VBG	acl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
angiogenin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
the	DT	det	O
pattern	NN	nsubjpass	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
angiogenin	NN	nmod	B-Gene_or_gene_product
during	IN	case	O
the	DT	det	O
transition	NN	nmod	O
from	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
to	TO	case	O
ductal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
in	FW	compound	O
situ	FW	nmod	O
and	CC	cc	O
invasive	JJ	amod	O
carcinoma	NN	conj	B-Cancer
is	VBZ	auxpass	O
reported	VBN	ROOT	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
correlates	NNS	nmod	O
between	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
angiogenin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
239	CD	nummod	O
invasive	JJ	amod	O
carcinomas	NNS	nmod	B-Cancer
and	CC	cc	O
standard	JJ	amod	O
clinicopathological	JJ	amod	O
parameters	NNS	conj	O
,	,	punct	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
HIF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	compound	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
target	NN	compound	O
gene	NN	compound	O
DEC	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
angiogenin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-Organism_substance
and	CC	cc	O
nuclear	JJ	conj	B-Cellular_component
compartments	NNS	nmod	O
in	IN	case	O
in	FW	amod	O
situ	FW	dep	O
carcinoma	NN	nmod	B-Cancer
and	CC	cc	O
invasive	JJ	amod	O
carcinoma	NN	conj	B-Cancer
compared	VBN	case	O
with	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
that	IN	nsubj	O
angiogenin	NN	conj	B-Gene_or_gene_product
expression	NN	nsubjpass	O
in	IN	case	O
invasive	JJ	amod	O
carcinomas	NNS	nmod	B-Cancer
is	VBZ	auxpass	O
significantly	RB	advmod	O
positively	RB	advmod	O
associated	VBN	dep	O
with	IN	case	O
high	JJ	amod	O
tumour	NN	compound	B-Cancer
grade	NN	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
03	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
positive	JJ	amod	O
oestrogen	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
ER	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
status	NN	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
p	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
and	CC	cc	O
DEC	NN	nsubj	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
patient	NN	compound	B-Organism
age	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
8	CD	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
tumour	NN	compound	B-Cancer
size	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
25	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
status	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
69	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
56	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
32	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
difference	NN	compound	O
in	IN	prep	O
relapse	NN	compound	O
-	HYPH	punct	O
free	JJ	pobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
26	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
overall	JJ	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
63	CD	appos	O
)	-RRB-	punct	O
survival	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
stratified	VBN	acl	O
by	IN	case	O
angiogenin	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
angiogenin	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
important	JJ	ccomp	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
,	,	punct	O
through	IN	case	O
its	PRP$	nmod:poss	O
relationship	NN	nmod	O
with	IN	case	O
ER	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
it	PRP	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
target	NN	conj	O
for	IN	case	O
tamoxifen	NN	nmod	B-Simple_chemical
.	.	punct	O

Hereditary	JJ	compound	O
paraganglioma	NN	ROOT	B-Cancer
/	:	punct	O
pheochromocytoma	NN	conj	B-Cancer
and	CC	cc	O
inherited	VBD	conj	O
succinate	JJ	amod	B-Gene_or_gene_product
dehydrogenase	NN	compound	I-Gene_or_gene_product
deficiency	NN	dobj	O
.	.	punct	O

Mitochondrial	JJ	amod	B-Cellular_component
complex	NN	nsubj	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
succinate	JJ	amod	B-Gene_or_gene_product
dehydrogenase	NN	conj	I-Gene_or_gene_product
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
enzymatic	JJ	amod	O
complex	NN	ROOT	O
involved	VBN	acl	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
tricarboxylic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
TCA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
cycle	NN	nmod	O
and	CC	cc	O
oxidative	JJ	amod	O
phosphorylation	NN	conj	O
as	IN	case	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
respiratory	JJ	amod	O
chain	NN	nmod	O
.	.	punct	O

Germline	NN	compound	O
succinate	JJ	compound	B-Gene_or_gene_product
dehydrogenase	NN	compound	I-Gene_or_gene_product
subunit	NN	compound	I-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
SDHA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
mutations	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
few	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
a	DT	det	O
classical	JJ	amod	O
mitochondrial	JJ	amod	B-Cellular_component
neurodegenerative	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O

Mutations	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
genes	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
three	CD	nummod	O
other	JJ	amod	O
succinate	JJ	amod	B-Gene_or_gene_product
dehydrogenase	NN	compound	I-Gene_or_gene_product
subunits	NNS	dobj	O
(	-LRB-	punct	O
SDHB	NN	dep	B-Gene_or_gene_product
,	,	punct	O
SDHC	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
SDHD	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
affected	VBN	acl	O
by	IN	case	O
familial	JJ	nmod	O
or	CC	cc	O
'	``	conj	O
apparently	RB	advmod	O
sporadic	JJ	amod	O
'	''	punct	O
paraganglioma	NN	dep	B-Cancer
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
pheochromocytoma	NN	conj	B-Cancer
,	,	punct	O
an	DT	det	O
autosomal	NN	amod	O
inherited	VBN	amod	O
cancer	NN	compound	B-Cancer
-	HYPH	punct	O
susceptibility	NN	compound	O
syndrome	NN	appos	O
.	.	punct	O

These	DT	det	O
discoveries	NNS	nsubj	O
have	VBP	aux	O
dramatically	RB	advmod	O
changed	VBN	ROOT	O
the	DT	det	O
work	NN	compound	O
-	HYPH	punct	O
up	NN	amod	O
and	CC	cc	O
genetic	JJ	conj	O
counseling	NN	dobj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
and	CC	cc	O
families	NNS	conj	O
with	IN	case	O
paragangliomas	NNS	nmod	B-Cancer
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
pheochromocytomas	NNS	conj	B-Cancer
.	.	punct	O

The	DT	det	O
subsequent	JJ	amod	O
identification	NN	nsubj	O
of	IN	case	O
germline	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
gene	NN	compound	O
encoding	NN	compound	O
fumarase	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
-	:	punct	O
another	DT	det	O
TCA	NN	compound	B-Simple_chemical
cycle	NN	compound	O
enzyme	NN	conj	O
-	:	punct	O
-	:	punct	O
in	IN	case	O
a	DT	det	O
new	JJ	amod	O
hereditary	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
susceptibility	NN	nmod	O
to	TO	case	O
renal	JJ	amod	B-Cancer
,	,	punct	O
uterine	JJ	conj	B-Cancer
and	CC	cc	O
cutaneous	JJ	conj	B-Cancer
tumors	NNS	nmod	I-Cancer
has	VBZ	aux	O
highlighted	VBN	ROOT	O
the	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
TCA	NN	compound	B-Simple_chemical
cycle	NN	nmod	O
and	CC	cc	O
,	,	punct	O
more	RBR	advmod	O
generally	RB	advmod	O
,	,	punct	O
of	IN	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Mouse	NN	compound	B-Organism
p10	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
alternative	JJ	amod	O
spliced	JJ	amod	O
form	NN	appos	O
of	IN	case	O
p15INK4b	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
inhibits	VBZ	ROOT	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	dobj	O
and	CC	cc	O
malignant	JJ	amod	O
transformation	NN	conj	O
.	.	punct	O

The	DT	det	O
INK4	NN	compound	B-Gene_or_gene_product
family	NN	nsubj	O
of	IN	case	O
proteins	NNS	nmod	O
negatively	RB	advmod	O
regulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	dobj	O
at	IN	case	O
the	DT	det	O
G	NN	compound	O
(	-LRB-	punct	O
1	CD	dep	O
)	-RRB-	punct	O
-	:	punct	O
S	NN	compound	O
transition	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
cyclin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinases	NNS	dobj	I-Gene_or_gene_product
.	.	punct	O

Two	CD	nsubj	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
inhibitors	NNS	nmod	O
,	,	punct	O
p16	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
INK4A	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p15	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
INK4B	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
have	VBP	ROOT	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
activities	NNS	dobj	O
and	CC	cc	O
are	VBP	auxpass	O
inactivated	VBN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	nmod	B-Cancer
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
both	DT	det	O
INK4	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubj	O
express	VBP	ROOT	O
alternative	JJ	amod	O
splicing	NN	compound	O
variants	NNS	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	dep	O
to	TO	case	O
p16	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
INK4A	NN	nmod	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
INK4A	NN	compound	B-Gene_or_gene_product
locus	NN	nsubj	O
encodes	VBZ	ROOT	O
a	DT	det	O
splice	NN	compound	O
variant	NN	dobj	O
,	,	punct	O
termed	VBN	acl	O
p12	NN	xcomp	B-Gene_or_gene_product
-	:	punct	O
-	:	punct	O
specifically	RB	advmod	O
expressed	VBN	acl	O
in	IN	prep	O
human	JJ	amod	B-Organism
pancreas	NN	pobj	B-Organ
-	HYPH	punct	O
-	:	punct	O
and	CC	cc	O
ARF	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
protein	NN	appos	O
encoded	VBN	acl	O
by	IN	case	O
an	DT	det	O
alternative	JJ	amod	O
reading	NN	compound	O
frame	NN	nmod	O
that	WDT	nsubj	O
acts	VBZ	acl:relcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
through	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
the	DT	det	O
human	JJ	amod	B-Organism
INK4B	NN	compound	B-Gene_or_gene_product
locus	NN	nsubj	O
encodes	VBZ	ROOT	O
the	DT	det	O
p15	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
INK4B	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
tumor	NN	compound	B-Cancer
suppressor	NN	dobj	O
and	CC	cc	O
one	CD	nummod	O
alternatively	RB	advmod	O
spliced	VBN	amod	O
form	NN	conj	O
,	,	punct	O
termed	VBN	acl	O
as	IN	case	O
p10	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
p10	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
arises	VBZ	acl:relcl	O
from	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
an	DT	det	O
alternative	JJ	amod	O
splice	NN	compound	O
donor	NN	compound	O
site	NN	nmod	O
within	IN	case	O
intron	NN	nmod	B-Cellular_component
1	CD	nummod	I-Cellular_component
,	,	punct	O
is	VBZ	auxpass	O
conserved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	B-Organism
genome	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
widely	RB	advmod	O
expressed	VBN	conj	O
in	IN	case	O
mouse	NN	compound	B-Organism
tissues	NNS	nmod	B-Tissue
.	.	punct	O

Similarly	RB	advmod	O
to	TO	case	O
mouse	NN	compound	B-Organism
p15	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
INK4B	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
p10	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
induced	VBN	ROOT	O
by	IN	case	O
oncogenic	JJ	amod	O
insults	NNS	nmod	O
and	CC	cc	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
treatment	NN	conj	O
and	CC	cc	O
acts	VBZ	conj	O
as	IN	case	O
a	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
inhibitor	NN	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
mouse	NN	compound	B-Organism
p10	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
in	IN	case	O
a	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
mouse	NN	compound	B-Organism
p10	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
inhibit	VB	xcomp	O
foci	NNS	compound	B-Cell
formation	NN	dobj	O
and	CC	cc	O
anchorage	NN	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	conj	O
in	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
these	DT	det	O
antitransforming	VBG	amod	O
properties	NNS	nsubj	O
of	IN	case	O
mouse	NN	compound	B-Organism
p10	NN	nmod	B-Gene_or_gene_product
are	VBP	cop	O
also	RB	advmod	O
p53	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
INK4B	NN	compound	B-Gene_or_gene_product
locus	NN	nsubj	O
,	,	punct	O
similarly	RB	advmod	O
to	TO	case	O
INK4A	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ARF	NNP	appos	I-Gene_or_gene_product
,	,	punct	O
harbors	VBZ	ccomp	O
two	CD	nummod	O
different	JJ	amod	O
splicing	NN	compound	O
variants	NNS	dobj	O
that	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
retinoblastoma	NN	conj	B-Gene_or_gene_product
pathways	NNS	dep	O
,	,	punct	O
the	DT	det	O
two	CD	nummod	O
major	JJ	amod	O
molecular	JJ	amod	O
pathways	NNS	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
suppression	NN	nmod	O
.	.	punct	O

Rofecoxib	NNS	ROOT	B-Simple_chemical
as	IN	case	O
adjunctive	JJ	amod	O
therapy	NN	nmod	O
for	IN	case	O
haemophilic	JJ	amod	O
arthropathy	NN	nmod	O
.	.	punct	O

Joint	JJ	compound	B-Multi-tissue_structure
haemorrhage	NN	nsubj	O
and	CC	cc	O
subsequent	JJ	amod	O
haemophilic	JJ	amod	O
arthropathy	JJ	conj	O
are	VBP	cop	O
significant	JJ	amod	O
complications	NNS	ROOT	O
in	IN	case	O
haemophilia	NN	nmod	O
.	.	punct	O

The	DT	det	O
pathophysiology	NN	nsubj	O
involves	VBZ	ROOT	O
inflammation	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Cyclooxygenase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
inhibitors	NNS	nsubj	O
are	VBP	cop	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
agents	NNS	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
have	VBP	acl:relcl	O
potent	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
,	,	punct	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
and	CC	cc	O
analgesic	JJ	conj	O
properties	NNS	dobj	O
yet	RB	advmod	O
do	VBP	aux	O
not	RB	neg	O
affect	VB	ROOT	O
platelet	NN	compound	B-Cell
function	NN	dobj	O
in	IN	case	O
the	DT	det	O
manner	NN	nmod	O
of	IN	case	O
traditional	JJ	amod	O
non	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
steroidal	JJ	amod	I-Simple_chemical
anti	JJ	npadvmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
inflammatory	JJ	amod	I-Simple_chemical
drugs	NNS	nmod	I-Simple_chemical
.	.	punct	O

These	DT	det	O
properties	NNS	nsubj	O
make	VBP	ROOT	O
such	JJ	amod	O
agents	NNS	dobj	O
potentially	RB	advmod	O
useful	JJ	amod	O
as	IN	case	O
adjunctive	JJ	amod	O
therapy	NN	nmod	O
in	IN	case	O
haemophilia	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
only	RB	advmod	O
one	CD	nummod	O
prior	JJ	amod	O
report	NN	attr	O
describing	VBG	acl	O
rofecoxib	JJ	compound	B-Simple_chemical
treatment	NN	dobj	O
in	IN	case	O
a	DT	det	O
single	JJ	amod	O
haemophilia	NN	compound	O
patient	NN	nmod	B-Organism
.	.	punct	O

Our	PRP$	poss	O
objectives	NNS	nsubj	O
were	VBD	ROOT	O
to	TO	aux	O
determine	VB	xcomp	O
the	DT	det	O
safety	NN	dobj	O
and	CC	cc	O
efficacy	NN	conj	O
of	IN	case	O
rofecoxib	JJ	nmod	B-Simple_chemical
in	IN	mark	O
treating	VBG	advcl	O
acute	JJ	amod	O
haemarthrosis	NN	dobj	O
,	,	punct	O
chronic	JJ	amod	O
synovitis	NN	conj	O
,	,	punct	O
target	NN	compound	O
joints	NNS	conj	B-Multi-tissue_structure
and	CC	cc	O
pain	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
conducted	VBD	ROOT	O
a	DT	det	O
retrospective	JJ	amod	O
medical	JJ	amod	O
record	NN	compound	O
review	NN	dobj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
rofecoxib	NN	nmod	B-Simple_chemical
for	IN	case	O
acute	JJ	amod	O
haemarthrosis	NN	nmod	O
,	,	punct	O
chronic	JJ	amod	O
synovitis	NN	conj	O
,	,	punct	O
target	NN	compound	O
joint	JJ	dobj	B-Multi-tissue_structure
or	CC	cc	O
pain	NN	conj	O
.	.	punct	O

The	DT	det	O
safety	NN	nsubjpass	O
and	CC	cc	O
efficacy	NN	conj	O
of	IN	case	O
rofecoxib	JJ	compound	B-Simple_chemical
treatment	NN	nmod	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
based	VBN	case	O
on	IN	case	O
subjective	JJ	amod	O
patient	NN	compound	B-Organism
reports	NNS	nmod	O
and	CC	cc	O
physical	JJ	amod	O
examinations	NNS	conj	O
during	IN	case	O
follow	NN	amod	O
-	HYPH	punct	O
up	RP	prt	O
clinic	JJ	amod	O
visits	NNS	nmod	O
.	.	punct	O

A	DT	det	O
total	NN	nsubjpass	O
of	IN	case	O
28	CD	nummod	O
patients	NNS	nmod	B-Organism
between	IN	case	O
3	CD	nummod	O
and	CC	cc	O
37	CD	conj	O
years	NNS	nmod	O
of	IN	case	O
age	NN	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
for	IN	case	O
a	DT	det	O
total	NN	nmod	O
of	IN	case	O
42	CD	nummod	O
courses	NNS	nmod	O
of	IN	case	O
rofecoxib	JJ	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

All	DT	det	O
courses	NNS	nsubjpass	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
for	IN	case	O
safety	NN	nmod	O
and	CC	cc	O
31	CD	conj	O
for	IN	case	O
efficacy	NN	nmod	O
.	.	punct	O

Rofecoxib	NNP	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
used	VBN	ROOT	O
for	IN	case	O
eight	CD	nummod	O
acute	JJ	amod	O
haemarthrosis	NN	nmod	O
,	,	punct	O
four	CD	nummod	O
target	NN	compound	O
joints	NNS	appos	B-Multi-tissue_structure
,	,	punct	O
seven	CD	nummod	O
cases	NNS	appos	O
of	IN	case	O
synovitis	NN	nmod	O
and	CC	cc	O
12	CD	nummod	O
episodes	NNS	conj	O
of	IN	case	O
pain	NN	nmod	O
.	.	punct	O

Efficacy	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
particularly	RB	advmod	O
for	IN	case	O
chronic	JJ	amod	O
synovitis	NN	nmod	O
and	CC	cc	O
pain	NN	conj	O
and	CC	cc	O
no	DT	neg	O
serious	JJ	amod	O
adverse	JJ	amod	O
events	NNS	nsubj	O
occurred	VBD	conj	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
largest	JJS	amod	O
study	NN	attr	O
to	TO	prep	O
date	NN	pobj	O
evaluating	VBG	acl	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitors	NNS	dobj	O
as	IN	case	O
adjunctive	JJ	amod	O
therapy	NN	nmod	O
in	IN	case	O
haemophilia	NN	nmod	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
these	DT	det	O
agents	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
adjunctive	JJ	amod	O
therapy	NN	ccomp	O
in	IN	case	O
the	DT	det	O
management	NN	nmod	O
of	IN	case	O
haemophilia	NN	nmod	O
.	.	punct	O

Thalidomide	NN	nsubj	B-Simple_chemical
and	CC	cc	O
angiostatin	NN	conj	B-Gene_or_gene_product
inhibit	VBP	ROOT	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
in	IN	case	O
a	DT	det	O
murine	JJ	amod	B-Organism
xenograft	NN	compound	B-Cancer
model	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
impact	NN	dobj	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
and	CC	cc	O
angiostatin	NN	conj	B-Gene_or_gene_product
on	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	B-Cancer
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Human	JJ	amod	B-Organism
umbilical	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
treated	VBN	dep	O
with	IN	case	O
angiostatin	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
thalidomide	NN	conj	B-Simple_chemical
and	CC	cc	O
bFGF	NN	conj	B-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
MTT	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Human	JJ	amod	B-Organism
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
CaSki	NN	dep	B-Cell
and	CC	cc	O
SiHa	NN	conj	B-Cell
)	-RRB-	punct	O
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
flanks	NNS	nmod	B-Organism_subdivision
of	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

After	IN	mark	O
tumors	NNS	nsubj	B-Cancer
developed	VBN	advcl	O
,	,	punct	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
angiostatin	NN	compound	B-Gene_or_gene_product
20	CD	nummod	O
mg	NN	dep	O
/	:	punct	O
kg	NN	appos	O
/	:	punct	O
day	NN	nmod	O
or	CC	cc	O
thalidomide	NN	compound	B-Simple_chemical
200	CD	compound	O
mg	NN	dep	O
/	:	punct	O
kg	NN	compound	O
/	:	punct	O
day	NN	conj	O
for	IN	prep	O
30	CD	nummod	O
days	NNS	pobj	O
.	.	punct	O

Fractional	JJ	amod	O
tumor	NN	compound	B-Cancer
growth	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
analysis	NN	nsubjpass	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
was	VBD	auxpass	O
used	VBN	conj	O
to	TO	mark	O
determine	VB	xcomp	O
degree	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

TUNEL	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
assess	VB	xcomp	O
apoptosis	NN	dobj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Angiostatin	NN	nsubj	B-Gene_or_gene_product
inhibited	VBD	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
by	IN	case	O
50	CD	compound	O
-	HYPH	punct	O
60	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Thalidomide	NNP	nsubj	B-Simple_chemical
had	VBD	ROOT	O
no	DT	neg	O
direct	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Angiostatin	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
thalidomide	NN	conj	B-Simple_chemical
both	CC	conj	O
inhibited	VBD	ROOT	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
by	IN	prep	O
about	RB	advmod	O
55	CD	nummod	O
%	NN	pobj	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
no	DT	neg	O
additive	JJ	amod	O
or	CC	cc	O
synergistic	JJ	conj	O
effect	NN	dobj	O
when	WRB	advmod	O
the	DT	det	O
two	CD	nummod	O
agents	NNS	nsubjpass	O
were	VBD	auxpass	O
combined	VBN	advcl	O
.	.	punct	O

Both	DT	det	O
agents	NNS	nsubj	O
inhibited	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
induced	VBD	amod	O
apoptosis	NN	conj	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
control	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Angiostatin	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
thalidomide	NN	conj	B-Simple_chemical
inhibit	VBP	appos	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
this	DT	det	O
xenograft	NN	amod	B-Cancer
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Therapeutic	JJ	amod	O
Electromagnetic	NNP	compound	O
Field	NNP	ROOT	O
(	-LRB-	punct	O
TEMF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
gamma	NN	compound	O
irradiation	NN	conj	O
on	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
growth	NN	nmod	O
,	,	punct	O
angiogenesis	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

BACKGROUND	NN	nsubjpass	O
:	:	punct	O
The	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
a	DT	det	O
rectified	VBN	amod	O
semi	NN	nmod	O
-	HYPH	punct	O
sinewave	NN	appos	O
signal	NN	dobj	O
(	-LRB-	punct	O
15	CD	compound	O
mT	NN	compound	O
amplitude	NN	dep	O
,	,	punct	O
120	CD	nummod	O
pulses	NNS	nsubjpass	O
per	IN	case	O
second	JJ	amod	O
,	,	punct	O
EMF	NNP	compound	O
Therapeutics	NNPS	nmod	O
,	,	punct	O
Inc	NNP	appos	O
.	.	punct	O
)	-RRB-	punct	O
(	-LRB-	punct	O
TEMF	NN	appos	O
)	-RRB-	punct	O
alone	RB	advmod	O
and	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
gamma	NN	compound	O
irradiation	NN	compound	O
(	-LRB-	punct	O
IR	NN	compound	O
)	-RRB-	punct	O
therapy	NN	nmod	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
bearing	VBG	acl	O
a	DT	det	O
human	JJ	amod	B-Organism
MDA	NN	compound	B-Cancer
MB231	NN	compound	I-Cancer
breast	NN	compound	I-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	dobj	I-Cancer
were	VBD	auxpass	O
tested	VBN	ROOT	O
.	.	punct	O

Green	JJ	compound	B-Gene_or_gene_product
fluorescence	NN	compound	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
transfected	VBN	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Tissue
fat	NN	compound	I-Tissue
pad	NN	nmod	I-Tissue
of	IN	case	O
young	JJ	amod	O
female	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Six	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
randomly	RB	advmod	O
divided	VBN	ROOT	O
into	IN	case	O
four	CD	nummod	O
treatment	NN	compound	O
groups	NNS	nmod	O
:	:	punct	O
untreated	JJ	amod	O
controls	NNS	dep	O
;	:	punct	O
10	CD	nummod	O
minute	NN	parataxis	O
daily	JJ	amod	O
TEMF	NN	dobj	O
;	:	punct	O
200	CD	nummod	O
cGy	NN	dep	O
of	IN	case	O
IR	NN	nmod	O
every	DT	det	O
other	JJ	amod	O
day	NN	nmod	O
(	-LRB-	punct	O
total	JJ	amod	O
800	CD	nummod	O
cGy	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
IR	NN	dep	O
plus	CC	cc	O
daily	RB	conj	O
TEMF	NN	conj	O
.	.	punct	O

Some	DT	det	O
mice	NNS	nsubjpass	B-Organism
in	IN	case	O
each	DT	det	O
group	NN	nmod	O
were	VBD	auxpass	O
euthanized	VBN	ROOT	O
24	CD	nummod	O
hours	NNS	npadvmod	O
after	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
IR	NN	nmod	O
.	.	punct	O

TEMF	NN	compound	O
treatment	NN	nsubj	O
continued	VBD	ROOT	O
for	IN	case	O
3	CD	nummod	O
additional	JJ	amod	O
weeks	NNS	nmod	O
.	.	punct	O

Tumor	NN	compound	B-Cancer
sections	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
stained	VBN	ROOT	O
for	IN	case	O
:	:	punct	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
CD31	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
PAS	NN	conj	B-Simple_chemical
or	CC	cc	O
hypoxia	NN	conj	B-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1alpha	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
Most	JJS	amod	O
tumors	NNS	nsubj	B-Cancer
less	JJR	advmod	O
than	IN	advmod	O
35	CD	nummod	O
mm3	NN	nmod	O
were	VBD	cop	O
white	JJ	appos	O
but	CC	cc	O
tumors	NNS	conj	B-Cancer
greater	JJR	advmod	O
than	IN	advmod	O
35	CD	nummod	O
mm3	NN	nmod	O
were	VBD	auxpass	O
pink	JJ	ROOT	O
and	CC	cc	O
had	VBD	conj	O
a	DT	det	O
vascularized	JJ	amod	O
capsule	NN	dobj	B-Cancer
.	.	punct	O

The	DT	det	O
cortex	NN	nsubj	B-Cancer
within	IN	case	O
100	CD	nummod	O
microns	NNS	nmod	O
of	IN	case	O
the	DT	det	O
capsule	NN	nmod	B-Cancer
had	VBD	ROOT	O
little	JJ	amod	O
vascularization	NN	dobj	O
.	.	punct	O

Blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nsubjpass	I-Multi-tissue_structure
,	,	punct	O
capillaries	NNS	conj	B-Tissue
,	,	punct	O
and	CC	cc	O
endothelial	JJ	amod	B-Cellular_component
pseudopods	NNS	conj	I-Cellular_component
were	VBD	auxpass	O
found	VBN	ROOT	O
at	IN	case	O
greater	JJR	amod	O
than	IN	dep	O
100	CD	nummod	O
microns	NNS	nmod	O
from	IN	case	O
the	DT	det	O
capsule	NN	nmod	B-Cancer
(	-LRB-	punct	O
subcortex	JJ	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Tumors	NNS	nsubj	B-Cancer
greater	JJR	advmod	O
than	IN	advmod	O
35	CD	nummod	O
mm3	NN	nmod	O
treated	VBN	acl	O
with	IN	case	O
IR	NN	compound	O
24	CD	nummod	O
hours	NNS	nmod	O
previously	RB	advmod	O
or	CC	cc	O
with	IN	case	O
TEMF	NN	conj	O
had	VBD	aux	O
decreased	VBN	ROOT	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
subcortex	JJ	nmod	B-Cancer
and	CC	cc	O
more	RBR	conj	O
endothelial	JJ	amod	B-Cellular_component
pseudopods	NNS	dep	I-Cellular_component
projecting	VBG	acl	O
into	IN	case	O
hypoxic	JJ	nmod	O
,	,	punct	O
HIF	NN	compound	B-Gene_or_gene_product
positive	JJ	amod	O
areas	NNS	conj	O
than	IN	case	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

Mice	NNS	nsubj	B-Organism
that	WDT	nsubj	O
received	VBD	acl:relcl	O
either	CC	cc:preconj	O
IR	NN	dobj	O
or	CC	cc	O
TEMF	NN	conj	O
had	VBD	ROOT	O
significantly	RB	advmod	O
fewer	JJR	amod	O
lung	NN	compound	B-Organ
metastatic	JJ	amod	O
sites	NNS	dobj	O
and	CC	cc	O
slower	JJR	conj	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
than	IN	mark	O
did	VBD	advcl	O
untreated	JJ	amod	O
mice	NNS	dobj	B-Organism
.	.	punct	O

No	DT	neg	O
harmful	JJ	amod	O
side	JJ	amod	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
TEMF	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
TEMF	NN	compound	O
therapy	NN	nsubj	O
provided	VBD	appos	O
a	DT	det	O
safe	JJ	amod	O
means	NNS	dobj	O
for	IN	mark	O
retarding	VBG	acl	O
tumor	NN	compound	B-Cancer
vascularization	NN	dobj	O
,	,	punct	O
growth	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

The	DT	det	O
threshold	NN	compound	O
level	NN	ROOT	O
of	IN	case	O
adenomatous	JJ	amod	B-Gene_or_gene_product
polyposis	NN	compound	I-Gene_or_gene_product
coli	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
for	IN	case	O
mouse	NN	compound	B-Organism
intestinal	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
adenomatous	JJ	amod	B-Gene_or_gene_product
polyposis	NN	compound	I-Gene_or_gene_product
coli	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
APC	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nsubj	O
,	,	punct	O
whose	WP$	nmod:poss	O
mutations	NNS	nsubj	O
are	VBP	cop	O
responsible	JJ	acl:relcl	O
for	IN	case	O
familial	JJ	amod	O
adenomatous	JJ	amod	O
polyposis	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
negative	JJ	amod	O
controller	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Wnt	NN	compound	B-Gene_or_gene_product
/	:	punct	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
APC	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	mark	O
suppressing	VBG	acl	O
intestinal	JJ	amod	B-Organ
tumorigenesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
mutant	JJ	amod	O
mice	NNS	dobj	B-Organism
carrying	VBG	acl	O
hypomorphic	JJ	amod	O
Apc	NN	compound	B-Gene_or_gene_product
alleles	NNS	compound	O
Apc	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
neoR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
Apc	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
neoF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
whose	WP$	nmod:poss	O
expression	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
reduced	VBN	parataxis	O
to	TO	case	O
20	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
10	CD	nummod	O
%	NN	conj	O
of	IN	case	O
the	DT	det	O
wild	JJ	amod	O
type	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Although	IN	mark	O
both	CC	det	O
hypomorphic	JJ	amod	O
heterozygotes	NNS	nsubj	O
developed	VBD	advcl	O
intestinal	JJ	amod	B-Pathological_formation
polyps	NN	dobj	I-Pathological_formation
,	,	punct	O
tumor	NN	compound	B-Cancer
multiplicities	NNS	nsubj	O
were	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
Delta716	JJ	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
mice	NNS	nmod	O
,	,	punct	O
heterozygotes	NNS	xcomp	O
of	IN	case	O
an	DT	det	O
Apc	NN	compound	B-Gene_or_gene_product
null	JJ	amod	O
allele	NN	nmod	O
.	.	punct	O

Like	IN	case	O
in	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
Delta716	JJ	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
mice	NNS	nmod	O
,	,	punct	O
loss	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
Apc	NN	compound	B-Gene_or_gene_product
allele	NN	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
for	IN	case	O
all	DT	det	O
polyps	NN	nmod	B-Pathological_formation
examined	VBN	acl	O
in	IN	case	O
the	DT	det	O
Apc	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
neoR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
neoF	JJ	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
mice	NNS	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
embryonic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
homozygous	JJ	amod	O
for	IN	case	O
these	DT	det	O
hypomorphic	JJ	amod	O
Apc	NN	compound	B-Gene_or_gene_product
alleles	NNS	nmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
was	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
accumulation	NN	nmod	O
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
/	:	punct	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
transcriptional	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
reduced	VBN	amod	O
APC	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
level	NN	nsubj	O
increases	VBZ	ccomp	O
intestinal	JJ	amod	B-Pathological_formation
polyp	NN	compound	I-Pathological_formation
multiplicity	NN	dobj	O
through	IN	case	O
quantitative	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
/	:	punct	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
transcription	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
estimated	VBD	ROOT	O
the	DT	det	O
threshold	NN	dobj	O
of	IN	case	O
APC	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
level	NN	nmod	O
that	WDT	nsubj	O
forms	VBZ	acl:relcl	O
one	CD	nummod	O
polyp	RB	dobj	B-Pathological_formation
per	IN	case	O
mouse	NN	nmod	B-Organism
as	IN	case	O
approximately	RB	advmod	O
15	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
wild	JJ	amod	O
type	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
therapeutic	JJ	amod	O
implications	NNS	dobj	O
concerning	VBG	case	O
Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
inhibitors	NNS	nmod	O
.	.	punct	O

The	DT	det	O
merits	NNS	ROOT	O
of	IN	prep	O
vascular	JJ	amod	B-Multi-tissue_structure
targeting	NN	pobj	O
for	IN	prep	O
gynecologic	JJ	amod	O
malignancies	NNS	pobj	B-Cancer
.	.	punct	O

Neovascularization	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
early	JJ	amod	O
and	CC	cc	O
critical	JJ	conj	O
step	NN	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
.	.	punct	O

Tumor	NN	compound	B-Multi-tissue_structure
vessels	NNS	nsubj	I-Multi-tissue_structure
are	VBP	cop	O
distinct	JJ	ROOT	O
from	IN	case	O
their	PRP$	nmod:poss	O
normal	JJ	amod	O
counterparts	NNS	nmod	O
morphologically	RB	advmod	O
as	RB	advmod	O
well	RB	mwe	O
as	IN	mwe	O
at	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
level	NN	advcl	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
on	IN	case	O
factors	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
development	NN	nmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
new	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
for	IN	mark	O
inhibiting	VBG	advcl	O
tumor	NN	compound	B-Cancer
neovascularization	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
process	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
is	VBZ	cop	O
complex	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
each	DT	det	O
tumor	NN	nsubj	B-Cancer
exhibits	VBZ	conj	O
unique	JJ	amod	O
features	NNS	dobj	O
in	IN	case	O
its	PRP$	nmod:poss	O
vasculature	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

An	DT	det	O
understanding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
relative	JJ	amod	O
contribution	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
pathways	NNS	nmod	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
vasculature	NN	nmod	I-Multi-tissue_structure
is	VBZ	cop	O
critical	JJ	ROOT	O
for	IN	mark	O
developing	VBG	advcl	O
effective	JJ	amod	O
and	CC	cc	O
selective	JJ	conj	O
therapeutic	JJ	conj	O
approaches	NNS	dobj	O
.	.	punct	O

Several	JJ	amod	O
such	JJ	amod	O
agents	NNS	nsubj	O
are	VBP	cop	O
currently	RB	advmod	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	ROOT	O
,	,	punct	O
and	CC	cc	O
many	JJ	amod	O
others	NNS	nsubj	O
are	VBP	conj	O
under	IN	prep	O
development	NN	pobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
and	CC	cc	O
factors	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
selected	VBN	amod	O
novel	JJ	amod	O
classes	NNS	nsubjpass	O
of	IN	case	O
antivascular	JJ	amod	B-Multi-tissue_structure
therapies	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
targeting	VBG	acl	O
tumor	NN	compound	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
other	JJ	amod	O
components	NNS	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vasculature	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O

Normal	JJ	amod	O
and	CC	cc	O
transforming	VBG	conj	O
functions	NNS	ROOT	O
of	IN	case	O
RUNX1	NN	nmod	B-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
perspective	NN	dep	O
.	.	punct	O

Converging	VBG	amod	O
studies	NNS	nsubj	O
from	IN	case	O
many	JJ	amod	O
investigators	NNS	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
RUNX1	NN	nsubj	B-Gene_or_gene_product
has	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
correct	JJ	amod	O
maintenance	NN	nmod	O
of	IN	case	O
essential	JJ	amod	O
cellular	JJ	amod	B-Cell
functions	NNS	nmod	O
during	IN	case	O
embryonic	JJ	amod	B-Developing_anatomical_structure
development	NN	nmod	O
and	CC	cc	O
after	IN	case	O
birth	NN	conj	O
.	.	punct	O

The	DT	det	O
discovery	NN	nsubj	O
that	IN	mark	O
this	DT	det	O
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
frequently	RB	advmod	O
mutated	VBN	acl	O
in	IN	case	O
human	JJ	amod	B-Organism
leukemia	NN	nmod	B-Cancer
has	VBZ	aux	O
increased	VBN	ROOT	O
the	DT	det	O
interest	NN	dobj	O
in	IN	case	O
the	DT	det	O
role	NN	nmod	O
that	IN	mark	O
RUNX1	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
in	IN	case	O
both	CC	cc:preconj	O
normal	JJ	amod	O
and	CC	cc	O
transforming	VBG	conj	O
pathways	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
an	DT	det	O
overview	NN	dobj	O
of	IN	case	O
the	DT	det	O
many	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
RUNX1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
hematopoietic	JJ	amod	B-Cell
self	NN	compound	O
-	HYPH	punct	O
renewal	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
and	CC	cc	O
summarize	VB	conj	O
the	DT	det	O
information	NN	dobj	O
that	WDT	nsubj	O
is	VBZ	cop	O
currently	RB	advmod	O
available	JJ	ccomp	O
on	IN	case	O
the	DT	det	O
many	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
RUNX1	NN	compound	B-Gene_or_gene_product
deregulation	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
leukemia	NN	nmod	B-Cancer
.	.	punct	O

Domain	NN	nsubj	O
5	CD	nummod	O
of	IN	case	O
cleaved	VBN	amod	O
high	JJ	amod	B-Gene_or_gene_product
molecular	JJ	amod	I-Gene_or_gene_product
weight	NN	compound	I-Gene_or_gene_product
kininogen	NN	nmod	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
through	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
.	.	punct	O

Domain	NN	nsubj	O
5	CD	nummod	O
(	-LRB-	punct	O
D5	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
cleaved	VBN	amod	O
high	JJ	amod	B-Gene_or_gene_product
molecular	JJ	amod	I-Gene_or_gene_product
weight	NN	compound	I-Gene_or_gene_product
kininogen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HKa	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
cell	NN	compound	B-Cell
signaling	NN	compound	O
pathways	NNS	nsubjpass	O
involved	VBN	acl	O
in	IN	case	O
HKa	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
inhibition	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
are	VBP	auxpass	O
incompletely	RB	advmod	O
delineated	VBN	conj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
examines	VBZ	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
HKa	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
inhibition	NN	dep	O
of	IN	case	O
two	CD	nummod	O
potent	JJ	amod	O
stimulators	NNS	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
,	,	punct	O
sphingosine	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
phosphate	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
S1P	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubj	O
act	VBP	acl:relcl	O
through	IN	case	O
the	DT	det	O
P13	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

HKa	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
inhibit	VBP	ROOT	O
bovine	JJ	amod	B-Organism
pulmonary	JJ	amod	B-Cell
artery	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	dobj	I-Cell
(	-LRB-	punct	O
BPAE	NN	appos	B-Cell
)	-RRB-	punct	O
or	CC	cc	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
chemotaxis	NN	conj	O
in	IN	case	O
the	DT	det	O
modified	VBN	amod	O
-	HYPH	punct	O
Boyden	NN	compound	O
chamber	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
toVEGF	NN	dep	B-Gene_or_gene_product
or	CC	cc	O
S1P	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
migration	NN	nmod	O
by	IN	case	O
HKa	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
urokinase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Both	CC	cc:preconj	O
HKa	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
decrease	VBP	ROOT	O
the	DT	det	O
speed	NN	dobj	O
of	IN	case	O
BPAE	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
alter	VBP	conj	O
the	DT	det	O
morphology	NN	dobj	O
in	IN	case	O
live	JJ	amod	O
,	,	punct	O
time	NN	compound	O
-	HYPH	punct	O
lapse	NN	dep	O
microscopy	NN	nmod	O
after	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
S1P	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
.	.	punct	O

HKa	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
reduce	VBP	ROOT	O
the	DT	det	O
localization	NN	dobj	O
of	IN	case	O
paxillin	NN	nmod	B-Gene_or_gene_product
to	TO	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	nmod	I-Cellular_component
after	IN	case	O
S1P	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
stimulation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signaling	NN	compound	O
pathways	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
HKa	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
downstream	JJ	amod	O
effector	NN	conj	O
,	,	punct	O
GSK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3alpha	NN	compound	I-Gene_or_gene_product
HKa	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
inhibit	VBP	conj	O
phosphorylation	NN	dobj	O
of	IN	case	O
Akt	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
GSK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3alpha	NN	conj	I-Gene_or_gene_product
after	IN	case	O
stimulation	NN	nmod	O
withVEGF	NNS	dep	B-Gene_or_gene_product
and	CC	cc	O
S1P	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Inhibitors	NNS	nsubj	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
P13	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
upstream	JJ	amod	O
activator	NN	appos	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
,	,	punct	O
block	VB	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
and	CC	cc	O
disrupt	VB	conj	O
paxillin	NN	compound	B-Gene_or_gene_product
localization	NN	dobj	O
to	TO	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	nmod	I-Cellular_component
after	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
S1P	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Therefore	RB	advmod	O
we	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
HKa	NN	nsubj	B-Gene_or_gene_product
through	IN	case	O
its	PRP$	nmod:poss	O
D5	NN	compound	O
domain	NN	nmod	O
alters	VBZ	ccomp	O
P13	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
to	TO	mark	O
inhibit	VB	xcomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
through	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	nmod	I-Cellular_component
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
affecting	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
secretion	NN	dobj	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
and	CC	cc	O
capillary	JJ	amod	B-Tissue
tube	NN	compound	I-Tissue
formation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
EA	NN	nmod	I-Cell
.	.	punct	I-Cell
hy	NN	dep	I-Cell
926	CD	nummod	I-Cell
cells	NNS	ROOT	I-Cell
.	.	punct	O

Angiogenesis	NN	nsubj	O
,	,	punct	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
multistep	NN	compound	O
process	NN	ROOT	O
,	,	punct	O
precisely	RB	advmod	O
regulated	VBN	acl	O
by	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
cytokines	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
stimulate	VBP	acl:relcl	O
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
migrate	VB	xcomp	O
,	,	punct	O
proliferate	VB	conj	O
and	CC	cc	O
differentiate	VBP	conj	O
to	TO	aux	O
form	VB	xcomp	O
new	JJ	amod	O
capillary	JJ	amod	B-Tissue
microvessels	NNS	dobj	I-Tissue
.	.	punct	O

Excessive	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nsubj	O
and	CC	cc	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
remodeling	NN	conj	O
appears	VBZ	ROOT	O
in	IN	case	O
psoriasis	NN	nmod	O
,	,	punct	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
diabetic	JJ	amod	O
retinopathy	NN	conj	O
and	CC	cc	O
solid	JJ	amod	B-Cancer
tumors	NNS	compound	I-Cancer
formation	NN	conj	O
.	.	punct	O

Thalidomide	NN	compound	B-Simple_chemical
[	-LRB-	punct	O
alpha	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phthalimido	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
glutarimide	NN	nsubjpass	I-Simple_chemical
]	-RRB-	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	xcomp	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
inhibitory	JJ	amod	O
action	NN	nmod	O
remains	VBZ	conj	O
unclear	JJ	xcomp	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
influence	NN	dobj	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
several	JJ	amod	O
steps	NNS	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
in	FW	amod	O
vitro	FW	dep	O
models	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
evaluated	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
secretion	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
capillary	JJ	amod	B-Tissue
formation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
EA	NN	nmod	I-Cell
.	.	punct	I-Cell
hy	NN	ROOT	I-Cell
926	CD	nummod	I-Cell
.	.	punct	O

Thalidomide	NN	nsubj	B-Simple_chemical
at	IN	case	O
the	DT	det	O
concentrations	NNS	nmod	O
of	IN	case	O
0	CD	nummod	O
.	.	punct	O
01	CD	nummod	O
microM	NN	nmod	O
and	CC	cc	O
10	CD	nummod	O
microM	NN	conj	O
inhibited	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
secretion	NN	dobj	O
into	IN	case	O
supernatants	NNS	nmod	O
,	,	punct	O
decreased	VBD	conj	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
formed	VBN	amod	O
capillary	JJ	amod	B-Tissue
tubes	NNS	nmod	I-Tissue
and	CC	cc	O
increased	VBN	amod	O
cell	NN	compound	B-Cell
adhesion	NN	conj	O
to	TO	case	O
collagen	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Administration	NN	ROOT	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
at	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	nummod	O
microM	NN	nsubj	O
increased	VBD	ROOT	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
,	,	punct	O
while	IN	mark	O
at	IN	case	O
10	CD	nummod	O
microM	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
decreased	VBD	advcl	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

Thalidomide	NN	ROOT	B-Simple_chemical
in	IN	case	O
concentrations	NNS	nmod	O
from	IN	case	O
0	CD	nmod	O
.	.	punct	O
1	CD	nummod	O
microM	NN	nsubj	O
to	TO	case	O
10	CD	nummod	O
microM	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
change	VB	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
of	IN	case	O
72	CD	nummod	O
-	HYPH	punct	O
h	NN	compound	O
cell	NN	compound	B-Cell
cultures	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
action	NN	nsubj	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
is	VBZ	cop	O
due	JJ	ccomp	O
to	TO	mark	O
direct	VB	xcomp	O
inhibitory	JJ	amod	O
action	NN	dobj	O
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
secretion	NN	nmod	O
and	CC	cc	O
capillary	JJ	amod	B-Tissue
microvessel	NN	compound	I-Tissue
formation	NN	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
immunomodulatory	JJ	amod	O
influence	NN	dep	O
on	IN	case	O
EA	NN	nmod	B-Cell
.	.	punct	I-Cell
hy	NN	dep	I-Cell
926	CD	nummod	I-Cell
cells	NNS	ROOT	I-Cell
migration	NN	dep	O
and	CC	cc	O
adhesion	NN	conj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
skin	NN	compound	B-Tissue
microvasculature	NN	compound	I-Tissue
angiogenesis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
permeability	NN	conj	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	nmod	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
PKC	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
induces	VBZ	ROOT	O
phenotypic	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
morphology	NN	nmod	O
of	IN	case	O
microvascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
affect	VBP	acl:relcl	O
major	JJ	amod	O
functions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
microvasculature	NN	nmod	B-Tissue
.	.	punct	O

These	DT	det	O
functions	NNS	nsubj	O
include	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
stages	NNS	dobj	O
of	IN	prep	O
sprouting	NN	pcomp	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
following	VBG	case	O
wounding	NN	nmod	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	conj	O
.	.	punct	O

The	DT	det	O
specific	JJ	amod	O
isoform	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
of	IN	case	O
PKC	NN	nmod	B-Gene_or_gene_product
responsible	JJ	amod	O
for	IN	case	O
each	DT	nmod	O
of	IN	case	O
these	DT	det	O
changes	NNS	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
previously	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
two	CD	nummod	O
inflammatory	JJ	amod	O
agents	NNS	dobj	O
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1beta	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
phorbol	NN	compound	B-Simple_chemical
myristic	JJ	amod	I-Simple_chemical
acetate	NN	conj	I-Simple_chemical
,	,	punct	O
to	TO	mark	O
activate	VB	advcl	O
PKC	NN	compound	B-Gene_or_gene_product
isozymes	NNS	dobj	O
and	CC	cc	O
specific	JJ	amod	O
inhibitors	NNS	conj	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Go6976	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
PKCbeta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
hispidin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
to	TO	mark	O
distinguish	VB	advcl	O
how	WRB	advmod	O
each	DT	nsubj	O
of	IN	case	O
these	DT	det	O
isoform	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
controls	VBZ	ccomp	O
angiogenesis	NN	dobj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
,	,	punct	O
and	CC	cc	O
permeability	NN	conj	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
,	,	punct	O
only	RB	advmod	O
inhibition	NN	nsubj	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
inhibited	VBD	ROOT	O
each	DT	dobj	O
of	IN	case	O
these	DT	det	O
functions	NNS	nmod	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
PKCbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Additional	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
Go6976	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
,	,	punct	O
Western	NN	compound	O
blots	NNS	conj	O
,	,	punct	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
phosphorylated	JJ	amod	O
and	CC	cc	O
nonphosphorylated	JJ	conj	O
forms	NNS	nmod	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
and	CC	cc	O
cytoplasm	NN	conj	B-Organism_substance
confirmed	VBD	ROOT	O
the	DT	det	O
specificity	NN	dobj	O
of	IN	case	O
PKCalpha	NN	compound	B-Gene_or_gene_product
inhibition	NN	nmod	O
by	IN	case	O
Go6976	NN	nmod	B-Simple_chemical
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
therefore	RB	advmod	O
indicate	VBP	ROOT	O
a	DT	det	O
specific	JJ	dobj	O
and	CC	cc	O
a	DT	det	O
regulatory	JJ	amod	O
role	NN	dep	O
of	IN	case	O
the	DT	det	O
PKCalpha	NN	compound	B-Gene_or_gene_product
isoform	NN	nmod	O
in	IN	case	O
three	CD	nummod	O
major	JJ	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
functions	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
important	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
maintenance	NN	nmod	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
homeostasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
differential	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-Organism
telomerase	NN	compound	B-Gene_or_gene_product
reverse	JJ	compound	I-Gene_or_gene_product
transcriptase	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
clinically	RB	advmod	O
more	RBR	advmod	O
aggressive	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
.	.	punct	O

p63	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
homologue	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
myoepithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
marker	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
but	CC	cc	O
p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
neoplastic	JJ	amod	O
cells	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
up	RB	advmod	O
to	TO	dep	O
11	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	B-Cancer
breast	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
aims	VBZ	ROOT	O
to	TO	mark	O
verify	VB	xcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
p63	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
several	JJ	amod	O
clinicopathological	JJ	amod	O
features	NNS	conj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
markers	NNS	conj	O
of	IN	case	O
clinical	JJ	amod	O
significance	NN	nmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
pathology	NN	nmod	I-Cancer
including	VBG	case	O
key	JJ	amod	O
regulators	NNS	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
,	,	punct	O
oncogenes	NNS	conj	O
,	,	punct	O
apoptosis	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
proteins	NNS	conj	O
,	,	punct	O
metalloproteinases	NNS	appos	B-Gene_or_gene_product
and	CC	cc	O
their	PRP$	nmod:poss	O
inhibitors	NNS	conj	O
.	.	punct	O

Immunohistochemistry	NN	nsubjpass	O
with	IN	case	O
27	CD	nummod	O
primary	JJ	amod	O
antibodies	NNS	nmod	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
100	CD	nummod	O
formalin	CD	npadvmod	O
-	HYPH	punct	O
fixed	VBN	amod	O
paraffin	NN	amod	O
-	HYPH	punct	O
embedded	JJ	amod	O
samples	NNS	nmod	O
of	IN	case	O
invasive	JJ	amod	B-Cancer
ductal	JJ	amod	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
16	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
carcinomas	NNS	nmod	B-Cancer
.	.	punct	O

p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
,	,	punct	O
hormone	NN	compound	O
receptor	NN	nmod:npmod	O
-	HYPH	punct	O
negative	JJ	amod	O
neoplasms	NNS	ROOT	B-Cancer
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
.	.	punct	O

p63	NN	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
advanced	JJ	amod	O
pathological	JJ	amod	O
stage	NN	nmod	O
,	,	punct	O
tumor	NN	compound	B-Cancer
size	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
telomerase	NN	compound	B-Gene_or_gene_product
reverse	JJ	compound	I-Gene_or_gene_product
transcriptase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
hTERT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	appos	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
matrix	NN	compound	I-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TIMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
TIMP1	NN	nmod	B-Gene_or_gene_product
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
proteolytic	JJ	amod	O
stimuli	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
preponderant	JJ	ccomp	O
in	IN	case	O
p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
carcinomas	NNS	nmod	O
.	.	punct	O

hTERT	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
nodal	JJ	amod	B-Multi-tissue_structure
metastases	NNS	nmod	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
proliferation	NN	conj	O
.	.	punct	O

VEGF	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	ROOT	O
angiogenesis	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
a	DT	det	O
fundamental	JJ	amod	O
event	NN	acl:relcl	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
dissemination	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
differential	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
in	IN	case	O
p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
clinically	RB	advmod	O
more	RBR	advmod	O
aggressive	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
these	DT	det	O
neoplasms	NNS	nmod	B-Cancer
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
by	IN	case	O
thrombospondin	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Angiogenesis	NN	nsubj	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Thrombospondin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nsubjpass	O
,	,	punct	O
and	CC	cc	O
down	RB	compound	O
-	HYPH	punct	O
regulation	NN	conj	O
of	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
alter	VB	xcomp	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
by	IN	mark	O
modulating	VBG	advcl	O
angiogenesis	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
types	NNS	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	B-Gene_or_gene_product
and	CC	cc	O
Ras	NN	conj	B-Gene_or_gene_product
.	.	punct	O

TSP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
activation	NN	nsubj	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
by	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

An	DT	det	O
understanding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	nmod	O
of	IN	case	O
TSP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
inhibition	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
will	MD	aux	O
aid	VB	ROOT	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
novel	JJ	amod	O
therapeutics	NNS	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
composition	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
by	IN	case	O
low	JJ	amod	B-Gene_or_gene_product
density	NN	compound	I-Gene_or_gene_product
lipoprotein	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
:	:	punct	O
activities	NNS	dep	O
based	VBN	case	O
on	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
mRNA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Low	JJ	amod	B-Gene_or_gene_product
density	NN	compound	I-Gene_or_gene_product
lipoprotein	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
catabolic	JJ	amod	O
receptor	NN	ROOT	O
for	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
(	-LRB-	punct	O
ECM	NN	appos	B-Cellular_component
)	-RRB-	punct	O
structural	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
for	IN	case	O
proteins	NNS	conj	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
ECM	NN	nmod	B-Cellular_component
.	.	punct	O

LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
also	RB	advmod	O
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
integrin	NN	compound	B-Gene_or_gene_product
maturation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
applied	VBD	ROOT	O
a	DT	det	O
proteomics	NNS	compound	O
strategy	NN	dobj	O
to	TO	mark	O
identify	VB	advcl	O
novel	JJ	amod	O
proteins	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
ECM	NN	compound	B-Cellular_component
modeling	NN	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
LRP	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
deficiency	NN	nsubjpass	O
in	IN	case	O
murine	JJ	amod	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
MEFs	NNS	appos	B-Cell
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product
III	CD	nummod	I-Gene_or_gene_product
collagen	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
pigment	NN	amod	B-Gene_or_gene_product
epithelium	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
accumulate	VBP	acl:relcl	O
in	IN	case	O
the	DT	det	O
substratum	NN	amod	B-Cellular_component
surrounding	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
collagen	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubjpass	O
,	,	punct	O
uPAR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
AP	NNP	compound	I-Gene_or_gene_product
/	:	punct	O
Endo	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
180	CD	appos	I-Gene_or_gene_product
,	,	punct	O
is	VBZ	auxpass	O
also	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
LRP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
MEFs	NNS	nmod	B-Cell
.	.	punct	O

Human	JJ	amod	B-Organism
LRP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
reversed	VBD	ROOT	O
the	DT	det	O
changes	NNS	dobj	O
in	IN	case	O
protein	NN	compound	O
expression	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
deficiency	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
endocytic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
LRP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
not	RB	neg	O
involved	VBN	parataxis	O
.	.	punct	O

Instead	RB	advmod	O
,	,	punct	O
regulation	NN	nsubj	O
occurred	VBD	ROOT	O
at	IN	case	O
the	DT	det	O
mRNA	NN	compound	O
level	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Jun	NN	compound	I-Gene_or_gene_product
amino	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
terminal	JJ	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
JNK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
blocked	VBD	ROOT	O
type	NN	compound	B-Gene_or_gene_product
III	CD	nummod	I-Gene_or_gene_product
collagen	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
MEFs	NNS	nmod	B-Cell
,	,	punct	O
suggesting	VBG	advcl	O
regulation	NN	dobj	O
of	IN	case	O
JNK	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
as	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
controls	VBZ	acl:relcl	O
mRNA	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
to	TO	mark	O
regulate	VB	acl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
factors	NNS	nmod	O
identified	VBN	acl	O
here	RB	advmod	O
suggests	VBZ	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
LRP	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	mark	O
determining	VBG	acl	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
structure	NN	dobj	O
and	CC	cc	O
in	IN	case	O
angiogenesis	NN	conj	O
.	.	punct	O

L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Carnitine	NNP	compound	I-Simple_chemical
ameliorates	VBZ	compound	O
methotrexate	NN	advmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
oxidative	JJ	amod	O
organ	NN	compound	B-Organ
injury	NN	ROOT	O
and	CC	cc	O
inhibits	VBZ	conj	O
leukocyte	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

Methotrexate	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
MTX	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
folic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
antagonist	NN	nsubj	O
widely	RB	advmod	O
used	VBN	acl	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
and	CC	cc	O
inflammatory	JJ	amod	O
diseases	NNS	conj	O
,	,	punct	O
affects	VBZ	ROOT	O
normal	JJ	amod	B-Tissue
tissues	NNS	dobj	I-Tissue
that	WDT	nsubj	O
have	VBP	acl:relcl	O
a	DT	det	O
high	JJ	amod	O
rate	NN	dobj	O
of	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
the	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
the	DT	det	O
gastrointestinal	JJ	amod	B-Cell
mucosal	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
free	JJ	amod	O
radicals	NNS	nmod	O
and	CC	cc	O
leukocytes	NNS	conj	B-Cell
in	IN	case	O
MTX	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
oxidative	JJ	amod	O
organ	NN	compound	B-Organ
damage	NN	nmod	O
and	CC	cc	O
the	DT	det	O
putative	JJ	amod	O
protective	JJ	amod	O
effect	NN	conj	O
of	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carnitine	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	appos	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
Wistar	NN	compound	B-Organism
albino	NN	compound	I-Organism
rats	NNS	nsubjpass	I-Organism
were	VBD	auxpass	O
administered	VBN	ROOT	O
a	DT	det	O
single	JJ	amod	O
dose	NN	dobj	O
of	IN	case	O
MTX	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
20	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	appos	O
)	-RRB-	punct	O
followed	VBN	acl	O
by	IN	case	O
either	CC	cc:preconj	O
saline	NN	nmod	B-Simple_chemical
or	CC	cc	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	conj	I-Simple_chemical
(	-LRB-	punct	O
500	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
5	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

After	IN	case	O
decapitation	NN	nmod	O
of	IN	prep	O
the	DT	det	O
rats	NNS	pobj	B-Organism
,	,	punct	O
trunk	NN	compound	B-Organism_substance
blood	NN	nsubjpass	I-Organism_substance
was	VBD	auxpass	O
obtained	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ileum	NN	nsubjpass	B-Multi-tissue_structure
,	,	punct	O
liver	NN	conj	B-Organ
,	,	punct	O
and	CC	cc	O
kidney	NN	nsubjpass	B-Organ
were	VBD	auxpass	O
removed	VBN	conj	O
for	IN	case	O
histological	JJ	amod	O
examination	NN	nmod	O
and	CC	cc	O
for	IN	case	O
the	DT	det	O
measurement	NN	conj	O
of	IN	case	O
malondialdehyde	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
MDA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
glutathione	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
GSH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
levels	NNS	conj	O
,	,	punct	O
myeloperoxidase	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
MPO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
activity	NN	conj	O
,	,	punct	O
and	CC	cc	O
collagen	NN	compound	B-Gene_or_gene_product
content	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
MTX	NN	compound	B-Simple_chemical
administration	NN	nsubj	O
increased	VBD	ccomp	O
the	DT	dep	O
MDA	NN	dobj	B-Simple_chemical
and	CC	cc	O
MPO	NN	conj	B-Simple_chemical
activities	NNS	dep	O
and	CC	cc	O
collagen	NN	compound	B-Gene_or_gene_product
content	NN	conj	O
and	CC	cc	O
decreased	VBN	conj	O
GSH	NN	compound	B-Simple_chemical
levels	NNS	dobj	O
in	IN	case	O
all	DT	det	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
while	IN	mark	O
these	DT	det	O
alterations	NNS	nsubjpass	O
were	VBD	auxpass	O
reversed	VBN	advcl	O
in	IN	case	O
L	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
group	NN	nmod	O
.	.	punct	O

The	DT	det	O
elevated	JJ	amod	O
serum	NN	compound	B-Organism_substance
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
level	NN	nsubjpass	O
observed	VBN	acl	O
following	VBG	case	O
MTX	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
was	VBD	auxpass	O
depressed	VBN	ROOT	O
with	IN	case	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nmod	I-Simple_chemical
.	.	punct	O

The	DT	det	O
oxidative	JJ	amod	O
burst	NN	nsubjpass	O
of	IN	case	O
neutrophils	NNS	nmod	B-Cell
stimulated	VBN	acl	O
by	IN	case	O
Annexin	NN	compound	B-Gene_or_gene_product
V	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
saline	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
MTX	NN	compound	B-Simple_chemical
group	NN	nmod	O
,	,	punct	O
while	IN	mark	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nsubj	I-Simple_chemical
abolished	VBD	advcl	O
this	DT	det	O
inhibition	NN	dobj	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
flow	NN	compound	O
cytometric	JJ	amod	O
measurements	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
leukocyte	NN	compound	B-Cell
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ccomp	O
in	IN	case	O
MTX	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nsubj	I-Simple_chemical
reversed	VBD	advcl	O
these	DT	det	O
effects	NNS	dobj	O
.	.	punct	O

Severe	JJ	amod	O
degeneration	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
intestinal	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
liver	NN	compound	B-Multi-tissue_structure
parenchyma	NN	conj	I-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
glomerular	JJ	amod	B-Tissue
and	CC	cc	O
tubular	JJ	conj	B-Tissue
epithelium	NN	conj	I-Tissue
observed	VBN	acl	O
in	IN	case	O
the	DT	det	O
saline	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
MTX	NN	compound	B-Simple_chemical
group	NN	nmod	O
was	VBD	auxpass	O
improved	VBN	ROOT	O
by	IN	case	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	compound	I-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Car	NNP	nsubj	I-Simple_chemical
,	,	punct	O
possibly	RB	advmod	O
via	IN	case	O
its	PRP$	nmod:poss	O
free	JJ	amod	O
radical	NN	amod	O
scavenging	NN	nmod	O
and	CC	cc	O
antioxidant	JJ	amod	O
properties	NNS	conj	O
,	,	punct	O
ameliorates	VBZ	ccomp	O
MTX	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
oxidative	JJ	amod	O
organ	NN	compound	B-Organ
injury	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
leukocyte	NN	compound	B-Cell
apoptosis	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
supplementation	NN	nsubj	O
with	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Carnitine	NNP	nmod	I-Simple_chemical
as	IN	case	O
an	DT	det	O
adjuvant	JJ	amod	O
therapy	NN	nmod	O
may	MD	aux	O
be	VB	aux	O
promising	JJ	ROOT	O
in	IN	prep	O
alleviating	VBG	pcomp	O
the	DT	det	O
systemic	JJ	amod	O
side	NN	compound	O
-	HYPH	punct	O
effects	NNS	dobj	O
of	IN	prep	O
chemotherapeutics	NNS	pobj	O
.	.	punct	O

Pericytes	NNS	nsubj	B-Cell
limit	VBP	ROOT	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
metastasis	NN	dobj	O
.	.	punct	O

Previously	RB	advmod	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
neural	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
NCAM	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
deficiency	NN	nsubj	O
in	IN	case	O
beta	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
facilitates	VBZ	ccomp	O
metastasis	NN	dobj	O
into	IN	case	O
distant	JJ	amod	O
organs	NNS	nmod	B-Organ
and	CC	cc	O
local	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
NCAM	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
beta	NN	compound	O
cell	NN	compound	O
tumors	NNS	nsubj	O
grew	VBD	ccomp	O
leaky	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
with	IN	case	O
perturbed	VBN	amod	O
pericyte	NN	compound	B-Cell
-	HYPH	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
interactions	NNS	nmod	O
and	CC	cc	O
deficient	JJ	amod	O
perivascular	JJ	amod	B-Immaterial_anatomical_entity
deposition	NN	conj	O
of	IN	case	O
ECM	NN	compound	B-Cellular_component
components	NNS	nmod	I-Cellular_component
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
expression	NN	nsubj	O
of	IN	case	O
NCAM	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
fibrosarcoma	NN	compound	B-Cancer
model	NN	nmod	O
(	-LRB-	punct	O
T241	NN	appos	B-Cancer
)	-RRB-	punct	O
improved	VBD	ROOT	O
pericyte	NN	compound	B-Cell
recruitment	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
perivascular	JJ	amod	B-Immaterial_anatomical_entity
deposition	NN	conj	O
of	IN	case	O
ECM	NN	compound	B-Cellular_component
molecules	NNS	nmod	I-Cellular_component
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
NCAM	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
limit	VB	ccomp	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
metastasis	NN	dobj	O
by	IN	mark	O
stabilizing	VBG	advcl	O
the	DT	det	O
microvessel	NN	compound	B-Tissue
wall	NN	dobj	I-Tissue
.	.	punct	O

To	TO	mark	O
directly	RB	advmod	O
address	VB	ROOT	O
whether	IN	mark	O
pericyte	NN	compound	B-Cell
dysfunction	NN	nsubj	O
increases	VBZ	ccomp	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	dobj	O
of	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	parataxis	O
beta	NN	compound	B-Cell
cell	NN	compound	I-Cell
tumorigenesis	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
pericyte	NN	compound	B-Cell
-	HYPH	punct	O
deficient	JJ	amod	O
Pdgfb	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
ret	VB	compound	O
/	SYM	punct	O
ret	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
beta	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cell	NN	compound	I-Cell
metastases	NNS	nmod	O
in	IN	case	O
distant	JJ	amod	O
organs	NNS	nmod	B-Organ
and	CC	cc	O
local	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
,	,	punct	O
demonstrating	VBG	advcl	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
pericytes	NNS	nmod	B-Cell
in	IN	mark	O
limiting	VBG	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
metastasis	NN	dobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
how	WRB	advmod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
trigger	VBP	acl	O
metastasis	NN	dobj	O
by	IN	mark	O
perturbing	VBG	advcl	O
pericyte	NN	compound	B-Cell
-	HYPH	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
interactions	NNS	dobj	O
.	.	punct	O

NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	ROOT	I-Gene_or_gene_product
and	CC	cc	O
IKK	NN	conj	B-Gene_or_gene_product
as	IN	case	O
therapeutic	JJ	amod	O
targets	NNS	nmod	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
NF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
associated	VBN	amod	O
regulatory	JJ	amod	O
factors	NNS	conj	O
(	-LRB-	punct	O
including	VBG	case	O
IkappaB	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	O
subunits	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
IkappaB	NN	compound	B-Gene_or_gene_product
family	NN	compound	O
member	NN	conj	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
are	VBP	auxpass	O
strongly	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
hematologic	JJ	amod	B-Cancer
and	CC	cc	O
solid	JJ	conj	B-Cancer
tumor	NN	compound	I-Cancer
malignancies	NNS	nmod	I-Cancer
.	.	punct	O

A	DT	det	O
role	NN	nsubj	O
for	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
appears	VBZ	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
regulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
control	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
promotion	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
invasion	NN	nmod	O
/	:	punct	O
metastasis	NN	conj	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
a	DT	det	O
role	NN	nmod	O
for	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
oncogenesis	NN	nmod	O
are	VBP	cop	O
observations	NNS	ROOT	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
alone	RB	advmod	O
or	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
cancer	NN	compound	B-Cancer
therapies	NNS	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
death	NN	nmod	O
or	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
other	JJ	amod	O
experimental	JJ	amod	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nsubj	I-Gene_or_gene_product
can	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
role	NN	dobj	O
in	IN	case	O
certain	JJ	amod	O
settings	NNS	nmod	O
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
can	MD	aux	O
be	VB	cop	O
important	JJ	conj	O
in	IN	mark	O
promoting	VBG	advcl	O
an	DT	det	O
apoptotic	JJ	amod	O
signal	NN	dobj	O
downstream	RB	amod	O
of	IN	case	O
certain	JJ	amod	O
cancer	NN	compound	B-Cancer
therapy	NN	compound	O
regimens	NNS	nmod	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	aux	O
appropriately	RB	advmod	O
move	VB	ROOT	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
inhibitors	NNS	dobj	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
,	,	punct	O
thorough	JJ	mark	O
approaches	NNS	nsubjpass	O
must	MD	aux	O
be	VB	auxpass	O
initiated	VBN	advcl	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
dictate	VBP	acl:relcl	O
the	DT	det	O
complexity	NN	dobj	O
of	IN	case	O
oncologic	JJ	amod	O
and	CC	cc	O
therapeutic	JJ	conj	O
outcomes	NNS	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
controlled	VBN	acl:relcl	O
by	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Runx2	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
MYC	NN	conj	B-Gene_or_gene_product
collaborate	NN	ROOT	O
in	IN	case	O
lymphoma	NN	compound	B-Cancer
development	NN	nmod	O
by	IN	mark	O
suppressing	VBG	advcl	O
apoptotic	JJ	amod	O
and	CC	cc	O
growth	NN	conj	O
arrest	NN	compound	O
pathways	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Members	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
Runx	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
MYC	NN	conj	B-Gene_or_gene_product
families	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	mark	O
collaborating	VBG	advcl	O
oncogenes	NNS	dobj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
potent	JJ	amod	O
collaboration	NN	nmod	O
is	VBZ	auxpass	O
elucidated	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
of	IN	case	O
Runx2	NN	compound	B-Gene_or_gene_product
/	:	punct	O
MYC	NN	compound	B-Gene_or_gene_product
mice	NNS	nmod	O
.	.	punct	O

As	IN	mark	O
shown	VBN	advcl	O
previously	RB	advmod	O
,	,	punct	O
ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
Runx2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	B-Organ
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
preneoplastic	JJ	amod	O
state	NN	nmod	O
defined	VBN	acl	O
by	IN	case	O
an	DT	det	O
accumulation	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
an	DT	det	O
immature	JJ	amod	O
phenotype	NN	nmod	O
and	CC	cc	O
a	DT	det	O
low	JJ	amod	O
proliferative	JJ	amod	O
rate	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MYC	NN	compound	I-Gene_or_gene_product
overexpression	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
rescue	VB	xcomp	O
proliferation	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
release	VB	conj	O
the	DT	det	O
differentiation	NN	compound	O
block	NN	dobj	O
imposed	VBN	acl	O
by	IN	case	O
Runx2	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
Runx2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
lymphomas	NNS	nmod	B-Cancer
reveals	VBZ	ROOT	O
a	DT	det	O
consistently	RB	advmod	O
low	JJ	amod	O
rate	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
lymphomas	NNS	nmod	B-Cancer
of	IN	case	O
MYC	NN	compound	B-Gene_or_gene_product
mice	NNS	nmod	O
which	WDT	nsubj	O
are	VBP	cop	O
often	RB	advmod	O
highly	RB	advmod	O
apoptotic	JJ	acl:relcl	O
.	.	punct	O

The	DT	det	O
low	JJ	amod	O
apoptosis	NN	compound	O
phenotype	NN	nsubj	O
is	VBZ	cop	O
dominant	JJ	ROOT	O
in	IN	case	O
Runx2	NN	compound	B-Gene_or_gene_product
/	:	punct	O
MYC	NN	compound	B-Gene_or_gene_product
tumors	NNS	nmod	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
Runx2	NN	nsubj	B-Gene_or_gene_product
confers	VBZ	ccomp	O
a	DT	det	O
potent	JJ	amod	O
survival	NN	compound	O
advantage	NN	dobj	O
to	IN	case	O
MYC	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
in	IN	case	O
Runx2	NN	compound	B-Gene_or_gene_product
/	:	punct	O
MYC	NN	compound	B-Gene_or_gene_product
tumors	NNS	nmod	O
was	VBD	auxpass	O
explored	VBN	ROOT	O
on	IN	case	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
heterozygote	NN	compound	O
background	NN	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
functional	JJ	amod	O
p53	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
retained	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
after	IN	case	O
transplantation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
explanted	VBN	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
displayed	VBD	parataxis	O
rapid	JJ	amod	O
allele	NN	compound	O
loss	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Runx2	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
MYC	NN	conj	B-Gene_or_gene_product
overcome	VBP	ccomp	O
distinct	JJ	amod	O
"	``	punct	O
fail	VB	compound	O
-	HYPH	punct	O
safe	JJ	amod	O
"	''	punct	O
responses	NNS	dobj	O
and	CC	cc	O
that	IN	mark	O
their	PRP$	nmod:poss	O
selection	NN	nsubj	O
as	IN	mark	O
collaborating	VBG	acl	O
genes	NNS	dobj	O
is	VBZ	cop	O
due	JJ	conj	O
to	TO	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
neutralize	VB	acl	O
each	DT	det	O
other	JJ	amod	O
'	''	punct	O
s	VBZ	preconj	O
negative	JJ	amod	O
growth	NN	compound	O
effect	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
Runx2	NN	compound	B-Gene_or_gene_product
/	:	punct	O
MYC	NN	compound	B-Gene_or_gene_product
combination	NN	nsubj	O
overcomes	VBZ	ROOT	O
the	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
genetic	JJ	amod	O
inactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mammalian	JJ	amod	B-Gene_or_gene_product
target	NN	nmod	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
rapamycin	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
mTOR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
by	IN	case	O
rapamycin	NN	nmod	B-Simple_chemical
increases	VBZ	ROOT	O
chemosensitivity	NN	dobj	O
of	IN	case	O
CaSki	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	prep	O
paclitaxel	NN	pobj	B-Simple_chemical
.	.	punct	O

Paclitaxel	NN	nsubjpass	B-Simple_chemical
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
anti	JJ	npadvmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
agent	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	xcomp	O
against	IN	case	O
several	JJ	amod	O
tumours	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
exact	JJ	amod	O
mechanism	NN	nsubjpass	O
underlying	VBG	acl	O
the	DT	det	O
cytotoxic	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
pacitaxel	NN	nmod	B-Simple_chemical
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
the	DT	det	O
survival	NN	npadvmod	O
-	HYPH	punct	O
signalling	NN	amod	O
pathway	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
of	IN	case	O
the	DT	det	O
cytotoxic	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
in	IN	case	O
human	JJ	amod	B-Organism
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Four	CD	nummod	O
human	JJ	amod	B-Organism
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
for	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
with	IN	case	O
various	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
the	DT	det	O
sensitivity	NN	nsubjpass	O
was	VBD	auxpass	O
analysed	VBN	conj	O
by	IN	case	O
an	DT	det	O
MTT	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

The	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	nsubjpass	O
and	CC	cc	O
sub	NN	compound	O
-	HYPH	punct	O
G1	NN	compound	O
population	NN	nsubjpass	O
were	VBD	auxpass	O
analysed	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
measured	VBN	ROOT	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	nmod	O
and	CC	cc	O
microscope	NN	compound	O
examination	NN	conj	O
.	.	punct	O

The	DT	det	O
protein	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
HeLa	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
demonstrated	VBD	ccomp	O
the	DT	det	O
highest	JJS	amod	O
sensitivity	NN	dobj	O
to	TO	case	O
paclitaxel	NN	nmod	B-Simple_chemical
,	,	punct	O
whereas	IN	dep	O
CaSki	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
showed	VBD	advcl	O
the	DT	det	O
lowest	JJS	dobj	O
.	.	punct	O

In	IN	case	O
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
paclitaxel	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
through	IN	case	O
an	DT	det	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
with	IN	case	O
prior	JJ	amod	O
G2	NN	dep	O
/	:	punct	O
M	NN	dep	O
arrest	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
paclitaxel	NN	nsubj	B-Simple_chemical
downregulated	VBD	ccomp	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
in	IN	case	O
both	CC	cc:preconj	O
HeLa	NN	compound	B-Cell
and	CC	cc	O
CaSki	NN	conj	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
in	IN	case	O
CaSki	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
were	VBD	cop	O
more	RBR	advmod	O
suggestive	JJ	acl:relcl	O
of	IN	case	O
a	DT	det	O
resistant	JJ	amod	O
phenotype	NN	nmod	O
,	,	punct	O
paclitaxel	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
mTOR	NN	nmod	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
downstream	JJ	amod	O
target	NN	nmod	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
.	.	punct	O

Pre	NN	compound	O
-	HYPH	punct	O
treatment	NN	nsubj	O
with	IN	case	O
rapamycin	NN	nmod	B-Simple_chemical
inhibited	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
mTOR	NN	compound	B-Gene_or_gene_product
signalling	NN	nmod	O
and	CC	cc	O
significantly	RB	advmod	O
enhanced	VBD	conj	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
CaSki	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
paclitaxel	NN	nmod	B-Simple_chemical
by	IN	mark	O
increasing	VBG	acl	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

This	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	ROOT	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
partly	RB	advmod	O
,	,	punct	O
through	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

Overall	RB	advmod	O
,	,	punct	O
paclitaxel	NN	nsubj	B-Simple_chemical
exerts	VBZ	ROOT	O
its	PRP$	nmod:poss	O
anti	JJ	compound	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
effects	NNS	dobj	O
on	IN	case	O
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	mark	O
inducing	VBG	advcl	O
apoptosis	NN	dobj	O
through	IN	case	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
,	,	punct	O
and	CC	cc	O
rapamycin	NN	nsubj	B-Simple_chemical
targeted	VBN	acl	O
to	TO	case	O
mTOR	NN	nmod	B-Gene_or_gene_product
can	MD	aux	O
sensitise	VB	conj	O
paclitaxel	NN	compound	B-Simple_chemical
-	HYPH	punct	O
resistant	JJ	amod	O
cervical	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Circulating	VBG	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	ROOT	I-Cell
in	IN	case	O
malignant	JJ	amod	B-Cancer
disease	NN	nmod	I-Cancer
.	.	punct	O

Cancer	NNP	nsubj	B-Cancer
is	VBZ	cop	O
a	DT	det	O
disease	NN	ROOT	O
largely	RB	advmod	O
dependent	JJ	amod	O
on	IN	case	O
neoangiogenesis	NN	nmod	O
.	.	punct	O

Cancer	NN	compound	B-Cancer
neoangiogenesis	NN	nsubjpass	O
is	VBZ	cop	O
often	RB	advmod	O
disordered	VBN	ROOT	O
and	CC	cc	O
abnormal	JJ	conj	O
,	,	punct	O
with	IN	case	O
evidence	NN	nmod	O
of	IN	mark	O
coexisting	VBG	acl	O
vascular	JJ	amod	B-Tissue
endothelial	JJ	amod	I-Tissue
dysfunction	NN	dobj	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
method	NN	nsubj	O
of	IN	mark	O
assessing	VBG	acl	O
vascular	JJ	amod	B-Tissue
endothelial	JJ	amod	I-Tissue
function	NN	dobj	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
is	VBZ	cop	O
via	IN	case	O
the	DT	det	O
quantification	NN	ROOT	O
of	IN	case	O
circulating	VBG	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
CEC	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

Unusual	JJ	advmod	O
in	IN	case	O
healthy	JJ	amod	O
individuals	NNS	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
presence	NN	nsubj	O
in	IN	case	O
elevated	JJ	amod	O
numbers	NNS	nmod	O
often	RB	advmod	O
indicates	VBZ	ROOT	O
substantial	JJ	amod	O
vascular	JJ	amod	B-Tissue
endothelial	JJ	amod	I-Tissue
perturbation	NN	dobj	O
.	.	punct	O

Another	DT	det	O
interesting	JJ	amod	O
cell	NN	compound	B-Cell
type	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
progenitor	NN	compound	I-Cell
cell	NN	ROOT	I-Cell
(	-LRB-	punct	O
EPC	NN	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
whose	WP$	nmod:poss	O
numbers	NNS	nsubj	O
increase	VBP	acl:relcl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
damage	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
research	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
EPCs	NNS	nsubj	B-Cell
have	VBP	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
vasculogenesis	NN	nmod	O
.	.	punct	O

Another	DT	det	O
marker	NN	nsubjpass	O
being	VBG	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
dysfunction	NN	nmod	O
and	CC	cc	O
coagulopathy	NN	conj	O
is	VBZ	cop	O
the	DT	det	O
endothelial	JJ	amod	B-Cellular_component
microparticle	NN	nmod	I-Cellular_component
(	-LRB-	punct	O
EMP	NN	appos	B-Cellular_component
)	-RRB-	punct	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
CECs	NNS	nsubj	B-Cell
,	,	punct	O
EPCs	NNS	conj	B-Cell
and	CC	cc	O
EMPs	NNS	conj	B-Cellular_component
may	MD	aux	O
represent	VB	ROOT	O
potentially	RB	advmod	O
novel	JJ	amod	O
methods	NNS	dobj	O
for	IN	mark	O
evaluating	VBG	acl	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
status	NN	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
summarize	VB	ROOT	O
the	DT	det	O
current	JJ	amod	O
position	NN	dobj	O
of	IN	case	O
CECs	NNS	nmod	B-Cell
,	,	punct	O
EPCs	NNS	conj	B-Cell
and	CC	cc	O
EMPs	NNS	conj	B-Cellular_component
in	IN	case	O
cell	NN	compound	B-Cell
biology	NN	compound	O
terms	NNS	nmod	O
,	,	punct	O
with	IN	case	O
particular	JJ	amod	O
emphasis	NN	nmod	O
on	IN	case	O
their	PRP$	nmod:poss	O
relationship	NN	nmod	O
to	TO	case	O
malignant	JJ	amod	B-Cancer
disease	NN	nmod	I-Cancer
.	.	punct	O

GDP	NN	compound	B-Simple_chemical
and	CC	cc	O
AGE	NN	conj	B-Simple_chemical
receptors	NNS	ROOT	O
:	:	punct	O
mechanisms	NNS	dep	O
of	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
damage	NN	nmod	O
.	.	punct	O

Long	JJ	compound	O
-	HYPH	punct	O
term	NN	compound	O
peritoneal	NN	compound	B-Multi-tissue_structure
dialysis	NN	nsubjpass	O
(	-LRB-	punct	O
PD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
limited	VBN	ROOT	O
by	IN	case	O
morphological	JJ	amod	O
changes	NNS	nmod	O
of	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Structural	JJ	amod	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
promoted	VBN	ROOT	O
by	IN	case	O
toxicity	NN	nmod	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
degradation	NN	compound	I-Simple_chemical
products	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
GDPs	NNS	appos	B-Simple_chemical
)	-RRB-	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
generated	VBN	acl:relcl	O
during	IN	case	O
heat	NN	compound	O
sterilization	NN	nmod	O
in	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
dialysis	NN	compound	O
fluids	NNS	nmod	O
(	-LRB-	punct	O
PDFs	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Besides	IN	case	O
their	PRP$	nmod:poss	O
direct	JJ	amod	O
toxicity	NN	compound	O
GDPs	NNS	nsubj	B-Simple_chemical
promote	VBP	ROOT	O
formation	NN	dobj	O
of	IN	case	O
advanced	JJ	amod	B-Simple_chemical
glycation	NN	compound	I-Simple_chemical
endproducts	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
AGEs	NNS	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

RAGE	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
receptor	NN	appos	B-Gene_or_gene_product
for	IN	case	I-Gene_or_gene_product
AGE	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
best	JJS	advmod	O
characterized	VBN	amod	O
signal	NN	compound	O
transduction	NN	compound	O
receptor	NN	ROOT	O
for	IN	case	O
AGEs	NNS	nmod	B-Simple_chemical
and	CC	cc	O
is	VBZ	auxpass	O
expressed	VBN	conj	O
on	IN	case	O
mesothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
PDFs	NNS	nmod	O
with	IN	case	O
different	JJ	amod	O
amounts	NNS	nmod	O
of	IN	case	O
GDPs	NNS	nmod	B-Simple_chemical
were	VBD	auxpass	O
compared	VBN	ROOT	O
on	IN	case	O
morphological	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
in	IN	case	O
a	DT	det	O
RAGE	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
/	SYM	punct	O
-	HYPH	punct	O
mouse	NN	compound	O
model	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
RAGE	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
structural	JJ	amod	O
damage	NN	compound	O
(	-LRB-	punct	O
e	NN	amod	O
.	.	punct	O
g	NN	nmod	O
.	.	punct	O
inflammation	NN	ROOT	O
,	,	punct	O
neoangiogenesis	NN	conj	O
and	CC	cc	O
fibrosis	NN	conj	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Further	JJ	amod	O
investigations	NNS	nsubjpass	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
with	IN	case	O
regard	NN	nmod	O
to	TO	mark	O
preventing	VBG	acl	O
peritoneal	JJ	amod	B-Multi-tissue_structure
fibrosis	NN	dobj	O
should	MD	aux	O
be	VB	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
maintain	VB	xcomp	O
the	DT	det	O
integrity	NN	dobj	O
of	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
in	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
dialysis	NN	compound	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Hyperfibrinogenemia	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
lymphatic	JJ	nmod	B-Multi-tissue_structure
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
hematogenous	JJ	amod	O
metastasis	NN	conj	O
and	CC	cc	O
worse	JJR	conj	O
clinical	JJ	amod	O
outcome	NN	dobj	O
in	IN	case	O
T2	NN	compound	B-Cancer
gastric	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Abnormal	JJ	amod	O
hemostasis	NN	nsubjpass	O
in	IN	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
described	VBN	dep	O
,	,	punct	O
however	RB	advmod	O
the	DT	det	O
correlation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
and	CC	cc	O
cancer	NN	compound	B-Cancer
metastasis	NN	conj	O
and	CC	cc	O
prognosis	NN	conj	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
reported	VBN	parataxis	O
in	IN	case	O
a	DT	det	O
large	JJ	amod	O
-	HYPH	punct	O
scale	NN	amod	O
clinical	JJ	amod	O
study	NN	nmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Preoperative	JJ	amod	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
retrospectively	RB	advmod	O
examined	VBN	ROOT	O
in	IN	case	O
405	CD	nummod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
underwent	VBD	acl:relcl	O
surgery	NN	dobj	O
for	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
association	NN	nsubjpass	O
of	IN	case	O
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
with	IN	case	O
clinical	JJ	amod	O
/	SYM	punct	O
pathological	JJ	dep	O
findings	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
outcome	NN	conj	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
There	EX	expl	O
was	VBD	appos	O
a	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
depth	NN	conj	O
of	IN	case	O
invasion	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Hyperfibrinogenemia	NN	nsubjpass	O
(	-LRB-	punct	O
>	NN	dep	O
310	CD	nummod	O
mg	NN	dep	O
/	:	punct	O
dl	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
independently	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
Odds	NNP	compound	O
Ratio	NNP	dep	O
;	:	punct	O
2	CD	dep	O
.	.	punct	O
342	CD	nummod	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0032	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
liver	NN	conj	B-Organ
(	-LRB-	punct	O
Odds	NNP	compound	O
Ratio	NNP	dep	O
;	:	punct	O
2	CD	dep	O
.	.	punct	O
933	CD	dobj	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0147	CD	dep	O
)	-RRB-	punct	O
metastasis	NN	ROOT	O
,	,	punct	O
not	RB	neg	O
with	IN	case	O
peritoneal	JJ	amod	B-Multi-tissue_structure
metastasis	NN	conj	O
in	IN	case	O
this	DT	det	O
series	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
with	IN	case	O
hyperfibrinogenemia	NN	nmod	O
showed	VBD	ROOT	O
worse	JJR	amod	O
clinical	JJ	amod	O
outcome	NN	dobj	O
in	IN	case	O
T2	NN	compound	B-Cancer
gastric	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	parataxis	O
no	DT	neg	O
correlation	NN	nsubj	O
of	IN	case	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
T3	NN	compound	B-Cancer
/	:	punct	I-Cancer
T4	NN	compound	I-Cancer
gastric	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
might	MD	aux	O
support	VB	appos	O
the	DT	det	O
idea	NN	dobj	O
that	IN	mark	O
hyperfibrinogenemia	NN	nsubj	O
can	MD	aux	O
augment	VB	ccomp	O
lymphatic	JJ	amod	B-Cell
and	CC	cc	O
hematogeneous	JJ	conj	O
metastasis	NN	dobj	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
major	JJ	amod	O
determinant	NN	acl:relcl	O
of	IN	case	O
the	DT	det	O
prognosis	NN	nmod	O
in	IN	case	O
T2	NN	compound	B-Cancer
gastric	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
in	IN	prep	O
the	DT	det	O
situation	NN	pobj	O
without	IN	prep	O
peritoneal	JJ	amod	B-Multi-tissue_structure
involvement	NN	pobj	O
,	,	punct	O
hyperfibrinogenemia	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
useful	JJ	amod	O
biomarker	NN	ROOT	O
to	TO	mark	O
predict	VB	acl	O
the	DT	det	O
possible	JJ	amod	O
metastasis	NN	dobj	O
and	CC	cc	O
worse	JJR	conj	O
clinical	JJ	amod	O
outcome	NN	dobj	O
in	IN	case	O
T2	NN	compound	B-Cancer
gastric	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Defective	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
HRK	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
promoter	NN	compound	O
methylation	NN	nmod	O
in	IN	case	O
primary	JJ	amod	O
central	JJ	amod	B-Cancer
nervous	JJ	amod	I-Cancer
system	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
.	.	punct	O

OBJECTIVES	NNS	ROOT	O
:	:	punct	O
Recently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	dep	O
that	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
HRK	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ccomp	O
by	IN	case	O
hypermethylation	NN	nmod	O
in	IN	case	O
astrocytic	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
aim	NN	nsubj	O
is	VBZ	ROOT	O
to	TO	mark	O
verify	VB	xcomp	O
the	DT	det	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
HRK	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-Cancer
central	JJ	amod	I-Cancer
nervous	JJ	amod	I-Cancer
system	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
(	-LRB-	punct	O
PCNSLs	NNS	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
hypermethylation	NN	compound	O
status	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
and	CC	cc	O
12q13	NN	conj	O
.	.	punct	O
1	CD	nummod	O
loss	NN	ROOT	O
of	IN	case	O
heterozygosity	NN	nmod	O
in	IN	case	O
31	CD	nummod	O
PCNSLs	NNS	nmod	B-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
A	DT	det	O
total	NN	nsubj	O
of	IN	case	O
13	CD	nummod	O
PCNSLs	NNS	nmod	B-Cancer
(	-LRB-	punct	O
31	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
demonstrated	VBD	dep	O
hypermethylation	NN	dobj	O
in	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
promoter	NN	nmod	O
or	CC	cc	O
exon	NN	conj	O
1	CD	nummod	O
;	:	punct	O
loss	NN	nsubjpass	O
of	IN	case	O
HRK	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
was	VBD	auxpass	O
immunohistochemically	RB	advmod	O
observed	VBN	parataxis	O
in	IN	case	O
9	CD	nummod	O
tumors	NNS	nmod	B-Cancer
and	CC	cc	O
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
promoter	NN	compound	O
methylation	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
higher	JJR	amod	O
apoptotic	JJ	amod	O
counts	NNS	nsubjpass	O
were	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
HRK	NN	compound	B-Gene_or_gene_product
positivity	NN	nmod	O
.	.	punct	O

PCNSLs	NNS	nsubj	B-Cancer
with	IN	case	O
HRK	NN	compound	B-Gene_or_gene_product
methylation	NN	nmod	O
also	RB	advmod	O
showed	VBD	ROOT	O
methylation	NN	dobj	O
of	IN	case	O
multiple	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
p14ARF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
p16INK4a	NN	conj	B-Gene_or_gene_product
,	,	punct	O
RB1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
p27Kip1	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
O6	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MGMT	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Patients	NNS	nsubj	B-Organism
with	IN	case	O
tumors	NNS	nmod	B-Cancer
demonstrating	VBG	acl	O
concurrent	JJ	amod	O
methylation	NN	dobj	O
of	IN	case	O
more	JJR	advmod	O
than	IN	quantmod	O
half	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
poorer	VBN	amod	O
survival	NN	dobj	O
and	CC	cc	O
earlier	JJR	amod	O
recurrence	NN	conj	O
.	.	punct	O

Hypermethylation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
HRK	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
alone	RB	advmod	O
was	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
overall	JJ	amod	O
outcome	NN	nmod	O
,	,	punct	O
but	CC	cc	O
relapse	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
shorter	JJR	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
transcriptional	JJ	amod	O
repression	NN	nsubjpass	O
of	IN	case	O
HRK	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
caused	VBN	ccomp	O
by	IN	case	O
promoter	NN	compound	O
hypermethylation	NN	nmod	O
in	IN	case	O
PCNSL	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
loss	NN	nsubj	O
of	IN	case	O
HRK	NN	nmod	B-Gene_or_gene_product
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
methylation	NN	compound	O
profile	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
genes	NNS	nmod	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
step	NN	conj	O
in	IN	case	O
the	DT	det	O
modulation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
death	NN	nmod	O
by	IN	case	O
apoptosis	NN	nmod	O
during	IN	case	O
PCNSL	NN	compound	B-Cancer
tumorigenesis	NN	nmod	O
.	.	punct	O

Differential	JJ	amod	O
mechanisms	NNS	ROOT	O
of	IN	case	O
radiosensitization	NN	nmod	O
by	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
in	IN	case	O
the	DT	det	O
monolayers	NNS	nmod	B-Cell
and	CC	cc	O
multicellular	JJ	amod	B-Cell
spheroids	NNS	conj	I-Cell
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
glioma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
using	VBG	acl	O
monolayer	JJ	compound	B-Cell
cultures	NNS	dobj	I-Cell
of	IN	case	O
human	JJ	amod	B-Organism
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nsubj	I-Simple_chemical
selectively	RB	advmod	O
inhibits	VBZ	ccomp	O
energy	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
DNA	NN	compound	B-Cellular_component
repair	NN	dobj	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
recovery	NN	compound	O
processes	NNS	conj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
monolayer	JJ	compound	B-Cell
cultures	NNS	nsubj	I-Cell
differ	VBP	ROOT	O
greatly	RB	advmod	O
from	IN	case	O
the	DT	det	O
complex	JJ	amod	O
environmental	JJ	amod	O
conditions	NNS	nmod	O
generated	VBN	acl	O
in	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
that	WDT	nsubj	O
develop	VBP	acl:relcl	O
inhomogeneous	JJ	amod	B-Pathological_formation
hypoxic	JJ	amod	I-Pathological_formation
and	CC	cc	O
necrotic	JJ	conj	B-Pathological_formation
regions	NNS	dobj	I-Pathological_formation
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
multicellular	JJ	amod	B-Cell
spheroids	NNS	nsubj	I-Cell
mimic	VBP	ROOT	O
heterogeneous	JJ	amod	O
cellular	JJ	amod	B-Cell
behavior	NN	dobj	O
and	CC	cc	O
the	DT	det	O
consequent	JJ	amod	O
functional	JJ	amod	O
characteristics	NNS	conj	O
of	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
serve	VBP	conj	O
as	IN	case	O
important	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
model	NN	nmod	O
to	TO	mark	O
investigate	VB	xcomp	O
tumor	NN	compound	B-Cancer
biology	NN	dobj	O
and	CC	cc	O
responses	NNS	conj	O
to	TO	case	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
agents	NNS	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
compares	VBZ	ROOT	O
the	DT	det	O
radiomodification	NN	dobj	O
by	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nmod	I-Simple_chemical
in	IN	case	O
monolayer	JJ	compound	B-Cell
cultures	NNS	nmod	I-Cell
and	CC	cc	O
spheroids	NNS	conj	B-Cell
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
glioma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
(	-LRB-	punct	O
BMG	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
)	-RRB-	punct	O
to	TO	mark	O
gain	VB	advcl	O
insight	NN	dobj	O
into	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
in	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
spheroids	NNS	ROOT	B-Cell
,	,	punct	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	intj	O
(	-LRB-	punct	O
2	CD	dep	O
.	.	punct	O
1	CD	nummod	O
p	NN	compound	O
mole	NN	nsubj	O
/	:	punct	O
cell	NN	compound	O
/	:	punct	O
h	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
lactate	NN	compound	B-Simple_chemical
production	NN	conj	O
(	-LRB-	punct	O
3	CD	dep	O
.	.	punct	O
67	CD	nummod	O
p	NN	compound	O
mole	NN	dep	O
/	:	punct	O
cell	NN	compound	O
/	:	punct	O
h	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
nearly	RB	advmod	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	ROOT	O
fold	RB	advmod	O
higher	JJR	amod	O
than	IN	case	O
in	IN	case	O
monolayer	JJ	compound	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
0	CD	dep	O
.	.	punct	O
83	CD	dep	O
and	CC	cc	O
1	CD	conj	O
.	.	punct	O
43	CD	nummod	O
p	NN	compound	O
mole	NN	compound	O
/	:	punct	O
cell	NN	compound	O
/	:	punct	O
h	NN	ROOT	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Presence	NN	nsubj	O
of	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	O
mM	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
2	CD	compound	O
-	SYM	punct	O
4	CD	nummod	O
h	NN	nmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
usage	NN	dobj	O
and	CC	cc	O
lactate	NN	compound	B-Simple_chemical
production	NN	conj	O
by	IN	case	O
70	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
spheroids	NNS	nmod	B-Cell
,	,	punct	O
while	IN	mark	O
a	DT	det	O
35	CD	nummod	O
%	NN	compound	O
reduction	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	advcl	O
in	IN	case	O
monolayer	JJ	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nsubj	I-Simple_chemical
drastically	RB	advmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
radiation	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
of	IN	case	O
spheroids	NNS	nmod	B-Cell
(	-LRB-	punct	O
by	IN	case	O
2	CD	compound	O
-	SYM	punct	O
3	CD	nummod	O
folds	NNS	appos	O
)	-RRB-	punct	O
;	:	punct	O
while	IN	mark	O
a	DT	det	O
40	CD	compound	O
%	NN	amod	O
increase	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	advcl	O
in	IN	case	O
monolayer	JJ	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Radiosensitization	NN	nsubj	O
by	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nmod	I-Simple_chemical
in	IN	case	O
monolayer	JJ	compound	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	cop	O
primarily	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
an	DT	det	O
increase	NN	ROOT	O
in	IN	case	O
mitotic	JJ	amod	O
death	NN	nmod	O
(	-LRB-	punct	O
23	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
linked	VBN	acl	O
to	TO	case	O
cytogenetic	JJ	amod	O
damage	NN	nmod	O
(	-LRB-	punct	O
micronuclei	NNS	appos	B-Cellular_component
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
a	DT	det	O
profound	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
(	-LRB-	punct	O
40	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
accounted	VBD	parataxis	O
for	IN	case	O
the	DT	det	O
sensitization	NN	nmod	O
in	IN	case	O
spheroids	NNS	nmod	B-Cell
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
Bax	NN	conj	B-Gene_or_gene_product
levels	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	advcl	O
in	IN	case	O
spheroids	NNS	nmod	B-Cell
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Bax	NN	compound	B-Gene_or_gene_product
ratio	NN	nsubj	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
monolayers	NNS	nmod	B-Cell
and	CC	cc	O
spheroids	NNS	conj	B-Cell
.	.	punct	O

Comet	NN	amod	O
assay	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
late	JJ	amod	O
onset	NN	dobj	O
of	IN	case	O
DNA	NN	compound	B-Cellular_component
breaks	NNS	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nmod	I-Simple_chemical
following	VBG	case	O
irradiation	NN	nmod	O
only	RB	advmod	O
in	IN	case	O
spheroids	NNS	nmod	B-Cell
,	,	punct	O
which	WDT	nsubj	O
corroborated	VBD	acl:relcl	O
well	RB	advmod	O
with	IN	case	O
the	DT	det	O
late	JJ	amod	O
onset	NN	nmod	O
of	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
.	.	punct	O

2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nsubj	I-Simple_chemical
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
delay	NN	dobj	O
in	IN	case	O
monolayers	NNS	nmod	B-Cell
,	,	punct	O
while	IN	mark	O
a	DT	det	O
transient	JJ	amod	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
delay	NN	nsubj	O
was	VBD	cop	O
apparent	JJ	advcl	O
in	IN	case	O
spheroids	NNS	nmod	B-Cell
.	.	punct	O

[	-LRB-	ROOT	O
Autologous	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cell	NN	intj	I-Cell
or	CC	cc	O
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
progenitor	NN	compound	I-Cell
cell	NN	compound	I-Cell
therapy	NN	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	O
limb	NN	compound	B-Organism_subdivision
ischaemia	NN	nmod	O
]	-RRB-	punct	O

No	DT	neg	O
effective	JJ	amod	O
medical	JJ	amod	O
therapies	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
sofar	RB	advmod	O
to	TO	mark	O
enhance	VB	xcomp	O
blood	NN	compound	B-Organism_substance
flow	NN	dobj	O
in	IN	case	O
the	DT	det	O
legs	NNS	nmod	B-Organism_subdivision
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	B-Multi-tissue_structure
arterial	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
(	-LRB-	punct	O
PAD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

For	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
limb	NN	compound	B-Organism_subdivision
threatening	VBG	compound	O
ischaemia	NN	nmod	O
the	DT	det	O
only	JJ	amod	O
option	NN	nsubj	O
for	IN	prep	O
relief	NN	pobj	O
of	IN	prep	O
rest	NN	compound	O
pain	NN	pobj	O
or	CC	cc	O
gangraena	NN	conj	O
is	VBZ	ROOT	O
amputation	NN	attr	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
evidence	NN	nsubj	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nmod	O
that	IN	mark	O
adult	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
progenitor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
participate	VBP	acl:relcl	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
called	VBN	conj	O
neoangiogenesis	NN	xcomp	O
or	CC	cc	O
neovascularization	NN	conj	O
.	.	punct	O

Clinical	JJ	amod	O
results	NNS	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
autologous	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
or	CC	cc	O
angiogenic	JJ	amod	O
growth	NN	compound	O
/	:	punct	O
differentiation	NN	compound	O
factors	NNS	conj	O
in	IN	case	O
end	NN	compound	O
-	HYPH	punct	O
stage	NN	compound	O
patients	NNS	nmod	B-Organism
with	IN	case	O
PAD	NN	nmod	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O

Considering	VBG	advcl	O
the	DT	det	O
relatively	RB	advmod	O
few	JJ	amod	O
number	NN	dobj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
treated	VBN	acl	O
by	IN	case	O
angiogenic	JJ	amod	O
therapy	NN	nmod	O
,	,	punct	O
the	DT	det	O
interpretation	NN	nsubj	O
of	IN	case	O
clinical	JJ	amod	O
results	NNS	nmod	O
needs	VBZ	ROOT	O
cautiousness	NN	dobj	O
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	B-Tissue
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
mandible	NN	nmod	B-Organ
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
distraction	NN	compound	O
rate	NN	nmod	O
on	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	nmod	O
in	IN	case	O
intramembraneous	JJ	amod	O
ossification	NN	nmod	O
after	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
mandible	NN	nmod	B-Organ
.	.	punct	O

Six	CD	nummod	O
edentulous	JJ	amod	O
patients	NNS	ROOT	B-Organism
(	-LRB-	punct	O
aged	JJ	dep	O
60	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
severely	RB	advmod	O
atrophic	JJ	amod	O
mandible	NN	amod	B-Organ
underwent	VBD	amod	O
bone	NN	compound	B-Tissue
augmentation	NN	conj	O
with	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
distraction	NN	compound	O
rates	NNS	nsubjpass	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
5	CD	dep	O
and	CC	cc	O
1	CD	conj	O
mm	NN	dep	O
/	SYM	punct	O
day	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
and	CC	cc	O
for	IN	case	O
each	DT	det	O
group	NN	conj	O
three	CD	nummod	O
patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
analyzed	VBN	parataxis	O
.	.	punct	O

Vascular	JJ	compound	B-Multi-tissue_structure
histomorphometry	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
in	IN	prep	O
two	CD	nummod	O
different	JJ	amod	O
areas	NNS	pobj	O
in	IN	prep	O
the	DT	det	O
distraction	NN	compound	O
gap	NN	pobj	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
first	JJ	nmod	O
and	CC	cc	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
second	JJ	amod	O
1	CD	compound	O
mm	NN	amod	O
area	NN	nmod	O
from	IN	prep	O
the	DT	det	O
osteotomy	NN	amod	O
line	NN	pobj	O
,	,	punct	O
representing	VBG	acl	O
the	DT	det	O
oldest	JJS	dobj	O
and	CC	cc	O
younger	JJR	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	B-Tissue
area	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Correlation	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
between	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
parameters	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
amount	NN	conj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	B-Tissue
formed	VBN	acl	O
during	IN	case	O
distraction	NN	nmod	O
.	.	punct	O

Histological	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
throughout	IN	case	O
the	DT	det	O
soft	JJ	amod	B-Tissue
connective	JJ	amod	I-Tissue
tissue	NN	nmod	I-Tissue
in	IN	case	O
the	DT	det	O
distraction	NN	compound	O
gap	NN	nmod	O
.	.	punct	O

The	DT	det	O
volume	NN	compound	O
density	NN	nsubj	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
investigated	VBN	amod	O
areas	NNS	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
1	CD	nummod	O
mm	NN	nmod	O
/	HYPH	punct	O
day	NN	compound	O
groups	NNS	dep	O
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
delay	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
this	DT	det	O
group	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
.	.	punct	O

A	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
volume	NN	nmod	O
and	CC	cc	O
bone	NN	compound	B-Tissue
volume	NN	compound	O
density	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
younger	JJR	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	B-Tissue
area	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
in	IN	conj	O
the	DT	det	O
oldest	JJS	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	B-Tissue
area	NN	pobj	O
.	.	punct	O

This	DT	det	O
correlation	NN	nsubj	O
was	VBD	cop	O
due	JJ	case	O
to	TO	case	O
a	DT	det	O
higher	JJR	amod	O
number	NN	ROOT	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
rather	RB	cc	O
than	IN	mwe	O
to	IN	case	O
a	DT	det	O
larger	JJR	amod	O
size	NN	conj	O
of	IN	case	O
the	DT	det	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
lower	JJR	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
density	NN	nsubj	O
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
patients	NNS	nmod	B-Organism
with	IN	case	O
1	CD	nummod	O
mm	NN	nmod	O
/	,	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ccomp	O
to	TO	case	O
disruption	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
soft	JJ	amod	B-Tissue
connective	JJ	amod	I-Tissue
tissue	NN	nmod	I-Tissue
of	IN	case	O
the	DT	det	O
gap	NN	nmod	O
or	CC	cc	O
to	TO	case	O
a	DT	det	O
less	RBR	advmod	O
optimal	JJ	amod	O
mechanical	JJ	amod	O
stimulation	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
involved	VBN	acl	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
probably	RB	advmod	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
slower	JJR	amod	O
rate	NN	nmod	O
of	IN	case	O
osteogenesis	NN	nmod	O
seen	VBN	acl	O
at	IN	case	O
the	DT	det	O
1	CD	nummod	O
mm	NN	nmod	O
/	HYPH	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	dep	O
compared	VBN	acl	O
with	IN	prep	O
the	DT	det	O
0	CD	pobj	O
.	.	punct	O
5	CD	nummod	O
mm	NN	ROOT	O
/	,	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	appos	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
concept	NN	dobj	O
that	IN	mark	O
a	DT	det	O
positive	JJ	amod	O
relationship	NN	nsubj	O
exists	VBZ	ccomp	O
between	IN	case	O
the	DT	det	O
density	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
the	DT	det	O
formation	NN	conj	O
of	IN	case	O
bone	NN	nmod	B-Tissue
.	.	punct	O

For	IN	case	O
distraction	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
mandible	NN	nmod	B-Organ
in	IN	case	O
elderly	JJ	amod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
a	DT	det	O
distraction	NN	compound	O
rate	NN	appos	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mm	NN	nsubj	O
/	HYPH	punct	O
day	NN	nsubj	O
seems	VBZ	ROOT	O
beneficial	JJ	xcomp	O
.	.	punct	O

Neoplastic	JJ	amod	O
transformation	NN	nsubjpass	O
of	IN	case	O
ciliary	JJ	amod	B-Tissue
body	NN	compound	I-Tissue
epithelium	NN	nmod	I-Tissue
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
loss	NN	nmod	O
of	IN	case	O
opticin	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Opticin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
discovered	VBN	amod	O
glycoprotein	NN	appos	O
present	JJ	amod	O
predominantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
vitreous	JJ	amod	B-Organism_substance
humour	NN	nmod	I-Organism_substance
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
synthesised	VBN	ROOT	O
and	CC	cc	O
secreted	VBN	conj	O
by	IN	case	O
the	DT	det	O
ciliary	JJ	amod	B-Tissue
body	NN	compound	I-Tissue
epithelium	NN	nmod	I-Tissue
(	-LRB-	punct	O
CBE	NN	appos	B-Tissue
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
CBE	NN	compound	B-Tissue
development	NN	nmod	O
in	IN	case	O
the	DT	det	O
embryo	NN	nmod	B-Developing_anatomical_structure
,	,	punct	O
and	CC	cc	O
production	NN	nsubj	O
continues	VBZ	conj	O
throughout	IN	prep	O
life	NN	pobj	O
.	.	punct	O

AIM	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
whether	IN	mark	O
a	DT	det	O
variety	NN	nsubj	O
of	IN	case	O
ciliary	JJ	amod	B-Cancer
body	NN	nmod	I-Cancer
tumours	NNS	ccomp	I-Cancer
synthesise	JJ	amod	O
opticin	NN	dobj	B-Gene_or_gene_product
to	TO	aux	O
characterise	VB	xcomp	O
further	RB	advmod	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
ciliary	JJ	amod	B-Multi-tissue_structure
body	NN	compound	I-Multi-tissue_structure
health	NN	nmod	O
and	CC	cc	O
disease	NN	conj	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Immunohistochemistry	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
distribution	NN	dobj	O
of	IN	case	O
opticin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
CBE	NN	nmod	B-Tissue
,	,	punct	O
and	CC	cc	O
in	IN	case	O
hyperplastic	JJ	amod	B-Cancer
and	CC	cc	O
neoplastic	JJ	conj	B-Cancer
CBE	NN	compound	I-Cancer
lesions	NNS	conj	I-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Opticin	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
immunolocalised	VBN	appos	O
to	TO	case	O
the	DT	det	O
basal	JJ	amod	B-Cellular_component
cell	NN	compound	I-Cellular_component
surface	NN	nmod	I-Cellular_component
and	CC	cc	O
basement	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
material	NN	conj	I-Cellular_component
of	IN	case	O
the	DT	det	O
non	JJ	npadvmod	B-Tissue
-	HYPH	punct	I-Tissue
pigmented	VBN	amod	I-Tissue
CBE	NN	nmod	I-Tissue
in	IN	case	O
nine	CD	nummod	O
donor	NN	compound	O
eyes	NNS	nmod	B-Organ
as	RB	advmod	O
well	RB	mwe	O
as	IN	mwe	O
four	CD	nummod	O
hyperplastic	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
CBE	NN	nmod	B-Tissue
(	-LRB-	punct	O
Fuchs	NNPS	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
adenoma	NN	appos	I-Cancer
)	-RRB-	punct	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
none	NN	nsubj	O
of	IN	case	O
eight	CD	nummod	O
neoplastic	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
(	-LRB-	punct	O
two	CD	nummod	O
adenoma	NN	dep	B-Cancer
and	CC	cc	O
six	CD	nummod	O
adenocarcinoma	NN	conj	B-Cancer
)	-RRB-	punct	O
of	IN	case	O
CBE	NN	nmod	B-Tissue
stained	VBD	ROOT	O
for	IN	case	O
opticin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
present	JJ	amod	O
series	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
theory	NN	dobj	O
that	IN	mark	O
opticin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
produced	VBN	acl	O
by	IN	agent	O
the	DT	det	O
non	JJ	npadvmod	B-Tissue
-	HYPH	punct	I-Tissue
pigmented	VBN	amod	I-Tissue
CBE	NN	pobj	I-Tissue
throughout	IN	prep	O
adult	JJ	amod	O
life	NN	pobj	O
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
opticin	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
by	IN	case	O
this	DT	det	O
tissue	NN	nmod	B-Tissue
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	prep	O
and	CC	cc	O
could	MD	aux	O
contribute	VB	conj	O
towards	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Collagen	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
poly	JJ	amod	B-Simple_chemical
glycolic	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
hybrid	NN	compound	O
matrix	NN	nsubj	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
accelerated	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	conj	O
in	IN	case	O
diabetic	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Because	IN	mark	O
poor	JJ	amod	O
skin	NN	compound	B-Pathological_formation
wound	NN	compound	I-Pathological_formation
healing	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
diabetes	NNS	nmod	O
is	VBZ	auxpass	O
thought	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
partly	RB	advmod	O
a	DT	det	O
result	NN	xcomp	O
from	IN	case	O
impaired	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
treatments	NNS	nsubj	O
that	WDT	nsubj	O
improve	VBP	acl:relcl	O
angiogenesis	NN	dobj	O
could	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
clinical	JJ	amod	O
applications	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
herein	RB	advmod	O
report	VBP	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
novel	JJ	amod	O
developed	VBN	amod	O
material	NN	nmod	O
,	,	punct	O
collagen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
poly	JJ	amod	B-Simple_chemical
glycolic	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
fiber	NN	compound	O
hybrid	NN	compound	O
matrix	NN	conj	O
,	,	punct	O
being	VBG	auxpass	O
used	VBN	advcl	O
together	RB	advmod	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
promote	VB	xcomp	O
wound	NN	compound	B-Pathological_formation
healing	NN	dobj	O
of	IN	prep	O
full	JJ	amod	O
-	HYPH	punct	O
thickness	NN	compound	O
skin	NN	compound	B-Organ
defects	NNS	pobj	O
on	IN	case	O
the	DT	det	O
back	NN	nmod	O
of	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetic	JJ	amod	O
Lepr	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
db	NN	appos	O
)	-RRB-	punct	O
mice	NNS	dep	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
therapeutic	JJ	amod	O
approach	NN	nsubj	O
markedly	RB	advmod	O
promotes	VBZ	ccomp	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	conj	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
other	JJ	amod	O
conditions	NNS	nmod	O
14	CD	nummod	O
days	NNS	dobj	O
after	IN	case	O
wounding	NN	pobj	O
.	.	punct	O

p18Ink4c	UH	nsubj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
p27Kip1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
collaborates	VBZ	ROOT	O
with	IN	case	O
Men1	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
suppress	VB	xcomp	O
neuroendocrine	JJ	compound	B-Cancer
organ	NN	compound	I-Cancer
tumors	NNS	dobj	I-Cancer
.	.	punct	O

Mutant	JJ	amod	O
mice	NNS	nsubj	B-Organism
lacking	VBG	acl	O
both	CC	cc:preconj	O
cyclin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
CDK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibitors	NNS	dobj	O
p18	NN	dep	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4c	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p27	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
Kip1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
develop	VBP	ROOT	O
a	DT	det	O
tumor	NN	compound	B-Cancer
spectrum	NN	compound	O
reminiscent	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
multiple	JJ	amod	B-Cancer
endocrine	JJ	amod	I-Cancer
neoplasia	NN	compound	I-Cancer
(	-LRB-	punct	O
MEN	NN	appos	B-Cancer
)	-RRB-	punct	O
syndromes	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
how	WRB	advmod	O
p18	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
p27	NN	conj	B-Gene_or_gene_product
genetically	RB	advmod	O
interact	VBP	ccomp	O
with	IN	case	O
Men1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	appos	O
mutated	VBN	acl	O
in	IN	case	O
familial	JJ	amod	O
MEN1	NN	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
characterized	VBD	ROOT	O
p18	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Men1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
p27	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Men1	NN	conj	B-Gene_or_gene_product
double	JJ	amod	O
mutant	JJ	amod	O
mice	NNS	dep	O
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
their	PRP$	nmod:poss	O
corresponding	JJ	amod	O
single	JJ	amod	B-Organism
mutant	JJ	amod	I-Organism
littermates	NNS	nmod	I-Organism
,	,	punct	O
the	DT	det	O
p18	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
;	:	punct	O
Men1	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
develop	VBP	ROOT	O
tumors	NNS	dobj	B-Cancer
at	IN	case	O
an	DT	det	O
accelerated	VBN	amod	O
rate	NN	nmod	O
and	CC	cc	O
with	IN	case	O
an	DT	det	O
increased	VBN	amod	O
incidence	NN	conj	O
in	IN	case	O
the	DT	det	O
pituitary	NN	nmod	B-Organ
,	,	punct	O
thyroid	NN	conj	B-Organ
,	,	punct	O
parathyroid	JJ	conj	B-Organ
,	,	punct	O
and	CC	cc	O
pancreas	NN	nmod	B-Organ
.	.	punct	O

In	IN	case	O
the	DT	det	O
pituitary	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
pancreatic	JJ	conj	B-Multi-tissue_structure
islets	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
retinoblastoma	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Rb	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
protein	NN	nmod	O
at	IN	case	O
both	CC	cc:preconj	O
CDK2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CDK4	NN	conj	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
sites	NNS	dep	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
p18	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
Men1	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
cells	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
further	RB	advmod	O
increased	VBN	conj	O
in	IN	case	O
p18	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
;	:	punct	O
Men1	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
cells	NNS	parataxis	O
.	.	punct	O

The	DT	det	O
remaining	VBG	amod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
Men1	NN	compound	B-Gene_or_gene_product
allele	NN	nsubjpass	O
was	VBD	auxpass	O
lost	VBN	ROOT	O
in	IN	case	O
most	JJS	amod	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
Men1	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
mice	NNS	conj	O
but	CC	cc	O
was	VBD	auxpass	O
retained	VBN	conj	O
in	IN	case	O
most	JJS	amod	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
p18	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
;	:	punct	O
Men1	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
mice	NNS	parataxis	O
.	.	punct	O

Combined	JJ	amod	O
mutations	NNS	nsubj	O
of	IN	case	O
p27	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
and	CC	cc	O
Men1	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
exhibit	VB	ROOT	O
noticeable	JJ	amod	O
synergistic	JJ	amod	O
stimulation	NN	dobj	O
of	IN	case	O
Rb	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
functional	JJ	amod	O
collaboration	NN	nsubj	O
exists	VBZ	ccomp	O
between	IN	case	O
p18	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Men1	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
Men1	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
regulate	VB	ccomp	O
additional	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
p18	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
p27	NN	conj	B-Gene_or_gene_product
differently	RB	advmod	O
.	.	punct	O

Punica	NN	compound	B-Organism
granatum	NN	ROOT	I-Organism
(	-LRB-	punct	O
pomegranate	NN	appos	B-Organism
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
potential	NN	conj	O
for	IN	case	O
prevention	NN	nmod	O
and	CC	cc	O
treatment	NN	conj	O
of	IN	case	O
inflammation	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	B-Cancer
.	.	punct	O

The	DT	det	O
last	JJ	amod	O
7	CD	nummod	O
years	NNS	nsubj	O
have	VBP	aux	O
seen	VBN	ROOT	O
over	IN	prep	O
seven	CD	nummod	O
times	NNS	pobj	O
as	IN	prep	O
many	JJ	amod	O
publications	NNS	pobj	O
indexed	VBN	acl	O
by	IN	case	O
Medline	NN	nmod	O
dealing	VBG	acl	O
with	IN	prep	O
pomegranate	NN	nmod	B-Organism
and	CC	cc	O
Punica	NNP	compound	B-Organism
granatum	NN	pobj	I-Organism
than	IN	prep	O
in	IN	prep	O
all	PDT	predet	O
the	DT	det	O
years	NNS	pobj	O
preceding	VBG	acl	O
them	PRP	dobj	O
.	.	punct	O

Because	IN	prep	O
of	IN	pcomp	O
this	DT	pobj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
virtual	JJ	amod	O
explosion	NN	pobj	O
of	IN	prep	O
interest	NN	pobj	O
in	IN	prep	O
pomegranate	NN	pobj	B-Organism
as	IN	prep	O
a	DT	det	O
medicinal	JJ	amod	O
and	CC	cc	O
nutritional	JJ	conj	O
product	NN	pobj	O
that	WDT	nsubj	O
has	VBZ	aux	O
followed	VBN	relcl	O
,	,	punct	O
this	DT	det	O
review	NN	nsubjpass	O
is	VBZ	auxpass	O
accordingly	RB	advmod	O
launched	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
pomegranate	NN	amod	B-Organism
tree	NN	nsubj	B-Organism_subdivision
,	,	punct	O
Punica	NNP	compound	B-Organism
granatum	NN	appos	I-Organism
,	,	punct	O
especially	RB	advmod	O
its	PRP$	poss	O
fruit	NN	appos	O
,	,	punct	O
possesses	VBZ	ROOT	O
a	DT	det	O
vast	JJ	amod	O
ethnomedical	JJ	amod	O
history	NN	dobj	O
and	CC	cc	O
represents	VBZ	conj	O
a	DT	det	O
phytochemical	JJ	amod	O
reservoir	NN	dobj	O
of	IN	case	O
heuristic	JJ	amod	O
medicinal	JJ	amod	O
value	NN	nmod	O
.	.	punct	O

The	DT	det	O
tree	NN	compound	O
/	SYM	punct	O
fruit	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
divided	VBN	ccomp	O
into	IN	case	O
several	JJ	amod	O
anatomical	JJ	amod	O
compartments	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
seed	NN	dep	B-Developing_anatomical_structure
,	,	punct	O
(	-LRB-	punct	O
2	LS	nummod	O
)	-RRB-	punct	O
juice	NN	conj	B-Organism_substance
,	,	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
peel	NN	conj	B-Tissue
,	,	punct	O
(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
leaf	NN	conj	B-Organ
,	,	punct	O
(	-LRB-	punct	O
5	LS	dep	O
)	-RRB-	punct	O
flower	NN	conj	B-Organism_subdivision
,	,	punct	O
(	-LRB-	punct	O
6	LS	appos	O
)	-RRB-	punct	O
bark	NN	conj	B-Tissue
,	,	punct	O
and	CC	cc	O
(	-LRB-	punct	O
7	LS	nummod	O
)	-RRB-	punct	O
roots	NNS	conj	B-Organ
,	,	punct	O
each	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
has	VBZ	ROOT	O
interesting	JJ	amod	O
pharmacologic	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

Juice	NNP	nsubj	B-Organism_substance
and	CC	cc	O
peels	NNS	conj	B-Tissue
,	,	punct	O
for	IN	prep	O
example	NN	pobj	O
,	,	punct	O
possess	VBP	ROOT	O
potent	JJ	amod	O
antioxidant	JJ	amod	O
properties	NNS	dobj	O
,	,	punct	O
while	IN	mark	O
juice	NN	nsubj	B-Organism_substance
,	,	punct	O
peel	NN	conj	B-Tissue
and	CC	cc	O
oil	NN	conj	B-Organism_substance
are	VBP	advcl	O
all	DT	advmod	O
weakly	RB	advmod	O
estrogenic	JJ	acomp	O
and	CC	cc	O
heuristically	RB	advmod	O
of	IN	prep	O
interest	NN	pobj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
menopausal	JJ	amod	O
symptoms	NNS	nmod	O
and	CC	cc	O
sequellae	NNS	conj	O
.	.	punct	O

The	DT	det	O
use	NN	nsubjpass	O
of	IN	prep	O
juice	NN	pobj	B-Organism_substance
,	,	punct	O
peel	NN	conj	B-Tissue
and	CC	cc	O
oil	NN	conj	B-Organism_substance
have	VBP	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
possess	VB	xcomp	O
anticancer	NN	compound	B-Cancer
activities	NNS	dobj	O
,	,	punct	O
including	VBG	case	O
interference	NN	nmod	O
with	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	conj	O
,	,	punct	O
invasion	NN	conj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

These	DT	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
plant	NN	compound	O
based	VBN	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
The	DT	det	O
phytochemistry	NN	nmod	O
and	CC	cc	O
pharmacological	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
all	DT	det	O
Punica	NNP	compound	B-Organism
granatum	NN	compound	I-Organism
components	NNS	nmod	O
suggest	VBP	conj	O
a	DT	det	O
wide	JJ	amod	O
range	NN	dobj	O
of	IN	case	O
clinical	JJ	amod	O
applications	NNS	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
and	CC	cc	O
prevention	NN	conj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
other	JJ	amod	O
diseases	NNS	conj	O
where	WRB	advmod	O
chronic	JJ	amod	O
inflammation	NN	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
essential	JJ	amod	O
etiologic	JJ	amod	O
role	NN	dobj	O
.	.	punct	O

Recombinant	JJ	amod	O
human	JJ	amod	B-Organism
prothrombin	NN	compound	B-Gene_or_gene_product
kringle	NN	nsubj	I-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
B16F10	NN	compound	B-Cancer
melanoma	NN	compound	I-Cancer
metastasis	NN	dobj	O
through	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
neovascularization	NN	nmod	O
and	CC	cc	O
reduction	NN	conj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
,	,	punct	O
a	DT	det	O
multi	NN	amod	O
-	HYPH	punct	O
step	NN	compound	O
process	NN	appos	O
which	WDT	nsubj	O
involves	VBZ	acl:relcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
basement	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
(	-LRB-	punct	O
BM	NN	appos	B-Cellular_component
)	-RRB-	punct	O
degradation	NN	conj	O
,	,	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
tumor	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
recombinant	JJ	amod	O
human	JJ	amod	B-Organism
prothrombin	NN	compound	B-Gene_or_gene_product
kringle	NN	compound	I-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
rk	RB	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
inhibited	VBD	ccomp	O
bovine	JJ	amod	B-Organism
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
with	IN	case	O
an	DT	det	O
IC	NN	nmod	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
concentration	NN	dobj	O
for	IN	case	O
half	JJ	nummod	O
maximal	JJ	amod	O
inhibition	NN	nmod	O
)	-RRB-	punct	O
of	IN	case	O
38	CD	nummod	O
nM	NN	nmod	O
and	CC	cc	O
inhibited	VBD	conj	O
adhesion	NN	dobj	O
to	TO	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
(	-LRB-	punct	O
ECM	NN	appos	B-Cellular_component
)	-RRB-	punct	O
proteins	NNS	nmod	O
.	.	punct	O

Because	IN	mark	O
tumor	NN	compound	B-Cancer
metastasis	NN	nsubj	O
requires	VBZ	advcl	O
angiogenesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
rk	RB	nsubj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
could	MD	aux	O
inhibit	VB	ccomp	O
metastases	NNS	dobj	O
induced	VBN	acl	O
by	IN	case	O
injection	NN	nmod	O
of	IN	case	O
B16F10	NN	compound	B-Cell
melanoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
into	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
metastatic	JJ	amod	O
tumors	NNS	nsubjpass	B-Cancer
in	IN	case	O
mouse	NN	compound	B-Organism
lung	NN	nmod	B-Organ
were	VBD	auxpass	O
markedly	RB	advmod	O
decreased	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
and	CC	cc	O
acute	JJ	amod	O
lung	NN	compound	B-Organ
injury	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
B16F10	NN	compound	B-Cancer
melanoma	NN	compound	I-Cancer
metastasis	NN	nmod	O
was	VBD	auxpass	O
diminished	VBN	conj	O
by	IN	case	O
systemic	JJ	amod	O
rk	IN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
treatment	NN	nmod	O
.	.	punct	O

In	IN	case	O
immunohistochemical	JJ	amod	O
analysis	NN	ROOT	O
,	,	punct	O
rk	RB	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
reduced	VBD	amod	O
expression	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
angiogenic	JJ	amod	O
activator	NN	acl:relcl	O
and	CC	cc	O
neovascularization	NN	conj	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	B-Organism
lung	NN	nmod	B-Organ
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
rk	RB	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nsubj	I-Gene_or_gene_product
diminished	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
mouse	NN	compound	B-Organism
lung	NN	nmod	B-Organ
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
tumor	NN	compound	B-Cancer
metastasis	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
inhibition	NN	nsubjpass	O
of	IN	case	O
B16F10	NN	compound	B-Cancer
melanoma	NN	compound	I-Cancer
metastasis	NN	nmod	O
by	IN	case	O
rk	RB	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
caused	VBN	ccomp	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
neovascularization	NN	nmod	O
and	CC	cc	O
reduction	NN	conj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
through	IN	case	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	nmod	I-Simple_chemical
mediates	VBZ	ROOT	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxyeicosatetraenoic	JJ	amod	I-Simple_chemical
acid	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
.	.	punct	O

20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Hydroxyeicosatetraenoic	JJ	amod	I-Simple_chemical
acid	NN	nsubjpass	I-Simple_chemical
(	-LRB-	punct	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
is	VBZ	auxpass	O
formed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
omega	NNS	compound	O
-	HYPH	punct	O
hydroxylation	NN	nmod	O
of	IN	case	O
arachidonic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
by	IN	case	O
cytochrome	NN	compound	B-Gene_or_gene_product
P450	NN	compound	I-Gene_or_gene_product
4A	NN	dep	I-Gene_or_gene_product
and	CC	cc	O
4F	NN	conj	B-Gene_or_gene_product
enzymes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubj	O
induces	VBZ	conj	O
angiogenic	JJ	amod	O
responses	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	nsubj	I-Simple_chemical
increases	VBZ	ccomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
proliferation	NN	dobj	O
via	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
WIT003	NN	nmod	B-Simple_chemical
[	-LRB-	punct	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxyeicosa	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
5	CD	dep	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
Z	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
,	,	punct	I-Simple_chemical
14	CD	nummod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
Z	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
dienoic	JJ	amod	I-Simple_chemical
acid	NN	dep	I-Simple_chemical
]	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	compound	I-Simple_chemical
analog	NN	appos	O
on	IN	case	O
human	JJ	amod	B-Organism
macrovascular	NN	nmod	B-Cell
or	CC	cc	O
microvascular	JJ	conj	B-Cell
EC	NN	dep	I-Cell
.	.	punct	O

WIT003	NN	nsubj	B-Simple_chemical
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
pure	JJ	amod	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	nsubj	I-Simple_chemical
,	,	punct	O
stimulated	VBD	ROOT	O
EC	NN	compound	B-Cell
proliferation	NN	dobj	O
by	IN	case	O
approximately	RB	advmod	O
40	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

These	DT	det	O
proliferative	JJ	amod	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
increased	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
release	NN	conj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	acl:relcl	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	compound	I-Simple_chemical
agonist	NN	compound	O
addition	NN	nmod	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
increased	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
proliferative	JJ	amod	O
effects	NNS	nsubjpass	O
of	IN	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	nmod	I-Simple_chemical
were	VBD	auxpass	O
markedly	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
neutralizing	VBG	amod	O
antibody	NN	nmod	O
.	.	punct	O

Polyethylene	NN	compound	B-Simple_chemical
glycol	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
superoxide	NN	compound	I-Simple_chemical
dismutase	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
PEG	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
SOD	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
markedly	RB	advmod	O
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
the	DT	det	O
increases	NNS	dobj	O
in	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
proliferative	JJ	amod	O
effects	NNS	conj	O
of	IN	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NNP	nmod	I-Simple_chemical
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
administration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NAD	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
P	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
H	NN	compound	I-Gene_or_gene_product
oxidase	NN	compound	I-Gene_or_gene_product
inhibitor	NN	compound	O
apocynin	NN	nmod	B-Simple_chemical
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
to	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NNP	nmod	I-Simple_chemical
.	.	punct	O

The	DT	det	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	compound	I-Simple_chemical
agonist	NN	nsubj	O
markedly	RB	advmod	O
increased	VBD	ROOT	O
superoxide	NN	compound	B-Simple_chemical
formation	NN	dobj	O
as	IN	mark	O
reflected	VBN	advcl	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
dihydroethidium	NN	compound	B-Simple_chemical
staining	NN	nmod	O
of	IN	case	O
EC	NN	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
this	DT	det	O
increase	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
PEG	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
SOD	NN	nmod	I-Simple_chemical
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
apocynin	NN	conj	B-Simple_chemical
.	.	punct	O

20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	nsubj	I-Simple_chemical
also	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
p42	NN	nmod:npmod	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
p44	NN	compound	I-Gene_or_gene_product
mitogen	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MAPK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
EC	NN	nmod	B-Cell
,	,	punct	O
whereas	IN	dep	O
an	DT	det	O
inhibitor	NN	nsubj	O
of	IN	case	O
MAPK	NN	nmod	B-Gene_or_gene_product
[	-LRB-	punct	O
U0126	NN	dep	B-Simple_chemical
,	,	punct	O
1	CD	conj	B-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
diamino	NN	compound	I-Simple_chemical
-	,	punct	I-Simple_chemical
2	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dicyano	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bis	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aminophenylthio	NN	compound	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
butadiene	NN	appos	I-Simple_chemical
]	-RRB-	punct	O
suppressed	VBD	parataxis	O
the	DT	det	O
proliferative	JJ	dobj	O
and	CC	cc	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
changes	NNS	dep	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
pro	NN	nmod:npmod	O
-	HYPH	punct	O
oxidant	JJ	amod	O
effects	NNS	conj	O
of	IN	case	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NNP	nmod	I-Simple_chemical
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	nsubj	I-Simple_chemical
stimulates	VBZ	ccomp	O
superoxide	NN	compound	B-Simple_chemical
formation	NN	dobj	O
by	IN	case	O
pathways	NNS	nmod	O
other	JJ	amod	O
than	IN	case	O
apocynin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	amod	O
NAD	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
P	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
H	NN	compound	I-Gene_or_gene_product
oxidase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
thereby	RB	advmod	O
activating	VBG	advcl	O
MAPK	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
then	RB	advmod	O
enhancing	VBG	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
synthesis	NN	dobj	O
that	WDT	nsubj	O
drives	VBZ	acl:relcl	O
EC	NN	compound	B-Cell
proliferation	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
20	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HETE	NN	nsubjpass	I-Simple_chemical
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
EC	NN	compound	B-Cell
functions	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
angiogenesis	NN	nmod	O
.	.	punct	O

Relationship	NN	ROOT	O
of	IN	case	O
cellular	JJ	amod	B-Cell
immunity	NN	nmod	O
,	,	punct	O
cytokines	NNS	conj	O
and	CC	cc	O
CRP	NN	conj	B-Gene_or_gene_product
with	IN	case	O
clinical	JJ	amod	O
course	NN	nmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
with	IN	case	O
endocrine	JJ	nmod:npmod	B-Anatomical_system
-	HYPH	punct	O
dependent	JJ	amod	O
distant	JJ	amod	O
metastases	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
immunotherapy	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
important	JJ	amod	O
benefits	NNS	dobj	O
and	CC	cc	O
survival	NN	conj	O
with	IN	case	O
an	DT	det	O
immunotherapy	NN	compound	O
schedule	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
endocrine	JJ	nmod:npmod	B-Anatomical_system
-	HYPH	punct	O
dependent	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
distant	JJ	amod	O
metastases	NNS	conj	O
.	.	punct	O

Here	RB	advmod	O
clinical	JJ	amod	O
outcome	NN	nsubj	O
is	VBZ	cop	O
updated	VBN	ROOT	O
and	CC	cc	O
its	PRP$	nmod:poss	O
correlation	NN	nsubjpass	O
with	IN	case	O
new	JJ	amod	O
immunological	JJ	amod	O
data	NNS	nmod	O
is	VBZ	auxpass	O
shown	VBN	conj	O
.	.	punct	O

In	IN	case	O
32	CD	nummod	O
evaluated	VBN	amod	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
with	IN	case	O
endocrine	JJ	nmod:npmod	B-Anatomical_system
-	HYPH	punct	O
dependent	JJ	amod	O
distant	JJ	amod	O
metastases	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
a	DT	det	O
new	JJ	amod	O
immunotherapy	NN	compound	O
schedule	NN	nmod	O
(	-LRB-	punct	O
cyclic	JJ	amod	O
administration	NN	dep	O
of	IN	case	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
interferon	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
interleukin	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
cellular	JJ	amod	B-Cell
immunity	NN	conj	O
,	,	punct	O
cytokines	NNS	conj	O
and	CC	cc	O
CRP	NN	conj	B-Gene_or_gene_product
were	VBD	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
clinical	JJ	amod	O
course	NN	nmod	O
.	.	punct	O

Estimated	VBN	amod	O
and	CC	cc	O
true	JJ	conj	O
5	CD	compound	O
-	SYM	punct	O
10	CD	nummod	O
year	NN	npadvmod	O
overall	JJ	advmod	O
survival	NN	compound	O
rates	NNS	nsubj	O
from	IN	case	O
first	JJ	amod	O
line	NN	compound	O
antiestrogen	NN	nmod	O
and	CC	cc	O
distant	JJ	amod	O
metastases	NNS	conj	O
were	VBD	cop	O
higher	JJR	ROOT	O
than	IN	mark	O
previously	RB	advmod	O
reported	VBN	advcl	O
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
population	NN	nmod	O
.	.	punct	O

Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
administration	NN	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
total	JJ	amod	O
lymphocytes	NNS	nmod	B-Cell
,	,	punct	O
CD4	NN	appos	B-Gene_or_gene_product
+	CC	cc	O
,	,	punct	O
CD8	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
,	,	punct	O
CD16	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
56	CD	conj	B-Gene_or_gene_product
+	CC	cc	O
(	-LRB-	punct	O
NK	NN	compound	O
)	-RRB-	punct	O
cells	NNS	conj	O
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
CRP	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
from	IN	case	O
P	NN	compound	O
<	CD	nmod	O
0	CD	nummod	O
.	.	punct	O
04	CD	nsubj	O
to	TO	case	O
P	NN	compound	O
<	ADD	nmod	O
0	CD	nummod	O
.	.	punct	O
000	CD	ROOT	O
)	-RRB-	punct	O
but	CC	cc	O
no	DT	neg	O
change	NN	conj	O
in	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
TGFbeta1	NN	conj	B-Gene_or_gene_product
during	IN	case	O
clinical	JJ	amod	O
benefit	NN	nmod	O
.	.	punct	O

During	IN	case	O
progressive	JJ	amod	O
disease	NN	nmod	O
no	DT	neg	O
change	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
former	JJ	amod	O
parameters	NNS	nmod	O
,	,	punct	O
concomitant	JJ	advcl	O
with	IN	case	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
10	CD	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
020	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	conj	O
in	IN	case	O
TGFbeta1	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
023	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
confirm	VBP	ROOT	O
that	IN	mark	O
cellular	JJ	amod	B-Cell
immunity	NN	nsubjpass	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
stimulated	VBN	ccomp	O
by	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
only	RB	advmod	O
during	IN	case	O
clinical	JJ	amod	O
benefit	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
different	JJ	amod	O
changes	NNS	nsubj	O
of	IN	case	O
proinflammatory	JJ	amod	O
cytokines	NNS	nmod	O
,	,	punct	O
CRP	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
inhibiting	VBG	amod	O
factors	NNS	conj	O
are	VBP	cop	O
consistent	JJ	ccomp	O
with	IN	case	O
associated	VBN	amod	O
clinical	JJ	amod	O
benefit	NN	nmod	O
or	CC	cc	O
with	IN	case	O
disease	NN	compound	O
progression	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Trib1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
Evi1	NN	conj	B-Gene_or_gene_product
cooperate	VBP	ROOT	O
with	IN	case	O
Hoxa	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
Meis1	NN	conj	B-Gene_or_gene_product
in	IN	case	O
myeloid	JJ	amod	B-Cell
leukemogenesis	NN	nmod	O
.	.	punct	O

Cooperative	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
Meis1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Hoxa9	NN	conj	B-Gene_or_gene_product
perturbs	NNS	ROOT	O
myeloid	JJ	amod	B-Cell
differentiation	NN	dobj	O
and	CC	cc	O
eventually	RB	advmod	O
leads	VBZ	conj	O
myeloid	JJ	amod	B-Cell
progenitors	NNS	dobj	I-Cell
to	TO	case	O
leukemia	NN	nmod	B-Cancer
,	,	punct	O
yet	CC	advmod	O
it	PRP	nsubj	O
remains	VBZ	parataxis	O
to	TO	mark	O
be	VB	auxpass	O
clarified	VBN	xcomp	O
what	WP	det	O
kinds	NNS	nsubjpass	O
of	IN	case	O
subsequent	JJ	amod	O
molecular	JJ	amod	O
processes	NNS	nmod	O
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
overt	JJ	amod	B-Cancer
leukemia	NN	nmod	I-Cancer
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
in	IN	case	O
Hoxa9	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
Meis1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	conj	O
,	,	punct	O
retroviral	JJ	amod	B-Organism
insertional	JJ	amod	O
mutagenesis	NN	nsubjpass	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
using	VBG	xcomp	O
retrovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
transfer	NN	dobj	O
.	.	punct	O

The	DT	det	O
mice	NNS	nsubj	B-Organism
that	WDT	nsubj	O
received	VBD	acl:relcl	O
Hoxa9	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Meis1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
transduced	VBN	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
developed	VBD	ROOT	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	dobj	I-Cancer
(	-LRB-	punct	O
AML	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
Trib1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Evi1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Ahi1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Raralpha	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Pitpnb	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
AK039950	NN	nsubjpass	B-Gene_or_gene_product
were	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
candidate	NN	compound	O
cooperative	JJ	amod	O
genes	NNS	nmod	O
located	JJ	amod	O
near	IN	case	O
common	JJ	amod	O
retroviral	JJ	amod	O
integration	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

Trib1	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
Evi1	NN	conj	B-Gene_or_gene_product
were	VBD	cop	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
due	JJ	case	O
to	TO	mwe	O
retroviral	JJ	amod	B-Organism
insertions	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
significantly	RB	advmod	O
accelerated	VBD	conj	O
the	DT	det	O
onset	NN	dobj	O
of	IN	case	O
Hoxa9	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Meis1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
induced	VBD	amod	O
AML	NN	nmod	B-Cancer
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
Trib1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
Evi1	NN	conj	B-Gene_or_gene_product
are	VBP	cop	O
the	DT	det	O
key	JJ	amod	O
collaborators	NNS	ccomp	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
Trib1	NN	nsubj	B-Gene_or_gene_product
by	IN	case	O
itself	PRP	nmod	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
myeloid	JJ	amod	B-Cell
oncogene	NN	ROOT	O
,	,	punct	O
enhancing	VBG	acl	O
phosphorylation	NN	dobj	O
of	IN	case	O
ERK	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
resulting	VBG	acl	O
in	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
oncogene	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
leukemogenesis	NN	nmod	O
.	.	punct	O

Pro	NN	compound	O
/	SYM	punct	O
antioxidant	JJ	amod	O
status	NN	ROOT	O
and	CC	cc	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
transcription	NN	compound	O
factor	NN	conj	O
in	IN	case	O
murine	JJ	amod	B-Organism
skin	NN	nmod	B-Organ
following	VBG	case	O
topical	JJ	amod	O
exposure	NN	nmod	O
to	TO	case	O
cumene	VB	compound	B-Simple_chemical
hydroperoxide	NN	nmod	I-Simple_chemical
.	.	punct	O

Organic	JJ	amod	B-Simple_chemical
peroxides	NNS	nsubj	I-Simple_chemical
,	,	punct	O
widely	RB	advmod	O
used	VBN	acl	O
in	IN	case	O
the	DT	det	O
chemical	NN	amod	O
and	CC	cc	O
pharmaceutical	JJ	conj	O
industries	NNS	nmod	O
,	,	punct	O
can	MD	aux	O
act	VB	ROOT	O
as	IN	case	O
skin	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
promoters	NNS	nmod	O
and	CC	cc	O
cause	VB	conj	O
epidermal	JJ	amod	B-Pathological_formation
hyperplasia	NN	dobj	I-Pathological_formation
.	.	punct	O

They	PRP	nsubjpass	O
are	VBP	auxpass	O
also	RB	advmod	O
known	VBN	ROOT	O
to	TO	mark	O
trigger	VB	xcomp	O
free	JJ	amod	B-Simple_chemical
radical	NN	amod	I-Simple_chemical
generation	NN	dobj	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
cumene	NN	compound	B-Simple_chemical
hydroperoxide	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
Cum	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	appos	I-Simple_chemical
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
activator	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
linked	VBN	acl:relcl	O
to	TO	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
regulating	VBG	acl	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
growth	NN	conj	O
and	CC	cc	O
transformation	NN	conj	O
.	.	punct	O

Previously	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
reported	VBD	ROOT	O
that	IN	mark	O
topical	JJ	amod	O
exposure	NN	nsubj	O
to	IN	case	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod	I-Simple_chemical
caused	VBD	ccomp	O
formation	NN	dobj	O
of	IN	case	O
free	JJ	amod	B-Simple_chemical
radicals	NNS	nmod	I-Simple_chemical
and	CC	cc	O
oxidative	JJ	amod	O
stress	NN	conj	O
in	IN	case	O
the	DT	det	O
skin	NN	nmod	B-Organ
of	IN	case	O
vitamin	NN	compound	B-Simple_chemical
E	NN	npadvmod	I-Simple_chemical
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
used	VBD	ROOT	O
JB6	NN	compound	O
P	NN	dobj	O
+	CC	cc	O
mouse	NN	compound	B-Organism
epidermal	JJ	amod	O
cells	NNS	conj	O
and	CC	cc	O
AP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
-	HYPH	punct	O
luciferase	NN	nmod:npmod	B-Gene_or_gene_product
reporter	NN	nmod:npmod	O
transgenic	JJ	amod	O
mice	NNS	conj	B-Organism
to	TO	mark	O
identify	VB	advcl	O
whether	IN	mark	O
exposure	NN	nsubj	O
to	IN	case	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod	I-Simple_chemical
caused	VBD	ccomp	O
activation	NN	dobj	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
oxidative	JJ	amod	O
stress	NN	nmod	O
,	,	punct	O
depletion	NN	conj	O
of	IN	case	O
antioxidants	NNS	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
formation	NN	conj	O
during	IN	case	O
two	CD	nummod	O
-	HYPH	punct	O
stage	NN	compound	O
carcinogenesis	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
exposure	NN	nsubj	O
to	IN	case	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod	I-Simple_chemical
reduced	VBD	ccomp	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
glutathione	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
GSH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
in	IN	case	O
mouse	NN	compound	B-Organism
epidermal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
JB6	NN	compound	B-Cell
P	NN	dep	I-Cell
+	CC	cc	I-Cell
)	-RRB-	punct	O
and	CC	cc	O
caused	VBD	conj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
AP	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Mice	NNS	nsubjpass	B-Organism
primed	VBN	acl	O
with	IN	prep	O
dimethyl	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
benz	NN	compound	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
a	DT	det	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
anthracene	NN	nsubjpass	I-Simple_chemical
(	-LRB-	punct	O
DMBA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
were	VBD	auxpass	O
topically	RB	advmod	O
exposed	VBN	ROOT	O
to	IN	case	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod	I-Simple_chemical
(	-LRB-	punct	O
82	CD	nummod	O
.	.	punct	O
6	CD	nummod	O
micromol	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
the	DT	det	O
positive	JJ	amod	O
control	NN	conj	O
,	,	punct	O
12	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
O	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
tetradecanoylphorbol	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
13	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetate	NN	appos	I-Simple_chemical
(	-LRB-	punct	O
TPA	NN	dep	B-Simple_chemical
,	,	punct	O
17	CD	nummod	O
nmol	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
twice	RB	advmod	O
weekly	RB	advmod	O
for	IN	case	O
29	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
skin	NN	nmod	B-Organ
was	VBD	auxpass	O
detected	VBN	ROOT	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
2	CD	nummod	O
weeks	NNS	nmod	O
following	VBG	case	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NN	compound	I-Simple_chemical
or	CC	cc	O
TPA	NN	compound	B-Simple_chemical
exposure	NN	nmod	O
.	.	punct	O

No	DT	neg	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
19	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
initiation	NN	dep	O
.	.	punct	O

Papilloma	NN	compound	B-Pathological_formation
formation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
DMBA	NNP	compound	B-Simple_chemical
-	HYPH	punct	O
TPA	NN	nmod	B-Simple_chemical
-	:	punct	O
and	CC	cc	O
DMBA	NNP	compound	B-Simple_chemical
-	HYPH	punct	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	npadvmod	I-Simple_chemical
-	HYPH	punct	O
exposed	VBN	amod	O
animals	NNS	nmod	B-Organism
,	,	punct	O
whereas	IN	dep	O
skin	NN	compound	B-Cancer
carcinomas	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

A	DT	det	O
greater	JJR	amod	O
accumulation	NN	nsubjpass	O
of	IN	case	O
peroxidative	JJ	amod	O
products	NNS	nmod	O
(	-LRB-	punct	O
thiobarbituric	JJ	amod	B-Simple_chemical
acid	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
reactive	JJ	amod	O
substances	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
inflammation	NN	conj	O
and	CC	cc	O
decreased	VBN	amod	O
levels	NNS	conj	O
of	IN	case	O
GSH	NN	nmod	B-Simple_chemical
and	CC	cc	O
total	JJ	amod	O
antioxidant	JJ	amod	O
reserves	NNS	conj	O
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
skin	NN	nmod	B-Organ
of	IN	case	O
DMBA	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
exposed	VBN	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Cum	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
carcinogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ccomp	O
by	IN	case	O
increased	VBN	amod	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activation	NN	nmod	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
antioxidant	JJ	amod	O
status	NN	nmod	O
.	.	punct	O

Hyperforin	NN	nsubj	B-Simple_chemical
blocks	VBZ	ROOT	O
neutrophil	NN	compound	B-Cell
activation	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
motility	NN	conj	O
and	CC	cc	O
recruitment	NN	conj	O
,	,	punct	O
and	CC	cc	O
restrains	VBZ	conj	O
inflammation	NN	compound	O
-	HYPH	punct	O
triggered	VBN	amod	O
angiogenesis	NN	dobj	O
and	CC	cc	O
lung	NN	compound	B-Organ
fibrosis	NN	conj	O
.	.	punct	O

Hyperforin	NN	ROOT	B-Simple_chemical
(	-LRB-	punct	O
Hyp	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
polyphenol	NN	compound	B-Simple_chemical
-	HYPH	punct	O
derivative	NN	appos	O
of	IN	prep	O
St	NN	pobj	B-Organism
.	.	punct	I-Organism

John	NNP	poss	B-Organism
'	POS	case	I-Organism
s	NNS	compound	I-Organism
wort	NN	nsubj	I-Organism
(	-LRB-	punct	O
Hypericum	NNP	compound	B-Organism
perforatum	NN	appos	I-Organism
)	-RRB-	punct	O
,	,	punct	O
has	VBZ	aux	O
emerged	VBN	ROOT	O
as	IN	prep	O
key	JJ	amod	O
player	NN	pobj	O
not	RB	neg	O
only	RB	cc:preconj	O
in	IN	case	O
the	DT	det	O
antidepressant	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
plant	NN	nmod	O
but	CC	cc	O
also	RB	advmod	O
as	IN	case	O
an	DT	det	O
inhibitor	NN	conj	O
of	IN	case	O
bacteria	NNS	compound	O
lymphocyte	NN	conj	B-Cell
and	CC	cc	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
proteinases	NNS	conj	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
whether	IN	mark	O
as	RB	advmod	O
well	RB	mwe	O
as	IN	mark	O
inhibiting	VBG	advcl	O
leukocyte	NN	compound	B-Gene_or_gene_product
elastase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
LE	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	dobj	O
,	,	punct	O
Hyp	NN	advmod	B-Simple_chemical
might	MD	aux	O
be	VB	cop	O
effective	JJ	parataxis	O
in	IN	mark	O
containing	VBG	advcl	O
both	CC	cc:preconj	O
polymorphonuclear	JJ	amod	B-Cell
neutrophil	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
PMN	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
leukocyte	NN	compound	I-Cell
recruitment	NN	dobj	O
and	CC	cc	O
unfavorable	JJ	amod	O
eventual	JJ	amod	O
tissue	NN	compound	B-Tissue
responses	NNS	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
without	IN	mark	O
affecting	VBG	advcl	O
in	FW	amod	O
vitro	FW	dep	O
human	JJ	amod	B-Organism
PMN	NN	compound	B-Cell
viability	NN	dobj	O
and	CC	cc	O
chemokine	NN	compound	O
-	HYPH	punct	O
receptor	NN	compound	O
expression	NN	conj	O
,	,	punct	O
Hyp	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
as	IN	case	O
stable	JJ	amod	O
dicyclohexylammonium	NN	compound	B-Simple_chemical
salt	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
was	VBD	cop	O
able	JJ	ccomp	O
to	TO	mark	O
inhibit	VB	xcomp	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
their	PRP$	nmod:poss	O
chemotaxis	NN	nsubj	O
and	CC	cc	O
chemoinvasion	NN	conj	O
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	dep	O
1	CD	nummod	O
microM	NN	dobj	O
for	IN	case	O
both	DT	nmod	O
)	-RRB-	punct	O
;	:	punct	O
this	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	parataxis	O
with	IN	case	O
a	DT	det	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
molecule	NN	compound	O
CD11b	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
formyl	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Met	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Leu	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Phe	NNP	npadvmod	I-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
neutrophils	NNS	nmod	B-Cell
and	CC	cc	O
block	NN	conj	O
of	IN	case	O
LE	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
triggered	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
gelatinase	NN	compound	B-Gene_or_gene_product
matrix	NN	compound	I-Gene_or_gene_product
metalloproteinase	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

PMN	NNP	npadvmod	B-Cell
-	HYPH	punct	O
triggered	VBN	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
both	CC	cc:preconj	O
local	JJ	amod	O
injection	NN	nmod	O
and	CC	cc	O
daily	RB	advmod	O
i	NN	conj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
administration	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Hyp	NN	compound	B-Simple_chemical
salt	NN	nmod	O
in	IN	case	O
an	DT	det	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
murine	JJ	amod	B-Organism
model	NN	nmod	O
.	.	punct	O

Furthermore	RB	ROOT	O
,	,	punct	O
i	LS	intj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
treatment	NN	nsubj	O
with	IN	case	O
Hyp	NN	nmod	B-Simple_chemical
reduces	VBZ	ROOT	O
acute	JJ	amod	O
PMN	NN	compound	B-Cell
recruitment	NN	dobj	O
and	CC	cc	O
enhances	VBZ	conj	O
resolution	NN	dobj	O
in	IN	case	O
a	DT	det	O
pulmonary	JJ	amod	B-Organ
bleomycin	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
inflammation	NN	compound	O
model	NN	nmod	O
,	,	punct	O
significantly	RB	advmod	O
reducing	VBG	advcl	O
consequent	JJ	amod	O
fibrosis	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Hyp	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
powerful	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
compound	NN	ccomp	O
with	IN	case	O
therapeutic	JJ	amod	O
potential	NN	nmod	O
,	,	punct	O
and	CC	cc	O
they	PRP	nsubj	O
elucidate	VBP	conj	O
mechanistic	JJ	amod	O
keys	NNS	dobj	O
.	.	punct	O

Impaired	JJ	amod	O
apoptosis	NN	nsubjpass	O
of	IN	case	O
pulmonary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
intimal	JJ	amod	B-Tissue
proliferation	NN	nmod	O
and	CC	cc	O
irreversibility	NN	conj	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
hypertension	NN	nmod	O
in	IN	case	O
congenital	JJ	amod	O
heart	NN	compound	B-Organ
disease	NN	nmod	O
.	.	punct	O

OBJECTIVES	NNS	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubj	O
sought	VBD	dep	O
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
cellular	JJ	amod	B-Cell
and	CC	cc	O
histologic	JJ	conj	O
basis	NN	dobj	O
of	IN	case	O
irreversible	JJ	amod	O
pulmonary	JJ	amod	B-Organ
hypertension	NN	nmod	O
(	-LRB-	punct	O
PHT	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
clinical	JJ	amod	O
setting	NN	nmod	O
of	IN	case	O
congenital	JJ	amod	O
heart	NN	compound	B-Organ
disease	NN	nmod	O
(	-LRB-	punct	O
CHD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Although	IN	mark	O
many	JJ	amod	O
children	NNS	nsubj	B-Organism
with	IN	case	O
CHD	NN	nmod	O
develop	VBP	advcl	O
pulmonary	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
disease	NN	dobj	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	dep	O
why	WRB	advmod	O
this	DT	det	O
complication	NN	nsubj	O
is	VBZ	cop	O
reversible	JJ	ccomp	O
after	IN	prep	O
complete	JJ	amod	O
repair	NN	pobj	O
in	IN	prep	O
some	DT	det	O
cases	NNS	pobj	O
but	CC	cc	O
irreversible	JJ	conj	O
in	IN	case	O
others	NNS	nmod	O
.	.	punct	O

Because	IN	mark	O
failure	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	nmod	O
might	MD	aux	O
lead	VB	advcl	O
to	TO	case	O
intimal	JJ	amod	B-Tissue
proliferation	NN	nmod	O
and	CC	cc	O
lack	NN	conj	O
of	IN	case	O
reversibility	NN	nmod	O
of	IN	case	O
PHT	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
this	DT	dobj	O
and	CC	cc	O
other	JJ	amod	O
key	JJ	amod	O
markers	NNS	conj	O
of	IN	case	O
vasoactivity	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
PHT	NN	nmod	O
and	CC	cc	O
CHD	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
assessed	VBD	dep	O
antiapoptotic	JJ	amod	O
and	CC	cc	O
proapoptotic	JJ	conj	O
markers	NNS	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Cell
and	CC	cc	O
perivascular	JJ	conj	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
lung	NN	compound	B-Multi-tissue_structure
biopsy	NN	compound	I-Multi-tissue_structure
samples	NNS	nmod	I-Multi-tissue_structure
from	IN	case	O
18	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
CHD	NN	nmod	O
,	,	punct	O
7	CD	advmod	O
with	IN	case	O
reversible	JJ	nmod	O
and	CC	cc	O
11	CD	conj	O
with	IN	case	O
irreversible	JJ	amod	O
PHT	NN	nmod	O
,	,	punct	O
and	CC	cc	O
6	CD	nummod	O
control	NN	amod	O
patients	NNS	conj	B-Organism
.	.	punct	O

Immunostaining	NN	nsubjpass	O
for	IN	case	O
endothelial	JJ	amod	B-Gene_or_gene_product
nitric	JJ	amod	I-Gene_or_gene_product
oxide	NN	compound	I-Gene_or_gene_product
synthase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
CD34	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
markers	NNS	appos	O
of	IN	case	O
vasoactivity	NN	nmod	O
and	CC	cc	O
neoangiogenesis	NN	conj	O
)	-RRB-	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
performed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
antiapoptotic	JJ	amod	O
protein	NN	compound	O
Bcl	NN	nsubjpass	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
was	VBD	auxpass	O
highly	RB	advmod	O
expressed	VBN	dep	O
by	IN	case	O
pulmonary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
of	IN	case	O
irreversible	JJ	amod	O
PHT	NN	nmod	O
but	CC	cc	O
in	IN	case	O
no	DT	neg	O
cases	NNS	conj	O
of	IN	case	O
reversible	JJ	amod	O
PHT	NN	nmod	O
,	,	punct	O
nor	CC	cc	O
in	IN	case	O
control	JJ	amod	O
patients	NNS	conj	B-Organism
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Intimal	JJ	amod	B-Tissue
proliferation	NN	nsubj	O
was	VBD	cop	O
present	JJ	ROOT	O
in	IN	case	O
10	CD	compound	O
of	IN	advmod	O
11	CD	nummod	O
irreversible	JJ	amod	O
PHT	NN	compound	O
cases	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
never	RB	neg	O
observed	VBN	conj	O
in	IN	case	O
reversible	JJ	amod	O
PHT	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
perivascular	JJ	amod	B-Cell
inflammatory	JJ	amod	I-Cell
T	NN	compound	I-Cell
-	:	punct	I-Cell
cells	NNS	nsubj	I-Cell
expressed	VBD	ROOT	O
more	RBR	amod	O
antiapoptotic	JJ	amod	O
proteins	NNS	dobj	O
in	IN	case	O
irreversible	JJ	amod	O
PHT	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Irreversible	JJ	amod	O
PHT	NN	compound	O
cases	NNS	nsubj	O
were	VBD	cop	O
also	RB	advmod	O
more	RBR	advmod	O
likely	JJ	ROOT	O
to	TO	mark	O
show	VB	xcomp	O
compensatory	JJ	amod	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
new	JJ	amod	O
small	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	conj	O
at	IN	case	O
the	DT	det	O
sites	NNS	nmod	O
of	IN	case	O
native	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
stenosis	NN	nmod	O
or	CC	cc	O
occlusion	NN	conj	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Irreversible	JJ	amod	O
PHT	NN	nsubjpass	O
is	VBZ	auxpass	O
strongly	RB	advmod	O
associated	VBN	dep	O
with	IN	case	O
impaired	JJ	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	nmod	O
and	CC	cc	O
antiapoptotic	JJ	amod	O
signaling	NN	conj	O
from	IN	case	O
perivascular	JJ	amod	B-Cell
inflammatory	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
changes	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
intimal	JJ	amod	B-Tissue
proliferation	NN	nmod	O
and	CC	cc	O
vessel	NN	compound	B-Multi-tissue_structure
narrowing	VBG	conj	O
,	,	punct	O
and	CC	cc	O
thereby	RB	advmod	O
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
clinical	JJ	amod	O
outcomes	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
pulmonary	JJ	amod	B-Organ
hypertension	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
Dll4	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
signaling	NN	nmod	O
induces	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
immature	JJ	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
poor	JJ	amod	O
tissue	NN	compound	B-Tissue
perfusion	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
various	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
modifiers	NNS	conj	O
critical	JJ	amod	O
for	IN	prep	O
providing	VBG	pcomp	O
arterial	JJ	amod	B-Multi-tissue_structure
or	CC	cc	O
venous	JJ	conj	B-Multi-tissue_structure
identity	NN	dobj	O
,	,	punct	O
interaction	NN	dep	O
with	IN	case	O
the	DT	det	O
surrounding	VBG	amod	O
stroma	NN	nmod	B-Tissue
and	CC	cc	O
tissues	NNS	conj	B-Tissue
,	,	punct	O
hierarchic	JJ	amod	B-Tissue
network	NN	compound	I-Tissue
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
recruitment	NN	conj	O
of	IN	prep	O
pericytes	NNS	pobj	B-Cell
.	.	punct	O

Notch	NN	compound	B-Gene_or_gene_product
receptors	NNS	nsubj	O
and	CC	cc	O
ligands	NNS	conj	O
(	-LRB-	punct	O
Jagged	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
Delta	NNP	conj	B-Gene_or_gene_product
-	HYPH	punct	O
like	NNP	appos	O
)	-RRB-	punct	O
play	VBP	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Dll4	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
Notch	NN	compound	B-Gene_or_gene_product
ligands	NNS	nmod	O
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
arterial	JJ	amod	B-Multi-tissue_structure
specification	NN	dobj	O
and	CC	cc	O
maturation	NN	compound	O
events	NNS	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
function	NN	nmod	O
by	IN	case	O
either	CC	cc:preconj	O
targeted	VBN	amod	O
allele	NN	compound	O
deletion	NN	nmod	O
or	CC	cc	O
use	NN	conj	O
of	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
Dll4	NN	compound	B-Gene_or_gene_product
extracellular	JJ	amod	B-Immaterial_anatomical_entity
domain	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
increased	VBN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
proliferation	NN	nmod	O
but	CC	cc	O
defective	JJ	amod	O
maturation	NN	conj	O
.	.	punct	O

Newly	RB	amod	O
forming	VBG	compound	O
vessels	NNS	nsubj	B-Multi-tissue_structure
have	VBP	ROOT	O
thin	JJ	amod	O
caliber	NN	dobj	B-Immaterial_anatomical_entity
,	,	punct	O
a	DT	det	O
markedly	RB	advmod	O
reduced	VBN	amod	O
vessel	NN	compound	B-Immaterial_anatomical_entity
lumen	NN	appos	I-Immaterial_anatomical_entity
,	,	punct	O
markedly	RB	advmod	O
reduced	VBD	amod	O
pericyte	NN	compound	B-Cell
recruitment	NN	dobj	O
,	,	punct	O
and	CC	cc	O
deficient	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
perfusion	NN	conj	O
.	.	punct	O

sDll4	NN	nsubj	B-Gene_or_gene_product
similarly	RB	advmod	O
induced	VBD	ROOT	O
defective	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
response	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
implants	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
reduced	VBN	amod	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

Interference	NN	nsubj	O
with	IN	case	O
Dll4	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
particularly	RB	advmod	O
desirable	JJ	ROOT	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
that	WDT	nsubj	O
have	VBP	aux	O
highly	RB	advmod	O
induced	VBN	acl:relcl	O
Dll4	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Notch	NN	compound	B-Gene_or_gene_product
pathway	NN	dobj	O
.	.	punct	O

SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
by	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

SWAP	NNP	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
phosphatidylinositol	NN	compound	B-Simple_chemical
trisphosphate	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
PtdIns	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	LS	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
P	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
binding	NN	compound	O
protein	NN	attr	O
,	,	punct	O
which	WDT	nsubj	O
acts	VBZ	acl:relcl	O
in	IN	case	O
F	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
rearrangement	NN	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
SWAP	NNP	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	dep	I-Gene_or_gene_product
in	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
MEFs	NNS	appos	B-Cell
)	-RRB-	punct	O
by	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
use	NN	nmod	O
of	IN	case	O
MEFs	NNS	nmod	B-Cell
defective	JJ	amod	O
in	IN	case	O
SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

v	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	nsubj	I-Gene_or_gene_product
morphologically	RB	advmod	O
transformed	VBD	ROOT	O
MEFs	NNS	dobj	B-Cell
lacking	VBG	acl	O
SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	dobj	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
growth	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
in	IN	case	O
culture	NN	nmod	O
was	VBD	cop	O
slower	JJR	conj	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
supplemented	VBN	acl	O
with	IN	case	O
exogenous	JJ	amod	O
SWAP	NNP	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
MEFs	NNS	nsubj	B-Cell
deficient	JJ	amod	O
in	IN	case	O
SWAP	NNP	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
were	VBD	cop	O
unable	JJ	ROOT	O
to	TO	aux	O
grow	VB	xcomp	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
while	IN	mark	O
those	DT	nsubj	O
expressing	VBG	acl	O
SWAP70	NN	dobj	B-Gene_or_gene_product
readily	RB	advmod	O
formed	VBD	advcl	O
colonies	NNS	dobj	B-Cell
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
SWAP	NNP	nsubjpass	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
anchorage	JJ	amod	O
independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	compound	I-Gene_or_gene_product
transformed	VBD	amod	O
MEFs	NNS	nmod	B-Cell
.	.	punct	O

When	WRB	advmod	O
transplanted	VBN	advcl	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
tumors	NNS	nsubj	B-Cancer
formed	VBN	acl	O
by	IN	case	O
the	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	nmod	I-Gene_or_gene_product
transformed	VBD	advcl	O
SWAP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
MEFs	NNS	nsubj	O
were	VBD	cop	O
smaller	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
formed	VBN	acl	O
by	IN	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
exogenous	JJ	amod	O
SWAP	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
SWAP	NNP	nsubjpass	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
and	CC	cc	O
contributes	VBZ	conj	O
to	TO	case	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
in	IN	case	O
MEFs	NNS	nmod	B-Cell
transformed	VBN	acl	O
by	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Src	NNP	nmod	I-Gene_or_gene_product
.	.	punct	O

Tsg101	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
targeted	VBN	amod	O
overexpression	NN	conj	O
in	IN	case	O
transgenic	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
reveals	VBZ	conj	O
weak	JJ	amod	O
oncogenic	JJ	amod	O
properties	NNS	dobj	O
for	IN	case	O
mammary	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
initiation	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
reported	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
Tumor	NNP	compound	B-Gene_or_gene_product
Susceptibility	NNP	compound	I-Gene_or_gene_product
Gene	NN	nsubjpass	I-Gene_or_gene_product
101	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TSG101	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
upregulated	VBN	ccomp	O
in	IN	case	O
selected	VBN	amod	O
human	JJ	amod	B-Organism
malignancies	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
exogenous	JJ	amod	O
Tsg101	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
suggested	VBN	conj	O
to	TO	mark	O
transform	VB	xcomp	O
immortalized	JJ	amod	O
fibroblasts	NNS	dobj	B-Cell
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

To	IN	case	O
date	NN	nmod	O
,	,	punct	O
the	DT	det	O
potential	JJ	amod	O
oncogenic	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
Tsg101	NN	nmod	B-Gene_or_gene_product
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
examined	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
owing	VBG	xcomp	O
to	IN	case	O
the	DT	det	O
lack	NN	nmod	O
of	IN	case	O
appropriate	JJ	amod	O
model	NN	compound	O
systems	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Tsg101	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
this	DT	det	O
observation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
the	DT	det	O
first	JJ	amod	O
transgenic	JJ	amod	O
mouse	NN	compound	B-Organism
model	NN	dobj	O
with	IN	case	O
a	DT	det	O
targeted	VBN	amod	O
overexpression	NN	nmod	O
of	IN	case	O
Tsg101	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
developing	VBG	amod	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
to	TO	mark	O
test	VB	advcl	O
whether	IN	mark	O
exogenous	JJ	amod	O
Tsg101	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
initiating	VBG	advcl	O
tumorigenesis	NN	dobj	O
.	.	punct	O

Normal	JJ	amod	O
functionality	NN	nsubjpass	O
of	IN	case	O
exogenous	JJ	amod	O
Tsg101	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
tested	VBN	ROOT	O
by	IN	mark	O
rescuing	VBG	advcl	O
the	DT	det	O
survival	NN	dobj	O
of	IN	case	O
Tsg101	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
conditional	JJ	amod	O
knockout	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
Tsg101	NN	nmod	B-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
downstream	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
MAP	NN	compound	B-Gene_or_gene_product
kinases	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

Despite	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
these	DT	det	O
signal	NN	compound	O
transducers	NNS	nmod	O
,	,	punct	O
the	DT	det	O
mammary	JJ	amod	B-Organ
gland	NN	nsubj	I-Organ
of	IN	case	O
females	NNS	nmod	O
expressing	VBG	acl	O
exogenous	JJ	amod	O
Tsg101	NN	dobj	B-Gene_or_gene_product
developed	VBN	ROOT	O
normally	RB	advmod	O
throughout	IN	case	O
the	DT	det	O
reproductive	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O

In	IN	case	O
aging	NN	amod	O
females	NNS	nmod	O
,	,	punct	O
the	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
Tsg101	NN	nmod	B-Gene_or_gene_product
seemed	VBN	ROOT	O
to	TO	mark	O
increase	VB	xcomp	O
the	DT	det	O
susceptibility	NN	dobj	O
of	IN	case	O
mammary	JJ	amod	B-Tissue
epithelia	NN	nmod	I-Tissue
toward	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
owing	VBG	advcl	O
to	IN	case	O
the	DT	det	O
long	JJ	amod	O
latency	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
formation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
sporadic	JJ	amod	O
occurrence	NN	conj	O
of	IN	case	O
bona	FW	compound	O
fide	FW	compound	O
mammary	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
,	,	punct	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
Tsg101	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
has	VBZ	ccomp	O
only	RB	advmod	O
weak	JJ	amod	O
oncogenic	JJ	amod	O
properties	NNS	dobj	O
.	.	punct	O

Instead	RB	advmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
initiation	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
therefore	RB	advmod	O
likely	JJ	ROOT	O
that	IN	mark	O
Tsg101	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
more	RBR	advmod	O
predominant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	mark	O
spontaneously	RB	advmod	O
arising	VBG	acl	O
breast	NN	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
in	IN	case	O
primary	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	conj	O
in	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Disturbances	NNS	nsubj	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
proteins	NNS	nmod	O
take	VBP	ROOT	O
part	NN	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
many	JJ	amod	O
human	JJ	amod	B-Organism
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	cop	O
the	DT	det	O
assessment	NN	ROOT	O
of	IN	case	O
correlations	NNS	nmod	O
among	IN	case	O
proteins	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
apoptosis	NN	compound	O
-	HYPH	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
-	:	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
relationships	NNS	conj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
with	IN	case	O
selected	VBN	amod	O
clinicopathological	JJ	amod	O
features	NNS	nmod	O
in	IN	case	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
the	DT	det	O
avidin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
biotin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
peroxidase	NN	compound	B-Gene_or_gene_product
method	NN	dobj	O
,	,	punct	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	appos	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
56	CD	nummod	O
samples	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
in	IN	case	O
22	CD	nummod	O
matched	VBN	amod	O
pairs	NNS	conj	O
of	IN	case	O
primary	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
evaluation	NN	nsubjpass	O
of	IN	case	O
immunostaining	NN	nmod	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
10	CD	nummod	O
different	JJ	amod	O
tumor	NN	compound	B-Cancer
fields	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
mean	JJ	amod	O
percentage	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
positive	JJ	amod	O
staining	NN	nmod	O
was	VBD	auxpass	O
evaluated	VBN	conj	O
.	.	punct	O

The	DT	det	O
significance	NN	nsubjpass	O
of	IN	prep	O
the	DT	det	O
associations	NNS	pobj	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
using	VBG	xcomp	O
Spearman	JJ	compound	O
correlation	NN	compound	O
analysis	NN	dobj	O
and	CC	cc	O
the	DT	det	O
chi	NN	npadvmod	O
-	HYPH	punct	O
square	JJ	amod	O
test	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
positive	JJ	amod	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
immunostaining	NN	conj	O
in	IN	case	O
44	CD	nmod	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
28	CD	appos	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
58	CD	conj	O
.	.	punct	O
9	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
the	DT	det	O
studied	VBN	amod	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
and	CC	cc	O
in	IN	case	O
63	CD	conj	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
45	CD	appos	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
72	CD	conj	O
.	.	punct	O
7	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
associations	NNS	nmod	O
among	IN	case	O
studied	VBN	amod	O
proteins	NNS	nmod	O
revealed	VBD	ROOT	O
positive	JJ	amod	O
correlation	NN	dobj	O
between	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Bax	NN	conj	B-Gene_or_gene_product
in	IN	case	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
03	CD	dep	O
,	,	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
307	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Statistically	RB	advmod	O
significant	JJ	amod	O
relationship	NN	nsubj	O
between	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	B-Organism_subdivision
cancers	NNS	nmod	B-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	conj	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
02	CD	dep	O
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
increased	VBN	amod	O
expression	NN	conj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
xL	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
in	IN	case	O
metastatic	JJ	amod	O
sites	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
could	MD	aux	O
indicate	VB	ROOT	O
an	DT	det	O
association	NN	dobj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
with	IN	case	O
oral	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
suppose	VBP	ROOT	O
that	DT	mark	O
knowledge	NN	nsubj	O
about	IN	case	O
heterogeneity	NN	nmod	O
between	IN	case	O
primary	JJ	nmod	O
and	CC	cc	O
metastatic	JJ	conj	O
tumor	NN	dep	B-Cancer
might	MD	aux	O
help	VB	ccomp	O
to	TO	mark	O
understand	VB	xcomp	O
mechanisms	NNS	dobj	O
of	IN	case	O
oral	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

An	DT	det	O
antibody	NN	nsubj	B-Gene_or_gene_product
directed	VBN	acl	I-Gene_or_gene_product
against	IN	case	I-Gene_or_gene_product
PDGF	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
enhances	VBZ	ROOT	O
the	DT	det	O
antitumor	NN	dobj	B-Cancer
and	CC	cc	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
activities	NNS	conj	O
of	IN	case	O
an	DT	det	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Platelet	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
PDGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	conj	O
(	-LRB-	punct	O
PDGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
play	VBP	ROOT	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
tumorigenesis	NN	nmod	O
through	IN	mark	O
stimulating	VBG	advcl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
promoting	VBG	conj	O
angiogenesis	NN	dobj	O
via	IN	mark	O
enhancing	VBG	advcl	O
pericyte	NN	compound	B-Cell
recruitment	NN	dobj	O
and	CC	cc	O
vessel	NN	compound	B-Multi-tissue_structure
maturation	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
neutralizing	VBG	amod	O
antibody	NN	dobj	O
,	,	punct	O
1B3	NN	appos	B-Simple_chemical
,	,	punct	O
directed	VBN	acl	O
against	IN	case	O
mouse	NN	compound	B-Organism
PDGFRbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

1B3	NN	nsubj	B-Simple_chemical
binds	VBZ	ROOT	O
to	TO	case	O
PDGFRbeta	NN	nmod	B-Gene_or_gene_product
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
(	-LRB-	punct	O
9x10	NN	dep	O
(	-LRB-	punct	O
-	:	punct	O
11	CD	nummod	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
blocks	VBZ	conj	O
PDGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
BB	NN	dobj	I-Gene_or_gene_product
from	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
the	DT	det	O
receptor	NN	nmod	O
with	IN	case	O
an	DT	det	O
IC	NN	nmod	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
approximately	RB	advmod	O
1	CD	nmod	O
.	.	punct	O
2	CD	nummod	O
nM	NN	ROOT	O
.	.	punct	O

The	DT	det	O
antibody	NN	nsubj	O
also	RB	advmod	O
blocks	VBZ	ROOT	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
stimulated	VBN	amod	O
activation	NN	dobj	O
of	IN	case	O
PDGFRbeta	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
downstream	JJ	amod	O
signaling	VBG	amod	O
molecules	NNS	conj	O
,	,	punct	O
including	VBG	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
MAPK	NN	conj	B-Gene_or_gene_product
p42	NN	conj	I-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
44	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
animal	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
1B3	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
antitumor	NN	dobj	B-Cancer
and	CC	cc	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
activities	NNS	conj	O
of	IN	case	O
DC101	NN	nmod	B-Simple_chemical
,	,	punct	O
an	DT	det	O
antibody	NN	appos	O
directed	VBN	acl	O
against	IN	case	O
mouse	NN	compound	B-Organism
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
a	DT	det	O
pancreatic	JJ	amod	B-Cancer
(	-LRB-	punct	O
BxPC	JJ	compound	B-Cancer
-	SYM	punct	I-Cancer
3	CD	nmod	I-Cancer
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
(	-LRB-	punct	I-Cancer
NCI	NN	compound	I-Cancer
-	:	punct	I-Cancer
H460	NN	appos	I-Cancer
)	-RRB-	punct	I-Cancer
tumor	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
models	NNS	conj	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	case	O
1B3	NN	nmod	B-Simple_chemical
and	CC	cc	O
DC101	NN	conj	B-Simple_chemical
in	IN	case	O
BxPC	JJ	compound	B-Cancer
-	SYM	punct	I-Cancer
3	CD	nummod	I-Cancer
xenograft	NN	npadvmod	I-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
mice	NNS	nmod	B-Organism
resulted	VBD	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cancer
regression	NN	nmod	O
in	IN	case	O
58	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	B-Organism
compared	VBN	advcl	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
18	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
DC101	NN	nmod	B-Simple_chemical
alone	RB	advmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
lend	VBP	ROOT	O
great	JJ	amod	O
support	NN	dobj	O
to	TO	mark	O
use	VB	acl	O
PDGFRbeta	NN	compound	B-Gene_or_gene_product
antagonists	NNS	dobj	I-Gene_or_gene_product
in	IN	case	O
combinations	NNS	nmod	O
with	IN	case	O
other	JJ	amod	O
antitumor	NN	nmod	B-Cancer
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
agents	NNS	conj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
p53	NN	compound	B-Gene_or_gene_product
response	NN	nsubj	O
and	CC	cc	O
immune	JJ	amod	O
reaction	NN	conj	O
underlie	VBP	ROOT	O
highly	RB	advmod	O
effective	JJ	amod	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
radiotherapy	NN	dobj	O
in	IN	case	O
follicular	JJ	amod	B-Cancer
lymphoma	NN	nmod	I-Cancer
.	.	punct	O

Very	RB	amod	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
irradiation	NN	nsubj	O
(	-LRB-	punct	O
2	CD	nummod	O
x	CC	cc	O
2	CD	conj	O
Gy	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
,	,	punct	O
effective	JJ	conj	O
,	,	punct	O
and	CC	cc	O
safe	JJ	conj	O
local	JJ	amod	O
treatment	NN	ROOT	O
for	IN	case	O
follicular	JJ	amod	B-Cancer
lymphoma	NN	nmod	I-Cancer
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
biologic	JJ	amod	O
mechanisms	NNS	dobj	O
of	IN	case	O
this	DT	det	O
extremely	RB	advmod	O
effective	JJ	amod	O
response	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
by	IN	case	O
microarray	NN	nmod	O
the	DT	det	O
gene	NN	compound	O
-	HYPH	punct	O
expression	NN	compound	O
profile	NN	dobj	O
of	IN	case	O
patients	NNS	poss	B-Organism
'	POS	case	O
biopsies	NNS	nmod	B-Cancer
taken	VBN	acl	O
before	RB	advmod	O
and	CC	cc	O
after	IN	conj	O
radiation	NN	pobj	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
patients	NNS	nmod	B-Organism
,	,	punct	O
a	DT	det	O
major	JJ	amod	O
and	CC	cc	O
consistent	JJ	conj	O
induction	NN	nsubjpass	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
was	VBD	auxpass	O
seen	VBN	ROOT	O
.	.	punct	O

p53	NN	compound	B-Gene_or_gene_product
targets	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cycle	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
showed	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
regulation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
both	DT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	ccomp	O
simultaneously	RB	advmod	O
.	.	punct	O

p53	NN	compound	B-Gene_or_gene_product
up	RB	prt	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
proliferation	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
apoptosis	NN	conj	O
were	VBD	auxpass	O
substantiated	VBN	ROOT	O
using	VBG	xcomp	O
immunohistochemistry	NN	dobj	O
,	,	punct	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
intrinsic	JJ	nmod	O
and	CC	cc	O
the	DT	det	O
extrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathways	NNS	conj	O
.	.	punct	O

The	DT	det	O
other	JJ	amod	O
induced	VBN	amod	O
genes	NNS	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
whole	JJ	amod	O
set	NN	dobj	O
of	IN	case	O
biologically	RB	advmod	O
meaningful	JJ	amod	O
genes	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
macrophage	NN	compound	B-Cell
activation	NN	nmod	O
and	CC	cc	O
TH1	NN	compound	B-Gene_or_gene_product
immune	JJ	amod	O
response	NN	conj	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
analysis	NN	nsubj	O
suggested	VBD	ROOT	O
a	DT	det	O
specific	JJ	amod	O
activation	NN	dobj	O
or	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
resident	JJ	amod	O
macrophages	NNS	nmod	B-Cell
by	IN	case	O
apoptotic	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

These	DT	det	O
biologic	JJ	amod	O
insights	NNS	nsubj	O
are	VBP	cop	O
important	JJ	amod	O
arguments	NNS	ROOT	O
to	TO	mark	O
advocate	VB	acl	O
the	DT	det	O
use	NN	dobj	O
of	IN	prep	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
radiotherapy	NN	pobj	O
as	IN	case	O
an	DT	det	O
effective	JJ	amod	O
palliative	JJ	amod	O
treatment	NN	nmod	O
for	IN	case	O
follicular	JJ	amod	B-Cancer
lymphoma	NN	nmod	I-Cancer
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
report	NN	ROOT	O
of	IN	case	O
the	DT	det	O
radiation	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
p53	NN	compound	B-Gene_or_gene_product
apoptotic	JJ	amod	O
response	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
this	DT	det	O
apoptotic	JJ	amod	O
response	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
immunologically	RB	advmod	O
silent	JJ	ccomp	O
.	.	punct	O

Caffeine	NNP	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
adenosine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
accumulation	NN	dobj	O
of	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
hypoxic	JJ	amod	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Frequent	JJ	amod	O
coffee	NN	compound	O
consumption	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
reduced	VBN	amod	O
risk	NN	nmod	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
case	NN	compound	O
-	HYPH	punct	O
control	NN	amod	O
studies	NNS	nmod	O
.	.	punct	O

Coffee	NNP	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
leading	VBG	amod	O
source	NN	attr	O
of	IN	prep	O
methylxanthines	NNS	pobj	B-Simple_chemical
,	,	punct	O
such	JJ	amod	O
as	IN	prep	O
caffeine	NN	pobj	B-Simple_chemical
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
hypoxia	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	xcomp	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
caffeine	NN	nmod	B-Simple_chemical
on	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	compound	O
accumulation	NN	nmod	O
and	CC	cc	O
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
HT29	NN	nmod	I-Cell
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
caffeine	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
inhibits	VBZ	ccomp	O
adenosine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
accumulation	NN	dobj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
are	VBP	auxpass	O
increased	VBN	ccomp	O
through	IN	case	O
A3	NN	compound	B-Gene_or_gene_product
adenosine	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
stimulation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
effects	NNS	nsubjpass	O
on	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
are	VBP	auxpass	O
mediated	VBN	parataxis	O
via	IN	case	O
the	DT	det	O
A2B	NN	compound	B-Gene_or_gene_product
subtype	NN	nmod	O
.	.	punct	O

Pretreatment	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
caffeine	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
reduces	VBZ	ROOT	O
adenosine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
caffeine	NN	nmod	B-Simple_chemical
seems	VBZ	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
the	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
2	CD	nummod	B-Gene_or_gene_product
(	-LRB-	punct	O
ERK1	NN	dep	B-Gene_or_gene_product
/	:	punct	O
2	CD	nummod	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
p38	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Akt	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
adenosine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
accumulation	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
transcriptional	JJ	amod	O
activation	NN	conj	O
,	,	punct	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
protein	NN	compound	O
accumulation	NN	conj	O
.	.	punct	O

From	IN	prep	O
a	DT	det	O
functional	JJ	amod	O
perspective	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
observe	VBP	ROOT	O
that	IN	mark	O
caffeine	NN	nsubj	B-Simple_chemical
also	RB	advmod	O
significantly	RB	advmod	O
inhibits	VBZ	ccomp	O
the	DT	det	O
A3	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
stimulated	VBN	amod	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
of	IN	case	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Conditioned	JJ	amod	O
media	NNS	nsubj	O
prepared	VBN	acl	O
from	IN	case	O
colon	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
treated	VBN	acl	O
with	IN	case	O
an	DT	det	O
adenosine	NN	compound	B-Simple_chemical
analog	NN	nmod	O
increased	VBD	ROOT	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
adenosine	NN	nsubj	B-Simple_chemical
could	MD	aux	O
modulate	VB	ccomp	O
the	DT	det	O
migration	NN	dobj	O
of	IN	case	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
an	DT	det	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
/	:	punct	O
VEGF	NN	conj	B-Gene_or_gene_product
/	:	punct	O
IL	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
mechanism	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
caffeine	NN	nsubj	B-Simple_chemical
has	VBZ	conj	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
inhibit	VB	acl	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
.	.	punct	O

Medical	JJ	amod	O
therapy	NN	ROOT	O
for	IN	case	O
intermittent	JJ	amod	O
claudication	NN	nmod	O
.	.	punct	O

Medical	JJ	amod	O
therapy	NN	nsubj	O
to	TO	mark	O
improve	VB	acl	O
symptoms	NNS	dobj	O
,	,	punct	O
stabilise	JJ	ROOT	O
the	DT	det	O
underlying	VBG	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
disease	NN	dobj	O
and	CC	cc	O
improve	VB	conj	O
lower	JJR	amod	B-Organism_subdivision
limb	NN	compound	I-Organism_subdivision
outcomes	NNS	dobj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
and	CC	cc	O
effective	JJ	conj	O
adjunct	NN	conj	O
to	TO	case	O
lifestyle	NN	compound	O
modification	NN	nmod	O
and	CC	cc	O
surgical	JJ	amod	O
or	CC	cc	O
endovascular	JJ	conj	B-Immaterial_anatomical_entity
interventions	NNS	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
IC	NN	nmod	O
.	.	punct	O

Randomised	VBN	amod	O
placebo	NN	compound	O
controlled	JJ	amod	O
trials	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
phosphodiesterase	NN	compound	B-Gene_or_gene_product
III	CD	nummod	I-Gene_or_gene_product
inhibitor	NN	compound	O
cilostazol	NN	compound	B-Simple_chemical
100mg	JJ	compound	O
bid	NN	nsubj	O
improves	VBZ	ccomp	O
pain	NN	dep	O
-	HYPH	punct	O
free	JJ	amod	O
and	CC	cc	O
maximum	JJ	conj	O
walking	NN	compound	O
distance	NN	dobj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
quality	NN	conj	O
of	IN	prep	O
life	NN	pobj	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
intermittent	JJ	amod	O
claudication	NN	nmod	O
in	IN	case	O
whom	WP	nmod	O
there	EX	expl	O
is	VBZ	conj	O
no	DT	neg	O
evidence	NN	nsubj	O
of	IN	case	O
tissue	NN	compound	B-Tissue
necrosis	NN	nmod	O
or	CC	cc	O
rest	NN	compound	O
pain	NN	conj	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
summarises	VBZ	ROOT	O
the	DT	det	O
evidence	NN	dobj	O
from	IN	case	O
8	CD	nummod	O
pivotal	JJ	amod	O
trials	NNS	nmod	O
of	IN	case	O
cilostazol	NN	nmod	B-Simple_chemical
involving	VBG	acl	O
over	IN	case	O
2000	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
intermittent	JJ	amod	O
claudication	NN	nmod	O
treated	VBN	acl	O
for	IN	case	O
up	RB	advmod	O
to	TO	quantmod	O
6	CD	nummod	O
months	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
comparatively	RB	advmod	O
less	JJR	amod	O
evidence	NN	attr	O
to	TO	aux	O
support	VB	acl	O
the	DT	det	O
use	NN	dobj	O
of	IN	prep	O
other	JJ	amod	O
treatment	NN	compound	O
modalities	NNS	pobj	O
for	IN	prep	O
relief	NN	pobj	O
of	IN	prep	O
symptoms	NNS	pobj	O
in	IN	prep	O
intermittent	JJ	amod	O
claudication	NN	pobj	O
,	,	punct	O
but	CC	cc	O
there	EX	expl	O
is	VBZ	conj	O
considerable	JJ	amod	O
interest	NN	nsubj	O
in	IN	case	O
therapeutic	JJ	amod	O
angiogenesis	NN	nmod	O
to	TO	mark	O
promote	VB	acl	O
new	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	dobj	O
and	CC	cc	O
enhance	VBP	conj	O
collateralisation	NN	dobj	O
of	IN	prep	O
the	DT	det	O
lower	JJR	amod	B-Organism_subdivision
limb	NN	pobj	I-Organism_subdivision
using	VBG	acl	O
recombinant	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
proteins	NNS	dobj	O
or	CC	cc	O
gene	NN	compound	O
transfer	NN	compound	O
strategies	NNS	conj	O
.	.	punct	O

The	DT	det	O
rationale	NN	nsubjpass	O
for	IN	case	O
therapeutic	JJ	amod	O
angiogenesis	NN	nmod	O
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
,	,	punct	O
together	RB	advmod	O
with	IN	prep	O
the	DT	det	O
most	RBS	advmod	O
recent	JJ	amod	O
results	NNS	pobj	O
from	IN	case	O
randomised	VBN	amod	O
trials	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	B-Multi-tissue_structure
arterial	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
.	.	punct	O

Modulating	VBG	ROOT	O
metastasis	NN	dobj	O
by	IN	case	O
a	DT	det	O
lymphangiogenic	JJ	amod	O
switch	NN	nmod	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
dissemination	NN	nsubj	O
is	VBZ	cop	O
difficult	JJ	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
,	,	punct	O
and	CC	cc	O
few	JJ	amod	O
treatment	NN	compound	O
options	NNS	nsubj	O
exist	VBP	conj	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
advanced	JJ	amod	O
-	HYPH	punct	O
stage	NN	compound	O
disease	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	nmod	O
during	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
implemented	VBD	ROOT	O
a	DT	det	O
noninvasive	JJ	amod	O
molecular	JJ	amod	O
imaging	NN	compound	O
technique	NN	dobj	O
to	TO	mark	O
facilitate	VB	acl	O
the	DT	det	O
assessment	NN	dobj	O
of	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
process	NN	nmod	O
.	.	punct	O

The	DT	det	O
metastatic	JJ	amod	O
potentials	NNS	nsubjpass	O
of	IN	case	O
several	JJ	amod	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
models	NNS	nmod	O
,	,	punct	O
LAPC	NN	appos	B-Cell
-	HYPH	punct	I-Cell
4	CD	nummod	I-Cell
,	,	punct	O
LAPC	NN	conj	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
,	,	punct	O
PC3	NN	conj	B-Cell
and	CC	cc	O
CWR22Rv	NN	conj	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
were	VBD	auxpass	O
compared	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
labeled	VBN	ROOT	O
with	IN	case	O
luciferase	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
bioluminescence	NN	compound	O
imaging	VBG	amod	O
reporter	NN	compound	O
gene	NN	appos	O
,	,	punct	O
to	TO	mark	O
enable	VB	advcl	O
optical	JJ	amod	O
imaging	NN	dobj	O
.	.	punct	O

After	IN	case	O
tumor	NN	compound	B-Cancer
implantation	NN	nmod	O
the	DT	det	O
animals	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
examined	VBN	ROOT	O
weekly	RB	advmod	O
during	IN	case	O
several	JJ	amod	O
months	NNS	nmod	O
for	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

Metastatic	JJ	amod	B-Cancer
lesions	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
the	DT	det	O
angiogenic	JJ	amod	O
and	CC	cc	O
lymphangiogenic	JJ	conj	O
profiles	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
were	VBD	auxpass	O
characterized	VBN	ROOT	O
.	.	punct	O

To	TO	mark	O
confirm	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
lymphangiogenesis	NN	nmod	O
in	IN	mark	O
mediating	VBG	advcl	O
metastasis	NN	dobj	O
,	,	punct	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
LAPC	NN	compound	B-Cell
-	:	punct	I-Cell
9	CD	nummod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
engineered	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	dobj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
metastases	NNS	nmod	B-Cancer
was	VBD	auxpass	O
evaluated	VBN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	ROOT	O
CWR22Rv	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
and	CC	cc	O
PC3	NN	conj	B-Cell
tumor	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
to	TO	mark	O
be	VB	cop	O
more	RBR	advmod	O
metastatic	JJ	ccomp	O
than	IN	case	O
LAPC	NN	nmod	B-Cell
-	HYPH	punct	I-Cell
4	CD	nummod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
disseminates	VBZ	acl:relcl	O
more	RBR	advmod	O
readily	RB	advmod	O
than	IN	case	O
LAPC	NN	nmod	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
production	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
lymphangiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
VEGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
lymphatics	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

In	IN	case	O
agreement	NN	nmod	O
,	,	punct	O
induced	VBD	amod	O
overexpression	NN	ROOT	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
LAPC	NN	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
enhanced	VBN	amod	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
.	.	punct	O

Taken	VBN	ROOT	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
studies	NNS	dobj	O
,	,	punct	O
based	VBN	case	O
on	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
imaging	NN	amod	O
approach	NN	nmod	O
for	IN	case	O
semiquantitative	JJ	amod	O
detection	NN	nmod	O
of	IN	case	O
micrometastases	NNS	nmod	O
,	,	punct	O
point	VBP	parataxis	O
to	TO	case	O
an	DT	det	O
important	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
lymphatics	NNS	nmod	I-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
process	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	nsubj	I-Gene_or_gene_product
seems	VBZ	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
metastasis	NN	nmod	O
.	.	punct	O

An	DT	det	O
assay	NN	ROOT	O
to	TO	mark	O
measure	VB	acl	O
angiogenesis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
fat	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
reverses	VBZ	appos	O
rodent	JJ	amod	O
obesity	NN	dobj	O
.	.	punct	O

A	DT	det	O
validated	JJ	amod	O
assay	NN	nsubjpass	O
in	IN	case	O
human	JJ	amod	B-Organism
fat	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
is	VBZ	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
obesity	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Human	JJ	amod	B-Organism
fat	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
fragments	NNS	nsubjpass	O
from	IN	case	O
surgery	NN	nmod	O
were	VBD	auxpass	O
placed	VBN	appos	O
in	IN	prep	O
96	CD	nummod	O
-	HYPH	punct	O
well	JJ	compound	O
plates	NNS	pobj	O
,	,	punct	O
embedded	JJ	advcl	O
in	IN	case	O
fibrin	NN	compound	B-Gene_or_gene_product
thrombin	NN	compound	B-Gene_or_gene_product
clot	NN	nmod	B-Organism_substance
and	CC	cc	O
overlaid	VB	conj	O
with	IN	case	O
cell	NN	compound	B-Cell
culture	NN	compound	O
media	NNS	nmod	O
containing	VBG	acl	O
20	CD	nummod	O
%	NN	amod	O
fetal	JJ	amod	O
bovine	JJ	amod	B-Organism
serum	NN	dobj	B-Organism_substance
.	.	punct	O

After	IN	prep	O
15	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
the	DT	det	O
clots	NNS	nsubjpass	B-Organism_substance
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
histology	NN	nmod	O
and	CC	cc	O
electron	NN	conj	O
microscopy	NN	conj	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
taxol	NN	nmod	B-Simple_chemical
,	,	punct	O
cobalt	NN	compound	B-Simple_chemical
chloride	NN	conj	I-Simple_chemical
and	CC	cc	O
a	DT	det	O
heparin	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
steroid	NN	compound	I-Simple_chemical
combination	NN	conj	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
fat	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
assay	NN	nmod	O
and	CC	cc	O
compared	VBN	conj	O
to	TO	case	O
the	DT	det	O
validated	VBN	amod	O
human	JJ	amod	B-Organism
placental	JJ	amod	B-Multi-tissue_structure
vein	NN	compound	I-Multi-tissue_structure
angiogenesis	NN	compound	O
model	NN	nmod	O
(	-LRB-	punct	O
HPVAM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nsubj	I-Multi-tissue_structure
initiated	VBD	appos	O
growth	NN	dobj	O
and	CC	cc	O
elongated	VBN	conj	O
from	IN	case	O
the	DT	det	O
fat	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
fragments	NNS	nmod	O
over	IN	case	O
15	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

Presence	NN	nsubjpass	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
with	IN	case	O
histology	NN	nmod	O
and	CC	cc	O
electron	NN	compound	O
microscopy	NN	conj	O
.	.	punct	O

Taxol	NN	ROOT	B-Simple_chemical
at	IN	prep	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
completely	RB	advmod	O
inhibited	VBD	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
while	IN	mark	O
Taxol	NN	nsubj	B-Simple_chemical
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
8	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
and	CC	cc	O
the	DT	det	O
heparin	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
steroid	NN	conj	I-Simple_chemical
partially	RB	advmod	O
inhibited	VBD	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
response	NN	nsubj	O
to	TO	case	O
taxol	NN	amod	B-Simple_chemical
and	CC	cc	O
heparin	NN	conj	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
steroid	NN	nmod	I-Simple_chemical
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
HPVAM	NNP	nmod	O
,	,	punct	O
a	DT	det	O
validated	JJ	amod	O
angiogenesis	NN	compound	O
assay	NN	appos	O
.	.	punct	O

Cobalt	NN	compound	B-Simple_chemical
chloride	NN	nsubj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
stimulator	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
stimulated	VBD	ROOT	O
angiogenesis	NN	compound	O
initiation	NN	dobj	O
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
in	IN	case	O
fat	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
the	DT	det	O
HPVAM	NNP	conj	O
,	,	punct	O
but	CC	cc	O
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	nsubjpass	O
was	VBD	auxpass	O
stimulated	VBN	conj	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
fat	NN	compound	B-Tissue
assay	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
This	DT	det	O
angiogenesis	NN	compound	O
assay	NN	nsubj	O
based	VBN	case	O
on	IN	case	O
human	JJ	amod	B-Organism
fat	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
uses	VBZ	ROOT	O
three	CD	nummod	O
-	HYPH	punct	O
dimensionally	RB	advmod	O
intact	JJ	amod	O
human	JJ	amod	B-Organism
tissue	NN	dobj	B-Tissue
.	.	punct	O

The	DT	det	O
vessels	NNS	nsubjpass	B-Multi-tissue_structure
are	VBP	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
quiescient	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
within	IN	case	O
the	DT	det	O
fat	NN	nmod	B-Tissue
.	.	punct	O

These	DT	det	O
properties	NNS	nsubj	O
allow	VBP	ROOT	O
the	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubjpass	O
to	TO	mark	O
be	VB	auxpass	O
evaluated	VBN	ccomp	O
in	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
setting	NN	nmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
fat	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
is	VBZ	cop	O
not	RB	neg	O
identical	JJ	ROOT	O
to	TO	case	O
placental	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

This	DT	det	O
assay	NN	nsubj	O
allows	VBZ	ROOT	O
exploration	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
fat	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

Subcellular	JJ	amod	O
localisation	NN	ROOT	O
of	IN	case	O
BAG	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
regulation	NN	conj	O
of	IN	case	O
vitamin	NN	nmod:npmod	B-Gene_or_gene_product
D	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transactivation	NN	compound	O
and	CC	cc	O
involucrin	NN	conj	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
oral	JJ	amod	B-Cell
keratinocytes	NNS	nmod	I-Cell
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
oral	JJ	amod	B-Organism_subdivision
carcinogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
oral	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
,	,	punct	O
cytoplasmic	JJ	amod	B-Organism_substance
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
overexpression	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
marker	NN	ROOT	O
of	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

BAG	NNP	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
regulates	VBZ	ROOT	O
cellular	JJ	amod	B-Cell
growth	NN	dobj	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
through	IN	case	O
interactions	NNS	nmod	O
with	IN	case	O
diverse	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
vitamin	NN	compound	B-Gene_or_gene_product
D	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VDR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
keratinocyte	NN	nmod	B-Cell
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

BAG	NNP	nsubjpass	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
ubiquitously	RB	advmod	O
in	IN	case	O
human	JJ	amod	B-Organism
cells	NNS	nmod	B-Cell
as	IN	case	O
three	CD	nummod	O
major	JJ	amod	O
isoforms	NNS	nmod	O
of	IN	case	O
50	CD	nummod	O
kDa	NN	compound	O
(	-LRB-	punct	O
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1L	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
46	CD	nummod	O
kDa	NN	appos	O
(	-LRB-	punct	O
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1M	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
36	CD	nummod	O
kDa	NN	conj	O
(	-LRB-	punct	O
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1S	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
from	IN	case	O
a	DT	det	O
single	JJ	amod	O
mRNA	NN	nmod	O
.	.	punct	O

In	IN	case	O
oral	JJ	amod	B-Cell
keratinocytes	NNS	nmod	I-Cell
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1L	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1M	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1S	NN	conj	I-Gene_or_gene_product
,	,	punct	O
enhanced	VBD	ROOT	O
VDR	NN	compound	B-Gene_or_gene_product
transactivation	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
1alpha	NN	compound	B-Simple_chemical
,	,	punct	I-Simple_chemical
25	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dihydroxyvitamin	NN	compound	I-Simple_chemical
D3	NN	nmod	I-Simple_chemical
.	.	punct	O

BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	nsubj	I-Gene_or_gene_product
was	VBD	cop	O
nucleoplasmic	JJ	ROOT	B-Organism_substance
and	CC	cc	O
nucleolar	JJ	conj	B-Cellular_component
,	,	punct	O
whereas	IN	dep	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1S	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1M	NN	conj	I-Gene_or_gene_product
were	VBD	cop	O
cytoplasmic	JJ	parataxis	B-Organism_substance
and	CC	cc	O
nucleoplasmic	JJ	conj	B-Organism_substance
in	IN	case	O
localisation	NN	nmod	O
.	.	punct	O

Having	VBG	aux	O
identified	VBD	advcl	O
the	DT	det	O
nucleolar	JJ	amod	B-Cellular_component
localisation	NN	compound	O
sequence	NN	dobj	O
in	IN	case	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
mutation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
sequence	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
prevent	VB	ccomp	O
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1L	NN	dobj	I-Gene_or_gene_product
from	IN	mark	O
potentiating	VBG	advcl	O
VDR	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	nsubj	I-Gene_or_gene_product
also	RB	advmod	O
potentiated	VBD	ROOT	O
transactivation	NN	dobj	O
of	IN	case	O
known	JJ	amod	O
vitamin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
responsive	JJ	amod	O
gene	NN	compound	O
promoters	NNS	nmod	O
,	,	punct	O
osteocalcin	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
24	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
hydroxylase	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
enhanced	VBN	conj	O
VDR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
transcription	NN	dobj	O
and	CC	cc	O
protein	NN	compound	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
keratinocyte	NN	compound	B-Cell
differentiation	NN	compound	O
marker	NN	nmod	O
,	,	punct	O
involucrin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
endogenous	JJ	amod	O
gene	NN	compound	O
regulation	NN	dobj	O
by	IN	case	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	dep	I-Gene_or_gene_product
by	IN	mark	O
potentiating	VBG	advcl	O
nuclear	JJ	amod	B-Gene_or_gene_product
hormone	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
function	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
BAG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1L	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
24	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
hydroxylase	NN	compound	I-Gene_or_gene_product
regulation	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	B-Simple_chemical
D	NN	compound	I-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	B-Cell
response	NN	conj	O
of	IN	case	O
oral	JJ	amod	B-Cell
keratinocytes	NNS	nmod	I-Cell
to	TO	case	O
1alpha	NN	compound	B-Simple_chemical
,	,	punct	I-Simple_chemical
25	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dihydroxyvitamin	NN	compound	I-Simple_chemical
D3	NN	nmod	I-Simple_chemical
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-Organism_substance
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
isoforms	NNS	nmod	O
,	,	punct	O
BAG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1L	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
act	VB	ROOT	O
to	TO	mark	O
suppress	VB	xcomp	O
tumorigenesis	NN	dobj	O
.	.	punct	O

Transporters	NNS	ROOT	O
,	,	punct	O
enzymes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
enalapril	VB	amod	B-Simple_chemical
removal	NN	conj	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
(	-LRB-	punct	O
CC531	NN	nmod:npmod	B-Cell
-	:	punct	O
induced	VBN	appos	O
)	-RRB-	punct	O
liver	NN	compound	B-Organ
metastatic	JJ	amod	O
model	NN	nmod	O
.	.	punct	O

Temporal	JJ	amod	O
changes	NNS	nsubjpass	O
in	IN	case	O
physiological	JJ	amod	O
spaces	NNS	nmod	O
,	,	punct	O
protein	NN	compound	O
expression	NN	conj	O
of	IN	case	O
transporters	NNS	nmod	O
and	CC	cc	O
enzymes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
enalapril	JJ	amod	B-Simple_chemical
removal	NN	conj	O
were	VBD	auxpass	O
appraised	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
liver	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	nmod	O
developed	VBN	acl	O
from	IN	case	O
male	JJ	amod	O
Wag	NNP	compound	B-Organism
/	SYM	punct	I-Organism
Rij	NNP	compound	I-Organism
rats	NNS	nmod	I-Organism
after	IN	case	O
the	DT	det	O
intraportal	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
CC531	NN	compound	B-Cell
colon	NN	compound	I-Cell
adenocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
;	:	punct	O
sham	VBN	nmod:npmod	O
-	HYPH	punct	O
operated	VBN	amod	O
preparations	NNS	nsubj	O
received	VBD	parataxis	O
PBS	NN	dobj	O
.	.	punct	O

Liver	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
spaces	NNS	nsubj	O
,	,	punct	O
investigated	VBN	acl	O
with	IN	case	O
multiple	JJ	amod	O
indicator	NN	compound	O
dilution	NN	compound	O
technique	NN	nmod	O
in	IN	case	O
liver	NN	compound	B-Organ
perfusion	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
were	VBD	aux	O
unchanged	JJ	ROOT	O
at	IN	case	O
week	NN	nmod	O
3	CD	nummod	O
after	IN	case	O
tumor	NN	compound	B-Cancer
induction	NN	nmod	O
.	.	punct	O

At	IN	prep	O
week	NN	pobj	O
4	CD	nummod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
sinusoidal	JJ	amod	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
volume	NN	nsubj	O
and	CC	cc	O
albumin	NN	compound	B-Gene_or_gene_product
Disse	JJ	compound	O
space	NN	conj	O
in	IN	prep	O
tumor	NN	npadvmod	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
livers	NNS	pobj	B-Organ
were	VBD	cop	O
slightly	RB	advmod	O
lower	JJR	ROOT	O
compared	VBN	case	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
shams	NNS	nmod	O
.	.	punct	O

Increased	VBN	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
canalicular	JJ	amod	B-Multi-tissue_structure
ATP	NN	compound	B-Simple_chemical
transporters	NNS	nmod	O
,	,	punct	O
P	NN	compound	O
-	HYPH	punct	O
glycoprotein	NN	appos	O
,	,	punct	O
multidrug	JJ	compound	B-Gene_or_gene_product
resistance	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
associated	VBN	amod	I-Gene_or_gene_product
protein	NN	appos	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Mrp2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
bile	VB	amod	B-Simple_chemical
salt	NN	compound	I-Simple_chemical
export	NN	compound	O
pump	NN	conj	O
(	-LRB-	punct	O
Bsep	NN	appos	O
)	-RRB-	punct	O
at	IN	case	O
week	NN	nmod	O
2	CD	nummod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
unchanged	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
Ntcp	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Oatp1a1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Oatp1a4	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Mct2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
decreased	VBD	amod	O
levels	NNS	conj	O
of	IN	case	O
cytochrome	NN	compound	B-Gene_or_gene_product
P450	NN	compound	I-Gene_or_gene_product
3a2	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
Cyp3a2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
glutathione	NN	compound	B-Gene_or_gene_product
S	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
transferase	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
Gst4	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
at	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
peritumor	NN	nmod	B-Cell
vs	CC	cc	O
.	.	punct	O
sham	VBN	nmod:npmod	O
-	HYPH	punct	O
operated	VBN	amod	O
liver	NN	compound	B-Tissue
tissues	NNS	ROOT	I-Tissue
with	IN	case	O
Western	NN	compound	O
blotting	NN	nmod	O
.	.	punct	O

The	DT	det	O
steady	JJ	amod	O
-	HYPH	punct	O
state	NN	compound	O
extraction	NN	compound	O
ratio	NN	nsubj	O
of	IN	case	O
enalapril	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
substrate	NN	appos	O
that	WDT	nsubj	O
enters	VBZ	acl:relcl	O
the	DT	det	O
liver	NN	dobj	B-Organ
rapidly	RB	advmod	O
via	IN	case	O
Oatp1a1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
primarily	RB	advmod	O
undergoes	VBZ	ROOT	O
metabolism	NN	dobj	O
by	IN	case	O
the	DT	det	O
carboxylesterases	NNS	nmod	O
,	,	punct	O
was	VBD	aux	O
unaffected	JJ	conj	O
by	IN	case	O
liver	NN	compound	B-Organ
metastasis	NN	nmod	O
at	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
regardless	RB	advmod	O
of	IN	case	O
its	PRP$	poss	O
delivery	NN	nmod	O
via	IN	case	O
the	DT	det	O
portal	JJ	amod	B-Multi-tissue_structure
vein	NN	nmod	I-Multi-tissue_structure
or	CC	cc	O
hepatic	JJ	amod	B-Multi-tissue_structure
artery	NN	conj	I-Multi-tissue_structure
into	IN	case	O
the	DT	det	O
perfused	JJ	amod	O
liver	NN	compound	B-Organ
preparations	NNS	nmod	O
.	.	punct	O

Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	ROOT	O
,	,	punct	O
stem	NN	compound	B-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	B-Cell
origin	NN	conj	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
breast	NN	compound	B-Tissue
epithelium	NN	compound	I-Tissue
comprises	VBZ	compound	O
cells	NNS	ROOT	B-Cell
at	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
stem	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
progenitor	NN	compound	B-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
more	RBR	advmod	O
differentiated	VBN	amod	O
epithelial	JJ	amod	B-Cell
and	CC	cc	O
myoepithelial	JJ	conj	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
stem	NN	compound	B-Cell
/	:	punct	O
progenitor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
other	JJ	amod	O
tissue	NN	compound	B-Multi-tissue_structure
compartments	NNS	conj	I-Multi-tissue_structure
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
strong	JJ	amod	O
evidence	NN	nsubj	O
suggesting	VBG	acl	O
that	IN	mark	O
aberrant	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
induces	VBZ	ccomp	O
mammary	JJ	amod	B-Cancer
tumors	NNS	dobj	I-Cancer
from	IN	case	O
stem	NN	compound	B-Cell
/	:	punct	O
progenitor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
Wnt	NN	nsubj	B-Gene_or_gene_product
exerts	VBZ	conj	O
its	PRP$	nmod:poss	O
oncogenic	JJ	amod	O
effects	NNS	dobj	O
through	IN	case	O
LRP5	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
6	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
activation	NN	conj	O
of	IN	case	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
mTOR	NN	compound	B-Gene_or_gene_product
pathways	NNS	conj	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
using	VBG	acl	O
avian	JJ	amod	B-Organism
retrovirus	NN	compound	I-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
introduction	NN	dobj	O
of	IN	case	O
oncogenes	NNS	nmod	O
into	IN	case	O
a	DT	det	O
small	JJ	amod	O
subset	NN	nmod	O
of	IN	case	O
somatic	JJ	amod	B-Cell
mammary	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
suggest	VBP	ROOT	O
that	IN	mark	O
polyoma	NN	compound	B-Organism
middle	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
PyMT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
may	MD	aux	O
also	RB	advmod	O
preferentially	RB	advmod	O
transform	VB	ccomp	O
stem	NN	compound	B-Cell
/	:	punct	O
progenitor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
stem	NN	compound	B-Cell
/	:	punct	O
progenitor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
may	MD	aux	O
be	VB	cop	O
especially	RB	advmod	O
susceptible	JJ	ccomp	O
to	TO	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Whether	IN	mark	O
more	RBR	amod	O
differentiated	VBN	amod	O
cells	NNS	nsubjpass	B-Cell
may	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
transformed	VBN	nsubjpass	O
by	IN	case	O
particular	JJ	amod	O
oncogenes	NNS	nmod	O
is	VBZ	auxpass	O
actively	RB	advmod	O
debated	VBN	ROOT	O
;	:	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
presently	RB	advmod	O
unclear	JJ	parataxis	O
whether	IN	mark	O
stem	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
or	CC	cc	O
differentiated	VBN	amod	O
mammary	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
are	VBP	cop	O
more	RBR	advmod	O
susceptible	JJ	ccomp	O
to	TO	case	O
transformation	NN	nmod	O
by	IN	case	O
individual	JJ	amod	O
oncogenes	NNS	nmod	O
.	.	punct	O

Better	JJR	amod	O
stem	NN	compound	B-Cell
cell	NN	nsubjpass	I-Cell
and	CC	cc	O
progenitor	NN	compound	B-Cell
cell	NN	compound	I-Cell
markers	NNS	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
ability	NN	conj	O
to	TO	case	O
specifically	RB	advmod	O
target	VB	compound	O
oncogenes	NNS	nmod	O
into	IN	case	O
different	JJ	amod	O
mammary	JJ	amod	B-Cell
cell	NN	compound	I-Cell
types	NNS	nmod	O
will	MD	aux	O
be	VB	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
spectrum	NN	dobj	O
of	IN	case	O
oncogene	NN	compound	O
transformation	NN	nmod	O
for	IN	case	O
stem	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
versus	CC	cc	O
more	RBR	amod	O
differentiated	VBN	amod	O
cells	NNS	conj	B-Cell
.	.	punct	O

Ovarian	JJ	amod	B-Cancer
cancers	NNS	nsubj	I-Cancer
overexpress	VBP	ROOT	O
the	DT	det	O
antimicrobial	JJ	amod	O
protein	NN	dobj	O
hCAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
18	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
derivative	JJ	amod	O
LL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nummod	I-Gene_or_gene_product
increases	VBZ	dep	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
pro	NN	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
peptide	NN	nmod	O
,	,	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	appos	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
pro	NN	compound	O
-	HYPH	punct	O
form	NN	conj	O
,	,	punct	O
human	JJ	amod	B-Gene_or_gene_product
cationic	JJ	amod	I-Gene_or_gene_product
antimicrobial	JJ	amod	I-Gene_or_gene_product
protein	NN	appos	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
hCAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
18	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
cancer	NN	compound	B-Cancer
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
is	VBZ	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
damaged	VBN	nmod	O
and	CC	cc	O
inflamed	JJ	conj	O
tissue	NN	conj	B-Tissue
,	,	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	dep	I-Gene_or_gene_product
functions	NNS	nsubj	O
as	IN	case	O
a	DT	det	O
chemoattractant	NN	nmod	O
,	,	punct	O
mitogen	NN	conj	O
and	CC	cc	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
factor	NN	conj	O
suggesting	VBG	ROOT	O
that	IN	mark	O
the	DT	det	O
peptide	NN	nsubj	O
may	MD	aux	O
potentiate	VB	ccomp	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
characterize	VB	xcomp	O
the	DT	det	O
distribution	NN	dobj	O
of	IN	case	O
hCAP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
cancerous	JJ	conj	O
ovarian	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
to	TO	mark	O
examine	VB	conj	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nmod	I-Gene_or_gene_product
on	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
hCAP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nmod	I-Gene_or_gene_product
was	VBD	aux	O
localized	JJ	ROOT	O
to	TO	case	O
immune	JJ	amod	B-Cell
and	CC	cc	O
granulosa	NN	conj	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
normal	JJ	amod	B-Tissue
ovarian	JJ	amod	I-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ovarian	JJ	amod	B-Cancer
tumors	NNS	nsubj	I-Cancer
displayed	VBD	ROOT	O
significantly	RB	advmod	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
hCAP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nmod	I-Gene_or_gene_product
where	WRB	advmod	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	acl:relcl	O
in	IN	case	O
tumor	NN	nmod	B-Cell
and	CC	cc	O
stromal	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Protein	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
statistically	RB	advmod	O
compared	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
degree	NN	nmod	O
of	IN	case	O
immune	JJ	amod	B-Cell
cell	NN	compound	I-Cell
infiltration	NN	nmod	O
and	CC	cc	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
in	IN	case	O
epithelial	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
derived	VBN	amod	I-Cancer
ovarian	JJ	amod	I-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	conj	O
was	VBD	auxpass	O
observed	VBN	conj	O
for	IN	case	O
both	DT	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
ovarian	JJ	amod	B-Organism_substance
tumor	NN	compound	I-Organism_substance
tissue	NN	compound	I-Organism_substance
lysates	NNS	nsubj	I-Organism_substance
and	CC	cc	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
express	VBP	ccomp	O
hCAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Treatment	NN	ROOT	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
with	IN	case	O
recombinant	JJ	amod	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nummod	I-Gene_or_gene_product
stimulated	VBN	amod	O
proliferation	NN	nmod	O
,	,	punct	O
chemotaxis	NN	conj	O
,	,	punct	O
invasion	NN	conj	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	DT	mark	O
hCAP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	dep	I-Gene_or_gene_product
/	SYM	punct	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
overexpressed	VBN	acl:relcl	O
in	IN	case	O
ovarian	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
suggest	VBP	conj	O
LL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
37	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
ovarian	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
through	IN	case	O
direct	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
initiation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
recruitment	NN	conj	O
of	IN	case	O
immune	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
further	JJ	amod	O
evidence	NN	dobj	O
of	IN	case	O
the	DT	det	O
existing	JJ	amod	O
relationship	NN	nmod	O
between	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
molecules	NNS	nmod	O
and	CC	cc	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	conj	O
.	.	punct	O

Tumor	NN	compound	B-Cancer
microenvironment	NN	ROOT	O
,	,	punct	O
a	DT	det	O
dangerous	JJ	amod	O
society	NN	appos	O
leading	VBG	acl	O
to	TO	case	O
cancer	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

From	IN	case	O
mechanisms	NNS	ROOT	O
to	TO	case	O
therapy	NN	nmod	O
and	CC	cc	O
prevention	NN	conj	O
.	.	punct	O

Cancer	NNP	nsubjpass	B-Cancer
is	VBZ	auxpass	O
no	RB	neg	O
longer	RBR	advmod	O
considered	VBN	ROOT	O
by	IN	agent	O
scientists	NNS	pobj	O
just	RB	advmod	O
a	DT	det	O
jumble	NN	nmod	O
of	IN	case	O
mutated	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

To	TO	aux	O
grow	VB	advcl	O
,	,	punct	O
invade	NN	conj	O
and	CC	cc	O
metastasize	NN	conj	O
,	,	punct	O
a	DT	det	O
treacherous	JJ	amod	O
society	NN	nsubjpass	O
between	IN	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
host	NN	compound	B-Cell
cells	NNS	conj	I-Cell
must	MD	aux	O
be	VB	auxpass	O
formed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
association	NN	nsubj	O
provides	VBZ	conj	O
novel	JJ	amod	O
and	CC	cc	O
effective	JJ	conj	O
clinical	JJ	dep	O
targets	NNS	dobj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
control	NN	nmod	O
and	CC	cc	O
prevention	NN	conj	O
.	.	punct	O

This	DT	det	O
collection	NN	nsubj	O
of	IN	prep	O
reviews	NNS	pobj	O
at	IN	prep	O
the	DT	det	O
front	NN	amod	O
-	HYPH	punct	O
edge	NN	pobj	O
of	IN	prep	O
scientific	JJ	amod	O
knowledge	NN	pobj	O
focuses	VBZ	ROOT	O
on	IN	case	O
host	NN	compound	B-Cell
-	HYPH	punct	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
interactions	NNS	nmod	O
,	,	punct	O
the	DT	det	O
disastrous	JJ	amod	O
consequences	NNS	nsubj	O
they	PRP	nsubj	O
can	MD	aux	O
produce	VB	relcl	O
and	CC	cc	O
approaches	VBZ	conj	O
the	DT	det	O
ways	NNS	dobj	O
to	TO	aux	O
break	VB	acl	O
up	RP	prt	O
these	DT	det	O
cellular	JJ	amod	B-Cell
conspiracies	NNS	dobj	O
,	,	punct	O
to	TO	aux	O
leave	VB	parataxis	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
unattended	VBD	conj	O
and	CC	cc	O
vulnerable	JJ	conj	O
.	.	punct	O

[	-LRB-	punct	O
Photodynamic	JJ	amod	O
therapy	NN	ROOT	O
in	IN	case	O
severe	JJ	amod	O
chronic	JJ	amod	O
central	JJ	amod	O
serous	JJ	amod	B-Organism_substance
chorioretinopaty	NN	nmod	O
]	-RRB-	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
efficacy	NN	dobj	O
of	IN	case	O
Photodynamic	NNP	compound	O
Therapy	NNP	nmod	O
(	-LRB-	punct	O
PDT	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
chronic	JJ	amod	O
Central	JJ	compound	O
Serous	NNP	amod	B-Organism_substance
Chorioretinopathy	NNP	nmod	O
(	-LRB-	punct	O
CSC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Patients	NNS	nsubjpass	B-Organism
diagnosed	VBN	acl	O
with	IN	case	O
chronic	JJ	amod	O
CSC	NN	nmod	O
,	,	punct	O
with	IN	case	O
clinical	JJ	amod	O
evidence	NN	nmod	O
of	IN	case	O
activity	NN	nmod	O
and	CC	cc	O
treated	VBN	conj	O
with	IN	case	O
Photodynamic	NNP	compound	O
Therapy	NNP	nmod	O
,	,	punct	O
are	VBP	auxpass	O
included	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
report	NN	nmod	O
.	.	punct	O

All	DT	nsubjpass	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
complete	JJ	amod	O
ophthalmological	JJ	amod	O
examination	NN	nmod	O
,	,	punct	O
including	VBG	case	O
assessment	NN	nmod	O
of	IN	case	O
the	DT	det	O
best	RBS	amod	O
corrected	VBN	amod	O
visual	JJ	amod	O
acuity	NN	nmod	O
(	-LRB-	punct	O
BCVA	NN	appos	O
)	-RRB-	punct	O
using	VBG	acl	O
an	DT	det	O
ETDRS	NN	compound	O
chart	NN	dobj	O
,	,	punct	O
fluorescein	NN	conj	B-Simple_chemical
and	CC	cc	O
indocyanine	NN	conj	B-Simple_chemical
angiography	NN	dep	O
and	CC	cc	O
optical	JJ	amod	O
coherence	NN	compound	O
tomography	NN	conj	O
(	-LRB-	punct	O
OCT	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
objective	NN	nsubj	O
of	IN	case	O
the	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
mean	JJ	amod	O
visual	JJ	amod	O
acuity	NN	compound	O
change	NN	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
11	CD	nummod	O
eyes	NNS	nsubjpass	B-Organ
of	IN	case	O
11	CD	nummod	O
patients	NNS	nmod	B-Organism
were	VBD	auxpass	O
included	VBN	dep	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
had	VBD	acl:relcl	O
a	DT	det	O
mean	NN	amod	O
follow	NN	compound	O
-	HYPH	punct	O
up	RP	dep	O
period	NN	dobj	O
of	IN	prep	O
11	CD	nummod	O
months	NNS	pobj	O
.	.	punct	O

The	DT	det	O
mean	NN	amod	O
BCVA	NN	nsubj	O
increased	VBD	ROOT	O
from	IN	case	O
20	CD	nummod	O
/	SYM	punct	O
76	CD	compound	O
to	TO	dep	O
20	CD	conj	O
/	SYM	punct	O
64	CD	nmod	O
.	.	punct	O

35	CD	nummod	O
%	NN	nsubj	O
of	IN	prep	O
eyes	NNS	pobj	B-Organ
improved	VBD	ccomp	O
their	PRP$	nmod:poss	O
BCVA	NN	dobj	O
by	IN	case	O
2	CD	nummod	O
lines	NNS	nmod	O
or	CC	cc	O
more	JJR	conj	O
,	,	punct	O
45	CD	nummod	O
%	NN	nsubj	O
remained	VBD	ROOT	O
stable	JJ	acomp	O
and	CC	cc	O
18	CD	nummod	O
%	NN	nsubj	O
lost	VBD	conj	O
2	CD	nummod	O
lines	NNS	dobj	O
or	CC	cc	O
more	JJR	conj	O
.	.	punct	O

Choroidal	JJ	amod	B-Multi-tissue_structure
hyperpermeability	NN	nsubjpass	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
every	DT	det	O
case	NN	nmod	O
.	.	punct	O

Neurosensorial	JJ	amod	O
retinal	JJ	amod	B-Multi-tissue_structure
detachment	NN	nsubj	O
decreased	VBD	ROOT	O
in	IN	case	O
80	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
cases	NNS	nmod	O
.	.	punct	O

Only	RB	advmod	O
one	CD	nummod	O
eye	NN	nsubj	B-Organ
received	VBD	ROOT	O
a	DT	det	O
second	JJ	amod	O
PDT	NN	compound	O
treatment	NN	dobj	O
due	JJ	case	O
to	TO	case	O
choroidal	VB	amod	B-Multi-tissue_structure
neovascularization	NN	nmod	O
.	.	punct	O

An	DT	det	O
increase	NN	nsubjpass	O
of	IN	prep	O
atrophy	NN	pobj	O
over	IN	prep	O
the	DT	det	O
Retinal	NNP	compound	B-Tissue
Pigment	NNP	compound	I-Tissue
Epithelium	NNP	pobj	I-Tissue
(	-LRB-	punct	O
RPE	NN	appos	B-Tissue
)	-RRB-	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
another	DT	det	O
patient	NN	nmod	B-Organism
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
PDT	NN	nsubj	O
can	MD	aux	O
reduce	VB	dep	O
the	DT	det	O
clinical	JJ	amod	O
signs	NNS	dobj	O
of	IN	case	O
activity	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
choroidal	JJ	amod	B-Multi-tissue_structure
hyperpermeability	NN	nmod	O
or	CC	cc	O
neurosensorial	JJ	amod	O
retinal	JJ	amod	B-Multi-tissue_structure
detachment	NN	conj	O
,	,	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
affected	VBN	acl	O
by	IN	case	O
chronic	JJ	amod	O
CSC	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
visual	JJ	amod	O
acuity	NN	nmod	O
is	VBZ	cop	O
variable	JJ	ROOT	O
,	,	punct	O
probably	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
extent	NN	nmod	O
of	IN	case	O
RPE	NN	compound	B-Tissue
damage	NN	nmod	O
.	.	punct	O

Angiopoietin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
prevents	VBZ	ROOT	O
VEGF	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	B-Tissue
permeability	NN	dobj	O
by	IN	prep	O
sequestering	VBG	pcomp	O
Src	NNP	dobj	B-Gene_or_gene_product
through	IN	prep	O
mDia	NNS	pobj	B-Gene_or_gene_product
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
Angiopoietin	NN	conj	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Ang1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
are	VBP	cop	O
both	CC	cc:preconj	O
potent	JJ	amod	O
proangiogenic	JJ	amod	O
factors	NNS	ROOT	O
,	,	punct	O
but	CC	cc	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NN	nsubj	B-Gene_or_gene_product
causes	VBZ	acl:relcl	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	dobj	O
,	,	punct	O
Ang1	NN	nsubj	B-Gene_or_gene_product
stabilizes	VBZ	acl:relcl	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
and	CC	cc	O
protects	VBZ	conj	O
them	PRP	dobj	O
from	IN	case	O
VEGF	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
plasma	NN	compound	B-Organism_substance
leakage	NN	nmod	O
.	.	punct	O

The	DT	det	O
antivascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	compound	O
mechanisms	NNS	nsubjpass	O
deployed	VBN	acl	O
by	IN	case	O
Ang1	NN	nmod	B-Gene_or_gene_product
are	VBP	auxpass	O
still	RB	advmod	O
undefined	JJ	ROOT	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Ang1	NN	nsubj	B-Gene_or_gene_product
halts	VBZ	ccomp	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
induce	VB	acl	O
the	DT	det	O
phosphorylation	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
redistribution	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
molecule	NN	compound	O
VE	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
thereby	RB	advmod	O
rescuing	VBG	advcl	O
the	DT	det	O
endothelial	JJ	amod	B-Tissue
barrier	NN	amod	I-Tissue
function	NN	dobj	O
.	.	punct	O

Ang1	NN	nsubj	B-Gene_or_gene_product
inhibits	VBZ	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
Src	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
upstream	JJ	amod	O
component	NN	dobj	O
of	IN	case	O
the	DT	det	O
pathway	NN	nmod	O
linking	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
receptors	NNS	dobj	O
to	TO	case	O
VE	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
internalization	NN	nmod	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
Ang1	NN	nsubj	B-Gene_or_gene_product
promotes	VBZ	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
mDia	NNS	nmod	B-Gene_or_gene_product
through	IN	case	O
RhoA	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
association	NN	nmod	O
of	IN	case	O
mDia	NNS	nmod	B-Gene_or_gene_product
with	IN	case	O
Src	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

This	DT	nsubj	O
ultimately	RB	advmod	O
deprives	VBZ	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
receptors	NNS	dobj	O
of	IN	case	O
an	DT	det	O
essential	JJ	amod	O
molecule	NN	nmod	O
required	VBN	acl	O
for	IN	mark	O
promoting	VBG	advcl	O
the	DT	det	O
disruption	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
contacts	NNS	nmod	O
and	CC	cc	O
paracellular	JJ	amod	B-Immaterial_anatomical_entity
permeability	NN	conj	O
.	.	punct	O

RUNX1	NN	compound	B-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
-	:	punct	O
binding	VBG	compound	O
mutations	NNS	nsubjpass	O
and	CC	cc	O
RUNX1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
PRDM16	NN	compound	B-Gene_or_gene_product
cryptic	JJ	amod	O
fusions	NNS	conj	O
in	IN	case	O
BCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
ABL	NN	nmod	B-Gene_or_gene_product
+	CC	cc	O
leukemias	NNS	conj	O
are	VBP	auxpass	O
frequently	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
secondary	JJ	amod	O
trisomy	NN	nmod	O
21	CD	nummod	B-Cellular_component
and	CC	cc	O
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
clonal	JJ	amod	B-Cell
evolution	NN	nmod	O
and	CC	cc	O
imatinib	JJ	compound	B-Simple_chemical
resistance	NN	conj	O
.	.	punct	O

Acquired	VBN	amod	O
molecular	JJ	amod	O
abnormalities	NNS	nsubj	O
(	-LRB-	punct	O
mutations	NNS	dep	O
or	CC	cc	O
chromosomal	JJ	amod	B-Cellular_component
translocations	NNS	conj	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
RUNX1	NN	compound	B-Gene_or_gene_product
transcription	NN	compound	O
factor	NN	compound	O
gene	NN	nmod	O
are	VBP	cop	O
frequent	JJ	ROOT	O
in	IN	case	O
acute	JJ	amod	B-Cancer
myeloblastic	JJ	amod	I-Cancer
leukemias	NNS	nmod	I-Cancer
(	-LRB-	punct	O
AMLs	NNS	appos	B-Cancer
)	-RRB-	punct	O
and	CC	cc	O
in	IN	case	O
therapy	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
myelodysplastic	JJ	amod	O
syndromes	NNS	conj	O
,	,	punct	O
but	CC	cc	O
rarely	RB	advmod	O
in	IN	case	O
acute	JJ	amod	B-Cancer
lymphoblastic	JJ	amod	I-Cancer
leukemias	NNS	conj	I-Cancer
(	-LRB-	punct	O
ALLs	NNS	appos	B-Cancer
)	-RRB-	punct	O
and	CC	cc	O
chronic	JJ	amod	B-Cancer
myelogenous	JJ	amod	I-Cancer
leukemias	NNS	conj	I-Cancer
(	-LRB-	punct	O
CMLs	NNS	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Among	IN	prep	O
18	CD	nummod	O
BCR	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ABL	NN	pobj	B-Gene_or_gene_product
+	CC	cc	O
leukemias	NNS	conj	O
presenting	VBG	acl	O
acquired	VBD	amod	O
trisomy	NN	dobj	O
of	IN	case	O
chromosome	NN	nmod	B-Cellular_component
21	CD	nummod	I-Cellular_component
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	O
frequency	NN	dobj	O
(	-LRB-	punct	O
33	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
recurrent	JJ	amod	O
point	NN	compound	O
mutations	NNS	nmod	O
(	-LRB-	punct	O
4	CD	dep	O
in	IN	case	O
myeloid	JJ	amod	B-Cancer
blast	NN	compound	I-Cancer
crisis	NN	nmod	I-Cancer
[	-LRB-	punct	I-Cancer
BC	NN	dep	I-Cancer
]	-RRB-	punct	I-Cancer
CML	NN	conj	I-Cancer
and	CC	cc	O
one	CD	conj	O
in	IN	case	O
chronic	JJ	amod	B-Cancer
phase	NN	compound	I-Cancer
CML	NN	nmod	I-Cancer
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
binding	NN	compound	O
region	NN	nmod	O
of	IN	case	O
RUNX1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
did	VBD	aux	O
not	RB	neg	O
found	VBN	ROOT	O
any	DT	det	O
mutation	NN	dobj	O
in	IN	case	O
de	FW	amod	O
novo	FW	dep	O
BCR	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ABL	NN	nmod	B-Gene_or_gene_product
+	CC	cc	O
ALLs	NNS	conj	O
or	CC	cc	O
lymphoid	JJ	amod	B-Cancer
BC	NN	compound	I-Cancer
CML	NN	conj	I-Cancer
.	.	punct	O

Emergence	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
RUNX1	NN	compound	B-Gene_or_gene_product
mutations	NNS	nmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
at	IN	case	O
diagnosis	NN	nmod	O
or	CC	cc	O
before	IN	case	O
the	DT	det	O
acquisition	NN	conj	O
of	IN	case	O
trisomy	JJ	nmod	O
21	CD	nummod	B-Cellular_component
during	IN	case	O
disease	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
report	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	O
frequency	NN	dobj	O
of	IN	case	O
cryptic	JJ	amod	O
chromosomal	JJ	amod	B-Cellular_component
RUNX1	NN	compound	B-Gene_or_gene_product
translocation	NN	nmod	O
to	TO	case	O
a	DT	det	O
novel	JJ	amod	O
recently	RB	advmod	O
described	VBN	amod	O
gene	NN	compound	O
partner	NN	nmod	O
,	,	punct	O
PRDM16	NN	appos	B-Gene_or_gene_product
on	IN	case	O
chromosome	NN	compound	B-Cellular_component
1p36	NN	nmod	I-Cellular_component
,	,	punct	O
for	IN	case	O
3	CD	nmod	O
(	-LRB-	punct	O
21	CD	nummod	O
.	.	punct	O
4	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
of	IN	case	O
14	CD	nummod	O
investigated	VBN	amod	O
patients	NNS	nmod	B-Organism
:	:	punct	O
2	CD	nummod	O
myeloid	JJ	amod	B-Cancer
BC	NN	compound	I-Cancer
CMLs	NNS	dep	I-Cancer
and	CC	cc	O
,	,	punct	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	conj	O
,	,	punct	O
1	CD	nummod	O
therapy	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
BCR	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ABL	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
ALL	NN	conj	O
.	.	punct	O

Two	CD	nummod	O
patients	NNS	nsubj	B-Organism
presented	VBD	ROOT	O
both	CC	cc:preconj	O
RUNX1	NN	compound	B-Gene_or_gene_product
mutations	NNS	dobj	O
and	CC	cc	O
RUNX1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
PRDM16	NN	compound	B-Gene_or_gene_product
fusion	NN	conj	O
.	.	punct	O

These	DT	det	O
events	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
short	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
support	VBP	conj	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
a	DT	det	O
cooperative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
BCR	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ABL	NN	nmod	B-Gene_or_gene_product
with	IN	case	O
molecular	JJ	amod	O
RUNX1	NN	compound	B-Gene_or_gene_product
abnormalities	NNS	nmod	O
on	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
arrest	NN	compound	O
phenotype	NN	nmod	O
observed	VBN	acl	O
during	IN	case	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-Cancer
and	CC	cc	O
in	IN	case	O
BCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
ABL	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
ALL	NN	conj	O
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
lung	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
by	IN	case	O
adeno	NN	nmod:npmod	B-Organism
-	HYPH	punct	I-Organism
associated	VBN	amod	I-Organism
virus	NN	nmod:npmod	I-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
vasostatin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubj	O
have	VBP	dep	O
strong	JJ	amod	O
therapeutic	JJ	dep	O
potential	NN	dobj	O
as	IN	case	O
antitumor	JJ	compound	B-Cancer
agents	NNS	nmod	O
in	IN	mark	O
suppressing	VBG	advcl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
progression	NN	conj	O
.	.	punct	O

Vasostatin	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
domain	NN	appos	O
of	IN	case	O
calreticulin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
the	DT	det	O
effectiveness	NN	dobj	O
of	IN	case	O
vasostatin	NN	nmod	B-Gene_or_gene_product
delivered	VBN	acl	O
by	IN	case	O
recombinant	JJ	amod	B-Organism
pseudotype	NN	compound	I-Organism
adeno	CD	compound	I-Organism
-	HYPH	punct	I-Organism
associated	VBN	amod	I-Organism
virus	NN	nmod	I-Organism
2	CD	nummod	I-Organism
/	SYM	punct	O
5	CD	nummod	B-Organism
(	-LRB-	punct	O
rAAV2	NN	dep	B-Organism
/	:	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NNP	appos	I-Organism
)	-RRB-	punct	O
as	IN	case	O
a	DT	det	O
gene	NN	compound	O
therapy	NN	compound	O
approach	NN	nmod	O
for	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
treatment	NN	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
used	VBD	ROOT	O
rAAV2	NN	dobj	B-Organism
/	:	punct	O
5	CD	conj	B-Organism
to	TO	mark	O
deliver	VB	xcomp	O
vasostatin	NN	dobj	B-Gene_or_gene_product
intratumorally	RB	advmod	B-Cancer
or	CC	cc	O
systemically	RB	advmod	O
in	IN	prep	O
different	JJ	amod	O
mouse	NN	compound	B-Organism
lung	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
models	NNS	compound	O
-	:	punct	O
-	HYPH	punct	O
subcutaneous	JJ	amod	O
,	,	punct	O
orthotopic	JJ	amod	O
xenograft	NN	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
spontaneous	JJ	amod	O
metastasis	NN	compound	O
lung	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
models	NNS	conj	O
.	.	punct	O

The	DT	det	O
therapeutic	JJ	amod	O
efficacy	NN	nsubjpass	O
of	IN	case	O
rAAV2	NN	compound	B-Organism
/	:	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NNP	nmod	I-Organism
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	mark	O
monitoring	VBG	advcl	O
tumor	NN	compound	B-Cancer
volume	NN	dobj	O
,	,	punct	O
survival	NN	compound	O
rate	NN	conj	O
,	,	punct	O
and	CC	cc	O
degree	NN	conj	O
of	IN	case	O
neovascularization	NN	nmod	O
after	IN	case	O
treatment	NN	nmod	O
in	IN	case	O
these	DT	det	O
models	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Mice	NNS	nsubj	B-Organism
bearing	VBG	acl	O
subcutaneous	JJ	amod	B-Cancer
tumor	NN	dobj	I-Cancer
of	IN	case	O
rAAV2	NN	compound	B-Organism
/	:	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NNP	compound	I-Organism
pretreated	VBD	amod	O
Lewis	JJ	compound	B-Cell
lung	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
showed	VBD	appos	O
>	NN	amod	O
50	CD	compound	O
%	NN	compound	O
reduction	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
volume	NN	nmod	O
and	CC	cc	O
reduced	VBD	conj	O
spontaneous	JJ	amod	O
pulmonary	JJ	amod	B-Organ
metastases	NNS	dobj	O
.	.	punct	O

The	DT	det	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
suppressive	JJ	amod	O
action	NN	nsubj	O
of	IN	case	O
rAAV2	NN	compound	B-Organism
/	SYM	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NN	nmod	I-Organism
in	IN	case	O
subcutaneous	JJ	amod	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
A549	NN	compound	I-Cancer
xenograft	NN	nmod	I-Cancer
correlated	VBD	ROOT	O
with	IN	case	O
a	DT	det	O
reduced	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	B-Tissue
vessels	NNS	nmod	I-Tissue
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
the	DT	det	O
orthotopic	JJ	amod	O
xenograft	NN	compound	B-Cancer
model	NN	nmod	O
,	,	punct	O
rAAV2	NN	compound	B-Organism
/	:	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NNP	nsubj	I-Organism
suppressed	VBD	ROOT	O
metastasis	NN	dobj	O
of	IN	case	O
A549	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
to	TO	case	O
mediastinal	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
contralateral	JJ	amod	O
lung	NN	conj	B-Organ
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
treatment	NN	nsubj	O
of	IN	case	O
immunocompetent	JJ	amod	O
mice	NNS	nmod	B-Organism
in	IN	case	O
the	DT	det	O
spontaneous	JJ	amod	O
lung	NN	compound	B-Organ
metastases	NNS	compound	O
model	VBP	nmod	O
with	IN	case	O
rAAV2	NN	compound	B-Organism
/	SYM	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NNP	nmod	I-Organism
after	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
excision	NN	nmod	O
prolonged	VBD	ROOT	O
their	PRP$	nmod:poss	O
median	JJ	amod	O
survival	NN	dobj	O
from	IN	case	O
21	CD	compound	O
to	TO	dep	O
51	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
days	NNS	ROOT	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	appos	O
the	DT	det	O
effectiveness	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	B-Organism
/	SYM	punct	O
5	CD	nummod	B-Organism
-	HYPH	punct	I-Organism
VAS	NNP	nmod	I-Organism
as	IN	case	O
an	DT	det	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
in	IN	mark	O
suppressing	VBG	acl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
during	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
,	,	punct	O
validating	VBG	advcl	O
the	DT	det	O
application	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	B-Organism
/	SYM	punct	O
5	CD	compound	B-Organism
-	HYPH	punct	I-Organism
VAS	NN	compound	I-Organism
gene	NN	compound	O
therapy	NN	nmod	O
in	IN	case	O
treatment	NN	nmod	O
against	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Radiation	NN	compound	O
retinopathy	NN	nsubj	O
is	VBZ	cop	O
treatable	JJ	ROOT	O
with	IN	case	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
vascular	JJ	amod	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
bevacizumab	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Avastin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
report	VB	dep	O
on	IN	case	O
bevacizumab	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
for	IN	prep	O
radiation	NN	compound	O
retinopathy	NN	pobj	O
affecting	VBG	acl	O
the	DT	det	O
macula	NN	dobj	B-Tissue
.	.	punct	O

PATIENTS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Twenty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
patients	NNS	appos	B-Organism
with	IN	prep	O
radiation	NN	compound	O
retinopathy	NN	pobj	O
(	-LRB-	punct	O
edema	NN	dep	B-Pathological_formation
,	,	punct	O
hemorrhages	NNS	conj	O
,	,	punct	O
capillary	JJ	amod	B-Tissue
dropout	NN	conj	O
,	,	punct	O
and	CC	cc	O
neovascularization	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
subjective	JJ	amod	O
or	CC	cc	O
objective	JJ	conj	O
loss	NN	nsubjpass	O
of	IN	case	O
vision	NN	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
.	.	punct	O

Treatment	NN	nsubj	O
involved	VBD	ROOT	O
intravitreal	JJ	amod	O
injection	NN	dobj	O
of	IN	case	O
bevacizumab	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
1	CD	nummod	O
.	.	punct	O
25	CD	nummod	O
mg	NN	conj	O
in	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	nummod	O
mL	NN	ROOT	O
)	-RRB-	punct	O
every	DT	det	O
6	CD	compound	O
-	SYM	punct	O
12	CD	nummod	O
weeks	NNS	appos	O
.	.	punct	O

Treatment	NN	nsubjpass	O
was	VBD	auxpass	O
discontinued	VBN	ROOT	O
at	IN	case	O
patient	NN	compound	B-Organism
request	NN	nmod	O
or	CC	cc	O
if	IN	mark	O
there	EX	expl	O
was	VBD	conj	O
no	DT	neg	O
measurable	JJ	amod	O
response	NN	nsubj	O
to	TO	case	O
therapy	NN	nmod	O
.	.	punct	O

Main	JJ	amod	O
outcome	NN	compound	O
measures	NNS	nsubj	O
included	VBD	ROOT	O
best	RBS	advmod	O
corrected	VBN	amod	O
visual	JJ	amod	O
acuity	NN	dobj	O
,	,	punct	O
ophthalmic	JJ	amod	O
examination	NN	conj	O
,	,	punct	O
retinal	JJ	amod	B-Multi-tissue_structure
photography	NN	conj	O
,	,	punct	O
and	CC	cc	O
angiography	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Bevacizumab	NN	compound	B-Simple_chemical
treatment	NN	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	dep	O
by	IN	case	O
reductions	NNS	nmod	O
in	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
hemorrhage	NN	nmod	O
,	,	punct	O
exudation	NN	conj	O
,	,	punct	O
and	CC	cc	O
edema	NN	conj	B-Pathological_formation
.	.	punct	O

Visual	JJ	amod	O
acuities	NNS	nsubj	O
were	VBD	ROOT	O
stable	JJ	acomp	O
or	CC	cc	O
improved	VBD	conj	O
in	IN	case	O
86	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
18	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Three	CD	nummod	O
patients	NNS	nsubj	B-Organism
discontinued	VBD	ROOT	O
therapy	NN	dobj	O
.	.	punct	O

Each	DT	nsubj	O
was	VBD	ROOT	O
legally	RB	advmod	O
blind	JJ	acomp	O
before	IN	case	O
treatment	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
1	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
experienced	VBN	conj	O
little	JJ	dobj	O
to	TO	prep	O
no	DT	neg	O
subjective	JJ	amod	O
improvement	NN	pobj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
2	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
was	VBD	cop	O
poorly	RB	advmod	O
compliant	JJ	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
2	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Three	CD	nummod	O
patients	NNS	nsubj	B-Organism
(	-LRB-	punct	O
14	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
regained	VBD	ROOT	O
2	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
lines	NNS	dobj	O
of	IN	case	O
visual	JJ	amod	O
acuity	NN	nmod	O
.	.	punct	O

No	DT	neg	O
ocular	JJ	amod	O
or	CC	cc	O
systemic	JJ	conj	O
bevacizumab	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
related	JJ	amod	O
side	JJ	compound	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Intravitreal	JJ	amod	O
bevacizumab	NN	nsubjpass	B-Simple_chemical
can	MD	aux	O
be	VB	auxpass	O
used	VBN	appos	O
to	TO	aux	O
treat	VB	xcomp	O
radiation	NN	compound	O
retinopathy	NN	dobj	O
.	.	punct	O

In	IN	case	O
most	JJS	amod	O
cases	NNS	compound	O
treatment	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
leakage	NN	nmod	O
,	,	punct	O
stabilization	NN	conj	O
,	,	punct	O
or	CC	cc	O
improved	JJ	amod	O
vision	NN	conj	O
.	.	punct	O

An	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
strategy	NN	nsubj	O
may	MD	aux	O
reduce	VB	ROOT	O
tissue	NN	compound	B-Tissue
damage	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
radiation	NN	compound	O
vasculopathy	NN	nmod	O
and	CC	cc	O
neuropathy	NN	conj	O
.	.	punct	O

Mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
signaling	NN	nsubj	O
promotes	VBZ	ROOT	O
growth	NN	dobj	O
and	CC	cc	O
vascularization	NN	conj	O
of	IN	case	O
fibrosarcoma	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
signaling	NN	nsubj	O
through	IN	case	O
multiple	JJ	amod	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
MAPK	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
kinase	NN	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
MKK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
pathways	NNS	nmod	O
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
vascularization	NN	conj	O
of	IN	prep	O
soft	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
tissue	NN	compound	I-Cancer
sarcomas	NNS	pobj	I-Cancer
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
malignant	JJ	amod	B-Cancer
tumors	NNS	acl:relcl	I-Cancer
derived	VBN	acl	O
from	IN	case	O
mesenchymal	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
this	DT	dobj	O
using	VBG	acl	O
HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
1080	CD	dep	I-Cell
,	,	punct	O
NCI	NN	conj	B-Cell
,	,	punct	O
and	CC	cc	O
Shac	NN	compound	B-Cell
fibrosarcoma	NN	compound	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
and	CC	cc	O
anthrax	NN	compound	B-Organism
lethal	JJ	amod	B-Simple_chemical
toxin	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
LeTx	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
bacterial	JJ	amod	O
toxin	NN	appos	O
that	WDT	nsubj	O
inactivates	VBZ	acl:relcl	O
MKKs	NNS	dobj	B-Gene_or_gene_product
.	.	punct	O

Western	NN	amod	O
blots	NNS	nsubj	O
confirmed	VBD	ROOT	O
that	IN	mark	O
LeTx	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
reduced	VBD	ccomp	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
phosphorylated	VBN	amod	O
extracellular	JJ	amod	B-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
p38	NN	compound	B-Gene_or_gene_product
MAPK	NN	conj	I-Gene_or_gene_product
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Although	IN	mark	O
short	JJ	amod	O
treatments	NNS	nsubj	O
with	IN	case	O
LeTx	NN	nmod	B-Simple_chemical
only	RB	advmod	O
modestly	RB	advmod	O
affected	VBN	advcl	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
sustained	JJ	amod	O
treatment	NN	nsubj	O
markedly	RB	advmod	O
reduced	VBD	ROOT	O
cell	NN	compound	B-Cell
numbers	NNS	dobj	O
.	.	punct	O

LeTx	NN	nsubj	B-Simple_chemical
also	RB	advmod	O
substantially	RB	advmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
release	NN	dobj	O
of	IN	case	O
angioproliferative	JJ	amod	O
factors	NNS	nmod	O
including	VBG	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
derived	VBN	acl	O
from	IN	case	O
malignant	JJ	amod	B-Cancer
fibrous	JJ	amod	I-Cancer
histiocytomas	NNS	nmod	I-Cancer
,	,	punct	O
leiomyosarcomas	NNS	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
liposarcomas	NNS	conj	B-Cancer
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
LeTx	NN	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
MAPK	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
and	CC	cc	O
blocked	VBD	conj	O
fibrosarcoma	NN	compound	B-Cancer
growth	NN	dobj	O
.	.	punct	O

Growth	NN	compound	O
inhibition	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
cellular	JJ	amod	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
extensive	JJ	amod	O
necrosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
mean	NN	compound	O
vessel	NN	compound	B-Multi-tissue_structure
density	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
reduction	NN	conj	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
expression	NN	nmod	O
of	IN	case	O
angioproliferative	JJ	amod	O
cytokines	NNS	nmod	O
.	.	punct	O

Vital	JJ	amod	O
imaging	NN	nsubj	O
using	VBG	acl	O
high	JJ	amod	O
-	HYPH	punct	O
resolution	NN	dobj	O
ultrasound	VBP	dobj	O
enhanced	VBN	acl	O
with	IN	case	O
contrast	NN	compound	O
microbubbles	NNS	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
LeTx	NN	nmod	B-Simple_chemical
on	IN	case	O
tumor	NN	compound	B-Cancer
perfusion	NN	nmod	O
were	VBD	cop	O
remarkably	RB	advmod	O
rapid	JJ	ccomp	O
(	-LRB-	punct	O
less	JJR	advmod	O
than	IN	mwe	O
24	CD	nummod	O
h	NN	dep	O
)	-RRB-	punct	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
perfusion	NN	nmod	O
within	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
nontumor	NN	amod	B-Tissue
tissues	NNS	conj	I-Tissue
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
our	PRP$	nmod:poss	O
initial	JJ	amod	O
hypothesis	NN	nmod	O
and	CC	cc	O
lead	VB	conj	O
us	PRP	dobj	O
to	TO	mark	O
propose	VB	xcomp	O
that	IN	mark	O
MKK	NN	compound	B-Gene_or_gene_product
inhibition	NN	nsubj	O
by	IN	case	O
LeTx	NN	nmod	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
broadly	RB	advmod	O
effective	JJ	amod	O
strategy	NN	ccomp	O
for	IN	mark	O
targeting	VBG	advcl	O
neovascularization	NN	dobj	O
in	IN	case	O
fibrosarcomas	NNS	nmod	B-Cancer
and	CC	cc	O
other	JJ	amod	O
similar	JJ	amod	O
proliferative	JJ	amod	B-Cancer
lesions	NNS	conj	I-Cancer
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
putative	JJ	amod	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	compound	O
receptor	NN	ROOT	O
with	IN	case	O
oncogenic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
detected	VBN	ROOT	O
transforming	NN	amod	O
activity	NN	dobj	O
by	IN	case	O
a	DT	det	O
tumorigenicity	NN	compound	O
assay	NN	nmod	O
using	VBG	acl	O
NIH3T3	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
transfected	VBN	acl	O
with	IN	case	O
DNA	NN	nmod	B-Cellular_component
from	IN	case	O
a	DT	det	O
chronic	JJ	amod	O
myeloproliferative	JJ	amod	O
disorder	NN	compound	O
patient	NN	nmod	B-Organism
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
cDNA	NN	compound	O
cloning	NN	dobj	O
of	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
oncogene	NN	nmod	O
,	,	punct	O
designated	VBN	acl	O
UFO	NN	xcomp	B-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
allusion	NN	advcl	O
to	TO	case	O
the	DT	det	O
as	RB	advmod	O
yet	RB	advmod	O
unidentified	JJ	amod	O
function	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
protein	NN	nmod	O
.	.	punct	O

Nucleotide	NN	compound	O
sequence	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
a	DT	det	O
3116bp	NN	compound	O
cDNA	NN	compound	O
clone	NN	nmod	O
revealed	VBD	ROOT	O
a	DT	det	O
2682	CD	nummod	O
-	HYPH	punct	O
bp	NN	nmod:npmod	O
-	HYPH	punct	O
long	JJ	amod	O
open	JJ	amod	O
reading	NN	compound	O
frame	NN	dobj	O
capable	JJ	amod	O
of	IN	mark	O
directing	VBG	advcl	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
a	DT	det	O
894	CD	nummod	O
amino	NN	compound	O
acid	NN	compound	O
polypeptide	NN	nmod	O
.	.	punct	O

The	DT	det	O
predicted	VBN	amod	O
UFO	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
exhibits	VBZ	ROOT	O
characteristic	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
a	DT	det	O
transmembrane	JJ	amod	B-Cellular_component
receptor	NN	nmod	O
with	IN	case	O
associated	VBN	amod	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
UFO	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogene	NN	nsubj	O
maps	VBZ	ROOT	O
to	TO	case	O
human	JJ	amod	B-Organism
chromosome	NN	compound	O
19q13	NN	nmod	O
.	.	punct	O
1	CD	nummod	O
and	CC	cc	O
is	VBZ	auxpass	O
transcribed	VBN	conj	O
into	IN	case	O
two	CD	nmod	O
5	CD	nummod	O
.	.	punct	O
0	CD	nummod	O
kb	NN	ROOT	O
and	CC	cc	O
3	CD	conj	O
.	.	punct	O
2	CD	nummod	O
kb	NN	compound	O
mRNAs	NNS	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
human	JJ	amod	B-Organism
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
.	.	punct	O

The	DT	det	O
UFO	NN	compound	B-Gene_or_gene_product
locus	NN	nsubjpass	O
is	VBZ	auxpass	O
evolutionarily	RB	advmod	O
conserved	VBN	ROOT	O
between	IN	case	O
vertebrate	JJ	amod	O
species	NNS	nmod	O
.	.	punct	O

A	DT	ROOT	O
4	CD	nummod	O
.	.	punct	O
0	CD	nummod	O
kb	NN	compound	O
mRNA	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-Organism
UFO	NN	compound	B-Gene_or_gene_product
homolog	NN	nmod	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
mouse	NN	compound	B-Organism
tissues	NNS	nmod	B-Tissue
.	.	punct	O

We	PRP	nsubj	O
thus	RB	advmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
element	NN	dobj	O
of	IN	case	O
the	DT	det	O
complex	JJ	amod	O
signaling	NN	compound	O
network	NN	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	nmod	B-Cell
proliferation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Proteomic	JJ	amod	O
comparison	NN	nsubj	O
of	IN	case	O
nasopharyngeal	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
C666	NN	dep	I-Cell
-	:	punct	I-Cell
1	CD	conj	I-Cell
and	CC	cc	O
NP69	NN	conj	B-Cell
identifies	VBZ	ROOT	O
down	RB	amod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
annexin	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
beta2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
tubulin	NN	conj	I-Gene_or_gene_product
for	IN	case	O
nasopharyngeal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

CONTEXT	NN	ROOT	O
:	:	punct	O
Nasopharyngeal	JJ	compound	B-Cancer
carcinoma	NN	nsubj	I-Cancer
(	-LRB-	punct	O
NPC	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
common	JJ	amod	O
in	IN	prep	O
southern	JJ	amod	O
China	NNP	pobj	O
and	CC	cc	O
North	NNP	compound	O
Africa	NNP	conj	O
,	,	punct	O
has	VBZ	dep	O
a	DT	det	O
complex	JJ	amod	O
etiology	NN	dobj	O
involving	VBG	acl	O
interplay	NN	dobj	O
between	IN	case	O
viral	JJ	amod	O
,	,	punct	O
environmental	JJ	conj	O
,	,	punct	O
and	CC	cc	O
hereditary	JJ	conj	O
factors	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
almost	RB	advmod	O
constantly	RB	advmod	O
associated	VBN	conj	O
with	IN	prep	O
the	DT	det	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	pobj	I-Organism
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
prognosis	NN	nsubj	O
of	IN	case	O
locally	RB	advmod	O
advanced	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
diseases	NNS	nmod	O
is	VBZ	cop	O
poor	JJ	advcl	O
,	,	punct	O
increased	VBN	ROOT	O
understanding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
NPC	NN	nmod	B-Cancer
would	MD	aux	O
be	VB	cop	O
important	JJ	xcomp	O
for	IN	mark	O
discovering	VBG	advcl	O
novel	JJ	amod	O
markers	NNS	dobj	O
for	IN	prep	O
patients	NNS	poss	B-Organism
'	POS	case	O
management	NN	pobj	O
.	.	punct	O

OBJECTIVES	NNS	ROOT	O
:	:	punct	O
To	TO	mark	O
compare	VB	dep	O
the	DT	det	O
proteomic	JJ	amod	O
expression	NN	compound	O
profile	NN	dobj	O
between	IN	case	O
an	DT	det	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	nmod:npmod	I-Organism
virus	NN	nmod:npmod	I-Organism
-	HYPH	punct	O
associated	VBN	amod	O
NPC	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
(	-LRB-	punct	O
C666	NN	appos	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
normal	JJ	amod	O
NP	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	conj	I-Cell
(	-LRB-	punct	O
NP69	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
proteins	NNS	nsubjpass	O
with	IN	case	O
differential	JJ	amod	O
expression	NN	nmod	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
40	CD	nummod	O
undifferentiated	JJ	amod	O
NPC	NN	compound	B-Cell
paraffin	NN	dep	O
-	HYPH	punct	O
embedded	JJ	amod	O
specimens	NNS	nmod	B-Tissue
.	.	punct	O

DESIGN	NN	dep	O
:	:	punct	O
Differentially	RB	advmod	O
expressed	VBN	amod	O
proteins	NNS	nsubjpass	O
discovered	VBN	acl	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
were	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
mass	NN	compound	O
spectrometry	NN	nmod	O
.	.	punct	O

After	IN	case	O
confirmation	NN	nmod	O
by	IN	case	O
immunocytochemical	JJ	amod	O
staining	NN	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
in	IN	case	O
patient	NN	compound	B-Organism
samples	NNS	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
using	VBG	xcomp	O
40	CD	nummod	O
pairs	NNS	dobj	O
of	IN	case	O
undifferentiated	JJ	amod	O
NPCs	NNS	nmod	B-Cell
together	RB	advmod	O
with	IN	case	O
their	PRP$	nmod:poss	O
adjacent	JJ	amod	O
normal	JJ	amod	B-Tissue
epithelia	NN	nmod	I-Tissue
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Proteomic	JJ	amod	O
findings	NNS	nsubj	O
indicated	VBD	appos	O
that	IN	mark	O
adenosine	NN	compound	B-Gene_or_gene_product
triphosphate	VBP	compound	I-Gene_or_gene_product
synthase	NN	compound	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
chain	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	cop	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ccomp	O
,	,	punct	O
whereas	IN	dep	O
annexin	NN	nsubjpass	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
annexin	NN	compound	B-Gene_or_gene_product
V	NN	compound	I-Gene_or_gene_product
,	,	punct	O
beta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
tubulin	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
profilin	NN	conj	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
were	VBD	auxpass	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	advcl	O
.	.	punct	O

After	IN	mark	O
confirming	VBG	advcl	O
the	DT	det	O
results	NNS	dobj	O
in	IN	case	O
agar	NN	compound	O
-	HYPH	punct	O
processed	VBN	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
annexin	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
tubulin	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
lower	JJR	xcomp	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
than	IN	case	O
in	IN	case	O
adjacent	JJ	amod	O
normal	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
100	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
90	CD	nummod	O
%	NN	conj	O
of	IN	prep	O
the	DT	det	O
patients	NNS	poss	B-Organism
'	POS	case	O
specimens	NNS	pobj	B-Cell
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
annexin	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
was	VBD	auxpass	O
positively	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
prognostic	JJ	amod	O
factor	NN	ccomp	O
in	IN	case	O
NPC	NN	nmod	B-Cancer
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
annexin	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
tubulin	NN	compound	I-Gene_or_gene_product
down	RB	advmod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
is	VBZ	cop	O
important	JJ	ccomp	O
in	IN	case	O
NPC	NN	compound	B-Cancer
formation	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
represent	VB	conj	O
potential	JJ	amod	O
targets	NNS	dobj	O
for	IN	prep	O
further	JJ	amod	O
investigations	NNS	pobj	O
.	.	punct	O

MMTV	NNP	nmod:npmod	B-Organism
-	HYPH	punct	O
cre	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
fur	NN	compound	B-Gene_or_gene_product
inactivation	NN	nsubj	O
concomitant	JJ	ROOT	O
with	IN	case	O
PLAG1	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogene	NN	compound	O
activation	NN	compound	O
delays	NNS	nmod	O
salivary	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
tumorigenesis	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Proprotein	NN	compound	O
convertases	NNS	nsubj	O
are	VBP	cop	O
serine	NN	amod	B-Amino_acid
endoproteases	NNS	ROOT	O
implicated	VBN	acl	O
in	IN	case	O
the	DT	det	O
proteolytic	JJ	amod	O
processing	NN	nmod	O
of	IN	case	O
a	DT	det	O
large	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
regulatory	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

An	DT	det	O
important	JJ	amod	O
role	NN	nsubjpass	O
of	IN	case	O
proprotein	NN	compound	O
convertases	VBZ	nmod	O
in	IN	case	O
tumorigenic	JJ	amod	O
processes	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
by	IN	case	O
various	JJ	amod	O
studies	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
proprotein	NN	compound	O
convertase	NN	compound	O
furin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
PLAG1	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogene	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
salivary	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
tumorigenesis	NN	nmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

PLAG1	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubjpass	O
in	IN	case	O
salivary	JJ	amod	B-Organ
glands	NNS	nmod	I-Organ
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
result	VB	xcomp	O
in	IN	case	O
salivary	JJ	amod	B-Cancer
gland	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
in	IN	case	O
100	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	B-Organism
within	IN	case	O
5	CD	nummod	O
weeks	NNS	nmod	O
after	IN	prep	O
birth	NN	pobj	O
.	.	punct	O

MMTV	NNP	nmod:npmod	B-Organism
-	HYPH	punct	O
cre	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
inactivation	NN	nsubj	O
of	IN	case	O
fur	NN	nmod	B-Gene_or_gene_product
without	IN	case	O
over	RB	advmod	O
-	HYPH	punct	O
expression	NN	nmod	O
of	IN	case	O
PLAG1	NN	nmod	B-Gene_or_gene_product
caused	VBD	ROOT	O
smaller	JJR	amod	O
but	CC	cc	O
histologically	RB	advmod	O
normal	JJ	amod	O
salivary	JJ	amod	B-Organ
glands	NNS	dobj	I-Organ
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nsubjpass	I-Multi-tissue_structure
close	RB	amod	O
to	IN	case	O
the	DT	det	O
salivary	JJ	amod	B-Organ
glands	NNS	nmod	I-Organ
were	VBD	auxpass	O
enlarged	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
histology	NN	nsubj	O
showed	VBD	conj	O
that	IN	mark	O
they	PRP	nsubj	O
had	VBD	ccomp	O
activated	VBN	amod	O
follicles	NNS	dobj	B-Multi-tissue_structure
.	.	punct	O

When	WRB	advmod	O
genetic	JJ	amod	O
ablation	NN	nsubjpass	O
of	IN	case	O
1	CD	nummod	O
or	CC	cc	O
2	CD	conj	O
alleles	NNS	nmod	O
of	IN	case	O
fur	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
the	DT	det	O
PLAG1	NN	compound	B-Gene_or_gene_product
transgene	NN	nmod	O
were	VBD	auxpass	O
simultaneously	RB	advmod	O
achieved	VBN	advcl	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
delay	NN	nsubjpass	O
in	IN	case	O
tumorigenesis	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
furin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
PLAG1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
salivary	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
tumorigenesis	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Isotype	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
inhibitors	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
glycolytic	JJ	amod	O
key	JJ	amod	O
regulator	NN	compound	O
pyruvate	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
subtype	NN	compound	I-Gene_or_gene_product
M2	NN	nmod	I-Gene_or_gene_product
moderately	RB	advmod	O
decelerate	VBP	ROOT	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
.	.	punct	O

Tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
express	VBP	ROOT	O
the	DT	det	O
glycolytic	JJ	amod	O
regulator	NN	dobj	O
pyruvate	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
subtype	NN	compound	I-Gene_or_gene_product
M2	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
M2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
PK	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
occur	VB	acl:relcl	O
in	IN	case	O
a	DT	det	O
tetrameric	JJ	amod	O
form	NN	nmod	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
substrate	JJ	compound	O
phosphoenolpyruvate	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
PEP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
dimeric	JJ	amod	O
form	NN	conj	O
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
PEP	NN	compound	B-Simple_chemical
affinity	NN	nmod	O
.	.	punct	O

The	DT	det	O
transition	NN	nsubj	O
between	IN	case	O
both	DT	det	O
conformations	NNS	nmod	O
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
important	JJ	conj	O
for	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
targeted	VBD	ROOT	O
M2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
PK	NN	dobj	I-Gene_or_gene_product
by	IN	case	O
synthetic	JJ	amod	O
peptide	NN	compound	O
aptamers	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
specifically	RB	advmod	O
bind	VBP	acl:relcl	O
to	TO	case	O
M2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PK	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
shift	VB	conj	O
the	DT	det	O
isoenzyme	NN	dobj	O
into	IN	case	O
its	PRP$	nmod:poss	O
low	JJ	amod	O
affinity	NN	compound	O
dimeric	JJ	amod	O
conformation	NN	nmod	O
.	.	punct	O

The	DT	det	O
aptamer	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
dimerization	NN	nsubj	O
and	CC	cc	O
inactivation	NN	conj	O
of	IN	case	O
M2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PK	NN	nmod	I-Gene_or_gene_product
led	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
PK	NN	compound	B-Gene_or_gene_product
mass	NN	compound	O
-	:	punct	O
action	NN	compound	O
ratio	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
ATP	NN	conj	B-Simple_chemical
:	:	punct	O
ADP	NN	compound	B-Simple_chemical
ratio	NN	dep	O
in	IN	case	O
the	DT	det	O
target	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
M2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PK	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
peptide	NN	compound	O
aptamers	NNS	nmod	O
moderately	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
immortalized	VBN	amod	O
NIH3T3	NN	compound	B-Cell
cell	NN	compound	I-Cell
populations	NNS	nmod	I-Cell
by	IN	mark	O
decelerating	VBG	advcl	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
but	CC	cc	O
without	IN	mark	O
affecting	VBG	conj	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
M2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PK	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
peptide	NN	compound	O
aptamers	NNS	nsubj	O
also	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
proliferation	NN	compound	O
rate	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
U	NN	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
OS	NN	compound	I-Cell
osteosarcoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
developed	VBD	ROOT	O
the	DT	det	O
first	JJ	amod	O
specific	JJ	amod	O
inhibitors	NNS	dobj	O
of	IN	case	O
the	DT	det	O
pyruvate	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
isoenzyme	NN	compound	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
M2	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
present	JJ	amod	O
evidence	NN	conj	O
that	IN	mark	O
these	DT	det	O
inhibitors	NNS	nsubj	O
moderately	RB	advmod	O
decelerate	VBP	ccomp	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
.	.	punct	O

Hematogenous	JJ	amod	O
metastasis	NN	nsubj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
requires	VBZ	ROOT	O
isolated	VBN	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Recent	JJ	amod	O
studies	NNS	nsubj	O
of	IN	case	O
cancer	NN	compound	B-Cancer
metastasis	NN	nmod	O
have	VBP	aux	O
focused	VBN	dep	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
premetastatic	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
circulating	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

We	PRP	nsubj	O
did	VBD	ROOT	O
a	DT	det	O
blind	JJ	amod	O
prospective	JJ	amod	O
study	NN	dobj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
isolated	VBN	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ITC	NN	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
within	IN	case	O
the	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
at	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
,	,	punct	O
premetastatic	JJ	amod	B-Multi-tissue_structure
sites	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubjpass	I-Multi-tissue_structure
and	CC	cc	O
peripheral	JJ	amod	B-Organism_substance
blood	NN	compound	I-Organism_substance
samples	NNS	conj	I-Organism_substance
from	IN	case	O
810	CD	nummod	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
were	VBD	auxpass	O
collected	VBN	dep	O
at	IN	case	O
the	DT	det	O
Central	NNP	compound	O
Hospital	NNP	nmod	O
,	,	punct	O
National	NNP	compound	O
Cancer	NNP	compound	O
Center	NNP	appos	O
(	-LRB-	punct	O
Tokyo	NNP	appos	O
,	,	punct	O
Japan	NNP	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
samples	NNS	nsubjpass	O
were	VBD	auxpass	O
transferred	VBN	ROOT	O
to	IN	case	O
Kyushu	NNP	compound	O
University	NNP	compound	O
Hospital	NNP	nmod	O
(	-LRB-	punct	O
Beppu	NNP	dep	O
,	,	punct	O
Japan	NNP	appos	O
)	-RRB-	punct	O
where	WRB	advmod	O
they	PRP	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	acl:relcl	O
by	IN	case	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
reverse	NN	dep	O
transcription	NN	compound	O
-	:	punct	O
PCR	NN	nmod	O
for	IN	case	O
three	CD	nummod	O
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
markers	NNS	nmod	O
,	,	punct	O
carcinoembryonic	JJ	amod	B-Gene_or_gene_product
antigen	NN	appos	I-Gene_or_gene_product
,	,	punct	O
cytokeratin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
19	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
cytokeratin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
7	CD	conj	I-Gene_or_gene_product
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
VEGFR	NNP	conj	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
ITCs	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
peripheral	JJ	amod	B-Organism_substance
blood	NN	nmod	I-Organism_substance
and	CC	cc	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	conj	I-Multi-tissue_structure
even	RB	advmod	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
frequency	NN	nsubjpass	O
of	IN	case	O
ITC	NN	nmod	B-Cell
in	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
stage	NN	nmod	O
of	IN	case	O
disease	NN	nmod	O
by	IN	case	O
ANOVA	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
01	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Gastric	JJ	amod	B-Cancer
cancer	NN	nsubj	I-Cancer
metastasized	VBD	ROOT	O
when	WRB	advmod	O
ITCs	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
observed	VBN	advcl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
the	DT	det	O
380	CD	nummod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
were	VBD	cop	O
ITC	NN	nmod:npmod	B-Cell
negative	JJ	acl:relcl	O
and	CC	cc	O
showed	VBD	conj	O
low	JJ	amod	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
synchronous	JJ	amod	O
(	-LRB-	punct	O
at	IN	case	O
the	DT	det	O
time	NN	dep	O
of	IN	case	O
surgery	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
heterochronous	JJ	amod	O
(	-LRB-	punct	O
recurrent	JJ	dep	O
)	-RRB-	punct	O
metastases	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
ITCs	NNS	nsubj	B-Cell
circulate	VBP	appos	O
even	RB	advmod	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
disease	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
elevated	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
facilitates	VBZ	ROOT	O
the	DT	det	O
establishment	NN	dobj	O
of	IN	case	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
simultaneous	JJ	amod	O
presence	NN	nsubj	O
of	IN	case	O
ITC	NN	nmod	B-Cell
and	CC	cc	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
expression	NN	nmod	O
at	IN	case	O
premetastatic	JJ	amod	B-Multi-tissue_structure
sites	NNS	nmod	I-Multi-tissue_structure
is	VBZ	cop	O
clinically	RB	advmod	O
significant	JJ	ccomp	O
for	IN	case	O
disease	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

Acute	JJ	amod	O
ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
disrupts	VBZ	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
cell	NN	compound	B-Cell
signaling	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Physiological	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
various	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
signaling	NN	nmod	O
through	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
VEGF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
single	JJ	amod	O
dose	NN	nsubj	O
of	IN	case	O
ethanol	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
1	CD	dep	O
.	.	punct	O
4	CD	nummod	O
g	NN	dep	O
/	SYM	punct	O
kg	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
yielding	VBG	acl	O
a	DT	det	O
blood	NN	compound	B-Organism_substance
alcohol	NN	compound	B-Simple_chemical
concentration	NN	dobj	O
of	IN	case	O
100	CD	nummod	O
mg	NN	nmod	O
/	:	punct	O
dl	NN	appos	O
,	,	punct	O
significantly	RB	advmod	O
impairs	VBZ	ccomp	O
angiogenesis	NN	dobj	O
in	IN	case	O
murine	JJ	amod	B-Organism
wounds	NNS	nmod	B-Pathological_formation
,	,	punct	O
despite	IN	case	O
adequate	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
suggesting	VBG	advcl	O
direct	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
ethanol	NN	nmod	B-Simple_chemical
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
signaling	NN	nmod	O
(	-LRB-	punct	O
40	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ethanol	NN	nsubj	B-Simple_chemical
influences	VBZ	acl:relcl	O
angiogenesis	NN	dobj	O
in	IN	case	O
wounds	NNS	nmod	B-Pathological_formation
,	,	punct	O
we	PRP	nsubj	O
employed	VBD	ROOT	O
two	CD	nummod	O
different	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
angiogenesis	NN	compound	O
assays	NNS	dobj	O
to	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
acute	JJ	amod	O
ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
(	-LRB-	punct	O
100	CD	nummod	O
mg	NN	dep	O
/	:	punct	O
dl	NN	appos	O
)	-RRB-	punct	O
would	MD	aux	O
have	VB	ccomp	O
long	RB	advmod	O
-	HYPH	punct	O
lasting	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
VEGF	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
capillary	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
.	.	punct	O

Ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
reduced	VBN	amod	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
cord	NN	compound	B-Tissue
formation	NN	nmod	O
on	IN	case	O
collagen	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
reduced	VBD	amod	O
capillary	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
structure	NN	conj	O
on	IN	case	O
Matrigel	NNP	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
decreased	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
phosphorylation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
ethanol	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
by	IN	case	O
4	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methylpyrazole	NN	nmod	I-Simple_chemical
partially	RB	advmod	O
abrogated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
ethanol	NN	nmod	B-Simple_chemical
on	IN	case	O
endothelial	JJ	amod	B-Tissue
cell	NN	compound	I-Tissue
cord	NN	compound	I-Tissue
formation	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
mice	NNS	nsubj	B-Organism
treated	VBN	acl	O
with	IN	case	O
t	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butanol	NN	nmod	I-Simple_chemical
,	,	punct	O
an	DT	det	O
alcohol	NN	appos	B-Simple_chemical
not	RB	neg	O
metabolized	VBN	acl	O
by	IN	case	O
alcohol	NN	compound	B-Gene_or_gene_product
dehydrogenase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
exhibited	VBD	ROOT	O
no	DT	neg	O
change	NN	dobj	O
in	IN	case	O
wound	NN	compound	B-Pathological_formation
vascularity	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
products	NNS	nsubj	O
of	IN	case	O
ethanol	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
are	VBP	cop	O
important	JJ	amod	O
factors	NNS	ccomp	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
ethanol	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
changes	NNS	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
responsiveness	NN	nmod	O
to	TO	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
caused	VBD	ROOT	O
both	CC	cc:preconj	O
decreased	VBN	amod	O
angiogenesis	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
hypoxia	NN	conj	O
in	IN	case	O
wounds	NNS	nmod	B-Pathological_formation
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
in	FW	amod	O
vitro	FW	dep	O
experiments	NNS	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
direct	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
ethanol	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
response	NN	nmod	O
to	TO	case	O
hypoxia	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	IN	mark	O
ethanol	NN	nsubj	B-Simple_chemical
diminished	VBD	advcl	O
nuclear	JJ	amod	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
levels	NNS	dobj	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
the	DT	det	O
data	NNS	nsubj	O
establish	VBP	ROOT	O
that	IN	mark	O
acute	JJ	amod	O
ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
significantly	RB	advmod	O
impairs	VBZ	ccomp	O
angiogenesis	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
this	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
responsiveness	NN	nmod	O
to	TO	case	O
both	CC	cc:preconj	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
hypoxia	NN	conj	O
.	.	punct	O

Adenomatoid	JJ	amod	B-Cancer
tumour	NN	ROOT	I-Cancer
of	IN	case	O
the	DT	det	O
liver	NN	nmod	B-Organ
.	.	punct	O

An	DT	det	O
unusual	JJ	amod	O
primary	JJ	amod	O
adenomatoid	JJ	compound	B-Cancer
tumour	NN	nsubjpass	I-Cancer
arising	VBG	acl	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
liver	NN	nmod	B-Organ
is	VBZ	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

Hepatectomy	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
patient	NN	nsubj	B-Organism
is	VBZ	cop	O
alive	JJ	conj	O
and	CC	cc	O
free	JJ	conj	O
of	IN	case	O
disease	NN	nmod	O
1	CD	nummod	O
year	NN	compound	O
postsurgery	NN	conj	O
.	.	punct	O

Grossly	RB	advmod	O
,	,	punct	O
the	DT	det	O
tumour	NN	nsubj	B-Cancer
showed	VBD	ROOT	O
a	DT	det	O
haemorrhagic	JJ	amod	O
cut	VBN	compound	O
surface	NN	dobj	O
with	IN	case	O
numerous	JJ	amod	O
microcystic	JJ	amod	B-Pathological_formation
structures	NNS	nmod	I-Pathological_formation
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
revealed	VBD	ROOT	O
cystic	JJ	amod	O
or	CC	cc	O
angiomatoid	NN	conj	O
spaces	NNS	dobj	O
of	IN	case	O
various	JJ	amod	O
sizes	NNS	nmod	O
lined	VBN	acl	O
by	IN	case	O
cuboidal	JJ	nmod	O
,	,	punct	O
low	JJ	amod	O
-	HYPH	punct	O
columnar	NN	conj	O
,	,	punct	O
or	CC	cc	O
flattened	VBN	amod	O
epithelioid	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
vacuolated	VBN	amod	B-Organism_substance
cytoplasm	NN	nmod	I-Organism_substance
and	CC	cc	O
round	RB	conj	O
to	TO	case	O
oval	JJ	compound	O
nuclei	NNS	nmod	B-Cellular_component
.	.	punct	O

The	DT	det	O
epithelioid	JJ	amod	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
entirely	RB	advmod	O
supported	VBN	ROOT	O
by	IN	case	O
proliferated	VBN	amod	O
capillaries	NNS	nmod	B-Tissue
and	CC	cc	O
arteries	NNS	conj	B-Multi-tissue_structure
together	RB	advmod	O
with	IN	case	O
collagenous	JJ	amod	B-Tissue
stroma	NN	nmod	I-Tissue
.	.	punct	O

Immunohistochemical	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
epithelioid	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
were	VBD	cop	O
strongly	RB	advmod	O
positive	JJ	ccomp	O
for	IN	case	O
a	DT	det	O
broad	JJ	amod	O
spectrum	NN	nmod	O
of	IN	case	O
cytokeratins	NNS	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
AE1	NN	compound	B-Gene_or_gene_product
/	:	punct	O
AE3	NN	dep	B-Gene_or_gene_product
,	,	punct	O
CAM5	NN	appos	B-Gene_or_gene_product
.	.	punct	I-Gene_or_gene_product
2	LS	ROOT	I-Gene_or_gene_product
,	,	punct	O
epithelial	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
antigen	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
cytokeratin	NN	conj	B-Gene_or_gene_product
7	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
mesothelial	JJ	amod	B-Tissue
markers	NNS	conj	O
(	-LRB-	punct	O
calretinin	NN	dep	B-Gene_or_gene_product
,	,	punct	O
Wilms	NNP	nmod:poss	B-Gene_or_gene_product
'	POS	case	I-Gene_or_gene_product
tumour	NN	appos	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
D2	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
40	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
cells	NNS	nsubj	B-Cell
were	VBD	cop	O
negative	JJ	ROOT	O
for	IN	case	O
Hep	NNP	compound	B-Gene_or_gene_product
par	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
,	,	punct	O
carcinoembryonic	JJ	amod	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
neural	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	conj	I-Gene_or_gene_product
,	,	punct	O
CD34	NN	appos	B-Gene_or_gene_product
,	,	punct	O
CD31	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
HMB45	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Atypically	RB	advmod	O
,	,	punct	O
abundant	JJ	amod	O
capillaries	NNS	nsubjpass	B-Tissue
were	VBD	auxpass	O
observed	VBN	ROOT	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
cystic	JJ	amod	B-Pathological_formation
proliferation	NN	nsubj	O
of	IN	case	O
epithelioid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
vacuoles	NNS	nmod	B-Cellular_component
and	CC	cc	O
immunohistochemical	JJ	amod	O
profile	NN	conj	O
of	IN	case	O
the	DT	det	O
epithelioid	JJ	amod	B-Tissue
element	NN	nmod	I-Tissue
were	VBD	cop	O
consistent	JJ	parataxis	O
with	IN	case	O
hepatic	JJ	amod	B-Cancer
adenomatoid	JJ	compound	I-Cancer
tumour	NN	nmod	I-Cancer
.	.	punct	O

Contemporary	JJ	amod	O
perspectives	NNS	nsubj	O
on	IN	prep	O
vital	JJ	amod	O
pulp	JJ	amod	B-Tissue
therapy	NN	pobj	O
:	:	punct	O
views	NNS	ROOT	O
from	IN	prep	O
the	DT	det	O
endodontists	NNS	pobj	O
and	CC	cc	O
pediatric	JJ	amod	O
dentists	NNS	conj	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
agreement	NN	nmod	O
between	IN	prep	O
pediatric	JJ	amod	O
dentists	NNS	pobj	O
and	CC	cc	O
endodontists	NNS	conj	O
at	IN	case	O
a	DT	det	O
pulp	JJ	amod	B-Tissue
therapy	NN	compound	O
symposium	NN	nmod	O
conjointly	RB	advmod	O
sponsored	VBN	acl	O
by	IN	agent	O
the	DT	det	O
American	NNP	compound	O
Association	NNP	pobj	O
of	IN	prep	O
Endodontists	NNPS	pobj	O
(	-LRB-	punct	O
AAE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
American	NNP	compound	O
Academy	NNP	conj	O
of	IN	prep	O
Pediatric	NNP	compound	O
Dentistry	NNP	pobj	O
(	-LRB-	punct	O
AAPD	NN	appos	O
)	-RRB-	punct	O
on	IN	prep	O
November	NNP	pobj	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	nummod	O
,	,	punct	O
2007	CD	nummod	O
.	.	punct	O

Presymposium	NN	compound	O
and	CC	cc	O
postsymposium	NN	conj	O
tests	NNS	nsubjpass	O
were	VBD	auxpass	O
administered	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
respondent	JJ	amod	O
answers	NNS	nsubjpass	O
were	VBD	auxpass	O
compared	VBN	conj	O
between	IN	prep	O
pediatric	JJ	amod	O
dentists	NNS	pobj	O
and	CC	cc	O
endodontists	NNS	conj	O
.	.	punct	O

Opinions	NNS	nsubjpass	O
on	IN	case	O
3	CD	nummod	O
areas	NNS	nmod	O
were	VBD	auxpass	O
sought	VBN	ROOT	O
:	:	punct	O
pulp	JJ	amod	B-Tissue
therapy	NN	dobj	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
primary	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
indirect	JJ	amod	O
pulp	JJ	amod	B-Tissue
treatment	NN	parataxis	O
(	-LRB-	punct	O
IPT	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
immature	JJ	amod	O
permanent	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
and	CC	cc	O
innovative	JJ	amod	O
treatment	NN	compound	O
options	NNS	conj	O
including	VBG	case	O
pulpal	JJ	amod	B-Tissue
revascularization	NN	nmod	O
and	CC	cc	O
regeneration	NN	conj	O
.	.	punct	O

Results	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
chi2	NN	compound	O
tests	NNS	nmod	O
.	.	punct	O

Comparisons	NNS	nsubj	O
of	IN	case	O
presymposium	NN	compound	O
and	CC	cc	O
postsymposium	NN	conj	O
responses	NNS	nmod	O
and	CC	cc	O
between	IN	case	O
the	DT	det	O
2	CD	nummod	O
groups	NNS	conj	O
of	IN	case	O
attendees	NNS	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
pediatric	JJ	amod	O
dentistry	NN	nsubj	O
and	CC	cc	O
endodontic	JJ	amod	O
communities	NNS	conj	O
agree	VBP	ccomp	O
that	IN	mark	O
formocresol	NN	nsubjpass	B-Simple_chemical
will	MD	aux	O
be	VB	auxpass	O
replaced	VBN	ccomp	O
as	IN	case	O
a	DT	det	O
primary	JJ	amod	O
tooth	NN	amod	B-Organ
pulpotomy	NN	compound	O
agent	NN	nmod	O
,	,	punct	O
that	IN	mark	O
mineral	JJ	amod	B-Simple_chemical
trioxide	NN	nsubj	I-Simple_chemical
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
choice	NN	relcl	O
to	TO	aux	O
take	VB	xcomp	O
its	PRP$	poss	O
place	NN	dobj	O
,	,	punct	O
that	IN	mark	O
IPT	NN	nsubj	O
in	IN	case	O
primary	JJ	amod	O
teeth	NNS	compound	B-Organ
holds	VBZ	nsubj	O
hope	VBP	relcl	O
as	IN	prep	O
a	DT	det	O
replacement	NN	pobj	O
for	IN	prep	O
pulpotomy	NN	pobj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
IPT	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
acceptable	JJ	amod	O
pulp	JJ	amod	B-Tissue
therapy	NN	compound	O
technique	NN	conj	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
young	JJ	amod	O
permanent	JJ	amod	O
teeth	NNS	nmod	B-Organ
.	.	punct	O

Both	DT	det	O
groups	NNS	nsubj	O
believe	VBP	ROOT	O
that	IN	mark	O
pulp	JJ	amod	B-Tissue
revascularization	NN	nsubj	O
and	CC	cc	O
regeneration	NN	conj	O
will	MD	aux	O
be	VB	ccomp	O
viable	JJ	amod	O
treatment	NN	compound	O
modalities	NNS	attr	O
in	IN	prep	O
the	DT	det	O
future	NN	pobj	O
.	.	punct	O

The	DT	det	O
AAE	NN	nsubjpass	O
and	CC	cc	O
the	DT	det	O
AAPD	NN	conj	O
are	VBP	cop	O
positioned	JJ	ROOT	O
to	TO	mark	O
begin	VB	xcomp	O
preparation	NN	dobj	O
of	IN	prep	O
best	JJS	amod	O
practice	NN	compound	O
guidelines	NNS	pobj	O
that	WDT	nsubj	O
share	VBP	relcl	O
common	JJ	amod	O
language	NN	nmod	O
and	CC	cc	O
treatment	NN	conj	O
recommendations	NNS	dobj	O
for	IN	case	O
pulp	JJ	amod	B-Tissue
therapies	NNS	nmod	O
performed	VBN	acl	O
by	IN	case	O
both	DT	det	O
specialties	NNS	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
platelet	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
/	:	punct	O
thymidine	NN	compound	B-Gene_or_gene_product
phosphorylase	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
tumor	NN	compound	B-Cancer
behavior	NN	nmod	O
.	.	punct	O

Platelet	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PD	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ECGF	NN	nsubj	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
similar	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
pyrimidine	NN	compound	O
enzyme	NN	compound	O
thymidine	NN	compound	B-Gene_or_gene_product
phosphorylase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
high	JJ	amod	O
TP	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
at	IN	case	O
tumor	NN	compound	B-Cancer
sites	NNS	nmod	O
is	VBZ	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
,	,	punct	O
induction	NN	xcomp	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
high	JJ	amod	O
TP	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
most	RBS	advmod	O
likely	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

TP	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
not	RB	neg	O
only	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
tumor	NN	compound	B-Tissue
surrounding	NN	amod	I-Tissue
tissues	NNS	conj	I-Tissue
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	B-Cell
infiltrating	NN	amod	I-Cell
macrophages	NNS	nmod	I-Cell
.	.	punct	O

TP	NN	nsubj	B-Gene_or_gene_product
catalyzes	VBZ	ROOT	O
the	DT	det	O
conversion	NN	dobj	O
of	IN	case	O
thymidine	NN	nmod	B-Simple_chemical
to	TO	case	O
thymine	NN	nmod	B-Simple_chemical
and	CC	cc	O
doxyribose	NN	amod	B-Simple_chemical
-	,	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phosphate	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
dR	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
P	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
latter	JJ	nsubj	O
in	IN	prep	O
its	PRP$	poss	O
parent	NN	compound	O
form	NN	pobj	O
or	CC	cc	O
in	IN	case	O
its	PRP$	poss	O
sugar	NN	compound	B-Simple_chemical
form	NN	pobj	O
,	,	punct	O
deoxyribose	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
dR	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
may	MD	aux	O
modulate	VB	ROOT	O
cellular	JJ	amod	B-Cell
energy	NN	compound	O
metabolism	NN	dobj	O
or	CC	cc	O
be	VB	cop	O
a	DT	det	O
substrate	NN	conj	O
in	IN	case	O
a	DT	det	O
chemical	JJ	amod	O
reaction	NN	nmod	O
generating	VBG	acl	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	dobj	I-Simple_chemical
.	.	punct	O

L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyribose	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dR	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
thymidine	NN	compound	B-Simple_chemical
phosphorylase	NN	compound	I-Simple_chemical
inhibitor	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
TPI	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
can	MD	aux	O
reverse	VB	ROOT	O
these	DT	det	O
effects	NNS	dobj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
TP	NN	compound	B-Gene_or_gene_product
induction	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
yet	RB	advmod	O
completely	RB	advmod	O
clear	JJ	ROOT	O
,	,	punct	O
but	CC	cc	O
TNF	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
IL10	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
other	JJ	amod	O
cytokines	NNS	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
clearly	RB	advmod	O
shown	VBN	conj	O
to	TO	mark	O
induce	VB	xcomp	O
its	PRP$	nmod:poss	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
various	JJ	amod	O
complex	JJ	amod	O
interactions	NNS	nsubj	O
of	IN	case	O
TP	NN	nmod	B-Gene_or_gene_product
give	VBP	ROOT	O
it	PRP	dative	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
cellular	JJ	amod	B-Cell
functioning	VBG	nmod	O
and	CC	cc	O
,	,	punct	O
hence	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
an	DT	det	O
ideal	JJ	amod	O
target	NN	conj	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Reversal	NN	ROOT	O
of	IN	case	O
the	DT	det	O
malignant	JJ	amod	O
phenotype	NN	nmod	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
A2780	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
transfection	NN	nmod	O
with	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
PTEN	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
phosphatase	NN	compound	B-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
tensin	NN	compound	I-Gene_or_gene_product
homologue	NN	nmod	I-Gene_or_gene_product
deleted	VBN	acl	I-Gene_or_gene_product
on	IN	case	I-Gene_or_gene_product
chromosome	NN	nmod	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	dep	O
identified	VBN	acl	O
on	IN	case	O
human	JJ	amod	B-Organism
chromosome	NN	compound	B-Cellular_component
10q23	NN	nmod	I-Cellular_component
.	.	punct	O

Substantial	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
inhibit	VB	ccomp	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
many	JJ	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
upregulation	NN	nsubj	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
by	IN	case	O
transfection	NN	compound	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
to	TO	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
can	MD	aux	O
inhibit	VB	ccomp	O
growth	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
and	CC	cc	O
to	TO	mark	O
explore	VB	conj	O
the	DT	det	O
potential	NN	dobj	O
for	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
therapy	NN	nmod	O
of	IN	case	O
ovarian	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

METHOD	NN	nsubjpass	O
:	:	punct	O
Wild	JJ	compound	O
-	HYPH	punct	O
type	NN	nsubjpass	O
and	CC	cc	O
phosphatase	NN	compound	O
-	HYPH	punct	O
inactive	JJ	amod	O
(	-LRB-	punct	O
C124A	NN	dep	O
)	-RRB-	punct	O
PTEN	NN	compound	B-Gene_or_gene_product
plasmids	NNS	conj	O
were	VBD	auxpass	O
transfected	VBN	dep	O
into	IN	case	O
ovarian	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cancer	NN	compound	I-Cell
A2780	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
effects	NNS	nsubjpass	O
on	IN	case	O
cell	NN	compound	B-Cell
apoptosis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
and	CC	cc	O
cell	NN	compound	B-Cell
invasion	NN	conj	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
TUNEL	NN	compound	O
assay	NN	conj	O
,	,	punct	O
MTT	NN	compound	O
assay	NN	conj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
-	HYPH	punct	O
healing	NN	compound	O
assay	NN	conj	O
and	CC	cc	O
transwell	NN	compound	O
assay	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	DT	cc:preconj	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nsubj	O
and	CC	cc	O
mutant	JJ	amod	O
PTEN	NN	conj	B-Gene_or_gene_product
can	MD	aux	O
upregulate	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
dramatically	RB	advmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
PTEN	NN	compound	B-Gene_or_gene_product
not	RB	neg	O
phosphatase	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
inactive	JJ	amod	O
PTEN	NNS	dep	B-Gene_or_gene_product
that	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
apoptosis	NN	dobj	O
and	CC	cc	O
decrease	VB	conj	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
,	,	punct	O
invasion	NN	conj	O
and	CC	cc	O
proliferation	NN	conj	O
in	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	B-Gene_or_gene_product
had	VBD	aux	O
played	VBN	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
dependent	JJ	amod	O
on	IN	case	O
its	PRP$	nmod:poss	O
phosphatase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Enhanced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
PTEN	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
gene	NN	compound	O
transfer	NN	nmod	O
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
reverse	VB	xcomp	O
the	DT	det	O
malignant	JJ	amod	O
phenotype	NN	dobj	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
transfection	NN	conj	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
might	MD	aux	O
be	VB	cop	O
another	DT	det	O
novel	JJ	amod	O
approach	NN	conj	O
for	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
in	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Allogeneic	JJ	amod	O
injection	NN	nsubj	O
of	IN	case	O
fetal	JJ	amod	B-Cell
membrane	NN	nmod:npmod	I-Cell
-	:	punct	I-Cell
derived	VBN	amod	I-Cell
mesenchymal	JJ	amod	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
induces	VBZ	ROOT	O
therapeutic	JJ	amod	O
angiogenesis	NN	dobj	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
hind	NN	amod	B-Organism_subdivision
limb	NN	compound	I-Organism_subdivision
ischemia	NN	nmod	O
.	.	punct	O

Bone	NN	compound	B-Cell
marrow	NN	npadvmod	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
mesenchymal	JJ	amod	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
BM	NN	compound	B-Cell
-	:	punct	I-Cell
MSC	NN	appos	I-Cell
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
attractive	JJ	amod	O
therapeutic	JJ	amod	O
cell	NN	compound	B-Cell
source	NN	xcomp	O
for	IN	case	O
tissue	NN	compound	B-Tissue
regeneration	NN	nmod	O
and	CC	cc	O
repair	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
remains	VBZ	ROOT	O
unknown	JJ	xcomp	O
whether	IN	prep	O
or	CC	cc	O
not	RB	conj	O
allogeneic	JJ	amod	O
transplantation	NN	dep	O
of	IN	case	O
mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
MSC	NN	appos	B-Cell
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
fetal	JJ	amod	B-Multi-tissue_structure
membranes	NNS	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
FM	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
generally	RB	advmod	O
discarded	VBN	acl:relcl	O
as	IN	case	O
medical	JJ	amod	O
waste	NN	nmod	O
after	IN	case	O
delivery	NN	nmod	O
,	,	punct	O
has	VBZ	conj	O
therapeutic	JJ	amod	O
potential	NN	dobj	O
.	.	punct	O

FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nsubjpass	I-Cell
were	VBD	auxpass	O
obtained	VBN	ROOT	O
from	IN	case	O
Lewis	NNP	compound	O
rats	NNS	nmod	B-Organism
and	CC	cc	O
had	VBD	conj	O
surface	NN	compound	O
antigen	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
multipotent	JJ	amod	O
potential	JJ	conj	O
partly	RB	advmod	O
similar	JJ	amod	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nmod	I-Cell
.	.	punct	O

Compared	VBN	mark	O
with	IN	prep	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	pobj	I-Cell
,	,	punct	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nsubj	I-Cell
secreted	VBD	ROOT	O
a	DT	det	O
comparable	JJ	amod	O
amount	NN	dobj	O
of	IN	case	O
hepatocyte	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
despite	IN	case	O
a	DT	det	O
small	JJ	amod	O
amount	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nsubj	I-Cell
and	CC	cc	O
BM	NN	compound	B-Cell
-	:	punct	I-Cell
MSC	NN	conj	I-Cell
both	CC	dep	O
expressed	VBD	ROOT	O
major	JJ	amod	O
histocompatibility	NN	compound	O
complex	NN	compound	O
(	-LRB-	punct	O
MHC	NN	compound	O
)	-RRB-	punct	O
class	NN	compound	O
I	CD	nummod	O
but	CC	cc	O
not	RB	cc	O
MHC	NN	compound	O
class	NN	compound	O
II	CD	nummod	O
antigens	NNS	dobj	O
and	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
elicit	VB	conj	O
allogeneic	JJ	amod	O
lymphocyte	NN	compound	B-Cell
proliferation	NN	dobj	O
in	IN	case	O
mixed	JJ	amod	O
lymphocyte	NN	compound	B-Cell
culture	NN	nmod	O
.	.	punct	O

FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nsubjpass	I-Cell
or	CC	cc	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	conj	I-Cell
obtained	VBN	acl	O
from	IN	case	O
Lewis	JJ	compound	O
rats	NNS	nmod	B-Organism
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
a	DT	det	O
MHC	NN	npadvmod	O
-	HYPH	punct	O
mismatched	VBN	amod	O
August	NNP	compound	O
-	HYPH	punct	O
Copenhagen	NNP	compound	O
-	HYPH	punct	O
Irish	NNP	compound	O
rat	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
hind	NN	amod	B-Organism_subdivision
limb	NN	compound	I-Organism_subdivision
ischemia	NN	nmod	O
.	.	punct	O

Three	CD	nummod	O
weeks	NNS	nsubj	O
after	IN	case	O
injection	NN	pobj	O
,	,	punct	O
blood	NN	compound	B-Organism_substance
perfusion	NN	appos	O
and	CC	cc	O
capillary	JJ	amod	B-Tissue
density	NN	conj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nmod	I-Cell
and	CC	cc	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
groups	NNS	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
phosphate	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
buffered	VBN	amod	I-Simple_chemical
saline	NN	compound	I-Simple_chemical
group	NN	advcl	O
,	,	punct	O
and	CC	cc	O
allogeneic	JJ	amod	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nsubjpass	I-Cell
and	CC	cc	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	conj	I-Cell
were	VBD	auxpass	O
still	RB	advmod	O
observed	VBN	conj	O
.	.	punct	O

In	IN	case	O
nonischemic	JJ	amod	O
hind	NN	amod	B-Tissue
limb	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
,	,	punct	O
allogeneic	JJ	amod	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
and	CC	cc	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
injection	NN	nsubjpass	O
were	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
comparatively	RB	advmod	O
small	JJ	amod	O
amount	NN	nmod	O
of	IN	case	O
T	NN	compound	B-Cell
lymphocyte	NN	compound	I-Cell
infiltration	NN	nmod	O
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
injection	NN	advcl	O
of	IN	case	O
allogeneic	JJ	amod	O
splenic	JJ	amod	B-Cell
lymphocytes	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
allogeneic	JJ	amod	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	compound	I-Cell
injection	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
elicit	VB	ROOT	O
a	DT	det	O
lymphocyte	NN	compound	B-Cell
proliferative	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
provided	VBD	conj	O
significant	JJ	amod	O
improvement	NN	dobj	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
hind	NN	amod	B-Organism_subdivision
limb	NN	compound	I-Organism_subdivision
ischemia	NN	nmod	O
,	,	punct	O
comparable	JJ	conj	O
to	TO	case	O
the	DT	det	O
response	NN	nmod	O
to	TO	case	O
BM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nmod	I-Cell
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
allogeneic	JJ	amod	O
injection	NN	nsubj	O
of	IN	case	O
FM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSC	NN	nmod	I-Cell
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
new	JJ	amod	O
therapeutic	JJ	amod	O
strategy	NN	ROOT	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
severe	JJ	amod	O
peripheral	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
.	.	punct	O

Disclosure	NN	nsubjpass	O
of	IN	case	O
potential	JJ	amod	O
conflicts	NNS	nmod	O
of	IN	case	O
interest	NN	nmod	O
is	VBZ	auxpass	O
found	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
this	DT	det	O
article	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	nmod	O
in	IN	case	O
early	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
passage	NN	compound	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Malignancy	NN	nsubjpass	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
(	-LRB-	punct	O
Warburg	NN	compound	O
effect	NN	appos	O
)	-RRB-	punct	O
evidenced	VBN	acl	O
by	IN	case	O
increased	VBN	amod	O
trapping	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
18	CD	nummod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
F	NNP	intj	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
deoxyglucose	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
FdG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
imaged	VBN	acl	O
by	IN	case	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	nmod	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

[	-LRB-	punct	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
18	CD	nummod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
F	NNP	nsubj	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
deoxyglucose	NN	compound	I-Simple_chemical
uptake	NN	nsubj	O
correlates	VBZ	ROOT	O
with	IN	case	O
glucose	NN	compound	B-Gene_or_gene_product
transporter	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
GLUT	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
in	IN	case	O
established	JJ	amod	O
breast	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
that	WDT	mark	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
levels	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
leads	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
glycolysis	NN	nsubjpass	O
and	CC	cc	O
GLUT	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
can	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
induced	VBN	ROOT	O
independent	JJ	xcomp	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
other	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	nmod	I-Gene_or_gene_product
and	CC	cc	O
phosphorylated	VBD	amod	O
Akt	NNP	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
pAkt	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
investigates	VBZ	ROOT	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
pAkt	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
aerobic	JJ	amod	O
glycolysis	NN	conj	O
in	IN	case	O
low	JJ	amod	O
-	HYPH	punct	O
passage	NN	compound	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
under	IN	case	O
the	DT	det	O
assumption	NN	nmod	O
that	IN	mark	O
these	DT	nsubj	O
represent	VBP	ccomp	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
condition	NN	dobj	O
better	JJR	amod	O
than	IN	case	O
established	JJ	amod	O
lines	NNS	nmod	B-Cell
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
FdG	NN	compound	B-Simple_chemical
-	HYPH	punct	O
PET	NN	nmod	O
or	CC	cc	O
primary	JJ	amod	B-Cancer
breast	NN	compound	I-Cancer
cancers	NNS	conj	I-Cancer
,	,	punct	O
rates	NNS	nsubj	O
of	IN	case	O
glycolysis	NN	nmod	O
were	VBD	cop	O
diverse	JJ	ROOT	O
,	,	punct	O
being	VBG	cop	O
higher	JJR	advcl	O
in	IN	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
both	CC	cc:preconj	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	dobj	I-Gene_or_gene_product
and	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
lower	JJR	conj	O
in	IN	case	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
low	JJ	amod	O
or	CC	cc	O
negative	JJ	conj	O
in	IN	case	O
both	CC	det	O
transcription	NN	compound	O
factors	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
glycolytic	JJ	amod	O
rates	NNS	nmod	O
and	CC	cc	O
pAkt	JJ	compound	B-Gene_or_gene_product
levels	NNS	conj	O
.	.	punct	O

Two	CD	ROOT	O
of	IN	case	O
12	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
formed	VBD	acl	O
xenografts	NNS	dobj	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Both	DT	nsubj	O
were	VBD	cop	O
positive	JJ	ROOT	O
for	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
phosphorylated	VBD	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
only	RB	advmod	O
one	CD	nsubj	O
was	VBD	cop	O
positive	JJ	conj	O
for	IN	case	O
pAkt	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Glycolysis	NNP	nsubjpass	O
was	VBD	auxpass	O
affected	VBN	ROOT	O
by	IN	case	O
pharmacological	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	nmod	I-Gene_or_gene_product
and	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	conj	I-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	compound	I-Gene_or_gene_product
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	conj	I-Gene_or_gene_product
activities	NNS	nsubjpass	O
are	VBP	auxpass	O
both	CC	dep	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Intracerebral	JJ	amod	O
grafting	NN	ROOT	O
of	IN	case	O
cultured	VBN	amod	O
autologous	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
into	IN	case	O
the	DT	det	O
rat	NN	compound	B-Organism
striatum	NN	nmod	B-Multi-tissue_structure
:	:	punct	O
an	DT	det	O
assessment	NN	appos	O
of	IN	prep	O
graft	NN	compound	B-Tissue
size	NN	pobj	O
and	CC	cc	O
ultrastructure	NN	conj	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
a	DT	det	O
suitable	JJ	amod	O
donor	NN	compound	B-Cell
cell	NN	compound	I-Cell
population	NN	dobj	I-Cell
for	IN	case	O
gene	NN	compound	O
therapy	NN	compound	O
applications	NNS	nmod	O
to	TO	case	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
,	,	punct	O
primary	JJ	amod	O
fibroblasts	NNS	nsubjpass	B-Cell
isolated	VBN	acl	O
from	IN	case	O
skin	NN	compound	B-Multi-tissue_structure
biopsies	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
maintained	VBN	conj	O
in	IN	case	O
culture	NN	nmod	B-Cell
are	VBP	auxpass	O
employed	VBN	ROOT	O
as	IN	case	O
autologous	JJ	amod	O
cells	NNS	nmod	B-Cell
for	IN	case	O
intracerebral	JJ	amod	B-Immaterial_anatomical_entity
grafting	VBG	nmod	O
within	IN	case	O
the	DT	det	O
adult	JJ	amod	O
rat	NN	compound	B-Organism
striatum	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

Results	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
reveal	VBP	ROOT	O
that	IN	mark	O
cultured	VBN	amod	O
primary	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nsubj	I-Cell
cease	VBP	ccomp	O
to	TO	aux	O
proliferate	VB	xcomp	O
once	IN	mark	O
they	PRP	nsubj	O
reach	VBP	advcl	O
confluence	NN	dobj	O
;	:	punct	O
these	DT	det	O
cells	NNS	nsubj	B-Cell
are	VBP	cop	O
thus	RB	advmod	O
contact	NN	parataxis	O
inhibited	VBD	xcomp	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Following	VBG	case	O
implantation	NN	nmod	O
within	IN	case	O
the	DT	det	O
striatum	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
the	DT	det	O
volume	NN	nsubj	O
of	IN	prep	O
the	DT	det	O
primary	JJ	amod	O
fibroblast	NN	compound	B-Tissue
grafts	NNS	pobj	I-Tissue
,	,	punct	O
stained	VBN	advcl	O
immunohistochemically	RB	advmod	O
for	IN	prep	O
fibronectin	NN	pobj	B-Gene_or_gene_product
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
differ	VB	ROOT	O
significantly	RB	advmod	O
at	IN	case	O
3	CD	nummod	O
and	CC	cc	O
8	CD	conj	O
weeks	NNS	nmod	O
.	.	punct	O

The	DT	det	O
graft	NN	compound	B-Tissue
size	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
density	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
suspension	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
dependent	JJ	conj	O
on	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
number	NN	nmod	O
of	IN	mark	O
passages	NNS	acl	O
the	DT	det	O
cells	NNS	dobj	B-Cell
are	VBP	auxpass	O
taken	VBN	conj	O
through	IN	case	O
in	IN	case	O
culture	NN	nmod	O
prior	RB	case	O
to	TO	aux	O
grafting	VBG	advcl	O
or	CC	cc	O
on	IN	case	O
the	DT	det	O
postoperative	JJ	amod	O
survival	NN	compound	O
period	NN	conj	O
.	.	punct	O

Ultrastructural	JJ	amod	O
evidence	NN	nsubj	O
reveals	VBZ	ROOT	O
that	IN	mark	O
at	IN	case	O
8	CD	nummod	O
weeks	NNS	nmod	O
the	DT	det	O
grafts	NNS	nsubjpass	B-Tissue
are	VBP	auxpass	O
composed	VBN	ccomp	O
primarily	RB	advmod	O
of	IN	case	O
collagen	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
with	IN	case	O
rough	JJ	amod	O
endoplasmic	JJ	amod	B-Cellular_component
reticulum	NN	nmod	I-Cellular_component
and	CC	cc	O
vesicles	NNS	conj	B-Cellular_component
.	.	punct	O

Reactive	JJ	amod	O
astrocytic	JJ	amod	B-Cellular_component
processes	NNS	nsubj	I-Cellular_component
and	CC	cc	O
phagocytic	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
are	VBP	cop	O
also	RB	advmod	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
grafts	NNS	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	B-Tissue
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	B-Tissue
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	B-Tissue
;	:	punct	O
intercellular	JJ	amod	B-Cellular_component
junctions	NNS	nsubj	I-Cellular_component
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	B-Cellular_component
of	IN	case	I-Cellular_component
apposition	NN	nmod	I-Cellular_component
between	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
primary	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nsubj	I-Cell
are	VBP	cop	O
able	JJ	ccomp	O
to	TO	mark	O
survive	VB	xcomp	O
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
8	CD	nummod	O
weeks	NNS	nmod	O
following	VBG	case	O
intracerebral	JJ	amod	B-Immaterial_anatomical_entity
implantation	NN	nmod	O
and	CC	cc	O
continue	VBP	conj	O
to	TO	mark	O
synthesize	VB	xcomp	O
collagen	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
fibronectin	NN	conj	B-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
the	DT	det	O
grafts	NNS	nsubj	B-Tissue
maintain	VBP	ROOT	O
a	DT	det	O
constant	JJ	amod	O
volume	NN	dobj	O
between	IN	prep	O
3	CD	nummod	O
and	CC	cc	O
8	CD	conj	O
weeks	NNS	pobj	O
,	,	punct	O
thereby	RB	advmod	O
indicating	VBG	advcl	O
that	IN	mark	O
primary	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nsubj	I-Cell
do	VBP	aux	O
not	RB	neg	O
produce	VB	ccomp	O
tumors	NNS	dobj	B-Cancer
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
dynamic	JJ	amod	O
host	NN	nmod	O
-	:	punct	O
to	TO	prep	O
-	HYPH	punct	O
graft	NN	compound	B-Tissue
interactions	NNS	nsubj	O
-	:	punct	O
-	HYPH	punct	O
including	VBG	case	O
phagocytic	JJ	amod	O
migration	NN	nmod	O
,	,	punct	O
astrocytic	JJ	amod	O
hypertrophy	NN	conj	O
and	CC	cc	O
infiltration	NN	conj	O
within	IN	case	O
the	DT	det	O
grafts	NNS	nmod	B-Tissue
,	,	punct	O
and	CC	cc	O
angiogenesis	NN	conj	O
-	HYPH	punct	O
-	:	punct	O
are	VBP	ROOT	O
features	NNS	attr	O
that	WDT	nsubj	O
constitute	VBP	relcl	O
the	DT	det	O
structural	JJ	amod	O
integration	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
skin	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
grafted	VBN	acl	O
within	IN	case	O
the	DT	det	O
adult	JJ	amod	O
rat	NN	compound	B-Organism
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
.	.	punct	O

Angiogenesis	NN	ROOT	O
associated	VBN	acl	O
with	IN	case	O
visceral	JJ	amod	B-Tissue
and	CC	cc	O
subcutaneous	JJ	conj	B-Tissue
adipose	NN	compound	I-Tissue
tissue	NN	nmod	I-Tissue
in	IN	case	O
severe	JJ	amod	O
human	JJ	amod	B-Organism
obesity	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
expansion	NN	nsubjpass	O
of	IN	case	O
adipose	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
is	VBZ	auxpass	O
linked	VBN	dep	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
its	PRP$	poss	O
vasculature	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
regulation	NN	nsubjpass	O
of	IN	case	O
adipose	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
angiogenesis	NN	nmod	O
in	IN	case	O
humans	NNS	nmod	B-Organism
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
extensively	RB	advmod	O
studied	VBN	ROOT	O
.	.	punct	O

Our	PRP$	poss	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
the	DT	det	O
angiogenesis	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
subcutaneous	JJ	amod	B-Tissue
adipose	NN	compound	I-Tissue
tissue	NN	nmod	I-Tissue
(	-LRB-	punct	O
SAT	NN	appos	B-Tissue
)	-RRB-	punct	O
and	CC	cc	O
visceral	JJ	amod	B-Tissue
adipose	NN	compound	I-Tissue
tissue	NN	conj	I-Tissue
(	-LRB-	punct	O
VAT	NN	appos	B-Tissue
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
same	JJ	amod	O
obese	JJ	amod	O
patients	NNS	nmod	B-Organism
in	IN	case	O
an	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
model	NN	nmod	O
.	.	punct	O

RESEARCH	NNP	compound	O
DESIGN	NN	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Adipose	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
samples	NNS	dep	I-Tissue
from	IN	case	O
visceral	JJ	nmod	B-Tissue
(	-LRB-	punct	O
VAT	NN	appos	B-Tissue
)	-RRB-	punct	O
and	CC	cc	O
subcutaneous	JJ	conj	B-Tissue
(	-LRB-	punct	I-Tissue
SAT	NN	dep	I-Tissue
)	-RRB-	punct	I-Tissue
sites	NNS	dep	I-Tissue
,	,	punct	O
obtained	VBN	acl	O
from	IN	case	O
36	CD	nummod	O
obese	JJ	amod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
mean	JJ	amod	O
BMI	NN	appos	O
46	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
kg	NN	compound	O
/	:	punct	O
m	NN	nsubjpass	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
during	IN	case	O
bariatric	JJ	amod	O
surgery	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
layered	VBN	ROOT	O
on	IN	case	O
chick	NN	compound	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
CAM	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
SAT	NN	nsubj	B-Tissue
and	CC	cc	O
VAT	NN	conj	B-Tissue
expressed	VBD	dep	O
angiogenic	JJ	amod	O
factors	NNS	dobj	O
without	IN	case	O
significant	JJ	amod	O
difference	NN	nmod	O
for	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

Adipose	NN	compound	B-Tissue
tissue	NN	ROOT	I-Tissue
layered	VBD	acl	O
on	IN	case	O
CAM	NN	compound	B-Multi-tissue_structure
stimulated	JJ	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

Angiogenic	JJ	amod	O
stimulation	NN	nsubj	O
was	VBD	cop	O
macroscopically	RB	advmod	O
detectable	JJ	ROOT	O
,	,	punct	O
with	IN	case	O
engulfment	NN	nmod	O
of	IN	case	O
the	DT	det	O
samples	NNS	nmod	O
,	,	punct	O
in	IN	case	O
39	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
evidenced	VBN	conj	O
by	IN	case	O
angiography	NN	nmod	O
in	IN	case	O
59	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
samples	NNS	nmod	O
.	.	punct	O

A	DT	det	O
connection	NN	nsubjpass	O
between	IN	case	O
CAM	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
adipose	NN	conj	B-Tissue
tissue	NN	compound	I-Tissue
vessels	NNS	conj	I-Tissue
was	VBD	auxpass	O
evidenced	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
,	,	punct	O
with	IN	case	O
recruitment	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
avian	JJ	amod	B-Organism
and	CC	cc	O
human	JJ	conj	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
potency	NN	nsubj	O
of	IN	case	O
adipose	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
was	VBD	cop	O
not	RB	neg	O
related	JJ	ROOT	O
to	TO	case	O
its	PRP$	nmod:poss	O
localization	NN	nmod	O
(	-LRB-	punct	O
with	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
stimulation	NN	nmod	O
in	IN	case	O
60	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
SAT	NN	compound	B-Tissue
samples	NNS	nmod	I-Tissue
and	CC	cc	O
61	CD	nummod	O
%	NN	conj	O
of	IN	case	O
VAT	NN	compound	B-Tissue
samples	NNS	nmod	I-Tissue
)	-RRB-	punct	O
or	CC	cc	O
to	TO	case	O
adipocyte	NN	compound	B-Cell
size	NN	conj	O
or	CC	cc	O
inflammatory	JJ	amod	O
infiltrate	NN	conj	O
assessed	VBN	acl	O
in	IN	case	O
adipose	NN	compound	B-Tissue
samples	NNS	nmod	I-Tissue
before	IN	case	O
the	DT	det	O
graft	NN	nmod	B-Tissue
on	IN	case	O
CAM	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

Stimulation	NN	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	case	O
adipose	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
was	VBD	auxpass	O
nearly	RB	advmod	O
abolished	VBN	ROOT	O
by	IN	case	O
bevacizumab	NN	nmod	B-Simple_chemical
,	,	punct	O
which	WDT	nsubj	O
specifically	RB	advmod	O
targets	VBZ	acl:relcl	O
human	JJ	amod	B-Organism
VEGF	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
established	VBN	ROOT	O
a	DT	det	O
model	NN	dobj	O
to	TO	mark	O
study	VB	acl	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	case	O
human	JJ	amod	B-Organism
adipose	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

This	DT	det	O
model	NN	nsubj	O
highlighted	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
SAT	NN	nmod	B-Tissue
and	CC	cc	O
VAT	NN	conj	B-Tissue
.	.	punct	O

M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
signals	NNS	ROOT	O
through	IN	case	O
the	DT	det	O
MAPK	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
via	IN	case	O
Sp1	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
induce	VB	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
recruits	VBZ	appos	O
mononuclear	JJ	amod	B-Cell
phagocytes	NNS	dobj	I-Cell
which	WDT	nsubj	O
regulate	VBP	acl:relcl	O
processes	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
angiogenesis	NN	nmod	O
and	CC	cc	O
metastases	NNS	conj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

VEGF	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
as	IN	mark	O
it	PRP	nsubj	O
promotes	VBZ	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	conj	O
.	.	punct	O

Previously	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
reported	VBD	ROOT	O
that	IN	mark	O
in	FW	amod	O
vitro	FW	dep	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
induces	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
biologically	RB	advmod	O
-	HYPH	punct	O
active	JJ	amod	O
VEGF	NN	nmod	B-Gene_or_gene_product
from	IN	case	O
human	JJ	amod	B-Organism
monocytes	NNS	nmod	B-Cell
.	.	punct	O

METHODOLOGY	NN	nsubj	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
M	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
production	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
construct	NN	dobj	O
containing	VBG	acl	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	dobj	O
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
luciferase	NN	compound	B-Gene_or_gene_product
reporter	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
mutation	NN	nsubj	O
reducing	VBG	acl	O
HIF	NN	compound	B-Gene_or_gene_product
binding	NN	dobj	O
to	TO	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
had	VBD	ccomp	O
no	DT	neg	O
significant	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
luciferase	NN	compound	B-Gene_or_gene_product
production	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
stimulation	NN	nmod	O
.	.	punct	O

Further	JJ	amod	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
induced	VBD	ccomp	O
VEGF	NN	dobj	B-Gene_or_gene_product
through	IN	case	O
the	DT	det	O
MAPK	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
via	IN	case	O
the	DT	det	O
transcription	NN	compound	O
factor	NN	nmod	O
,	,	punct	O
Sp1	NN	appos	B-Gene_or_gene_product
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
ERK	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
Sp1	NN	conj	B-Gene_or_gene_product
suppressed	VBD	ROOT	O
M	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
VEGF	NN	dobj	B-Gene_or_gene_product
at	IN	case	O
the	DT	dep	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	compound	O
level	NN	conj	O
.	.	punct	O

M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
also	RB	advmod	O
induced	VBD	ROOT	O
the	DT	det	O
nuclear	JJ	amod	B-Cellular_component
localization	NN	dobj	O
of	IN	case	O
Sp1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
ERK	NN	compound	B-Gene_or_gene_product
inhibition	NN	nmod	O
.	.	punct	O

Finally	RB	ROOT	O
,	,	punct	O
mutating	VBG	xcomp	O
the	DT	det	O
Sp1	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
sites	NNS	dobj	O
within	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
or	CC	cc	O
inhibiting	VBG	conj	O
ERK	NN	dobj	B-Gene_or_gene_product
decreased	VBD	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	conj	O
in	IN	case	O
M	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
treated	VBN	amod	O
human	JJ	amod	B-Organism
monocytes	NNS	nmod	B-Cell
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
induced	VBD	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
an	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	compound	O
model	NN	dobj	O
to	TO	mark	O
illustrate	VB	acl	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
recruit	VB	acl	O
mononuclear	JJ	amod	B-Cell
phagocytes	NNS	dobj	I-Cell
,	,	punct	O
increase	VBP	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
enhance	VB	conj	O
angiogenesis	NN	dobj	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
the	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
a	DT	det	O
neutralizing	VBG	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
abolished	VBD	ROOT	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	dobj	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
These	DT	det	O
data	NNS	nsubj	O
delineate	VBP	ROOT	O
an	DT	det	O
ERK	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
Sp1	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
induced	VBD	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
and	CC	cc	O
demonstrate	VBP	conj	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
induce	VB	acl	O
angiogenesis	NN	dobj	O
via	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

PI3K	NN	nmod:npmod	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
transcriptional	JJ	amod	O
regulation	NN	ROOT	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
BMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
Smad	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
by	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
metastatic	JJ	amod	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Bone	NN	compound	B-Organ
morphogenetic	JJ	amod	O
proteins	NNS	nsubj	O
(	-LRB-	punct	O
BMPs	NNS	appos	O
)	-RRB-	punct	O
exert	VBP	dep	O
osteoinductive	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
PC	NN	appos	B-Cancer
)	-RRB-	punct	O
via	IN	case	O
uncharacterized	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
the	DT	det	O
nuclear	JJ	amod	B-Cellular_component
transcription	NN	compound	O
factor	NN	compound	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nsubjpass	I-Gene_or_gene_product
,	,	punct	O
implicated	VBN	acl	O
in	IN	case	O
PC	NN	compound	B-Cancer
metastasis	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
BMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	intj	I-Gene_or_gene_product
or	CC	cc	O
BMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
4	CD	conj	I-Gene_or_gene_product
/	SYM	punct	O
Smad	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
in	IN	case	O
PC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
achieved	VBN	ROOT	O
by	IN	case	O
IkappaBalpha	NN	compound	B-Gene_or_gene_product
super	NN	amod	O
-	HYPH	punct	O
repressor	NN	compound	O
adenoviral	JJ	amod	B-Organism
vector	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
was	VBD	auxpass	O
monitored	VBN	conj	O
by	IN	case	O
EMSA	NN	nmod	O
and	CC	cc	O
reporter	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

BMP	NN	compound	O
expression	NN	nsubjpass	O
and	CC	cc	O
activation	NN	conj	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
PCR	NN	nmod	O
and	CC	cc	O
reporter	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

Promoter	NN	compound	O
binding	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
by	IN	case	O
chromatin	NN	compound	B-Cellular_component
immunoprecipitation	NN	compound	O
(	-LRB-	punct	O
ChIP	NN	appos	O
)	-RRB-	punct	O
assay	NN	nmod	O
.	.	punct	O

Smad1	NN	compound	B-Gene_or_gene_product
/	SYM	punct	O
5	CD	appos	B-Gene_or_gene_product
/	SYM	punct	O
8	CD	nummod	B-Gene_or_gene_product
phosphorylation	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
PCR	NN	compound	O
and	CC	cc	O
chimeric	JJ	amod	O
BMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
BMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
luciferase	NN	compound	O
assays	NNS	nsubj	O
demonstrate	VBP	appos	O
that	IN	mark	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nsubj	I-Gene_or_gene_product
confers	VBZ	ccomp	O
robust	JJ	amod	O
and	CC	cc	O
selective	JJ	conj	O
activation	NN	dobj	O
of	IN	case	O
BMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
p65	NN	compound	B-Gene_or_gene_product
overexpressing	NN	nmod	O
or	CC	cc	O
rhTNF	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	dep	O
PC	NN	compound	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
significantly	RB	advmod	O
reduced	VBD	ROOT	O
transcript	NN	compound	O
levels	NNS	dobj	O
and	CC	cc	O
autocrine	JJ	compound	O
production	NN	conj	O
of	IN	case	O
BMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
by	IN	case	O
rhTNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
stimulated	VBD	amod	O
C4	NN	compound	B-Cell
-	:	punct	I-Cell
2B	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	conj	O
by	IN	case	O
the	DT	det	O
parental	JJ	amod	O
LNCaP	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
PI3K	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	nsubj	B-Gene_or_gene_product
suppressed	VBD	ROOT	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
BMP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
suppression	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
decreased	VBD	ROOT	O
the	DT	det	O
transcript	NN	compound	O
levels	NNS	dobj	O
and	CC	cc	O
BMP	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
Smad1	NN	nmod	B-Gene_or_gene_product
/	SYM	punct	O
5	CD	conj	B-Gene_or_gene_product
/	SYM	punct	O
8	CD	nummod	B-Gene_or_gene_product
,	,	punct	O
critical	JJ	amod	O
downstream	JJ	amod	O
targets	NNS	conj	O
of	IN	case	O
BMP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
signaling	NN	nmod	O
in	IN	case	O
PC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
the	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
BMPRII	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
BMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
modulation	NN	nmod	O
of	IN	case	O
Smad	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
by	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
PC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
ChIP	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nsubjpass	O
of	IN	case	O
BMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
gene	NN	nmod	O
by	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
attributed	VBN	ROOT	O
to	TO	mark	O
binding	NN	advcl	O
to	TO	case	O
kappab	NN	amod	B-Gene_or_gene_product
site	NN	nmod	O
on	IN	case	O
the	DT	det	O
BMP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
data	NNS	nsubj	O
suggest	VBP	dep	O
that	IN	mark	O
PI3K	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
NF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
axis	NN	nsubj	O
may	MD	aux	O
promote	VB	ccomp	O
PC	NN	compound	B-Multi-tissue_structure
bone	NN	compound	I-Multi-tissue_structure
metastasis	NN	dobj	O
in	IN	case	O
part	NN	nmod	O
by	IN	mark	O
regulating	VBG	advcl	O
transcription	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
BMP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
Smad	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
cascade	NN	nmod	O
in	IN	case	O
osteotropic	JJ	amod	B-Cell
PC	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
integrin	NN	compound	B-Gene_or_gene_product
alpha5beta1	NN	compound	I-Gene_or_gene_product
antagonistic	JJ	amod	O
peptide	NN	ROOT	O
,	,	punct	O
A5	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
,	,	punct	O
screened	VBN	acl	O
by	IN	case	O
Protein	NN	compound	O
Chip	NN	compound	O
system	NN	nmod	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
.	.	punct	O

Integrin	JJ	compound	B-Gene_or_gene_product
alpha5beta1	NN	nsubjpass	I-Gene_or_gene_product
immobilized	VBD	acl	O
on	IN	case	O
a	DT	det	O
ProteoChip	NNP	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
screen	VB	xcomp	O
new	JJ	amod	O
antagonistic	JJ	amod	O
peptides	NNS	dobj	O
from	IN	case	O
multiple	JJ	amod	O
hexapeptide	NN	amod	O
sub	NN	compound	O
-	HYPH	punct	O
libraries	NNS	nmod	O
of	IN	case	O
the	DT	det	O
positional	JJ	amod	O
scanning	NN	compound	O
synthetic	JJ	amod	O
peptide	NN	compound	O
combinatorial	JJ	amod	O
library	NN	nmod	O
(	-LRB-	punct	O
PS	NN	compound	O
-	:	punct	O
SPCL	NNP	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
integrin	NN	compound	B-Gene_or_gene_product
alpha5beta1	NN	compound	I-Gene_or_gene_product
-	:	punct	O
Fibronectin	NN	compound	B-Gene_or_gene_product
interaction	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
on	IN	prep	O
the	DT	det	O
chip	NN	pobj	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
peptide	NN	compound	O
ligand	NN	nsubjpass	O
,	,	punct	O
A5	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
VILVLF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
to	TO	case	O
integrin	NN	compound	B-Gene_or_gene_product
alpha5beta1	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
identified	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
hexapeptide	NN	amod	O
libraries	NNS	nmod	O
with	IN	case	O
this	DT	det	O
chip	NN	npadvmod	O
-	HYPH	punct	O
based	VBN	amod	O
screening	NN	amod	O
method	NN	nmod	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
a	DT	det	O
competitive	JJ	amod	O
inhibition	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

A5	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
the	DT	det	O
integrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
fibronectin	NN	compound	B-Gene_or_gene_product
interaction	NN	dobj	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
(	-LRB-	punct	O
IC	NN	appos	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
;	:	punct	O
1	CD	nummod	O
.	.	punct	O
56	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
28	CD	nummod	O
microM	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	B-Multi-tissue_structure
network	NN	compound	I-Multi-tissue_structure
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
A5	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
will	MD	aux	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	ccomp	O
of	IN	case	O
neovascularization	NN	nmod	O
.	.	punct	O

Evaluation	NN	ROOT	O
of	IN	case	O
electrical	JJ	amod	O
stimulation	NN	nmod	O
for	IN	case	O
ischemic	JJ	amod	O
wound	NN	compound	B-Pathological_formation
therapy	NN	nmod	O
:	:	punct	O
a	DT	det	O
feasibility	NN	compound	O
study	NN	dep	O
using	VBG	acl	O
the	DT	det	O
lapine	NN	compound	B-Organism
wound	NN	compound	B-Pathological_formation
model	NN	dobj	O
.	.	punct	O

Chronic	JJ	amod	O
wounds	NNS	nsubj	B-Pathological_formation
are	VBP	ROOT	O
a	DT	det	O
major	JJ	amod	O
secondary	JJ	amod	O
complication	NN	attr	O
for	IN	prep	O
many	JJ	amod	O
people	NNS	pobj	B-Organism
with	IN	prep	O
impaired	JJ	amod	O
mobility	NN	pobj	O
.	.	punct	O

Electrical	JJ	amod	O
stimulation	NN	nsubjpass	O
(	-LRB-	punct	O
ES	NN	appos	O
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
recommended	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
adjunctive	JJ	amod	O
therapy	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
optimal	JJ	amod	O
treatment	NN	compound	O
paradigms	NNS	nsubjpass	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
established	VBN	parataxis	O
.	.	punct	O

Our	PRP$	nmod:poss	O
group	NN	nsubj	O
seeks	VBZ	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
basic	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
ES	NN	compound	O
wound	NN	compound	B-Pathological_formation
therapy	NN	dobj	O
,	,	punct	O
an	DT	det	O
area	NN	appos	O
where	WRB	advmod	O
understanding	NN	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
limited	JJ	acl:relcl	O
.	.	punct	O

A	DT	det	O
feasibility	NN	compound	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
to	TO	mark	O
develop	VB	xcomp	O
the	DT	det	O
Ahn	NNP	compound	O
/	:	punct	O
Mustoe	NNP	compound	O
lapine	NN	nsubj	B-Organism
wound	NN	conj	B-Pathological_formation
model	NN	dobj	O
for	IN	case	O
systematic	JJ	amod	O
investigation	NN	nmod	O
of	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
electrical	JJ	amod	O
stimulation	NN	nmod	O
on	IN	case	O
ischemic	JJ	amod	O
wound	NN	compound	B-Pathological_formation
therapy	NN	nmod	O
.	.	punct	O

A	DT	det	O
standardized	JJ	amod	O
surgical	JJ	amod	O
procedure	NN	nsubj	O
incorporated	VBD	ROOT	O
a	DT	det	O
hybrid	NN	compound	O
stimulation	NN	compound	O
system	NN	dobj	O
comprising	VBG	acl	O
an	DT	det	O
implantable	JJ	amod	O
mini	NN	amod	O
-	HYPH	punct	O
stimulator	NN	dobj	O
and	CC	cc	O
surface	NN	compound	O
electrodes	NNS	conj	O
,	,	punct	O
with	IN	prep	O
creation	NN	pobj	O
of	IN	prep	O
repeatable	JJ	amod	O
ischemic	JJ	amod	O
wounds	NNS	pobj	B-Pathological_formation
.	.	punct	O

Twenty	CD	nummod	O
mature	JJ	amod	O
male	JJ	amod	O
New	NNP	compound	O
Zealand	NNP	compound	O
white	JJ	amod	O
rabbits	NNS	nsubjpass	B-Organism
(	-LRB-	punct	O
3	CD	compound	O
kg	NN	compound	O
weight	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
employed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
two	CD	nummod	O
empirically	RB	advmod	O
selected	VBN	amod	O
stimulation	NN	compound	O
paradigms	NNS	nmod	O
applied	VBN	acl	O
continuously	RB	advmod	O
for	IN	case	O
7	CD	compound	O
-	SYM	punct	O
21	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
using	VBG	xcomp	O
each	DT	det	O
animal	NN	dobj	O
as	IN	prep	O
its	PRP$	poss	O
own	JJ	amod	O
control	NN	pobj	O
.	.	punct	O

Outcomes	JJ	compound	O
measures	NNS	nsubj	O
included	VBD	ROOT	O
transcutaneous	JJ	amod	O
blood	NN	compound	B-Organism_substance
gas	NN	compound	O
levels	NNS	dobj	O
,	,	punct	O
histology	NN	conj	O
,	,	punct	O
total	JJ	amod	O
RNA	NN	compound	O
content	NN	conj	O
and	CC	cc	O
analysis	NN	conj	O
of	IN	case	O
alpha2	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
collagen	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
COL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagen	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
COL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
IV	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
alpha1	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
V	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
collagen	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
COL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
V	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	conj	O
using	VBG	acl	O
real	RB	amod	O
-	HYPH	punct	O
time	NN	compound	O
quantitative	JJ	amod	O
PCR	NN	dobj	O
.	.	punct	O

All	DT	det	O
markers	NNS	nsubj	O
for	IN	case	O
stimulated	VBN	amod	O
wounds	NNS	nmod	B-Pathological_formation
showed	VBD	ROOT	O
increased	VBN	amod	O
activity	NN	dobj	O
relative	JJ	case	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
stimulated	VBN	amod	O
control	NN	compound	O
wounds	NNS	nmod	B-Pathological_formation
between	IN	case	O
7	CD	nummod	O
and	CC	cc	O
14	CD	conj	O
days	NNS	nmod	O
following	VBG	case	O
injury	NN	nmod	O
,	,	punct	O
with	IN	case	O
peak	NN	amod	O
activity	NN	nmod	O
at	IN	case	O
14	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

By	IN	prep	O
21	CD	nummod	O
days	NNS	compound	O
post	JJ	compound	O
-	HYPH	punct	O
injury	NN	pobj	O
,	,	punct	O
all	DT	det	O
activity	NN	nsubj	O
had	VBD	aux	O
returned	VBN	ROOT	O
to	TO	case	O
near	IN	case	O
baseline	NN	compound	O
level	NN	nmod	O
.	.	punct	O

VEGF	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
COL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IV	CD	conj	I-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
significantly	RB	advmod	O
higher	JJR	xcomp	O
for	IN	case	O
pattern	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
110	CD	nummod	O
mus	NN	compound	O
pulse	NN	compound	O
width	NN	appos	O
)	-RRB-	punct	O
compared	VBN	case	O
to	TO	case	O
pattern	NN	compound	O
B	NN	nmod	O
(	-LRB-	punct	O
5	CD	nummod	O
mus	NN	compound	O
pulse	NN	compound	O
width	NN	appos	O
)	-RRB-	punct	O
at	IN	case	O
14	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
implying	VBG	xcomp	O
that	IN	mark	O
pattern	NN	compound	O
A	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
more	RBR	advmod	O
effective	JJ	ccomp	O
at	IN	mark	O
promoting	VBG	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O

All	DT	det	O
wounds	NNS	nsubj	B-Pathological_formation
were	VBD	auxpass	O
fully	RB	advmod	O
re	NN	advmod	O
-	HYPH	punct	O
epithelialized	VBN	ROOT	O
by	IN	agent	O
10	CD	nummod	O
days	NNS	compound	O
post	JJ	compound	O
-	HYPH	punct	O
injury	NN	pobj	O
.	.	punct	O

Both	DT	cc:preconj	O
COL	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	CD	nsubj	I-Gene_or_gene_product
and	CC	cc	O
COL	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
V	NN	conj	I-Gene_or_gene_product
showed	VBD	ROOT	O
statistically	RB	advmod	O
significant	JJ	dobj	O
(	-LRB-	punct	O
P	NN	nsubj	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
increased	VBD	amod	O
activity	NN	dobj	O
between	IN	case	O
day	NN	nmod	O
7	CD	nummod	O
and	CC	cc	O
day	NN	conj	O
14	CD	nummod	O
for	IN	case	O
pattern	NN	compound	O
A	NN	nmod	O
,	,	punct	O
potentially	RB	advmod	O
indicating	VBG	advcl	O
a	DT	det	O
continued	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
matrix	NN	compound	B-Cellular_component
remodeling	NN	nmod	O
.	.	punct	O

The	DT	det	O
early	JJ	amod	O
closure	NN	nsubj	O
of	IN	prep	O
all	DT	det	O
wounds	NNS	pobj	B-Pathological_formation
implies	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
rabbit	NN	compound	B-Organism
ear	NN	compound	B-Organ
model	NN	nsubj	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
valid	RB	ccomp	O
for	IN	case	O
chronic	JJ	amod	O
wound	NN	compound	B-Pathological_formation
studies	NNS	nmod	O
.	.	punct	O

VEGF	NN	ROOT	B-Gene_or_gene_product
,	,	punct	O
angiopoietin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
in	IN	case	O
bronchial	JJ	amod	O
asthma	NN	nmod	O
:	:	punct	O
new	JJ	amod	O
molecular	JJ	amod	O
targets	NNS	dep	O
in	IN	case	O
airway	NN	compound	B-Multi-tissue_structure
angiogenesis	NN	nmod	O
and	CC	cc	O
microvascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	conj	O
.	.	punct	O

Airway	NN	compound	B-Multi-tissue_structure
angiogenesis	NN	nsubjpass	O
and	CC	cc	O
microvascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	conj	O
are	VBP	auxpass	O
known	JJ	ROOT	O
features	NNS	dobj	O
of	IN	case	O
bronchial	JJ	amod	O
asthma	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanisms	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
structural	JJ	amod	O
alterations	NNS	nmod	O
are	VBP	aux	O
just	RB	advmod	O
beginning	VBG	conj	O
to	TO	aux	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
stimulates	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
the	DT	det	O
angiogenesis	NN	dobj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
considerable	JJ	amod	O
attentions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
devoted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
physiological	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
angiopoietin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
Ang	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
as	IN	case	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Ang	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
migration	NN	dobj	O
and	CC	cc	O
sprouting	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
coexpression	NN	conj	O
of	IN	case	O
Ang	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
enhanced	VBD	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Ang	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
also	RB	advmod	O
promotes	VBZ	ROOT	O
rapid	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
capillary	JJ	amod	B-Tissue
diameter	NN	nmod	O
,	,	punct	O
remodeling	NN	advcl	O
of	IN	case	O
the	DT	det	O
basal	JJ	amod	B-Cellular_component
lamina	NN	nmod	I-Cellular_component
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
stimulates	VBZ	conj	O
sprouting	NN	dobj	O
of	IN	prep	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	pobj	I-Multi-tissue_structure
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
VEGF	NNP	nsubj	B-Gene_or_gene_product
,	,	punct	O
Ang	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
may	MD	aux	O
play	VB	ROOT	O
complementary	JJ	amod	O
and	CC	cc	O
coordinated	VBN	conj	O
roles	NNS	dobj	O
in	IN	case	O
airway	NN	compound	B-Multi-tissue_structure
angiogenesis	NN	nmod	O
and	CC	cc	O
microvascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	conj	O
,	,	punct	O
and	CC	cc	O
these	DT	det	O
structural	JJ	amod	O
changes	NNS	nsubj	O
are	VBP	cop	O
potentially	RB	advmod	O
reversible	JJ	conj	O
by	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
.	.	punct	O

The	DT	det	O
scope	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
review	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
discuss	VB	xcomp	O
from	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
point	NN	nmod	O
of	IN	case	O
view	NN	acl	O
the	DT	det	O
potential	JJ	amod	O
interactions	NNS	dobj	O
between	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
angiopoietins	VBZ	conj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
asthmatic	JJ	amod	O
airways	NNS	nmod	B-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
focus	VBP	conj	O
on	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
implications	NNS	nmod	O
targeting	VBG	acl	O
for	IN	case	O
these	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
an	DT	det	O
increasing	VBG	amod	O
number	NN	nsubj	O
of	IN	case	O
patents	NNS	nmod	O
which	WDT	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
focused	VBN	acl:relcl	O
on	IN	case	O
the	DT	det	O
inhibitors	NNS	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
action	NN	nmod	O
.	.	punct	O

These	DT	det	O
inhibitors	NNS	nsubjpass	O
are	VBP	auxpass	O
directed	VBN	ROOT	O
towards	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
substrates	NNS	conj	O
for	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
will	MD	aux	O
also	RB	advmod	O
discuss	VB	ROOT	O
several	JJ	amod	O
patents	NNS	dobj	O
regarding	VBG	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
action	NN	nmod	O
in	IN	case	O
the	DT	det	O
present	JJ	amod	O
review	NN	nmod	O
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
transplanted	VBN	amod	O
mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
rats	NNS	nmod	B-Organism
of	IN	case	O
different	JJ	amod	O
ages	NNS	nmod	O
on	IN	case	O
the	DT	det	O
improvement	NN	nmod	O
of	IN	case	O
heart	NN	compound	B-Organ
function	NN	nmod	O
after	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	compound	I-Cell
(	-LRB-	punct	O
MSCs	NNS	appos	B-Cell
)	-RRB-	punct	O
transplantation	NN	nsubj	O
is	VBZ	cop	O
of	IN	case	O
therapeutic	JJ	amod	O
potential	NN	appos	O
after	IN	case	O
ischemic	JJ	amod	O
injury	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
experimental	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nmod	O
.	.	punct	O

Clinically	RB	advmod	O
,	,	punct	O
elderly	JJ	amod	O
patients	NNS	nsubj	B-Organism
are	VBP	cop	O
more	RBR	advmod	O
vulnerable	JJ	ROOT	O
to	TO	case	O
acute	JJ	amod	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
(	-LRB-	punct	O
AMI	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

But	CC	cc	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
characteristics	NNS	nmod	O
of	IN	case	O
young	JJ	amod	O
donor	NN	npadvmod	O
-	:	punct	O
derived	VBN	amod	O
MSCs	NNS	nmod	B-Cell
transplanted	VBN	acl	O
to	TO	case	O
old	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
AMI	NN	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
transplanted	VBN	amod	O
MSCs	NNS	nmod	B-Cell
from	IN	case	O
rats	NNS	nmod	B-Organism
of	IN	case	O
different	JJ	amod	O
ages	NNS	nmod	O
on	IN	case	O
the	DT	det	O
improvement	NN	nmod	O
of	IN	case	O
heart	NN	compound	B-Organ
function	NN	nmod	O
after	IN	case	O
AMI	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
MSCs	NNS	nsubjpass	B-Cell
from	IN	case	O
Sprague	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Dawley	NNP	compound	I-Organism
(	-LRB-	punct	I-Organism
SD	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
rats	NNS	nmod	I-Organism
were	VBD	auxpass	O
isolated	VBN	dep	O
and	CC	cc	O
cultured	VBN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
apoptosis	NN	compound	O
characteristics	NNS	nsubjpass	O
of	IN	case	O
MSCs	NNS	nmod	B-Cell
were	VBD	auxpass	O
observed	VBN	ROOT	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
ischemia	NN	nmod	O
and	CC	cc	O
anoxia	NN	conj	O
.	.	punct	O

SD	NN	compound	B-Organism
rats	NNS	nsubj	I-Organism
underwent	VBD	ROOT	O
MI	NN	dobj	O
received	VBD	conj	O
intramyocardial	JJ	amod	B-Immaterial_anatomical_entity
injection	NN	dobj	O
of	IN	case	O
MSCs	NNS	nmod	B-Cell
from	IN	case	O
young	JJ	amod	O
donor	NN	compound	O
rats	NNS	nmod	B-Organism
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
8	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
old	JJ	amod	O
donor	NN	compound	O
rats	NNS	conj	B-Organism
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
8	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

AMI	NN	compound	O
control	NN	compound	O
group	NN	nsubj	O
received	VBD	ROOT	O
equal	JJ	amod	O
volume	NN	compound	O
physiological	JJ	amod	O
saline	NN	dobj	O
.	.	punct	O

Immunofluorescence	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
observe	VB	xcomp	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
the	DT	det	O
grafted	VBN	amod	O
cells	NNS	nmod	B-Cell
into	IN	case	O
cardiomyocytes	NNS	nmod	B-Cell
.	.	punct	O

Four	CD	nummod	O
weeks	NNS	nsubjpass	O
after	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
,	,	punct	O
reverse	JJ	amod	O
transcriptase	NN	compound	O
-	:	punct	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubjpass	O
(	-LRB-	punct	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
for	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
VIII	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
immunohistochemistry	NN	conj	O
for	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
density	NN	nmod	O
,	,	punct	O
TUNEL	NN	conj	O
,	,	punct	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
for	IN	case	O
cardiomyocyte	NN	compound	B-Cell
apoptosis	NN	nmod	O
,	,	punct	O
echocardiography	NN	conj	O
and	CC	cc	O
hemodynamic	JJ	amod	O
detection	NN	conj	O
for	IN	case	O
heart	NN	compound	B-Organ
function	NN	nmod	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
apoptosis	NN	compound	O
rate	NN	nsubj	O
of	IN	case	O
the	DT	det	O
old	JJ	amod	O
donor	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
MSCs	NN	compound	B-Cell
group	NN	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	appos	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
young	JJ	amod	O
donor	NN	npadvmod	O
-	:	punct	O
derived	VBN	amod	O
MSCs	NN	compound	B-Cell
group	NN	nmod	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
ischemia	NN	nmod	O
and	CC	cc	O
anoxia	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Engrafted	VBN	amod	O
MSCs	NNS	nsubj	B-Cell
survived	VBD	ROOT	O
,	,	punct	O
proliferated	VBD	conj	O
and	CC	cc	O
differentiated	VBN	conj	O
into	IN	prep	O
myocardium	NN	npadvmod	B-Cell
-	HYPH	punct	I-Cell
like	JJ	amod	I-Cell
cells	NNS	pobj	I-Cell
.	.	punct	O

VEGF	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	nsubj	O
and	CC	cc	O
capillary	JJ	amod	B-Tissue
density	NN	conj	O
in	IN	case	O
the	DT	det	O
old	JJ	amod	O
donor	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
group	NN	nmod	O
were	VBD	cop	O
lower	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
the	DT	det	O
young	JJ	amod	O
donor	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
group	NN	nmod	O
but	CC	cc	O
higher	JJR	conj	O
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
transplantation	NN	nsubj	O
of	IN	case	O
old	JJ	amod	O
donor	NN	nmod:npmod	O
-	:	punct	O
derived	VBN	amod	O
MSCs	NNS	nmod	B-Cell
attenuated	VBD	ROOT	O
apoptosis	NN	dobj	O
of	IN	case	O
cardiomyocytes	NNS	nmod	B-Cell
in	IN	case	O
the	DT	det	O
peri	NN	nmod:npmod	O
-	HYPH	punct	O
infarct	NN	amod	O
region	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
and	CC	cc	O
the	DT	det	O
effect	NN	conj	O
was	VBD	aux	O
elevated	JJ	conj	O
in	IN	case	O
young	JJ	amod	O
donor	NN	nmod:npmod	O
-	:	punct	O
derived	VBN	amod	O
MSCs	NNS	nmod	B-Cell
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
heart	NN	compound	B-Organ
functions	NNS	nsubj	O
(	-LRB-	punct	O
left	JJ	amod	O
ventricle	NN	compound	B-Multi-tissue_structure
ejection	NN	compound	O
fraction	NN	dep	O
(	-LRB-	punct	O
LVEF	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
left	VBD	ROOT	O
ventricle	NN	compound	B-Multi-tissue_structure
fractional	JJ	amod	O
shortening	NN	dobj	O
(	-LRB-	punct	O
LVFS	NN	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
were	VBD	auxpass	O
improved	VBN	conj	O
more	RBR	advmod	O
significantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
old	JJ	amod	O
donor	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
MSCs	NN	compound	B-Cell
group	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
and	CC	cc	O
the	DT	det	O
heart	NN	compound	B-Organ
function	NN	conj	O
in	IN	case	O
the	DT	det	O
young	JJ	amod	O
donor	NN	nmod:npmod	O
-	:	punct	O
derived	VBN	amod	O
MSCs	NN	compound	B-Cell
group	NN	nmod	O
further	RB	advmod	O
improved	VBD	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Young	JJ	amod	O
donor	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
MSCs	NNS	nsubj	B-Cell
can	MD	aux	O
improve	VB	appos	O
heart	NN	compound	B-Organ
function	NN	dobj	O
significantly	RB	advmod	O
through	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
decreasing	VBG	conj	O
cardiomyocyte	NN	compound	B-Cell
apoptosis	NN	dobj	O
when	WRB	advmod	O
transplanted	VBN	advcl	O
to	TO	case	O
the	DT	det	O
infarcted	VBN	amod	O
area	NN	nmod	O
.	.	punct	O

Clinical	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
chicken	NN	compound	B-Gene_or_gene_product
ovalbumin	NN	compound	I-Gene_or_gene_product
upstream	JJ	amod	I-Gene_or_gene_product
promoter	NN	dep	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Chicken	NN	compound	B-Gene_or_gene_product
ovalbumin	NN	compound	I-Gene_or_gene_product
upstream	JJ	amod	I-Gene_or_gene_product
promoter	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
plays	VBZ	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
.	.	punct	O

A	DT	det	O
previous	JJ	amod	O
study	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
enhanced	VBD	ccomp	O
invasiveness	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
no	DT	neg	O
published	VBN	amod	O
data	NNS	nsubj	O
are	VBP	cop	O
available	JJ	ROOT	O
concerning	VBG	case	O
the	DT	det	O
biological	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
significance	NN	nmod	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	poss	O
objective	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
its	PRP$	nmod:poss	O
association	NN	conj	O
with	IN	case	O
clinicopathological	JJ	amod	O
features	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
evaluate	VB	conj	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
COUP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
indicator	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
COUP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Tissue
cancer	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
and	CC	cc	O
adjacent	JJ	amod	O
normal	JJ	amod	B-Tissue
tissues	NNS	conj	I-Tissue
from	IN	case	O
95	CD	nummod	O
primary	JJ	amod	O
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

The	DT	det	O
correlation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
clinicopathologic	JJ	amod	O
features	NNS	conj	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
3	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nsubjpass	O
(	-LRB-	punct	O
DFS	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
overall	JJ	amod	O
survival	NN	conj	O
(	-LRB-	punct	O
OS	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
different	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
COUP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
Kaplan	NNP	compound	O
-	HYPH	punct	O
Meier	NNP	amod	O
method	NN	nmod	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
COUP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
age	NN	conj	O
at	IN	case	O
surgery	NN	nmod	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
histopathologic	JJ	amod	O
differentiation	NN	conj	O
,	,	punct	O
vessel	NN	compound	B-Multi-tissue_structure
invasion	NN	conj	O
,	,	punct	O
carcinoembryonic	JJ	amod	B-Gene_or_gene_product
antigen	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
CEA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
nodal	JJ	amod	O
involvement	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
survival	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
COUP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
group	NN	nsubj	O
had	VBD	ccomp	O
a	DT	det	O
significantly	RB	advmod	O
better	JJR	amod	O
OS	NN	dobj	O
compared	VBN	case	O
to	TO	case	O
COUP	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
negative	JJ	amod	O
group	NN	advcl	O
(	-LRB-	punct	O
80	CD	nummod	O
.	.	punct	O
4	CD	nummod	O
%	NN	dep	O
vs	CC	cc	O
.	.	punct	O
57	CD	conj	O
.	.	punct	O
7	CD	nummod	O
%	NN	npadvmod	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
0491	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Based	VBN	prep	O
on	IN	prep	O
our	PRP$	poss	O
results	NNS	pobj	O
,	,	punct	O
COUP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TFII	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
biomarker	NN	dobj	O
for	IN	case	O
good	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Homeostatic	JJ	amod	O
functions	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
:	:	punct	O
regulation	NN	dep	O
of	IN	case	O
energy	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
antioxidant	JJ	amod	O
defense	NN	conj	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
tumor	NN	compound	B-Cancer
suppressor	NN	nsubj	O
plays	VBZ	ROOT	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
organism	NN	nmod	O
by	IN	mark	O
supervising	VBG	advcl	O
strict	JJ	amod	O
compliance	NN	dobj	O
of	IN	prep	O
individual	JJ	amod	O
cells	NNS	pobj	B-Cell
to	TO	aux	O
needs	NNS	advcl	O
of	IN	prep	O
the	DT	det	O
whole	JJ	amod	O
organisms	NNS	pobj	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
widely	RB	advmod	O
accepted	VBN	ROOT	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
acts	VBZ	ccomp	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
stresses	NNS	nmod	O
and	CC	cc	O
abnormalities	NNS	conj	O
in	IN	case	O
cell	NN	compound	B-Cell
physiology	NN	nmod	O
by	IN	mark	O
mobilizing	VBG	advcl	O
the	DT	det	O
repair	NN	compound	O
processes	NNS	dobj	O
or	CC	cc	O
by	IN	mark	O
removing	VBG	conj	O
the	DT	det	O
diseased	JJ	amod	O
cells	NNS	dobj	B-Cell
through	IN	mark	O
initiating	VBG	advcl	O
the	DT	det	O
cell	NN	compound	B-Cell
death	NN	compound	O
programs	NNS	dobj	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
indicate	VBP	ROOT	O
that	IN	mark	O
even	RB	advmod	O
under	IN	case	O
normal	JJ	amod	O
physiological	JJ	amod	O
conditions	NNS	nsubj	O
certain	JJ	amod	O
activities	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
participate	VBP	ccomp	O
in	IN	case	O
homeostatic	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
metabolic	JJ	amod	O
processes	NNS	nmod	O
and	CC	cc	O
that	IN	mark	O
these	DT	det	O
activities	NNS	nsubj	O
are	VBP	cop	O
important	JJ	conj	O
for	IN	case	O
prevention	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

These	DT	det	O
novel	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
help	NN	ROOT	O
to	TO	mark	O
align	VB	xcomp	O
metabolic	JJ	amod	O
processes	NNS	dobj	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
energy	NN	compound	O
status	NN	conj	O
,	,	punct	O
to	TO	mark	O
maintain	VB	advcl	O
optimal	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
to	TO	aux	O
boost	VB	conj	O
the	DT	det	O
energy	NN	nmod:npmod	O
efficient	JJ	amod	O
mitochondrial	JJ	amod	B-Cellular_component
respiration	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
ATP	NN	compound	B-Simple_chemical
deficiency	NN	nmod	O
.	.	punct	O

Additional	JJ	amod	O
activities	NNS	ROOT	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
non	JJ	advmod	O
-	HYPH	punct	O
stressed	JJ	amod	O
cells	NNS	nmod	B-Cell
tune	VBP	amod	O
up	RP	advmod	O
the	DT	det	O
antioxidant	JJ	amod	O
defense	NN	compound	O
mechanisms	NNS	dobj	O
reducing	VBG	acl	O
the	DT	det	O
probability	NN	dobj	O
of	IN	case	O
mutations	NNS	nmod	O
caused	VBN	acl	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
oxidation	NN	nmod	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
daily	JJ	amod	O
stresses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
mitochondrial	JJ	amod	B-Cellular_component
respiration	NN	conj	O
greatly	RB	advmod	O
accounts	VBZ	ROOT	O
for	IN	prep	O
the	DT	det	O
deficient	JJ	amod	O
respiration	NN	pobj	O
of	IN	prep	O
the	DT	det	O
predominance	NN	pobj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
modulated	VBN	amod	O
antioxidant	JJ	amod	O
defense	NN	compound	O
mechanisms	NNS	nmod	O
contributes	VBZ	advcl	O
to	TO	case	O
mutagenesis	NN	nmod	O
and	CC	cc	O
additionally	RB	advmod	O
boosts	VBZ	conj	O
the	DT	det	O
carcinogenesis	NN	compound	O
process	NN	dobj	O
.	.	punct	O

Involvement	NN	ROOT	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nmod	O
in	IN	case	O
cerebral	JJ	amod	B-Pathological_formation
cavernous	JJ	amod	I-Pathological_formation
malformations	NNS	nmod	I-Pathological_formation
.	.	punct	O

BACKGROUND	NN	ROOT	O
AND	CC	cc	O
PURPOSE	NN	conj	O
:	:	punct	O
Cerebral	JJ	amod	B-Pathological_formation
cavernous	JJ	amod	I-Pathological_formation
malformations	NNS	nsubj	I-Pathological_formation
(	-LRB-	punct	O
CCMs	NNS	appos	B-Pathological_formation
)	-RRB-	punct	O
are	VBP	cop	O
prevalent	JJ	amod	O
cerebral	JJ	amod	B-Pathological_formation
vascular	JJ	amod	I-Pathological_formation
lesions	NNS	dep	I-Pathological_formation
involving	VBG	acl	O
aberrant	JJ	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
underlying	VBG	amod	O
mechanism	NN	nsubjpass	O
is	VBZ	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

Phosphatase	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
tension	NN	conj	I-Gene_or_gene_product
homolog	NN	dep	I-Gene_or_gene_product
deleted	VBN	acl	I-Gene_or_gene_product
on	IN	case	I-Gene_or_gene_product
chromosome	NN	nmod	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
PTEN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
frequently	RB	advmod	O
deficient	JJ	ROOT	O
in	IN	case	O
various	JJ	amod	O
pathologies	NNS	nmod	O
due	JJ	case	O
to	TO	mwe	O
mutation	NN	nmod	O
or	CC	cc	O
epigenetic	JJ	amod	O
alterations	NNS	conj	O
.	.	punct	O

PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
hypermethylation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
epigenetic	JJ	amod	O
silencing	NN	compound	O
mechanism	NN	ROOT	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	ROOT	O
aimed	VBN	acl	O
to	TO	mark	O
investigate	VB	xcomp	O
whether	IN	mark	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
surgical	JJ	amod	O
specimens	NNS	nmod	O
of	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
69	CD	dep	O
)	-RRB-	punct	O
by	IN	case	O
methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

The	DT	det	O
methylation	NN	compound	O
status	NN	nsubjpass	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
clinical	JJ	amod	O
manifestations	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
PTEN	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
analyzed	VBN	acl:relcl	O
by	IN	case	O
both	CC	cc:preconj	O
Western	NN	compound	O
blot	NN	nmod	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
proliferation	NN	dobj	O
and	CC	cc	O
the	DT	det	O
potential	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	conj	O
affected	VBN	acl	O
by	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
methylation	NN	nmod	O
,	,	punct	O
proliferating	VBG	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
nuclear	JJ	amod	I-Gene_or_gene_product
antigen	NN	conj	I-Gene_or_gene_product
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
phosphor	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Akt	NNP	conj	I-Gene_or_gene_product
and	CC	cc	O
phosphor	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Erk1	NN	conj	I-Gene_or_gene_product
,	,	punct	I-Gene_or_gene_product
2	CD	dobj	I-Gene_or_gene_product
were	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
immunofluorescence	NN	nmod	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
in	IN	case	O
CCM	NN	compound	B-Pathological_formation
specimens	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubj	O
revealed	VBD	ROOT	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	dobj	O
in	IN	case	O
15	CD	nmod	O
.	.	punct	O
9	CD	nummod	O
%	NN	amod	O
CCMs	NNS	ROOT	B-Pathological_formation
.	.	punct	O

Strikingly	RB	advmod	O
,	,	punct	O
5	CD	compound	O
of	IN	advmod	O
6	CD	nummod	O
familial	JJ	amod	O
CCMs	NNS	nsubj	B-Pathological_formation
showed	VBD	ROOT	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	dobj	O
(	-LRB-	punct	O
83	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	acl:relcl	O
than	IN	case	O
in	IN	case	O
sporadic	JJ	amod	O
cases	NNS	nmod	O
(	-LRB-	punct	O
9	CD	nummod	O
.	.	punct	O
4	CD	nummod	O
%	NN	dep	O
;	:	punct	O
P	NN	compound	O
<	ADD	appos	O
0	CD	nummod	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nsubj	O
appeared	VBD	ROOT	O
more	RBR	advmod	O
frequently	RB	advmod	O
in	IN	case	O
multiple	JJ	amod	O
CCMs	NNS	nmod	B-Pathological_formation
,	,	punct	O
including	VBG	case	O
familial	JJ	amod	O
cases	NNS	nmod	O
(	-LRB-	punct	O
46	CD	nummod	O
.	.	punct	O
7	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
than	IN	case	O
that	DT	advcl	O
in	IN	case	O
single	JJ	amod	O
-	HYPH	punct	O
lesioned	VBN	amod	O
CCMs	NNS	nmod	B-Pathological_formation
(	-LRB-	punct	O
11	CD	nummod	O
.	.	punct	O
8	CD	nummod	O
%	NN	dep	O
;	:	punct	O
P	NN	compound	O
<	ADD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Immunostaining	NN	nsubj	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	conj	O
revealed	VBD	ROOT	O
a	DT	det	O
more	RBR	advmod	O
significant	JJ	amod	O
PTEN	NN	compound	B-Gene_or_gene_product
downregulation	NN	dobj	O
in	IN	case	O
PTEN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
methylated	VBN	amod	O
CCMs	NNS	nmod	B-Pathological_formation
in	IN	case	O
comparison	NN	nmod	O
to	TO	case	O
PTEN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
unmethylated	JJ	amod	O
CCMs	NNS	nmod	B-Pathological_formation
.	.	punct	O

Reduced	VBN	amod	O
PTEN	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
proliferating	VBG	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
nuclear	JJ	amod	I-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
to	TO	case	O
the	DT	det	O
activation	NN	conj	O
of	IN	case	O
Erk1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
2	CD	conj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
Akt	NNP	conj	B-Gene_or_gene_product
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
reported	VBD	dep	O
here	RB	advmod	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nmod	O
in	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
,	,	punct	O
particularly	RB	advmod	O
in	IN	case	O
familial	JJ	amod	O
CCMs	NNS	nmod	B-Pathological_formation
,	,	punct	O
suggesting	VBG	advcl	O
this	DT	det	O
epigenetic	JJ	amod	O
alteration	NN	dobj	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
pathomechanism	NN	nmod	O
of	IN	case	O
CCMs	NNS	nmod	B-Pathological_formation
.	.	punct	O

The	DT	det	O
identification	NN	nsubj	O
of	IN	case	O
Erk1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
2	CD	dep	B-Gene_or_gene_product
as	IN	case	O
triggered	VBN	amod	O
signaling	NN	nmod	O
in	IN	case	O
the	DT	det	O
lesions	NNS	nmod	B-Pathological_formation
may	MD	aux	O
be	VB	cop	O
valuable	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
effective	JJ	amod	O
therapy	NN	nmod	O
for	IN	case	O
this	DT	det	O
disease	NN	nmod	O
.	.	punct	O

Aflibercept	NN	ROOT	B-Simple_chemical
(	-LRB-	punct	O
AVE0005	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
:	:	punct	O
an	DT	det	O
alternative	JJ	amod	O
strategy	NN	dep	O
for	IN	mark	O
inhibiting	VBG	acl	O
tumour	NN	compound	B-Cancer
angiogenesis	NN	dobj	O
by	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Aberrant	JJ	amod	O
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
landmark	NN	compound	O
feature	NN	appos	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
important	JJ	acl:relcl	O
for	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
growth	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
various	JJ	amod	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

The	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
pathway	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	nmod	O
and	CC	cc	O
best	RBS	conj	O
-	HYPH	punct	O
studied	VBN	amod	O
angiogenic	JJ	amod	O
pathways	NNS	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
may	MD	aux	O
provide	VB	ROOT	O
clinical	JJ	amod	O
benefits	NNS	dobj	O
to	TO	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

OBJECTIVES	NNS	nsubjpass	O
:	:	punct	O
Strategies	NNS	appos	O
to	TO	mark	O
inhibit	VB	acl	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
pathway	NN	dobj	O
,	,	punct	O
including	VBG	case	O
antibodies	NNS	nmod	B-Gene_or_gene_product
to	IN	case	I-Gene_or_gene_product
VEGF	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
antibodies	NNS	nsubjpass	B-Gene_or_gene_product
to	TO	case	I-Gene_or_gene_product
the	DT	det	I-Gene_or_gene_product
extracellular	JJ	amod	I-Gene_or_gene_product
domain	NN	nmod	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
VEGFR	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
or	CC	cc	O
VEGFR	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
decoy	NN	compound	O
receptors	NNS	nmod	O
for	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
tyrosine	NN	compound	B-Simple_chemical
kinase	NN	compound	I-Simple_chemical
inhibitors	NNS	conj	I-Simple_chemical
of	IN	case	O
VEGFRs	NNS	nmod	B-Gene_or_gene_product
,	,	punct	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
This	DT	det	O
review	NN	compound	O
outlines	NNS	dep	O
and	CC	cc	O
compares	VBZ	conj	O
the	DT	det	O
latest	JJS	amod	O
development	NN	dobj	O
of	IN	case	O
these	DT	det	O
strategies	NNS	nmod	O
,	,	punct	O
with	IN	prep	O
emphasis	NN	pobj	O
on	IN	prep	O
aflibercept	NN	pobj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
decoy	NN	compound	O
fusion	NN	compound	O
protein	NN	appos	O
of	IN	case	O
domain	NN	nmod	O
2	CD	nummod	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
domain	NN	conj	O
3	CD	nummod	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
with	IN	case	O
the	DT	det	O
Fc	NN	compound	O
fragment	NN	nmod	O
of	IN	case	O
IgG1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
Aflibercept	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
early	JJ	amod	O
clinical	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

Multiple	JJ	amod	O
studies	NNS	nsubj	O
are	VBP	cop	O
ongoing	JJ	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
clinical	JJ	amod	O
benefits	NNS	dobj	O
of	IN	case	O
aflibercept	NN	nmod	B-Simple_chemical
in	IN	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
perfluorocarbon	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
based	VBN	amod	O
artificial	JJ	amod	O
oxygen	NN	compound	B-Simple_chemical
carriers	NNS	nmod	O
on	IN	case	O
tissue	NN	npadvmod	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
engineered	VBN	amod	I-Multi-tissue_structure
trachea	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
biological	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
perfluorocarbon	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
based	VBN	amod	O
artificial	JJ	amod	O
oxygen	NN	compound	B-Simple_chemical
carrier	NN	nmod	O
(	-LRB-	punct	O
Oxygent	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
tissue	NN	compound	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
engineered	VBN	amod	I-Multi-tissue_structure
trachea	NNS	compound	I-Multi-tissue_structure
(	-LRB-	punct	O
TET	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
construction	NN	nmod	O
.	.	punct	O

Media	NNS	nsubj	O
supplemented	VBD	ROOT	O
with	IN	prep	O
and	CC	cc	O
without	IN	conj	O
10	CD	nummod	O
%	NN	compound	O
Oxygent	NNP	nsubjpass	B-Simple_chemical
were	VBD	auxpass	O
compared	VBN	conj	O
in	IN	prep	O
all	DT	det	O
assessments	NNS	pobj	O
.	.	punct	O

Partial	JJ	amod	O
tissue	NN	compound	B-Tissue
oxygen	NN	compound	B-Simple_chemical
tension	NN	nsubjpass	O
(	-LRB-	punct	O
PtO	NN	appos	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
with	IN	case	O
polarographic	JJ	amod	O
microprobes	NNS	nmod	O
;	:	punct	O
epithelial	JJ	amod	B-Cell
metabolism	NN	nsubjpass	O
was	VBD	auxpass	O
monitored	VBN	conj	O
by	IN	case	O
microdialysis	NN	nmod	O
inside	IN	case	O
the	DT	det	O
TET	NN	compound	B-Tissue
epithelium	NN	nmod	I-Tissue
perfused	VBN	acl	O
with	IN	case	O
the	DT	det	O
medium	NN	compound	O
underneath	NN	nmod	O
.	.	punct	O

Chondrocyte	NNP	compound	B-Cell
-	HYPH	punct	O
DegraPol	NN	compound	O
constructs	NNS	nsubjpass	O
were	VBD	auxpass	O
cultured	VBN	ROOT	O
for	IN	case	O
1	CD	nummod	O
month	NN	nmod	O
with	IN	case	O
the	DT	det	O
medium	NN	nmod	O
before	IN	case	O
glycosaminoglycan	JJ	amod	B-Simple_chemical
assessment	NN	nmod	O
and	CC	cc	O
histology	NN	conj	O
.	.	punct	O

Tissue	NN	compound	B-Tissue
reaction	NN	nsubj	O
of	IN	case	O
TET	NN	compound	B-Tissue
epithelial	JJ	amod	I-Tissue
scaffolds	NNS	nmod	I-Tissue
immersed	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
medium	NN	nmod	O
was	VBD	auxpass	O
evaluated	VBN	conj	O
on	IN	case	O
the	DT	det	O
chick	NN	compound	B-Organism
embryo	NN	compound	B-Multi-tissue_structure
chorioallantoic	JJ	amod	I-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Oxygent	JJ	amod	B-Simple_chemical
perfusion	NN	compound	O
medium	NN	nsubj	O
increased	VBD	ROOT	O
the	DT	det	O
TET	NN	compound	B-Tissue
epithelial	JJ	amod	I-Tissue
PtO	NN	dobj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
51	CD	dep	O
.	.	punct	O
2	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	appos	O
.	.	punct	O
3	CD	nummod	O
mm	NN	ROOT	O
Hg	NNP	dep	O
vs	CC	cc	O
.	.	punct	O
33	CD	nummod	O
.	.	punct	O
4	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
mm	NN	compound	O
Hg	NN	ROOT	O
at	IN	case	O
200	CD	nummod	O
microm	NN	compound	O
thickness	NN	nmod	O
;	:	punct	O
12	CD	dep	O
.	.	punct	O
5	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
mm	NN	compound	O
Hg	NNP	ROOT	O
vs	CC	cc	O
.	.	punct	O
3	LS	nummod	O
.	.	punct	O
1	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
1	CD	nummod	O
mm	NN	compound	O
Hg	NN	ROOT	O
at	IN	case	O
400	CD	nummod	O
microm	JJ	compound	O
thickness	NN	nmod	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nummod	O
.	.	punct	O
01	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
decreased	VBD	conj	O
the	DT	det	O
lactate	NN	compound	B-Simple_chemical
concentration	NN	dobj	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
63	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
08	CD	dep	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
80	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
06	CD	nummod	O
mmol	NN	compound	O
/	:	punct	O
L	NN	dep	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
lactate	NN	conj	B-Simple_chemical
/	:	punct	O
pyruvate	NN	dep	B-Simple_chemical
(	-LRB-	punct	O
1	CD	nummod	O
.	.	punct	O
87	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
26	CD	dep	O
vs	CC	cc	O
.	.	punct	O
3	LS	nummod	O
.	.	punct	O
36	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
.	.	punct	O
13	CD	dep	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
lactate	NN	conj	B-Simple_chemical
/	:	punct	O
glucose	NN	compound	B-Simple_chemical
ratios	NNS	ROOT	O
(	-LRB-	punct	O
0	CD	dep	O
.	.	punct	O
10	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
00	CD	dep	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
29	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
14	CD	dep	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	nmod	O
.	.	punct	O
05	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Chondrocyte	NNP	compound	B-Cell
-	HYPH	punct	O
DegraPol	NNP	nsubj	O
in	IN	prep	O
Oxygent	JJ	amod	B-Simple_chemical
group	NN	pobj	O
presented	VBD	ROOT	O
lower	JJR	amod	O
glycosaminoglycan	JJ	amod	B-Simple_chemical
value	NN	dobj	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
03	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
00	CD	npadvmod	O
vs	CC	cc	O
.	.	punct	O
0	LS	nummod	O
.	.	punct	O
13	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
00	CD	dep	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
;	:	punct	O
histology	NN	compound	O
slides	NNS	nsubj	O
showed	VBD	ROOT	O
poor	JJ	amod	O
acid	NN	compound	O
mucopolysaccharides	VBZ	compound	B-Simple_chemical
formation	NN	dobj	O
.	.	punct	O

Orthogonal	JJ	amod	O
polarization	NN	compound	O
spectral	JJ	amod	O
imaging	NN	nsubj	O
showed	VBD	ROOT	O
no	DT	neg	O
difference	NN	dobj	O
in	IN	case	O
functional	JJ	amod	O
capillary	JJ	amod	B-Tissue
density	NN	nmod	O
between	IN	case	O
the	DT	det	O
scaffolds	NNS	nmod	O
cultured	VBN	acl	O
on	IN	prep	O
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membranes	NNS	pobj	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
foreign	JJ	amod	O
body	NN	compound	O
reaction	NN	nsubj	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
Oxygent	JJ	nsubj	B-Simple_chemical
increases	VBZ	ccomp	O
TET	NN	compound	B-Tissue
epithelial	JJ	amod	I-Tissue
PtO	NN	dobj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
improves	VBZ	ccomp	O
epithelial	JJ	amod	B-Tissue
metabolism	NN	dobj	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
impair	VB	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
and	CC	cc	O
tends	VBZ	conj	O
to	TO	case	O
slow	VB	amod	O
cartilage	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	nmod	O
.	.	punct	O

The	DT	det	O
semaphorin	NN	compound	B-Gene_or_gene_product
7A	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
lost	VBN	ROOT	O
during	IN	case	O
melanoma	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
transformation	NN	nsubj	O
of	IN	case	O
normal	JJ	amod	O
melanocytes	NNS	nmod	B-Cell
,	,	punct	O
or	CC	cc	O
melanocyte	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
to	TO	case	O
melanoma	NN	nmod	B-Cancer
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
complex	JJ	amod	O
process	NN	ROOT	O
involving	VBG	acl	O
multiple	JJ	amod	O
mechanisms	NNS	dobj	O
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
proteins	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
function	VBP	acl:relcl	O
as	IN	case	O
brakes	NNS	nmod	O
on	IN	case	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
or	CC	cc	O
cell	NN	compound	B-Cell
survival	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
recognized	VBN	ROOT	O
early	RB	advmod	O
on	IN	case	O
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
mechanism	NN	nmod	O
for	IN	case	O
initiation	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
melanoma	NN	nmod	B-Cancer
.	.	punct	O

Semaphorins	NNS	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
their	PRP$	nmod:poss	O
cognate	JJ	amod	O
receptors	NNS	conj	O
,	,	punct	O
Plexins	NNS	appos	B-Gene_or_gene_product
and	CC	cc	O
neuropilins	NNS	conj	B-Gene_or_gene_product
,	,	punct	O
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
neuronal	JJ	amod	B-Cell
pathfinding	NN	nmod	O
,	,	punct	O
immune	JJ	amod	O
function	NN	conj	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
through	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
migration	NN	conj	O
.	.	punct	O

Semaphorin	NN	compound	B-Gene_or_gene_product
7A	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
Sema7A	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
membrane	NN	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
linked	VBN	amod	O
semaphorin	NN	ROOT	B-Gene_or_gene_product
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
by	IN	case	O
human	JJ	amod	B-Organism
keratinocytes	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	conj	O
that	IN	mark	O
Sema7A	NN	nsubj	B-Gene_or_gene_product
binds	VBZ	ccomp	O
to	TO	case	O
human	JJ	amod	B-Organism
melanocytes	NNS	nmod	B-Cell
through	IN	case	O
beta1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
integrins	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	compound	I-Gene_or_gene_product
receptor	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Sema7A	NN	nsubj	B-Gene_or_gene_product
stimulates	VBZ	ccomp	O
cytoskeletal	JJ	amod	B-Cellular_component
reorganization	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
melanocytes	NNS	nmod	B-Cell
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
adhesion	NN	nmod	O
and	CC	cc	O
dendrite	NN	compound	B-Cellular_component
formation	NN	conj	O
.	.	punct	O

Downstream	JJ	amod	O
targets	NNS	nsubj	O
of	IN	case	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
melanocytes	NNS	nmod	B-Cell
include	VBP	ROOT	O
cofilin	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
LIM	NN	compound	B-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
both	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
critical	JJ	amod	O
mediators	NNS	ccomp	O
of	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	nmod	I-Gene_or_gene_product
using	VBG	acl	O
immunohistochemistry	NN	dobj	O
on	IN	case	O
sections	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
and	CC	cc	O
matched	VBN	conj	O
metastatic	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
from	IN	case	O
19	CD	nummod	O
subjects	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
a	DT	det	O
large	JJ	amod	O
melanoma	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
microarray	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
show	VBP	ROOT	O
a	DT	det	O
significant	JJ	amod	O
loss	NN	dobj	O
of	IN	case	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
metastatic	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
compared	VBN	case	O
with	IN	case	O
primary	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
the	DT	det	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
protein	NN	ccomp	O
for	IN	case	O
melanoma	NN	nmod	B-Cancer
.	.	punct	O

Coagulation	NN	compound	O
function	NN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
pancreatic	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
coagulation	NN	compound	O
function	NN	nsubj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
pancreatic	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
is	VBZ	cop	O
abnormal	JJ	appos	O
and	CC	cc	O
the	DT	det	O
reason	NN	nsubj	O
is	VBZ	punct	O
not	RB	neg	O
very	RB	advmod	O
clear	JJ	acomp	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
retrospectively	RB	advmod	O
analyzed	VBD	ROOT	O
the	DT	det	O
coagulation	NN	compound	O
function	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
pancreatic	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
From	IN	prep	O
June	NNP	pobj	O
2004	CD	nummod	O
to	IN	prep	O
December	NNP	pobj	O
2007	CD	nummod	O
,	,	punct	O
132	CD	nummod	O
patients	NNS	nsubj	B-Organism
received	VBD	dep	O
diagnosis	NN	dobj	O
and	CC	cc	O
treatment	NN	conj	O
in	IN	case	O
our	PRP$	nmod:poss	O
hospital	NN	nmod	O
.	.	punct	O

The	DT	det	O
coagulative	JJ	amod	O
parameters	NNS	nsubj	O
including	VBG	case	O
the	DT	det	O
prothrombin	NN	compound	B-Gene_or_gene_product
time	NN	nmod	O
,	,	punct	O
activated	VBN	ROOT	O
partial	JJ	amod	O
thromboplastin	NN	compound	B-Gene_or_gene_product
time	NN	dobj	O
,	,	punct	O
and	CC	cc	O
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
collected	VBN	conj	O
and	CC	cc	O
studied	VBN	conj	O
retrospectively	RB	advmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
average	JJ	amod	O
fibrinogen	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
pancreatic	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
(	-LRB-	punct	O
476	CD	appos	O
.	.	punct	O
21	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
142	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
mg	NN	dep	O
/	:	punct	O
dl	NN	dep	O
,	,	punct	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	appos	O
than	IN	case	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
cholangiolithiasis	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
403	CD	dep	O
.	.	punct	O
28	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
126	CD	dep	O
.	.	punct	O
41	LS	meta	O
)	-RRB-	punct	O
mg	NN	dep	O
/	:	punct	O
dl	NN	dep	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
pancreatic	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
fibrinogen	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
group	NN	nmod	O
with	IN	case	O
jaundice	NN	nmod	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
patients	NNS	nmod	B-Organism
without	IN	case	O
jaundice	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
received	VBD	relcl	O
Pancreaticoduodenectomy	NNP	dobj	O
,	,	punct	O
Whipple	NNP	appos	O
'	POS	punct	O
s	NNS	compound	O
operation	NN	dobj	O
,	,	punct	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
fibrinogen	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
group	NN	nmod	O
with	IN	case	O
local	JJ	amod	O
invasiveness	NN	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
group	NN	nmod	O
without	IN	case	O
invasiveness	NN	nmod	O
.	.	punct	O

The	DT	det	O
group	NN	nsubj	O
with	IN	case	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
than	IN	case	O
the	DT	det	O
group	NN	nmod	O
without	IN	case	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubj	O
of	IN	case	O
intraoperative	JJ	amod	O
blood	NN	compound	B-Organism_substance
loss	NN	nmod	O
between	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
vitamin	NN	compound	B-Simple_chemical
K	NN	nmod	I-Simple_chemical
,	,	punct	O
(	-LRB-	punct	O
748	CD	dep	O
.	.	punct	O
27	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
448	CD	nummod	O
.	.	punct	O
51	CD	nummod	O
)	-RRB-	punct	O
ml	NN	attr	O
,	,	punct	O
and	CC	cc	O
those	DT	conj	O
without	IN	case	O
vitamin	NN	compound	B-Simple_chemical
K	NN	nmod	I-Simple_chemical
,	,	punct	O
(	-LRB-	punct	O
767	CD	nummod	O
.	.	punct	O
31	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
547	CD	dep	O
.	.	punct	O
89	CD	nummod	O
)	-RRB-	punct	O
ml	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
>	NN	amod	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
fibrinogen	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
pancreatic	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
was	VBD	auxpass	O
elevated	JJ	dep	O
.	.	punct	O

The	DT	det	O
elevated	JJ	amod	O
fibrinogen	NN	compound	B-Gene_or_gene_product
level	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
invasiveness	NN	amod	O
and	CC	cc	O
lymphatic	JJ	conj	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

Using	VBG	csubj	O
vitamin	NN	compound	B-Simple_chemical
K	NN	dobj	I-Simple_chemical
in	IN	case	O
perioperation	NN	compound	O
management	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
reduce	VB	ROOT	O
intraoperative	JJ	amod	O
blood	NN	compound	B-Organism_substance
loss	NN	dobj	O
.	.	punct	O

Molecular	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
genetic	JJ	amod	O
instability	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
chronic	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

Genetic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
driving	VBG	amod	O
force	NN	attr	O
for	IN	prep	O
tumor	NN	compound	B-Cancer
development	NN	pobj	O
as	IN	mark	O
it	PRP	nsubj	O
facilitates	VBZ	advcl	O
the	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
cell	NN	compound	B-Cell
death	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
therefore	RB	advmod	O
promotes	VBZ	conj	O
malignant	JJ	amod	O
transformation	NN	dobj	O
.	.	punct	O

Chronic	JJ	amod	O
inflammation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
common	JJ	amod	O
underlying	VBG	amod	O
condition	NN	ROOT	O
for	IN	case	O
human	JJ	amod	B-Organism
tumor	NN	compound	B-Cancer
development	NN	nmod	O
,	,	punct	O
accounting	VBG	advcl	O
for	IN	case	O
approximately	RB	advmod	O
20	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

TNFalpha	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
inflammation	NN	compound	O
cytokine	NN	ROOT	O
and	CC	cc	O
is	VBZ	cop	O
crucial	JJ	conj	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
inflammation	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
TNFalpha	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
cause	VB	ccomp	O
DNA	NN	compound	B-Cellular_component
damages	NNS	dobj	O
through	IN	case	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
ROS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

TNFalpha	NN	compound	B-Gene_or_gene_product
treatment	NN	nsubj	O
in	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	B-Cell
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
gene	NN	compound	O
mutations	NNS	nmod	O
,	,	punct	O
gene	NN	compound	O
amplification	NN	conj	O
,	,	punct	O
micronuclei	NNS	compound	B-Cellular_component
formation	NN	conj	O
and	CC	cc	O
chromosomal	JJ	amod	B-Cellular_component
instability	NN	conj	O
.	.	punct	O

Antioxidants	NNS	nsubj	O
significantly	RB	advmod	O
reduced	VBD	ROOT	O
TNFalpha	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
genetic	JJ	amod	O
damage	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TNFalpha	NN	compound	B-Gene_or_gene_product
treatment	NN	nsubj	O
alone	RB	advmod	O
led	VBD	ROOT	O
to	TO	case	O
increased	VBN	amod	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
suppressed	VBN	acl:relcl	O
by	IN	case	O
antioxidants	NNS	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
genetic	JJ	amod	O
instability	NN	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
inflammation	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

PTTG	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
promotes	VBZ	ROOT	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Human	JJ	amod	B-Organism
pituitary	JJ	amod	B-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
transforming	NN	compound	I-Gene_or_gene_product
gene	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PTTG	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
overexpression	NN	nsubj	O
correlates	VBZ	ROOT	O
with	IN	case	O
metastasis	NN	nmod	O
in	IN	case	O
multiple	JJ	amod	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
yet	RB	advmod	O
its	PRP$	nmod:poss	O
molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
of	IN	case	O
action	NN	nmod	O
remain	VBP	conj	O
elusive	JJ	xcomp	O
.	.	punct	O

We	PRP	nsubj	O
detected	VBD	ROOT	O
PTTG	NN	compound	B-Gene_or_gene_product
overexpression	NN	dobj	O
in	IN	case	O
66	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
111	CD	appos	O
of	IN	case	O
169	CD	nmod	O
)	-RRB-	punct	O
of	IN	case	O
primary	JJ	amod	O
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	O
ESCC	NN	appos	B-Cancer
)	-RRB-	punct	O
tumor	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
.	.	punct	O

PTTG	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Ectopic	JJ	amod	O
PTTG	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
in	IN	case	O
a	DT	det	O
representative	JJ	amod	O
ESCC	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
EC9706	NN	appos	B-Cell
,	,	punct	O
increased	VBD	ROOT	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
and	CC	cc	O
promoted	VBD	conj	O
in	FW	amod	O
vivo	FW	dep	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	dobj	O
.	.	punct	O

Suppressing	VBG	csubj	O
PTTG	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
by	IN	case	O
siRNA	NN	nmod	O
decreased	VBD	ROOT	O
cell	NN	compound	B-Cell
motility	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
PTTG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
HA	NNP	compound	O
/	:	punct	O
EC9706	NN	nmod	O
and	CC	cc	O
KYSE150	NN	conj	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
mass	NN	compound	O
spectrometric	JJ	amod	O
analysis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
that	IN	mark	O
PTTG	NN	compound	B-Gene_or_gene_product
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
S100A4	NN	ccomp	B-Gene_or_gene_product
and	CC	cc	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
secretion	NN	conj	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
tissue	NN	compound	B-Tissue
inhibitor	NN	conj	O
of	IN	case	O
metalloproteinase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
secretion	NN	nmod	O
to	TO	case	O
the	DT	det	O
culture	NN	compound	O
media	NNS	nmod	O
.	.	punct	O

PTTG	NN	nsubj	B-Gene_or_gene_product
induced	VBD	ROOT	O
S100A4	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	conj	O
and	CC	cc	O
protein	NN	conj	O
expression	NN	dobj	O
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
Western	NN	compound	O
blot	NN	nmod	O
and	CC	cc	O
reverse	JJ	amod	O
transcription	NN	compound	O
-	HYPH	punct	O
PCR	NN	conj	O
.	.	punct	O

Attenuating	NN	csubj	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
by	IN	case	O
siRNA	NN	nmod	O
constrained	VBD	ROOT	O
PTTG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
HA	NN	compound	O
/	:	punct	O
EC9706	NN	compound	O
cell	NN	compound	O
motility	NN	dobj	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

PTTG	NN	nsubj	B-Gene_or_gene_product
activated	VBD	ROOT	O
E	NN	compound	O
-	HYPH	punct	O
box	NN	compound	O
transcription	NN	dobj	O
and	CC	cc	O
induced	VBD	conj	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
EC9706	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
may	MD	aux	O
act	VB	ccomp	O
on	IN	case	O
an	DT	det	O
E	NNP	compound	O
-	HYPH	punct	O
box	NN	compound	O
motif	NN	nmod	O
within	IN	case	O
the	DT	det	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

Chromatin	NN	compound	B-Cellular_component
immunoprecipitation	NN	compound	O
assays	NNS	nsubj	O
further	RB	advmod	O
confirmed	VBD	ROOT	O
specific	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NN	compound	I-Gene_or_gene_product
binding	NN	dobj	O
to	TO	case	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

PTTG	NN	compound	B-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
galectin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
transactivation	NN	nsubjpass	O
and	CC	cc	O
expression	NN	conj	O
were	VBD	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
both	DT	det	O
inductions	NNS	nsubjpass	O
were	VBD	auxpass	O
suppressed	VBN	conj	O
by	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	compound	I-Gene_or_gene_product
RNAi	NNS	compound	O
cotranfection	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
elucidate	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
of	IN	case	O
PTTG	NN	compound	B-Gene_or_gene_product
overexpression	NN	nmod	O
in	IN	mark	O
promoting	VBG	advcl	O
tumor	NN	compound	B-Cancer
metastasis	NN	dobj	O
,	,	punct	O
whereby	WRB	advmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
PTTG	NN	nsubj	B-Gene_or_gene_product
modulates	VBZ	parataxis	O
expression	NN	dobj	O
and	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
factors	NNS	nmod	O
to	TO	mark	O
facilitate	VB	xcomp	O
cell	NN	compound	B-Cell
motility	NN	dobj	O
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
metabolic	JJ	amod	O
changes	NNS	nmod	O
underlying	VBG	acl	O
growth	NN	compound	O
factor	NN	compound	O
angiogenic	JJ	amod	O
activation	NN	dobj	O
:	:	punct	O
identification	NN	dep	O
of	IN	case	O
new	JJ	amod	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	nmod	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
fundamental	JJ	amod	O
process	NN	ROOT	O
to	TO	case	O
normal	JJ	nmod	O
and	CC	cc	O
abnormal	JJ	conj	O
tissue	NN	compound	B-Tissue
growth	NN	dep	O
and	CC	cc	O
repair	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
consists	VBZ	acl:relcl	O
of	IN	mark	O
recruiting	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
toward	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
stimulus	NN	nmod	O
.	.	punct	O

The	DT	det	O
cells	NNS	nsubj	B-Cell
subsequently	RB	advmod	O
proliferate	VBP	ROOT	O
and	CC	cc	O
differentiate	VBP	conj	O
to	TO	mark	O
form	VB	xcomp	O
endothelial	JJ	amod	B-Tissue
tubes	NNS	dobj	I-Tissue
and	CC	cc	O
capillary	JJ	conj	B-Tissue
-	HYPH	punct	I-Tissue
like	JJ	conj	I-Tissue
structures	NNS	pobj	I-Tissue
.	.	punct	O

Little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
metabolic	JJ	amod	O
adaptation	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
such	PDT	det:predet	O
a	DT	det	O
transformation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
metabolic	JJ	amod	O
changes	NNS	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	nmod	O
by	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
using	VBG	acl	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	dobj	I-Cell
(	-LRB-	punct	O
HUVECs	NNS	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
[	-LRB-	punct	B-Simple_chemical
1	CD	appos	I-Simple_chemical
,	,	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
13	CD	nummod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
C	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
glucose	NN	dep	I-Simple_chemical
and	CC	cc	O
mass	NN	conj	O
isotopomer	NN	compound	O
distribution	NN	compound	O
analysis	NN	dep	O
.	.	punct	O

The	DT	det	O
metabolism	NN	nsubj	O
of	IN	case	O
[	-LRB-	punct	B-Simple_chemical
1	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
13	CD	nummod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
C	NN	nmod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
glucose	NN	dep	I-Simple_chemical
by	IN	case	O
HUVEC	NN	nmod	B-Cell
allows	VBZ	ROOT	O
us	PRP	dobj	O
to	TO	aux	O
trace	VB	xcomp	O
many	JJ	dobj	O
of	IN	case	O
the	DT	det	O
main	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
metabolic	JJ	amod	O
pathways	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
glycogen	NN	compound	B-Simple_chemical
synthesis	NN	nmod	O
,	,	punct	O
the	DT	det	O
pentose	NN	compound	B-Simple_chemical
cycle	NN	dobj	O
and	CC	cc	O
the	DT	det	O
glycolytic	JJ	amod	O
pathways	NNS	conj	O
.	.	punct	O

So	RB	advmod	O
we	PRP	nsubj	O
established	VBD	ROOT	O
that	IN	mark	O
these	DT	det	O
pathways	NNS	nsubj	O
were	VBD	cop	O
crucial	JJ	ccomp	O
to	TO	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
under	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
stimulation	NN	nmod	O
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitor	NN	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
glycogen	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
pentose	NN	compound	B-Simple_chemical
cycle	NN	compound	O
pathway	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
glycogen	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
depleted	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
low	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
medium	NN	nmod	O
,	,	punct	O
but	CC	cc	O
conserved	VBN	conj	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
direct	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
key	JJ	amod	O
enzymes	NNS	nmod	O
to	TO	case	O
glycogen	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
pentose	NN	compound	B-Simple_chemical
phosphate	NN	compound	O
pathways	NNS	conj	O
reduced	VBD	ccomp	O
HUVEC	NN	compound	B-Cell
viability	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
regard	NN	nmod	O
,	,	punct	O
inhibitors	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	amod	O
antitumoral	JJ	amod	B-Cancer
agents	NNS	xcomp	O
.	.	punct	O

To	TO	aux	O
sum	VB	advcl	O
up	RP	prt	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
metabolic	JJ	amod	O
pathways	NNS	nmod	O
offers	VBZ	ccomp	O
a	DT	det	O
novel	JJ	amod	O
and	CC	cc	O
powerful	JJ	conj	O
therapeutic	JJ	dep	O
approach	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
simultaneously	RB	advmod	O
inhibits	VBZ	acl:relcl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
-	:	punct	O
induced	VBN	amod	O
angiogenesis	NN	conj	O
.	.	punct	O

Rab	NN	compound	B-Gene_or_gene_product
GTPase	NN	compound	O
regulation	NN	ROOT	O
of	IN	case	O
VEGFR2	NN	compound	B-Gene_or_gene_product
trafficking	NN	nmod	O
and	CC	cc	O
signaling	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFR2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	nmod	O
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
vascular	JJ	amod	B-Multi-tissue_structure
physiology	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
VEGFR2	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
and	CC	cc	O
trafficking	NN	conj	O
is	VBZ	auxpass	O
coordinated	VBN	acl:relcl	O
are	VBP	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
tested	VBN	ROOT	O
endocytic	JJ	amod	O
Rab	NN	compound	B-Gene_or_gene_product
GTPases	NNS	dobj	O
for	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
VEGFR2	NN	compound	B-Gene_or_gene_product
trafficking	NN	nmod	O
and	CC	cc	O
signaling	NN	conj	O
linked	VBN	acl	O
to	TO	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

METHODS	NNS	nsubj	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
Quiescent	NN	amod	O
VEGFR2	NN	nsubj	B-Gene_or_gene_product
displays	VBZ	ROOT	O
endosomal	JJ	amod	B-Cellular_component
localization	NN	dobj	O
and	CC	cc	O
colocalization	NN	conj	O
with	IN	case	O
the	DT	det	O
Rab5a	NN	compound	B-Gene_or_gene_product
GTPase	NN	nmod	O
,	,	punct	O
an	DT	det	O
early	JJ	amod	O
endosome	NN	compound	B-Cellular_component
fusion	NN	compound	O
regulator	NN	appos	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
GTP	NN	nmod	B-Simple_chemical
or	CC	cc	O
GDP	NN	conj	B-Simple_chemical
-	:	punct	O
bound	VBN	amod	O
Rab5a	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubj	O
block	VBP	ROOT	O
activated	VBN	amod	O
VEGFR2	NN	compound	B-Gene_or_gene_product
trafficking	NN	dobj	O
and	CC	cc	O
degradation	NN	conj	O
.	.	punct	O

Manipulation	NN	nsubj	O
of	IN	case	O
Rab7a	NN	compound	B-Gene_or_gene_product
GTPase	NN	compound	O
activity	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
late	JJ	amod	B-Cellular_component
endosomes	NNS	nmod	I-Cellular_component
using	VBG	acl	O
overexpression	NN	dobj	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nmod	O
or	CC	cc	O
mutant	JJ	amod	O
proteins	NNS	conj	O
blocks	VBZ	ROOT	O
activated	VBD	amod	O
VEGFR2	NN	compound	B-Gene_or_gene_product
trafficking	NN	dobj	O
and	CC	cc	O
degradation	NN	conj	O
.	.	punct	O

Depletion	NN	nsubj	O
of	IN	case	O
Rab7a	NN	nmod	B-Gene_or_gene_product
decreased	VBD	ROOT	O
VEGFR2	NN	compound	B-Gene_or_gene_product
Y1175	NN	compound	O
phosphorylation	NN	dobj	O
but	CC	cc	O
increased	VBN	amod	O
p42	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
44	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
pERK1	NN	appos	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
MAPK	NN	compound	B-Gene_or_gene_product
phosphorylation	NN	conj	O
.	.	punct	O

Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
Rab5a	NN	compound	B-Gene_or_gene_product
depletion	NN	nmod	O
but	CC	cc	O
decreased	VBD	conj	O
by	IN	case	O
Rab7a	NN	compound	B-Gene_or_gene_product
depletion	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Rab5a	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
Rab7a	NN	conj	B-Gene_or_gene_product
regulate	VBP	dep	O
VEGFR2	NN	compound	B-Gene_or_gene_product
trafficking	VBG	dobj	O
toward	IN	case	O
early	JJ	amod	B-Cellular_component
and	CC	cc	O
late	JJ	conj	B-Cellular_component
endosomes	NNS	nmod	I-Cellular_component
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
VEGFR2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
regulation	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
function	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
different	JJ	amod	O
but	CC	cc	O
specific	JJ	conj	O
Rab	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	dep	O
GTP	NN	compound	B-Simple_chemical
hydrolysis	NN	compound	O
activity	NN	nmod	O
required	VBN	acl	O
for	IN	case	O
endosomal	JJ	amod	B-Cellular_component
trafficking	NN	nmod	O
.	.	punct	O

FOXO3a	NN	nsubj	B-Gene_or_gene_product
elicits	VBZ	ROOT	O
a	DT	det	O
pro	NN	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
transcription	NN	compound	O
program	NN	dobj	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
response	NN	conj	O
to	TO	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Organ
carcinogen	NN	compound	O
nicotine	NN	nmod:npmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
derived	VBN	amod	I-Simple_chemical
nitrosaminoketone	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
NNK	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Long	JJ	compound	O
-	HYPH	punct	O
term	NN	compound	O
carcinogen	NN	compound	O
exposure	NN	nsubj	O
exerts	VBZ	ROOT	O
continuous	JJ	amod	O
pressure	NN	dobj	O
on	IN	case	O
key	JJ	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
repair	VBP	acl:relcl	O
or	CC	cc	O
eliminate	VB	conj	O
carcinogen	NN	npadvmod	O
-	HYPH	punct	O
damaged	VBN	amod	O
cells	NNS	dobj	B-Cell
giving	VBG	acl	O
rise	NN	dobj	O
to	TO	case	O
selective	JJ	amod	O
failures	NNS	nmod	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

FOXO3a	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	ROOT	O
that	WDT	nsubj	O
elicits	VBZ	acl:relcl	O
a	DT	det	O
protective	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
diverse	JJ	amod	O
cellular	JJ	amod	B-Cell
stresses	NNS	nmod	O
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
recently	RB	advmod	O
observed	VBD	ROOT	O
that	IN	mark	O
FOXO3a	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
inactivation	NN	nsubj	O
occurs	VBZ	ccomp	O
frequently	RB	advmod	O
in	IN	case	O
carcinogen	NN	compound	O
-	HYPH	punct	O
induced	VBN	amod	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
LAC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
FOXO3a	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
LAC	NN	compound	B-Cancer
suppression	NN	nmod	O
by	IN	mark	O
eliciting	VBG	advcl	O
a	DT	det	O
protective	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
carcinogenic	JJ	amod	O
stress	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
this	DT	det	O
possibility	NN	dobj	O
by	IN	mark	O
examining	VBG	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
FOXO3a	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
response	NN	nmod	O
to	TO	case	O
nicotine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
derived	VBN	amod	I-Simple_chemical
nitrosaminoketone	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
NNK	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
lung	NN	compound	B-Organ
carcinogen	NN	appos	O
implicated	VBN	acl	O
as	IN	case	O
a	DT	det	O
cause	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
LAC	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
restoration	NN	nsubj	O
of	IN	case	O
FOXO3a	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
FOXO3a	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
LAC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
increases	VBZ	ccomp	O
sensitivity	NN	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
a	DT	det	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	JJ	amod	O
intermediate	NN	nmod	O
of	IN	case	O
NNK	NN	nmod	B-Simple_chemical
.	.	punct	O

Prior	JJ	case	O
to	TO	case	O
this	DT	det	O
cellular	JJ	amod	B-Cell
outcome	NN	nmod	O
,	,	punct	O
FOXO3a	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
functionally	RB	advmod	O
activated	VBN	ROOT	O
and	CC	cc	O
mediates	VBZ	conj	O
a	DT	det	O
large	JJ	amod	O
-	HYPH	punct	O
scale	NN	amod	O
transcription	NN	compound	O
program	NN	dobj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
this	DT	det	O
damage	NN	nmod	O
involving	VBG	acl	O
a	DT	det	O
significant	JJ	amod	O
modulation	NN	dobj	O
of	IN	case	O
440	CD	nummod	O
genes	NNS	nmod	O
.	.	punct	O

Genes	NNS	nsubj	O
most	RBS	advmod	O
significantly	RB	advmod	O
represented	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
program	NN	nmod	O
are	VBP	cop	O
those	DT	nmod	O
with	IN	case	O
roles	NNS	nmod	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	dep	O
and	CC	cc	O
proliferation	NN	conj	O
>	NN	dep	O
protein	NN	compound	O
synthesis	NN	dep	O
>	NN	dep	O
gene	NN	compound	O
expression	NN	nmod	O
>	NN	dep	O
cell	NN	compound	B-Cell
death	NN	compound	O
>	NN	amod	O
cell	NN	compound	B-Cell
cycle	NN	dep	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
show	VBP	ROOT	O
that	IN	mark	O
FOXO3a	NN	nsubj	B-Gene_or_gene_product
directs	VBZ	ccomp	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
carcinogenic	JJ	amod	O
transcription	NN	compound	O
program	NN	dobj	O
that	WDT	nsubj	O
culminates	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
elimination	NN	nmod	O
of	IN	case	O
carcinogen	NN	npadvmod	O
-	HYPH	punct	O
damaged	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
FOXO3a	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
suppressor	NN	ccomp	O
of	IN	case	O
carcinogenic	JJ	amod	O
damage	NN	nmod	O
in	IN	case	O
LAC	NN	nmod	B-Cancer
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nsubj	O
in	IN	case	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
/	:	punct	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
increases	VBZ	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
neurogenesis	NN	conj	O
in	IN	case	O
culture	NN	nmod	O
but	CC	cc	O
has	VBZ	conj	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
these	DT	det	O
functions	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
polycomb	NN	compound	O
gene	NN	compound	O
Bmi	NN	nsubjpass	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
self	NN	compound	O
-	HYPH	punct	O
renewal	NN	nmod	O
of	IN	case	O
stem	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
diverse	JJ	amod	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
including	VBG	case	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
(	-LRB-	punct	O
CNS	NN	appos	B-Anatomical_system
)	-RRB-	punct	O
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
is	VBZ	cop	O
elevated	JJ	ROOT	O
in	IN	case	O
most	JJS	amod	O
human	JJ	amod	B-Organism
gliomas	NNS	nmod	B-Cancer
,	,	punct	O
irrespective	RB	amod	O
of	IN	case	O
grade	NN	nmod	O
,	,	punct	O
raising	VBG	advcl	O
the	DT	det	O
question	NN	dobj	O
of	IN	prep	O
whether	IN	mark	O
Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	pcomp	O
to	TO	aux	O
promote	VB	xcomp	O
self	NN	compound	O
-	HYPH	punct	O
renewal	NN	dobj	O
or	CC	cc	O
tumorigenesis	NN	conj	O
by	IN	case	O
CNS	NN	compound	B-Cell
stem	NN	compound	I-Cell
/	:	punct	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	dobj	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
Nestin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Bmi	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
GFP	NN	compound	B-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	dobj	B-Organism
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
two	CD	nummod	O
independent	JJ	amod	O
lines	NNS	nmod	O
with	IN	case	O
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
fetal	JJ	amod	B-Anatomical_system
and	CC	cc	O
adult	JJ	conj	B-Anatomical_system
CNS	NN	nmod	I-Anatomical_system
demonstrated	VBD	ROOT	O
that	IN	mark	O
transgenic	JJ	amod	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
formed	VBD	ccomp	O
larger	JJR	amod	O
colonies	NNS	dobj	O
,	,	punct	O
more	JJR	advmod	O
self	NN	npadvmod	O
-	HYPH	punct	O
renewing	VBG	amod	O
divisions	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
more	JJR	amod	O
neurons	NNS	conj	B-Cell
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nsubj	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
CNS	NN	compound	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
frequency	NN	nmod	O
,	,	punct	O
subventricular	JJ	amod	B-Immaterial_anatomical_entity
zone	NN	compound	I-Immaterial_anatomical_entity
proliferation	NN	conj	O
,	,	punct	O
olfactory	JJ	amod	B-Multi-tissue_structure
bulb	NN	nmod:poss	I-Multi-tissue_structure
neurogenesis	NN	conj	O
,	,	punct	O
or	CC	cc	O
neurogenesis	NN	conj	O
/	:	punct	O
gliogenesis	NN	conj	O
during	IN	prep	O
development	NN	pobj	O
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
born	VBN	ROOT	O
with	IN	case	O
enlarged	JJ	amod	O
lateral	JJ	amod	B-Multi-tissue_structure
ventricles	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
a	DT	det	O
minority	NN	conj	O
developed	VBD	conj	O
idiopathic	JJ	amod	O
hydrocephalus	NN	advmod	O
as	IN	case	O
adults	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
none	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transgenic	JJ	amod	O
mice	NNS	nmod	B-Organism
formed	VBD	conj	O
detectable	JJ	amod	O
CNS	NN	compound	B-Cancer
tumors	NNS	dobj	I-Cancer
,	,	punct	O
even	RB	advmod	O
when	WRB	advmod	O
aged	JJ	advcl	O
.	.	punct	O

The	DT	det	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nmod	O
in	IN	case	O
culture	NN	nmod	O
were	VBD	cop	O
largely	RB	advmod	O
attributable	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
attenuated	VBN	amod	O
induction	NN	nmod	O
of	IN	case	O
p16	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Ink4a	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
p19	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
Arf	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
proteins	NNS	dep	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
generally	RB	advmod	O
not	RB	neg	O
expressed	VBN	acl:relcl	O
by	IN	case	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
/	:	punct	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
young	JJ	amod	O
mice	NNS	nmod	B-Organism
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
therefore	RB	advmod	O
has	VBZ	ROOT	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
culture	NN	nmod	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
appear	VB	conj	O
to	TO	mark	O
be	VB	cop	O
sufficient	JJ	xcomp	O
to	TO	mark	O
induce	VB	xcomp	O
tumorigenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Erbb2	NN	nsubj	B-Gene_or_gene_product
suppresses	VBZ	ROOT	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
checkpoint	NN	amod	O
activation	NN	dobj	O
and	CC	cc	O
UV	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
mouse	NN	compound	B-Organism
skin	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
Erbb2	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
cause	NN	appos	O
of	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
melanoma	NN	compound	I-Cancer
skin	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
Erbb2	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
skin	NN	compound	B-Organ
tumorigenesis	NN	nmod	O
by	IN	mark	O
suppressing	VBG	advcl	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
this	DT	det	O
hypothesis	NN	nmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
Ha	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
before	IN	case	O
UV	NN	compound	O
exposure	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
both	DT	dep	O
56	CD	nummod	O
%	NN	nmod	O
fewer	JJR	amod	O
skin	NN	compound	B-Cancer
tumors	NNS	dep	I-Cancer
and	CC	cc	O
tumors	NNS	conj	B-Cancer
that	WDT	nsubj	O
were	VBD	cop	O
70	CD	nummod	O
%	NN	nmod:npmod	O
smaller	JJR	ccomp	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
milder	NN	amod	O
epidermal	JJ	amod	B-Pathological_formation
hyperplasia	NN	nmod	I-Pathological_formation
,	,	punct	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
accumulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
decreased	VBN	amod	O
levels	NNS	conj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
regulator	NN	nmod	O
Cdc25a	NN	dep	B-Gene_or_gene_product
,	,	punct	O
suggesting	VBG	xcomp	O
altered	JJ	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
regulation	NN	dobj	O
on	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Further	JJ	amod	O
investigation	NN	nsubj	O
using	VBG	acl	O
inhibition	NN	dobj	O
or	CC	cc	O
genetic	JJ	amod	O
deletion	NN	conj	O
of	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vitro	FW	advmod	O
revealed	VBD	ROOT	O
reduced	VBN	amod	O
Cdc25a	NN	compound	B-Gene_or_gene_product
levels	NNS	dobj	O
and	CC	cc	O
increased	VBD	amod	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
arrest	NN	conj	O
in	IN	case	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
irradiated	JJ	amod	O
cells	NNS	nmod	B-Cell
lacking	VBG	acl	O
Erbb2	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

Ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
Cdc25a	NN	nmod	B-Gene_or_gene_product
prevented	VBD	ROOT	O
UV	NN	nmod:npmod	O
-	:	punct	O
induced	VBN	amod	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
arrest	NN	dobj	O
in	IN	case	O
keratinocytes	NNS	nmod	B-Cell
lacking	VBG	acl	O
Erbb2	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
maintenance	NN	nsubj	O
of	IN	case	O
Cdc25a	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
suppresses	VBZ	ccomp	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O

Examination	NN	nsubj	O
of	IN	case	O
checkpoint	NN	amod	O
pathway	NN	compound	O
activation	NN	nmod	O
upstream	RB	advmod	O
of	IN	case	O
Cdc25a	NN	nmod	B-Gene_or_gene_product
revealed	VBD	ROOT	O
Erbb2	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
alter	VB	ccomp	O
Ataxia	NNP	compound	O
Telangiectasia	NN	dobj	O
and	CC	cc	O
Rad3	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	O
related	JJ	amod	O
/	SYM	punct	O
Ataxia	NNP	compound	O
Telangiectasia	NN	compound	O
Mutated	VBN	amod	O
activity	NN	dep	O
but	CC	cc	O
increased	VBD	amod	O
inhibitory	JJ	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
Chk1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Ser	NN	nmod	B-Amino_acid
(	-LRB-	punct	I-Amino_acid
280	CD	appos	I-Amino_acid
)	-RRB-	punct	I-Amino_acid
.	.	punct	O

Since	IN	mark	O
Akt	NNP	nsubj	B-Gene_or_gene_product
phosphorylates	VBZ	advcl	O
Chk1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Ser	NN	dobj	B-Amino_acid
(	-LRB-	punct	I-Amino_acid
280	CD	appos	I-Amino_acid
)	-RRB-	punct	I-Amino_acid
,	,	punct	O
the	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
Erbb2	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
phosphatidyl	NN	compound	B-Gene_or_gene_product
inositol	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
PI3K	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
/	:	punct	O
Akt	DT	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
during	IN	case	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O

Erbb2	NN	compound	B-Gene_or_gene_product
ablation	NN	nsubj	O
reduced	VBD	ROOT	O
the	DT	det	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
activation	NN	dobj	O
of	IN	case	O
PI3K	NN	nmod	B-Gene_or_gene_product
while	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
PI3K	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	nsubj	B-Gene_or_gene_product
increased	VBD	advcl	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
Erbb2	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
increases	VBZ	ROOT	O
skin	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
through	IN	case	O
inhibitory	JJ	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
Chk1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Cdc25a	NN	compound	B-Gene_or_gene_product
maintenance	NN	conj	O
,	,	punct	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
arrest	NN	nmod	O
via	IN	case	O
a	DT	det	O
PI3K	NN	nmod:npmod	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

The	DT	det	O
EGFR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
GEP100	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Arf6	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
AMAP1	NN	dep	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	ROOT	O
specific	JJ	amod	O
to	TO	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Tumors	NNS	nsubj	B-Cancer
are	VBP	ROOT	O
tissue	NN	nmod:npmod	B-Tissue
-	HYPH	punct	O
specific	JJ	amod	O
diseases	NNS	attr	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
mechanisms	NNS	nsubj	O
of	IN	case	O
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
are	VBP	cop	O
highly	RB	advmod	O
diverse	JJ	conj	O
.	.	punct	O

In	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
biomarkers	VBZ	nsubjpass	O
that	WDT	nsubj	O
specifically	RB	advmod	O
correlate	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
phenotypes	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O

A	DT	det	O
small	JJ	amod	O
GTPase	NN	compound	O
Arf6	NN	nsubj	B-Gene_or_gene_product
primarily	RB	advmod	O
regulates	VBZ	ROOT	O
recycling	NN	dobj	O
of	IN	case	O
plasma	NN	compound	B-Organism_substance
membrane	NN	compound	B-Cellular_component
components	NNS	nmod	I-Cellular_component
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
Arf6	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
effector	NN	compound	O
AMAP1	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
DDEF1	NN	dep	B-Gene_or_gene_product
,	,	punct	O
DEF1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
ASAP1	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
centaurin	NN	compound	B-Gene_or_gene_product
beta4	NN	conj	I-Gene_or_gene_product
)	-RRB-	punct	O
are	VBP	auxpass	O
abnormally	RB	advmod	O
overexpressed	VBN	ccomp	O
in	IN	case	O
some	DT	det	O
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
used	VBN	conj	O
for	IN	case	O
their	PRP$	nmod:poss	O
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
is	VBZ	cop	O
independent	JJ	ROOT	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
upregulation	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
occurs	VBZ	conj	O
only	RB	advmod	O
in	IN	case	O
highly	RB	advmod	O
malignant	JJ	amod	B-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
recently	RB	advmod	O
identified	VBD	ROOT	O
GEP100	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
BRAG2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	mark	O
be	VB	cop	O
responsible	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
Arf6	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
invasion	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
by	IN	mark	O
directly	RB	advmod	O
binding	VBG	advcl	O
to	TO	case	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
series	NN	nsubj	O
of	IN	case	O
our	PRP$	nmod:poss	O
studies	NNS	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
invasion	NN	compound	O
pathway	NN	nmod	O
of	IN	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
prerequisite	JJ	ccomp	O
that	IN	mark	O
Arf6	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
AMAP1	NN	conj	B-Gene_or_gene_product
both	DT	nsubjpass	O
are	VBP	auxpass	O
highly	RB	advmod	O
overexpressed	VBN	ccomp	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
EGFR	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	conj	O
by	IN	case	O
ligands	NNS	nmod	O
.	.	punct	O

Pathological	JJ	amod	O
analyses	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
significant	JJ	amod	O
large	JJ	amod	O
population	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-Organism
ductal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
may	MD	aux	O
utilize	VB	ccomp	O
the	DT	det	O
EGFR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
GEP100	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Arf6	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
AMAP1	NN	compound	B-Gene_or_gene_product
pathway	NN	dobj	O
for	IN	case	O
their	PRP$	poss	O
malignancy	NN	nmod	O
.	.	punct	O

Microenvironments	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
highly	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
malignancy	NN	nmod	O
of	IN	case	O
mammary	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
an	DT	det	O
aspect	NN	dobj	O
of	IN	case	O
the	DT	det	O
precise	JJ	amod	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
some	DT	det	O
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
full	JJ	amod	O
invasiveness	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
acquired	VBN	acl:relcl	O
just	RB	advmod	O
by	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
alterations	NNS	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
factors	NNS	nsubj	O
from	IN	case	O
microenvironments	NNS	nmod	O
may	MD	aux	O
also	RB	advmod	O
be	VB	cop	O
necessary	JJ	conj	O
.	.	punct	O

Possible	JJ	amod	O
translation	NN	nsubjpass	O
of	IN	case	O
our	PRP$	nmod:poss	O
knowledge	NN	nmod	O
to	TO	case	O
cancer	NN	compound	B-Cancer
therapeutics	NNS	nmod	O
will	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Met	JJ	compound	B-Gene_or_gene_product
amplification	NN	ROOT	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
in	IN	case	O
Cdkn2a	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
melanocytes	NNS	nmod	O
.	.	punct	O

While	IN	mark	O
many	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	advcl	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
,	,	punct	O
the	DT	det	O
relevant	JJ	amod	O
molecular	JJ	amod	O
events	NNS	nsubjpass	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
disease	NN	compound	O
progression	NN	nmod	O
are	VBP	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

Most	JJS	amod	O
primary	JJ	amod	O
human	JJ	amod	B-Organism
melanomas	NNS	nsubj	B-Cancer
exhibit	VBP	ROOT	O
loss	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
CDKN2A	NN	compound	B-Gene_or_gene_product
locus	NN	nmod	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
canonical	JJ	amod	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
Cdkn2a	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mouse	NN	compound	B-Organism
melanocyte	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
to	TO	mark	O
screen	VB	advcl	O
for	IN	case	O
secondary	JJ	amod	O
genetic	JJ	amod	O
events	NNS	nmod	O
in	IN	case	O
melanoma	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

Upon	IN	case	O
investigation	NN	nmod	O
,	,	punct	O
intrachromosomal	JJ	amod	B-Cellular_component
gene	NN	compound	O
amplification	NN	appos	O
of	IN	case	O
Met	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
receptor	NN	compound	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	appos	O
implicated	VBN	acl	O
in	IN	case	O
melanoma	NN	compound	B-Cancer
progression	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
Cdkn2a	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O

RNA	NN	compound	O
interference	NN	nsubj	O
targeting	VBG	acl	O
Met	VBN	dobj	B-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
delay	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

MET	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	B-Organism
melanoma	NN	nmod	B-Cancer
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	B-Cancer
disease	NN	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
validates	VBZ	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
Met	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
in	IN	case	O
melanoma	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
progression	NN	nmod	O
in	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
Cdkn2a	JJ	compound	B-Gene_or_gene_product
deficiency	NN	nmod	O
.	.	punct	O

Activated	VBN	amod	O
platelets	NNS	nsubj	B-Cell
enhance	VBP	ROOT	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
invasion	NN	dobj	O
in	IN	case	O
a	DT	det	O
cellular	JJ	amod	B-Cell
model	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
platelet	NN	compound	B-Cell
counts	NNS	nsubjpass	O
and	CC	cc	O
systemic	JJ	amod	O
coagulation	NN	compound	O
activation	NN	conj	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

Platelet	NN	compound	B-Cell
activation	NN	nsubj	O
occurs	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
microenvironment	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
influence	VB	conj	O
local	JJ	amod	O
invasion	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
cellular	JJ	amod	B-Cell
model	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
invasion	NN	nmod	O
to	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
activated	VBN	amod	O
platelets	NNS	nmod	B-Cell
on	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
SKOV3	NN	appos	B-Cell
.	.	punct	O

SKOV3	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
exposed	VBN	ROOT	O
to	TO	mark	O
washed	VBN	xcomp	O
,	,	punct	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
activating	NN	compound	I-Gene_or_gene_product
peptide	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
TRAP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
activated	VBN	dep	O
or	CC	cc	O
TRAP	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	O
naive	JJ	amod	O
platelets	NNS	dobj	B-Cell
under	IN	case	O
various	JJ	amod	O
experimental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
invasion	NN	nsubjpass	O
was	VBD	auxpass	O
assayed	VBN	conj	O
in	IN	case	O
Matrigel	NNP	compound	O
chambers	NNS	nmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
platelets	NNS	nmod	B-Cell
on	IN	case	O
the	DT	det	O
content	NN	nmod	O
of	IN	case	O
urokinase	NN	compound	B-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
uPA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
in	IN	case	O
SKOV3	NN	compound	B-Cell
cell	NN	compound	I-Cell
conditioned	JJ	amod	O
medium	NN	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
using	VBG	xcomp	O
an	DT	det	O
ELISA	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

TRAP	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
activated	VBN	amod	O
platelets	NNS	nsubj	B-Cell
stimulated	VBD	ROOT	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
SKOV3	NN	compound	B-Cell
cell	NN	compound	I-Cell
invasion	NN	nmod	O
.	.	punct	O

Exposure	NN	nsubj	O
to	TO	case	O
activated	VBN	amod	O
platelet	NN	compound	B-Cell
membranes	NNS	nmod	B-Cellular_component
and	CC	cc	O
to	TO	case	O
soluble	JJ	amod	O
proteins	NNS	conj	O
contained	VBN	csubj	O
in	IN	case	O
activated	VBN	amod	O
platelet	NN	nmod	B-Cell
releasate	VBP	ROOT	O
both	CC	cc:preconj	O
contributed	VBD	xcomp	O
to	TO	case	O
the	DT	det	O
observed	VBN	amod	O
increase	NN	nmod	O
in	IN	case	O
invasion	NN	nmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
platelet	NN	compound	B-Cell
activation	NN	nmod	O
with	IN	case	O
prostaglandin	NN	compound	B-Simple_chemical
E1	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
PGE	NN	appos	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
1	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
attenuated	VBD	ROOT	O
the	DT	det	O
invasive	JJ	amod	O
capacity	NN	dobj	O
of	IN	case	O
SKOV3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Exposure	NN	nsubj	O
to	TO	case	O
platelets	NNS	nmod	B-Cell
resulted	VBD	ROOT	O
in	IN	case	O
significantly	RB	advmod	O
increased	VBN	amod	O
uPA	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
content	NN	nmod	O
of	IN	case	O
SKOV3	NN	compound	B-Cell
cell	NN	compound	I-Cell
conditioned	JJ	amod	O
medium	NN	nmod	O
.	.	punct	O

Activated	VBN	amod	O
platelets	NNS	nsubj	B-Cell
enhance	VBP	ROOT	O
SKOV3	NN	compound	B-Cell
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
invasion	NN	dobj	O
through	IN	case	O
Matrigel	NN	nmod	O
and	CC	cc	O
increase	VBP	conj	O
the	DT	det	O
amount	NN	dobj	O
of	IN	case	O
uPA	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
secreted	VBN	acl	O
into	IN	case	O
SKOV3	NN	compound	B-Cell
cell	NN	compound	I-Cell
conditioned	JJ	amod	O
medium	NN	nmod	O
.	.	punct	O

If	IN	mark	O
generalizable	JJ	advcl	O
to	TO	case	O
additional	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
human	JJ	amod	B-Organism
disease	NN	conj	O
,	,	punct	O
this	DT	det	O
observation	NN	nsubj	O
may	MD	aux	O
partially	RB	advmod	O
explain	VB	ROOT	O
the	DT	det	O
adverse	JJ	amod	O
prognosis	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
thrombocytosis	NN	nmod	O
in	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Platelets	NNS	nsubj	B-Cell
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
potential	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

AngiomiRs	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
-	HYPH	punct	O
key	JJ	amod	O
regulators	NNS	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
through	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
critical	JJ	ROOT	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nmod	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O

Aberrant	JJ	amod	O
angiogenesis	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ischemia	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	B-Cancer
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
revealed	VBN	ROOT	O
important	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
miRNAs	NN	nmod	O
in	IN	mark	O
regulating	VBG	acl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
function	NN	dobj	O
,	,	punct	O
especially	RB	advmod	O
angiogenesis	NN	nmod	O
.	.	punct	O

Mice	NNS	nsubj	B-Organism
with	IN	prep	O
EC	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
specific	JJ	amod	O
deletion	NN	pobj	O
of	IN	prep	O
Dicer	NNP	pobj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
enzyme	NN	appos	O
for	IN	mark	O
generating	VBG	acl	O
miRNAs	NN	dobj	O
,	,	punct	O
display	VBP	ROOT	O
defective	JJ	amod	O
postnatal	JJ	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

Specific	JJ	amod	O
miRNAs	NN	nsubjpass	O
(	-LRB-	punct	O
angiomiRs	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
have	VBP	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

miRNA	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
126	CD	nsubj	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
EC	NNP	nmod:npmod	B-Cell
-	HYPH	punct	O
restricted	JJ	amod	O
miRNA	NN	appos	O
,	,	punct	O
regulates	VBZ	ROOT	O
vascular	JJ	amod	B-Multi-tissue_structure
integrity	NN	dobj	O
and	CC	cc	O
developmental	JJ	amod	O
angiogenesis	NN	conj	O
.	.	punct	O

miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
378	CD	nsubj	I-Gene_or_gene_product
,	,	punct	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
296	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
92	CD	nummod	B-Gene_or_gene_product
cluster	NN	nsubj	O
contribute	VBP	ROOT	O
to	TO	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

Manipulating	VBG	amod	O
angiomiRs	NN	nsubj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
settings	NNS	nmod	O
of	IN	case	O
pathological	JJ	amod	O
vascularization	NN	nmod	O
represents	VBZ	ROOT	O
a	DT	det	O
new	JJ	amod	O
therapeutic	JJ	amod	O
approach	NN	dobj	O
.	.	punct	O

Promoting	VBG	ROOT	O
angiogenesis	NN	dobj	O
via	IN	case	O
manipulation	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
responsiveness	NN	nmod	O
with	IN	case	O
notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
.	.	punct	O

Promoting	VBG	csubj	O
angiogenesis	NN	dobj	O
via	IN	case	O
delivery	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
other	JJ	amod	O
angiogenic	JJ	amod	O
factors	NNS	conj	O
is	VBZ	cop	O
both	CC	cc:preconj	O
a	DT	det	O
potential	JJ	amod	O
therapy	NN	ROOT	O
for	IN	case	O
cardiovascular	JJ	amod	B-Anatomical_system
diseases	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
critical	JJ	amod	O
aspect	NN	conj	O
for	IN	case	O
tissue	NN	compound	B-Tissue
regeneration	NN	nmod	O
.	.	punct	O

The	DT	det	O
recent	JJ	amod	O
demonstration	NN	nsubj	O
that	IN	mark	O
VEGF	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
modulated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
suggests	VBZ	ROOT	O
that	IN	mark	O
inhibiting	VBG	nsubj	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
may	MD	aux	O
enhance	VB	ccomp	O
regional	JJ	amod	O
neovascularization	NN	dobj	O
,	,	punct	O
by	IN	mark	O
altering	VBG	advcl	O
the	DT	det	O
responsiveness	NN	dobj	O
of	IN	case	O
local	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
angiogenic	JJ	amod	O
stimuli	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
this	DT	det	O
possibility	NN	dobj	O
with	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
assays	NNS	nmod	O
using	VBG	acl	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
a	DT	det	O
rodent	JJ	amod	O
hindlimb	JJ	compound	B-Organism_subdivision
ischemia	NN	compound	O
model	NN	conj	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
cultured	VBN	amod	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
DAPT	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
gamma	NN	compound	B-Gene_or_gene_product
secretase	NN	compound	I-Gene_or_gene_product
inhibitor	NN	appos	O
,	,	punct	O
increased	VBN	ROOT	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
sprout	NN	compound	B-Tissue
formation	NN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
VEGF	NN	compound	B-Gene_or_gene_product
stimulation	NN	nmod	O
with	IN	case	O
a	DT	det	O
biphasic	JJ	amod	O
dependence	NN	nmod	O
on	IN	case	O
DAPT	NN	compound	B-Simple_chemical
concentration	NN	nmod	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
delivery	NN	nsubj	O
of	IN	case	O
an	DT	det	O
appropriate	JJ	amod	O
combination	NN	nmod	O
of	IN	case	O
DAPT	NN	nmod	B-Simple_chemical
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
from	IN	case	O
an	DT	det	O
injectable	JJ	amod	O
alginate	JJ	compound	O
hydrogel	NN	compound	O
system	NN	nmod	O
into	IN	case	O
ischemic	JJ	amod	O
hindlimbs	NN	nmod	B-Organism_subdivision
led	VBD	ROOT	O
to	IN	case	O
a	DT	det	O
faster	JJR	amod	O
recovery	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Organism_substance
flow	NN	nmod	O
than	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
DAPT	NN	conj	B-Simple_chemical
alone	RB	advmod	O
;	:	punct	O
perfusion	NN	compound	O
levels	NNS	nsubj	O
reached	VBD	parataxis	O
80	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
level	NN	nmod	O
by	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
with	IN	case	O
combined	JJ	amod	O
DAPT	NN	nmod	B-Simple_chemical
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
delivery	NN	conj	O
.	.	punct	O

Direct	JJ	amod	O
intramuscular	JJ	amod	B-Immaterial_anatomical_entity
or	CC	cc	O
intraperitoneal	JJ	conj	B-Immaterial_anatomical_entity
injection	NN	nsubj	O
of	IN	case	O
DAPT	NN	nmod	B-Simple_chemical
did	VBD	aux	O
not	RB	neg	O
result	VB	ROOT	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
improvement	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
appropriate	JJ	amod	O
presentation	NN	nsubj	O
of	IN	case	O
DAPT	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
gel	NN	compound	O
delivery	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
its	PRP$	nmod:poss	O
activity	NN	nmod	O
.	.	punct	O

DAPT	NN	compound	B-Simple_chemical
delivery	NN	nsubj	O
from	IN	prep	O
the	DT	det	O
hydrogels	NNS	pobj	O
also	RB	advmod	O
did	VBD	aux	O
not	RB	neg	O
lead	VB	ROOT	O
to	TO	case	O
any	DT	det	O
adverse	JJ	amod	O
side	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
systemic	JJ	amod	O
introduction	NN	nmod	O
of	IN	case	O
DAPT	NN	nmod	B-Simple_chemical
.	.	punct	O

Altogether	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
approach	NN	dobj	O
to	TO	mark	O
promote	VB	acl	O
angiogenesis	NN	dobj	O
by	IN	mark	O
controlling	VBG	advcl	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
,	,	punct	O
and	CC	cc	O
may	MD	aux	O
provide	VB	conj	O
new	JJ	amod	O
options	NNS	dobj	O
to	TO	mark	O
treat	VB	acl	O
patients	NNS	dobj	B-Organism
with	IN	case	O
diseases	NNS	nmod	O
that	WDT	nsubj	O
diminish	VBP	acl:relcl	O
angiogenic	JJ	amod	O
responsiveness	NN	dobj	O
.	.	punct	O

[	-LRB-	punct	O
Activation	NN	ROOT	O
of	IN	case	O
sterol	NN	amod	B-Gene_or_gene_product
regulatory	JJ	amod	I-Gene_or_gene_product
element	NN	compound	I-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
involvement	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
]	-RRB-	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
study	VB	dep	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
sterol	NN	amod	B-Gene_or_gene_product
regulatory	JJ	amod	I-Gene_or_gene_product
element	NN	compound	I-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
SREBP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
critical	JJ	amod	O
role	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
were	VBD	auxpass	O
cultured	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
SREBP	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Cdc42	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
Western	NN	compound	O
blot	NN	nmod	O
and	CC	cc	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
outward	RB	amod	O
growth	NN	compound	O
migration	NN	compound	O
model	NN	nsubjpass	O
and	CC	cc	O
transwell	NN	compound	O
chamber	NN	compound	O
assay	NN	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
ECs	NNS	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

RESULTS	NNS	dep	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
SREBP	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
activated	VBN	ROOT	O
during	IN	case	O
ECs	NNS	compound	B-Cell
migration	NN	nmod	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
increased	VBN	amod	O
active	JJ	amod	O
form	NN	compound	O
SREBP	NN	dobj	B-Gene_or_gene_product
in	IN	mark	O
migrating	VBG	advcl	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
migrating	VBG	amod	O
ECs	NNS	compound	B-Cell
population	NN	nmod	O
.	.	punct	O

SREBP	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
decreased	VBD	ROOT	O
as	IN	mark	O
ECs	NNS	compound	B-Cell
migration	NN	nsubj	O
slowed	VBD	advcl	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
Coincidental	NN	dep	O
with	IN	case	O
SREBP	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
,	,	punct	O
mRNA	NN	compound	O
expression	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
target	NN	compound	O
genes	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
low	JJ	amod	B-Gene_or_gene_product
density	NN	compound	I-Gene_or_gene_product
lipoprotein	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
HMG	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
CoA	NN	compound	I-Gene_or_gene_product
reductase	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
fatty	JJ	amod	B-Gene_or_gene_product
acid	NN	compound	I-Gene_or_gene_product
synthase	NN	conj	I-Gene_or_gene_product
also	RB	advmod	O
increased	VBD	parataxis	O
in	IN	mark	O
migrating	VBG	advcl	O
ECs	NNS	compound	B-Cell
population	NN	dobj	O
as	IN	mark	O
detected	VBN	advcl	O
by	IN	case	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
Migration	NN	nsubj	O
induced	VBD	parataxis	O
SREBP	NN	compound	B-Gene_or_gene_product
activation	NN	nsubjpass	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
was	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
SREBP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
acting	VBG	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
RNAi	NNS	nmod	O
and	CC	cc	O
pharmacologically	RB	advmod	O
by	IN	case	O
25	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxycholesterol	NN	conj	I-Simple_chemical
;	:	punct	O
(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
SREBP	NN	nmod	B-Gene_or_gene_product
led	VBD	parataxis	O
to	TO	case	O
decreased	VBN	amod	O
ECs	NNS	compound	B-Cell
migration	NN	nmod	O
in	IN	case	O
various	JJ	amod	O
models	NNS	nmod	O
;	:	punct	O
(	-LRB-	punct	O
5	LS	dep	O
)	-RRB-	punct	O
Cells	NNS	nsubj	B-Cell
genetically	RB	advmod	O
deficient	JJ	amod	O
in	IN	case	O
SREBP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
acting	VBG	amod	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
S1P	NN	conj	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
S2P	NN	conj	B-Gene_or_gene_product
,	,	punct	O
phenotypically	RB	advmod	O
exhibited	VBD	parataxis	O
impaired	JJ	amod	O
migration	NN	dobj	O
;	:	punct	O
(	-LRB-	punct	O
6	LS	dep	O
)	-RRB-	punct	O
SREBP	NN	compound	B-Gene_or_gene_product
inhibition	NN	nsubj	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
suppressed	VBD	parataxis	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
small	JJ	amod	O
GTPase	NN	compound	O
Cdc42	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
molecule	NN	appos	O
for	IN	case	O
ECs	NNS	compound	B-Cell
motility	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
SREBP	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	appos	O
during	IN	nmod	O
and	CC	cc	O
plays	VBZ	conj	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
ECs	NNS	compound	B-Cell
migration	NN	nmod	O
.	.	punct	O

Targeting	VBG	amod	O
SREBP	NNP	nsubj	B-Gene_or_gene_product
could	MD	aux	O
become	VB	ROOT	O
a	DT	det	O
novel	JJ	amod	O
approach	NN	attr	O
in	IN	mark	O
fighting	VBG	acl	O
diseases	NNS	dobj	O
involving	VBG	acl	O
abnormal	JJ	amod	O
ECs	NNS	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

Fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
fibroblasts	NNS	nsubj	O
provide	VBP	ROOT	O
a	DT	det	O
suitable	JJ	amod	O
microenvironment	NN	dobj	O
for	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
in	IN	case	O
esophageal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
Tumor	NN	compound	B-Cell
fibroblasts	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
TF	NN	appos	B-Cell
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
complex	JJ	amod	O
process	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
stroma	NN	compound	B-Tissue
interactions	NNS	nmod	O
and	CC	cc	O
tumorigenesis	NN	conj	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
specific	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
TF	NN	nmod	B-Cell
in	IN	case	O
the	DT	det	O
esophageal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
microenvironment	NN	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
An	DT	det	O
Affymetrix	NNP	compound	O
expression	NN	compound	O
microarray	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
compare	VB	xcomp	O
gene	NN	compound	O
expression	NN	compound	O
profiles	NNS	dobj	O
between	IN	case	O
six	CD	nummod	O
pairs	NNS	nmod	O
of	IN	case	O
TFs	NN	nmod	B-Cell
and	CC	cc	O
normal	JJ	amod	O
fibroblasts	NNS	conj	B-Cell
from	IN	case	O
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
ESCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Differentially	RB	advmod	O
expressed	VBN	amod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
subset	NN	nsubjpass	O
was	VBD	auxpass	O
evaluated	VBN	conj	O
by	IN	case	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	nmod	O
PCR	NN	dep	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
About	IN	advmod	O
43	CD	nummod	O
%	NN	nsubjpass	O
(	-LRB-	punct	O
126	CD	compound	O
of	IN	case	O
292	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
known	JJ	amod	O
deregulated	JJ	amod	O
genes	NNS	nmod	O
in	IN	case	O
TFs	NN	nmod	B-Cell
were	VBD	auxpass	O
associated	VBN	dep	O
with	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
remodeling	NN	conj	O
,	,	punct	O
and	CC	cc	O
immune	JJ	amod	O
response	NN	conj	O
.	.	punct	O

Up	IN	compound	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
FGFR2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
the	DT	det	O
most	RBS	advmod	O
significant	JJ	amod	O
change	NN	dobj	O
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
six	CD	nummod	O
tested	VBN	amod	O
TFs	NN	nmod	B-Cell
compared	VBN	case	O
with	IN	case	O
their	PRP$	nmod:poss	O
paired	JJ	amod	O
normal	JJ	amod	O
fibroblasts	NNS	advcl	B-Cell
.	.	punct	O

A	DT	det	O
further	JJ	amod	O
study	NN	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
FGFR2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
fibroblasts	NNS	nsubjpass	O
were	VBD	auxpass	O
only	RB	advmod	O
observed	VBN	ccomp	O
inside	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
and	CC	cc	O
not	RB	neg	O
in	IN	case	O
tumor	NN	compound	B-Tissue
-	HYPH	punct	I-Tissue
surrounding	VBG	amod	I-Tissue
stromal	JJ	amod	I-Tissue
tissues	NNS	conj	I-Tissue
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
FGFR2	NN	nsubjpass	B-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
as	IN	case	O
a	DT	det	O
TF	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
specific	JJ	amod	O
marker	NN	nmod	O
in	IN	case	O
ESCC	NN	nmod	B-Cancer
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
conditioned	JJ	amod	O
medium	NN	nsubjpass	O
from	IN	case	O
TFs	NN	nmod	B-Cell
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
able	JJ	xcomp	O
to	TO	mark	O
promote	VB	xcomp	O
ESCC	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
invasion	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
study	NN	nsubj	O
provides	VBZ	appos	O
new	JJ	amod	O
candidate	NN	compound	O
genes	NNS	dobj	O
for	IN	case	O
the	DT	det	O
esophageal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
microenvironment	NN	nmod	O
.	.	punct	O

Based	VBN	advcl	O
on	IN	prep	O
our	PRP$	poss	O
results	NNS	pobj	O
,	,	punct	O
we	PRP	nsubj	O
hypothesize	VBP	ROOT	O
that	IN	mark	O
FGFR2	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
-	:	punct	O
TFs	NN	nsubj	O
might	MD	aux	O
provide	VB	ccomp	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
with	IN	case	O
a	DT	det	O
suitable	JJ	amod	O
microenvironment	NN	nmod	O
via	IN	case	O
secretion	NN	nmod	O
of	IN	case	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
could	MD	aux	O
promote	VB	acl:relcl	O
cancer	NN	compound	B-Cancer
development	NN	dobj	O
and	CC	cc	O
progression	NN	conj	O
through	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
,	,	punct	O
induction	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
inhibition	NN	appos	O
of	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	nmod	O
,	,	punct	O
enhancement	NN	appos	O
of	IN	case	O
cell	NN	compound	B-Cell
mobility	NN	nmod	O
,	,	punct	O
and	CC	cc	O
promotion	NN	conj	O
of	IN	case	O
the	DT	det	O
epithelial	JJ	amod	B-Cell
-	HYPH	punct	O
mesenchymal	JJ	amod	B-Cell
transition	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Role	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
ARF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
oncogenesis	NN	nmod	O
]	-RRB-	punct	O

The	DT	det	O
paper	NN	nsubj	O
reviews	VBZ	ROOT	O
the	DT	det	O
data	NNS	dobj	O
available	JJ	amod	O
in	IN	case	O
the	DT	det	O
literature	NN	nmod	O
on	IN	case	O
a	DT	det	O
role	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
ARF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
oncogenesis	NN	nmod	O
and	CC	cc	O
considers	VBZ	conj	O
the	DT	det	O
structure	NN	dobj	O
of	IN	case	O
a	DT	det	O
gene	NN	nmod	O
encoding	VBG	acl	O
ARF	NN	compound	B-Gene_or_gene_product
protein	NN	dobj	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
53	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
independent	JJ	conj	O
functions	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
are	VBP	cop	O
under	IN	case	O
many	JJ	amod	O
studies	NNS	ROOT	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
evidence	NN	nsubj	O
for	IN	case	O
the	DT	det	O
implication	NN	nmod	O
of	IN	case	O
ARF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
more	JJR	amod	O
and	CC	cc	O
more	JJR	conj	O
information	NN	attr	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
ARF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
a	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
autophagy	NN	conj	O
.	.	punct	O

The	DT	det	O
importance	NN	nsubj	O
of	IN	case	O
this	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
in	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
is	VBZ	cop	O
beyond	IN	case	O
question	NN	nsubj	O
as	IN	case	O
the	DT	det	O
inactivation	NN	nmod	O
of	IN	case	O
ARF	NN	compound	B-Gene_or_gene_product
suppressor	NN	compound	O
activity	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
rapid	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
neoplasia	NN	nmod	B-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
exact	JJ	amod	O
mechanisms	NNS	nsubj	O
of	IN	case	O
ARF	NN	compound	B-Gene_or_gene_product
action	NN	nmod	O
yet	RB	advmod	O
remain	VBP	ROOT	O
unclear	JJ	xcomp	O
and	CC	cc	O
require	VB	conj	O
further	JJ	amod	O
studies	NNS	dobj	O
by	IN	case	O
different	JJ	amod	O
specialists	NNS	nmod	O
at	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
molecular	JJ	amod	O
genetic	JJ	nmod	O
and	CC	cc	O
other	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
investigation	NN	nmod	O
.	.	punct	O

Mechanical	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factor	NN	compound	O
CCN1	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
CYR61	NN	compound	B-Gene_or_gene_product
gene	NN	conj	O
requires	VBZ	ROOT	O
the	DT	det	O
combined	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
MRTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
CREB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
binding	NN	conj	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
histone	NN	compound	I-Gene_or_gene_product
acetyltransferase	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Smooth	NNP	amod	B-Tissue
muscle	NN	nmod:npmod	I-Tissue
-	HYPH	punct	I-Tissue
rich	JJ	amod	I-Tissue
tissues	NNS	nsubj	I-Tissue
respond	VBP	ROOT	O
to	TO	case	O
mechanical	JJ	amod	O
overload	NN	nmod	O
by	IN	case	O
an	DT	det	O
adaptive	JJ	amod	O
hypertrophic	JJ	amod	O
growth	NN	nmod	O
combined	VBN	acl	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
potentiates	VBZ	acl:relcl	O
their	PRP$	nmod:poss	O
mechanical	JJ	amod	O
overload	NN	npadvmod	O
-	HYPH	punct	O
bearing	VBG	amod	O
capabilities	NNS	dobj	O
.	.	punct	O

Neovascularization	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
mechanical	JJ	amod	O
strain	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
CCN1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
immediate	JJ	amod	O
-	HYPH	punct	O
early	JJ	amod	O
gene	NN	nmod:npmod	O
-	HYPH	punct	O
encoded	VBN	amod	O
matricellular	JJ	amod	O
molecule	NN	appos	O
critical	JJ	amod	O
for	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nmod	O
and	CC	cc	O
repair	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
mechanical	JJ	amod	O
strain	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
CCN1	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
involves	VBZ	ccomp	O
signaling	VBG	compound	O
cascades	NNS	dobj	O
through	IN	case	O
RhoA	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
actin	NN	compound	B-Cellular_component
remodeling	NN	nmod	O
and	CC	cc	O
the	DT	det	O
p38	NN	compound	B-Gene_or_gene_product
stress	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
SAPK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Actin	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
controls	VBZ	ROOT	O
serum	NN	compound	B-Gene_or_gene_product
response	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
SRF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	dobj	O
via	IN	case	O
SRF	NN	compound	B-Gene_or_gene_product
interaction	NN	nmod	O
with	IN	case	O
the	DT	det	O
myocardin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
transcriptional	JJ	amod	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
MRTF	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
tethering	NN	conj	O
to	IN	case	O
a	DT	det	O
single	JJ	amod	O
CArG	NN	compound	O
box	NN	compound	O
sequence	NN	nmod	O
within	IN	case	O
the	DT	det	O
CCN1	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

Such	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
abolished	VBN	ROOT	O
in	IN	case	O
mechanically	RB	advmod	O
stimulated	VBN	amod	O
mouse	NN	compound	B-Organism
MRTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NNP	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
cells	NNS	nmod	O
or	CC	cc	O
upon	IN	case	O
inhibition	NN	conj	O
of	IN	case	O
CREB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
CBP	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
histone	NN	compound	I-Gene_or_gene_product
acetyltransferase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
HAT	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
either	CC	cc:preconj	O
pharmacologically	RB	advmod	O
or	CC	cc	O
by	IN	case	O
siRNAs	NNS	nmod	O
.	.	punct	O

Mechanical	JJ	amod	O
strain	NN	nsubj	O
induced	VBD	ROOT	O
CBP	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
acetylation	NN	dobj	O
of	IN	case	O
histones	NNS	nmod	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
4	CD	conj	B-Gene_or_gene_product
at	IN	case	O
the	DT	det	O
SRF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
binding	VBG	compound	O
site	NN	nmod	O
and	CC	cc	O
within	IN	case	O
the	DT	det	O
CCN1	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
coding	NN	compound	O
region	NN	conj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
p38	NN	compound	B-Gene_or_gene_product
SAPK	NN	nmod	I-Gene_or_gene_product
reduced	VBD	ROOT	O
CBP	NN	compound	B-Gene_or_gene_product
HAT	NN	compound	I-Gene_or_gene_product
activity	NN	dobj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
recruitment	NN	conj	O
to	TO	case	O
the	DT	det	O
SRF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O
MRTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
complex	NN	ROOT	O
,	,	punct	O
whereas	IN	dep	O
enforced	VBN	amod	O
induction	NN	dep	O
of	IN	case	O
p38	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
upstream	JJ	amod	O
activators	NNS	nmod	O
(	-LRB-	punct	O
e	NN	compound	O
.	.	punct	O
g	NN	nmod	O
.	.	punct	O
MKK3	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
MKK6	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
enhanced	VBD	ROOT	O
both	CC	cc:preconj	O
CBP	NN	compound	B-Gene_or_gene_product
HAT	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
CCN1	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
activities	NNS	conj	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
mechanical	JJ	amod	O
overload	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
CCN1	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	nsubjpass	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
nuclear	JJ	amod	O
localization	NN	nmod	O
of	IN	case	O
MRTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
enrichment	NN	conj	O
of	IN	case	O
the	DT	det	O
CCN1	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
with	IN	case	O
both	CC	cc:preconj	O
MRTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
acetylated	VBN	amod	O
histone	NN	compound	B-Gene_or_gene_product
H3	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
signal	NN	nmod:npmod	O
-	HYPH	punct	O
controlled	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
SRF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
MRTF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
CBP	NN	conj	B-Gene_or_gene_product
provides	VBZ	ccomp	O
a	DT	det	O
novel	JJ	amod	O
connection	NN	dobj	O
between	IN	case	O
mechanical	JJ	amod	O
stimuli	NNS	nmod	O
and	CC	cc	O
angiogenic	JJ	amod	O
gene	NN	compound	O
expression	NN	conj	O
.	.	punct	O

Angiogenesis	NN	ROOT	O
in	IN	case	O
platelet	NN	compound	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Platelet	NN	compound	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
PECAM	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
previously	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
;	:	punct	O
additionally	RB	advmod	O
,	,	punct	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PECAM	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibodies	NNS	nsubjpass	I-Gene_or_gene_product
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	parataxis	O
to	TO	mark	O
inhibit	VB	xcomp	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	dobj	O
.	.	punct	O

Studies	NNS	nsubjpass	O
were	VBD	auxpass	O
therefore	RB	advmod	O
performed	VBN	ROOT	O
with	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	nmod	O
to	TO	mark	O
further	RB	advmod	O
define	VB	xcomp	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
.	.	punct	O

Vascularization	NN	nsubjpass	O
of	IN	case	O
subcutaneous	JJ	amod	O
Matrigel	NNP	compound	O
implants	VBZ	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	conj	O
were	VBD	auxpass	O
both	DT	cc:preconj	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O

Reciprocal	JJ	amod	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
transplants	NNS	nsubj	O
that	WDT	nsubj	O
involved	VBD	acl:relcl	O
both	CC	cc:preconj	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
and	CC	cc	O
PECAM	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	conj	O
mice	NNS	dobj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
impaired	JJ	amod	O
angiogenic	JJ	amod	O
response	NN	nsubj	O
resulted	VBD	ccomp	O
from	IN	case	O
a	DT	det	O
loss	NN	nmod	O
of	IN	case	O
endothelial	JJ	nmod	B-Cell
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
leukocyte	NN	conj	B-Cell
,	,	punct	O
PECAM	NN	appos	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
wound	NN	advcl	B-Pathological_formation
migration	NN	nsubjpass	O
and	CC	cc	O
single	JJ	amod	O
-	HYPH	punct	O
cell	NN	compound	B-Cell
motility	NN	conj	O
by	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
compromised	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
filopodia	NN	compound	B-Cellular_component
formation	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
feature	NN	appos	O
of	IN	case	O
motile	JJ	compound	O
cells	NNS	nmod	B-Cell
,	,	punct	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
treated	VBN	acl	O
with	IN	case	O
either	DT	cc:preconj	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PECAM	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
siRNA	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
PECAM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoted	VBD	ROOT	O
filopodia	NN	compound	B-Cellular_component
formation	NN	dobj	O
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
protein	NN	compound	O
expression	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
Cdc42	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
Rho	NN	compound	B-Gene_or_gene_product
GTPase	NN	appos	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
promote	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	prep	O
filopodia	NN	pobj	B-Cellular_component
.	.	punct	O

In	IN	case	O
the	DT	det	O
developing	VBG	amod	O
retinal	JJ	amod	B-Multi-tissue_structure
vasculature	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
numerous	JJ	amod	O
,	,	punct	O
long	JJ	advmod	B-Cellular_component
filamentous	JJ	amod	I-Cellular_component
filopodia	NN	nsubjpass	I-Cellular_component
,	,	punct	O
emanating	VBG	acl	O
from	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
at	IN	case	O
the	DT	det	O
tips	NNS	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
sprouts	NNS	nmod	B-Tissue
,	,	punct	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
animals	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	conj	O
in	IN	case	O
the	DT	det	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
further	RB	advmod	O
establish	VBP	ROOT	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
PECAM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
stimulate	VB	ccomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
motility	NN	dobj	O
by	IN	mark	O
promoting	VBG	advcl	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
filopodia	NN	nmod	B-Cellular_component
.	.	punct	O

Desipramine	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
skin	NN	compound	B-Cell
squamous	JJ	amod	I-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
and	CC	cc	O
affects	VBZ	conj	O
glucocorticoid	NN	nmod:npmod	B-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
tricyclic	JJ	amod	O
antidepressant	JJ	amod	O
desipramine	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
DMI	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
growth	NN	compound	O
inhibition	NN	nmod	O
and	CC	cc	O
translocation	NN	conj	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
GR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	B-Organism_substance
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
in	IN	case	O
cancerous	JJ	amod	B-Cell
and	CC	cc	O
noncancerous	JJ	conj	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
the	DT	det	O
effect	NN	conj	O
of	IN	case	O
DMI	NN	nmod	B-Simple_chemical
on	IN	case	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	nmod	O
.	.	punct	O

Nontumorigenic	JJ	nsubj	O
,	,	punct	O
immortalized	VBN	appos	O
keratinocytes	NNS	ROOT	B-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
(	-LRB-	punct	O
3PC	NN	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
papilloma	NN	conj	B-Cell
(	-LRB-	punct	O
MT1	NN	appos	B-Cell
/	:	punct	I-Cell
2	CD	nummod	I-Cell
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
squamous	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinoma	NN	conj	I-Cell
(	-LRB-	punct	O
Ca3	NN	compound	B-Cell
/	SYM	punct	I-Cell
7	LS	nummod	I-Cell
)	-RRB-	punct	O
cell	NN	compound	B-Cell
lines	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
initially	RB	advmod	O
used	VBN	dep	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
cell	NN	compound	B-Cell
growth	NN	compound	O
inhibition	NN	dobj	O
by	IN	case	O
DMI	NN	nmod	B-Simple_chemical
.	.	punct	O

Although	IN	mark	O
,	,	punct	O
the	DT	det	O
growth	NN	nsubjpass	O
of	IN	case	O
all	DT	det	O
three	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
was	VBD	auxpass	O
suppressed	VBN	advcl	O
by	IN	case	O
DMI	NN	nmod	B-Simple_chemical
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
more	RBR	advmod	O
effective	JJ	ROOT	O
in	IN	case	O
Ca3	NN	compound	B-Cell
/	SYM	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
next	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
DMI	NN	nmod	B-Simple_chemical
on	IN	case	O
Ca3	NN	compound	B-Cell
/	SYM	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
resistant	JJ	amod	O
to	TO	case	O
growth	NN	compound	O
inhibition	NN	nmod	O
by	IN	case	O
the	DT	det	O
synthetic	JJ	amod	O
glucocorticoid	NN	compound	B-Simple_chemical
fluocinolone	NN	compound	I-Simple_chemical
acetonide	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
FA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

DMI	NN	nsubj	B-Simple_chemical
inhibited	VBD	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
in	IN	case	O
a	DT	det	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

The	DT	det	O
translocation	NN	nsubjpass	O
of	IN	case	O
GR	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
FA	NN	nmod	B-Simple_chemical
alone	RB	advmod	O
,	,	punct	O
DMI	NN	nmod	B-Simple_chemical
alone	RB	advmod	O
,	,	punct	O
and	CC	cc	O
combination	NN	conj	O
of	IN	case	O
both	DT	det	O
agents	NNS	nmod	O
.	.	punct	O

FA	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
in	IN	case	O
Ca3	NN	compound	B-Cell
/	SYM	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
luciferase	NN	compound	B-Gene_or_gene_product
reporter	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	I-Gene_or_gene_product
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
response	NN	compound	O
element	NN	nmod	O
(	-LRB-	punct	O
GRE	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
DMI	NN	nsubj	B-Simple_chemical
alone	RB	advmod	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	conj	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
DMI	NN	nsubj	B-Simple_chemical
inhibited	VBD	ROOT	O
FA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
,	,	punct	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	dep	O
transcription	NN	dobj	O
when	WRB	advmod	O
both	DT	det	O
agents	NNS	nsubjpass	O
were	VBD	auxpass	O
given	VBN	advcl	O
together	RB	advmod	O
.	.	punct	O

Pretreatment	NN	nsubj	O
with	IN	case	O
DMI	NN	nmod	B-Simple_chemical
followed	VBN	acl	O
by	IN	case	O
combination	NN	nmod	O
of	IN	case	O
DMI	NN	nmod	B-Simple_chemical
and	CC	cc	O
FA	NN	conj	B-Simple_chemical
decreased	VBD	ROOT	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
more	JJR	amod	O
than	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
FA	NN	nmod	B-Simple_chemical
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
metallothionein	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Mt	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
GR	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
significantly	RB	advmod	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	case	O
DMI	NN	nmod	B-Simple_chemical
and	CC	cc	O
FA	NN	conj	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
enhanced	VBN	conj	O
significantly	RB	advmod	O
by	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
FA	NN	nmod	B-Simple_chemical
but	CC	cc	O
not	RB	cc	O
DMI	NN	conj	B-Simple_chemical
.	.	punct	O

DMI	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
Ca3	NN	compound	B-Cell
/	SYM	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
to	TO	mark	O
affect	VB	conj	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
.	.	punct	O

MEK5	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK5	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
modulates	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
and	CC	cc	O
focal	JJ	amod	B-Cellular_component
contact	NN	compound	I-Cellular_component
turnover	NN	conj	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
from	IN	prep	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
existing	VBG	amod	O
ones	NNS	pobj	O
requires	VBZ	ROOT	O
highly	RB	advmod	O
coordinated	VBN	amod	O
restructuring	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
surrounding	JJ	amod	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	conj	I-Cellular_component
.	.	punct	O

Directed	JJ	amod	O
EC	NN	compound	B-Cell
migration	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
central	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
and	CC	cc	O
depends	VBZ	conj	O
on	IN	case	O
cellular	JJ	amod	B-Cell
signaling	NN	compound	O
cascades	NNS	nmod	O
that	WDT	nsubj	O
initiate	VBP	acl:relcl	O
and	CC	cc	O
control	VBP	conj	O
the	DT	det	O
structural	JJ	amod	O
rearrangements	NNS	dobj	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
basis	NN	pobj	O
of	IN	case	O
earlier	JJR	amod	O
findings	NNS	nmod	O
that	IN	mark	O
ERK5	NN	compound	B-Gene_or_gene_product
deficiency	NN	nsubj	O
in	IN	case	O
mouse	NN	compound	B-Organism
EC	NN	nmod	B-Cell
results	VBZ	ccomp	O
in	IN	case	O
massive	JJ	amod	O
defects	NNS	nmod	O
in	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
architecture	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
we	PRP	nsubj	O
focused	VBD	ROOT	O
on	IN	case	O
the	DT	det	O
impact	NN	nmod	O
of	IN	case	O
the	DT	det	O
MEK5	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK5	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
on	IN	case	O
EC	NN	compound	B-Cell
migration	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
retroviral	JJ	amod	O
gene	NN	compound	O
transfer	NN	compound	O
approach	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
MEK5	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK5	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
strongly	RB	advmod	O
inhibits	VBZ	ccomp	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
massive	JJ	amod	O
morphological	JJ	amod	O
changes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
area	NN	nsubjpass	O
covered	VBN	acl	O
by	IN	agent	O
spread	JJ	amod	O
EC	NN	pobj	B-Cell
was	VBD	auxpass	O
dramatically	RB	advmod	O
enlarged	VBN	ROOT	O
,	,	punct	O
accompanied	VBN	advcl	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
focal	JJ	amod	B-Cellular_component
contacts	NNS	nmod	I-Cellular_component
and	CC	cc	O
altered	JJ	amod	O
organization	NN	conj	O
of	IN	case	O
actin	NN	compound	B-Gene_or_gene_product
filaments	NNS	nmod	B-Cellular_component
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
cells	NNS	nsubj	B-Cell
were	VBD	cop	O
more	RBR	advmod	O
rigid	JJ	ROOT	O
and	CC	cc	O
show	VBP	conj	O
reduced	VBN	amod	O
motility	NN	dobj	O
.	.	punct	O

This	DT	det	O
phenotype	NN	nsubjpass	O
was	VBD	auxpass	O
most	RBS	advmod	O
likely	RB	advmod	O
based	VBN	ROOT	O
on	IN	case	O
decreased	VBN	amod	O
focal	JJ	amod	B-Cellular_component
contact	NN	compound	I-Cellular_component
turnover	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
p130Cas	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
player	NN	appos	O
in	IN	case	O
directed	VBN	amod	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	IN	mark	O
ERK5	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
not	RB	neg	O
only	RB	advmod	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
EC	NN	compound	B-Cell
survival	NN	nmod	O
and	CC	cc	O
stress	NN	compound	O
response	NN	conj	O
but	CC	cc	O
also	RB	advmod	O
controls	VBZ	conj	O
migration	NN	dobj	O
and	CC	cc	O
morphology	NN	conj	O
of	IN	case	O
EC	NN	nmod	B-Cell
.	.	punct	O

EPOX	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	case	O
degradation	NN	nmod	O
of	IN	case	O
Mcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
through	IN	case	O
ERK	NN	compound	B-Gene_or_gene_product
inactivation	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Antiangiogenic	JJ	amod	O
therapy	NN	nsubjpass	O
is	VBZ	auxpass	O
considered	VBN	dep	O
as	IN	case	O
an	DT	det	O
effective	JJ	amod	O
strategy	NN	nmod	O
for	IN	mark	O
controlling	VBG	acl	O
the	DT	det	O
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Among	IN	case	O
a	DT	det	O
myriad	NN	nmod	O
of	IN	case	O
biological	JJ	amod	O
activities	NNS	nmod	O
described	VBN	acl	O
for	IN	case	O
xanthone	NN	compound	B-Simple_chemical
derivatives	NNS	nmod	I-Simple_chemical
,	,	punct	O
the	DT	det	O
anticancer	NN	compound	B-Cancer
activity	NN	nsubj	O
is	VBZ	cop	O
quite	RB	advmod	O
remarkable	JJ	ROOT	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
clearly	RB	advmod	O
resolved	VBN	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
antiangiogenic	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
3	CD	nmod	B-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
di	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	intj	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
epoxypropoxy	NN	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
xanthone	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
EPOX	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
Mcl	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
targeting	VBG	amod	O
drug	NN	appos	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
EPOX	NN	nmod	B-Simple_chemical
,	,	punct	O
we	PRP	nsubj	O
did	VBD	parataxis	O
cell	NN	compound	B-Cell
viability	NN	dobj	O
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	conj	O
,	,	punct	O
tube	NN	compound	B-Tissue
formation	NN	compound	O
assay	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
Matrigel	NNP	compound	O
plug	NN	compound	O
assay	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
EPOX	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
signaling	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
did	VBD	ROOT	O
immunoblotting	VBG	dobj	O
,	,	punct	O
immunoprecipitation	NN	conj	O
,	,	punct	O
and	CC	cc	O
immunofluorescence	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

Intracellular	JJ	amod	B-Immaterial_anatomical_entity
glutathione	NN	compound	B-Simple_chemical
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
monochlorobimane	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
glutathione	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
specific	JJ	amod	O
probe	NN	appos	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
EPOX	NN	nsubj	B-Simple_chemical
induced	VBD	dep	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
proteasome	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
Mcl	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
degradation	NN	nmod	O
.	.	punct	O

Down	NN	compound	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	prep	O
Mcl	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	pobj	I-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
Mcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
free	JJ	amod	O
Bim	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
activation	NN	appos	O
of	IN	prep	O
Bax	NN	pobj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
then	RB	advmod	O
signaling	NN	conj	O
of	IN	case	O
mitochondria	NN	npadvmod	B-Cellular_component
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
glutathione	NN	compound	B-Simple_chemical
depletion	NN	nsubjpass	O
and	CC	cc	O
extracellular	JJ	amod	B-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
ERK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inactivation	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
EPOX	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Glutathione	NN	compound	B-Simple_chemical
supplementation	NN	nsubj	O
reversed	VBD	ROOT	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
EPOX	NN	nmod	B-Simple_chemical
on	IN	case	O
ERK	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
increases	VBZ	acl:relcl	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
Mcl	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
at	IN	case	O
T	NN	nmod	O
(	-LRB-	punct	O
163	CD	nummod	O
.	.	punct	O
)	-RRB-	punct	O
Overexpression	NN	nsubj	O
of	IN	case	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
ERK	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MEK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
partially	RB	advmod	O
reversed	VBD	conj	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
EPOX	NN	nmod	B-Simple_chemical
on	IN	case	O
Mcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
dephosphorylation	NN	nmod	O
,	,	punct	O
ubiquitination	NN	conj	O
,	,	punct	O
and	CC	cc	O
degradation	NN	conj	O
,	,	punct	O
further	RB	advmod	O
implicating	VBG	advcl	O
ERK	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
Mcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
stability	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubj	O
provides	VBZ	appos	O
evidence	NN	dobj	O
that	IN	mark	O
EPOX	NN	nsubj	B-Simple_chemical
induces	VBZ	ccomp	O
glutathione	NN	compound	B-Simple_chemical
depletion	NN	dobj	O
,	,	punct	O
ERK	NN	compound	B-Gene_or_gene_product
inactivation	NN	conj	O
,	,	punct	O
and	CC	cc	O
Mcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
degradation	NN	conj	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
EPOX	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
antiangiogenic	JJ	amod	O
agent	NN	ccomp	O
,	,	punct	O
making	VBG	xcomp	O
it	PRP	nsubj	O
a	DT	det	O
promising	JJ	amod	O
lead	NN	amod	O
compound	NN	ccomp	O
for	IN	case	O
further	JJ	amod	O
development	NN	nmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
pathologies	NNS	nmod	O
.	.	punct	O

Targeting	VBG	ROOT	O
angiogenesis	NN	dobj	O
:	:	punct	O
progress	NN	dep	O
with	IN	case	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF	NN	compound	I-Gene_or_gene_product
treatment	NN	nmod	O
with	IN	case	O
large	JJ	amod	O
molecules	NNS	nmod	O
.	.	punct	O

Angiogenesis	NNP	compound	O
-	HYPH	punct	O
-	HYPH	punct	O
one	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
hallmarks	NNS	pobj	O
of	IN	prep	O
cancer	NN	pobj	B-Cancer
-	HYPH	punct	O
-	:	punct	O
has	VBZ	aux	O
emerged	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
valid	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	nmod	O
in	IN	case	O
oncology	NN	nmod	O
.	.	punct	O

The	DT	det	O
VEGF	NNP	compound	B-Gene_or_gene_product
system	NN	nsubj	O
represents	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
mediator	NN	dobj	O
of	IN	case	O
tumor	NN	npadvmod	B-Cancer
-	HYPH	punct	O
initiated	VBN	amod	O
angiogenesis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
first	JJ	amod	O
target	NN	conj	O
of	IN	case	O
antiangiogenesis	NN	compound	O
agents	NNS	nmod	O
introduced	VBN	acl	O
in	IN	case	O
clinical	JJ	amod	O
practice	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF	NNP	compound	I-Gene_or_gene_product
therapies	NNS	nsubj	O
have	VBP	aux	O
clearly	RB	advmod	O
demonstrated	VBN	advcl	O
antitumor	NN	compound	B-Cancer
efficacy	NN	dobj	O
in	IN	case	O
various	JJ	amod	O
malignancies	NNS	nmod	B-Cancer
,	,	punct	O
especially	RB	advmod	O
when	WRB	advmod	O
combined	VBN	advcl	O
with	IN	case	O
conventional	JJ	amod	O
cytotoxic	JJ	amod	O
chemotherapy	NN	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
mechanism	NN	nsubjpass	O
of	IN	case	O
action	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

This	DT	det	O
Review	NNP	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
rationale	NN	dobj	O
for	IN	prep	O
using	VBG	pcomp	O
antiangiogenic	JJ	amod	O
compounds	NNS	dobj	O
and	CC	cc	O
will	MD	aux	O
focus	VB	conj	O
on	IN	prep	O
large	JJ	amod	O
molecules	NNS	pobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
antibodies	NNS	nmod	O
,	,	punct	O
that	WDT	nsubj	O
target	VBP	ccomp	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
system	NN	dobj	O
.	.	punct	O

Clinical	JJ	amod	O
data	NNS	nsubjpass	O
on	IN	case	O
bevacizumab	NN	nmod	B-Simple_chemical
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
in	IN	prep	O
detail	NN	pobj	O
.	.	punct	O

Predictive	JJ	amod	O
markers	NNS	nsubjpass	O
for	IN	case	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF	NNP	compound	I-Gene_or_gene_product
agents	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
yet	RB	advmod	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
and	CC	cc	O
questions	NNS	conj	O
regarding	VBG	prep	O
the	DT	det	O
usefulness	NN	pobj	O
of	IN	prep	O
bevacizumab	NN	pobj	B-Simple_chemical
in	IN	prep	O
the	DT	det	O
adjuvant	JJ	amod	O
setting	NN	pobj	O
as	RB	advmod	O
well	RB	advmod	O
as	IN	mark	O
its	PRP$	poss	O
continued	VBN	amod	O
use	NN	nsubj	O
beyond	IN	prep	O
progression	NN	pobj	O
remain	VBP	conj	O
unanswered	JJ	xcomp	O
,	,	punct	O
in	IN	case	O
spite	NN	dep	O
of	IN	case	O
negative	JJ	amod	O
data	NNS	nmod	O
on	IN	case	O
bevacizumab	NN	nmod	B-Simple_chemical
in	IN	mark	O
treating	VBG	acl	O
patients	NNS	dobj	B-Organism
with	IN	case	O
adjuvant	JJ	amod	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Nonetheless	RB	advmod	O
,	,	punct	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF	NN	compound	I-Gene_or_gene_product
therapy	NN	nsubj	O
has	VBZ	aux	O
enhanced	VBN	ROOT	O
the	DT	det	O
arsenal	NN	dobj	O
of	IN	case	O
anticancer	NN	compound	B-Cancer
therapies	NNS	nmod	O
and	CC	cc	O
has	VBZ	aux	O
provided	VBN	conj	O
new	JJ	amod	O
insights	NNS	dobj	O
into	IN	case	O
the	DT	det	O
biology	NN	nmod	O
of	IN	case	O
malignancy	NN	nmod	B-Cancer
.	.	punct	O

[	-LRB-	punct	O
Ambiguity	NN	compound	O
role	NN	ROOT	O
of	IN	case	O
neutrophils	NNS	nmod	B-Cell
in	IN	case	O
oncogenesis	NN	nmod	O
]	-RRB-	punct	O

The	DT	det	O
review	NN	nsubjpass	O
is	VBZ	auxpass	O
focused	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
participation	NN	nmod	O
of	IN	case	O
polymorphonuclear	JJ	amod	B-Cell
granulocytes	NNS	nmod	I-Cell
(	-LRB-	punct	O
neutrophils	NNS	appos	B-Cell
)	-RRB-	punct	O
in	IN	case	O
development	NN	nmod	O
and	CC	cc	O
spreading	NN	conj	O
of	IN	case	O
a	DT	det	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
consider	VBP	ROOT	O
both	CC	cc:preconj	O
the	DT	det	O
well	JJ	advmod	O
known	JJ	amod	O
functions	NNS	dobj	O
of	IN	case	O
neutrophils	NNS	nmod	B-Cell
(	-LRB-	punct	O
degranulation	NN	dep	O
,	,	punct	O
production	NN	appos	O
of	IN	case	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
ROS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
recently	RB	advmod	O
shown	VBN	amod	O
one	CD	conj	O
(	-LRB-	punct	O
presentation	NN	dep	O
of	IN	case	O
an	DT	det	O
antigene	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
special	JJ	amod	O
attention	NN	nsubjpass	O
is	VBZ	auxpass	O
focused	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
ambiguity	NN	nmod	O
of	IN	case	O
the	DT	det	O
neutrophil	NN	compound	B-Cell
role	NN	nmod	O
in	IN	case	O
oncogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
dominant	JJ	amod	O
view	NN	nsubj	O
is	VBZ	ROOT	O
that	IN	mark	O
neutrophils	NNS	nsubj	B-Cell
display	VBP	ccomp	O
exclusively	RB	advmod	O
antitumor	NN	compound	B-Cancer
properties	NNS	dobj	O
.	.	punct	O

The	DT	det	O
update	JJ	compound	O
information	NN	compound	O
testifies	VBZ	nsubj	O
about	IN	case	O
protumoral	JJ	amod	B-Cancer
activity	NN	nmod	O
of	IN	case	O
neutrophils	NNS	nmod	B-Cell
:	:	punct	O
they	PRP	nsubj	O
migrate	VBP	ROOT	O
to	TO	case	O
a	DT	det	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
promote	VB	conj	O
angiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
at	IN	case	O
late	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
interesting	JJ	ROOT	O
that	IN	mark	O
certain	JJ	amod	O
components	NNS	nsubj	O
of	IN	case	O
neutrophil	NN	compound	B-Cell
cytotoxic	JJ	amod	O
arsenal	JJ	nmod	O
(	-LRB-	punct	O
ROS	NN	dep	B-Simple_chemical
,	,	punct	O
cytokines	NNS	conj	O
,	,	punct	O
specific	JJ	amod	O
enzymes	NNS	appos	O
)	-RRB-	punct	O
participate	VBP	ccomp	O
both	CC	cc:preconj	O
in	IN	case	O
antitumoral	JJ	amod	B-Cancer
defenses	NNS	dobj	O
of	IN	case	O
an	DT	det	O
organism	NN	nmod	O
and	CC	cc	O
protumoral	JJ	amod	B-Cancer
activity	NN	conj	O
.	.	punct	O

Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubj	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
are	VBP	cop	O
the	DT	det	O
result	NN	ROOT	O
of	IN	case	O
loss	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
polarity	NN	nmod	O
.	.	punct	O

Recruiting	VBG	csubj	O
a	DT	det	O
new	JJ	amod	O
blood	NN	compound	B-Organism_substance
supply	NN	dobj	O
is	VBZ	ROOT	O
a	DT	det	O
rate	NN	npadvmod	O
-	HYPH	punct	O
limiting	VBG	amod	O
step	NN	attr	O
in	IN	prep	O
tumor	NN	compound	B-Cancer
progression	NN	pobj	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
three	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Organism_subdivision
carcinogenesis	NN	nmod	O
,	,	punct	O
disorganized	VBN	ROOT	O
,	,	punct	O
proliferative	JJ	amod	O
transformed	VBN	amod	O
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nsubj	I-Cell
express	VBP	conj	O
significantly	RB	advmod	O
higher	JJR	amod	O
expression	NN	dobj	O
of	IN	case	O
angiogenic	JJ	amod	O
genes	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
their	PRP$	nmod:poss	O
polarized	VBN	amod	O
,	,	punct	O
growth	NN	npadvmod	O
-	HYPH	punct	O
arrested	VBN	amod	O
nonmalignant	JJ	amod	B-Cell
counterparts	NNS	nmod	I-Cell
.	.	punct	O

Elevated	JJ	amod	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
secretion	NN	nsubj	O
by	IN	case	O
malignant	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
enhanced	VBD	ROOT	O
recruitment	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
in	IN	case	O
heterotypic	JJ	amod	O
cocultures	NNS	nmod	O
.	.	punct	O

Significantly	RB	advmod	O
,	,	punct	O
phenotypic	JJ	amod	O
reversion	NN	nsubj	O
of	IN	case	O
malignant	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
via	IN	case	O
reexpression	NN	nmod	O
of	IN	case	O
HoxD10	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
lost	VBN	acl:relcl	O
in	IN	case	O
malignant	JJ	amod	O
progression	NN	nmod	O
,	,	punct	O
significantly	RB	advmod	O
attenuated	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
independent	JJ	amod	O
fashion	NN	nmod	O
and	CC	cc	O
reduced	VBD	amod	O
EC	NN	compound	B-Cell
migration	NN	conj	O
.	.	punct	O

This	DT	nsubj	O
was	VBD	ccomp	O
due	JJ	advmod	O
primarily	RB	advmod	O
to	IN	aux	O
restoring	VBG	advcl	O
polarity	NN	dobj	O
:	:	punct	O
forced	VBN	amod	O
proliferation	NN	nsubj	O
of	IN	case	O
polarized	VBN	nmod	O
,	,	punct	O
nonmalignant	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
did	VBD	aux	O
not	RB	neg	O
induce	VB	parataxis	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
EC	NN	compound	B-Cell
recruitment	NN	conj	O
,	,	punct	O
whereas	IN	punct	O
disrupting	VBG	advcl	O
the	DT	det	O
architecture	NN	dobj	O
of	IN	prep	O
growth	NN	npadvmod	O
-	HYPH	punct	O
arrested	VBN	pobj	O
,	,	punct	O
reverted	VBN	csubj	O
cells	NNS	nsubj	B-Cell
did	VBD	ROOT	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
disrupting	VBG	csubj	O
cytostructure	NN	dobj	B-Cellular_component
activates	VBZ	ccomp	O
the	DT	det	O
angiogenic	JJ	amod	O
switch	NN	dobj	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
hypoxia	NN	conj	O
and	CC	cc	O
restoring	VBG	conj	O
organization	NN	dobj	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
clusters	NNS	nmod	I-Cancer
reduces	VBZ	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
EC	NN	compound	B-Cell
activation	NN	conj	O
to	TO	case	O
levels	NNS	nmod	O
found	VBN	acl	O
in	IN	case	O
quiescent	JJ	amod	O
nonmalignant	JJ	amod	B-Tissue
epithelium	NN	nmod	I-Tissue
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
confirm	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
tissue	NN	compound	B-Tissue
architecture	NN	nmod	O
and	CC	cc	O
polarity	NN	conj	O
in	IN	case	O
malignant	JJ	amod	O
progression	NN	nmod	O
.	.	punct	O

Metronomic	NNP	amod	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	ROOT	I-Simple_chemical
,	,	punct	O
oxaliplatin	NN	appos	B-Simple_chemical
and	CC	cc	O
irinotecan	NN	conj	B-Simple_chemical
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Metronomic	JJ	amod	O
chemotherapy	NN	nsubj	O
(	-LRB-	punct	O
the	DT	det	O
frequent	JJ	amod	O
,	,	punct	O
long	JJ	amod	O
term	NN	dep	O
,	,	punct	O
low	JJ	amod	O
dose	NN	compound	O
administration	NN	appos	O
of	IN	case	O
chemotherapeutic	JJ	amod	O
drugs	NNS	nmod	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
promising	JJ	amod	O
therapy	NN	ROOT	O
because	IN	mark	O
it	PRP	nsubj	O
enhances	VBZ	advcl	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
endothelial	JJ	amod	B-Cell
activity	NN	dobj	O
of	IN	case	O
conventional	JJ	amod	O
chemotherapeutics	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
with	IN	case	O
lower	JJR	conj	O
or	CC	cc	O
no	DT	conj	O
toxic	JJ	amod	O
effects	NNS	dep	O
compared	VBN	acl	O
to	TO	mark	O
maximum	NN	xcomp	O
tolerated	JJ	amod	O
dose	NN	compound	O
administration	NN	dobj	O
.	.	punct	O

The	DT	det	O
aims	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
were	VBD	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
,	,	punct	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
the	DT	det	O
antiangiogenic	JJ	amod	O
and	CC	cc	O
antitumor	JJ	conj	B-Cancer
activities	NNS	intj	O
of	IN	case	O
metronomic	JJ	amod	O
irinotecan	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
CPT	NN	dep	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	nummod	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
oxaliplatin	NN	appos	B-Simple_chemical
(	-LRB-	punct	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
metronomic	JJ	amod	O
combination	NN	dobj	O
of	IN	case	O
these	DT	det	O
drugs	NNS	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	B-Cell
proliferation	NN	nsubjpass	O
,	,	punct	O
combination	NN	compound	O
studies	NNS	nsubjpass	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
secretion	NN	compound	O
analyses	NNS	conj	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
(	-LRB-	punct	I-Cell
HMVEC	NN	compound	I-Cell
-	HYPH	punct	I-Cell
d	NN	dep	I-Cell
)	-RRB-	punct	I-Cell
and	CC	cc	O
colorectal	JJ	amod	B-Cell
cancer	NN	conj	I-Cell
(	-LRB-	punct	I-Cell
HT	NN	compound	I-Cell
-	HYPH	punct	I-Cell
29	CD	appos	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
exposed	VBN	acl	O
for	IN	case	O
144	CD	nummod	O
h	NN	nmod	O
to	TO	case	O
metronomic	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
SN	NN	nmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
38	CD	dep	I-Simple_chemical
,	,	punct	O
the	DT	det	O
active	JJ	amod	O
metabolite	NN	appos	O
of	IN	case	O
CPT	NN	nmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
11	CD	dep	I-Simple_chemical
,	,	punct	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NNP	conj	I-Simple_chemical
and	CC	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	conj	I-Simple_chemical
.	.	punct	O

HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
model	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
and	CC	cc	O
tumour	NN	compound	B-Cancer
growth	NN	conj	O
,	,	punct	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
quantification	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	conj	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
after	IN	case	O
the	DT	det	O
administration	NN	nmod	O
of	IN	case	O
metronomic	JJ	amod	O
CPT	NN	nmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	dep	I-Simple_chemical
,	,	punct	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NNP	conj	I-Simple_chemical
,	,	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	dep	I-Simple_chemical
and	CC	cc	O
their	PRP$	nmod:poss	O
simultaneous	JJ	amod	O
combination	NN	conj	O
.	.	punct	O

Low	JJ	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
SN	NN	nmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
38	CD	dep	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	conj	I-Simple_chemical
and	CC	cc	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NNP	conj	I-Simple_chemical
,	,	punct	O
preferentially	RB	advmod	O
inhibited	VBD	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
.	.	punct	O

Simultaneous	JJ	amod	O
and	CC	cc	O
continuous	JJ	conj	O
exposure	NN	nsubj	O
of	IN	case	O
HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	intj	I-Cell
and	CC	cc	O
HMVEC	NN	conj	B-Cell
-	HYPH	punct	I-Cell
d	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
low	JJ	amod	O
concentrations	NNS	nmod	O
SN	NNP	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
38	CD	conj	I-Simple_chemical
+	CC	cc	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NN	conj	I-Simple_chemical
+	CC	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	dep	I-Simple_chemical
for	IN	case	O
144	CD	nummod	O
h	NN	nmod	O
showed	VBD	ROOT	O
a	DT	det	O
strong	JJ	amod	O
antagonism	NN	dobj	O
and	CC	cc	O
an	DT	det	O
unfavorable	JJ	amod	O
dose	NN	compound	O
-	HYPH	punct	O
reduction	NN	compound	O
index	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
ternary	JJ	amod	O
combination	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
secretion	NN	nmod	O
in	IN	case	O
HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
a	DT	det	O
xenograft	NN	amod	B-Cancer
model	NN	compound	O
metronomic	JJ	amod	O
CPT	NN	nmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	dep	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	conj	I-Simple_chemical
and	CC	cc	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NNP	conj	I-Simple_chemical
,	,	punct	O
significantly	RB	advmod	O
inhibits	VBZ	ROOT	O
HT	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
29	CD	nummod	I-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
toxicity	NN	nmod	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	JJ	pobj	O
,	,	punct	O
metronomic	JJ	amod	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	dep	I-Simple_chemical
+	CC	cc	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NN	conj	I-Simple_chemical
+	CC	cc	O
CPT	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	nummod	I-Simple_chemical
therapy	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
microvascular	JJ	amod	B-Tissue
count	NN	dobj	O
.	.	punct	O

The	DT	det	O
metronomic	JJ	amod	O
concept	NN	nsubj	O
might	MD	aux	O
not	RB	neg	O
universally	RB	advmod	O
apply	VB	ROOT	O
to	IN	case	O
every	DT	det	O
cytotoxic	JJ	amod	O
drug	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
metronomic	JJ	amod	O
combination	NN	compound	O
regimens	NNS	conj	O
should	MD	aux	O
be	VB	auxpass	O
used	VBN	advcl	O
with	IN	prep	O
caution	NN	pobj	O
.	.	punct	O

A	DT	det	O
key	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
the	DT	det	O
integrin	NN	compound	B-Gene_or_gene_product
alpha2beta1	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
developmental	JJ	conj	O
angiogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
alpha2beta1	NN	compound	B-Gene_or_gene_product
integrin	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
small	JJ	amod	O
molecule	NN	compound	O
inhibitors	NNS	nmod	O
(	-LRB-	punct	O
SMIs	NNS	appos	O
)	-RRB-	punct	O
designed	VBN	acl	O
to	TO	mark	O
disrupt	VB	xcomp	O
integrin	NN	compound	B-Gene_or_gene_product
alpha2	NN	dobj	I-Gene_or_gene_product
I	CD	dep	O
or	CC	cc	O
beta1	NN	conj	B-Gene_or_gene_product
I	CD	nummod	O
-	HYPH	punct	O
like	VBP	case	O
domain	NN	compound	O
function	NN	nmod	O
on	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
unchallenged	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
fibrillar	JJ	amod	B-Gene_or_gene_product
collagen	NN	nsubj	I-Gene_or_gene_product
induced	VBD	ROOT	O
robust	JJ	amod	O
capillary	JJ	amod	B-Tissue
morphogenesis	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
tube	NN	compound	B-Tissue
formation	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
by	IN	case	O
SMI496	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
beta1	NN	npadvmod	B-Gene_or_gene_product
I	CD	nummod	O
-	HYPH	punct	O
like	VBP	amod	O
domain	NN	compound	O
inhibitor	NN	appos	O
and	CC	cc	O
by	IN	case	O
function	NN	compound	O
-	HYPH	punct	O
blocking	VBG	conj	O
anti	JJ	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alpha2beta1	NN	dep	I-Simple_chemical
but	CC	cc	O
not	RB	cc	O
-	HYPH	punct	B-Simple_chemical
alpha1beta1	NN	conj	I-Simple_chemical
antibodies	NNS	conj	I-Simple_chemical
.	.	punct	O

Endothelial	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
bound	VBD	ROOT	O
fluorescein	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
labeled	VBN	amod	O
collagen	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
fibrils	VBZ	dobj	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
interaction	NN	appos	O
specifically	RB	advmod	O
inhibited	VBN	acl	O
by	IN	case	O
SMI496	NN	nmod	B-Simple_chemical
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
SMI496	NN	nsubj	B-Simple_chemical
caused	VBD	ROOT	O
cell	NN	compound	B-Cell
retraction	NN	dobj	O
and	CC	cc	O
cytoskeletal	JJ	amod	O
collapse	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
delayed	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
.	.	punct	O

SMI	NN	compound	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
supplementing	VBG	advcl	O
the	DT	det	O
growth	NN	compound	O
medium	NN	dobj	O
of	IN	case	O
zebrafish	NN	compound	B-Organism
embryos	NNS	nmod	B-Developing_anatomical_structure
expressing	VBG	acl	O
green	JJ	amod	B-Gene_or_gene_product
fluorescent	NN	amod	I-Gene_or_gene_product
protein	NN	dobj	I-Gene_or_gene_product
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

SMI496	NN	nsubj	B-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
a	DT	det	O
control	JJ	amod	O
compound	NN	conj	O
,	,	punct	O
interfered	VBN	ROOT	O
with	IN	case	O
angiogenesis	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reversibly	RB	advmod	O
inhibiting	VBG	advcl	O
sprouting	NN	dobj	O
from	IN	prep	O
the	DT	det	O
axial	JJ	amod	B-Multi-tissue_structure
vessels	NNS	pobj	I-Multi-tissue_structure
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
characterized	VBD	ROOT	O
zebrafish	NN	compound	B-Organism
alpha2	NN	compound	B-Gene_or_gene_product
integrin	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
discovered	VBD	conj	O
that	IN	mark	O
this	DT	det	O
integrin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
highly	RB	advmod	O
conserved	VBN	ccomp	O
,	,	punct	O
especially	RB	advmod	O
the	DT	det	O
I	NN	compound	O
domain	NN	nmod	O
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
a	DT	det	O
similar	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
phenotype	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
morpholino	NN	amod	O
-	HYPH	punct	O
mediated	VBN	amod	O
knockdown	NN	nmod	O
of	IN	case	O
the	DT	det	O
integrin	NN	compound	B-Gene_or_gene_product
alpha2	NN	compound	I-Gene_or_gene_product
subunit	NN	nmod	O
.	.	punct	O

By	IN	prep	O
live	JJ	amod	O
videomicroscopy	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
confirmed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
vessels	NNS	nsubj	B-Multi-tissue_structure
were	VBD	cop	O
largely	RB	advmod	O
nonfunctional	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
alpha2beta1	NN	compound	B-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
strong	JJ	amod	O
biochemical	JJ	amod	O
and	CC	cc	O
genetic	JJ	conj	O
evidence	NN	dobj	O
of	IN	case	O
a	DT	det	O
central	JJ	amod	O
role	NN	nmod	O
for	IN	case	O
alpha2beta1	NN	compound	B-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
developmental	JJ	conj	O
angiogenesis	NN	nmod	O
.	.	punct	O

Islet	NN	amod	B-Cell
endothelial	JJ	amod	I-Cell
activation	NN	nsubjpass	O
and	CC	cc	O
oxidative	JJ	amod	O
stress	NN	compound	O
gene	NN	compound	O
expression	NN	conj	O
is	VBZ	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
IL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1Ra	JJ	nummod	I-Simple_chemical
treatment	NN	nmod	O
in	IN	case	O
the	DT	det	O
type	NN	compound	O
2	CD	nummod	O
diabetic	JJ	amod	O
GK	NN	compound	B-Organism
rat	NN	nmod	I-Organism
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Inflammation	NN	nsubj	O
followed	VBN	acl	O
by	IN	case	O
fibrosis	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
component	NN	dep	O
of	IN	case	O
islet	NN	compound	B-Multi-tissue_structure
dysfunction	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
rodent	JJ	nmod	O
and	CC	cc	O
human	JJ	conj	B-Organism
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	dep	O
.	.	punct	O

Because	IN	mark	O
islet	NN	compound	B-Multi-tissue_structure
inflammation	NN	nsubj	O
may	MD	aux	O
originate	VB	advcl	O
from	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
assessed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
selected	VBN	amod	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	nmod	O
in	IN	case	O
islets	NNS	nmod	B-Multi-tissue_structure
from	IN	case	O
a	DT	det	O
spontaneous	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
,	,	punct	O
the	DT	det	O
Goto	NN	compound	B-Organism
-	HYPH	punct	I-Organism
Kakizaki	NNP	compound	I-Organism
(	-LRB-	punct	I-Organism
GK	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
rat	NN	dobj	I-Organism
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
examined	VBD	ROOT	O
islet	NN	compound	B-Tissue
endotheliuml	NNS	dobj	I-Tissue
/	SYM	punct	O
oxidative	JJ	amod	O
stress	NN	compound	O
(	-LRB-	punct	O
OS	NN	appos	O
)	-RRB-	punct	O
/	:	punct	O
inflammation	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
gene	NN	compound	O
expression	NN	conj	O
,	,	punct	O
islet	NN	compound	B-Multi-tissue_structure
vascularization	NN	conj	O
and	CC	cc	O
fibrosis	NN	conj	O
after	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
interleukin	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
IL	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
receptor	NN	compound	I-Simple_chemical
antagonist	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
IL	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
1Ra	CD	dep	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

METHODOLOGY	NNP	compound	O
/	:	punct	O
PRINCIPAL	NNP	compound	O
FINDINGS	NN	ROOT	O
:	:	punct	O
Gene	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
analyzed	VBN	parataxis	O
by	IN	case	O
quantitative	JJ	amod	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
on	IN	case	O
islets	NNS	nmod	B-Multi-tissue_structure
isolated	VBN	acl	O
from	IN	case	O
10	CD	nummod	O
-	HYPH	punct	O
week	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
diabetic	JJ	amod	O
GK	NN	nmod	B-Organism
and	CC	cc	O
control	NN	amod	O
Wistar	NNP	compound	B-Organism
rats	NNS	conj	I-Organism
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
GK	NN	compound	B-Organism
rats	NNS	nsubj	I-Organism
were	VBD	cop	O
treated	VBN	amod	O
s	NNS	ROOT	O
.	.	punct	O
c	DT	nsubj	O
twice	RB	advmod	O
daily	RB	ROOT	O
with	IN	case	O
IL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1Ra	CD	nmod	I-Simple_chemical
(	-LRB-	punct	O
Kineret	NNP	nmod	B-Simple_chemical
,	,	punct	O
Amgen	NNP	conj	O
,	,	punct	O
100	CD	nummod	O
mg	NN	appos	O
/	:	punct	O
kg	NN	nmod	O
/	:	punct	O
day	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
saline	NN	conj	B-Simple_chemical
,	,	punct	O
from	IN	prep	O
4	CD	nummod	O
weeks	NNS	pobj	O
of	IN	case	O
age	NN	compound	O
onwards	NNS	nmod	O
(	-LRB-	punct	O
onset	NN	dep	O
of	IN	case	O
diabetes	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Four	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
islet	NN	dep	B-Multi-tissue_structure
gene	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
pancreas	NN	compound	B-Organ
immunochemistry	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

Thirty	CD	compound	O
-	HYPH	punct	O
two	CD	nummod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
selected	VBN	ROOT	O
encoding	VBG	amod	O
molecules	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	nmod	O
,	,	punct	O
particularly	RB	advmod	O
fibrinolysis	NN	nmod	O
,	,	punct	O
vascular	JJ	amod	B-Multi-tissue_structure
tone	NN	conj	O
,	,	punct	O
OS	NN	conj	O
,	,	punct	O
angiogenesis	NN	conj	O
and	CC	cc	O
also	RB	advmod	O
inflammation	NN	conj	O
.	.	punct	O

All	DT	det	O
genes	NNS	nsubjpass	O
except	IN	case	O
those	DT	nmod	O
encoding	VBG	acl	O
angiotensinogen	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
epoxide	NN	conj	B-Gene_or_gene_product
hydrolase	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
decreased	VBN	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
12	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
lipoxygenase	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
that	WDT	nsubj	O
showed	VBD	conj	O
no	DT	neg	O
change	NN	dobj	O
)	-RRB-	punct	O
,	,	punct	O
were	VBD	auxpass	O
significantly	RB	advmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
in	IN	case	O
GK	NN	compound	B-Organism
islets	NNS	nmod	B-Multi-tissue_structure
.	.	punct	O

After	IN	case	O
IL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1Ra	JJ	nummod	I-Simple_chemical
treatment	NN	nmod	O
of	IN	case	O
GK	NN	compound	B-Organism
rats	NNS	nmod	I-Organism
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
most	RBS	advmod	O
selected	VBN	amod	O
genes	NNS	nsubj	O
implied	VBN	acl	O
in	IN	case	O
endothelium	NN	compound	B-Tissue
/	:	punct	O
OS	NN	compound	O
/	:	punct	O
immune	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
/	:	punct	O
fibrosis	NN	conj	O
were	VBD	cop	O
significantly	RB	advmod	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
.	.	punct	O

IL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1Ra	CD	nsubj	I-Simple_chemical
also	RB	advmod	O
improved	VBD	ROOT	O
islet	NN	compound	B-Multi-tissue_structure
vascularization	NN	dobj	O
,	,	punct	O
reduced	VBD	amod	O
fibrosis	NN	dobj	O
and	CC	cc	O
ameliorated	VBN	amod	O
glycemia	NN	conj	O
.	.	punct	O

CONCLUSIONS	NNS	nsubj	O
/	:	punct	O
SIGNIFICANCE	NN	appos	O
:	:	punct	O
GK	NN	compound	B-Organism
rat	NN	compound	I-Organism
islets	NNS	nsubj	B-Multi-tissue_structure
have	VBP	aux	O
increased	VBN	ROOT	O
mRNA	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
markers	NNS	nmod	O
of	IN	case	O
early	JJ	amod	O
islet	NN	compound	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
activation	NN	nmod	O
,	,	punct	O
possibly	RB	advmod	O
triggered	VBN	advcl	O
by	IN	case	O
several	JJ	amod	O
metabolic	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
also	RB	advmod	O
some	DT	det	O
defense	NN	compound	O
mechanisms	NNS	conj	O
.	.	punct	O

The	DT	det	O
beneficial	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
IL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1Ra	CD	nmod	I-Simple_chemical
on	IN	case	O
most	JJS	advmod	O
islet	NN	amod	B-Cell
endothelial	JJ	amod	I-Cell
/	:	punct	O
OS	NN	compound	O
/	:	punct	O
immune	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
/	:	punct	O
fibrosis	NN	compound	O
parameters	NNS	nsubj	O
analyzed	VBN	ROOT	O
highlights	VBZ	xcomp	O
a	DT	det	O
major	JJ	amod	O
endothelial	JJ	amod	B-Cell
-	HYPH	punct	O
related	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
GK	NN	compound	B-Organism
islet	NN	compound	B-Multi-tissue_structure
alterations	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
metabolically	RB	advmod	O
-	HYPH	punct	O
altered	JJ	amod	O
islet	NN	compound	B-Tissue
endothelium	NN	nsubj	I-Tissue
might	MD	aux	O
affect	VB	ROOT	O
the	DT	det	O
beta	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
microenvironment	NN	dobj	O
and	CC	cc	O
contribute	VBP	conj	O
to	TO	case	O
progressive	JJ	amod	O
type	NN	compound	O
2	CD	nummod	O
diabetic	JJ	amod	O
beta	NN	compound	B-Cell
-	:	punct	I-Cell
cell	NN	compound	I-Cell
dysfunction	NN	nmod	O
in	IN	case	O
GK	NN	compound	B-Organism
rats	NNS	nmod	I-Organism
.	.	punct	O

Counteracting	VBG	csubj	O
islet	NN	compound	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
inflammation	NN	dobj	O
might	MD	aux	O
be	VB	ROOT	O
one	CD	nummod	O
way	NN	attr	O
to	TO	aux	O
ameliorate	VB	relcl	O
/	SYM	punct	O
prevent	VBP	amod	O
beta	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
dysfunction	NN	dobj	O
in	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
.	.	punct	O

AVE8062	NN	ROOT	B-Simple_chemical
:	:	punct	O
a	DT	det	O
new	JJ	amod	O
combretastatin	NN	compound	B-Simple_chemical
derivative	NN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
disrupting	VBG	compound	O
agent	NN	appos	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
has	VBZ	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
promoting	VBG	advcl	O
and	CC	cc	O
supporting	VBG	conj	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
it	PRP	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	conj	O
.	.	punct	O

The	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
network	NN	nsubj	I-Multi-tissue_structure
is	VBZ	cop	O
the	DT	det	O
result	NN	ROOT	O
of	IN	case	O
pro	NN	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
inhibitory	JJ	conj	O
factors	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
of	IN	case	O
the	DT	det	O
interaction	NN	conj	O
between	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	conj	I-Cellular_component
.	.	punct	O

Different	JJ	amod	O
antiangiogenic	JJ	amod	O
therapeutics	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
to	TO	mark	O
improve	VB	xcomp	O
tumor	NN	compound	B-Cancer
control	NN	dobj	O
through	IN	case	O
vascular	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
targeting	VBG	dep	I-Simple_chemical
agents	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
VTA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

VTAs	NNS	nsubjpass	B-Simple_chemical
can	MD	aux	O
be	VB	auxpass	O
divided	VBN	ROOT	O
into	IN	case	O
two	CD	nummod	O
groups	NNS	nmod	O
:	:	punct	O
antiangiogenic	JJ	amod	B-Simple_chemical
agents	NNS	dep	I-Simple_chemical
and	CC	cc	O
vascular	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
disrupting	VBG	amod	I-Simple_chemical
agents	NNS	conj	I-Simple_chemical
(	-LRB-	punct	O
VDAs	NNS	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

VTAs	NNS	nsubj	B-Simple_chemical
inhibit	VBP	ROOT	O
specific	JJ	amod	O
factors	NNS	dobj	O
required	VBN	acl	O
to	TO	mark	O
induce	VB	xcomp	O
and	CC	cc	O
direct	VB	conj	O
the	DT	det	O
angiogenic	JJ	amod	O
process	NN	dobj	O
,	,	punct	O
with	IN	case	O
major	JJ	amod	O
activity	NN	nmod	O
against	IN	case	O
small	JJ	amod	O
tumor	NN	compound	B-Cancer
masses	NNS	nmod	I-Cancer
and	CC	cc	O
at	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
periphery	NN	conj	I-Tissue
,	,	punct	O
encompassing	VBG	advcl	O
monoclonal	JJ	amod	O
antibodies	NNS	dobj	O
and	CC	cc	O
small	JJ	amod	O
molecules	NNS	compound	O
inhibitors	NNS	conj	O
of	IN	case	O
the	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
domain	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

VDAs	NNS	nsubj	B-Simple_chemical
specifically	RB	advmod	O
target	NN	ROOT	O
and	CC	cc	O
destroy	VB	conj	O
well	RB	advmod	O
-	HYPH	punct	O
established	JJ	amod	O
tumor	NN	compound	B-Multi-tissue_structure
vessels	NNS	conj	I-Multi-tissue_structure
with	IN	case	O
ischemia	NN	nmod	O
and	CC	cc	O
destruction	NN	conj	O
of	IN	case	O
large	JJ	amod	O
masses	NNS	nmod	B-Cancer
with	IN	case	O
central	JJ	amod	O
hemorrhagic	JJ	amod	O
necrosis	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
a	DT	det	O
thin	JJ	amod	O
peripheral	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
layer	NN	nmod	I-Cancer
.	.	punct	O

VDAs	NNS	nsubjpass	B-Simple_chemical
can	MD	aux	O
be	VB	auxpass	O
divided	VBN	ROOT	O
into	IN	prep	O
biologics	NNS	pobj	O
,	,	punct	O
such	JJ	amod	O
as	IN	prep	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
,	,	punct	O
and	CC	cc	O
small	JJ	amod	O
-	HYPH	punct	O
molecule	NN	compound	O
agents	NNS	pobj	O
;	:	punct	O
this	DT	det	O
second	JJ	amod	O
group	NN	nsubj	O
includes	VBZ	parataxis	O
small	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
molecule	NN	compound	I-Simple_chemical
VDAs	NNS	dobj	I-Simple_chemical
like	IN	case	O
flavonoids	NNS	nmod	B-Simple_chemical
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
5	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethylxanthenone	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetic	JJ	amod	I-Simple_chemical
acid	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
DMXAA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
microtubule	JJ	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
destabilizing	VBG	amod	I-Simple_chemical
agents	NNS	conj	I-Simple_chemical
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
we	PRP	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
preclinical	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
results	NNS	conj	O
,	,	punct	O
of	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
promising	JJ	amod	O
antitubulin	NN	compound	B-Simple_chemical
agents	NNS	nmod	I-Simple_chemical
:	:	punct	O
the	DT	det	O
combretastatin	NN	compound	B-Simple_chemical
A4	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phosphate	NN	compound	I-Simple_chemical
derivative	NN	dep	I-Simple_chemical
,	,	punct	O
AVE8062A	NN	appos	B-Simple_chemical
.	.	punct	O

Targeting	VBG	ROOT	O
TNF	NN	dobj	B-Gene_or_gene_product
for	IN	prep	O
Treatment	NN	pobj	O
of	IN	prep	O
Cancer	NNP	pobj	B-Cancer
and	CC	cc	O
Autoimmunity	NN	conj	O
.	.	punct	O

Tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
first	RB	advmod	O
isolated	VBN	ROOT	O
two	CD	nummod	O
decades	NNS	nmod:npmod	O
ago	RB	advmod	O
as	IN	case	O
a	DT	det	O
macrophageproduced	JJ	amod	O
protein	NN	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
effectively	RB	advmod	O
kill	VB	acl:relcl	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
essential	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
for	IN	case	O
protection	NN	nmod	O
from	IN	case	O
bacterial	JJ	amod	O
infection	NN	nmod	O
and	CC	cc	O
for	IN	case	O
immune	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
cytotoxicity	NN	conj	O
.	.	punct	O

Extensive	JJ	amod	O
research	NN	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
has	VBZ	aux	O
revealed	VBN	ROOT	O
that	IN	mark	O
TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
players	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
initiation	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
,	,	punct	O
invasion	NN	conj	O
,	,	punct	O
angiogenesis	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

The	DT	det	O
proinflammatory	JJ	amod	O
activities	NNS	nsubj	O
link	VBP	ROOT	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	dobj	I-Gene_or_gene_product
with	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
psoriasis	NN	nmod	O
,	,	punct	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
disease	NN	conj	O
,	,	punct	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
systemic	JJ	amod	O
sclerosis	NN	conj	O
,	,	punct	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	conj	O
,	,	punct	O
multiple	JJ	amod	O
sclerosis	NN	conj	O
,	,	punct	O
diabetes	NNS	conj	O
and	CC	cc	O
ankylosing	VBG	conj	O
spondylitis	NN	dobj	O
.	.	punct	O

Systemic	JJ	amod	O
inhibitors	NNS	nsubjpass	O
of	IN	case	O
TNF	NN	nmod	B-Gene_or_gene_product
such	JJ	case	O
as	IN	mwe	O
etanercept	JJ	nmod	B-Simple_chemical
(	-LRB-	punct	O
Enbrel	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
(	-LRB-	punct	O
a	DT	det	O
soluble	JJ	amod	O
TNF	NN	compound	B-Gene_or_gene_product
receptor	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
infliximab	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
Remicade	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
adalimumab	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
Humira	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
(	-LRB-	punct	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
TNF	NN	compound	I-Gene_or_gene_product
antibodies	NNS	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
approved	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
treatment	NN	compound	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
disease	NN	nmod	O
,	,	punct	O
psoriasis	NN	conj	O
and	CC	cc	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
.	.	punct	O

These	DT	det	O
drugs	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
exhibit	VBP	ROOT	O
severe	JJ	amod	O
side	JJ	amod	O
effects	NNS	dobj	O
and	CC	cc	O
are	VBP	cop	O
expensive	JJ	conj	O
.	.	punct	O

Hence	RB	advmod	O
orally	RB	advmod	O
active	JJ	amod	O
blockers	NNS	nsubj	O
of	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
that	WDT	nsubj	O
are	VBP	cop	O
safe	JJ	ROOT	O
,	,	punct	O
efficacious	JJ	nsubjpass	O
and	CC	cc	O
inexpensive	JJ	conj	O
are	VBP	auxpass	O
urgently	RB	advmod	O
needed	VBN	conj	O
.	.	punct	O

Numerous	JJ	amod	O
products	NNS	nsubjpass	O
from	IN	prep	O
fruits	NNS	pobj	B-Organism_subdivision
,	,	punct	O
vegetable	JJ	amod	B-Organism_subdivision
and	CC	cc	O
traditional	JJ	amod	O
medicinal	JJ	amod	O
plants	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
which	WDT	nsubj	O
can	MD	aux	O
suppress	VB	ccomp	O
TNF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
TNF	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
but	CC	cc	O
their	PRP$	nmod:poss	O
clinical	JJ	amod	O
potential	NN	nsubj	O
is	VBZ	cop	O
yet	RB	advmod	O
uncertain	JJ	conj	O
.	.	punct	O

[	-LRB-	punct	O
Effect	NN	ROOT	O
of	IN	case	O
osteopontin	NN	compound	B-Gene_or_gene_product
silencing	NN	nmod	O
by	IN	case	O
lentivirus	NN	npadvmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
delivery	NN	nmod	O
of	IN	case	O
siRNA	NN	nmod	O
on	IN	case	O
glioma	NN	compound	B-Cell
cell	NN	compound	I-Cell
invasion	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
osteopontin	NN	compound	B-Gene_or_gene_product
silencing	NN	nmod	O
on	IN	case	O
the	DT	det	O
invasion	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
of	IN	case	O
U251	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
invasion	NN	nsubjpass	O
,	,	punct	O
apoptosis	NN	conj	O
and	CC	cc	O
levels	NNS	conj	O
of	IN	case	O
uPA	NN	compound	B-Gene_or_gene_product
,	,	punct	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
determined	VBN	dep	O
by	IN	case	O
invasion	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	conj	O
,	,	punct	O
Western	NN	compound	O
blot	NN	appos	O
and	CC	cc	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
fluorescence	NN	compound	O
quantitative	JJ	amod	O
PCR	NN	conj	O
respectively	RB	advmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Osteopontin	NN	compound	B-Gene_or_gene_product
small	JJ	amod	O
interference	NN	compound	O
RNA	NN	nsubj	O
(	-LRB-	punct	O
siRNA	NN	appos	O
)	-RRB-	punct	O
inhibited	VBD	appos	O
osteopontin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
cell	NN	compound	B-Cell
invasion	NN	conj	O
,	,	punct	O
promoted	VBD	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
U251	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	intj	I-Gene_or_gene_product
,	,	punct	O
uPA	NN	conj	B-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
decreased	VBN	ROOT	O
,	,	punct	O
while	IN	mark	O
Bax	NN	compound	B-Gene_or_gene_product
level	NN	nsubjpass	O
was	VBD	auxpass	O
elevated	JJ	advcl	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Osteopontin	NN	compound	B-Gene_or_gene_product
siRNA	NN	nsubj	O
can	MD	aux	O
inhibit	VB	appos	O
U251	NN	compound	B-Cell
cells	NNS	compound	I-Cell
invasion	NN	dobj	O
via	IN	case	O
the	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
uPA	NN	compound	B-Gene_or_gene_product
,	,	punct	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
levels	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
promote	VBP	conj	O
apoptosis	NN	dobj	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
Bax	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
level	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
osteopontin	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
glioma	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Magnitude	NN	nsubj	O
of	IN	case	O
malate	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aspartate	NN	nmod	I-Simple_chemical
reduced	VBN	amod	I-Simple_chemical
nicotinamide	NN	compound	I-Simple_chemical
adenine	NN	nsubj	I-Simple_chemical
dinucleotide	NN	ROOT	I-Simple_chemical
shuttle	NN	amod	O
activity	NN	dobj	O
in	IN	case	O
intact	JJ	amod	O
respiring	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Measurements	NNS	nsubjpass	O
of	IN	case	O
respiration	NN	nmod	O
,	,	punct	O
CO2	NN	conj	B-Simple_chemical
and	CC	cc	O
lactate	NN	compound	B-Simple_chemical
production	NN	conj	O
,	,	punct	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
various	JJ	amod	O
key	JJ	amod	O
metabolites	NNS	nmod	O
of	IN	case	O
the	DT	det	O
glycolytic	JJ	amod	O
sequence	NN	nmod	O
and	CC	cc	O
tricarboxylic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
cycle	NN	conj	O
were	VBD	auxpass	O
made	VBN	ROOT	O
on	IN	case	O
five	CD	nummod	O
lines	NNS	nmod	O
of	IN	case	O
rodent	JJ	amod	B-Organism
ascites	VBZ	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
two	CD	nummod	O
strains	NNS	nsubj	O
of	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	conj	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
Krebs	NN	compound	B-Cell
II	CD	nummod	I-Cell
carcinoma	NN	conj	I-Cell
,	,	punct	O
AS	JJ	compound	B-Cell
-	HYPH	punct	I-Cell
30D	NN	compound	I-Cell
carcinoma	NN	conj	I-Cell
,	,	punct	O
and	CC	cc	O
L1210	NN	compound	B-Cell
cells	NNS	conj	I-Cell
)	-RRB-	punct	O
incubated	VBN	conj	O
aerobically	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
uniformly	RB	advmod	O
labeled	VBN	amod	O
D	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
14C	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
.	.	punct	O

From	IN	case	O
these	DT	det	O
data	NNS	ROOT	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
earlier	JJR	amod	O
evidence	NN	conj	O
demonstrating	VBG	acl	O
that	IN	mark	O
the	DT	det	O
reduced	VBN	amod	O
nicotinamide	NN	compound	B-Simple_chemical
adenine	NN	compound	I-Simple_chemical
dinucleotide	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
NADH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
shuttle	NN	nsubj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
requires	VBZ	ccomp	O
a	DT	det	O
transaminase	NN	compound	O
step	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
thus	RB	advmod	O
identified	VBN	conj	O
as	IN	case	O
the	DT	det	O
malate	NN	compound	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	NN	nmod	O
(	-LRB-	punct	O
W	NN	dep	O
.	.	punct	O
V	NN	ROOT	O
.	.	punct	O
V	NN	ROOT	O
.	.	punct	O
Greenhouse	NN	ROOT	O
and	CC	cc	O
A	NN	conj	O
.	.	punct	O
L	NN	ROOT	O
.	.	punct	O
Lehninger	NNP	nsubjpass	O
,	,	punct	O
Cancer	NNP	compound	O
Res	NNP	appos	O
.	NNP	punct	O
,	,	punct	O
36	CD	appos	O
:	:	punct	O
1392	CD	nummod	O
-	SYM	punct	O
1396	CD	appos	O
,	,	punct	O
1976	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
metabolic	JJ	amod	O
flux	NN	compound	O
diagrams	NNS	nsubjpass	O
were	VBD	auxpass	O
constructed	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
five	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
diagrams	NNS	nsubj	O
show	VBP	ROOT	O
the	DT	det	O
relative	JJ	amod	O
rates	NNS	dobj	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
tricarboxylic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
cycle	NN	appos	O
,	,	punct	O
electron	NN	compound	B-Simple_chemical
transport	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	NN	conj	O
in	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Large	JJ	amod	O
amounts	NNS	nsubjpass	O
of	IN	case	O
cytosolic	JJ	amod	O
NADH	NN	nmod	B-Simple_chemical
were	VBD	auxpass	O
oxidized	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
respiratory	JJ	amod	O
chain	NN	nmod	O
via	IN	case	O
the	DT	det	O
NADH	NN	compound	B-Simple_chemical
shuttle	NN	nmod	O
,	,	punct	O
comprising	VBG	xcomp	O
anywhere	RB	advmod	O
from	IN	prep	O
about	RB	quantmod	O
20	CD	quantmod	O
to	TO	dep	O
80	CD	nummod	O
%	NN	pobj	O
of	IN	prep	O
the	DT	det	O
total	JJ	amod	O
flow	NN	pobj	O
of	IN	prep	O
reducing	VBG	pcomp	O
equivalents	NNS	dobj	O
to	TO	case	O
oxygen	NN	nmod	B-Simple_chemical
in	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Calculations	NNS	nsubj	O
of	IN	prep	O
the	DT	det	O
sources	NNS	pobj	O
of	IN	case	O
energy	NN	nmod	O
for	IN	case	O
adenosine	NN	compound	B-Simple_chemical
triphosphate	NN	compound	I-Simple_chemical
synthesis	NN	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
on	IN	case	O
the	DT	det	O
average	NN	nmod	O
about	IN	case	O
one	CD	nummod	O
-	HYPH	punct	O
third	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
respiratory	JJ	amod	O
adenosine	NN	compound	B-Simple_chemical
triphosphate	NN	nmod	I-Simple_chemical
is	VBZ	auxpass	O
generated	VBN	ccomp	O
by	IN	case	O
electron	NN	compound	B-Simple_chemical
flow	NN	compound	O
originating	VBG	nmod	O
from	IN	case	O
cytosolic	JJ	amod	B-Cellular_component
NADH	NN	nmod	B-Simple_chemical
via	IN	case	O
the	DT	det	O
malate	JJ	npadvmod	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	NN	nmod	O
.	.	punct	O

AKT2	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
downstream	JJ	amod	O
target	NN	ROOT	O
of	IN	case	O
metabotropic	JJ	amod	O
glutamate	JJ	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Grm1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
reported	VBD	ROOT	O
earlier	RBR	advmod	O
on	IN	case	O
the	DT	det	O
oncogenic	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
Grm1	NN	nmod	B-Gene_or_gene_product
by	IN	mark	O
demonstrating	VBG	advcl	O
that	IN	mark	O
stable	JJ	amod	O
Grm1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mouse	NN	compound	B-Organism
-	HYPH	punct	O
melanocytic	JJ	amod	B-Cell
clones	NNS	nsubj	I-Cell
proliferate	VBP	ccomp	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
growth	NN	compound	O
supplement	NN	nmod	O
and	CC	cc	O
anchorage	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
these	DT	det	O
clones	NNS	nsubj	B-Cell
also	RB	advmod	O
exhibit	VBP	ROOT	O
aggressive	JJ	amod	O
tumorigenic	JJ	amod	O
phenotypes	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
with	IN	case	O
short	JJ	amod	O
latency	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
formation	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
immunodeficient	JJ	nmod	B-Organism
and	CC	cc	O
syngeneic	JJ	conj	B-Organism
mice	NNS	dep	I-Organism
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
detected	VBD	ROOT	O
strong	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
AKT	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
allograft	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
specifically	RB	advmod	O
AKT2	NN	dobj	B-Gene_or_gene_product
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
isoform	NN	nmod	O
involved	VBN	acl	O
.	.	punct	O

In	IN	case	O
parallel	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
assessed	VBD	ROOT	O
several	JJ	amod	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Tissue
biopsy	NN	compound	I-Tissue
samples	NNS	dobj	I-Tissue
and	CC	cc	O
found	VBN	conj	O
again	RB	advmod	O
that	IN	mark	O
AKT2	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
the	DT	det	O
predominantly	RB	advmod	O
activated	VBN	amod	O
AKT	NN	ccomp	B-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Tissue
biopsies	NNS	nmod	I-Tissue
.	.	punct	O

In	IN	case	O
cultured	VBN	amod	O
stable	JJ	amod	O
Grm1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mouse	NN	compound	B-Organism
-	HYPH	punct	O
melanocytic	JJ	amod	B-Cell
clones	NNS	nmod	I-Cell
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
an	DT	det	O
metabotropic	JJ	amod	O
glutamate	JJ	compound	B-Gene_or_gene_product
receptor	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Grm1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expressing	VBG	acl	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
,	,	punct	I-Cell
C8161	NN	conj	I-Cell
,	,	punct	O
stimulation	NN	nsubj	O
of	IN	case	O
Grm1	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
its	PRP$	nmod:poss	O
agonist	NN	nmod	O
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
AKT	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
while	IN	mark	O
preincubation	NN	nsubj	O
with	IN	case	O
Grm1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
antagonist	NN	nmod	O
abolished	VBD	advcl	O
Grm1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
agonist	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
AKT	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
a	DT	det	O
reduction	NN	nsubjpass	O
in	IN	case	O
tumor	NN	compound	B-Cancer
volume	NN	nmod	O
of	IN	case	O
Grm1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mouse	NN	compound	B-Organism
-	HYPH	punct	O
melanocytic	JJ	amod	B-Tissue
-	HYPH	punct	I-Tissue
allografts	NNS	nmod	I-Tissue
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
small	JJ	amod	O
interfering	VBG	amod	O
AKT2	NN	compound	B-Gene_or_gene_product
RNA	NN	nmod	O
(	-LRB-	punct	O
siAKT2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
addition	NN	dep	O
to	TO	case	O
the	DT	det	O
MAPK	NN	compound	B-Gene_or_gene_product
pathway	NN	nsubj	O
previously	RB	advmod	O
reported	VBN	ccomp	O
being	VBG	cop	O
a	DT	det	O
downstream	JJ	amod	O
target	NN	nmod	O
of	IN	case	O
stimulated	VBN	amod	O
Grm1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
AKT2	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
another	DT	det	O
downstream	JJ	amod	O
target	NN	ccomp	O
in	IN	case	O
Grm1	NN	compound	B-Gene_or_gene_product
mediated	JJ	amod	O
melanocyte	NN	compound	B-Cell
transformation	NN	nmod	O
.	.	punct	O

Hormonal	JJ	amod	O
regulation	NN	ROOT	O
and	CC	cc	O
distinct	JJ	amod	O
functions	NNS	conj	O
of	IN	case	O
semaphorin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3B	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
semaphorin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3F	NN	conj	I-Gene_or_gene_product
in	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Semaphorins	NNS	nsubj	B-Gene_or_gene_product
comprise	VBP	ROOT	O
a	DT	det	O
family	NN	dobj	O
of	IN	case	O
molecules	NNS	nmod	O
that	WDT	nsubj	O
influence	VBP	acl:relcl	O
neuronal	JJ	amod	B-Cell
growth	NN	dobj	O
and	CC	cc	O
guidance	NN	conj	O
.	.	punct	O

Class	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
semaphorins	NNS	nsubj	I-Gene_or_gene_product
,	,	punct	O
semaphorin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3B	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
SEMA3B	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
semaphorin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3F	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
SEMA3F	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
illustrate	VBP	ROOT	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
by	IN	mark	O
forming	VBG	advcl	O
a	DT	det	O
complex	NN	dobj	O
with	IN	case	O
neuropilins	NNS	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
NP	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
or	CC	cc	O
NP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
plexins	NNS	conj	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
status	NN	dobj	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
semaphorins	NNS	nmod	B-Gene_or_gene_product
and	CC	cc	O
their	PRP$	nmod:poss	O
receptors	NNS	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
significantly	RB	advmod	O
reduced	VBD	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
SEMA3B	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
83	CD	nummod	O
kDa	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
SEMA3F	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
90	CD	nummod	O
kDa	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
plexin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A3	NN	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
surface	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
NP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
,	,	punct	O
NP	NN	dep	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
plexin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A1	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
surface	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
and	CC	cc	O
ovarian	JJ	conj	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
decreased	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
SEMA3B	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
SEMA3F	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
plexin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A3	NN	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
stage	NN	compound	O
3	CD	nummod	O
ovarian	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
treatment	NN	nsubj	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
luteinizing	VBG	amod	B-Gene_or_gene_product
hormone	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
follicle	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	VBG	compound	I-Gene_or_gene_product
hormone	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
estrogen	NN	conj	B-Simple_chemical
induced	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
upregulation	NN	dobj	O
of	IN	case	O
SEMA3B	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
whereas	IN	dep	O
SEMA3F	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
upregulated	VBN	parataxis	O
only	RB	advmod	O
by	IN	case	O
estrogen	NN	nmod	B-Simple_chemical
.	.	punct	O

Cotreatment	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
with	IN	case	O
a	DT	det	O
hormone	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
specific	JJ	amod	O
antagonist	NN	conj	O
blocked	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	O
.	.	punct	O

Ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
SEMA3B	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
SEMA3F	NN	conj	B-Gene_or_gene_product
reduced	VBD	ROOT	O
soft	JJ	amod	O
-	HYPH	punct	O
agar	NN	amod	O
colony	NN	compound	O
formation	NN	dobj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	B-Cell
invasion	NN	conj	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
cultures	NNS	nmod	I-Cell
.	.	punct	O

Forced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
SEMA3B	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
SEMA3F	NN	conj	B-Gene_or_gene_product
,	,	punct	O
inhibited	VBD	ROOT	O
viability	NN	dobj	O
of	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
SEMA3B	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
SEMA3F	NN	conj	B-Gene_or_gene_product
reduced	VBD	ROOT	O
focal	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
phosphorylation	NN	dobj	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Forced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
SEMA3F	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
SEMA3B	NN	conj	B-Gene_or_gene_product
in	IN	case	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
endothelial	JJ	amod	B-Tissue
cell	NN	compound	I-Tissue
tube	NN	compound	I-Tissue
formation	NN	dobj	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
loss	NN	nsubj	O
of	IN	case	O
SEMA3	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
hallmark	NN	ccomp	O
of	IN	case	O
cancer	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
gonadotropin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
estrogen	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
maintenance	NN	nsubj	O
of	IN	case	O
SEMA3	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
could	MD	aux	O
control	VB	ROOT	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
angiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Tobacco	NN	compound	B-Organism
smoke	NN	nsubj	O
promotes	VBZ	ROOT	O
lung	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
by	IN	mark	O
triggering	VBG	advcl	O
IKKbeta	NN	compound	B-Gene_or_gene_product
-	:	punct	O
and	CC	cc	O
JNK1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
inflammation	NN	dobj	B-Pathological_formation
.	.	punct	O

Chronic	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
tobacco	NN	compound	B-Organism
smoke	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
over	IN	advmod	O
60	CD	nummod	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
initiating	VBG	amod	O
carcinogens	NNS	dobj	O
,	,	punct	O
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	O
risk	NN	compound	O
factor	NN	ROOT	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
accounting	VBG	advcl	O
for	IN	case	O
a	DT	det	O
large	JJ	amod	O
portion	NN	nmod	O
of	IN	prep	O
cancer	NN	npadvmod	B-Cancer
-	HYPH	punct	O
related	JJ	amod	O
deaths	NNS	npadvmod	O
worldwide	VBP	pobj	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
well	RB	advmod	O
established	VBN	ROOT	O
that	IN	mark	O
tobacco	NN	compound	B-Organism
smoke	NN	nsubj	O
is	VBZ	ccomp	O
a	DT	det	O
tumor	NN	compound	B-Cancer
initiator	NN	attr	O
,	,	punct	O
but	CC	cc	O
we	PRP	nsubj	O
asked	VBD	conj	O
whether	IN	mark	O
it	PRP	nsubj	O
also	RB	advmod	O
acts	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
promoter	NN	nmod	O
once	IN	mark	O
malignant	JJ	amod	O
initiation	NN	nsubj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
caused	VBN	nmod	O
by	IN	case	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
,	,	punct	O
has	VBZ	aux	O
taken	VBN	advcl	O
place	NN	dobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
repetitive	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
tobacco	NN	compound	B-Organism
smoke	NN	nmod	O
promotes	VBZ	ccomp	O
tumor	NN	compound	B-Cancer
development	NN	dobj	O
both	CC	cc:preconj	O
in	IN	case	O
carcinogen	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	B-Organism
and	CC	cc	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	conj	B-Organism
undergoing	VBG	acl	O
sporadic	JJ	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
activation	NN	dobj	O
in	IN	case	O
lung	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Tumor	NN	compound	B-Cancer
promotion	NN	nsubj	O
is	VBZ	cop	O
due	JJ	acomp	O
to	TO	case	O
induction	NN	ROOT	O
of	IN	case	O
inflammation	NN	nmod	B-Pathological_formation
that	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
enhanced	VBN	amod	O
pneumocyte	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
abrogated	VBN	conj	O
by	IN	case	O
IKKbeta	NN	compound	B-Gene_or_gene_product
ablation	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
or	CC	cc	O
inactivation	NN	conj	O
of	IN	case	O
JNK1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Dose	NNP	compound	O
-	:	punct	O
and	CC	cc	O
time	NN	npadvmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
effects	NNS	ROOT	O
of	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
on	IN	case	O
cytotoxicity	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	conj	O
and	CC	cc	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
cytostatic	JJ	amod	O
drug	NN	compound	O
doxorubicin	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	JJ	amod	O
chemotherapeutic	JJ	amod	O
agent	NN	ROOT	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
used	VBN	acl:relcl	O
in	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

A	DT	det	O
key	JJ	amod	O
factor	NN	nsubj	O
in	IN	case	O
the	DT	det	O
response	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
chemotherapeutic	JJ	amod	O
drugs	NNS	nmod	O
is	VBZ	cop	O
the	DT	det	O
activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
apoptotic	JJ	amod	O
pathway	NN	nmod	O
,	,	punct	O
a	DT	det	O
pathway	NN	appos	O
that	WDT	nsubj	O
is	VBZ	cop	O
often	RB	advmod	O
impaired	JJ	acl:relcl	O
in	IN	case	O
chemoresistant	JJ	amod	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ccomp	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
in	IN	case	O
Hct	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
116	CD	nummod	I-Cell
human	JJ	amod	I-Cell
colon	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
clarify	VB	advcl	O
if	IN	mark	O
a	DT	det	O
time	NN	npadvmod	O
/	,	punct	O
concentration	NN	compound	O
range	NN	nsubj	O
for	IN	case	O
optimal	JJ	amod	O
doxorubicin	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
exists	VBZ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
compared	VBD	ROOT	O
a	DT	det	O
treatment	NN	compound	O
schedule	NN	dobj	O
were	VBD	cop	O
cells	NNS	nsubj	B-Cell
were	VBD	cop	O
bolus	NN	conj	O
incubated	VBN	acl	O
for	IN	case	O
3h	NN	nmod	O
with	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
followed	VBN	acl	O
by	IN	case	O
24h	NNS	nmod	O
in	IN	case	O
drug	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
medium	NN	nmod	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
continuous	JJ	amod	O
doxorubicin	NN	compound	B-Simple_chemical
treatment	NN	compound	O
schedule	NN	nmod	O
for	IN	case	O
24h	NNS	nmod	O
.	.	punct	O

Bolus	NN	compound	O
incubation	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
to	TO	mark	O
determine	VB	xcomp	O
effects	NNS	dobj	O
of	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
accumulated	VBN	acl	O
during	IN	case	O
the	DT	det	O
first	JJ	amod	O
3h	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
continuous	JJ	amod	O
incubation	NN	nsubj	O
allowed	VBD	parataxis	O
further	RB	amod	O
(	-LRB-	punct	O
continuous	JJ	amod	O
)	-RRB-	punct	O
exposure	NN	dobj	O
to	TO	case	O
doxorubicin	NN	nmod	B-Simple_chemical
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	appos	O
)	-RRB-	punct	O
treatment	NN	nsubj	O
with	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
resulted	VBD	ccomp	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
decrease	NN	nmod	O
of	IN	case	O
viable	JJ	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
concomitant	JJ	amod	O
increase	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	compound	O
)	-RRB-	punct	O
doxorubicin	NN	compound	B-Simple_chemical
incubation	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
serine	NN	nmod	B-Amino_acid
392	CD	nummod	I-Amino_acid
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
G2	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
increase	NN	conj	O
of	IN	case	O
proapoptotic	JJ	amod	O
protein	NN	compound	O
Bax	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
continuous	JJ	amod	O
(	-LRB-	punct	O
24h	NN	dep	O
)	-RRB-	punct	O
treatment	NN	nsubj	O
with	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
reduced	VBD	ROOT	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
living	VBG	amod	O
cells	NNS	nmod	B-Cell
with	IN	case	O
no	DT	neg	O
parallel	JJ	amod	O
raise	NN	nmod	O
in	IN	case	O
the	DT	det	O
amount	NN	nmod	O
of	IN	case	O
dead	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Continuous	JJ	amod	O
(	-LRB-	punct	O
24h	NN	dep	O
)	-RRB-	punct	O
treatment	NN	nsubj	O
with	IN	case	O
5	CD	compound	O
microM	NN	amod	O
doxorubicin	NN	nmod	B-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
in	IN	case	O
G0	NN	compound	O
/	:	punct	O
G1	NN	compound	O
phase	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
neither	CC	cc:preconj	O
accompanied	VBN	acl:relcl	O
by	IN	case	O
phosphorylation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
nor	CC	cc	O
enhanced	VBD	amod	O
expression	NN	conj	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
doxorubicin	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	B-Cell
death	NN	dobj	O
by	IN	case	O
apoptosis	NN	nmod	O
only	RB	advmod	O
at	IN	case	O
particular	JJ	amod	O
dose	NN	nmod	O
and	CC	cc	O
treatment	NN	compound	O
conditions	NNS	conj	O
and	CC	cc	O
imply	VBP	conj	O
a	DT	det	O
completely	RB	advmod	O
different	JJ	amod	O
cellular	JJ	amod	B-Cell
response	NN	dobj	O
following	VBG	case	O
bolus	NN	nmod	O
or	CC	cc	O
continuous	JJ	amod	O
exposure	NN	conj	O
to	TO	case	O
doxorubicin	NN	nmod	B-Simple_chemical
.	.	punct	O

Lactate	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dehydrogenase	NN	nsubjpass	I-Gene_or_gene_product
5	CD	nummod	I-Gene_or_gene_product
is	VBZ	auxpass	O
overexpressed	VBN	ROOT	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
transketolase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	NN	amod	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

AIMS	NNS	ROOT	O
:	:	punct	O
As	IN	mark	O
one	CD	pobj	O
of	IN	case	O
the	DT	det	O
five	CD	nummod	O
lactate	NN	compound	B-Gene_or_gene_product
dehydrogenase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
LDH	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
isoenzymes	NNS	nmod	O
,	,	punct	O
LDH5	NN	nsubj	B-Gene_or_gene_product
has	VBZ	dep	O
the	DT	det	O
highest	JJS	amod	O
efficiency	NN	dobj	O
to	TO	mark	O
catalyze	VB	acl	O
pyruvate	NN	compound	B-Simple_chemical
transformation	NN	dobj	O
to	TO	aux	O
lactate	VB	xcomp	B-Simple_chemical
.	.	punct	O

LDH5	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
induces	VBZ	ROOT	O
an	DT	det	O
upregulated	VBN	amod	O
glycolytic	JJ	amod	O
metabolism	NN	dobj	O
and	CC	cc	O
reduced	VBN	amod	O
dependence	NN	conj	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
LDH5	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
well	RB	advmod	O
characterized	VBN	amod	O
large	JJ	amod	O
cohort	NN	nmod	O
of	IN	case	O
primary	JJ	amod	B-Cancer
lung	NN	compound	I-Cancer
cancers	NNS	nmod	I-Cancer
in	IN	case	O
correlation	NN	nmod	O
to	TO	case	O
clinico	VB	nmod:npmod	O
-	HYPH	punct	O
pathological	JJ	amod	O
data	NNS	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
possible	JJ	amod	O
impact	NN	conj	O
on	IN	case	O
patient	NN	compound	B-Organism
survival	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Primary	JJ	amod	B-Cancer
lung	NN	compound	I-Cancer
cancers	NNS	nsubjpass	I-Cancer
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
269	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	B-Tissue
neoplastic	JJ	amod	I-Tissue
lung	NN	compound	I-Tissue
tissue	NN	conj	I-Tissue
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
35	CD	dep	O
)	-RRB-	punct	O
were	VBD	auxpass	O
tested	VBN	dep	O
for	IN	case	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
using	VBG	xcomp	O
a	DT	det	O
polyclonal	JJ	amod	O
LDH5	NN	compound	B-Gene_or_gene_product
antibody	NN	dobj	O
(	-LRB-	punct	O
ab53010	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubjpass	O
of	IN	case	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
were	VBD	auxpass	O
correlated	VBN	ROOT	O
to	TO	case	O
clinico	VB	nmod:npmod	O
-	HYPH	punct	O
pathological	JJ	amod	O
data	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
to	TO	case	O
patient	VB	nmod:poss	B-Organism
'	''	case	O
s	NNS	compound	O
survival	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
previously	RB	advmod	O
tested	VBN	amod	O
transketolase	NN	nmod	B-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	compound	O
(	-LRB-	punct	O
TKTL1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
were	VBD	auxpass	O
correlated	VBN	ROOT	O
to	TO	case	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
89	CD	dep	O
.	.	punct	O
5	CD	nummod	O
%	NN	nsubj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
238	CD	dep	O
)	-RRB-	punct	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
revealed	VBD	ROOT	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
whereas	IN	mark	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	advcl	O
in	IN	case	O
non	JJ	amod	B-Tissue
neoplastic	JJ	amod	I-Tissue
lung	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
34	CD	dep	O
)	-RRB-	punct	O
(	-LRB-	punct	O
p	NN	dep	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
0001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

LDH5	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
histological	JJ	amod	O
type	NN	nmod	O
(	-LRB-	punct	O
adenocarcinoma	NN	dep	B-Cancer
=	JJ	amod	O
57	CD	nummod	O
%	NN	dobj	O
,	,	punct	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
=	JJ	dep	O
45	CD	nummod	O
%	NN	dobj	O
,	,	punct	O
large	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
=	JJ	dep	O
46	CD	nummod	O
%	NN	dobj	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
006	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
TNM	NNP	compound	O
-	HYPH	punct	O
stage	NN	nmod	O
,	,	punct	O
grading	VBG	conj	O
or	CC	cc	O
survival	NN	conj	O
.	.	punct	O

A	DT	det	O
two	CD	nsubj	O
sided	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
TKTL1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
LDH5	NN	conj	B-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
shown	VBN	ROOT	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
002	CD	dep	O
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
overall	JJ	amod	O
cohort	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
for	IN	prep	O
each	DT	det	O
grading	NN	nmod	O
and	CC	cc	O
pN	NN	conj	O
group	NN	pobj	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
LDH5	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TKTL1	NN	conj	B-Gene_or_gene_product
within	IN	case	O
each	DT	det	O
histologic	JJ	amod	O
tumortype	NN	nmod	B-Cancer
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
revealed	VBN	ROOT	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
LDH5	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
overexpressed	VBN	dep	O
in	IN	case	O
NSCLC	NN	nmod	B-Cancer
and	CC	cc	O
could	MD	aux	O
hence	RB	advmod	O
serve	VB	conj	O
as	IN	case	O
an	DT	det	O
additional	JJ	amod	O
marker	NN	nmod	O
for	IN	case	O
malignancy	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
LDH5	NN	nsubj	B-Gene_or_gene_product
correlates	VBZ	ROOT	O
positively	RB	advmod	O
with	IN	case	O
the	DT	det	O
prognostic	JJ	amod	O
marker	NN	compound	O
TKTL1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
confirm	VBP	ROOT	O
a	DT	det	O
close	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
metabolic	JJ	amod	O
enzymes	NNS	nmod	O
and	CC	cc	O
indicate	VBP	conj	O
an	DT	det	O
alteration	NN	dobj	O
in	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Telomere	RB	compound	B-Cellular_component
/	SYM	punct	O
telomerase	NN	compound	B-Gene_or_gene_product
interplay	NN	ROOT	O
in	IN	case	O
virus	NN	compound	O
-	HYPH	punct	O
driven	VBN	amod	O
and	CC	cc	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
lymphomagenesis	NN	nmod	O
:	:	punct	O
pathogenic	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
implications	NNS	dep	O
.	.	punct	O

Telomerase	NN	nsubj	B-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
ribonucleoprotein	NN	compound	O
complex	NN	attr	O
critically	RB	advmod	O
involved	VBN	acl	O
in	IN	mark	O
extending	VBG	advcl	O
and	CC	cc	O
maintaining	VBG	conj	O
telomeres	NNS	conj	B-Cellular_component
.	.	punct	O

Unlike	IN	case	O
the	DT	det	O
majority	NN	nmod	O
of	IN	case	O
somatic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
hTERT	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
telomerase	NN	conj	B-Gene_or_gene_product
activity	NN	nsubj	O
are	VBP	cop	O
generally	RB	advmod	O
silent	JJ	acl:relcl	O
,	,	punct	O
normal	JJ	amod	O
lymphocytes	NNS	nsubj	B-Cell
show	VBP	ROOT	O
transient	JJ	amod	O
physiological	JJ	amod	O
hTERT	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
telomerase	NN	compound	B-Gene_or_gene_product
activity	NN	conj	O
according	VBG	case	O
to	IN	case	O
their	PRP$	nmod:poss	O
differentiation	NN	compound	O
/	:	punct	O
activation	NN	compound	O
status	NN	nmod	O
.	.	punct	O

During	IN	case	O
lymphomagenesis	NN	nmod	O
,	,	punct	O
induction	NN	nsubj	O
of	IN	case	O
persistent	JJ	amod	O
telomerase	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
activity	NN	conj	O
may	MD	aux	O
occur	VB	ROOT	O
before	IN	nmod	O
or	CC	cc	O
after	IN	conj	O
telomere	RB	compound	B-Cellular_component
shortening	VBG	dobj	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
different	JJ	amod	O
mechanisms	NNS	nmod	O
through	IN	case	O
which	WDT	nmod	O
transforming	NN	amod	O
factors	NNS	nsubj	O
/	:	punct	O
agents	NNS	conj	O
may	MD	aux	O
activate	VB	acl:relcl	O
telomerase	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Available	JJ	amod	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
timing	NN	nsubj	O
of	IN	case	O
telomerase	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
may	MD	aux	O
allow	VB	ccomp	O
the	DT	det	O
distinction	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
lymphomagenetic	JJ	amod	O
models	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
an	DT	det	O
early	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
telomerase	NN	nmod	B-Gene_or_gene_product
via	IN	case	O
exogenous	JJ	amod	O
regulators	NNS	nmod	O
of	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
along	IN	case	O
with	IN	case	O
an	DT	det	O
increased	VBN	amod	O
lymphocyte	NN	compound	B-Cell
growth	NN	nmod	O
and	CC	cc	O
a	DT	det	O
subsequent	JJ	amod	O
selection	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
increased	VBN	amod	O
transforming	VBG	amod	O
potential	NN	nmod	O
may	MD	aux	O
characterize	VB	ccomp	O
several	JJ	amod	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
lymphoid	JJ	amod	B-Pathological_formation
malignancies	NNS	dobj	I-Pathological_formation
;	:	punct	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
a	DT	det	O
progressive	JJ	amod	O
shortening	NN	nsubj	O
of	IN	case	O
telomeres	NNS	nmod	B-Cellular_component
,	,	punct	O
leading	VBG	acl	O
to	TO	case	O
genetic	JJ	amod	O
instability	NN	nmod	O
which	WDT	nsubj	O
favors	VBZ	acl:relcl	O
a	DT	det	O
subsequent	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
telomerase	NN	nmod	B-Gene_or_gene_product
via	IN	case	O
endogenous	JJ	amod	O
regulators	NNS	nmod	O
may	MD	aux	O
occur	VB	ccomp	O
in	IN	case	O
most	JJS	amod	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
unrelated	JJ	amod	O
lymphoid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
models	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
clinically	RB	advmod	O
relevant	JJ	amod	O
implications	NNS	dobj	O
,	,	punct	O
particularly	RB	advmod	O
for	IN	case	O
the	DT	det	O
tailoring	NN	nmod	O
of	IN	case	O
therapeutic	JJ	amod	O
strategies	NNS	nmod	O
targeting	VBG	acl	O
telomerase	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Betulin	NN	nsubj	B-Simple_chemical
induces	VBZ	ROOT	O
mitochondrial	JJ	amod	B-Cellular_component
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	compound	I-Gene_or_gene_product
release	NN	compound	O
associated	JJ	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
betulin	NN	nsubj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
naturally	RB	advmod	O
abundant	JJ	amod	O
compound	NN	appos	O
,	,	punct	O
has	VBZ	ccomp	O
anticancer	NN	compound	B-Cancer
functions	NNS	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
betulin	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
inhibited	VBD	ccomp	O
cell	NN	compound	B-Cell
viability	NN	dobj	O
in	IN	case	O
cervix	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
HeLa	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
hepatoma	NN	compound	B-Cell
HepG2	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
lung	NN	compound	B-Cell
adenocarcinoma	NN	compound	I-Cell
A549	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
MCF	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
IC	NN	nmod	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
values	NNS	dobj	O
ranging	VBG	acl	O
from	IN	case	O
10	CD	compound	O
to	TO	dep	O
15	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
mL	NN	nmod	O
.	.	punct	O

While	IN	mark	O
betulin	NN	nsubj	B-Simple_chemical
exhibited	VBD	advcl	O
only	RB	advmod	O
moderate	JJ	amod	O
anticancer	NN	compound	B-Cancer
activity	NN	dobj	O
in	IN	case	O
other	JJ	amod	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
such	JJ	case	O
as	IN	mwe	O
hepatoma	NN	compound	B-Cell
SK	NN	compound	I-Cell
-	HYPH	punct	I-Cell
HEP	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
prostate	NN	compound	B-Cell
carcinoma	NN	appos	I-Cell
PC	NN	compound	I-Cell
-	:	punct	I-Cell
3	CD	conj	I-Cell
,	,	punct	O
and	CC	cc	O
lung	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
NCI	NN	compound	I-Cell
-	:	punct	I-Cell
H460	NN	conj	I-Cell
,	,	punct	O
with	IN	case	O
IC	NN	compound	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
values	NNS	nmod	O
ranging	VBG	acl	O
from	IN	case	O
20	CD	compound	O
to	TO	dep	O
60	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
mL	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
showed	VBD	ROOT	O
minor	JJ	amod	O
growth	NN	compound	O
inhibition	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
erythroleukemia	NN	compound	B-Cell
K562	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
>	NN	dep	O
100	CD	nummod	O
microg	NN	dep	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
investigated	VBD	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
anticancer	NN	compound	B-Cancer
activity	NN	nmod	O
by	IN	case	O
betulin	NN	nmod	B-Simple_chemical
,	,	punct	O
using	VBG	advcl	O
HeLa	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
as	IN	case	O
an	DT	det	O
experimental	JJ	amod	O
model	NN	nmod	O
.	.	punct	O

Betulin	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
10	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
induces	VBZ	ROOT	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
,	,	punct	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
morphological	JJ	amod	O
characteristics	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
membrane	NN	compound	B-Cellular_component
phosphatidylserine	NN	compound	B-Amino_acid
translocation	NN	nmod	O
,	,	punct	O
nuclear	JJ	amod	B-Cellular_component
condensation	NN	compound	O
/	:	punct	O
fragmentation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptotic	JJ	amod	B-Cellular_component
body	NN	compound	I-Cellular_component
formation	NN	conj	O
.	.	punct	O

A	DT	det	O
kinetics	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
depolarization	NN	nsubj	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
membrane	NN	compound	I-Cellular_component
potential	NN	nmod	O
and	CC	cc	O
the	DT	det	O
release	NN	conj	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	nmod	I-Gene_or_gene_product
occurred	VBD	ccomp	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
betulin	NN	nmod	B-Simple_chemical
.	.	punct	O

Betulin	NN	nsubj	B-Simple_chemical
,	,	punct	O
unlike	IN	prep	O
its	PRP$	poss	O
chemical	JJ	amod	O
derivative	JJ	amod	O
betulinic	JJ	compound	B-Simple_chemical
acid	NN	pobj	I-Simple_chemical
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
directly	RB	advmod	O
trigger	VB	ROOT	O
mitochondrial	JJ	amod	B-Cellular_component
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	compound	I-Gene_or_gene_product
release	NN	dobj	O
in	IN	case	O
isolated	VBN	amod	O
mitochondria	NN	nmod	B-Cellular_component
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
Bax	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
Bak	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
rapidly	RB	advmod	O
translocated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
30	CD	nummod	O
min	NN	dep	O
after	IN	case	O
betulin	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

The	DT	det	O
sequential	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	compound	I-Gene_or_gene_product
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
/	SYM	punct	O
-	SYM	punct	B-Gene_or_gene_product
7	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
cleavage	NN	conj	O
of	IN	case	O
poly	NN	amod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ADP	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ribose	NN	amod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
polymerase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
PARP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
behind	IN	case	O
those	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
events	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
specific	JJ	amod	O
downregulation	NN	nsubj	O
of	IN	case	O
either	DT	det	O
caspase	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
,	,	punct	O
Bax	NN	conj	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
Bak	NN	conj	B-Gene_or_gene_product
by	IN	case	O
siRNA	NN	nmod	O
effectively	RB	advmod	O
reduced	VBD	ROOT	O
PARP	NN	compound	B-Gene_or_gene_product
cleavage	NN	dobj	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
the	DT	det	O
lines	NNS	nsubj	O
of	IN	case	O
evidence	NN	nmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
betulin	NN	nsubj	B-Simple_chemical
triggers	VBZ	ccomp	O
apoptosis	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
the	DT	det	O
intrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

Adenovirus	NN	compound	B-Organism
5	CD	nummod	I-Organism
E1A	NN	nsubj	B-Gene_or_gene_product
enhances	VBZ	ROOT	O
histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
inhibitors	NNS	nmod:npmod	O
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	dobj	O
through	IN	case	O
Egr	NN	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
Bim	NN	compound	B-Gene_or_gene_product
upregulation	NN	nmod	O
.	.	punct	O

Histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
inhibitors	NNS	nsubj	O
(	-LRB-	punct	O
HDACi	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
potent	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
cancer	NN	compound	B-Cancer
agents	NNS	ROOT	O
for	IN	case	O
variety	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
types	NNS	nmod	O
.	.	punct	O

Suberoylanilide	NN	compound	B-Simple_chemical
hydroxamic	JJ	amod	I-Simple_chemical
acid	NN	nsubjpass	I-Simple_chemical
(	-LRB-	punct	O
SAHA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
approved	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
drug	NN	nmod	O
to	TO	mark	O
treat	VB	acl	O
cutaneous	JJ	amod	O
T	NN	compound	B-Cancer
cell	NN	compound	I-Cancer
lymphoma	NN	dobj	I-Cancer
,	,	punct	O
and	CC	cc	O
the	DT	det	O
combination	NN	nsubjpass	O
of	IN	case	O
HDACi	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
agents	NNS	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
actively	RB	advmod	O
tested	VBN	conj	O
in	IN	case	O
many	JJ	amod	O
clinical	JJ	amod	O
trials	NNS	nmod	O
.	.	punct	O

Adenovirus	NN	compound	B-Organism
5	CD	nummod	I-Organism
early	JJ	amod	B-Gene_or_gene_product
region	NN	compound	I-Gene_or_gene_product
1A	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
E1A	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
exhibit	VB	xcomp	O
high	JJ	amod	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
gene	NN	compound	O
therapy	NN	nsubjpass	O
using	VBG	acl	O
E1A	NN	dobj	B-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
tested	VBN	conj	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
proapoptotic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
HDACi	NN	nmod	O
was	VBD	auxpass	O
robustly	RB	advmod	O
enhanced	VBN	ccomp	O
by	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
multiple	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
normal	JJ	amod	O
cells	NNS	conj	B-Cell
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
combination	NN	nsubj	O
of	IN	case	O
E1A	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
therapy	NN	nmod	O
and	CC	cc	O
SAHA	NN	conj	B-Simple_chemical
showed	VBD	ccomp	O
high	JJ	amod	O
therapeutic	JJ	amod	O
efficacy	NN	dobj	O
with	IN	case	O
low	JJ	amod	O
toxicity	NN	nmod	O
in	FW	amod	O
vivo	FW	dep	O
ovarian	JJ	amod	B-Cancer
and	CC	cc	O
breast	NN	compound	B-Cancer
xenograft	NN	compound	I-Cancer
models	NNS	nmod	O
.	.	punct	O

SAHA	NN	nsubj	B-Simple_chemical
downregulated	VBD	ROOT	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
XL	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
upregulated	VBD	amod	O
proapoptotic	JJ	amod	O
BH3	NN	compound	O
-	:	punct	O
only	JJ	advmod	O
protein	NN	compound	O
Bim	NN	conj	B-Gene_or_gene_product
,	,	punct	O
whose	WP$	nmod:poss	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
enhanced	VBN	acl:relcl	O
by	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
alterations	NNS	nsubj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
family	NN	compound	O
proteins	NNS	nmod	O
were	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

SAHA	NN	nsubj	B-Simple_chemical
enhanced	VBD	ROOT	O
acetylation	NN	dobj	O
of	IN	case	O
histone	NN	compound	B-Gene_or_gene_product
H3	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
Bim	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
region	NN	nmod	O
,	,	punct	O
while	IN	mark	O
E1A	NN	nsubj	B-Gene_or_gene_product
upregulated	VBD	advcl	O
Egr	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	dobj	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
directly	RB	advmod	O
involved	VBN	ccomp	O
in	IN	case	O
Bim	NN	compound	B-Gene_or_gene_product
transactivation	NN	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
not	RB	neg	O
only	RB	cc:preconj	O
a	DT	det	O
novel	JJ	amod	O
insight	NN	dobj	O
into	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
underlying	VBG	acl	O
anti	RB	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activity	NN	dobj	O
of	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
a	DT	det	O
rationale	NN	conj	O
for	IN	case	O
the	DT	det	O
combined	JJ	amod	O
HDACi	NN	nmod	O
and	CC	cc	O
E1A	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
therapy	NN	conj	O
in	IN	case	O
future	JJ	amod	O
clinical	JJ	amod	O
trials	NNS	nmod	O
.	.	punct	O

Constitutively	RB	advmod	O
nuclear	JJ	amod	B-Cellular_component
FOXO3a	NN	compound	B-Gene_or_gene_product
localization	NN	nsubj	O
predicts	VBZ	ROOT	O
poor	JJ	amod	O
survival	NN	dobj	O
and	CC	cc	O
promotes	VBZ	conj	O
Akt	JJ	compound	B-Gene_or_gene_product
phosphorylation	NN	dobj	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
PI3K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signal	NN	compound	O
pathway	NN	nsubj	O
plays	VBZ	appos	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
development	NN	conj	O
of	IN	case	O
drug	NN	compound	O
-	HYPH	punct	O
resistance	NN	nmod	O
.	.	punct	O

Cytotoxic	JJ	amod	O
chemotherapy	NN	compound	O
resistance	NN	nsubjpass	O
is	VBZ	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
limited	JJ	amod	O
therapeutic	JJ	amod	O
options	NNS	nmod	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
.	.	punct	O

METHODOLOGY	NNP	compound	O
/	:	punct	O
PRINCIPAL	NNP	compound	O
FINDINGS	NNP	ROOT	O
:	:	punct	O
Examination	NN	nsubj	O
of	IN	case	O
FOXO3a	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
phosphorylated	VBN	amod	O
-	:	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
P	NN	compound	O
-	HYPH	punct	O
Akt	NNP	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
tissue	NN	compound	I-Cancer
microarrays	NNS	nmod	O
showed	VBD	dep	O
nuclear	JJ	amod	B-Cellular_component
FOXO3a	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
associated	VBN	parataxis	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
positivity	NN	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
052	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
poor	JJ	amod	O
prognosis	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
014	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
P	NN	compound	O
-	HYPH	punct	O
Akt	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
invasive	JJ	amod	B-Cancer
ductal	JJ	amod	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Using	VBG	advcl	O
tamoxifen	NN	compound	B-Simple_chemical
and	CC	cc	O
doxorubicin	NN	conj	B-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	conj	O
and	CC	cc	O
-	HYPH	punct	O
resistant	JJ	conj	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
as	IN	case	O
models	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
doxorubicin	NN	compound	B-Simple_chemical
-	:	punct	O
but	CC	cc	O
not	RB	cc	O
tamoxifen	NN	compound	B-Simple_chemical
-	HYPH	punct	O
resistance	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
nuclear	JJ	amod	B-Cellular_component
accumulation	NN	nmod	O
of	IN	case	O
FOXO3a	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
the	DT	det	O
finding	NN	nmod	O
that	IN	mark	O
sustained	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
FOXO3a	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
established	VBD	ROOT	O
that	IN	mark	O
doxorubicin	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
induces	VBZ	ccomp	O
proliferation	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
FOXO3a	NN	compound	B-Gene_or_gene_product
nuclear	JJ	amod	B-Cellular_component
relocation	NN	conj	O
in	IN	case	O
sensitive	JJ	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
FOXO3a	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
in	IN	case	O
doxorubicin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	amod	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
promote	VB	xcomp	O
Akt	JJ	compound	B-Gene_or_gene_product
phosphorylation	NN	dobj	O
and	CC	cc	O
arrest	NN	compound	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	case	O
endogenous	JJ	amod	O
FOXO3a	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
reduced	VBD	ROOT	O
PI3K	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

Using	VBG	advcl	O
MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
FOXO3a	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	ccomp	O
by	IN	case	O
4	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxytamoxifen	NN	nmod	I-Simple_chemical
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
FOXO3a	NN	compound	B-Gene_or_gene_product
induction	NN	nsubj	O
up	RB	advmod	O
-	:	punct	O
regulates	VBZ	ccomp	O
PI3K	NN	compound	B-Gene_or_gene_product
-	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
and	CC	cc	O
enhanced	VBN	amod	O
doxorubicin	NN	compound	B-Simple_chemical
resistance	NN	conj	O
.	.	punct	O

However	RB	advmod	O
FOXO3a	NN	compound	B-Gene_or_gene_product
induction	NN	nsubj	O
has	VBZ	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
FOXO3a	NN	nsubjpass	B-Gene_or_gene_product
or	CC	cc	O
its	PRP$	nmod:poss	O
downstream	JJ	amod	O
activity	NN	conj	O
is	VBZ	auxpass	O
deregulated	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
cytotoxic	JJ	amod	O
drug	NN	compound	O
resistant	JJ	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
sustained	JJ	amod	O
FOXO3a	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
can	MD	aux	O
enhance	VB	ccomp	O
hyperactivation	NN	dobj	O
of	IN	case	O
the	DT	det	O
PI3K	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	nsubj	O
/	:	punct	O
SIGNIFICANCE	NN	appos	O
:	:	punct	O
Together	RB	advmod	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nsubjpass	O
and	CC	cc	O
poor	JJ	amod	O
survival	NN	conj	O
in	IN	case	O
invasive	JJ	amod	B-Cancer
ductal	JJ	amod	I-Cancer
breast	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
are	VBP	auxpass	O
linked	VBN	ccomp	O
to	TO	case	O
an	DT	det	O
uncoupling	NN	nmod	O
of	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
FOXO3a	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
axis	NN	nmod	O
.	.	punct	O

In	IN	case	O
these	DT	det	O
breast	NN	compound	B-Cancer
cancers	NNS	nsubj	I-Cancer
activated	VBD	ROOT	O
Akt	NNP	nsubj	B-Gene_or_gene_product
fails	VBZ	ccomp	O
to	TO	mark	O
inactivate	VB	xcomp	O
and	CC	cc	O
re	NN	advmod	O
-	HYPH	punct	O
localize	VB	conj	O
FOXO3a	NN	dobj	B-Gene_or_gene_product
to	TO	case	O
the	DT	det	O
cytoplasm	NN	nmod	B-Organism_substance
,	,	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-Cellular_component
-	HYPH	punct	O
targeted	VBN	amod	O
FOXO3a	NN	nsubj	B-Gene_or_gene_product
does	VBZ	aux	O
not	RB	neg	O
induce	VB	conj	O
cell	NN	compound	B-Cell
death	NN	dobj	O
or	CC	cc	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	conj	O
.	.	punct	O

As	IN	case	O
such	JJ	amod	O
,	,	punct	O
sustained	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
FOXO3a	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
may	MD	aux	O
culminate	VB	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
progression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
development	NN	conj	O
of	IN	case	O
an	DT	det	O
aggressive	JJ	amod	O
phenotype	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
cytotoxic	JJ	amod	O
chemotherapy	NN	compound	O
resistant	JJ	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
models	NNS	nmod	O
.	.	punct	O

Skin	NN	ROOT	B-Organ
deep	RB	amod	O
and	CC	cc	O
deeper	JJR	conj	O
:	:	punct	O
multiple	JJ	amod	O
pathways	NNS	dep	O
in	IN	case	O
basal	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinogenesis	NN	nmod	O
.	.	punct	O

This	DT	det	O
perspective	NN	nsubj	O
places	VBZ	ROOT	O
the	DT	det	O
report	NN	dobj	O
by	IN	prep	O
Villani	NNP	pobj	O
et	FW	cc	O
al	FW	dobj	O
.	.	punct	O
that	DT	nsubj	O
appears	VBZ	ROOT	O
in	IN	prep	O
this	DT	det	O
issue	NN	pobj	O
of	IN	prep	O
the	DT	det	O
journal	NN	pobj	O
(	-LRB-	punct	O
beginning	VBG	advcl	O
on	IN	prep	O
page	NN	pobj	O
1222	CD	nummod	O
)	-RRB-	punct	O
in	IN	prep	O
the	DT	det	O
context	NN	pobj	O
of	IN	prep	O
recent	JJ	amod	O
work	NN	pobj	O
showing	VBG	acl	O
an	DT	det	O
intersection	NN	dobj	O
between	IN	case	O
two	CD	nummod	O
important	JJ	amod	O
developmental	JJ	amod	O
pathways	NNS	nmod	O
implicated	VBN	acl	O
in	IN	case	O
oncogenesis	NN	nmod	O
:	:	punct	O
the	DT	det	O
hedgehog	JJ	dep	B-Gene_or_gene_product
and	CC	cc	O
insulin	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	dep	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
pathways	NNS	nmod	O
.	.	punct	O

Villani	NNP	ROOT	O
et	FW	dep	O
al	FW	conj	O
.	.	punct	O
define	VB	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
IGF	NN	compound	B-Gene_or_gene_product
regulatory	JJ	amod	O
protein	NN	compound	O
Igfbp2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
genetic	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
basal	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinogenesis	NN	nmod	O
driven	VBN	acl	O
by	IN	case	O
targeted	VBN	amod	O
constitutive	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
hedgehog	JJ	amod	B-Gene_or_gene_product
signaling	NN	nmod	O
.	.	punct	O

Placed	VBN	ROOT	O
in	IN	prep	O
the	DT	det	O
framework	NN	pobj	O
of	IN	prep	O
other	JJ	amod	O
recently	RB	advmod	O
published	VBN	amod	O
work	NN	pobj	O
,	,	punct	O
the	DT	det	O
observations	NNS	appos	O
of	IN	prep	O
Villani	NNP	pobj	O
et	FW	cc	O
al	FW	conj	O
.	.	punct	O
both	DT	det	O
raise	NN	amod	O
questions	NNS	ROOT	O
about	IN	case	O
the	DT	det	O
cell	NN	nmod	B-Cell
of	IN	case	O
origin	NN	nmod	O
for	IN	case	O
basal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
define	VB	conj	O
additional	JJ	amod	O
putative	JJ	amod	O
therapeutic	JJ	amod	O
and	CC	cc	O
preventive	JJ	conj	O
targets	NNS	dobj	O
for	IN	case	O
this	DT	det	O
disease	NN	nmod	O
.	.	punct	O

Brick1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
actin	NN	compound	B-Gene_or_gene_product
cytoskeleton	NN	nmod	B-Cellular_component
required	VBN	acl	O
for	IN	case	O
embryonic	JJ	amod	B-Developing_anatomical_structure
development	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
transformation	NN	conj	O
.	.	punct	O

Brick1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
Brk1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
less	RBR	advmod	O
-	HYPH	punct	O
studied	VBN	amod	O
component	NN	ROOT	O
of	IN	prep	O
the	DT	det	O
Wave	NNP	nmod	B-Gene_or_gene_product
/	SYM	punct	O
Scar	NN	compound	B-Gene_or_gene_product
pathway	NN	pobj	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
branched	JJ	amod	O
nucleation	NN	nmod	O
of	IN	case	O
actin	NN	compound	B-Gene_or_gene_product
fibers	NNS	nmod	B-Cellular_component
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
relevance	NN	nsubjpass	O
of	IN	case	O
Brk1	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
emphasized	VBN	ROOT	O
by	IN	case	O
correlative	JJ	amod	O
data	NNS	nmod	O
showing	VBG	acl	O
that	IN	mark	O
Von	NNP	compound	O
Hippel	NNP	compound	O
-	HYPH	punct	O
Lindau	NNP	compound	O
(	-LRB-	punct	O
VHL	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nsubjpass	B-Organism
that	WDT	nsubj	O
also	RB	advmod	O
lose	VBP	acl:relcl	O
the	DT	det	O
BRK1	NN	compound	B-Gene_or_gene_product
gene	NN	dobj	O
are	VBP	auxpass	O
protected	VBN	ccomp	O
against	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

This	DT	nsubj	O
contrasts	VBZ	ROOT	O
with	IN	case	O
recent	JJ	amod	O
evidence	NN	nmod	O
suggesting	VBG	acl	O
that	IN	mark	O
the	DT	det	O
Wave	NN	compound	B-Gene_or_gene_product
complex	NN	nsubj	O
may	MD	aux	O
function	VB	ccomp	O
as	IN	case	O
an	DT	det	O
invasion	NN	compound	O
suppressor	NN	nmod	O
in	IN	case	O
epithelial	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
downregulation	NN	nsubj	O
of	IN	case	O
Brk1	NN	nmod	B-Gene_or_gene_product
results	VBZ	ccomp	O
in	IN	case	O
abnormal	JJ	amod	O
actin	NN	compound	B-Gene_or_gene_product
stress	NN	compound	B-Cellular_component
fiber	NN	compound	I-Cellular_component
formation	NN	nmod	O
and	CC	cc	O
vinculin	NN	compound	B-Gene_or_gene_product
distribution	NN	conj	O
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
Arp2	NN	nmod	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
Wave	NN	conj	B-Gene_or_gene_product
proteins	NNS	dep	O
at	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
protrusions	NNS	nmod	O
.	.	punct	O

Brk1	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
transformation	NN	conj	O
by	IN	case	O
oncogenes	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
Brk1	NN	compound	B-Gene_or_gene_product
downregulation	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
defective	JJ	amod	O
directional	JJ	amod	O
migration	NN	nmod	O
and	CC	cc	O
invasive	JJ	amod	O
growth	NN	conj	O
in	IN	case	O
renal	JJ	amod	B-Cell
cell	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
other	JJ	amod	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
types	NNS	conj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
genetic	JJ	amod	O
ablation	NN	nsubj	O
of	IN	case	O
Brk1	NN	nmod	B-Gene_or_gene_product
results	VBZ	ROOT	O
in	IN	case	O
dramatic	JJ	amod	O
defects	NNS	nmod	O
in	IN	case	O
embryo	NN	compound	B-Developing_anatomical_structure
compaction	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
protein	NN	nmod	O
in	IN	case	O
actin	NN	compound	B-Gene_or_gene_product
dynamics	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
genetic	JJ	amod	O
loss	NN	nsubj	O
or	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
BRK1	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	cop	O
protective	JJ	xcomp	O
against	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
proliferation	NN	nmod	O
and	CC	cc	O
motility	NN	compound	O
defects	NNS	conj	O
in	IN	case	O
affected	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Ras	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
association	NN	compound	I-Gene_or_gene_product
domain	NN	compound	I-Gene_or_gene_product
family	NN	compound	I-Gene_or_gene_product
1C	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	O
promotes	VBZ	ROOT	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
and	CC	cc	O
attenuates	VBZ	conj	O
apoptosis	NN	dobj	O
.	.	punct	O

BACKGROUND	NN	nsubj	O
:	:	punct	O
The	DT	det	O
Ras	NN	compound	B-Gene_or_gene_product
association	NN	compound	I-Gene_or_gene_product
domain	NN	compound	I-Gene_or_gene_product
family	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
RASSF1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	appos	O
is	VBZ	cop	O
a	DT	det	O
Ras	NN	compound	B-Gene_or_gene_product
effector	NN	ROOT	O
encoding	VBG	acl	O
two	CD	nummod	O
major	JJ	amod	O
mRNA	NN	compound	O
forms	NNS	dobj	O
,	,	punct	O
RASSF1A	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
RASSF1C	NN	conj	B-Gene_or_gene_product
,	,	punct	O
derived	VBN	acl	O
by	IN	case	O
alternative	JJ	amod	O
promoter	NN	compound	O
selection	NN	nmod	O
and	CC	cc	O
alternative	JJ	amod	O
mRNA	NN	compound	O
splicing	NN	conj	O
.	.	punct	O

RASSF1A	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	ROOT	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
very	RB	advmod	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
RASSF1C	NN	nmod	B-Gene_or_gene_product
both	CC	case	O
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
transformed	VBN	conj	O
cells	NNS	nmod	B-Cell
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Gene	NN	compound	O
silencing	NN	nsubjpass	O
and	CC	cc	O
over	IN	compound	O
-	HYPH	punct	O
expression	NN	compound	O
techniques	NNS	conj	O
were	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
modulate	VB	xcomp	O
RASSF1C	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Affymetrix	NNP	compound	O
-	HYPH	punct	O
microarray	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
using	VBG	xcomp	O
T47D	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
over	IN	advmod	O
-	HYPH	punct	O
expressing	VBG	amod	O
RASSF1C	NN	dobj	B-Gene_or_gene_product
to	TO	mark	O
identify	VB	xcomp	O
RASSF1C	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	dobj	O
.	.	punct	O

RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nsubjpass	O
and	CC	cc	O
western	NN	compound	O
blot	NN	compound	O
techniques	NNS	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
validate	JJ	xcomp	O
target	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Cell	NN	compound	B-Cell
invasion	NN	nsubjpass	O
and	CC	cc	O
apoptosis	NN	compound	O
assays	NNS	conj	O
were	VBD	auxpass	O
also	RB	advmod	O
performed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
article	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	dep	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	mark	O
altering	VBG	acl	O
RASSF1C	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
silencing	VBG	nsubj	O
RASSF1C	NN	compound	B-Gene_or_gene_product
mRNA	NN	dobj	O
in	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
(	-LRB-	punct	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB231	NN	dep	I-Cell
and	CC	cc	O
T47D	NN	conj	B-Cell
)	-RRB-	punct	O
caused	VBD	ccomp	O
a	DT	det	O
small	JJ	amod	O
but	CC	cc	O
significant	JJ	conj	O
decrease	NN	dobj	O
in	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
inducible	JJ	amod	O
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
of	IN	case	O
RASSF1C	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB231	NN	dep	I-Cell
and	CC	cc	O
T47D	NN	conj	B-Cell
)	-RRB-	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
small	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
report	VBP	ROOT	O
on	IN	case	O
the	DT	det	O
identification	NN	nmod	O
of	IN	case	O
novel	JJ	amod	O
RASSF1C	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
.	.	punct	O

RASSF1C	NN	nsubj	B-Gene_or_gene_product
down	RB	advmod	O
-	HYPH	punct	O
regulates	VBZ	ROOT	O
several	JJ	amod	O
pro	NN	compound	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
genes	NNS	dobj	O
and	CC	cc	O
up	RB	advmod	O
-	HYPH	punct	O
regulates	VBZ	conj	O
several	JJ	amod	O
growth	NN	dobj	O
promoting	VBG	acl	O
genes	NNS	dobj	O
in	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
down	RB	compound	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
caspase	NN	nmod	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
via	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
RASSF1C	NN	nmod	B-Gene_or_gene_product
reduces	VBZ	ccomp	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod:poss	I-Cell
'	POS	case	O
sensitivity	NN	dobj	O
to	TO	case	O
the	DT	det	O
apoptosis	NN	nmod	O
inducing	VBG	acl	O
agent	NN	dobj	O
,	,	punct	O
etoposide	NN	appos	B-Simple_chemical
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
RASSF1C	NN	compound	B-Gene_or_gene_product
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
enhances	VBZ	ccomp	O
T47D	NN	compound	B-Cell
cell	NN	compound	I-Cell
invasion	NN	dobj	O
/	:	punct	O
migration	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	dep	O
that	IN	mark	O
RASSF1C	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
unlike	IN	case	O
RASSF1A	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	ccomp	O
,	,	punct	O
but	CC	cc	O
instead	RB	advmod	O
may	MD	aux	O
play	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
stimulating	VBG	advcl	O
metastasis	NN	dobj	O
and	CC	cc	O
survival	NN	conj	O
in	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Role	NN	nsubj	O
of	IN	case	O
stromal	JJ	amod	B-Cell
myofibroblasts	NNS	nmod	I-Cell
in	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
stromal	JJ	amod	B-Cell
expression	NN	nsubj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
smooth	JJ	amod	I-Gene_or_gene_product
muscle	NN	compound	I-Gene_or_gene_product
actin	NN	nmod	I-Gene_or_gene_product
correlates	VBZ	ROOT	O
with	IN	case	O
worse	JJR	amod	O
clinical	JJ	amod	O
outcome	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Recently	RB	advmod	O
,	,	punct	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	dep	O
as	IN	mark	O
having	VBG	advcl	O
an	DT	det	O
important	JJ	amod	O
function	NN	dobj	O
in	IN	case	O
epithelial	JJ	amod	B-Cancer
solid	JJ	amod	I-Cancer
tumor	NN	compound	I-Cancer
biology	NN	nmod	O
.	.	punct	O

There	EX	expl	O
have	VBP	aux	O
been	VBN	ROOT	O
no	DT	det	O
reports	NNS	attr	O
showing	VBG	acl	O
the	DT	det	O
relativity	NN	dobj	O
of	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	conj	O
by	IN	case	O
a	DT	det	O
quantitative	JJ	amod	O
analysis	NN	nmod	O
of	IN	prep	O
the	DT	det	O
myofibroblasts	NNS	pobj	B-Cell
that	WDT	nsubj	O
were	VBD	relcl	O
an	DT	det	O
important	JJ	amod	O
player	NN	attr	O
in	IN	prep	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	pobj	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
immunohistochemically	RB	advmod	O
investigate	VB	xcomp	O
the	DT	det	O
correlation	NN	dobj	O
between	IN	case	O
the	DT	det	O
desmoplastic	JJ	amod	O
reaction	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinicopathology	NN	conj	O
of	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
study	NN	nsubj	O
included	VBD	appos	O
60	CD	nummod	O
patients	NNS	dobj	B-Organism
with	IN	case	O
a	DT	det	O
known	JJ	amod	O
prognosis	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	B-Cancer
breast	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
quantified	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
myofibroblasts	NNS	nmod	B-Cell
in	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

After	IN	case	O
staining	VBG	compound	O
samples	NNS	nmod	O
for	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMA	NNP	nmod	I-Gene_or_gene_product
,	,	punct	O
their	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
extracted	VBN	ROOT	O
and	CC	cc	O
quantified	VBN	conj	O
as	IN	case	O
a	DT	det	O
relative	JJ	amod	O
percentage	NN	nmod	O
by	IN	case	O
computer	NN	npadvmod	O
-	HYPH	punct	O
assisted	VBN	amod	O
image	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
There	EX	expl	O
was	VBD	ROOT	O
relatively	RB	advmod	O
wide	JJ	amod	O
variation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	nmod	I-Gene_or_gene_product
with	IN	case	O
the	DT	det	O
percentage	NN	nmod	O
of	IN	case	O
the	DT	det	O
area	NN	nmod	O
from	IN	prep	O
0	CD	pobj	O
.	.	punct	O
68	CD	nummod	O
to	TO	dep	O
28	CD	npadvmod	O
.	.	punct	O
15	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
mean	NN	appos	O
8	CD	nummod	O
.	.	punct	O
48	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
5	CD	nummod	O
.	.	punct	O
40	CD	nummod	O
%	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
metastasis	NN	compound	O
group	NN	nsubj	O
showed	VBD	ROOT	O
significantly	RB	advmod	O
higher	JJR	amod	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
no	DT	neg	O
metastasis	NN	compound	O
group	NN	advcl	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
divided	VBN	ROOT	O
into	IN	case	O
two	CD	nummod	O
groups	NNS	nmod	O
according	VBG	prep	O
to	IN	mwe	O
their	PRP$	nmod:poss	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMA	NN	compound	I-Gene_or_gene_product
expression	NN	pobj	O
using	VBG	advcl	O
a	DT	det	O
cutoff	NN	compound	O
point	NN	dobj	O
at	IN	case	O
the	DT	det	O
mean	NN	amod	O
value	NN	nmod	O
of	IN	case	O
8	CD	nmod	O
.	.	punct	O
48	CD	nummod	O
%	NN	npadvmod	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	compound	I-Gene_or_gene_product
group	NN	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
poorer	VBN	amod	O
overall	JJ	amod	O
survival	NN	compound	O
rate	NN	dobj	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
001	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
were	VBD	auxpass	O
identified	VBN	ccomp	O
as	IN	case	O
independent	JJ	amod	O
predictive	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Myofibroblasts	NNS	nsubj	B-Cell
represent	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	dobj	O
for	IN	case	O
invasive	JJ	amod	O
growth	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
translated	VBN	acl:relcl	O
into	IN	case	O
a	DT	det	O
poor	JJ	amod	O
clinical	JJ	amod	O
prognosis	NN	nmod	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
invasive	JJ	amod	B-Cancer
breast	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
disintegrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
like	NN	amod	O
and	CC	cc	O
cysteine	NN	compound	B-Amino_acid
-	HYPH	punct	O
rich	JJ	amod	O
domains	NNS	nsubj	O
of	IN	case	O
ADAM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
mediate	NN	ROOT	O
interactions	NNS	dobj	O
between	IN	case	O
melanoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
.	.	punct	O

A	DT	det	O
characteristic	NN	nsubj	O
of	IN	case	O
malignant	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
is	VBZ	cop	O
their	PRP$	nmod:poss	O
capacity	NN	ROOT	O
to	TO	mark	O
invade	VB	acl	O
their	PRP$	nmod:poss	O
surrounding	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
metastasize	VB	conj	O
to	TO	prep	O
distant	JJ	amod	O
organs	NNS	pobj	B-Organ
.	.	punct	O

During	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
,	,	punct	O
proteolytic	JJ	amod	O
activities	NNS	nsubj	O
of	IN	case	O
tumor	NN	nmod	B-Cell
and	CC	cc	O
stromal	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
modify	VBP	ROOT	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	dobj	I-Cellular_component
to	TO	mark	O
produce	VB	xcomp	O
a	DT	det	O
microenvironment	NN	amod	O
suitable	JJ	dobj	O
for	IN	case	O
their	PRP$	poss	O
growth	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

In	IN	prep	O
recent	JJ	amod	O
years	NNS	pobj	O
the	DT	det	O
family	NN	nsubjpass	O
of	IN	case	O
ADAM	NN	compound	B-Gene_or_gene_product
proteases	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
ascribed	VBN	amod	O
important	JJ	amod	O
roles	NNS	ROOT	O
in	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
.	.	punct	O

ADAM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
melanoma	NN	nmod	B-Cancer
at	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
-	HYPH	punct	I-Tissue
stroma	NN	compound	I-Tissue
border	NN	nmod	I-Tissue
where	WRB	advmod	O
direct	JJ	amod	O
or	CC	cc	O
indirect	JJ	conj	O
interactions	NNS	nsubj	O
between	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
occur	VBP	conj	O
.	.	punct	O

To	TO	mark	O
analyze	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
ADAM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
for	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
melanoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
stromal	JJ	amod	B-Cell
fibroblasts	NNS	conj	I-Cell
,	,	punct	O
we	PRP	nsubj	O
produced	VBD	ROOT	O
the	DT	det	O
recombinant	JJ	amod	O
disintegrin	NN	preconj	B-Gene_or_gene_product
-	HYPH	punct	O
like	NN	compound	O
and	CC	cc	O
cysteine	NN	compound	B-Amino_acid
-	HYPH	punct	O
rich	JJ	amod	O
domain	NN	dobj	O
of	IN	prep	O
ADAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
DC	NN	compound	O
-	:	punct	O
9	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Melanoma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
and	CC	cc	O
human	JJ	amod	B-Organism
fibroblasts	NNS	conj	B-Cell
adhered	VBN	ROOT	O
to	TO	case	O
immobilized	VBN	amod	O
DC	NN	nmod	O
-	:	punct	O
9	CD	dep	O
in	IN	case	O
a	DT	det	O
Mn	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
+	CC	cc	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	O
dependent	JJ	amod	O
fashion	NN	nmod	O
suggesting	VBG	acl	O
an	DT	det	O
integrin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
process	NN	dobj	O
.	.	punct	O

Inhibition	NN	compound	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
adhesion	NN	nsubjpass	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
was	VBD	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
several	JJ	amod	O
beta1	NN	compound	B-Gene_or_gene_product
integrin	NN	compound	I-Gene_or_gene_product
receptors	NNS	nmod	O
independent	JJ	amod	O
of	IN	case	O
the	DT	dep	O
RGD	NN	nmod	O
and	CC	cc	O
ECD	NN	compound	O
recognition	NN	compound	O
motif	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
interaction	NN	nsubj	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
and	CC	cc	O
high	JJ	amod	B-Cell
invasive	JJ	amod	I-Cell
melanoma	NN	compound	I-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
soluble	JJ	amod	O
recombinant	JJ	amod	O
DC	NN	nmod	O
-	:	punct	O
9	CD	nummod	O
resulted	VBD	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
MMP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Silencing	NN	nsubj	O
of	IN	case	O
ADAM	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
melanoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
significantly	RB	advmod	O
reduced	VBD	ROOT	O
cell	NN	compound	B-Cell
adhesion	NN	dobj	O
to	TO	case	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Ablation	NN	nsubj	O
of	IN	case	O
ADAM	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
almost	RB	advmod	O
completely	RB	advmod	O
abolished	VBD	ROOT	O
these	DT	det	O
cellular	JJ	amod	B-Cell
interactions	NNS	dobj	O
and	CC	cc	O
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
invasion	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
ADAM	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
mediating	VBG	advcl	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
contacts	NNS	dobj	O
between	IN	case	O
fibroblasts	NNS	nmod	B-Cell
and	CC	cc	O
melanoma	NN	compound	B-Cell
cells	NNS	conj	I-Cell
and	CC	cc	O
that	IN	mark	O
these	DT	det	O
interactions	NNS	nsubj	O
contribute	VBP	conj	O
to	TO	case	O
proteolytic	JJ	amod	O
activities	NNS	nmod	O
required	VBN	acl	O
during	IN	case	O
invasion	NN	nmod	O
of	IN	case	O
melanoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Emerging	VBG	amod	O
metabolic	JJ	amod	O
targets	NNS	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
are	VBP	cop	O
different	JJ	ROOT	O
from	IN	case	O
normal	JJ	amod	O
cells	NNS	nmod	B-Cell
in	IN	case	O
their	PRP$	nmod:poss	O
metabolic	JJ	amod	O
properties	NNS	nmod	O
.	.	punct	O

Normal	JJ	amod	O
cells	NNS	nsubj	B-Cell
mostly	RB	advmod	O
rely	VBP	ROOT	O
on	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
oxidative	JJ	amod	O
phosphorylation	NN	nmod	O
to	TO	mark	O
produce	VB	acl	O
energy	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
depend	VBP	ROOT	O
mostly	RB	advmod	O
on	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
aerobic	JJ	amod	O
breakdown	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
into	IN	case	O
ATP	NN	nmod	B-Simple_chemical
.	.	punct	O

This	DT	det	O
altered	JJ	amod	O
energy	NN	compound	O
dependency	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
as	IN	prep	O
the	DT	det	O
"	``	punct	O
Warburg	NNP	compound	O
effect	NN	pobj	O
"	''	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	ROOT	O
recent	JJ	amod	O
years	NNS	pobj	O
,	,	punct	O
investigating	VBG	pcomp	O
the	DT	det	O
metabolic	JJ	amod	O
changes	NNS	nsubj	O
within	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
has	VBZ	aux	O
been	VBN	cop	O
a	DT	det	O
rapidly	RB	advmod	O
growing	VBG	amod	O
area	NN	dobj	B-Cancer
.	.	punct	O

Emerging	VBG	amod	O
evidence	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
oncogenes	NNS	nsubj	O
that	WDT	nsubj	O
drive	VBP	acl:relcl	O
the	DT	det	O
cancer	NN	compound	B-Cancer
-	HYPH	punct	O
promoting	VBG	amod	O
signals	NNS	dobj	O
also	RB	advmod	O
drive	VBP	ccomp	O
the	DT	det	O
altered	JJ	amod	O
metabolism	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
exact	JJ	amod	O
mechanisms	NNS	nsubj	O
underlying	VBG	acl	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	dobj	O
are	VBP	cop	O
unclear	JJ	advcl	O
,	,	punct	O
the	DT	det	O
existing	VBG	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
increased	VBN	amod	O
glycolysis	NN	nsubj	O
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
support	NN	amod	O
malignant	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	nsubj	O
thorough	JJ	case	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
unique	JJ	amod	O
metabolism	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
will	MD	aux	O
help	VB	ROOT	O
to	TO	aux	O
design	VB	xcomp	O
of	IN	prep	O
more	RBR	advmod	O
effective	JJ	amod	O
drugs	NNS	pobj	O
targeting	VBG	acl	O
metabolic	JJ	amod	O
pathways	NNS	dobj	O
,	,	punct	O
which	WDT	nsubj	O
will	MD	aux	O
greatly	RB	advmod	O
impact	VB	ccomp	O
the	DT	det	O
capacity	NN	dobj	O
to	TO	mark	O
effectively	RB	advmod	O
treat	VB	acl	O
cancer	NN	compound	B-Cancer
patients	NNS	dobj	B-Organism
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
an	DT	det	O
overview	NN	dobj	O
of	IN	prep	O
the	DT	det	O
current	JJ	amod	O
understanding	NN	pobj	O
of	IN	case	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	nmod	O
upon	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
,	,	punct	O
and	CC	cc	O
discussion	NN	conj	O
on	IN	case	O
the	DT	det	O
potential	JJ	amod	O
metabolic	JJ	amod	O
targets	NNS	nmod	O
for	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

MTSS1	NN	ROOT	B-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
multifunctional	JJ	amod	O
protein	NN	dep	O
and	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	conj	O
in	IN	case	O
cancer	NN	compound	B-Cancer
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

MTSS1	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	O
metastasis	NN	compound	B-Gene_or_gene_product
suppressor	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
first	RB	advmod	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
missing	VBG	nmod	O
in	IN	case	O
metastatic	JJ	amod	O
bladder	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
MTSS1	NN	nmod	B-Gene_or_gene_product
that	WDT	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
caused	VBN	acl:relcl	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
methylation	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
many	JJ	amod	O
other	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

While	IN	mark	O
accumlating	VBG	amod	O
evidence	NN	nsubj	O
for	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
MTSS1	NN	nmod	B-Gene_or_gene_product
support	VBP	ROOT	O
the	DT	det	O
concept	NN	nsubj	O
that	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
unlikely	JJ	acomp	O
to	TO	aux	O
be	VB	cop	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	dobj	O
,	,	punct	O
but	CC	cc	O
actually	RB	advmod	O
acts	VBZ	conj	O
as	IN	case	O
a	DT	det	O
scaffold	JJ	amod	O
protein	NN	nmod	O
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
multiple	JJ	amod	O
partners	NNS	nmod	O
to	TO	mark	O
regulate	VB	xcomp	O
actin	NN	compound	B-Gene_or_gene_product
dynamics	NNS	dobj	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
MTSS1	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
Shh	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
the	DT	det	O
developing	VBG	amod	O
hair	NN	compound	B-Multi-tissue_structure
follicle	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
in	IN	case	O
basal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	conj	I-Cancer
of	IN	case	O
the	DT	det	O
skin	NN	nmod	B-Organ
.	.	punct	O

Such	JJ	amod	O
evidence	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
MTSS1	NN	nsubj	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
multiple	JJ	amod	O
functional	JJ	amod	O
molecular	JJ	amod	O
player	NN	nmod	O
and	CC	cc	O
has	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
development	NN	nmod	O
,	,	punct	O
carcinogenesis	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
biochemical	JJ	amod	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
MTSS1	NN	nsubj	B-Gene_or_gene_product
functions	VBZ	acl:relcl	O
in	IN	case	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
the	DT	det	O
physiological	JJ	amod	O
role	NN	conj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
in	IN	case	O
animals	NNS	nmod	O
remain	VBP	ROOT	O
largely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
current	JJ	amod	O
knowledge	NN	dobj	O
of	IN	case	O
MTSS1	NN	nmod:poss	B-Gene_or_gene_product
'	''	punct	O
s	VBZ	compound	O
role	NN	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cancer
metastasis	NN	nmod	O
,	,	punct	O
carcinogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
development	NN	conj	O
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
significance	NN	nsubjpass	O
of	IN	case	O
MTSS1	NN	nmod	B-Gene_or_gene_product
will	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Ras	NN	compound	B-Gene_or_gene_product
p21	NN	compound	I-Gene_or_gene_product
onco	JJ	compound	O
-	HYPH	punct	O
protein	NN	ROOT	O
in	IN	case	O
the	DT	det	O
sera	NN	nmod	B-Organism_substance
of	IN	case	O
mice	NNS	nmod	B-Organism
carrying	VBG	acl	O
an	DT	det	O
experimentally	RB	advmod	O
induced	VBN	amod	O
tumor	NN	dobj	B-Cancer
and	CC	cc	O
in	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cancer
patients	NNS	conj	B-Organism
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
established	VBN	ROOT	O
a	DT	det	O
model	NN	compound	O
system	NN	dobj	O
to	TO	mark	O
detect	VB	acl	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
sera	NN	nmod	B-Organism_substance
of	IN	case	O
Balb	NN	compound	B-Organism
/	:	punct	I-Organism
c	NN	compound	I-Organism
mice	NNS	nmod	I-Organism
carrying	VBG	acl	O
tumors	NNS	dobj	B-Cancer
induced	VBN	acl	O
by	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
cell	NN	compound	B-Cell
line	NN	nmod	I-Cell
transformed	VBN	acl	O
with	IN	case	O
the	DT	det	O
Harvey	NNP	compound	B-Organism
murine	JJ	amod	I-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
helper	NN	compound	O
Friend	NN	compound	B-Organism
murine	JJ	amod	I-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

As	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
ELISA	NN	nmod	O
and	CC	cc	O
immunoblot	NN	compound	O
assays	NNS	conj	O
,	,	punct	O
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nsubj	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
serum	NN	nmod	B-Organism_substance
increased	VBD	ROOT	O
with	IN	case	O
increased	VBN	amod	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
ras	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
frequently	RB	advmod	O
activated	VBN	xcomp	O
in	IN	case	O
human	JJ	amod	B-Organism
tumours	NNS	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
sera	NN	nmod	B-Organism_substance
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

In	IN	case	O
only	RB	advmod	O
3	CD	nummod	O
out	IN	advmod	O
of	IN	advmod	O
13	CD	nummod	O
cases	NNS	nmod	O
,	,	punct	O
representing	VBG	acl	O
patients	NNS	dobj	B-Organism
with	IN	case	O
adenocarcinomas	NNS	nmod	B-Cancer
of	IN	case	O
the	DT	det	O
stomach	NN	compound	B-Organ
receiving	VBG	compound	O
chemotherapy	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nsubjpass	I-Gene_or_gene_product
detected	VBN	acl	O
at	IN	case	O
elevated	JJ	amod	O
levels	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
the	DT	det	O
following	VBG	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
no	DT	neg	O
substantial	JJ	amod	O
change	NN	nsubjpass	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
observed	VBN	ROOT	O
;	:	punct	O
nine	CD	dep	O
with	IN	case	O
breast	NN	nmod	B-Cancer
,	,	punct	O
5	CD	nummod	O
colon	NN	conj	B-Cancer
,	,	punct	O
5	CD	nummod	O
lung	NN	conj	B-Cancer
,	,	punct	O
5	CD	nummod	O
ovarian	JJ	appos	B-Cancer
and	CC	cc	O
5	CD	conj	O
hepatocellular	JJ	amod	B-Cancer
carcinomas	NNS	conj	I-Cancer
.	.	punct	O

Serum	NN	compound	B-Organism_substance
soluble	JJ	amod	O
vascular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
valuable	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	ROOT	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Vascular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
VAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
regulates	VBZ	dep	O
leukocyte	NN	compound	B-Cell
tissue	NN	compound	I-Cell
infiltration	NN	dobj	O
.	.	punct	O

Elevated	JJ	amod	O
serum	NN	compound	B-Organism_substance
soluble	JJ	amod	O
VAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
levels	NNS	nsubj	O
occur	VBP	ROOT	O
in	IN	case	O
certain	JJ	amod	O
diseases	NNS	nmod	O
having	VBG	acl	O
an	DT	det	O
inflammatory	JJ	amod	O
component	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
showed	VBD	ROOT	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
that	IN	mark	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
is	VBZ	cop	O
significantly	RB	advmod	O
higher	JJR	acl:relcl	O
relative	JJ	case	O
to	TO	case	O
controls	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
decreased	VBN	amod	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	conj	I-Multi-tissue_structure
and	CC	cc	O
liver	NN	compound	B-Organ
metastasis	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
described	VBN	ROOT	O
for	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
determines	VBZ	ROOT	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
preoperative	JJ	amod	O
serum	NN	compound	B-Organism_substance
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
and	CC	cc	O
clinicopathological	JJ	amod	O
features	NNS	conj	O
and	CC	cc	O
prognosis	NN	conj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Preoperative	JJ	amod	O
serum	NN	nsubjpass	B-Organism_substance
was	VBD	auxpass	O
collected	VBN	dep	O
from	IN	case	O
107	CD	nummod	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
and	CC	cc	O
33	CD	nummod	O
normal	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
assayed	VBN	ROOT	O
by	IN	case	O
enzyme	NN	nmod:npmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
mean	NN	amod	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
level	NN	nsubj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	dep	O
relative	JJ	case	O
to	TO	case	O
controls	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
decreased	VBD	conj	O
with	IN	case	O
disease	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	B-Cancer
size	NN	nsubjpass	O
,	,	punct	O
serosal	JJ	amod	B-Multi-tissue_structure
invasion	NN	appos	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	appos	O
,	,	punct	O
peritoneal	JJ	amod	B-Multi-tissue_structure
dissemination	NN	conj	O
,	,	punct	O
and	CC	cc	O
TNM	NN	compound	O
classification	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
level	NN	nmod	O
.	.	punct	O

sVAP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
independent	JJ	amod	O
predictive	JJ	amod	O
marker	NN	ROOT	O
for	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
having	VBG	acl	O
low	JJ	amod	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	conj	O
had	VBD	ROOT	O
significantly	RB	advmod	O
poorer	VBN	amod	O
prognosis	NN	dobj	O
relative	JJ	case	O
to	TO	case	O
patients	NNS	nmod	B-Organism
having	VBG	acl	O
elevated	JJ	amod	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
all	DT	nmod	O
or	CC	cc	O
stages	NNS	conj	O
I	CD	compound	O
-	:	punct	O
III	CD	nummod	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	dobj	B-Organism
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Low	JJ	amod	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	dep	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Determining	VBG	csubj	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
valuable	JJ	ROOT	O
for	IN	mark	O
predicting	VBG	advcl	O
prognosis	NN	dobj	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
.	.	punct	O

Metabolic	JJ	amod	O
regulation	NN	ROOT	O
by	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
are	VBP	ROOT	O
increasingly	RB	advmod	O
aware	JJ	acomp	O
that	IN	mark	O
cellular	JJ	amod	B-Cell
metabolism	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
vital	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
diseases	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
regulator	NN	conj	O
of	IN	case	O
metabolic	JJ	amod	O
pathways	NNS	nmod	O
.	.	punct	O

By	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
means	NNS	conj	O
,	,	punct	O
p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
able	JJ	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
oxidative	JJ	amod	O
phosphorylation	NN	conj	O
,	,	punct	O
glutaminolysis	NN	conj	O
,	,	punct	O
insulin	NN	compound	B-Gene_or_gene_product
sensitivity	NN	conj	O
,	,	punct	O
nucleotide	NN	compound	B-Simple_chemical
biosynthesis	NN	conj	O
,	,	punct	O
mitochondrial	JJ	amod	B-Cellular_component
integrity	NN	conj	O
,	,	punct	O
fatty	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
oxidation	NN	conj	O
,	,	punct	O
antioxidant	JJ	amod	B-Simple_chemical
response	NN	conj	O
,	,	punct	O
autophagy	NN	conj	O
and	CC	cc	O
mTOR	NN	conj	B-Gene_or_gene_product
signalling	NN	acl	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
to	TO	prep	O
positively	RB	advmod	O
and	CC	cc	O
negatively	RB	advmod	O
regulate	VB	ROOT	O
many	JJ	dobj	O
of	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
,	,	punct	O
combined	VBN	advcl	O
with	IN	case	O
feedback	NN	nmod	O
signalling	NN	acl	O
from	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
to	TO	case	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
demonstrates	VBZ	conj	O
the	DT	det	O
reciprocal	JJ	amod	O
and	CC	cc	O
flexible	JJ	conj	O
nature	NN	dobj	O
of	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
,	,	punct	O
facilitating	VBG	advcl	O
a	DT	det	O
diverse	JJ	amod	O
range	NN	dobj	O
of	IN	case	O
responses	NNS	nmod	O
to	TO	case	O
metabolic	JJ	amod	O
stress	NN	nmod	O
.	.	punct	O

Intriguingly	RB	advmod	O
,	,	punct	O
metabolic	JJ	amod	O
stress	NN	nsubj	O
triggers	VBZ	ROOT	O
primarily	RB	advmod	O
an	DT	det	O
adaptive	NN	dobj	O
(	-LRB-	punct	O
rather	RB	cc	O
than	IN	mwe	O
pro	NN	dep	O
-	HYPH	punct	O
apoptotic	JJ	dep	O
)	-RRB-	punct	O
p53	NN	compound	B-Gene_or_gene_product
response	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	aux	O
emerging	VBG	conj	O
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
metabolic	JJ	amod	O
homeostasis	NN	nmod	O
.	.	punct	O

A	DT	det	O
better	JJR	amod	O
understanding	NN	nsubj	O
of	IN	mark	O
how	WRB	advmod	O
p53	NN	nsubj	B-Gene_or_gene_product
coordinates	VBZ	ROOT	O
metabolic	JJ	amod	O
adaptation	NN	dobj	O
will	MD	aux	O
facilitate	VB	ccomp	O
the	DT	det	O
identification	NN	dobj	O
of	IN	case	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	nmod	O
and	CC	cc	O
will	MD	aux	O
also	RB	advmod	O
illuminate	VB	conj	O
the	DT	det	O
wider	JJR	amod	O
role	NN	dobj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
biology	NN	nmod	O
.	.	punct	O

Use	NN	ROOT	O
of	IN	case	O
DNA	NN	compound	B-Cellular_component
microarray	NN	nmod	O
and	CC	cc	O
small	JJ	amod	O
animal	NN	compound	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	conj	O
in	IN	case	O
preclinical	JJ	amod	O
drug	NN	compound	O
evaluation	NN	nmod	O
of	IN	case	O
RAF265	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Raf	NNP	compound	I-Gene_or_gene_product
/	:	punct	O
VEGFR	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitor	NN	appos	O
.	.	punct	O

Positron	NN	compound	O
emission	NN	compound	O
tomography	NN	compound	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
imaging	NN	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
a	DT	det	O
useful	JJ	amod	O
tool	NN	nsubj	O
for	IN	mark	O
assessing	VBG	acl	O
early	JJ	amod	O
biologic	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
particularly	RB	advmod	O
useful	JJ	conj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
cancer	NN	compound	B-Cancer
therapeutics	NNS	nmod	O
.	.	punct	O

RAF265	NN	nsubjpass	B-Simple_chemical
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Raf	NNP	compound	I-Gene_or_gene_product
/	:	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitor	NN	appos	O
,	,	punct	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
preclinical	JJ	amod	O
setting	NN	nmod	O
for	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
the	DT	det	O
uptake	NN	dobj	O
of	IN	case	O
PET	NN	compound	O
tracers	NNS	nmod	O
in	IN	case	O
the	DT	det	O
A375M	NN	compound	O
(	-LRB-	punct	O
B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Raf	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
V600E	NN	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
human	JJ	amod	O
melanoma	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
.	.	punct	O

RAF265	NN	nsubj	B-Simple_chemical
inhibited	VBD	ROOT	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
18	CD	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
F	NNP	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
fluoro	NNS	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
d	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
FDG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
accumulation	NN	dobj	O
in	IN	case	O
cell	NN	compound	B-Cell
culture	NN	nmod	O
at	IN	case	O
28	CD	nummod	O
hours	NNS	nmod	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

RAF265	NN	nsubj	B-Simple_chemical
also	RB	advmod	O
inhibited	VBD	ROOT	O
FDG	NN	compound	B-Simple_chemical
accumulation	NN	dobj	O
in	IN	case	O
tumor	NN	nmod	B-Cancer
xenografts	NNS	advmod	I-Cancer
after	IN	case	O
1	CD	nummod	O
day	NN	nmod	O
of	IN	case	O
drug	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

This	DT	det	O
decrease	NN	nsubj	O
persisted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
remaining	VBG	amod	O
2	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
treated	VBN	amod	O
tumor	NN	nmod	B-Cancer
xenografts	NNS	advmod	I-Cancer
revealed	VBD	ROOT	O
significantly	RB	advmod	O
decreased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
regulating	VBG	acl	O
glucose	NN	dobj	B-Simple_chemical
and	CC	cc	O
thymidine	NN	compound	B-Simple_chemical
metabolism	NN	conj	O
and	CC	cc	O
revealed	VBD	conj	O
changes	NNS	dobj	O
in	IN	case	O
apoptotic	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
imaging	VBG	amod	O
tracers	NNS	compound	O
FDG	NN	nsubj	B-Simple_chemical
,	,	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
3	CD	conj	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
18	CD	nummod	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
F	NNP	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
fluorothymidine	NN	conj	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
annexin	NN	compound	B-Gene_or_gene_product
V	NN	conj	I-Gene_or_gene_product
could	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
potential	JJ	amod	O
imaging	NN	amod	O
biomarkers	NNS	nmod	O
for	IN	case	O
RAF265	NN	compound	B-Simple_chemical
therapy	NN	compound	O
monitoring	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
concluded	VBD	ROOT	O
that	IN	mark	O
RAF265	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
highly	RB	advmod	O
efficacious	JJ	ccomp	O
in	IN	case	O
this	DT	det	O
xenograft	NN	amod	B-Cancer
model	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
melanoma	NN	nmod	B-Cancer
and	CC	cc	O
decreases	VBZ	conj	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	dobj	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
culture	NN	compound	O
assays	NNS	conj	O
,	,	punct	O
and	CC	cc	O
small	JJ	amod	O
animal	NN	compound	O
FDG	NN	compound	B-Simple_chemical
PET	NN	compound	O
scans	NNS	conj	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
1	CD	nummod	O
day	NN	nmod	O
after	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
use	NN	dobj	O
of	IN	case	O
FDG	NN	compound	B-Simple_chemical
PET	NN	nmod	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	nmod	O
with	IN	case	O
RAF265	NN	nmod	B-Simple_chemical
to	TO	mark	O
assess	VB	acl	O
early	JJ	amod	O
tumor	NN	compound	B-Cancer
response	NN	dobj	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
small	JJ	amod	O
animal	NN	compound	O
PET	NN	compound	O
studies	NNS	conj	O
may	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
complementary	JJ	amod	O
technologies	NNS	nmod	O
in	IN	case	O
drug	NN	compound	O
development	NN	nmod	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
microarray	NN	compound	O
analysis	NN	nsubj	O
allows	VBZ	ROOT	O
for	IN	case	O
analysis	NN	nmod	O
of	IN	case	O
drug	NN	compound	O
effects	NNS	nmod	O
on	IN	case	O
multiple	JJ	amod	O
pathways	NNS	nmod	O
linked	VBN	acl	O
to	TO	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
can	MD	aux	O
suggest	VB	conj	O
corresponding	JJ	xcomp	O
imaging	VBG	xcomp	O
tracers	NNS	dobj	O
for	IN	case	O
further	JJ	amod	O
analysis	NN	nmod	O
as	IN	case	O
biomarkers	NNS	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
response	NN	nmod	O
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-Organism
hepotacellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
reveals	VBZ	ROOT	O
molecular	JJ	amod	O
pathways	NNS	dobj	O
and	CC	cc	O
networks	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
studying	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	O
HCC	NN	appos	B-Cancer
)	-RRB-	punct	O
metastasis	NN	nmod	O
remains	VBZ	ROOT	O
challenging	VBG	xcomp	O
.	.	punct	O

We	PRP	nsubj	O
performed	VBD	ROOT	O
comparative	JJ	amod	O
proteomic	JJ	amod	O
and	CC	cc	O
pathway	NN	conj	O
analysis	NN	dobj	O
of	IN	case	O
four	CD	nummod	O
human	JJ	amod	B-Organism
metastatic	JJ	amod	B-Cell
HCC	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
to	TO	mark	O
identify	VB	advcl	O
metastasis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
proteins	NNS	dobj	O
.	.	punct	O

These	DT	det	O
HCC	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
had	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
genetic	JJ	amod	O
background	NN	dobj	O
but	CC	cc	O
with	IN	case	O
an	DT	det	O
increasing	VBG	amod	O
potential	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
dimensional	JJ	amod	O
electrophoresis	NN	nmod	O
(	-LRB-	punct	O
2	CD	nummod	O
-	HYPH	punct	O
DE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
MALDI	NN	compound	O
-	HYPH	punct	O
TOF	NN	compound	O
mass	NN	compound	O
spectrometry	NN	conj	O
,	,	punct	O
a	DT	det	O
total	NN	appos	O
of	IN	case	O
125	CD	nummod	O
proteins	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
post	JJ	nmod:npmod	O
-	HYPH	punct	O
translational	JJ	amod	O
modification	NN	compound	O
forms	NNS	conj	O
or	CC	cc	O
isoforms	NNS	conj	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
differentially	RB	advmod	O
expressed	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Among	IN	prep	O
them	PRP	pobj	O
,	,	punct	O
29	CD	nsubj	O
were	VBD	ROOT	O
gradually	RB	advmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	acomp	O
whereas	IN	mark	O
17	CD	nsubj	O
were	VBD	auxpass	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	advcl	O
with	IN	prep	O
increasing	VBG	amod	O
metastatic	JJ	amod	O
potential	NN	pobj	O
.	.	punct	O

Instead	RB	advmod	O
of	IN	prep	O
a	DT	det	O
traditional	JJ	amod	O
single	JJ	amod	O
-	HYPH	punct	O
gene	NN	compound	O
readout	NN	pobj	O
,	,	punct	O
global	JJ	amod	O
bioinformatics	NNS	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
,	,	punct	O
which	WDT	nsubj	O
revealed	VBD	ccomp	O
that	IN	mark	O
the	DT	det	O
glycolysis	NN	compound	O
pathway	NN	nsubj	O
was	VBD	cop	O
the	DT	det	O
most	RBS	advmod	O
significantly	RB	advmod	O
enriched	JJ	amod	O
pathway	NN	ccomp	O
.	.	punct	O

The	DT	det	O
heat	NN	compound	B-Gene_or_gene_product
shock	NN	compound	I-Gene_or_gene_product
proteins	NNS	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
HSPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
centered	JJ	ROOT	O
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
centered	JJ	amod	O
networks	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
enriched	VBN	conj	O
in	IN	case	O
the	DT	det	O
result	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
imply	VB	acl:relcl	O
the	DT	det	O
key	JJ	amod	O
function	NN	dobj	O
of	IN	mark	O
inflaming	VBG	acl	O
on	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

Meanwhile	RB	advmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	prep	O
HDGF	NN	pobj	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
protein	NN	nsubj	O
and	CC	cc	O
a	DT	det	O
target	NN	conj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
induced	VBD	ROOT	O
cell	NN	compound	B-Cell
apoptosis	NN	dobj	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
HCC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

This	DT	det	O
work	NN	nsubj	O
provides	VBZ	ROOT	O
a	DT	det	O
demonstration	NN	dobj	O
that	IN	mark	O
a	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
bioinformatics	NNS	nmod	O
and	CC	cc	O
comparative	JJ	amod	O
proteomics	NNS	conj	O
can	MD	aux	O
help	VB	ccomp	O
in	IN	prep	O
finding	VBG	pcomp	O
out	RP	prt	O
potential	JJ	amod	O
biomarkers	NNS	dobj	O
associated	VBN	acl	O
with	IN	case	O
HCC	NN	compound	B-Cancer
metastasis	NN	nmod	O
on	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
pathways	NNS	nmod	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
by	IN	case	O
FGF	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
involves	VBZ	ROOT	O
activity	NN	dobj	O
of	IN	case	O
EGR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
sensitizes	VBZ	conj	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	dep	I-Cell
to	TO	case	O
cell	NN	compound	B-Cell
death	NN	nmod	O
.	.	punct	O

Inhibitor	NN	nsubj	B-Gene_or_gene_product
of	IN	prep	I-Gene_or_gene_product
differentiation	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	pobj	I-Gene_or_gene_product
(	-LRB-	punct	O
Id	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
helix	NN	compound	O
-	HYPH	punct	O
loop	NN	compound	O
-	HYPH	punct	O
helix	NN	compound	O
(	-LRB-	punct	O
HLH	JJ	compound	O
)	-RRB-	punct	O
family	NN	nmod	O
of	IN	case	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
gene	NN	compound	O
transcription	NN	dobj	O
through	IN	case	O
their	PRP$	nmod:poss	O
inhibitory	JJ	amod	O
binding	NN	nmod	O
to	TO	case	O
basic	JJ	amod	O
-	HYPH	punct	O
HLH	JJ	dep	O
transcription	NN	compound	O
factors	NNS	nmod	O
.	.	punct	O

Similarly	RB	advmod	O
to	TO	case	O
other	JJ	amod	O
members	NNS	advcl	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
,	,	punct	O
Id	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
repression	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
differentiation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
.	.	punct	O

The	DT	det	O
dual	JJ	amod	O
function	NN	nsubj	O
of	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
inhibition	NN	appos	O
of	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
might	MD	aux	O
be	VB	cop	O
interdependent	JJ	ROOT	O
,	,	punct	O
as	IN	mark	O
cell	NN	compound	B-Cell
differentiation	NN	nsubjpass	O
is	VBZ	auxpass	O
generally	RB	advmod	O
coupled	VBN	advcl	O
with	IN	case	O
the	DT	det	O
exit	NN	nmod	O
from	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
.	.	punct	O

Fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
multiple	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
different	JJ	amod	O
biological	JJ	amod	O
processes	NNS	nmod	O
during	IN	case	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
(	-LRB-	punct	O
CNS	NN	appos	B-Anatomical_system
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
"	``	punct	O
neuronal	JJ	amod	B-Cell
-	HYPH	punct	O
like	UH	amod	O
"	``	punct	O
differentiation	NN	dobj	O
and	CC	cc	O
trigger	VBP	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
neuroblastoma	NN	compound	B-Cell
SK	NN	compound	I-Cell
-	HYPH	punct	I-Cell
N	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
MC	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Although	IN	mark	O
regulation	NN	nsubjpass	O
of	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nmod	O
by	IN	case	O
several	JJ	amod	O
mitogenic	JJ	amod	O
factors	NNS	nmod	O
is	VBZ	auxpass	O
well	RB	advmod	O
-	HYPH	punct	O
established	VBN	advcl	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

Using	VBG	advcl	O
human	JJ	amod	B-Organism
neuroblastoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
,	,	punct	O
SK	NN	compound	B-Cell
-	HYPH	punct	I-Cell
N	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
MC	NNP	appos	I-Cell
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
with	IN	case	O
FGF	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
resulted	VBD	ccomp	O
in	IN	case	O
early	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
Id	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
occurs	VBZ	ROOT	O
within	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
from	IN	case	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
treatment	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
ERK1	NN	nmod	B-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
pathway	NN	dep	O
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
stimulates	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
early	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
response	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Egr	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
demonstrate	VBP	ROOT	O
direct	JJ	amod	O
interaction	NN	dobj	O
of	IN	case	O
Egr	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
with	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	IN	case	O
cell	NN	compound	B-Cell
culture	NN	conj	I-Cell
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
Id	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	dep	O
accumulation	NN	nmod	O
of	IN	case	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
treated	VBN	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
delayed	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
.	.	punct	O

Vimentin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
preferentially	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
with	IN	case	O
low	JJ	amod	O
estrogen	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
high	JJ	amod	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
growth	NN	compound	O
fraction	NN	conj	O
.	.	punct	O

Vimentin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
,	,	punct	O
growth	NN	compound	O
fractions	NNS	conj	O
(	-LRB-	punct	O
GF	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
estrogen	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
ER	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
levels	NNS	conj	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
for	IN	case	O
90	CD	nummod	O
untreated	JJ	amod	O
primary	JJ	amod	O
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

Coexpression	NN	nsubjpass	O
of	IN	case	O
keratin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
vimentin	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
approximately	RB	advmod	O
20	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
regardless	RB	advmod	O
of	IN	case	O
menopausal	JJ	amod	O
status	NN	nmod	O
.	.	punct	O

Vimentin	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
expressed	VBN	ROOT	O
preferentially	RB	advmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
high	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	compound	I-Cancer
ductal	JJ	amod	I-Cancer
breast	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
(	-LRB-	punct	O
15	CD	compound	O
of	IN	advmod	O
28	CD	nummod	O
histologic	JJ	amod	O
grade	NN	dep	O
3	CD	nummod	O
vs	CC	cc	O
.	.	punct	O
0	CD	nummod	O
of	IN	advmod	O
40	CD	nummod	O
grades	NNS	ROOT	O
1	CD	dep	O
and	CC	cc	O
2	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O

Vimentin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
preferentially	RB	advmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
with	IN	case	O
high	JJ	amod	O
GF	NN	nmod	O
(	-LRB-	punct	O
greater	JJR	advmod	O
than	IN	advmod	O
15	CD	nummod	O
%	NN	dep	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
positive	JJ	nmod	O
by	IN	case	O
immunoperoxidase	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
low	JJ	amod	O
ER	NN	compound	B-Gene_or_gene_product
levels	NNS	conj	O
(	-LRB-	punct	O
less	JJR	advmod	O
than	IN	advmod	O
60	CD	nummod	O
fmols	NNS	dep	O
/	:	punct	O
mg	NN	compound	O
protein	NN	dep	O
by	IN	case	O
a	DT	det	O
monoclonal	JJ	amod	O
enzyme	NN	compound	O
immunoassay	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Sixty	NNP	compound	O
-	HYPH	punct	O
eight	CD	nummod	O
percent	NN	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
this	DT	det	O
group	NN	nmod	O
were	VBD	cop	O
vimentin	NN	nmod:npmod	B-Gene_or_gene_product
positive	JJ	ROOT	O
and	CC	cc	O
88	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
all	DT	det	O
vimentin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
tumors	NNS	nmod	B-Cancer
fell	VBD	conj	O
into	IN	case	O
this	DT	det	O
category	NN	nmod	O
.	.	punct	O

More	JJR	amod	O
than	IN	quantmod	O
50	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
coexpressed	VBD	ROOT	O
vimentin	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
keratin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
vimentin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
helpful	JJ	ROOT	O
in	IN	mark	O
identifying	VBG	advcl	O
a	DT	det	O
substantial	JJ	amod	O
subset	NN	dobj	O
of	IN	case	O
ER	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
independent	JJ	amod	O
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
with	IN	case	O
poor	JJ	amod	O
prognostic	JJ	amod	O
indicators	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Expression	NN	ROOT	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
the	DT	det	O
clinical	JJ	amod	O
significance	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
NSCLC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
45	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
and	CC	cc	O
adjacent	JJ	amod	O
tissue	NN	conj	B-Tissue
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
and	CC	cc	O
normal	JJ	amod	O
lung	NN	compound	B-Tissue
tissue	NN	conj	I-Tissue
was	VBD	auxpass	O
checked	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

The	DT	det	O
relation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
and	CC	cc	O
the	DT	det	O
multiple	JJ	amod	O
factors	NNS	conj	O
of	IN	case	O
pathological	JJ	amod	O
type	NN	nmod	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
P	NN	compound	O
-	HYPH	punct	O
TNM	NNP	compound	O
stage	NN	conj	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	compound	O
rates	NNS	nsubj	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
NSCLC	NN	nmod	B-Cancer
and	CC	cc	O
normal	JJ	amod	O
lung	NN	compound	B-Multi-tissue_structure
tissue	NN	compound	I-Multi-tissue_structure
sections	NNS	conj	I-Multi-tissue_structure
were	VBD	appos	O
73	CD	attr	O
.	.	punct	O
33	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
15	CD	conj	O
.	.	punct	O
56	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
pathological	JJ	amod	O
type	NN	nmod	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
P	NN	compound	O
-	HYPH	punct	O
TNM	NNP	compound	O
stage	NN	conj	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
(	-LRB-	punct	O
P	NN	appos	O
>	NN	amod	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
might	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
members	NNS	nsubj	O
of	IN	case	O
an	DT	det	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
microRNA	NN	compound	O
cluster	NN	nmod	O
cooperate	VBP	ROOT	O
to	TO	mark	O
transform	VB	xcomp	O
B	NN	compound	B-Cell
lymphocytes	NNS	dobj	I-Cell
.	.	punct	O

Epstein	NN	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	nsubj	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
transforms	VBZ	ROOT	O
B	NN	compound	B-Cell
lymphocytes	NNS	dobj	I-Cell
through	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
latent	JJ	amod	O
viral	JJ	amod	O
proteins	NNS	nmod	O
EBNA	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
LMP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
apparent	JJ	acomp	O
that	IN	mark	O
microRNAs	NN	nsubj	O
(	-LRB-	punct	O
miRNAs	NN	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
contribute	VBP	ccomp	O
to	TO	case	O
EBV	NN	nmod:poss	B-Organism
'	POS	punct	O
s	NNS	compound	O
oncogenic	JJ	amod	O
properties	NNS	nmod	O
;	:	punct	O
recombinant	JJ	amod	B-Organism
EBVs	NNS	nsubj	I-Organism
that	WDT	nsubj	O
lack	VBP	acl:relcl	O
the	DT	det	O
BHRF1	NN	compound	B-Gene_or_gene_product
miRNA	NN	compound	O
cluster	NN	dobj	O
display	VBP	parataxis	O
a	DT	det	O
reduced	VBN	amod	O
ability	NN	dobj	O
to	TO	mark	O
transform	VB	acl	O
B	NN	compound	B-Cell
lymphocytes	NNS	dobj	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
infected	JJ	amod	O
cells	NNS	nsubj	B-Cell
evince	VBP	ROOT	O
a	DT	det	O
marked	JJ	amod	O
upregulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
EBNA	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
.	.	punct	O

Using	VBG	advcl	O
recombinant	JJ	amod	O
viruses	NNS	dobj	O
that	WDT	nsubj	O
lack	VBP	acl:relcl	O
only	RB	advmod	O
one	CD	nummod	O
member	NN	dobj	O
of	IN	case	O
the	DT	det	O
cluster	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
all	DT	det	O
three	CD	nummod	O
BHRF1	NN	compound	B-Gene_or_gene_product
miRNAs	NNS	nsubj	O
contribute	VBP	ccomp	O
to	TO	case	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
transformation	NN	nmod	O
.	.	punct	O

Recombinants	NNS	nsubj	O
that	WDT	nsubj	O
lacked	VBD	relcl	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	dobj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
displayed	VBN	ROOT	O
enhanced	VBN	amod	O
EBNA	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
initiated	VBN	acl	O
at	IN	case	O
the	DT	det	O
Cp	NN	compound	O
and	CC	cc	O
Wp	NN	conj	O
promoters	NNS	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
deletion	NN	nsubj	O
of	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
reduced	VBD	ccomp	O
the	DT	det	O
expression	NN	compound	O
level	NN	dobj	O
of	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
possibly	RB	advmod	O
that	DT	conj	O
of	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
one	CD	nummod	O
miRNA	NN	nmod	O
can	MD	aux	O
potentiate	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
miRNAs	NN	nmod	O
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
cluster	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
phenotypic	JJ	amod	O
traits	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
null	JJ	amod	O
mutant	NN	nmod	O
could	MD	aux	O
result	VB	ROOT	O
partly	RB	advmod	O
from	IN	case	O
reduced	VBN	amod	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
expression	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
using	VBG	advcl	O
an	DT	det	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
double	JJ	amod	O
mutant	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
could	MD	aux	O
directly	RB	advmod	O
assess	VB	ROOT	O
and	CC	cc	O
confirm	VBP	conj	O
the	DT	det	O
contribution	NN	dobj	O
of	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
to	TO	case	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
transformation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
potentiating	NN	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
on	IN	case	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BHRF1	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
synthesis	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
reproduced	VBN	ccomp	O
with	IN	case	O
simple	JJ	amod	O
expression	NN	compound	O
plasmids	NNS	nmod	O
,	,	punct	O
provided	VBD	ccomp	O
that	IN	mark	O
both	DT	det	O
miRNAs	NNS	nsubjpass	O
are	VBP	auxpass	O
processed	VBN	ccomp	O
from	IN	case	O
the	DT	det	O
same	JJ	amod	O
transcript	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
this	DT	det	O
enhancing	JJ	amod	O
effect	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
result	VB	ROOT	O
from	IN	case	O
an	DT	det	O
idiosyncrasy	NN	nmod	O
of	IN	case	O
the	DT	det	O
EBV	NN	compound	B-Organism
genome	NN	nmod	O
but	CC	cc	O
rather	RB	advmod	O
reflects	VBZ	conj	O
a	DT	det	O
general	JJ	amod	O
property	NN	dobj	O
of	IN	case	O
these	DT	det	O
miRNAs	NNS	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
highlights	VBZ	ROOT	O
the	DT	det	O
advantages	NNS	dobj	O
of	IN	mark	O
arranging	VBG	acl	O
the	DT	det	O
BHRF1	NN	compound	B-Gene_or_gene_product
miRNAs	NN	dobj	O
in	IN	case	O
clusters	NNS	nmod	O
:	:	punct	O
it	PRP	nsubj	O
allows	VBZ	parataxis	O
the	DT	det	O
synchronous	JJ	amod	O
and	CC	cc	O
synergistic	JJ	conj	O
expression	NN	dobj	O
of	IN	case	O
genetic	JJ	amod	O
elements	NNS	nmod	O
that	WDT	nsubj	O
cooperate	VBP	acl:relcl	O
to	TO	mark	O
transform	VB	xcomp	O
their	PRP$	nmod:poss	O
target	NN	compound	O
cells	NNS	dobj	B-Cell
.	.	punct	O

Sunitinib	NN	nsubj	B-Simple_chemical
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
pheochromocytoma	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	mark	O
inhibiting	VBG	advcl	O
VEGFR2	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	conj	B-Gene_or_gene_product
/	:	punct	O
S6K1	NN	compound	B-Gene_or_gene_product
pathways	NNS	dobj	O
through	IN	case	O
modulation	NN	nmod	O
of	IN	case	O
Bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
BAD	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Sunitinib	NNP	nsubj	B-Simple_chemical
is	VBZ	ROOT	O
an	DT	det	O
oral	JJ	amod	B-Organism_subdivision
multitargeted	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	attr	O
with	IN	case	O
antiangiogenic	JJ	amod	O
and	CC	cc	O
antitumor	NN	conj	B-Cancer
activity	NN	nmod	O
that	WDT	nsubj	O
mainly	RB	advmod	O
targets	VBZ	acl:relcl	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptors	NNS	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFRs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Very	RB	advmod	O
recently	RB	advmod	O
,	,	punct	O
sunitinib	NN	nsubjpass	B-Simple_chemical
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
active	JJ	amod	O
agent	NN	xcomp	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
pheochromocytomas	NNS	nmod	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
whether	IN	mark	O
sunitinib	NN	nsubj	B-Simple_chemical
acts	VBZ	ccomp	O
only	RB	advmod	O
through	IN	case	O
an	DT	det	O
antiangiogenic	JJ	amod	O
mechanism	NN	nmod	O
or	CC	cc	O
whether	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
also	RB	advmod	O
directly	RB	advmod	O
target	VB	conj	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Sunitinib	NNP	nsubj	B-Simple_chemical
markedly	RB	advmod	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
of	IN	case	O
PC12	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
a	DT	det	O
dose	NN	compound	O
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
manner	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
support	NN	nmod	O
of	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
sunitinib	NN	nsubj	B-Simple_chemical
induced	VBD	ccomp	O
a	DT	det	O
reduction	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
antiapoptotic	JJ	amod	O
molecule	NN	compound	O
Bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
dephosphorylation	NN	conj	O
of	IN	case	O
the	DT	det	O
proapoptotic	JJ	amod	O
molecule	NN	compound	O
BAD	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
BAD	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
these	DT	det	O
apoptotic	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
sunitinib	NN	nsubj	B-Simple_chemical
inhibited	VBD	ccomp	O
phosphorylation	NN	dobj	O
of	IN	case	O
Akt	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
mTOR	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
was	VBD	auxpass	O
followed	VBN	conj	O
by	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
S6K1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	JJ	amod	O
target	NN	acl:relcl	O
of	IN	case	O
mTOR	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Knockdown	NN	nsubj	O
of	IN	case	O
VEGFR	NNP	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
attenuated	VBD	ROOT	O
the	DT	det	O
sunitinib	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
effects	NNS	dobj	O
,	,	punct	O
including	VBG	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
mTOR	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
confirmed	VBD	acl:relcl	O
that	IN	mark	O
these	DT	det	O
effects	NNS	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
addition	NN	ROOT	O
,	,	punct	O
silencing	NN	intj	O
of	IN	case	O
S6K1	NN	compound	B-Gene_or_gene_product
induced	VBD	amod	O
apoptosis	NN	nmod	O
accompanied	VBN	acl	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
BAD	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
,	,	punct	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
with	IN	case	O
sunitinib	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
together	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
sunitinib	NN	nsubj	B-Simple_chemical
initially	RB	advmod	O
exerts	VBZ	ccomp	O
its	PRP$	nmod:poss	O
apoptotic	JJ	amod	O
effect	NN	dobj	O
through	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
,	,	punct	O
when	WRB	advmod	O
followed	VBN	advcl	O
by	IN	case	O
reduction	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
downstream	JJ	amod	O
effectors	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
S6K1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
may	MD	aux	O
lead	VB	acl:relcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
antiapoptotic	JJ	amod	O
molecule	NN	compound	O
Bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
proapoptotic	JJ	amod	O
molecule	NN	compound	O
BAD	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
PC12	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
PC12	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
do	VBP	aux	O
not	RB	neg	O
precisely	RB	advmod	O
reflect	VB	ROOT	O
the	DT	det	O
pathogenesis	NN	dobj	O
of	IN	case	O
malignant	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
confirmed	VBD	ROOT	O
the	DT	det	O
key	JJ	amod	O
findings	NNS	dobj	O
by	IN	mark	O
replicating	VBG	advcl	O
these	DT	det	O
experiments	NNS	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
neuroblastoma	NN	compound	B-Cell
SK	NN	compound	I-Cell
-	HYPH	punct	I-Cell
N	NN	compound	I-Cell
-	HYPH	punct	I-Cell
SH	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Development	NN	ROOT	O
of	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
for	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
with	IN	case	O
endometrial	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Controlling	VBG	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nsubj	O
is	VBZ	cop	O
currently	RB	advmod	O
a	DT	det	O
key	JJ	amod	O
issue	NN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	nmod	O
in	IN	case	O
various	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
endometrial	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymphangiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
implicated	VBN	conj	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
developed	VBD	ROOT	O
an	DT	det	O
animal	NN	compound	O
model	NN	dobj	O
by	IN	mark	O
using	VBG	advcl	O
an	DT	det	O
endometrial	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
,	,	punct	O
HEC1A	NN	appos	B-Cell
.	.	punct	O

This	DT	det	O
cell	NN	compound	B-Cell
line	NN	nsubj	I-Cell
is	VBZ	cop	O
not	RB	neg	O
invasive	JJ	ROOT	O
by	IN	case	O
nature	NN	nmod	O
and	CC	cc	O
secretes	VBZ	conj	O
moderate	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
;	:	punct	O
intrauterine	JJ	compound	B-Immaterial_anatomical_entity
injection	NN	nsubj	O
of	IN	case	O
HEC1A	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
into	IN	case	O
Balb	NN	compound	B-Organism
/	:	punct	I-Organism
c	DT	compound	I-Organism
nude	JJ	compound	I-Organism
mice	NNS	nmod	I-Organism
resulted	VBD	parataxis	O
in	IN	case	O
uterine	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
after	IN	case	O
8	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
analyze	VB	advcl	O
the	DT	det	O
contribution	NN	dobj	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
corresponding	JJ	amod	O
gene	NN	nsubjpass	O
was	VBD	auxpass	O
stably	RB	advmod	O
introduced	VBN	ROOT	O
into	IN	case	O
HEC1A	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
HEC1A	NN	compound	B-Cell
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
then	RB	advmod	O
produced	VBD	acl:relcl	O
more	JJR	amod	O
than	IN	quantmod	O
10	CD	compound	O
times	NNS	nmod	O
the	DT	det	O
amount	NN	dobj	O
of	IN	prep	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	pobj	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
number	NN	nsubj	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
HEC1A	NN	compound	O
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
C	NN	compound	O
cells	NNS	nmod	O
than	IN	case	O
in	IN	case	O
HEC1A	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
3	CD	dep	O
.	.	punct	O
2	CD	dep	O
vs	CC	cc	O
1	CD	conj	O
.	.	punct	O
1	CD	nummod	O
nodes	NNS	ROOT	O
/	:	punct	O
animal	NN	appos	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Augmented	JJ	amod	O
lymphangiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
within	IN	case	O
tumors	NNS	nmod	B-Cancer
when	WRB	advmod	O
HEC1A	NN	compound	O
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
C	NN	compound	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
inoculated	VBN	advcl	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	nsubj	I-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
in	IN	case	O
addition	NN	dep	O
to	TO	mark	O
serving	VBG	advcl	O
as	IN	prep	O
a	DT	det	O
platform	NN	pobj	O
to	TO	aux	O
test	VB	acl	O
the	DT	det	O
efficacy	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
therapeutic	JJ	amod	O
modalities	NNS	nmod	O
against	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17F	NN	compound	I-Gene_or_gene_product
deficiency	NN	nsubj	O
inhibits	VBZ	ROOT	O
small	JJ	amod	B-Organ
intestinal	JJ	amod	I-Organ
tumorigenesis	NN	dobj	O
in	IN	case	O
ApcMin	NN	nmod	B-Gene_or_gene_product
/	,	punct	O
+	CC	cc	O
mice	NNS	conj	O
.	.	punct	O

IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17	CD	nsubj	I-Gene_or_gene_product
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
gut	NN	compound	B-Organism_subdivision
homeostasis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
17F	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
intestinal	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
addressed	VBN	ROOT	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
ablation	NN	nsubj	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17F	NN	nmod	I-Gene_or_gene_product
significantly	RB	advmod	O
inhibits	VBZ	ccomp	O
spontaneous	JJ	amod	O
intestinal	JJ	amod	B-Organ
tumorigenesis	NN	dobj	O
in	IN	case	O
the	DT	det	O
small	JJ	amod	B-Organ
intestine	NN	nmod	I-Organ
of	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Min	NN	dep	O
/	SYM	punct	O
+	CC	cc	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17F	NN	compound	I-Gene_or_gene_product
ablation	NN	nsubj	O
decreased	VBD	ROOT	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1beta	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
Cox	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17	CD	nummod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
17RC	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	conj	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	ccomp	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Min	NN	dep	O
/	SYM	punct	O
+	CC	cc	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

Lack	NN	nsubj	O
of	IN	prep	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17F	NN	pobj	I-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
reverse	VB	ROOT	O
the	DT	det	O
splenomegaly	NN	dobj	B-Pathological_formation
but	CC	cc	O
partially	RB	advmod	O
restored	VBD	conj	O
thymic	JJ	amod	B-Organ
atrophy	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
local	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
17F	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
intestine	NN	nmod	B-Organ
.	.	punct	O

IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17F	NN	compound	I-Gene_or_gene_product
deficient	JJ	amod	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Min	NN	dep	O
/	SYM	punct	O
+	CC	cc	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
showed	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
immune	JJ	amod	B-Cell
cell	NN	compound	I-Cell
infiltration	NN	nmod	O
in	IN	case	O
the	DT	det	O
lamina	NN	compound	B-Tissue
propria	NN	nmod	I-Tissue
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
17A	NN	nmod	I-Gene_or_gene_product
from	IN	case	O
CD4	NN	compound	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
cells	NNS	nmod	O
in	IN	case	O
the	DT	det	O
lamina	NN	compound	B-Tissue
propria	NN	nmod	I-Tissue
remains	VBZ	ROOT	O
unchanged	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17F	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
the	DT	det	O
proinflammatory	JJ	amod	O
and	CC	cc	O
essential	JJ	conj	O
role	NN	dobj	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
17F	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
develop	VB	acl	O
spontaneous	JJ	amod	O
intestinal	JJ	amod	B-Organ
tumorigenesis	NN	dobj	O
in	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Min	NN	dep	O
/	SYM	punct	O
+	CC	cc	O
)	-RRB-	punct	O
mice	NNS	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17A	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Curcumin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
metastatic	JJ	amod	O
progression	NN	dobj	O
of	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	nmod	I-Cell
through	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
urokinase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	compound	I-Gene_or_gene_product
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

Curcumin	NN	nsubjpass	B-Simple_chemical
(	-LRB-	punct	O
1	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
7	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bis	NN	dep	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methoxyphenyl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
heptadiene	NN	compound	I-Simple_chemical
-	,	punct	I-Simple_chemical
3	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dione	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
extracted	VBN	ROOT	O
from	IN	prep	O
the	DT	det	O
plant	NN	compound	O
Curcuma	NNP	compound	B-Organism
longa	NN	pobj	I-Organism
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
recently	RB	advmod	O
reported	VBN	ROOT	O
for	IN	case	O
its	PRP$	nmod:poss	O
anticancer	NN	compound	B-Cancer
effect	NN	nmod	O
on	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
this	DT	det	O
anticancer	NN	compound	B-Cancer
effect	NN	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	advcl	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
on	IN	case	O
human	JJ	amod	B-Organism
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
carcinoma	NN	compound	I-Cell
MCF	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
and	CC	cc	O
examined	VBN	conj	O
for	IN	case	O
cell	NN	compound	B-Cell
viability	NN	nmod	O
by	IN	case	O
MTT	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

The	DT	det	O
cells	NNS	compound	B-Cell
invasion	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
transwell	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

The	DT	det	O
binding	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
to	TO	case	O
DNA	NN	nmod	B-Cellular_component
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
nuclear	JJ	amod	B-Organism_substance
extracts	NNS	nmod	I-Organism_substance
using	VBG	acl	O
Trans	JJ	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
AM	NNP	compound	I-Gene_or_gene_product
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
ELISA	NN	compound	O
kit	NN	dobj	O
.	.	punct	O

Western	NN	compound	O
blot	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
uPA	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
curcumin	NN	compound	B-Simple_chemical
dose	NN	nsubj	O
-	:	punct	O
dependently	RB	advmod	O
inhibited	VBN	ccomp	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
the	DT	det	O
proliferation	NN	dep	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Meanwhile	RB	advmod	O
,	,	punct	O
the	DT	det	O
adhesion	NN	compound	O
and	CC	cc	O
invasion	NN	conj	O
ability	NN	nsubjpass	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
sharply	RB	advmod	O
inhibited	VBN	ROOT	O
when	WRB	advmod	O
treated	VBN	advcl	O
with	IN	case	O
different	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
.	.	punct	O

Curcumin	NN	nsubj	B-Simple_chemical
also	RB	advmod	O
significantly	RB	advmod	O
decreased	VBD	ROOT	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
the	DT	det	O
expression	NN	dep	O
of	IN	case	O
uPA	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	conj	I-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
curcumin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ccomp	O
the	DT	det	O
adhesion	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
through	IN	mark	O
down	RB	advmod	O
-	HYPH	punct	O
regulating	VBG	advcl	O
the	DT	det	O
protein	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
uPA	NN	nmod	B-Gene_or_gene_product
via	IN	case	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
therapeutic	JJ	amod	O
potential	NN	nsubj	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
deserves	VBZ	ROOT	O
further	JJ	amod	O
study	NN	dobj	O
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MYC	NNP	nsubj	I-Gene_or_gene_product
functions	VBZ	ROOT	O
as	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
switch	NN	nmod	O
to	TO	mark	O
alter	VB	advcl	O
the	DT	det	O
response	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
oncostatin	NN	compound	B-Gene_or_gene_product
M	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Cytokines	NNS	nsubj	O
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
creating	VBG	advcl	O
an	DT	det	O
inflammatory	JJ	amod	O
microenvironment	NN	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
now	RB	advmod	O
considered	VBN	acl:relcl	O
a	DT	det	O
hallmark	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Although	IN	mark	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
can	MD	aux	O
exploit	VB	advcl	O
cytokine	NN	compound	O
signaling	NN	dobj	O
to	TO	mark	O
promote	VB	xcomp	O
growth	NN	dobj	O
,	,	punct	O
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
the	DT	det	O
response	NN	nsubj	O
of	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
premalignant	JJ	conj	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
cytokines	NNS	nmod	O
present	JJ	amod	O
in	IN	case	O
a	DT	det	O
developing	VBG	amod	O
tumor	NN	compound	B-Cancer
microenvironment	NN	nmod	O
remains	VBZ	ROOT	O
unclear	JJ	xcomp	O
.	.	punct	O

Oncostatin	NN	compound	B-Gene_or_gene_product
M	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
OSM	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
family	NN	compound	O
cytokine	NN	appos	O
responsible	JJ	amod	O
for	IN	case	O
STAT3	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
development	NN	nmod	O
,	,	punct	O
progression	NN	conj	O
,	,	punct	O
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Paradoxically	RB	advmod	O
,	,	punct	O
OSM	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
also	RB	advmod	O
suppress	VB	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
certain	JJ	amod	B-Cell
tumor	NN	nmod:npmod	I-Cell
-	:	punct	I-Cell
derived	VBN	amod	I-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
.	.	punct	O

Using	VBG	advcl	O
isogenic	JJ	amod	O
human	JJ	amod	B-Organism
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	dobj	I-Cell
(	-LRB-	punct	O
HMEC	NNS	appos	B-Cell
)	-RRB-	punct	O
at	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
OSM	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
suppressed	VBD	ccomp	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MYC	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
engaged	VBD	conj	O
a	DT	det	O
p16	NN	compound	B-Gene_or_gene_product
-	:	punct	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
independent	JJ	amod	O
growth	NN	compound	O
arrest	NN	dobj	O
that	WDT	nsubj	O
required	VBD	acl:relcl	O
STAT3	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
STAT3	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
by	IN	mark	O
expressing	VBG	acl	O
a	DT	det	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
STAT3	NN	compound	B-Gene_or_gene_product
protein	NN	dobj	O
or	CC	cc	O
a	DT	det	O
STAT3	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
shRNA	NN	conj	O
prevented	VBD	ROOT	O
the	DT	det	O
OSM	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
arrest	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MYC	NN	nmod	I-Gene_or_gene_product
from	IN	case	O
a	DT	det	O
constitutive	JJ	amod	O
promoter	NN	nmod	O
also	RB	advmod	O
abrogated	VBD	ROOT	O
the	DT	det	O
STAT3	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
arrest	NN	dobj	O
,	,	punct	O
and	CC	cc	O
strikingly	RB	advmod	O
,	,	punct	O
cooperated	VBD	conj	O
with	IN	case	O
OSM	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
promote	VB	xcomp	O
anchorage	NN	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
(	-LRB-	punct	O
AIG	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
property	NN	appos	O
associated	VBN	acl	O
with	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Cooperative	JJ	amod	O
transformation	NN	nsubj	O
by	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MYC	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
OSM	NN	conj	B-Gene_or_gene_product
required	VBD	ROOT	O
PI3K	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
AKT	NN	conj	B-Gene_or_gene_product
signaling	NN	dobj	O
,	,	punct	O
showing	VBG	advcl	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
multiple	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
downstream	RB	amod	O
of	IN	case	O
the	DT	det	O
OSM	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
in	IN	mark	O
defining	VBG	acl	O
the	DT	det	O
cellular	JJ	amod	B-Cell
response	NN	dobj	O
to	TO	case	O
cytokines	NNS	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
identify	VBP	ROOT	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MYC	NNP	dobj	I-Gene_or_gene_product
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
molecular	JJ	amod	O
switch	NN	nmod	O
that	WDT	nsubj	O
alters	VBZ	acl:relcl	O
the	DT	det	O
cellular	JJ	amod	B-Cell
response	NN	dobj	O
to	TO	case	O
OSM	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
signaling	NN	nmod	O
from	IN	case	O
tumor	NN	nmod	B-Cancer
suppressive	JJ	amod	O
to	TO	case	O
tumor	NN	nmod	B-Cancer
promoting	VBG	acl	O
.	.	punct	O

PTHrP	NN	nsubj	B-Gene_or_gene_product
drives	VBZ	ROOT	O
breast	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
initiation	NN	dobj	O
,	,	punct	O
progression	NN	conj	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
therapy	NN	compound	O
target	NN	conj	O
.	.	punct	O

Parathyroid	JJ	amod	B-Gene_or_gene_product
hormone	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
PTHrP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
secreted	VBN	amod	O
factor	NN	ROOT	O
expressed	VBN	acl	O
in	IN	case	O
almost	RB	advmod	O
all	DT	amod	O
normal	JJ	amod	O
fetal	JJ	amod	B-Tissue
and	CC	cc	O
adult	JJ	conj	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
range	NN	nmod	O
of	IN	case	O
developmental	JJ	amod	O
and	CC	cc	O
physiological	JJ	conj	O
processes	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
serum	NN	compound	B-Organism_substance
calcium	NN	compound	B-Simple_chemical
regulation	NN	nmod	O
.	.	punct	O

PTHrP	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
also	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
skeletal	JJ	amod	B-Organ
metastases	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
dysregulated	VBN	amod	O
expression	NN	nsubj	O
in	IN	case	O
advanced	JJ	amod	O
cancers	NNS	nmod	B-Cancer
causes	VBZ	conj	O
malignancy	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
hypercalcemia	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
PTHrP	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
frequently	RB	advmod	O
expressed	VBN	advcl	O
by	IN	case	O
breast	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
other	JJ	amod	O
solid	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
,	,	punct	O
its	PRP$	nmod:poss	O
effects	NNS	nsubj	O
on	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
are	VBP	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
in	IN	case	O
mice	NNS	nmod	B-Organism
pleiotropic	JJ	amod	O
involvement	NN	dobj	O
of	IN	case	O
PTHrP	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
key	JJ	amod	O
steps	NNS	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
-	:	punct	O
it	PRP	nsubj	O
influences	VBZ	parataxis	O
the	DT	det	O
initiation	NN	dobj	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
primary	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
metastases	NNS	conj	O
.	.	punct	O

Pthrp	JJ	compound	B-Gene_or_gene_product
ablation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Tissue
epithelium	NN	nmod	I-Tissue
of	IN	case	O
the	DT	det	O
PyMT	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
MMTV	NN	compound	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
mouse	NN	compound	B-Organism
model	NN	nmod	O
caused	VBD	ROOT	O
a	DT	det	O
delay	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
initiation	NN	nmod	O
,	,	punct	O
inhibited	VBD	conj	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
reduced	VBN	conj	O
metastasis	NN	dobj	O
to	TO	case	O
distal	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O

Mechanistically	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
reduced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
molecular	JJ	amod	O
markers	NNS	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
(	-LRB-	punct	O
Ki67	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
angiogenesis	NN	conj	O
(	-LRB-	punct	O
factor	NN	compound	B-Gene_or_gene_product
VIII	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
antiapoptotic	JJ	amod	O
factor	NN	compound	O
Bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cycle	NN	compound	O
progression	NN	nsubj	O
regulator	NN	parataxis	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
survival	NN	compound	O
factor	NN	compound	O
AKT1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

PTHrP	NN	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CXCR4	NN	conj	B-Gene_or_gene_product
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
PTHrP	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
specific	JJ	amod	O
neutralizing	VBG	amod	O
antibodies	NNS	nsubj	O
slowed	VBD	ROOT	O
the	DT	det	O
progression	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
xenografts	NNS	advmod	I-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
identify	VBP	ROOT	O
what	WP	dobj	O
we	PRP	nsubj	O
believe	VBP	ccomp	O
to	TO	aux	O
be	VB	cop	O
new	JJ	amod	O
functions	NNS	ccomp	O
for	IN	case	O
PTHrP	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
several	JJ	amod	O
key	JJ	amod	O
steps	NNS	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
PTHrP	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
constitute	VB	ccomp	O
a	DT	det	O
novel	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
.	.	punct	O

Aquaporins	NNS	ROOT	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
identification	NN	dep	O
and	CC	cc	O
involvement	NN	conj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
AND	CC	cc	O
OBJECTIVES	NNS	conj	O
:	:	punct	O
Aquaporins	NNS	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
AQPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
play	VBP	dep	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
water	NN	nmod	B-Simple_chemical
and	CC	cc	O
glycerol	NN	compound	B-Simple_chemical
transport	NN	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
AQPs	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
carcinogenesis	NN	nmod	O
has	VBZ	aux	O
become	VBN	ROOT	O
an	DT	det	O
area	NN	attr	O
of	IN	prep	O
great	JJ	amod	O
interest	NN	pobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
AQPs	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
expression	NN	compound	O
profile	NN	dobj	O
of	IN	case	O
AQPs	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
significance	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
screened	VBD	dep	O
the	DT	det	O
expression	NN	compound	O
profile	NN	dobj	O
of	IN	case	O
AQP0	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
in	IN	case	O
breast	NN	compound	B-Tissue
cancer	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
and	CC	cc	O
corresponding	VBG	conj	O
normal	JJ	amod	B-Tissue
tissues	NNS	dobj	I-Tissue
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
,	,	punct	O
Western	NN	compound	O
blotting	NN	conj	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
AQP1	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
3	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	O
5	CD	appos	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
10	CD	compound	B-Gene_or_gene_product
-	SYM	punct	O
12	CD	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
expressed	VBN	dep	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissues	NNS	conj	I-Tissue
,	,	punct	O
and	CC	cc	O
AQP1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
3	CD	compound	B-Gene_or_gene_product
-	SYM	punct	O
5	CD	conj	B-Gene_or_gene_product
exhibited	VBD	conj	O
differential	JJ	amod	O
expression	NN	dobj	O
.	.	punct	O

AQP1	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
cell	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
and	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	nsubj	O
was	VBD	cop	O
higher	JJR	conj	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
normal	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

AQP4	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
and	CC	cc	O
cytoplasm	NN	conj	B-Organism_substance
and	CC	cc	O
was	VBD	auxpass	O
detected	VBN	conj	O
markedly	RB	advmod	O
stronger	JJR	xcomp	O
in	IN	case	O
normal	JJ	nmod	O
than	IN	case	O
in	IN	case	O
cancer	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

AQP5	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
expressed	VBN	ROOT	O
mainly	RB	advmod	O
in	IN	case	O
cell	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
in	IN	case	O
carcinoma	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
,	,	punct	O
but	CC	cc	O
was	VBD	cop	O
almost	RB	advmod	O
absent	JJ	conj	O
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
AQP5	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
cellular	JJ	amod	B-Cell
differentiation	NN	nmod	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
clinicopathological	JJ	amod	O
staging	NN	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
observations	NNS	nsubj	O
suggested	VBD	dep	O
that	IN	mark	O
several	JJ	amod	O
subtypes	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
AQP	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
play	VBP	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Organism_subdivision
carcinogenesis	NN	nmod	O
.	.	punct	O

Research	NN	ROOT	O
and	CC	cc	O
discovery	NN	conj	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cancer
virus	NN	nmod	O
,	,	punct	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
.	.	punct	O

Human	JJ	amod	B-Organism
T	NN	compound	I-Organism
-	HYPH	punct	I-Organism
cell	NN	compound	I-Organism
lymphoma	NN	compound	I-Organism
virus	NN	nsubj	I-Organism
(	-LRB-	punct	I-Organism
HTLV	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
was	VBD	cop	O
the	DT	det	O
first	JJ	amod	O
human	JJ	amod	B-Organism
retrovirus	NN	nsubjpass	O
to	TO	mark	O
be	VB	auxpass	O
discovered	VBN	ROOT	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
recognized	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
cause	NN	nmod	O
of	IN	case	O
adult	JJ	amod	B-Cancer
T	NN	compound	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
leukemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
ATL	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

In	IN	prep	O
addition	NN	pobj	O
to	TO	prep	O
giving	VBG	pcomp	O
a	DT	det	O
historical	JJ	amod	O
perspective	NN	dobj	O
on	IN	prep	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
and	CC	cc	O
other	JJ	amod	O
retrovirus	NN	compound	O
research	NN	pobj	O
,	,	punct	O
this	DT	det	O
paper	NN	nsubj	O
discusses	VBZ	ROOT	O
the	DT	det	O
origin	NN	dobj	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nmod	I-Organism
;	:	punct	O
the	DT	det	O
modes	NNS	dep	O
of	IN	case	O
transmission	NN	nmod	O
and	CC	cc	O
global	JJ	amod	O
epidemiology	NN	conj	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
infection	NN	nmod	O
;	:	punct	O
the	DT	det	O
genome	NN	dep	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nmod	I-Organism
and	CC	cc	O
the	DT	det	O
mechanism	NN	conj	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	nmod	O
;	:	punct	O
the	DT	det	O
role	NN	dep	O
of	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nmod	I-Organism
in	IN	case	O
other	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
recent	JJ	amod	O
breakthroughs	NNS	conj	O
in	IN	case	O
ATL	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
nuclear	JJ	amod	B-Simple_chemical
factor	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
kappaB	NN	compound	I-Simple_chemical
essential	JJ	amod	I-Simple_chemical
modulator	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
binding	NN	compound	I-Simple_chemical
domain	NN	compound	I-Simple_chemical
peptide	NN	nmod	I-Simple_chemical
suppresses	VBZ	ROOT	O
the	DT	det	O
metastasis	NN	dobj	O
of	IN	case	O
highly	RB	advmod	O
metastatic	JJ	amod	O
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Nuclear	JJ	amod	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
activation	NN	nsubj	O
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
,	,	punct	O
thus	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
many	JJ	amod	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
OSCC	NN	nmod	B-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
little	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
experimental	JJ	amod	O
data	NNS	nsubj	O
are	VBP	cop	O
available	JJ	ROOT	O
about	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
inhibition	NN	nmod	O
on	IN	case	O
OSCC	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

OSCC	NN	compound	B-Cell
sublines	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
established	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
GFP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
parental	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
GSAS	NN	appos	B-Cell
,	,	punct	O
and	CC	cc	O
designated	VBN	conj	O
GSAS	NN	compound	B-Cell
/	:	punct	I-Cell
N3	NN	dobj	I-Cell
and	CC	cc	O
N5	NN	conj	B-Cell
according	VBG	case	O
to	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
passage	NN	compound	O
number	NN	nmod	O
after	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
by	IN	case	O
a	DT	det	O
serial	JJ	amod	O
orthotopic	JJ	amod	O
transplantation	NN	compound	O
model	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
migration	NN	nsubjpass	O
and	CC	cc	O
invasion	NN	conj	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activities	NNS	conj	O
and	CC	cc	O
expression	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
molecules	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
examined	VBN	conj	O
.	.	punct	O

In	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
experiments	NNS	nmod	O
,	,	punct	O
the	DT	det	O
metastasis	NN	nsubjpass	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
engrafted	VBN	amod	O
mice	NNS	nmod	B-Organism
were	VBD	auxpass	O
monitored	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
a	DT	det	O
selective	JJ	amod	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	O
,	,	punct	O
NEMO	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
binding	NN	compound	I-Simple_chemical
domain	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
NBD	NN	compound	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
peptide	NN	appos	I-Simple_chemical
,	,	punct	O
on	IN	case	O
metastasis	NN	nmod	O
in	IN	case	O
GSAS	NN	nmod:npmod	B-Cell
/	:	punct	I-Cell
N5	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
engrafted	VBN	amod	O
mice	NNS	nmod	B-Organism
were	VBD	auxpass	O
assessed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
engrafted	VBN	amod	O
tongue	NN	compound	B-Cancer
tumors	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
immunohistochemically	RB	advmod	O
examined	VBN	conj	O
.	.	punct	O

Highly	RB	advmod	O
metastatic	JJ	amod	O
GSAS	NN	nsubj	B-Cell
/	:	punct	I-Cell
N3	NN	conj	I-Cell
and	CC	cc	O
N5	NN	compound	B-Cell
cells	NNS	conj	I-Cell
showed	VBD	ROOT	O
an	DT	det	O
enhanced	VBN	amod	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activity	NN	dobj	O
,	,	punct	O
thus	RB	advmod	O
contributing	VBG	advcl	O
to	TO	case	O
increased	VBN	amod	O
migration	NN	nmod	O
,	,	punct	O
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	conj	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
parent	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	compound	O
levels	NNS	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
molecules	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
fibronectin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
beta1	NN	compound	B-Gene_or_gene_product
integrin	NN	conj	I-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
,	,	punct	O
-	:	punct	B-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
14	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
highly	RB	advmod	O
metastatic	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
NBD	NN	compound	B-Simple_chemical
peptide	NN	nsubj	I-Simple_chemical
suppressed	VBD	ROOT	O
metastasis	NN	dobj	O
and	CC	cc	O
tongue	NN	conj	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
in	IN	case	O
GSAS	NN	nmod:npmod	B-Cell
/	:	punct	I-Cell
N5	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
inoculated	VBN	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
and	CC	cc	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
the	DT	det	O
downregulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
molecules	NNS	nmod	O
in	IN	case	O
engrafted	VBN	amod	O
tongue	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activation	NN	nmod	O
by	IN	case	O
NBD	NN	compound	B-Simple_chemical
peptide	NN	nmod	I-Simple_chemical
may	MD	aux	O
provide	VB	ccomp	O
an	DT	det	O
effective	JJ	amod	O
approach	NN	dobj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
highly	RB	advmod	O
metastatic	JJ	amod	O
OSCC	NN	nmod	B-Cancer
.	.	punct	O

beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
signaling	NN	nsubj	O
controls	VBZ	ROOT	O
metastasis	NN	dobj	O
in	IN	case	O
Braf	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
activated	VBN	amod	O
Pten	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
melanomas	NNS	nmod	B-Cancer
.	.	punct	O

Malignant	JJ	amod	B-Cancer
melanoma	NN	nsubjpass	I-Cancer
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
frequent	JJ	amod	O
metastasis	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
specific	JJ	amod	O
changes	NNS	nsubjpass	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
this	DT	det	O
process	NN	dobj	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
delineated	VBN	parataxis	O
.	.	punct	O

Although	IN	mark	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
well	RB	advmod	O
known	VBN	advcl	O
that	IN	mark	O
Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
dysregulated	VBN	ccomp	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
,	,	punct	O
the	DT	det	O
functional	JJ	amod	O
implications	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
observation	NN	nmod	O
are	VBP	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

By	IN	mark	O
modulating	VBG	advcl	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
levels	NNS	dobj	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
melanoma	NN	nmod	B-Cancer
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	acl:relcl	O
on	IN	case	O
melanocyte	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
specific	JJ	amod	O
Pten	NNP	compound	B-Gene_or_gene_product
loss	NN	nmod	O
and	CC	cc	O
Braf	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
V600E	NN	appos	B-Amino_acid
)	-RRB-	punct	O
mutation	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
central	JJ	amod	O
mediator	NN	ccomp	O
of	IN	case	O
melanoma	NN	compound	B-Cancer
metastasis	NN	nmod	O
to	TO	case	O
the	DT	det	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
lungs	NNS	conj	B-Organ
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	B-Cancer
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	B-Gene_or_gene_product
/	:	punct	O
Erk	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
PI3K	NN	conj	B-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
.	.	punct	O

Highly	RB	advmod	O
metastatic	JJ	amod	O
tumors	NNS	nsubj	B-Cancer
with	IN	case	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
stabilization	NN	nmod	O
are	VBP	cop	O
very	RB	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
melanomas	NNS	nmod	B-Cancer
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
.	.	punct	O

Mitochondrial	JJ	amod	B-Cellular_component
apoptosis	NN	ROOT	O
and	CC	cc	O
FAK	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
disruption	NN	conj	O
by	IN	case	O
a	DT	det	O
novel	JJ	amod	O
histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	O
,	,	punct	O
HTPB	NN	appos	B-Simple_chemical
,	,	punct	O
in	IN	case	O
antitumor	NN	nmod	B-Cancer
and	CC	cc	O
antimetastatic	JJ	conj	O
mouse	NN	compound	B-Organism
models	NNS	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Compound	NN	compound	O
targeting	NN	compound	O
histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
HDAC	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
represents	VBZ	appos	O
a	DT	det	O
new	JJ	amod	O
era	NN	dobj	O
in	IN	case	O
molecular	JJ	amod	O
cancer	NN	compound	B-Cancer
therapeutics	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
effective	JJ	amod	O
HDAC	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nsubj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
remain	VBP	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
developed	VBN	xcomp	O
.	.	punct	O

METHODOLOGY	NNP	compound	O
/	:	punct	O
PRINCIPAL	NNP	compound	O
FINDINGS	NNP	nsubj	O
:	:	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
HDAC	NN	compound	B-Gene_or_gene_product
inhibitor	NN	dobj	O
,	,	punct	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Hydroxy	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phenylbutyryl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
amino	NN	compound	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
benzamide	RB	appos	I-Simple_chemical
(	-LRB-	punct	O
HTPB	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
chemotherapeutic	JJ	amod	O
drug	NN	nmod	O
for	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
HDAC	NN	compound	B-Gene_or_gene_product
inhibition	NN	nsubjpass	O
of	IN	case	O
HTPB	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
using	VBG	xcomp	O
HDAC	NN	compound	B-Gene_or_gene_product
activity	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

The	DT	det	O
antiproliferative	JJ	amod	O
and	CC	cc	O
anti	JJ	conj	O
-	HYPH	punct	O
migratory	JJ	dep	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
HTPB	NN	nmod	B-Simple_chemical
were	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	conj	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
ladder	NN	conj	O
,	,	punct	O
caspase	NN	compound	B-Gene_or_gene_product
activity	NN	conj	O
,	,	punct	O
Rho	NN	compound	B-Gene_or_gene_product
activity	NN	conj	O
,	,	punct	O
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
polymerization	NN	conj	O
,	,	punct	O
and	CC	cc	O
gelatin	NN	compound	O
-	HYPH	punct	O
zymography	NN	conj	O
for	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinases	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MMPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Mice	NNS	nsubjpass	B-Organism
with	IN	case	O
tumor	NN	compound	B-Cancer
xenograft	NN	nmod	I-Cancer
and	CC	cc	O
experimental	JJ	amod	O
metastasis	NN	compound	O
model	NN	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
effects	NNS	dobj	O
on	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
HTPB	NN	nsubj	B-Simple_chemical
was	VBD	cop	O
a	DT	det	O
pan	NN	compound	O
-	HYPH	punct	O
HDAC	NN	compound	B-Gene_or_gene_product
inhibitor	NN	ccomp	O
in	IN	mark	O
suppressing	VBG	advcl	O
cell	NN	compound	B-Cell
viability	NN	dobj	O
specifically	RB	advmod	O
of	IN	case	O
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	B-Cell
lung	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Upon	IN	case	O
HTPB	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
and	CC	cc	O
subsequently	RB	advmod	O
led	VBN	conj	O
to	TO	case	O
mitochondria	VB	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

HTPB	NN	nsubj	B-Simple_chemical
disrupted	VBD	ROOT	O
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
dynamics	NNS	dobj	O
via	IN	mark	O
downregulating	VBG	advcl	O
RhoA	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
HTPB	NN	nsubj	B-Simple_chemical
inhibited	VBD	ROOT	O
activity	NN	dobj	O
of	IN	case	O
MMP2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP9	NN	conj	B-Gene_or_gene_product
,	,	punct	O
reduced	VBD	amod	O
integrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta1	NN	nmod:npmod	I-Gene_or_gene_product
/	:	punct	O
focal	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
complex	NN	compound	I-Gene_or_gene_product
formation	NN	dobj	O
and	CC	cc	O
decreased	VBD	conj	O
pericellular	JJ	amod	O
poly	NN	amod	O
-	HYPH	punct	O
fibronectin	NN	compound	B-Gene_or_gene_product
assemblies	NNS	dobj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
intraperitoneal	JJ	amod	B-Immaterial_anatomical_entity
injection	NN	nsubj	O
or	CC	cc	O
oral	JJ	amod	B-Organism_subdivision
administration	NN	conj	O
of	IN	case	O
HTPB	NN	nmod	B-Simple_chemical
efficiently	RB	advmod	O
inhibited	VBD	ROOT	O
A549	NN	compound	B-Cancer
xenograft	NN	compound	I-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
without	IN	case	O
side	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

HTPB	NN	nsubj	B-Simple_chemical
delayed	VBD	ROOT	O
lung	NN	compound	B-Organ
metastasis	NN	dobj	O
of	IN	case	O
4T1	NN	compound	O
mouse	NN	compound	B-Organism
breast	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

Acetylation	NN	nsubjpass	O
of	IN	case	O
histone	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
histone	NN	conj	B-Gene_or_gene_product
proteins	NNS	dep	O
,	,	punct	O
induction	NN	nsubjpass	O
of	IN	case	O
apoptotic	JJ	amod	O
-	HYPH	punct	O
related	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
de	FW	amod	O
-	HYPH	punct	O
phosphorylation	NN	conj	O
of	IN	case	O
focal	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
treated	VBN	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
/	:	punct	O
SIGNIFICANCE	NN	appos	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggested	VBD	dep	O
that	IN	mark	O
intrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathway	NN	nsubj	O
may	MD	aux	O
involve	VB	ccomp	O
in	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
growth	NN	compound	O
effects	NNS	nmod	O
of	IN	case	O
HTPB	NN	nmod	B-Simple_chemical
in	IN	case	O
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

HTPB	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
suppresses	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
metastasis	NN	dobj	O
partly	RB	advmod	O
through	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
integrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta1	NN	compound	I-Gene_or_gene_product
/	:	punct	O
FAK	NN	appos	B-Gene_or_gene_product
/	:	punct	O
MMP	NN	compound	B-Gene_or_gene_product
/	:	punct	O
RhoA	NN	compound	B-Gene_or_gene_product
/	:	punct	O
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
pathways	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
provided	VBN	ROOT	O
convincing	VBG	amod	O
preclinical	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
HTPB	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
HDAC	NN	compound	B-Gene_or_gene_product
targeted	JJ	amod	O
inhibitor	NN	ccomp	O
and	CC	cc	O
is	VBZ	cop	O
thus	RB	advmod	O
a	DT	det	O
promising	JJ	amod	O
candidate	NN	conj	O
for	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
chemotherapy	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
bradykinin	NN	conj	B-Gene_or_gene_product
B1	NN	compound	I-Gene_or_gene_product
receptors	NNS	dobj	I-Gene_or_gene_product
in	IN	case	O
precursor	NN	compound	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
of	IN	case	O
gallbladder	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

AIM	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
bradykinin	NN	compound	B-Gene_or_gene_product
B	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
receptors	NNS	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
B	NN	dep	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
R	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
two	CD	nummod	O
pathogenic	JJ	amod	O
models	NNS	nmod	O
of	IN	case	O
gallbladder	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
the	DT	det	O
metaplasia	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
dysplasia	NN	compound	I-Cancer
-	HYPH	punct	I-Cancer
carcinoma	NN	dobj	I-Cancer
and	CC	cc	O
the	DT	det	O
adenoma	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
carcinoma	NN	compound	I-Cancer
pathways	NNS	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Receptor	NN	compound	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
visualized	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
on	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
mum	NN	compound	O
sections	NNS	nmod	B-Multi-tissue_structure
of	IN	case	O
paraffin	NN	npadvmod	O
-	HYPH	punct	O
embedded	JJ	amod	O
tissue	NN	nmod	B-Tissue
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
receptors	NNS	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
biopsy	NN	compound	B-Cancer
samples	NNS	nmod	I-Cancer
from	IN	case	O
92	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
6	CD	nummod	O
males	NNS	dep	O
and	CC	cc	O
86	CD	nummod	O
females	NNS	conj	O
;	:	punct	O
age	NN	nsubj	O
ranging	VBG	acl	O
from	IN	case	O
28	CD	compound	O
to	TO	quantmod	O
86	CD	nummod	O
years	NNS	nmod	O
,	,	punct	O
mean	VBP	parataxis	O
56	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
.	.	punct	O

High	JJ	amod	O
HER2	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
in	IN	case	O
specimens	NNS	nmod	B-Cancer
was	VBD	auxpass	O
additionally	RB	advmod	O
investigated	VBN	ROOT	O
by	IN	case	O
fluorescence	NN	compound	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
.	.	punct	O

Cell	NN	compound	B-Cell
proliferation	NN	nsubjpass	O
in	IN	case	O
each	DT	det	O
sample	NN	nmod	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
Ki	NN	compound	O
-	HYPH	punct	O
67	CD	nummod	O
proliferation	NN	compound	O
marker	NN	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
HER2	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	O
was	VBD	cop	O
absent	JJ	appos	O
in	IN	case	O
adenomas	NNS	nmod	B-Cancer
and	CC	cc	O
in	IN	case	O
normal	JJ	amod	O
gallbladder	NN	compound	B-Tissue
epithelium	NN	conj	I-Tissue
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
intense	JJ	amod	O
staining	NN	nsubj	O
for	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
basolateral	JJ	amod	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
intestinal	JJ	amod	B-Cancer
metaplasia	NN	nmod	I-Cancer
(	-LRB-	punct	O
22	CD	nummod	O
/	SYM	punct	O
24	CD	nummod	O
;	:	punct	O
91	CD	dep	O
.	.	punct	O
7	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
carcinoma	NN	conj	B-Cancer
in	FW	compound	O
situ	FW	advmod	O
(	-LRB-	punct	O
9	CD	nummod	O
/	SYM	punct	O
10	CD	dep	O
;	:	punct	O
90	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
lesions	NNS	attr	B-Pathological_formation
that	WDT	nsubj	O
displayed	VBD	acl:relcl	O
a	DT	det	O
significantly	RB	advmod	O
high	JJ	amod	O
proliferation	NN	compound	O
index	NN	dobj	O
.	.	punct	O

Protein	NN	compound	O
up	RP	prt	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
epithelium	NN	nmod	B-Tissue
with	IN	case	O
metaplasia	NN	nmod	B-Cancer
or	CC	cc	O
carcinoma	NN	conj	B-Cancer
in	FW	compound	O
situ	FW	advmod	O
was	VBD	auxpass	O
not	RB	neg	O
accompanied	VBN	ROOT	O
by	IN	case	O
HER2	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
result	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
invasive	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
(	-LRB-	punct	O
0	CD	nummod	O
/	SYM	punct	O
12	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
B	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
distribution	NN	compound	O
pattern	NN	nsubj	O
mirrored	VBD	ROOT	O
that	DT	dobj	O
of	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
except	IN	mark	O
that	IN	mark	O
B	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
R	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
additionally	RB	advmod	O
observed	VBN	advcl	O
in	IN	case	O
the	DT	det	O
adenomas	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
B	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
R	NN	nsubj	I-Gene_or_gene_product
appeared	VBD	ROOT	O
either	CC	cc:preconj	O
as	IN	case	O
cytoplasmic	JJ	amod	B-Organism_substance
dots	NNS	dobj	O
or	CC	cc	O
labeling	VBG	conj	O
on	IN	case	O
the	DT	det	O
apical	JJ	amod	B-Cellular_component
cell	NN	compound	I-Cellular_component
membrane	NN	nmod	I-Cellular_component
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
composing	VBG	acl	O
the	DT	det	O
epithelia	NN	dobj	B-Tissue
with	IN	case	O
intestinal	JJ	amod	B-Cancer
metaplasia	NN	nmod	I-Cancer
(	-LRB-	punct	O
24	CD	nummod	O
/	SYM	punct	O
24	CD	nummod	O
;	:	punct	O
100	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
carcinoma	NN	conj	B-Cancer
in	FW	compound	I-Cancer
situ	FW	advmod	I-Cancer
(	-LRB-	punct	O
10	CD	nummod	O
/	SYM	punct	O
10	CD	nummod	O
;	:	punct	O
100	CD	nummod	O
%	NN	npadvmod	O
)	-RRB-	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
epithelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
of	IN	case	O
adenomas	NNS	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
both	CC	cc:preconj	O
HER2	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
4	CD	nummod	O
/	SYM	punct	O
12	CD	nummod	O
;	:	punct	O
33	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
B	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
R	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
1	CD	nummod	O
/	SYM	punct	O
12	CD	dep	O
;	:	punct	O
8	CD	dep	O
.	.	punct	O
3	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
a	DT	det	O
low	JJ	amod	O
expression	NN	dobj	O
in	IN	case	O
invasive	JJ	amod	B-Cancer
gallbladder	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
The	DT	det	O
up	RP	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
HER2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
B	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
R	NN	conj	I-Gene_or_gene_product
in	IN	case	O
precursor	NN	compound	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
of	IN	case	O
gallbladder	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
suggests	VBZ	appos	O
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	dobj	O
between	IN	case	O
these	DT	det	O
two	CD	nummod	O
receptors	NNS	nmod	O
that	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
importance	NN	acl:relcl	O
in	IN	case	O
the	DT	det	O
modulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
in	IN	case	O
gallbladder	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
tissues	NNS	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
distribution	NN	nsubjpass	O
of	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
immunohistochemically	RB	advmod	O
in	IN	case	O
fresh	JJ	amod	O
frozen	JJ	amod	O
sections	NNS	nmod	O
of	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
tissues	NNS	nmod	B-Tissue
.	.	punct	O

Immunodetection	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
bFGF	NN	compound	B-Gene_or_gene_product
mouse	NN	compound	B-Organism
monoclonal	JJ	amod	O
antibody	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
found	VBN	acl:relcl	O
to	TO	mark	O
react	VB	xcomp	O
with	IN	case	O
recombinant	JJ	amod	O
human	JJ	amod	B-Organism
bFGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
specifically	RB	advmod	O
neutralize	VB	conj	O
the	DT	det	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
bovine	JJ	amod	B-Organism
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
tissues	NNS	nmod	B-Tissue
was	VBD	auxpass	O
ubiquitously	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
basement	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
of	IN	case	O
all	DT	det	O
size	NN	compound	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
found	VBN	conj	O
in	IN	case	O
epidermal	JJ	amod	B-Cellular_component
or	CC	cc	O
epithelial	JJ	conj	B-Cellular_component
basement	NN	compound	I-Cellular_component
membranes	NNS	nmod	I-Cellular_component
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
tissues	NNS	nmod	B-Tissue
tested	VBN	acl	O
.	.	punct	O

Intensity	NN	nsubj	O
and	CC	cc	O
patterns	NNS	conj	O
of	IN	case	O
localization	NN	nmod	O
in	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
was	VBD	cop	O
consistent	JJ	ROOT	O
in	IN	case	O
various	JJ	amod	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
but	CC	cc	O
varied	VBD	conj	O
among	IN	case	O
different	JJ	amod	O
regions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
bed	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Whereas	IN	mark	O
homogeneous	JJ	amod	O
and	CC	cc	O
intense	JJ	conj	O
immunoreactivity	NN	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	advcl	O
in	IN	case	O
large	JJ	amod	O
and	CC	cc	O
intermediate	JJ	conj	O
size	NN	compound	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
heterogeneity	NN	nsubjpass	O
of	IN	case	O
expression	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
capillaries	NNS	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
intense	JJ	amod	O
immunoreactivity	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
branching	VBG	amod	O
capillaries	NNS	nmod	B-Tissue
.	.	punct	O

Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
staining	NN	nsubj	O
was	VBD	cop	O
heterogeneous	JJ	ROOT	O
and	CC	cc	O
varied	VBD	conj	O
in	IN	case	O
different	JJ	amod	O
regions	NNS	nmod	O
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
fibers	NNS	nmod	I-Cell
,	,	punct	O
smooth	VB	amod	B-Cell
muscle	NN	compound	I-Cell
cells	NNS	appos	I-Cell
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
the	DT	det	O
gut	NN	appos	B-Organism_subdivision
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	B-Multi-tissue_structure
,	,	punct	O
in	IN	case	O
central	JJ	amod	B-Cell
nervous	JJ	amod	I-Cell
system	NN	compound	I-Cell
neurons	NNS	nmod	I-Cell
and	CC	cc	O
cerebellar	JJ	amod	B-Cell
Purkinje	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
colon	NN	conj	B-Multi-tissue_structure
,	,	punct	O
endometrium	NN	conj	B-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
ducts	NNS	conj	I-Multi-tissue_structure
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	B-Organ
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
compartment	NN	nmod	I-Immaterial_anatomical_entity
of	IN	case	O
a	DT	det	O
diverse	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
organs	NNS	nmod	B-Organ
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
function	NN	nsubj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
parenchymal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
determined	VBN	xcomp	O
.	.	punct	O

Overexpression	NN	nsubj	O
confers	VBZ	ROOT	O
an	DT	det	O
oncogenic	JJ	amod	O
potential	NN	dobj	O
upon	IN	case	O
the	DT	det	O
eph	NN	amod	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

The	DT	det	O
eph	NN	amod	B-Gene_or_gene_product
gene	NN	nsubj	O
encodes	VBZ	ROOT	O
a	DT	det	O
putative	JJ	amod	O
receptor	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	dobj	I-Gene_or_gene_product
for	IN	case	O
an	DT	det	O
as	RB	advmod	O
yet	RB	advmod	O
unknown	JJ	amod	O
ligand	NN	nmod	O
.	.	punct	O

Some	DT	det	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	B-Gene_or_gene_product
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
acquire	VBP	ccomp	O
tumorigenic	JJ	amod	O
ability	NN	dobj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
and	CC	cc	O
make	VB	conj	O
colonies	NNS	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
with	IN	case	O
a	DT	det	O
viral	JJ	amod	O
LTR	NN	nmod	O
(	-LRB-	punct	O
Long	JJ	amod	O
Terminal	NNP	compound	O
Repeat	NNP	appos	O
)	-RRB-	punct	O
-	:	punct	O
driven	VBN	amod	O
artificial	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
eph	NN	amod	B-Gene_or_gene_product
gene	NN	nmod	O
to	TO	case	O
a	DT	det	O
high	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinases	NNS	nmod	I-Gene_or_gene_product
to	TO	case	O
cell	NN	compound	B-Cell
transformation	NN	nmod	O
.	.	punct	O

Energy	NN	compound	O
supply	NN	ROOT	O
of	IN	prep	O
the	DT	det	O
mitotic	JJ	amod	O
cell	NN	compound	O
cycle	NN	pobj	O
and	CC	cc	O
the	DT	det	O
Na	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	O
H	NN	conj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
-	HYPH	punct	O
antiport	NN	conj	O
in	IN	prep	O
ascites	VBZ	compound	B-Cancer
tumors	NNS	pobj	I-Cancer
.	.	punct	O

The	DT	det	O
activation	NN	nsubj	O
of	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
transport	NN	conj	O
is	VBZ	cop	O
due	JJ	ROOT	O
to	TO	prep	O
the	DT	det	O
exchange	NN	pobj	O
of	IN	prep	O
protons	NNS	pobj	B-Simple_chemical
formed	VBN	acl	O
via	IN	prep	O
glucose	NN	compound	B-Simple_chemical
conversion	NN	pobj	O
into	IN	prep	O
lactate	NN	pobj	B-Simple_chemical
for	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
,	,	punct	O
i	LS	intj	O
.	.	punct	O
e	LS	ROOT	O
.	.	punct	O
,	,	punct	O
to	TO	prep	O
the	DT	det	O
stimulation	NN	pobj	O
of	IN	prep	O
the	DT	det	O
Na	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	O
H	NN	compound	B-Simple_chemical
+	CC	cc	I-Simple_chemical
-	HYPH	punct	O
antiport	NN	pobj	O
.	.	punct	O

Experimental	JJ	amod	O
results	NNS	nsubj	O
and	CC	cc	O
theoretical	JJ	amod	O
calculations	NNS	conj	O
suggest	VBP	ROOT	O
that	IN	mark	O
in	IN	prep	O
glucose	NN	compound	B-Simple_chemical
-	HYPH	punct	O
containing	VBG	amod	O
medium	NN	nsubj	O
the	DT	det	O
Na	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
transport	NN	conj	O
increases	NNS	ccomp	O
from	IN	prep	O
0	CD	pobj	O
.	.	punct	O
75	CD	compound	O
to	TO	dep	O
1	CD	dobj	O
.	.	punct	O
78	CD	nummod	O
pmol	NN	compound	O
/	:	punct	O
hour	NN	ROOT	O
per	IN	prep	O
cell	NN	pobj	B-Cell
.	.	punct	O

The	DT	det	O
permeability	NN	nsubj	O
of	IN	case	O
plasma	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
for	IN	case	O
K	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
increases	VBZ	ROOT	O
2	CD	dobj	O
.	.	punct	O
75	CD	nummod	O
fold	NN	ROOT	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
passive	JJ	amod	O
flux	NN	nsubj	O
of	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
diminishes	NNS	advcl	O
.	.	punct	O

The	DT	det	O
intensity	NN	nsubj	O
of	IN	case	O
O2	NN	compound	B-Simple_chemical
adsorption	NN	nmod	O
by	IN	mark	O
ascites	VBZ	acl	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
does	VBZ	aux	O
not	RB	neg	O
practically	RB	advmod	O
depend	VB	ROOT	O
on	IN	case	O
the	DT	det	O
monovalent	JJ	amod	O
cation	NN	compound	B-Simple_chemical
concentration	NN	compound	O
gradient	NN	nmod	O
between	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
the	DT	det	O
culture	NN	compound	O
medium	NN	conj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
rate	NN	nsubj	O
of	IN	case	O
glycolysis	NN	nmod	O
decreases	VBZ	parataxis	O
simultaneously	RB	advmod	O
with	IN	case	O
the	DT	det	O
diminution	NN	nmod	O
of	IN	case	O
the	DT	det	O
concentration	NN	compound	O
gradient	NN	nmod	O
.	.	punct	O

In	IN	case	O
synchronized	JJ	amod	O
cultures	NNS	nmod	B-Cell
at	IN	case	O
the	DT	det	O
beginning	NN	nmod	O
of	IN	case	O
the	DT	det	O
mitotic	JJ	amod	O
cycle	NN	nmod	O
,	,	punct	O
the	DT	det	O
bulk	NN	nsubjpass	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
resynthesized	VBD	acl	O
via	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	auxpass	O
utilized	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
synthesis	NN	nmod	O
of	IN	case	O
biopolymers	NNS	nmod	O
,	,	punct	O
whereas	IN	mark	O
that	DT	mark	O
at	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
the	DT	det	O
S	NNP	compound	O
-	HYPH	punct	O
phase	NN	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
G2	NN	compound	O
-	HYPH	punct	O
phase	NN	conj	O
is	VBZ	auxpass	O
utilized	VBN	advcl	O
for	IN	case	O
cation	NN	compound	B-Simple_chemical
transport	NN	nmod	O
across	IN	case	O
plasma	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
.	.	punct	O

From	IN	prep	O
35	CD	quantmod	O
to	TO	quantmod	O
100	CD	nummod	O
%	NN	nsubjpass	O
of	IN	prep	O
the	DT	det	O
whole	JJ	amod	O
amount	NN	pobj	O
of	IN	prep	O
ATP	NN	pobj	B-Simple_chemical
resynthesized	VBD	acl	O
via	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	auxpass	O
utilized	VBN	ROOT	O
for	IN	case	O
transport	NN	compound	O
purposes	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
observed	VBN	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
Na	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	O
K	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
ratio	NN	conj	O
in	IN	case	O
ascites	VBZ	nmod	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
is	VBZ	auxpass	O
connected	VBN	ccomp	O
with	IN	case	O
their	PRP$	nmod:poss	O
enhanced	VBN	amod	O
ability	NN	nmod	O
to	TO	mark	O
synthesize	VB	acl	O
lactic	JJ	amod	B-Simple_chemical
acid	NN	dobj	I-Simple_chemical
.	.	punct	O

Presumably	RB	advmod	O
,	,	punct	O
glycolysis	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
regulatory	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
ratios	NNS	nmod	O
of	IN	case	O
monovalent	JJ	amod	O
cations	NNS	nmod	B-Simple_chemical
.	.	punct	O

[	-LRB-	punct	O
Tumor	NN	compound	B-Cancer
metastasis	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
fibrinolytic	JJ	amod	O
system	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O

Metastatic	JJ	amod	O
spread	NN	nsubj	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
appears	VBZ	ROOT	O
to	TO	mark	O
correlate	VB	xcomp	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
fibrolytic	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
fibrinolysis	NN	nmod	O
in	IN	case	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
decreased	VBD	ROOT	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	conj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
increased	VBD	parataxis	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	O
in	IN	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
.	.	punct	O

Electronmicroscopically	RB	advmod	O
,	,	punct	O
thrombus	NN	compound	B-Pathological_formation
formation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
primary	JJ	amod	O
site	NN	nmod	O
prevented	VBD	ROOT	O
tumor	NN	compound	B-Cancer
invasion	NN	dobj	O
and	CC	cc	O
metastasis	NN	compound	O
formation	NN	conj	O
.	.	punct	O

Plasminogen	NN	compound	B-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
content	NN	nsubjpass	O
of	IN	case	O
excised	VBN	amod	O
tumors	NNS	nmod	B-Cancer
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
SDS	NNP	compound	O
-	HYPH	punct	O
PAGE	NNP	nmod	O
,	,	punct	O
and	CC	cc	O
major	JJ	amod	O
PA	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
urokinase	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
UK	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
type	NN	nmod	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
study	NN	nsubjpass	O
with	IN	case	O
specific	JJ	amod	O
antisera	NNS	nmod	O
was	VBD	auxpass	O
done	VBN	ROOT	O
.	.	punct	O

When	WRB	advmod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
possessed	VBD	ROOT	O
a	DT	det	O
high	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
UK	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
laminin	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagen	NN	conj	I-Gene_or_gene_product
,	,	punct	O
components	NNS	dobj	O
of	IN	case	O
the	DT	det	O
basement	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
,	,	punct	O
disappeared	VBD	conj	O
from	IN	case	O
tumor	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PA	NN	nsubj	B-Gene_or_gene_product
through	IN	case	O
protease	NN	compound	O
cascade	NN	nmod	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Clinically	RB	advmod	O
,	,	punct	O
patients	NNS	nsubj	B-Organism
with	IN	case	O
advanced	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
are	VBP	cop	O
usually	RB	advmod	O
in	IN	case	O
a	DT	det	O
hypercoagulable	JJ	amod	O
state	NN	nsubj	O
with	IN	case	O
elevated	JJ	amod	O
fibrinogen	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
fibrin	NN	compound	B-Gene_or_gene_product
deposition	NN	conj	O
around	IN	case	O
tumor	NN	compound	B-Cancer
mass	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
serious	JJ	amod	O
problem	NN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
chemotherapy	NN	nmod	O
.	.	punct	O

UK	NN	compound	B-Gene_or_gene_product
infusion	NN	nsubj	O
prior	RB	case	O
to	IN	mwe	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	nmod	I-Simple_chemical
increased	VBD	ROOT	O
tissue	NN	compound	B-Tissue
concentration	NN	dobj	O
of	IN	case	O
antitumor	NN	compound	B-Cancer
agent	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
development	NN	nsubjpass	O
of	IN	case	O
consumption	NN	compound	O
coagulopathy	NN	nmod	O
characterized	VBN	acl	O
by	IN	case	O
progression	NN	nmod	O
from	IN	case	O
hypercoagulable	JJ	amod	O
state	NN	nmod	O
to	TO	mark	O
disseminated	VBN	acl	O
intravascular	JJ	amod	B-Immaterial_anatomical_entity
coagulation	NN	dobj	O
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
several	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
glycolysis	NN	compound	O
stimulation	NN	nmod	O
by	IN	case	O
neutral	JJ	amod	O
detergents	NNS	nmod	O
in	IN	case	O
3T3	NN	nmod	B-Cell
and	CC	cc	O
Ehrlich	NN	conj	B-Cell
ascites	VBZ	ROOT	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Glycolysis	NN	nsubj	O
of	IN	case	O
3T3	NN	nmod	B-Cell
and	CC	cc	O
Ehrlich	NN	conj	B-Cell
ascites	VBZ	ROOT	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
was	VBD	auxpass	O
greatly	RB	advmod	O
enhanced	VBN	parataxis	O
by	IN	case	O
Nonidet	NN	compound	B-Simple_chemical
P	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
40	CD	nmod	I-Simple_chemical
or	CC	cc	O
Triton	NNP	conj	B-Simple_chemical
X	NNP	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
100	CD	nmod	I-Simple_chemical
at	IN	case	O
about	RB	advmod	O
100	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
mg	NN	compound	O
cell	NN	compound	B-Cell
protein	NN	nmod	O
.	.	punct	O

This	DT	det	O
enhanced	VBN	amod	O
glycolysis	NN	nsubj	O
was	VBD	cop	O
partly	RB	advmod	O
sensitive	JJ	ROOT	O
to	TO	case	O
rutamycin	NN	nmod	B-Simple_chemical
and	CC	cc	O
partly	RB	advmod	O
sensitive	JJ	conj	O
to	TO	case	O
ouabain	NN	nmod	B-Simple_chemical
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
detergent	NN	nsubj	O
released	VBD	ccomp	O
the	DT	det	O
control	NN	dobj	O
of	IN	case	O
the	DT	det	O
ATPase	NN	nmod	B-Gene_or_gene_product
of	IN	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
and	CC	cc	O
of	IN	case	O
the	DT	det	O
plasma	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
Na	NN	nmod	B-Gene_or_gene_product
+	CC	cc	I-Gene_or_gene_product
K	NN	conj	I-Gene_or_gene_product
+	CC	cc	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ATPase	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Nonidet	NNP	compound	B-Simple_chemical
P	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
40	CD	nsubj	I-Simple_chemical
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
glycolysis	NN	nmod	O
in	IN	case	O
cell	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	I-Organism_substance
free	JJ	amod	I-Organism_substance
extracts	NNS	nmod	I-Organism_substance
from	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	conj	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
to	TO	case	O
which	WDT	nmod	O
soluble	JJ	amod	O
mitochondrial	JJ	amod	B-Cellular_component
ATPase	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
added	VBN	acl:relcl	O
.	.	punct	O

Measuring	VBG	advcl	O
ouabain	NN	compound	B-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	amod	O
22Na	NN	compound	O
efflux	NN	dobj	O
and	CC	cc	O
using	VBG	conj	O
ouabain	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	amod	O
lactate	NN	compound	B-Simple_chemical
production	NN	dobj	O
as	IN	case	O
a	DT	det	O
measure	NN	nmod	O
of	IN	case	O
ATP	NN	compound	B-Simple_chemical
hydrolysis	NN	nmod	O
by	IN	case	O
the	DT	det	O
Na	NN	nmod	B-Gene_or_gene_product
+	CC	cc	I-Gene_or_gene_product
K	NN	conj	I-Gene_or_gene_product
+	CC	cc	I-Gene_or_gene_product
pump	NN	conj	I-Gene_or_gene_product
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
Nonidet	NN	compound	B-Simple_chemical
P	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
40	CD	nsubj	I-Simple_chemical
greatly	RB	advmod	O
decreased	VBD	ccomp	O
the	DT	det	O
efficiency	NN	dobj	O
of	IN	prep	O
the	DT	det	O
Na	NN	pobj	B-Gene_or_gene_product
+	CC	cc	I-Gene_or_gene_product
K	NN	conj	I-Gene_or_gene_product
+	CC	cc	I-Gene_or_gene_product
pump	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Quercetin	NNP	nsubj	B-Simple_chemical
increased	VBD	ROOT	O
the	DT	det	O
efficiency	NN	dobj	O
of	IN	mark	O
pumping	VBG	acl	O
in	IN	case	O
EAT	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
absence	NN	dobj	O
and	CC	cc	O
presence	NN	conj	O
of	IN	prep	O
the	DT	det	O
detergent	NN	pobj	O
.	.	punct	O

Elevated	JJ	amod	O
levels	NNS	ROOT	O
of	IN	case	O
diacylglycerol	NN	nmod	B-Simple_chemical
and	CC	cc	O
decreased	VBD	conj	O
phorbol	NN	compound	B-Simple_chemical
ester	NN	compound	I-Simple_chemical
sensitivity	NN	dobj	O
in	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Diacylglycerol	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
DG	NNS	appos	B-Simple_chemical
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
phospholipid	JJ	amod	B-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
an	DT	det	O
endogenous	JJ	amod	O
activator	NN	conj	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
kinase	NN	nmod	O
is	VBZ	cop	O
one	CD	nummod	O
mechanism	NN	ccomp	O
by	IN	case	O
which	WDT	nmod	O
oncogenes	NNS	nsubj	O
transform	VBP	acl:relcl	O
cells	NNS	dobj	B-Cell
.	.	punct	O

The	DT	det	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
encoded	VBN	amod	O
proteins	NNS	nsubj	O
are	VBP	cop	O
similar	JJ	ROOT	O
to	TO	case	O
regulatory	JJ	amod	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	O
are	VBP	cop	O
candidates	NNS	conj	O
for	IN	case	O
the	DT	det	O
unknown	JJ	amod	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
phosphatidylinositol	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
PI	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
turnover	NN	dobj	O
.	.	punct	O

Differences	NNS	nsubjpass	O
in	IN	case	O
polyphosphoinositide	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
for	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

But	CC	cc	O
because	IN	mark	O
these	DT	det	O
experiments	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	advcl	O
on	IN	case	O
confluent	JJ	amod	O
cultures	NNS	nmod	O
of	IN	case	O
established	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
the	DT	det	O
differences	NNS	nsubj	O
are	VBP	cop	O
difficult	JJ	ROOT	O
to	TO	mark	O
attribute	VB	xcomp	O
to	TO	case	O
ras	NN	compound	B-Gene_or_gene_product
transformation	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
exponentially	RB	advmod	O
growing	VBG	csubj	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
fibroblasts	NNS	dobj	I-Cell
recently	RB	advmod	O
transformed	VBN	acl	O
by	IN	case	O
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	conj	I-Gene_or_gene_product
possess	NN	ccomp	O
elevated	JJ	amod	O
DG	NNS	compound	B-Simple_chemical
concentrations	NNS	dobj	O
without	IN	case	O
significant	JJ	amod	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
other	JJ	amod	O
polyphosphoinositide	NN	compound	B-Simple_chemical
metabolites	NNS	nmod	O
.	.	punct	O

The	DT	det	O
basal	JJ	amod	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
substrate	NN	nmod	O
of	IN	case	O
relative	JJ	amod	O
molecular	JJ	amod	O
mass	NN	nmod	O
(	-LRB-	punct	O
Mr	NN	appos	O
)	-RRB-	punct	O
80	CD	nummod	O
,	,	punct	O
000	CD	dep	O
(	-LRB-	punct	O
80K	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
further	JJ	amod	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
on	IN	case	O
addition	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	B-Simple_chemical
ester	NN	nmod	I-Simple_chemical
was	VBD	auxpass	O
greatly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O

Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
cells	NNS	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
less	JJR	amod	O
binding	NN	dobj	O
of	IN	case	O
phorbol	NN	compound	B-Simple_chemical
ester	NN	nmod	I-Simple_chemical
than	IN	case	O
control	NN	compound	O
cells	NNS	nmod	B-Cell
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
elevation	NN	nsubj	O
of	IN	case	O
DG	NNS	nmod	B-Simple_chemical
causes	VBZ	ccomp	O
partial	JJ	amod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	dobj	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	ROOT	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
receptor	NN	conj	O
.	.	punct	O

Epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
EGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
binds	VBZ	ROOT	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
and	CC	cc	O
specificity	NN	conj	O
to	TO	case	O
a	DT	det	O
single	JJ	amod	O
site	NN	nmod	O
on	IN	case	O
the	DT	det	O
external	JJ	amod	O
domain	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
transmembrane	NN	compound	B-Cellular_component
receptor	NN	nmod	O
to	TO	mark	O
activate	VB	xcomp	O
the	DT	det	O
tyrosine	NN	compound	O
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
cytoplasmic	JJ	amod	B-Organism_substance
portion	NN	nmod	O
.	.	punct	O

The	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
amplified	VBN	ROOT	O
and	CC	cc	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	conj	O
in	IN	case	O
several	JJ	amod	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
increased	VBN	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
constitutive	JJ	amod	O
activity	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
seen	VBN	acl	O
with	IN	case	O
oncogene	NN	compound	O
erb	NN	compound	B-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Synthesis	NN	nsubjpass	O
and	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
the	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
are	VBP	auxpass	O
regulated	VBN	ROOT	O
,	,	punct	O
in	IN	case	O
addition	NN	nmod	O
,	,	punct	O
covalent	JJ	amod	O
modification	NN	nsubj	O
by	IN	case	O
phosphorylation	NN	nmod	O
regulates	VBZ	parataxis	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
receptor	NN	compound	O
protein	NN	nmod	O
.	.	punct	O

Intramolecular	JJ	amod	O
self	NN	compound	O
-	HYPH	punct	O
phosphorylation	NN	nsubj	O
of	IN	case	O
Tyr1173	NN	nmod	B-Amino_acid
removes	VBZ	ROOT	O
a	DT	det	O
competitive	JJ	amod	O
inhibitory	JJ	amod	O
constraint	NN	dobj	O
to	TO	mark	O
enhance	VB	advcl	O
phosphorylation	NN	dobj	O
of	IN	case	O
substrates	NNS	nmod	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
Thr654	NN	nmod	B-Amino_acid
by	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
decreases	VBZ	ROOT	O
high	JJ	amod	O
affinity	NN	compound	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	dobj	O
and	CC	cc	O
EGF	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
stimulated	VBN	amod	O
tyrosine	NN	compound	O
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	conj	O
,	,	punct	O
providing	VBG	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	case	O
heterologous	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
tumor	NN	compound	B-Cancer
promoters	NNS	nmod	O
and	CC	cc	O
other	JJ	amod	O
ligand	NN	compound	B-Gene_or_gene_product
X	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
complexes	NNS	conj	O
.	.	punct	O

Extensive	JJ	amod	O
regulation	NN	nsubj	O
contributes	VBZ	ROOT	O
to	TO	case	O
normal	JJ	amod	O
growth	NN	compound	O
control	NN	nmod	O
,	,	punct	O
abrogation	NN	nsubj	O
of	IN	case	O
regulatory	JJ	amod	O
controls	NNS	nmod	O
contributes	VBZ	parataxis	O
to	TO	case	O
uncontrolled	JJ	amod	O
growth	NN	nmod	O
as	IN	mark	O
seen	VBN	advcl	O
with	IN	case	O
erb	NN	compound	B-Gene_or_gene_product
B	NN	compound	I-Gene_or_gene_product
transformation	NN	nmod	O
and	CC	cc	O
EGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
amplification	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Glutamine	NN	nsubj	B-Amino_acid
and	CC	cc	O
glucose	NN	conj	B-Simple_chemical
as	IN	case	O
energy	NN	compound	O
substrates	NNS	nmod	O
for	IN	prep	O
Ehrlich	NN	pobj	B-Cell
ascites	VBZ	ROOT	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Energy	NN	compound	O
metabolism	NN	nsubj	O
of	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ROOT	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
in	IN	case	O
the	DT	dep	O
presence	NN	dep	O
of	IN	case	O
5	CD	compound	O
mM	NN	amod	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
0	CD	conj	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nsubjpass	B-Amino_acid
was	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
rate	NN	nsubjpass	O
of	IN	case	O
oxygen	NN	compound	B-Simple_chemical
utilization	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nmod	B-Amino_acid
;	:	punct	O
5	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
an	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
respiration	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
glutamine	NN	conj	B-Amino_acid
,	,	punct	O
the	DT	det	O
Crabtree	NNP	compound	O
effect	NN	nsubj	O
decreased	VBD	ROOT	O
.	.	punct	O

In	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
the	DT	det	O
rates	NNS	nsubj	O
of	IN	case	O
oxygen	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
,	,	punct	O
the	DT	det	O
CO2	NN	compound	B-Simple_chemical
evolution	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
changes	NNS	conj	O
in	IN	case	O
the	DT	det	O
redox	NN	compound	O
states	NNS	nmod	O
of	IN	case	O
cytochromes	NNS	nmod	B-Gene_or_gene_product
indicate	VBP	ROOT	O
that	IN	mark	O
glucose	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
preferred	VBN	ccomp	O
by	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	xcomp	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
as	IN	case	O
energy	NN	compound	O
substrate	NN	nmod	O
.	.	punct	O

Glucose	NNP	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
glutamine	NN	compound	B-Amino_acid
utilization	NN	nmod	O
by	IN	case	O
34	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
glutaminolysis	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
glycolysis	NN	dobj	O
.	.	punct	O

Growth	NN	nmod:npmod	O
state	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
transformed	VBN	conj	O
murine	JJ	amod	B-Organism
cells	NNS	nmod	B-Cell
.	.	punct	O

We	PRP	nsubj	O
determined	VBD	ROOT	O
whether	IN	mark	O
growth	NN	compound	O
state	NN	nsubj	O
can	MD	aux	O
influence	VB	ccomp	O
the	DT	det	O
action	NN	dobj	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
by	IN	mark	O
measuring	VBG	advcl	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
growing	VBG	amod	O
and	CC	cc	O
stationary	JJ	conj	O
cultures	NNS	nmod	O
of	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
transformed	VBN	conj	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Two	CD	nummod	O
approaches	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
measure	VB	xcomp	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	dobj	I-Gene_or_gene_product
:	:	punct	O
assay	NN	dep	O
of	IN	case	O
intact	JJ	amod	O
cells	NNS	nmod	B-Cell
for	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
EGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
binding	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
phorbol	NN	compound	B-Simple_chemical
dibutyrate	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
PDBu	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
;	:	punct	O
and	CC	cc	O
assay	NN	conj	O
of	IN	case	O
detergent	JJ	amod	O
extracts	NNS	nmod	B-Organism_substance
for	IN	case	O
total	JJ	amod	O
calcium	NN	nmod	B-Simple_chemical
,	,	punct	O
phospholipid	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
kinase	NN	compound	O
activity	NN	appos	O
.	.	punct	O

In	IN	case	O
extracts	NNS	nmod	B-Organism_substance
of	IN	case	O
growing	VBG	amod	O
and	CC	cc	O
stationary	JJ	conj	O
Swiss	JJ	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
the	DT	det	O
total	JJ	amod	O
amount	NN	nsubj	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
was	VBD	cop	O
similar	JJ	ROOT	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
growth	NN	compound	O
state	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
alter	VB	ccomp	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
enzyme	NN	nmod	O
in	IN	case	O
the	DT	det	O
cell	NN	nmod	B-Cell
.	.	punct	O

The	DT	det	O
short	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
response	NN	nsubj	O
of	IN	case	O
Swiss	JJ	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
an	DT	det	O
activator	NN	nmod	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
also	RB	advmod	O
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
independent	JJ	xcomp	O
of	IN	case	O
growth	NN	compound	O
state	NN	nmod	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
50	CD	nummod	O
%	NN	amod	O
effective	JJ	amod	O
dose	NN	nsubj	O
for	IN	case	O
PDBu	NN	compound	B-Simple_chemical
inhibition	NN	nmod	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
was	VBD	cop	O
approximately	RB	advmod	O
7	CD	nummod	O
nM	NN	advcl	O
for	IN	case	O
both	CC	det	O
growth	NN	compound	O
conditions	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
response	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
to	TO	case	O
long	RB	advmod	O
-	HYPH	punct	O
term	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
PDBu	NN	nmod	B-Simple_chemical
was	VBD	cop	O
significantly	RB	advmod	O
different	JJ	ROOT	O
depending	VBG	case	O
upon	IN	case	O
the	DT	det	O
initial	JJ	amod	O
growth	NN	compound	O
state	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

In	IN	case	O
both	DT	det	O
growth	NN	compound	O
states	NNS	nmod	O
,	,	punct	O
PDBu	NN	nsubj	B-Simple_chemical
caused	VBD	ROOT	O
loss	NN	dobj	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
reflected	VBD	acl:relcl	O
a	DT	det	O
loss	NN	dobj	O
in	IN	case	O
protein	NN	compound	O
mass	NN	nmod	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
immunoblotting	VBG	nmod	O
with	IN	case	O
antiserum	NN	nmod	B-Organism_substance
to	TO	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
maximum	JJ	amod	O
decrease	NN	nsubj	O
approached	VBD	ROOT	O
100	CD	nummod	O
%	NN	dobj	O
in	IN	case	O
stationary	JJ	amod	O
cultures	NNS	nmod	O
versus	CC	cc	O
approximately	RB	advmod	O
75	CD	nummod	O
%	NN	conj	O
in	IN	case	O
growing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
levels	NNS	nsubj	O
in	IN	case	O
several	JJ	amod	O
transformed	VBN	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
were	VBD	cop	O
subject	JJ	ROOT	O
to	TO	mark	O
down	JJ	advcl	O
modulation	NN	dobj	O
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
growth	NN	compound	O
state	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
by	IN	case	O
tumor	NN	compound	B-Cancer
promoters	NNS	nmod	O
following	VBG	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
treatment	NN	nmod	O
of	IN	case	O
Swiss	JJ	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
PDBu	NN	nmod	B-Simple_chemical
also	RB	advmod	O
varied	VBD	ROOT	O
with	IN	case	O
growth	NN	compound	O
state	NN	nmod	O
.	.	punct	O

In	IN	case	O
down	RB	pcomp	O
modulated	VBN	amod	O
growing	VBG	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
PDBu	NNS	nsubj	B-Simple_chemical
caused	VBD	ROOT	O
almost	RB	advmod	O
complete	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
in	IN	case	O
down	RB	amod	O
modulated	VBN	amod	O
stationary	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
minimal	JJ	amod	O
inhibition	NN	nsubjpass	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
by	IN	case	O
PDBu	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
observed	VBN	parataxis	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
prolonged	JJ	amod	O
treatment	NN	nsubj	O
with	IN	case	O
tumor	NN	compound	B-Cancer
promoters	NNS	nmod	O
alters	VBZ	ccomp	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
to	TO	case	O
activators	NNS	nmod	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
growth	NN	nmod:npmod	O
state	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Suppression	NN	ROOT	O
and	CC	cc	O
re	NN	compound	O
-	HYPH	punct	O
expression	NN	conj	O
of	IN	case	O
transformed	VBN	amod	O
phenotype	NN	nmod	O
in	IN	case	O
hybrids	NNS	nmod	O
of	IN	case	O
HA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
early	JJ	amod	O
-	HYPH	punct	O
passage	NN	conj	O
rat	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	conj	I-Cell
.	.	punct	O

Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nsubjpass	I-Cell
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
transformed	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
gene	NN	nmod	O
from	IN	case	O
human	JJ	amod	B-Organism
EJ	NN	compound	B-Cell
bladder	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
fused	VBN	ROOT	O
with	IN	case	O
diploid	JJ	amod	O
embryonic	JJ	amod	O
rat	NN	compound	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Four	CD	nummod	O
selected	VBN	amod	O
cell	NN	compound	B-Cell
hybrids	NNS	nsubj	I-Cell
expressed	VBD	ROOT	O
the	DT	det	O
human	JJ	amod	B-Organism
transforming	NN	amod	O
gene	NN	compound	O
product	NN	compound	O
p21	NN	dobj	B-Gene_or_gene_product
at	IN	case	O
levels	NNS	nmod	O
of	IN	case	O
10	CD	compound	O
to	TO	dep	O
30	CD	nummod	O
%	NN	nmod	O
compared	VBN	case	O
to	TO	case	O
100	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
the	DT	det	O
transformed	VBN	amod	O
parental	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
hybrid	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
exhibited	VBD	ROOT	O
normal	JJ	amod	O
morphology	NN	dobj	O
,	,	punct	O
anchorage	JJ	amod	O
requirement	NN	conj	O
for	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
largely	RB	advmod	O
extended	VBD	conj	O
latency	NN	compound	O
periods	NNS	dobj	O
of	IN	case	O
tumorigenicity	NN	nmod	O
in	IN	case	O
newborn	JJ	amod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

Tumorigenic	JJ	amod	O
hybrid	NN	compound	B-Cell
derivatives	NNS	nsubj	I-Cell
contained	VBD	ROOT	O
lower	JJR	amod	O
numbers	NNS	dobj	O
of	IN	case	O
chromosomes	NNS	nmod	B-Cellular_component
than	IN	case	O
the	DT	det	O
tetraploid	JJ	amod	O
parental	JJ	amod	B-Cell
hybrids	NNS	nmod	I-Cell
.	.	punct	O

DNA	NN	nsubj	B-Cellular_component
of	IN	case	O
the	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
tumorigenic	JJ	amod	O
cell	NN	compound	B-Cell
hybrids	NNS	nmod	I-Cell
transformed	VBD	ROOT	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
anchorage	VB	xcomp	O
-	HYPH	punct	O
independent	JJ	amod	O
proliferation	NN	dobj	O
as	IN	mark	O
expected	VBN	advcl	O
for	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
human	JJ	amod	B-Organism
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
donor	NN	amod	O
DNA	NN	nmod	B-Cellular_component
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
transforming	VBG	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
can	MD	aux	O
be	VB	auxpass	O
suppressed	VBN	ccomp	O
at	IN	case	O
the	DT	det	O
post	JJ	npadvmod	O
-	HYPH	punct	O
translational	JJ	amod	O
level	NN	nmod	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
genome	NN	nmod	B-Cellular_component
from	IN	case	O
diploid	JJ	amod	O
embryonic	JJ	amod	O
rat	NN	compound	B-Organism
fibroblasts	NNS	nmod	B-Cell
but	CC	cc	O
additional	JJ	amod	O
controls	NNS	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
gene	NN	nmod	O
are	VBP	cop	O
likely	JJ	conj	O
to	TO	mark	O
exist	VB	xcomp	O
.	.	punct	O

Normal	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
contain	VBP	ROOT	O
suppressor	NN	compound	O
gene	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
which	WDT	nsubj	O
safeguard	VBP	acl:relcl	O
these	DT	det	O
cells	NNS	dobj	B-Cell
against	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
the	DT	det	O
product	NN	nmod	O
of	IN	case	O
the	DT	det	O
transforming	NN	amod	O
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
oncogene	NN	nmod	O
.	.	punct	O

Mast	NN	compound	B-Cell
cells	NNS	ROOT	I-Cell
and	CC	cc	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

The	DT	det	O
specific	JJ	amod	O
enhancement	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	B-Cancer
proliferation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Mast	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
unique	JJ	xcomp	O
among	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Cell
leukocytes	NNS	nmod	I-Cell
by	IN	case	O
virtue	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
capacity	NN	nmod	O
to	TO	mark	O
enhance	VB	acl	O
profoundly	RB	advmod	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

This	DT	det	O
phenomenon	NN	nsubj	O
occurs	VBZ	ROOT	O
at	IN	case	O
mast	NN	compound	B-Cell
cell	NN	compound	I-Cell
/	:	punct	O
tumor	NN	compound	B-Cancer
ratios	NNS	dobj	O
which	WDT	nsubj	O
reflect	VBP	acl:relcl	O
the	DT	det	O
stoichiometry	NN	dobj	O
of	IN	case	O
host	NN	compound	B-Cell
cell	NN	nmod	I-Cell
/	:	punct	O
tumor	NN	appos	B-Cancer
relationships	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
reside	VB	xcomp	O
in	IN	case	O
mast	NN	compound	B-Cell
cell	NN	compound	I-Cell
granules	NNS	nmod	B-Organism_substance
and	CC	cc	O
was	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
heparin	NN	nmod	B-Simple_chemical
by	IN	case	O
sequential	JJ	amod	O
purification	NN	nmod	O
and	CC	cc	O
enzymatic	JJ	amod	O
degradation	NN	conj	O
.	.	punct	O

This	DT	det	O
cellular	JJ	amod	B-Cell
interaction	NN	nsubj	O
was	VBD	cop	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	ROOT	O
,	,	punct	O
although	IN	mark	O
isolated	VBN	amod	O
granules	NNS	nsubj	B-Organism_substance
could	MD	aux	O
enhance	VB	advcl	O
fibroblast	NN	compound	B-Cell
proliferation	NN	dobj	O
.	.	punct	O

The	DT	det	O
findings	NNS	nsubjpass	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
in	IN	case	O
relation	NN	nmod	O
to	TO	case	O
previous	JJ	amod	O
morphologic	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
reports	NNS	appos	O
of	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
mast	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
cell	NN	npadvmod	I-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
tumor	NN	compound	B-Cancer
cytotoxicity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
role	NN	conj	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
connective	JJ	amod	B-Tissue
tissue	NN	compound	I-Tissue
proliferation	NN	conj	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
the	DT	det	O
putative	JJ	amod	O
transforming	NN	amod	O
protein	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
T	NN	compound	I-Organism
-	HYPH	punct	I-Organism
cell	NN	compound	I-Organism
leukemia	NN	compound	I-Organism
viruses	NNS	nmod	I-Organism
HTLV	NN	dep	I-Organism
-	:	punct	I-Organism
I	CD	dep	I-Organism
and	CC	cc	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
II	CD	conj	I-Organism
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-Organism
T	NN	compound	I-Organism
-	HYPH	punct	I-Organism
cell	NN	compound	I-Organism
leukemia	NN	compound	I-Organism
viruses	NNS	nsubj	I-Organism
HTLV	NN	compound	I-Organism
-	:	punct	I-Organism
I	CD	nsubj	I-Organism
and	CC	cc	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
II	CD	conj	I-Organism
are	VBP	cop	O
unique	JJ	ROOT	O
among	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
retroviruses	NNS	nmod	B-Organism
of	IN	case	O
vertebrates	NNS	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
transform	VB	acl	O
human	JJ	amod	B-Organism
T	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
close	JJ	amod	O
association	NN	conj	O
with	IN	case	O
human	JJ	amod	B-Organism
malignancies	NNS	nmod	B-Cancer
(	-LRB-	punct	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	dep	I-Cancer
and	CC	cc	O
leukemia	NN	conj	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Their	PRP$	poss	O
genomes	NNS	nsubj	O
are	VBP	ROOT	O
relatively	RB	advmod	O
simple	JJ	acomp	O
,	,	punct	O
containing	VBG	advcl	O
the	DT	det	O
genes	NNS	dobj	O
gag	NN	dep	B-Gene_or_gene_product
,	,	punct	O
pol	NN	conj	B-Gene_or_gene_product
,	,	punct	O
env	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
a	DT	det	O
3	CD	nummod	B-Cellular_component
'	``	punct	I-Cellular_component
region	NN	conj	I-Cellular_component
termed	VBN	acl	O
"	``	punct	O
X	NN	oprd	B-Cellular_component
.	.	punct	O
"	''	ROOT	O
This	DT	det	O
3	CD	nummod	B-Cellular_component
'	``	case	I-Cellular_component
region	NN	nsubj	I-Cellular_component
may	MD	aux	O
be	VB	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
potential	NN	nmod	O
of	IN	case	O
the	DT	det	O
viruses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
existence	NN	nsubjpass	O
of	IN	case	O
proteins	NNS	nmod	O
encoded	VBN	acl	O
by	IN	case	O
the	DT	det	O
3	CD	nummod	B-Cellular_component
'	``	punct	I-Cellular_component
region	NN	nmod	I-Cellular_component
has	VBZ	aux	O
been	VBN	auxpass	O
postulated	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
open	JJ	amod	O
reading	NN	compound	O
frames	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
this	DT	det	O
region	NN	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
a	DT	det	O
gene	NN	dobj	O
encoding	VBG	acl	O
a	DT	det	O
protein	NN	dobj	O
of	IN	case	O
40	CD	nummod	O
kilodaltons	NNS	nmod	O
in	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
I	CD	intj	I-Organism
and	CC	cc	O
37	CD	nummod	O
kilodaltons	NNS	nmod	O
in	IN	case	O
HTLV	NN	compound	B-Organism
-	:	punct	I-Organism
II	CD	nmod	I-Organism
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
these	DT	det	O
proteins	NNS	nsubjpass	O
be	VBP	auxpass	O
called	VBN	ccomp	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
p40xI	NN	oprd	B-Gene_or_gene_product
and	CC	cc	O
p37xII	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Cells	NNS	ROOT	B-Cell
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	compound	I-Organism
release	NN	compound	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	dobj	I-Gene_or_gene_product
.	.	punct	O

Chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	ROOT	I-Cell
and	CC	cc	O
hamster	NN	compound	B-Cell
BHK	NN	compound	I-Cell
cells	NNS	conj	I-Cell
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
RSV	NN	appos	B-Organism
)	-RRB-	punct	O
release	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
media	NNS	compound	O
growth	NN	compound	O
factors	NNS	nmod	O
which	WDT	nsubj	O
enhance	VBP	acl:relcl	O
markedly	RB	advmod	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
colony	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
gelified	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
at	IN	case	O
the	DT	det	O
restrictive	JJ	amod	O
temperature	NN	nmod	O
(	-LRB-	punct	O
41	CD	nummod	O
degrees	NNS	compound	O
5	CD	nummod	O
C	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
of	IN	case	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
CEF	NN	appos	B-Cell
)	-RRB-	punct	O
infected	VBN	acl	O
by	IN	case	O
RSV	NN	compound	B-Organism
mutants	NNS	nmod	O
with	IN	case	O
a	DT	det	O
ts	IN	compound	O
mutation	NN	nmod	O
of	IN	case	O
the	DT	det	O
src	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

This	DT	det	O
action	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
with	IN	case	O
uninfected	JJ	amod	O
CEF	NN	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
appears	VBZ	conj	O
to	TO	mark	O
require	VB	xcomp	O
some	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	O
src	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
the	DT	det	O
target	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
enhancing	VBG	amod	O
factors	NNS	nsubj	O
are	VBP	cop	O
proteins	NNS	ROOT	O
related	JJ	amod	O
to	TO	case	O
the	DT	det	O
family	NN	nmod	O
of	IN	case	O
the	DT	det	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TGFs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
by	IN	case	O
their	PRP$	nmod:poss	O
molecular	JJ	amod	O
weight	NN	nmod	O
(	-LRB-	punct	O
about	RB	advmod	O
20	CD	nummod	O
kd	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
their	PRP$	nmod:poss	O
heat	NN	compound	O
and	CC	cc	O
acid	NN	conj	O
resistance	NN	conj	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
sensitivity	NN	conj	O
to	TO	case	O
dithiothreitol	NN	nmod	B-Simple_chemical
.	.	punct	O

They	PRP	nsubj	O
do	VBP	aux	O
not	RB	neg	O
compete	VB	ROOT	O
with	IN	case	O
125I	NN	nummod	O
EGF	NN	nmod	B-Gene_or_gene_product
for	IN	case	O
binding	NN	nmod	O
on	IN	case	O
the	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
of	IN	case	O
the	DT	det	O
membrane	NN	nmod	B-Cellular_component
of	IN	case	O
A431	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

As	IN	mark	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nsubj	I-Cell
are	VBP	cop	O
devoid	JJ	advcl	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
their	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
potentiated	VBN	ROOT	O
by	IN	case	O
EGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
genetics	NNS	ROOT	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
SV	NNP	nmod	B-Organism
40	CD	nummod	I-Organism
.	.	punct	O

Experiments	NNS	nsubj	O
using	VBG	acl	O
the	DT	det	O
tsA	NN	compound	B-Gene_or_gene_product
58	CD	nummod	I-Gene_or_gene_product
allele	NN	dobj	O
of	IN	case	O
the	DT	det	O
SV	NNP	compound	B-Organism
40	CD	compound	I-Organism
-	HYPH	punct	O
A	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
SV	NN	compound	B-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
strictly	RB	advmod	O
required	VBN	ccomp	O
both	CC	cc:preconj	O
for	IN	case	O
immortalization	NN	nmod	O
and	CC	cc	O
induction	NN	compound	O
anchorage	VBP	compound	O
independence	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
immortalized	VBN	amod	O
phenotype	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
an	DT	det	O
extra	JJ	amod	B-Immaterial_anatomical_entity
cellular	JJ	amod	I-Immaterial_anatomical_entity
factor	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
synthesis	NN	nsubjpass	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
the	DT	det	O
excretion	NN	conj	O
of	IN	case	O
this	DT	det	O
factor	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
medium	NN	nmod	O
is	VBZ	auxpass	O
controlled	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
A	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
events	NNS	ROOT	O
leading	VBG	acl	O
to	TO	case	O
enhanced	VBN	amod	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
in	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod:npmod	I-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Transformation	NN	nsubj	O
by	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
dramatic	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
rate	NN	nmod	O
at	IN	case	O
which	WDT	nmod	O
the	DT	det	O
transformed	VBN	amod	O
cells	NNS	nsubj	B-Cell
transport	VBP	acl:relcl	O
glucose	NN	dobj	B-Simple_chemical
across	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
transport	NN	compound	O
rate	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
consequence	NN	ROOT	O
of	IN	case	O
an	DT	det	O
increased	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
transporters	NNS	nmod	O
in	IN	case	O
the	DT	det	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Utilizing	VBG	advcl	O
antibody	NN	dobj	O
raised	VBN	acl	O
against	IN	case	O
the	DT	det	O
purified	VBN	amod	O
human	JJ	amod	B-Organism
erythrocyte	NN	compound	B-Cell
glucose	NN	compound	B-Simple_chemical
transporter	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	dobj	O
as	IN	case	O
a	DT	det	O
membrane	NN	compound	B-Cellular_component
glycoprotein	NN	nmod	O
with	IN	case	O
a	DT	det	O
monomer	NN	compound	O
Mr	NN	nmod	O
of	IN	case	O
approximately	RB	advmod	O
41	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
rate	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
pp60src	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
transforming	VBG	amod	O
protein	NN	appos	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

This	DT	det	O
protein	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
protein	NN	compound	O
kinase	NN	xcomp	O
that	WDT	nsubj	O
phosphorylates	VBZ	acl:relcl	O
on	IN	case	O
tyrosine	NN	compound	O
residues	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
a	DT	det	O
major	JJ	amod	O
cellular	JJ	amod	B-Cell
protein	NN	nmod	O
of	IN	case	O
Mr	NN	nmod	O
36	CD	nummod	O
,	,	punct	O
000	CD	appos	O
in	IN	case	O
cells	NNS	nmod	B-Cell
infected	VBN	acl	O
with	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
partially	RB	advmod	O
transforming	VBG	amod	O
mutants	NNS	nmod	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
these	DT	det	O
mutants	NNS	nmod	O
(	-LRB-	punct	O
CU2	NN	appos	B-Organism
)	-RRB-	punct	O
increases	VBZ	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
only	RB	advmod	O
slightly	RB	advmod	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
render	VB	conj	O
the	DT	det	O
infected	JJ	amod	O
cells	NNS	nsubj	B-Cell
fully	RB	advmod	O
anchorage	VBP	ccomp	O
independent	JJ	xcomp	O
or	CC	cc	O
tumorigenic	JJ	conj	O
(	-LRB-	punct	O
although	IN	mark	O
other	JJ	amod	O
transformation	NN	compound	O
parameters	NNS	nsubjpass	O
are	VBP	auxpass	O
fully	RB	advmod	O
induced	VBN	advcl	O
)	-RRB-	punct	O
.	.	punct	O

Cells	NNS	nsubj	B-Cell
infected	VBN	acl	O
with	IN	case	O
this	DT	det	O
mutant	JJ	amod	O
display	VBP	ROOT	O
a	DT	det	O
36	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
-	HYPH	punct	O
dalton	NN	dep	O
protein	NN	dobj	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
phosphorylated	VBN	acl:relcl	O
to	TO	case	O
a	DT	det	O
considerably	RB	advmod	O
lesser	JJR	amod	O
extent	NN	nmod	O
than	IN	case	O
cells	NNS	nmod	B-Cell
infected	VBN	acl	O
with	IN	case	O
wild	JJ	amod	B-Organism
-	HYPH	punct	I-Organism
type	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Analyses	NNS	nsubj	O
of	IN	prep	O
this	DT	det	O
sort	NN	pobj	O
may	MD	aux	O
help	VB	ROOT	O
to	TO	mark	O
identify	VB	xcomp	O
the	DT	det	O
cellular	JJ	amod	B-Cell
targets	NNS	dobj	O
of	IN	case	O
pp60src	NN	nmod	B-Gene_or_gene_product
whose	WP$	nmod:poss	O
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
necessary	JJ	acl:relcl	O
for	IN	case	O
the	DT	det	O
increased	VBN	amod	O
glucose	NN	compound	B-Simple_chemical
transport	NN	compound	O
rate	NN	nmod	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
methylation	NN	ROOT	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	compound	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
established	VBN	acl	O
from	IN	case	O
two	CD	nummod	O
individuals	NNS	nmod	O
with	IN	case	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
acute	JJ	amod	I-Cancer
lymphocytic	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
T	NN	compound	B-Cancer
-	:	punct	I-Cancer
ALL	NN	appos	I-Cancer
)	-RRB-	punct	O
express	VBP	ROOT	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	compound	I-Gene_or_gene_product
antigens	NNS	dobj	I-Gene_or_gene_product
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
isogenic	JJ	amod	O
T	NN	compound	B-Cell
-	:	punct	I-Cell
cells	NNS	nsubj	I-Cell
do	VBP	parataxis	O
not	RB	neg	O
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
detectable	JJ	amod	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

All	DT	nsubjpass	O
of	IN	case	O
the	DT	det	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
sequences	NNS	nmod	O
detected	VBN	acl	O
by	IN	case	O
a	DT	det	O
cloned	VBN	amod	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
cDNA	NN	compound	O
probe	NN	nmod	O
are	VBP	auxpass	O
contained	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
BglII	NN	compound	B-Gene_or_gene_product
fragment	NN	nmod	O
which	WDT	nsubj	O
varies	VBZ	acl:relcl	O
slightly	RB	advmod	O
in	IN	case	O
size	NN	nmod	O
(	-LRB-	punct	O
4	CD	nummod	O
.	.	punct	O
0	CD	compound	O
to	TO	dep	O
4	CD	dep	O
.	.	punct	O
8	CD	nummod	O
kilobases	NNS	appos	O
)	-RRB-	punct	O
from	IN	case	O
one	CD	nummod	O
individual	NN	nmod	O
to	IN	prep	O
another	DT	pobj	O
.	.	punct	O

In	IN	case	O
DNA	NN	nmod	B-Cellular_component
from	IN	case	O
the	DT	det	O
T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cells	NNS	nmod	I-Cell
not	RB	neg	O
expressing	VBG	acl	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	dobj	O
,	,	punct	O
all	DT	nsubj	O
of	IN	case	O
the	DT	det	O
potential	JJ	amod	O
HpaII	NN	compound	B-Gene_or_gene_product
sites	NNS	nmod	O
within	IN	case	O
the	DT	det	O
BglII	NN	compound	B-Gene_or_gene_product
fragment	NN	nmod	B-Cellular_component
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
methylated	VBN	xcomp	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
at	IN	case	O
least	JJS	mwe	O
some	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
were	VBD	auxpass	O
not	RB	neg	O
methylated	VBN	ROOT	O
in	IN	case	O
DNA	NN	nmod	B-Cellular_component
from	IN	case	O
the	DT	det	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cells	NNS	nmod	I-Cell
expressing	VBG	acl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
T	NN	compound	B-Cell
-	:	punct	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	nmod	I-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
surface	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
the	DT	det	O
appearance	NN	dobj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
partial	JJ	amod	O
demethylation	NN	conj	O
of	IN	case	O
the	DT	det	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
sequences	NNS	nmod	O
.	.	punct	O

T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
established	VBN	acl	O
from	IN	case	O
human	JJ	amod	B-Organism
T	NN	compound	I-Organism
-	HYPH	punct	I-Organism
cell	NN	compound	I-Organism
leukemia	NN	compound	I-Organism
-	:	punct	I-Organism
lymphoma	NN	compound	I-Organism
virus	NN	compound	I-Organism
associated	JJ	amod	O
T	NN	compound	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
cell	NN	compound	I-Pathological_formation
neoplasias	NNS	nmod	I-Pathological_formation
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
acute	JJ	amod	I-Cell
lymphocytic	JJ	amod	I-Cell
leukemia	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
expressed	VBD	ROOT	O
both	CC	cc:preconj	O
DR	NN	compound	B-Gene_or_gene_product
antigens	NNS	dobj	I-Gene_or_gene_product
and	CC	cc	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
mRNA	NN	conj	O
;	:	punct	O
the	DT	det	O
HpaII	NN	compound	B-Gene_or_gene_product
sites	NNS	nsubj	O
within	IN	case	O
the	DT	det	O
BglII	NN	compound	B-Gene_or_gene_product
fragment	NN	nmod	B-Cellular_component
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
DNA	NN	nmod	B-Cellular_component
of	IN	case	O
these	DT	det	O
human	JJ	amod	B-Organism
T	NN	compound	I-Organism
-	HYPH	punct	I-Organism
cell	NN	compound	I-Organism
leukemia	NN	compound	I-Organism
-	:	punct	I-Organism
lymphoma	NN	compound	I-Organism
virus	NN	compound	I-Organism
-	HYPH	punct	O
positive	JJ	amod	O
T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
were	VBD	cop	O
in	IN	case	O
all	DT	det	O
cases	NNS	parataxis	O
at	IN	advmod	O
least	JJS	mwe	O
partially	RB	advmod	O
unmethylated	JJ	advcl	O
.	.	punct	O

Uncultured	JJ	amod	O
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
T	NN	compound	I-Cell
-	:	punct	I-Cell
cells	NNS	nsubj	I-Cell
from	IN	case	O
human	JJ	amod	B-Organism
T	NN	compound	I-Organism
-	HYPH	punct	I-Organism
cell	NN	compound	I-Organism
leukemia	NN	compound	I-Organism
-	:	punct	I-Organism
lymphoma	NN	nmod:npmod	I-Organism
virus	NN	nmod:npmod	I-Organism
-	:	punct	O
infected	JJ	amod	O
individuals	NNS	nmod	B-Organism
expressed	VBD	ROOT	O
DR	NN	compound	B-Gene_or_gene_product
antigens	NNS	dobj	I-Gene_or_gene_product
at	IN	case	O
a	DT	det	O
low	JJ	amod	O
level	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
locus	NN	nsubjpass	B-Cellular_component
was	VBD	auxpass	O
partially	RB	advmod	O
unmethylated	JJ	conj	O
.	.	punct	O

After	IN	case	O
48	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
DR	NN	compound	B-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
substantially	RB	advmod	O
increased	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
significant	JJ	amod	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	conj	O
in	IN	case	O
methylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
DR	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
locus	NN	nmod	B-Cellular_component
or	CC	cc	O
in	IN	case	O
the	DT	det	O
amount	NN	conj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
which	WDT	nsubj	O
was	VBD	cop	O
present	JJ	acl:relcl	O
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
DR	NN	compound	B-Gene_or_gene_product
antigens	NNS	nmod	I-Gene_or_gene_product
also	RB	advmod	O
can	MD	aux	O
be	VB	auxpass	O
modulated	VBN	ccomp	O
post	JJ	dobj	O
-	HYPH	punct	O
transcriptionally	RB	advmod	O
.	.	punct	O

Hemostasis	NN	ROOT	O
and	CC	cc	O
mechanism	NN	conj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
selective	JJ	amod	O
antimetastatic	JJ	amod	O
drugs	NNS	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	dobj	I-Cancer
.	.	punct	O

The	DT	det	O
selective	JJ	amod	O
antimetastatic	JJ	amod	O
agents	NNS	nsubjpass	O
p	NN	dep	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethyl	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
triazeno	NN	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
benzoic	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
potassium	NN	compound	I-Simple_chemical
salt	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
DM	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
COOK	NN	conj	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
5	CD	conj	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethyl	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
triazeno	NN	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
imidazole	NN	amod	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carboxamide	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
DTIC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
1	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
di	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dioxopiperazin	NN	amod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
yl	NN	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
propane	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
ICRF	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
159	CD	appos	I-Simple_chemical
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
markedly	RB	advmod	O
depress	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
spontaneous	JJ	amod	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
s	NNS	dobj	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O

Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	ROOT	I-Cancer
,	,	punct	O
with	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
unrelated	JJ	acl	O
to	TO	case	O
cytotoxicity	NN	nmod	O
for	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
on	IN	case	O
hemostasis	NN	nmod	O
of	IN	case	O
DM	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
COOK	NN	nmod	I-Simple_chemical
,	,	punct	O
DTIC	NN	conj	B-Simple_chemical
and	CC	cc	O
ICRF	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
159	CD	conj	I-Simple_chemical
have	VBP	aux	O
thus	RB	advmod	O
been	VBN	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
a	DT	det	O
purely	RB	advmod	O
cytotoxic	JJ	amod	O
agent	NN	nmod	O
,	,	punct	O
cyclophosphamide	NN	appos	B-Simple_chemical
,	,	punct	O
in	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
i	LS	dobj	O
.	.	punct	O
m	LS	ROOT	O
.	.	punct	O

Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	ROOT	I-Cancer
.	.	punct	O

The	DT	det	O
parameters	NNS	nsubj	O
considered	VBN	acl	O
are	VBP	ROOT	O
the	DT	det	O
number	NN	attr	O
of	IN	prep	O
platelets	NNS	pobj	B-Cell
and	CC	cc	O
their	PRP$	poss	O
aggregability	NN	conj	O
,	,	punct	O
prothrombin	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
partial	JJ	amod	O
thromboplastin	NN	conj	B-Gene_or_gene_product
times	NNS	conj	O
,	,	punct	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
concentration	NN	conj	O
and	CC	cc	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
procoagulant	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

Slight	JJ	amod	O
variations	NNS	nsubjpass	O
are	VBP	auxpass	O
caused	VBN	ROOT	O
by	IN	case	O
drug	NN	compound	O
treatment	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
mice	NNS	nmod	B-Organism
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
untreated	JJ	amod	O
tumor	NN	npadvmod	B-Cancer
-	:	punct	O
bearing	VBG	amod	O
controls	NNS	nmod	B-Organism
;	:	punct	O
the	DT	det	O
pattern	NN	nsubj	O
of	IN	case	O
effects	NNS	nmod	O
of	IN	case	O
the	DT	det	O
selective	JJ	amod	O
antimetastatic	JJ	amod	O
agents	NNS	nmod	O
does	VBZ	aux	O
not	RB	neg	O
differ	VB	parataxis	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
reference	NN	compound	O
cytotoxic	JJ	amod	O
compound	NN	nmod	O
used	VBN	acl	O
,	,	punct	O
cyclophosphamide	NN	appos	B-Simple_chemical
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
thus	RB	advmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
on	IN	case	O
hemostasis	NN	nmod	O
of	IN	case	O
the	DT	det	O
drugs	NNS	nmod	O
examined	VBN	acl	O
can	MD	aux	O
contribute	VB	ccomp	O
only	RB	advmod	O
marginally	RB	advmod	O
to	TO	case	O
their	PRP$	nmod:poss	O
antimetastatic	JJ	amod	O
action	NN	nmod	O
,	,	punct	O
since	IN	case	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	nsubjpass	O
on	IN	case	O
hemostasis	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
to	TO	mark	O
significantly	RB	advmod	O
affect	VB	xcomp	O
metastasis	NN	compound	O
formation	NN	dobj	O
.	.	punct	O

Metabolic	JJ	amod	O
alterations	NNS	ROOT	O
in	IN	case	O
a	DT	det	O
noncachectic	JJ	amod	O
animal	NN	compound	O
tumor	NN	compound	B-Cancer
system	NN	nmod	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
energy	NN	nsubj	O
expended	VBN	ROOT	O
by	IN	agent	O
the	DT	det	O
host	NN	pobj	O
to	TO	aux	O
synthesize	VB	xcomp	O
substrate	NN	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
utilized	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
cause	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Organism_substance
cachexia	NN	nmod	I-Organism_substance
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
glucose	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
alanine	NN	compound	B-Amino_acid
kinetics	NNS	conj	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
tracer	NN	compound	O
methodology	NN	nmod	O
in	IN	case	O
a	DT	det	O
sarcoma	NN	npadvmod	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
rat	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
mercaptopicolinic	JJ	amod	I-Simple_chemical
acid	NN	nmod	I-Simple_chemical
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
gluconeogenesis	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
examined	VBN	ROOT	O
on	IN	case	O
this	DT	det	O
model	NN	nmod	O
.	.	punct	O

Both	DT	cc:preconj	O
tumor	NN	compound	B-Cancer
-	:	punct	O
bearing	NN	nsubj	O
(	-LRB-	punct	O
TB	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
nontumor	NN	compound	B-Cancer
bearing	NN	compound	O
(	-LRB-	punct	O
NTB	NN	appos	O
)	-RRB-	punct	O
animals	NNS	conj	B-Organism
were	VBD	aux	O
gaining	VBG	ROOT	O
weight	NN	dobj	O
prior	RB	case	O
to	TO	prep	O
study	VB	nmod	O
and	CC	cc	O
the	DT	det	O
tumors	NNS	conj	B-Cancer
were	VBD	cop	O
relatively	RB	advmod	O
small	JJ	conj	O
.	.	punct	O

The	DT	det	O
TB	NN	compound	O
animals	NNS	nsubj	B-Organism
had	VBD	ROOT	O
significantly	RB	advmod	O
lower	JJR	amod	O
plasma	NN	compound	B-Organism_substance
glucose	NN	dobj	B-Simple_chemical
and	CC	cc	O
higher	JJR	amod	O
blood	NN	compound	B-Organism_substance
lactic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
levels	NNS	conj	O
compared	VBN	case	O
with	IN	case	O
NTB	NN	compound	O
animals	NNS	nmod	O
.	.	punct	O

After	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
gluconeogenesis	NN	nmod	O
,	,	punct	O
the	DT	det	O
plasma	NN	compound	B-Organism_substance
glucose	NN	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
and	CC	cc	O
the	DT	det	O
blood	NN	compound	B-Organism_substance
lactate	NN	nsubj	B-Simple_chemical
increased	VBD	conj	O
significantly	RB	advmod	O
more	JJR	advmod	O
in	IN	case	O
TB	NN	nmod	O
than	IN	case	O
NTB	NN	compound	O
animals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
glucose	NN	compound	B-Simple_chemical
turnover	NN	compound	O
rate	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
greater	JJR	ROOT	O
in	IN	case	O
TB	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
NTB	NN	compound	O
animals	NNS	advcl	O
,	,	punct	O
as	IN	mark	O
was	VBD	cop	O
the	DT	det	O
rate	NN	advcl	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
recycling	NN	nmod	O
and	CC	cc	O
the	DT	det	O
rate	NN	conj	O
of	IN	case	O
gluconeogenesis	NN	nmod	O
(	-LRB-	punct	O
alanine	NN	nsubj	B-Amino_acid
leads	VBZ	parataxis	O
to	TO	case	O
glucose	NN	nmod	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
both	CC	det	O
energy	NN	compound	O
demanding	VBG	amod	O
processes	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
animal	NN	nsubj	O
,	,	punct	O
even	RB	advmod	O
prior	RB	amod	O
to	TO	case	O
significant	JJ	amod	O
cachexia	NN	nmod	B-Cancer
,	,	punct	O
has	VBZ	ccomp	O
an	DT	det	O
excess	JJ	amod	O
demand	NN	dobj	O
for	IN	prep	O
energy	NN	pobj	O
,	,	punct	O
the	DT	det	O
provision	NN	dobj	O
of	IN	prep	O
which	WDT	pobj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
significant	JJ	amod	O
factor	NN	nmod	O
in	IN	case	O
malignant	JJ	amod	B-Cancer
cachexia	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
cultured	VBN	amod	O
myoblast	NN	compound	B-Cell
differentiation	NN	nmod	O
by	IN	case	O
the	DT	det	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
occurs	VBZ	ROOT	O
after	IN	case	O
myogenin	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
Rb	NN	conj	B-Gene_or_gene_product
up	RB	cc	O
-	HYPH	punct	O
regulation	NN	conj	O
and	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
exerted	VBN	conj	O
by	IN	case	O
transformation	NN	compound	O
-	HYPH	punct	O
competent	JJ	amod	O
cytoplasmic	JJ	amod	B-Organism_substance
mutants	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
SVLT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
interferes	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
C2	NN	compound	B-Cell
myoblasts	NNS	nmod	I-Cell
.	.	punct	O

SVLT	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubjpass	O
,	,	punct	O
defective	JJ	amod	O
either	CC	advmod	O
in	IN	case	O
the	DT	det	O
Rb	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
site	NN	nmod	O
,	,	punct	O
near	IN	case	O
the	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
end	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
region	NN	nmod	O
that	WDT	nsubj	O
affects	VBZ	acl:relcl	O
binding	VBG	dobj	O
to	TO	case	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
transport	NN	compound	O
signal	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
employed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
the	DT	det	O
interference	NN	nsubj	O
was	VBD	cop	O
especially	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
these	DT	det	O
functional	JJ	amod	O
domains	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
(	-LRB-	punct	O
wt	NN	appos	O
)	-RRB-	punct	O
SVLT	NN	nsubj	B-Gene_or_gene_product
strongly	RB	advmod	O
inhibited	VBD	ccomp	O
the	DT	det	O
terminal	JJ	amod	O
differentiation	NN	dobj	O
of	IN	case	O
mouse	NN	compound	B-Organism
C2	NN	compound	B-Cell
myoblasts	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
this	DT	det	O
arrest	NN	nsubj	O
occurred	VBD	conj	O
only	RB	advmod	O
after	IN	case	O
the	DT	det	O
synthesis	NN	nmod	O
of	IN	case	O
myogenin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
initial	JJ	amod	O
step	NN	appos	O
in	IN	case	O
biochemical	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Neither	CC	preconj	O
the	DT	det	O
synthesis	NN	nsubj	O
nor	CC	cc	O
some	DT	det	O
basic	JJ	amod	O
activities	NNS	conj	O
of	IN	case	O
MyoD	NN	nmod	B-Gene_or_gene_product
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
affected	VBN	xcomp	O
by	IN	case	O
wt	JJ	case	O
SVLT	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
these	DT	det	O
transformants	NNS	nmod	B-Cell
,	,	punct	O
mitogen	NN	compound	O
depletion	NN	nsubj	O
elicited	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
Rb	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
comparable	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
normal	JJ	amod	O
C2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
;	:	punct	O
wt	IN	case	O
SVLT	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
promoted	VBD	parataxis	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
a	DT	det	O
large	JJ	amod	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
induced	VBN	amod	O
Rb	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Mutations	NNS	nsubj	O
affecting	VBG	acl	O
nuclear	JJ	amod	B-Cellular_component
transport	NN	dobj	O
were	VBD	cop	O
far	RB	advmod	O
more	RBR	advmod	O
critical	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
ability	NN	nmod	O
to	TO	mark	O
interfere	VB	acl	O
with	IN	case	O
myogenic	JJ	amod	O
differentiation	NN	nmod	O
than	IN	mark	O
were	VBD	cop	O
those	DT	advcl	O
affecting	VBG	acl	O
the	DT	det	O
transforming	VBG	amod	O
potential	NN	dobj	O
;	:	punct	O
cytoplasmic	JJ	amod	B-Organism_substance
SVLT	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
fully	RB	advmod	O
compatible	JJ	parataxis	O
with	IN	case	O
the	DT	det	O
terminal	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
C2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
despite	IN	mark	O
enabling	VBG	advcl	O
them	PRP	dobj	O
to	TO	aux	O
grow	VB	xcomp	O
in	IN	prep	O
semisolid	JJ	amod	O
medium	NN	pobj	O
,	,	punct	O
thus	RB	advmod	O
showing	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
myogenesis	NN	npadvmod	O
-	HYPH	punct	O
inhibiting	VBG	amod	O
property	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
dissociated	VBN	ccomp	O
from	IN	case	O
transforming	VBG	amod	O
competence	NN	nmod	O
.	.	punct	O

The	DT	det	O
remaining	VBG	amod	O
SVLT	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubj	O
presented	VBD	ROOT	O
different	JJ	amod	O
degrees	NNS	dobj	O
of	IN	case	O
ability	NN	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
differentiation	NN	dobj	O
(	-LRB-	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
tissue	NN	nmod:npmod	B-Tissue
-	HYPH	punct	O
specific	JJ	amod	O
markers	NNS	nmod	O
in	IN	case	O
transformants	NNS	nmod	B-Cell
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
inhibiting	VBG	amod	O
mutants	NNS	nsubj	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
Rb	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
site	NN	compound	O
mutant	NN	nmod	O
,	,	punct	O
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
promote	VB	xcomp	O
a	DT	det	O
higher	JJR	amod	O
state	NN	dobj	O
of	IN	case	O
Rb	NN	compound	B-Gene_or_gene_product
phosphorylation	NN	nmod	O
than	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
either	CC	cc:preconj	O
normal	JJ	amod	O
cells	NNS	nmod	B-Cell
or	CC	cc	O
cytoplasmic	JJ	amod	B-Organism_substance
-	HYPH	punct	O
SVLT	NNP	compound	B-Gene_or_gene_product
transformants	NNS	conj	B-Cell
.	.	punct	O

A	DT	det	O
transcript	NN	ROOT	O
from	IN	case	O
the	DT	det	O
long	JJ	amod	B-Cellular_component
terminal	JJ	amod	I-Cellular_component
repeats	NNS	nmod	I-Cellular_component
of	IN	case	O
a	DT	det	O
murine	JJ	amod	B-Organism
retrovirus	NN	nmod	I-Organism
associated	VBN	acl	O
with	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
genes	NNS	nmod	O
.	.	punct	O

Infection	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-Organism
or	CC	cc	O
murine	JJ	conj	B-Organism
cells	NNS	nmod	B-Cell
with	IN	case	O
murine	JJ	amod	B-Organism
leukemia	NN	compound	I-Organism
viruses	NNS	nmod	I-Organism
rapidly	RB	advmod	O
increases	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubj	O
belong	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-Gene_or_gene_product
superfamily	NN	nmod	O
and	CC	cc	O
are	VBP	auxpass	O
involved	VBN	conj	O
in	IN	case	O
T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
lymphocyte	NN	compound	I-Cell
activation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
class	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
major	JJ	amod	I-Gene_or_gene_product
histocompatibility	NN	compound	I-Gene_or_gene_product
complex	NN	compound	I-Gene_or_gene_product
antigens	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
recently	RB	advmod	O
that	IN	mark	O
the	DT	det	O
long	JJ	amod	B-Cellular_component
terminal	JJ	amod	I-Cellular_component
repeat	NN	nsubj	I-Cellular_component
(	-LRB-	punct	O
LTR	NN	appos	B-Cellular_component
)	-RRB-	punct	O
of	IN	case	O
Moloney	NN	compound	B-Organism
murine	JJ	amod	I-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod	I-Organism
encodes	VBZ	ccomp	O
a	DT	det	O
trans	JJ	amod	O
activator	NN	dobj	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
transcription	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
class	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
major	JJ	amod	I-Gene_or_gene_product
histocompatibility	NN	compound	I-Gene_or_gene_product
complex	NN	compound	I-Gene_or_gene_product
genes	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
cytokine	NN	compound	B-Gene_or_gene_product
genes	NNS	conj	O
.	.	punct	O

The	DT	det	O
portion	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-Cellular_component
responsible	JJ	amod	O
for	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
was	VBD	auxpass	O
mapped	VBN	ROOT	O
by	IN	case	O
deletions	NNS	nmod	O
to	TO	mark	O
lie	VB	acl	O
within	IN	case	O
the	DT	det	O
U3	NN	compound	O
region	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
a	DT	det	O
transcript	NN	nsubjpass	O
is	VBZ	auxpass	O
initiated	VBN	ccomp	O
within	IN	case	O
the	DT	det	O
U3	NN	compound	O
region	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
its	PRP$	nmod:poss	O
presence	NN	nsubj	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
trans	JJ	amod	O
-	HYPH	punct	O
activating	VBG	amod	O
activity	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
LTR	NN	compound	B-Cellular_component
region	NN	nmod	O
reveals	VBZ	ROOT	O
a	DT	det	O
potential	JJ	amod	O
internal	JJ	amod	O
promoter	NN	compound	O
element	NN	dobj	O
for	IN	case	O
RNA	NN	compound	B-Gene_or_gene_product
polymerase	NN	compound	I-Gene_or_gene_product
III	CD	nummod	I-Gene_or_gene_product
transcription	NN	nmod	O
within	IN	case	O
the	DT	det	O
U3	NN	compound	O
region	NN	nmod	O
.	.	punct	O

Studies	NNS	nsubj	O
with	IN	case	O
polymerase	NN	compound	O
inhibitors	NNS	nmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
LTR	NN	compound	B-Cellular_component
transcript	NN	nsubj	O
,	,	punct	O
designated	VBN	acl	O
let	NN	ccomp	B-Gene_or_gene_product
(	-LRB-	punct	O
LTR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
encoded	VBN	amod	I-Gene_or_gene_product
trans	JJ	amod	I-Gene_or_gene_product
activator	NN	dobj	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
product	NN	ccomp	O
of	IN	case	O
RNA	NN	compound	B-Gene_or_gene_product
polymerase	NN	nmod	I-Gene_or_gene_product
III	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubjpass	O
whereby	WRB	advmod	O
RNA	NN	compound	B-Organism
leukemia	NN	compound	I-Organism
viruses	NNS	nsubj	I-Organism
cause	VBP	acl:relcl	O
lymphoid	JJ	amod	B-Cancer
neoplasia	NN	dobj	I-Cancer
after	IN	case	O
a	DT	det	O
long	JJ	amod	O
latent	JJ	amod	O
period	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
extensively	RB	advmod	O
studied	VBN	ROOT	O
but	CC	cc	O
are	VBP	auxpass	O
only	RB	advmod	O
partially	RB	advmod	O
understood	VBN	conj	O
.	.	punct	O

The	DT	det	O
region	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-Cellular_component
identified	VBN	acl	O
here	RB	advmod	O
as	IN	mark	O
being	VBG	cop	O
important	JJ	advcl	O
in	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
critical	JJ	amod	O
determinant	NN	xcomp	O
of	IN	case	O
the	DT	det	O
leukemogenicity	NN	nmod	O
and	CC	cc	O
latency	NN	conj	O
of	IN	case	O
Moloney	NN	compound	B-Organism
murine	JJ	amod	I-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
retrovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
potentially	RB	advmod	O
contributing	VBG	acl	O
to	TO	case	O
leukemogenesis	NN	nmod	O
.	.	punct	O

Anti	NNP	nmod:npmod	O
-	HYPH	punct	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	dep	I-Gene_or_gene_product
antibodies	NNS	nsubj	O
inhibit	VBP	ROOT	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
tumorigenicity	NN	dobj	O
and	CC	cc	O
increase	NN	conj	O
mouse	NN	compound	B-Organism
spleen	NN	compound	B-Cell
natural	JJ	amod	I-Cell
killer	NN	compound	I-Cell
cell	NN	compound	I-Cell
activity	NN	dobj	O
.	.	punct	O

Implications	NNS	ROOT	O
for	IN	case	O
a	DT	det	O
possible	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
/	:	punct	O
host	NN	compound	B-Cell
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
interactions	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
effects	NNS	nsubj	O
on	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
stroma	NN	compound	B-Tissue
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
immune	JJ	amod	O
function	NN	conj	O
suggest	VBP	ROOT	O
its	PRP$	nmod:poss	O
possible	JJ	amod	O
involvement	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

This	DT	det	O
hypothesis	NN	nsubjpass	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
2G7	NN	compound	O
IgG2b	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
neutralizes	VBZ	acl:relcl	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
-	:	punct	B-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
-	HYPH	punct	B-Gene_or_gene_product
beta	NN	conj	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
231	CD	nummod	I-Cell
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	conj	I-Cell
.	.	punct	O

Inoculation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
in	IN	case	O
athymic	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
decreases	VBZ	ROOT	O
mouse	NN	compound	B-Organism
spleen	NN	compound	B-Cell
natural	JJ	amod	I-Cell
killer	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
NK	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
cell	NN	compound	I-Cell
activity	NN	dobj	O
.	.	punct	O

Intraperitoneal	JJ	amod	B-Immaterial_anatomical_entity
injections	NNS	nsubj	O
of	IN	case	O
2G7	NN	nmod	O
starting	VBG	case	O
1	CD	nummod	O
d	NN	nmod	O
after	IN	case	O
intraperitoneal	JJ	amod	B-Immaterial_anatomical_entity
inoculation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
suppressed	VBD	ROOT	O
intraabdominal	JJ	amod	B-Cancer
tumor	NN	dobj	I-Cancer
and	CC	cc	O
lung	NN	compound	B-Organ
metastases	NNS	conj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
nonneutralizing	VBG	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nsubj	I-Gene_or_gene_product
12H5	NN	nummod	O
IgG2a	NN	nummod	O
had	VBD	advcl	O
no	DT	neg	O
effect	NN	dobj	O
.	.	punct	O

2G7	NN	nsubj	O
transiently	RB	advmod	O
inhibited	VBD	ROOT	O
growth	NN	dobj	O
of	IN	case	O
established	JJ	amod	O
MDA	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
231	CD	nummod	I-Cancer
subcutaneous	JJ	amod	I-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Histologically	RB	advmod	O
,	,	punct	O
both	CC	det	O
2G7	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
and	CC	cc	O
control	JJ	conj	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
identical	JJ	ROOT	O
.	.	punct	O

Intraperitoneal	JJ	amod	B-Immaterial_anatomical_entity
administration	NN	nsubj	O
of	IN	case	O
2G7	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
mouse	NN	compound	B-Organism
spleen	NN	compound	B-Cell
NK	NN	compound	I-Cell
cell	NN	compound	I-Cell
activity	NN	nmod	O
.	.	punct	O

2G7	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
MDA	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
231	CD	nummod	I-Cancer
primary	JJ	amod	I-Cancer
tumor	NN	dobj	I-Cancer
or	CC	cc	O
metastases	NNS	conj	B-Cancer
formation	NN	conj	O
,	,	punct	O
nor	CC	cc	O
did	VBD	aux	O
it	PRP	nsubj	O
stimulate	VB	conj	O
NK	NN	nmod:npmod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
cytotoxicity	NN	dobj	O
in	IN	case	O
beige	NN	compound	B-Organism
NK	NN	nmod:npmod	I-Organism
-	HYPH	punct	I-Organism
deficient	JJ	amod	I-Organism
nude	JJ	compound	I-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
free	JJ	amod	O
conditioned	JJ	amod	O
medium	NN	nsubj	O
from	IN	case	O
MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
231	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
inhibited	VBD	ROOT	O
the	DT	det	O
NK	NN	compound	B-Cell
cell	NN	compound	I-Cell
activity	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
blood	NN	compound	B-Cell
lymphocytes	NNS	nmod	I-Cell
.	.	punct	O

This	DT	det	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
neutralizing	VBG	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
2G7	NN	compound	O
antibody	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
a	DT	det	O
nonspecific	JJ	amod	O
IgG2	NN	conj	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
possible	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
mammary	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
by	IN	mark	O
suppressing	VBG	advcl	O
host	NN	compound	O
immune	JJ	amod	O
surveillance	NN	dobj	O
.	.	punct	O

Enhanced	VBN	amod	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	ROOT	O
of	IN	case	O
a	DT	det	O
Stat3	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
related	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	B-Cell
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	B-Gene_or_gene_product
oncoprotein	NN	nmod	O
.	.	punct	O

Cytokines	NNS	nsubj	B-Gene_or_gene_product
and	CC	cc	O
growth	NN	compound	B-Gene_or_gene_product
factors	NNS	conj	I-Gene_or_gene_product
induce	VBP	ROOT	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	B-Gene_or_gene_product
transducers	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activators	NNS	compound	I-Gene_or_gene_product
of	IN	amod	I-Gene_or_gene_product
transcription	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
STATs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Cells	NNS	nsubjpass	B-Cell
stably	RB	advmod	O
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	B-Gene_or_gene_product
oncogene	NN	compound	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
STAT	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Assays	NNS	nsubj	O
of	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	nmod	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
binding	NN	compound	O
specificity	NN	conj	O
,	,	punct	O
and	CC	cc	O
antigenicity	NN	conj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	B-Gene_or_gene_product
or	CC	cc	O
a	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
STAT	NN	compound	B-Gene_or_gene_product
family	NN	compound	O
member	NN	conj	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	B-Gene_or_gene_product
oncoprotein	NN	nmod	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	nmod	O
of	IN	case	O
Stat3	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
Src	NN	compound	B-Gene_or_gene_product
transformation	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Src	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
activate	VB	ccomp	O
STAT	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathways	NNS	dobj	O
and	CC	cc	O
raise	VBP	conj	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
Stat3	NN	nsubj	B-Gene_or_gene_product
contributes	VBZ	ccomp	O
to	TO	case	O
oncogenesis	NN	nmod	O
by	IN	case	O
Src	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Bicistronic	JJ	amod	O
retroviral	JJ	amod	O
vector	NN	nsubj	O
reveals	VBZ	ROOT	O
capacity	NN	dobj	O
of	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
induce	VB	acl	O
erythroleukemia	NN	dobj	B-Cancer
and	CC	cc	O
to	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
operate	VB	conj	O
with	IN	prep	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	VBN	pobj	I-Gene_or_gene_product
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
v	NN	det	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nsubj	I-Gene_or_gene_product
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
avian	JJ	amod	O
erythroid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
the	DT	det	O
combined	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	conj	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
two	CD	nummod	O
oncogenes	NNS	nsubjpass	O
were	VBD	auxpass	O
engineered	VBN	ROOT	O
into	IN	case	O
a	DT	det	O
retrovirus	NN	compound	O
bicistronic	JJ	amod	O
vector	NN	nmod	O
with	IN	case	O
an	DT	det	O
internal	JJ	amod	O
ribosomal	JJ	amod	B-Cellular_component
entry	NN	compound	O
site	NN	nmod	O
(	-LRB-	punct	O
IRES	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
into	IN	case	O
a	DT	det	O
vector	NN	conj	O
with	IN	case	O
a	DT	det	O
splice	NN	compound	O
acceptor	NN	nmod	O
(	-LRB-	punct	O
SPL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	nsubj	O
allowed	VBD	ROOT	O
coexpression	NN	dobj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
proteins	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
comparison	NN	conj	O
with	IN	case	O
the	DT	det	O
same	JJ	amod	O
vector	NN	nmod	O
containing	VBG	acl	O
either	CC	cc:preconj	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	dobj	I-Gene_or_gene_product
or	CC	cc	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	VBN	conj	I-Gene_or_gene_product
only	RB	advmod	O
.	.	punct	O

Both	CC	cc:preconj	O
the	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
IRES	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
/	:	punct	O
myb	VBD	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	compound	O
constructs	NNS	conj	O
transformed	VBD	ROOT	O
erythroid	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
after	IN	case	O
infection	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
or	CC	cc	O
blastoderm	JJ	amod	B-Cell
cultures	NNS	conj	I-Cell
.	.	punct	O

The	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
/	:	punct	O
myb	VBD	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	nsubj	O
exhibited	VBD	ROOT	O
a	DT	det	O
5	CD	nummod	O
-	SYM	punct	O
10	CD	nummod	O
-	HYPH	punct	O
fold	VB	dep	O
higher	JJR	amod	O
transformed	VBN	amod	O
colony	NN	dep	O
forming	NN	acl	O
efficiency	NN	dobj	O
than	IN	case	O
the	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	nmod	O
in	IN	case	O
the	DT	det	O
blastoderm	JJ	amod	B-Cell
assay	NN	dobj	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
injected	VBN	advcl	O
into	IN	case	O
chicken	NN	compound	B-Organism
embryos	NNS	nmod	B-Developing_anatomical_structure
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
helper	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
both	DT	det	O
viruses	NNS	nsubj	O
induced	VBD	ROOT	O
an	DT	det	O
erythroleukemia	NN	dobj	B-Cancer
in	IN	case	O
about	RB	advmod	O
half	NN	nmod	O
of	IN	prep	O
the	DT	det	O
animals	NNS	pobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
no	DT	neg	O
leukemia	NN	nsubjpass	B-Cancer
was	VBD	auxpass	O
observed	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
myb	JJ	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
with	IN	case	O
spliced	VBN	amod	O
vectors	NNS	nmod	O
containing	VBG	acl	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	dobj	I-Gene_or_gene_product
alone	RB	advmod	O
or	CC	cc	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	conj	I-Gene_or_gene_product
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
nor	CC	cc	O
with	IN	case	O
erbA	NN	compound	B-Gene_or_gene_product
IRES	NN	conj	O
and	CC	cc	O
erbA	NN	conj	B-Gene_or_gene_product
/	:	punct	O
myb	VBD	compound	B-Gene_or_gene_product
IRES	NN	compound	O
viruses	NNS	conj	O
produced	VBN	acl	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
helper	NN	compound	O
virus	NN	nmod	O
.	.	punct	O

The	DT	det	O
average	JJ	amod	O
latency	NN	nsubj	O
of	IN	case	O
leukemia	NN	compound	B-Cancer
induction	NN	nmod	O
was	VBD	cop	O
shorter	JJR	ROOT	O
for	IN	case	O
the	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
/	:	punct	O
myb	VBD	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
3	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
weeks	NNS	appos	O
)	-RRB-	punct	O
than	IN	case	O
for	IN	case	O
the	DT	det	O
erbA	NN	compound	B-Gene_or_gene_product
IRES	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
5	CD	nummod	O
weeks	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
for	IN	case	O
both	DT	det	O
viruses	NNS	nmod	O
the	DT	det	O
leukemic	JJ	amod	B-Cell
blasts	NNS	nsubj	I-Cell
retained	VBD	ROOT	O
full	JJ	amod	O
factor	NN	compound	O
dependence	NN	dobj	O
for	IN	case	O
growth	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
inducing	VBG	advcl	O
an	DT	det	O
erythroleukemia	NN	dobj	B-Cancer
when	WRB	advmod	O
expressed	VBN	advcl	O
by	IN	case	O
a	DT	det	O
high	JJ	amod	O
titer	NN	compound	O
bicistronic	JJ	amod	O
retrovirus	NN	nmod	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
virus	NN	compound	O
spreading	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
its	PRP$	nmod:poss	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
transforming	VBG	amod	O
potential	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
enhanced	VBN	conj	O
by	IN	case	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	VBN	nmod	I-Gene_or_gene_product
.	.	punct	O

VEGF165	NN	nsubj	B-Gene_or_gene_product
expressed	VBN	acl	O
by	IN	case	O
a	DT	det	O
replication	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
recombinant	JJ	amod	O
adenovirus	NN	compound	B-Organism
vector	NN	nmod	O
induces	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	ROOT	O
the	DT	det	O
concept	NN	dobj	O
that	IN	mark	O
localized	JJ	amod	O
delivery	NN	nsubj	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
via	IN	case	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
transfer	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
ischemic	JJ	amod	O
disorders	NNS	nmod	O
,	,	punct	O
the	DT	det	O
replication	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
adenovirus	NN	compound	B-Organism
(	-LRB-	punct	O
Ad	NN	appos	B-Organism
)	-RRB-	punct	O
vector	NN	compound	O
AdCMV	NN	dobj	O
.	.	punct	O
VEGF165	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
where	WRB	advmod	O
CMV	NN	nsubj	B-Organism
is	VBZ	cop	O
cytomegalovirus	NN	acl:relcl	B-Organism
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
is	VBZ	cop	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
)	-RRB-	punct	O
containing	VBG	acl	O
the	DT	det	O
cDNA	NN	dobj	B-Cellular_component
for	IN	case	O
human	JJ	amod	B-Organism
VEGF165	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
secreted	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
specific	JJ	amod	O
angiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	appos	O
,	,	punct	O
was	VBD	auxpass	O
constructed	VBN	ROOT	O
.	.	punct	O

Human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	ROOT	I-Cell
(	-LRB-	punct	O
HUVECs	NNS	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
rat	NN	compound	B-Cell
aorta	NN	dep	I-Cell
smooth	VBP	amod	I-Cell
muscle	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
RASMCs	NNS	appos	B-Cell
)	-RRB-	punct	O
infected	VBN	acl	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
5	CD	dep	O
and	CC	cc	O
20	CD	conj	O
plaque	NN	conj	O
-	HYPH	punct	O
forming	VBG	amod	O
units	NNS	dep	O
[	-LRB-	punct	O
pfu	NN	appos	O
]	-RRB-	punct	O
per	IN	case	O
cell	NN	nmod	B-Cell
)	-RRB-	punct	O
demonstrated	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
protein	NN	compound	O
secretion	NN	conj	O
into	IN	case	O
the	DT	det	O
supernatant	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
conditioned	JJ	amod	O
medium	NN	nsubj	O
from	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
enhanced	VBD	ROOT	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
neither	CC	cc:preconj	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubjpass	O
nor	CC	cc	O
secreted	VBN	amod	O
protein	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
uninfected	JJ	amod	O
HUVECs	NNS	nmod	B-Cell
or	CC	cc	O
RASMCs	NNS	conj	B-Cell
or	CC	cc	O
in	IN	case	O
cells	NNS	conj	B-Cell
infected	VBN	acl	O
with	IN	case	O
the	DT	det	O
control	JJ	compound	O
vector	NN	compound	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	ROOT	I-Gene_or_gene_product
(	-LRB-	punct	O
where	WRB	advmod	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	nsubj	I-Gene_or_gene_product
is	VBZ	ccomp	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
galactosidase	NN	attr	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Assessment	NN	nsubj	O
of	IN	case	O
starved	VBN	amod	O
HUVECs	NNS	nmod	B-Cell
at	IN	case	O
14	CD	nummod	O
days	NNS	nmod	O
demonstrated	VBD	ROOT	O
sixfold	RB	xcomp	O
more	JJR	amod	O
cells	NNS	dobj	B-Cell
for	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
infected	JJ	amod	O
HUVECs	NNS	ROOT	B-Cell
(	-LRB-	punct	O
20	CD	nummod	O
pfu	NN	dep	O
per	IN	case	O
cell	NN	nmod	B-Cell
)	-RRB-	punct	O
than	IN	case	O
for	IN	case	O
either	CC	cc:preconj	O
infected	JJ	amod	O
or	CC	cc	O
uninfected	JJ	conj	O
control	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

RASMC	NN	compound	B-Cell
proliferation	NN	nsubj	O
was	VBD	aux	O
unaffected	JJ	ROOT	O
by	IN	case	O
infection	NN	nmod	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	ROOT	B-Gene_or_gene_product
.	.	punct	O

When	WRB	advmod	O
plated	VBN	ROOT	O
in	IN	case	O
2	CD	nummod	O
%	NN	amod	O
serum	NN	nmod	B-Organism_substance
on	IN	case	O
dishes	NNS	nmod	O
precoated	VBN	acl	O
with	IN	case	O
reconstituted	VBN	amod	O
basement	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
(	-LRB-	punct	O
Matrigel	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
HUVECs	NNS	conj	B-Cell
infected	VBN	acl	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	ROOT	B-Gene_or_gene_product
(	-LRB-	punct	O
20	CD	nummod	O
pfu	NN	dep	O
per	IN	case	O
cell	NN	nmod	B-Cell
)	-RRB-	punct	O
differentiated	VBN	acl	O
into	IN	case	O
capillary	JJ	npadvmod	B-Tissue
-	HYPH	punct	I-Tissue
like	JJ	amod	I-Tissue
structures	NNS	nmod	I-Tissue
.	.	punct	O

Under	IN	case	O
similar	JJ	amod	O
conditions	NNS	ROOT	O
,	,	punct	O
both	DT	cc:preconj	O
uninfected	JJ	amod	O
HUVECs	NNS	appos	B-Cell
and	CC	cc	O
HUVECs	NNS	conj	B-Cell
infected	VBN	acl	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	nsubj	I-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
differentiate	VB	ROOT	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	ROOT	B-Gene_or_gene_product
to	TO	mark	O
function	VB	acl	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
either	CC	cc:preconj	O
AdCMV	NN	appos	O
.	.	punct	O

VEGF165	NN	ROOT	B-Gene_or_gene_product
or	CC	cc	O
AdCMV	NN	conj	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
10	CD	dep	O
)	-RRB-	punct	O
pfu	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
resuspended	VBN	ROOT	O
in	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mL	NN	compound	O
Matrigel	NN	ROOT	O
and	CC	cc	O
injected	VBD	conj	O
subcutaneously	RB	advmod	O
into	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Immunohistochemical	JJ	amod	O
staining	NN	nsubj	O
demonstrated	VBD	ROOT	O
VEGF	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
tissues	NNS	nmod	B-Tissue
surrounding	VBG	acl	O
the	DT	det	O
Matrigel	NNP	compound	O
plugs	NNS	dobj	O
containing	VBG	acl	O
AdCMV	NN	dobj	O
.	.	punct	O
VEGF165	NN	nsubjpass	B-Gene_or_gene_product
up	IN	advmod	O
to	TO	dep	O
3	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
injection	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
VEGF	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
control	NN	compound	O
plugs	NNS	nmod	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	ROOT	I-Gene_or_gene_product
.	.	punct	O

Two	CD	nummod	O
weeks	NNS	npadvmod	O
after	IN	prep	O
injection	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
histological	JJ	amod	O
evidence	NN	nsubj	O
of	IN	case	O
neovascularization	NN	nmod	O
in	IN	case	O
the	DT	det	O
tissues	NNS	nmod	B-Tissue
surrounding	VBG	acl	O
the	DT	det	O
Matrigel	NNP	dobj	O
containing	VBG	acl	O
AdCMV	NN	dobj	O
.	.	punct	O
VEGF165	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
significant	JJ	amod	O
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	ROOT	I-Gene_or_gene_product
.	.	punct	O

Furthermore	RB	ROOT	O
,	,	punct	O
the	DT	det	O
Matrigel	NNP	compound	O
plugs	NNS	prep	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	nsubj	B-Gene_or_gene_product
demonstrated	VBD	ROOT	O
hemoglobin	NN	compound	B-Gene_or_gene_product
content	NN	dobj	O
fourfold	RB	advmod	O
higher	JJR	amod	O
than	IN	case	O
the	DT	det	O
plugs	NNS	nmod	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	B-Gene_or_gene_product
gal	NN	ROOT	I-Gene_or_gene_product
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
concept	NN	nmod	O
that	IN	mark	O
Ad	NN	compound	B-Organism
vectors	NNS	nsubj	O
may	MD	aux	O
provide	VB	ccomp	O
a	DT	det	O
useful	JJ	amod	O
strategy	NN	dobj	O
for	IN	case	O
efficient	JJ	amod	O
local	JJ	amod	O
delivery	NN	nmod	O
of	IN	case	O
VEGF165	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
ischemic	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Modulation	NN	ROOT	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
myeloid	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NNP	nmod	I-Gene_or_gene_product
.	.	punct	O

Apoptosis	NN	nsubj	O
(	-LRB-	punct	O
programmed	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	appos	O
)	-RRB-	punct	O
regulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
population	NN	compound	O
size	NN	dobj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
whereby	WRB	advmod	O
hematopoietic	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
HGFs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
modulate	VBP	acl:relcl	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
myeloid	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
protein	NN	nmod	O
and	CC	cc	O
mRNA	NN	compound	O
synthesis	NN	conj	O
for	IN	mark	O
altering	VBG	acl	O
apoptosis	NN	dobj	O
in	IN	case	O
growth	NN	compound	O
factor	NN	compound	O
-	:	punct	O
stimulated	VBN	nmod	O
vs	CC	cc	O
.	.	punct	O
quiescent	JJ	amod	O
leukemic	JJ	amod	B-Cell
TF1	NN	compound	I-Cell
cells	NNS	ROOT	I-Cell
.	.	punct	O

Lysates	NNS	nsubjpass	B-Organism_substance
of	IN	case	O
cells	NNS	nmod	B-Cell
from	IN	case	O
the	DT	det	O
granulocyte	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
macrophage	NN	compound	I-Gene_or_gene_product
colony	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	NN	compound	I-Gene_or_gene_product
factor	NN	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
GM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NNP	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
dependent	JJ	amod	O
myeloid	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
TF1	NN	nmod	I-Cell
were	VBD	auxpass	O
separated	VBN	ROOT	O
into	IN	case	O
high	JJ	amod	O
molecular	JJ	amod	O
weight	NN	compound	O
(	-LRB-	punct	O
HMW	NN	appos	O
)	-RRB-	punct	O
pellets	NNS	nmod	O
of	IN	case	O
intact	JJ	amod	O
DNA	NN	nmod	B-Cellular_component
and	CC	cc	O
supernatants	NNS	conj	O
of	IN	case	O
fragmented	JJ	amod	O
low	JJ	amod	O
MW	NN	compound	O
(	-LRB-	punct	O
LMW	NN	compound	O
)	-RRB-	punct	O
DNA	NN	nmod	B-Cellular_component
,	,	punct	O
and	CC	cc	O
the	DT	det	O
DNA	NN	nsubjpass	B-Cellular_component
purified	VBN	acl	O
from	IN	case	O
these	DT	det	O
fractions	NNS	nmod	O
was	VBD	auxpass	O
quantified	VBN	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
fetal	JJ	amod	B-Organism_substance
bovine	JJ	amod	I-Organism_substance
serum	NN	conj	I-Organism_substance
(	-LRB-	punct	O
FBS	NN	appos	B-Organism_substance
)	-RRB-	punct	O
,	,	punct	O
70	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
was	VBD	auxpass	O
fragmented	JJ	ROOT	O
after	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
characteristic	JJ	amod	O
apoptotic	JJ	amod	O
ladder	NN	compound	O
-	HYPH	punct	O
like	JJ	case	O
pattern	NN	nmod	O
on	IN	case	O
agarose	NN	amod	B-Simple_chemical
gel	NN	compound	O
electrophoresis	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
this	DT	det	O
proportion	NN	nsubj	O
had	VBD	aux	O
initially	RB	advmod	O
been	VBN	cop	O
<	``	amod	O
5	CD	nummod	O
%	NN	parataxis	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
less	JJR	advmod	O
than	IN	quantmod	O
5	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
was	VBD	auxpass	O
fragmented	JJ	ROOT	O
in	IN	case	O
cells	NNS	nmod	B-Cell
incubated	VBN	acl	O
with	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
plus	CC	cc	O
FBS	NN	compound	B-Organism_substance
or	CC	cc	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	conj	I-Gene_or_gene_product
alone	RB	advmod	O
.	.	punct	O

Delayed	VBN	amod	O
addition	NN	nsubj	O
of	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
FBS	NN	conj	B-Organism_substance
,	,	punct	O
permitted	VBD	ROOT	O
partial	JJ	amod	O
rescue	NN	dobj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
inhibiting	VBG	advcl	O
increasing	VBG	amod	O
rates	NNS	dobj	O
of	IN	case	O
accumulation	NN	nmod	O
of	IN	case	O
fragmented	JJ	amod	O
DNA	NN	nmod	B-Cellular_component
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
macro	JJ	compound	O
-	HYPH	punct	O
molecular	JJ	amod	O
synthesis	NN	compound	O
inhibitor	NN	compound	O
cycloheximide	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
CHX	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
or	CC	cc	O
actinomycin	NN	compound	B-Simple_chemical
D	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
Act	NN	compound	B-Simple_chemical
D	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
was	VBD	cop	O
present	JJ	advcl	O
for	IN	case	O
26	CD	nummod	O
hours	NNS	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
FBS	NN	conj	B-Organism_substance
,	,	punct	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
FBS	NN	conj	B-Organism_substance
,	,	punct	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
upon	IN	case	O
addition	NN	nmod	O
of	IN	case	O
CHX	NN	nmod	B-Simple_chemical
or	CC	cc	O
Act	NNP	compound	B-Simple_chemical
D	NN	conj	I-Simple_chemical
.	.	punct	O

The	DT	det	O
latter	JJ	amod	O
effect	NN	nsubj	O
persisted	VBD	ROOT	O
even	RB	advmod	O
with	IN	case	O
the	DT	det	O
late	JJ	amod	O
addition	NN	nmod	O
of	IN	case	O
CHX	NN	nmod	B-Simple_chemical
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
disparate	JJ	amod	O
mechanisms	NNS	nsubj	O
of	IN	case	O
enhancing	VBG	nmod	O
or	CC	cc	O
inhibiting	VBG	conj	O
apoptosis	NN	conj	O
exist	VBP	ccomp	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
related	JJ	amod	O
to	TO	case	O
environmental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
HGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
cellular	JJ	amod	B-Cell
synthesis	NN	nmod	O
of	IN	case	O
distinct	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
mRNA	NN	conj	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
doxycycline	NN	nmod	B-Simple_chemical
on	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
growth	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
gelatinase	NN	compound	O
activity	NN	conj	O
of	IN	case	O
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Metastatic	JJ	amod	O
disease	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
causes	NNS	nmod	O
of	IN	case	O
death	NN	nmod	O
from	IN	case	O
cancer	NN	nmod	B-Cancer
in	IN	case	O
human	JJ	amod	B-Organism
beings	NNS	nmod	O
.	.	punct	O

Several	JJ	amod	O
enzyme	NN	compound	O
systems	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
process	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
metalloproteinases	NNS	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
MPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
appear	VBP	conj	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
major	JJ	amod	O
group	NN	xcomp	O
involved	VBN	acl	O
in	IN	case	O
most	JJS	amod	O
instances	NNS	nmod	O
of	IN	case	O
neoplastic	JJ	amod	O
invasion	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
MP	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
many	JJ	amod	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

MPs	NNS	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
play	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

Tetracyclines	NNS	nsubj	B-Simple_chemical
are	VBP	ROOT	O
antimicrobial	JJ	amod	O
agents	NNS	attr	O
that	WDT	nsubj	O
can	MD	aux	O
suppress	VB	acl:relcl	O
MP	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
including	VBG	case	O
gingiva	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
bone	NN	conj	B-Tissue
,	,	punct	O
and	CC	cc	O
cartilage	NN	conj	B-Tissue
.	.	punct	O

Several	JJ	amod	O
reports	NNS	nsubj	O
have	VBP	aux	O
indicated	VBN	ROOT	O
that	IN	mark	O
tetracyclines	NNS	nsubj	B-Simple_chemical
can	MD	aux	O
suppress	VB	ccomp	O
tumor	NN	compound	B-Cancer
MPs	NNS	dobj	B-Gene_or_gene_product
as	RB	advmod	O
well	RB	advmod	O
.	.	punct	O

A	DT	det	O
synthetic	JJ	amod	O
tetracycline	NN	nsubj	B-Simple_chemical
,	,	punct	O
doxycycline	NN	appos	B-Simple_chemical
,	,	punct	O
inhibits	VBZ	ROOT	O
migration	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
435	CD	nummod	I-Cell
breast	NN	compound	I-Cell
adenocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
a	DT	det	O
reconstituted	VBN	amod	O
basement	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
(	-LRB-	punct	O
Matrigel	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
assay	NN	appos	O
used	VBN	acl	O
as	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
surrogate	NN	nmod	O
for	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
process	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
invasion	NN	nmod	O
through	IN	case	O
basement	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
doxycycline	NN	nsubj	B-Simple_chemical
diminishes	VBZ	ROOT	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
this	DT	det	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
and	CC	cc	O
also	RB	advmod	O
decreases	VBZ	conj	O
its	PRP$	nmod:poss	O
gelatinolytic	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
gel	NN	compound	O
zymography	NN	nmod	O
.	.	punct	O

Transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promotes	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
neoplastic	JJ	amod	O
transformation	NN	nsubjpass	O
of	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
various	JJ	amod	O
means	NNS	nmod	O
has	VBZ	aux	O
consistently	RB	advmod	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
resistance	NN	nmod	O
to	IN	case	O
the	DT	det	O
mito	NN	nmod:npmod	O
-	HYPH	punct	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
such	JJ	amod	O
phenotype	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
mechanistic	JJ	amod	O
role	NN	dobj	O
during	IN	case	O
the	DT	det	O
transformation	NN	nmod	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
"	``	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
resistant	JJ	dep	O
"	``	punct	O
phenotype	NN	nmod	O
in	IN	case	O
a	DT	det	O
clonal	JJ	amod	O
strain	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
passage	NN	compound	O
WB	NN	compound	B-Cell
-	HYPH	punct	I-Cell
F344	NN	compound	I-Cell
normal	JJ	amod	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
the	DT	det	O
proliferation	NN	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
was	VBD	auxpass	O
markedly	RB	advmod	O
inhibited	VBN	parataxis	O
by	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
control	JJ	compound	B-Cell
WB	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
in	IN	case	O
continuous	JJ	amod	O
culture	NN	nmod	O
slowly	RB	advmod	O
developed	VBD	ROOT	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
resistance	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
the	DT	det	O
same	JJ	amod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
exposed	VBN	advcl	O
to	TO	case	O
step	NN	compound	O
-	HYPH	punct	O
wise	JJ	amod	O
increases	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
concentration	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
medium	NN	nmod	O
,	,	punct	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
resistance	NN	nmod	O
was	VBD	auxpass	O
accelerated	VBN	ROOT	O
.	.	punct	O

Cells	NNS	nsubj	B-Cell
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
grown	VBN	acl:relcl	O
in	IN	case	O
medium	NN	nmod	O
containing	VBG	acl	O
1	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	compound	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	dobj	I-Gene_or_gene_product
developed	VBD	ROOT	O
colony	NN	npadvmod	O
-	HYPH	punct	O
forming	VBG	amod	O
capacity	NN	dobj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
containing	VBG	acl	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	dobj	I-Gene_or_gene_product
.	.	punct	O

Cells	NNS	nsubj	B-Cell
which	WDT	nsubjpass	O
were	VBD	auxpass	O
grown	VBN	acl:relcl	O
in	IN	case	O
media	NNS	nmod	O
containing	VBG	acl	O
5	CD	nummod	O
and	CC	cc	O
10	CD	conj	O
ng	NN	compound	O
/	:	punct	O
ml	NN	compound	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	dobj	I-Gene_or_gene_product
demonstrated	VBD	ROOT	O
a	DT	det	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	prep	O
colony	NN	npadvmod	O
-	HYPH	punct	O
forming	VBG	amod	O
efficiency	NN	pobj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	compound	O
medium	NN	pobj	O
without	IN	case	O
added	VBN	amod	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
tumorigenicity	NN	conj	O
in	IN	case	O
isogeneic	JJ	amod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

These	DT	det	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
resistant	JJ	amod	O
cells	NNS	nsubj	B-Cell
also	RB	advmod	O
exhibited	VBD	ROOT	O
progressively	RB	advmod	O
increasing	VBG	amod	O
levels	NNS	dobj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
and	CC	cc	O
myc	NN	compound	B-Gene_or_gene_product
mRNA	NN	conj	O
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
resistance	NN	conj	O
to	TO	case	O
the	DT	det	O
cytotoxicity	NN	nmod	O
of	IN	case	O
Adriamycin	NN	nmod	B-Simple_chemical
and	CC	cc	O
melphalan	NN	conj	B-Simple_chemical
.	.	punct	O

The	DT	det	O
latter	JJ	amod	O
phenomenon	NN	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
mdr	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
cellular	JJ	amod	B-Cell
glutathione	NN	compound	B-Simple_chemical
level	NN	conj	O
,	,	punct	O
and	CC	cc	O
glutathione	NN	compound	B-Gene_or_gene_product
S	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
transferase	NN	compound	I-Gene_or_gene_product
activity	NN	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
chronic	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
high	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
promotes	VBZ	ccomp	O
the	DT	det	O
spontaneous	JJ	amod	O
neoplastic	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
liver	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
process	NN	nsubj	O
may	MD	aux	O
represent	VB	conj	O
one	CD	dobj	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
adaptation	NN	nmod	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
multidrug	NN	nmod:npmod	O
-	HYPH	punct	O
resistant	JJ	amod	O
phenotype	NN	nmod	O
during	IN	case	O
the	DT	det	O
carcinogenesis	NN	nmod	O
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
latency	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
transcripts	NNS	nmod	O
that	WDT	nsubj	O
map	VBP	acl:relcl	O
antisense	JJ	dep	O
to	TO	case	O
the	DT	det	O
ICP4	NN	compound	B-Gene_or_gene_product
homolog	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
of	IN	case	O
Marek	NNP	nmod:poss	B-Organism
'	POS	case	I-Organism
s	VBZ	compound	I-Organism
disease	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Two	CD	nummod	O
small	JJ	amod	O
RNAs	NNS	ROOT	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
9	CD	dep	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
75	CD	nummod	O
kb	NN	nsubjpass	O
)	-RRB-	punct	O
,	,	punct	O
named	VBN	acl	O
Marek	NNP	nmod:poss	B-Gene_or_gene_product
'	POS	punct	I-Gene_or_gene_product
s	VBZ	compound	I-Gene_or_gene_product
disease	NN	compound	I-Gene_or_gene_product
virus	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
MDV	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
small	JJ	amod	I-Gene_or_gene_product
RNAs	NNS	xcomp	I-Gene_or_gene_product
(	-LRB-	punct	O
MSRs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
10	CD	nummod	O
-	HYPH	punct	O
kb	NN	compound	O
RNA	NN	conj	O
,	,	punct	O
all	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
map	VBP	acl:relcl	O
antisense	JJ	amod	O
to	TO	case	O
the	DT	det	O
MDV	NN	compound	B-Organism
ICP4	NN	compound	B-Gene_or_gene_product
homolog	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
readily	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
MDCC	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MSB1	NN	compound	I-Cell
MDV	NNP	compound	B-Organism
-	:	punct	O
transformed	VBN	amod	O
T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
lymphoblastoid	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
RNAs	NNS	nsubj	O
were	VBD	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
in	IN	case	O
reticuloendotheliosis	NN	compound	B-Organism
virus	NN	compound	I-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
T	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

When	WRB	advmod	O
MDV	NN	nsubjpass	B-Organism
was	VBD	auxpass	O
reactivated	VBN	advcl	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
lymphoblastoid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
25	CD	nummod	O
micrograms	NNS	nmod	O
of	IN	case	O
iododeoxyuridine	NN	nmod	B-Simple_chemical
per	IN	case	O
ml	NN	nmod	O
,	,	punct	O
the	DT	det	O
relative	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
transcripts	NNS	nmod	O
decreased	VBD	ROOT	O
.	.	punct	O

These	DT	det	O
RNAs	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
by	IN	case	O
Northern	NN	compound	O
(	-LRB-	punct	O
RNA	NN	appos	O
)	-RRB-	punct	O
hybridization	NN	nmod	O
in	IN	case	O
productively	RB	advmod	O
infected	JJ	amod	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
48	CD	nummod	O
h	NN	compound	O
postinfection	NN	dep	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
were	VBD	cop	O
apparent	JJ	amod	O
140	CD	nummod	O
h	NN	compound	O
postinfection	NN	dep	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
Northern	NN	compound	O
hybridization	NN	dobj	O
,	,	punct	O
RNase	NN	compound	B-Gene_or_gene_product
protection	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
primer	NN	compound	O
extension	NN	compound	O
analysis	NN	dobj	O
,	,	punct	O
the	DT	det	O
MSRs	NNP	nsubjpass	B-Gene_or_gene_product
were	VBD	auxpass	O
determined	VBN	ROOT	O
to	TO	mark	O
map	VB	xcomp	O
antisense	JJ	amod	O
to	IN	case	O
the	DT	det	O
predicted	VBN	amod	O
translational	JJ	amod	O
start	NN	compound	O
site	NN	nmod	O
of	IN	case	O
the	DT	det	O
ICP4	NN	compound	B-Gene_or_gene_product
homolog	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

The	DT	det	O
conclusion	NN	nsubj	O
most	RBS	advmod	O
consistent	JJ	amod	O
with	IN	case	O
the	DT	det	O
data	NNS	nmod	O
is	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
two	CD	nummod	O
MSRs	NNS	nsubj	B-Gene_or_gene_product
are	VBP	aux	O
overlapping	VBG	ccomp	O
,	,	punct	O
spliced	VBN	amod	O
RNAs	NNS	dobj	O
.	.	punct	O

Both	DT	det	O
small	JJ	amod	O
RNAs	NNS	nsubj	O
contain	VBP	ROOT	O
a	DT	det	O
latency	NN	compound	O
promoter	NN	compound	O
binding	NN	compound	O
factor	NN	compound	O
consensus	NN	compound	O
recognition	NN	compound	O
sequence	NN	dobj	O
located	JJ	amod	O
toward	IN	case	O
their	PRP$	nmod:poss	O
5	CD	nummod	O
'	''	punct	O
ends	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
two	CD	nummod	O
potential	JJ	amod	O
ICP4	NN	compound	B-Gene_or_gene_product
recognition	NN	compound	O
consensus	NN	compound	O
sequences	NNS	conj	O
,	,	punct	O
one	CD	appos	O
in	IN	case	O
each	DT	det	O
orientation	NN	nmod	O
.	.	punct	O

The	DT	det	O
region	NN	nsubj	O
contains	VBZ	ROOT	O
a	DT	det	O
number	NN	dobj	O
of	IN	prep	O
small	JJ	amod	O
open	JJ	amod	O
reading	NN	compound	O
frames	NNS	pobj	O
on	IN	case	O
each	DT	det	O
side	NN	nmod	O
and	CC	cc	O
within	IN	case	O
the	DT	det	O
MSRs	NNP	conj	B-Gene_or_gene_product
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
exact	JJ	amod	O
endpoints	NNS	nsubj	O
are	VBP	cop	O
unknown	JJ	advcl	O
,	,	punct	O
the	DT	det	O
large	JJ	amod	O
10	CD	nummod	O
-	HYPH	punct	O
kb	NN	compound	O
species	NNS	nsubj	O
spans	VBZ	ROOT	O
the	DT	det	O
entire	JJ	amod	O
ICP4	NN	compound	B-Gene_or_gene_product
homolog	NN	compound	I-Gene_or_gene_product
region	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
believe	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
group	NN	nsubj	O
of	IN	case	O
RNAs	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
map	VBP	acl:relcl	O
antisense	JJ	dobj	O
to	TO	case	O
the	DT	det	O
ICP4	NN	compound	B-Gene_or_gene_product
homolog	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
are	VBP	cop	O
latency	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
transcripts	NNS	ccomp	O
of	IN	case	O
MDV	NN	nmod	B-Organism
.	.	punct	O

Increased	VBN	amod	O
expression	NN	ROOT	O
of	IN	case	O
specific	JJ	amod	O
protein	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
phosphatases	NNS	nmod	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
neoplastically	RB	advmod	O
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
neu	NN	compound	B-Gene_or_gene_product
oncogene	NN	nmod	O
.	.	punct	O

Protein	NN	compound	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	compound	O
/	:	punct	O
dephosphorylation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
fundamental	JJ	amod	O
mechanism	NN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
neoplastic	JJ	amod	O
transformation	NN	conj	O
;	:	punct	O
this	DT	det	O
metabolic	JJ	amod	O
process	NN	nsubjpass	O
is	VBZ	auxpass	O
modulated	VBN	parataxis	O
by	IN	case	O
the	DT	det	O
opposing	JJ	amod	O
activities	NNS	nmod	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinases	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	O
protein	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
phosphatases	NNS	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
PTPases	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

While	IN	mark	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinases	NNS	nmod	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
examined	VBN	advcl	O
extensively	RB	advmod	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Organism_subdivision
tumorigenesis	NN	nmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
PTPases	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
is	VBZ	cop	O
virtually	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

To	TO	aux	O
address	VB	advcl	O
this	DT	det	O
issue	NN	dobj	O
,	,	punct	O
an	DT	det	O
activated	VBN	amod	O
neu	NN	compound	B-Gene_or_gene_product
oncogene	NN	nsubjpass	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
into	IN	case	O
an	DT	det	O
immortalized	VBN	amod	O
nontumorigenic	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
(	-LRB-	punct	O
184B5	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
substantial	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
P185neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
led	VBD	acl:relcl	O
to	TO	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
progressively	RB	advmod	O
growing	VBG	amod	O
carcinomas	NNS	nmod	B-Cancer
after	IN	case	O
such	JJ	amod	O
cells	NNS	nmod	B-Cell
were	VBD	auxpass	O
inoculated	VBN	conj	O
into	IN	case	O
athymic	JJ	amod	O
nude	JJ	compound	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
a	DT	det	O
striking	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
PTPases	NNS	nmod	B-Gene_or_gene_product
,	,	punct	O
LAR	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
PTP1B	NN	conj	B-Gene_or_gene_product
,	,	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
3	CD	nummod	O
independently	RB	advmod	O
neu	NN	compound	B-Gene_or_gene_product
transformed	VBD	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
their	PRP$	nmod:poss	O
derived	VBN	amod	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

This	DT	det	O
elevation	NN	nsubjpass	O
was	VBD	auxpass	O
verified	VBN	ROOT	O
at	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
levels	NNS	dep	O
.	.	punct	O

TC	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PTP	NN	compound	I-Gene_or_gene_product
PTPase	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
only	RB	advmod	O
slightly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
these	DT	det	O
neu	NN	compound	B-Gene_or_gene_product
transformed	VBD	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
expression	NN	nsubjpass	O
of	IN	case	O
CD45	NN	compound	B-Gene_or_gene_product
PTPase	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
observed	VBN	conj	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
differential	JJ	amod	O
expression	NN	conj	O
between	IN	case	O
P185neu	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
LAR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
PTP1B	NN	conj	B-Gene_or_gene_product
,	,	punct	O
directly	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
tumorigenicity	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
rat	NN	compound	B-Organism
mammary	JJ	amod	B-Cancer
carcinomas	NNS	nsubj	I-Cancer
with	IN	case	O
elevated	JJ	amod	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
(	-LRB-	punct	O
neu	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
had	VBD	ROOT	O
sharply	RB	advmod	O
elevated	JJ	amod	O
LAR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PTPase	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
rat	NN	compound	B-Organism
mammary	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
with	IN	case	O
little	JJ	nmod	O
or	CC	cc	O
no	DT	conj	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	dep	O
(	-LRB-	punct	O
7	CD	dep	B-Simple_chemical
,	,	punct	I-Simple_chemical
12	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethylbenzanthracene	NN	appos	I-Simple_chemical
induced	VBD	dep	O
)	-RRB-	punct	O
;	:	punct	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
LAR	NN	compound	B-Gene_or_gene_product
PTPase	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
directly	RB	advmod	O
correlated	VBN	parataxis	O
with	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
in	IN	case	O
rat	NN	compound	B-Organism
mammary	JJ	amod	B-Cancer
carcinomas	NNS	conj	I-Cancer
that	WDT	nsubj	O
have	VBP	acl:relcl	O
an	DT	det	O
induced	VBN	amod	O
increase	NN	dobj	O
in	IN	case	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
a	DT	det	O
consistent	JJ	amod	O
and	CC	cc	O
substantial	JJ	conj	O
increase	NN	nsubj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
PTPases	NNS	nmod	B-Gene_or_gene_product
occurs	VBZ	acl:relcl	O
.	.	punct	O

The	DT	det	O
relationship	NN	nsubj	O
between	IN	case	O
P185neu	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
protein	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
specific	JJ	amod	O
PTPase	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Organism_subdivision
tumorigenesis	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
effects	NNS	ROOT	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
skeletal	JJ	amod	B-Tissue
muscle	NN	compound	I-Tissue
glucose	NN	compound	B-Simple_chemical
metabolism	NN	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
anabolic	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
have	VBP	aux	O
been	VBN	auxpass	O
suggested	VBN	appos	O
for	IN	case	O
use	NN	nmod	O
to	TO	mark	O
reverse	VB	acl	O
malnutrition	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
host	NN	nsubj	O
and	CC	cc	O
tumor	NN	conj	B-Cancer
sensitivities	NNS	dep	O
to	TO	case	O
insulin	NN	nmod	B-Gene_or_gene_product
are	VBP	cop	O
critical	JJ	ROOT	O
for	IN	case	O
such	JJ	amod	O
treatments	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
aim	VBP	acl:relcl	O
to	TO	mark	O
improve	VB	xcomp	O
patient	NN	compound	B-Organism
nutrition	NN	dobj	O
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
studied	VBD	ROOT	O
insulin	NN	compound	B-Gene_or_gene_product
effects	NNS	dobj	O
on	IN	case	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
skeletal	JJ	amod	B-Tissue
muscle	NN	compound	I-Tissue
metabolism	NN	conj	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
18F	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
fluoro	NNS	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	conj	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Six	CD	nummod	O
patients	NNS	nsubj	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
twice	RB	advmod	O
underwent	VBD	appos	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
-	HYPH	punct	O
PET	NN	dep	O
imaging	NN	xcomp	O
:	:	punct	O
once	RB	advmod	O
after	IN	dep	O
fasting	VBG	pcomp	O
overnight	RB	advmod	O
and	CC	cc	O
once	RB	conj	O
during	IN	conj	O
euglycemic	JJ	amod	O
hyperinsulinemic	JJ	amod	O
clamp	NN	pobj	O
.	.	punct	O

The	DT	det	O
dynamic	JJ	amod	O
uptake	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
analogue	NN	nmod	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	nsubjpass	I-Simple_chemical
was	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
diseased	JJ	amod	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
upper	JJ	amod	B-Organism_subdivision
arm	NN	compound	I-Organism_subdivision
skeletal	JJ	amod	B-Tissue
muscle	NN	conj	I-Tissue
in	IN	case	O
both	DT	det	O
metabolic	JJ	amod	O
states	NNS	nmod	O
.	.	punct	O

The	DT	det	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
uptake	NN	nsubjpass	O
in	IN	case	O
muscle	NN	nmod	B-Organ
and	CC	cc	O
the	DT	det	O
whole	JJ	amod	O
body	NN	compound	B-Organism_subdivision
glucose	NN	compound	B-Simple_chemical
use	NN	conj	O
during	IN	case	O
euglycemic	JJ	amod	O
hyperinsulinemic	JJ	amod	O
clamp	NN	nmod	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
weight	NN	pobj	O
-	HYPH	punct	O
matched	VBN	amod	O
healthy	JJ	amod	O
subjects	NNS	nmod	O
studied	VBN	acl	O
under	IN	case	O
similar	JJ	amod	O
circumstances	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
lymphomatous	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
,	,	punct	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
uptake	NN	compound	O
rates	NNS	nsubj	O
were	VBD	cop	O
similar	JJ	dep	O
in	IN	prep	O
overnight	JJ	amod	O
fasting	NN	intj	O
and	CC	cc	O
euglycemic	JJ	amod	O
hyperinsulinemic	JJ	amod	O
clamp	NN	conj	O
(	-LRB-	punct	O
38	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
versus	CC	cc	O
41	CD	conj	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	dep	O
mumol	NN	dep	O
/	:	punct	O
100	CD	nummod	O
g	NN	nmod	O
/	SYM	punct	O
minute	NN	dep	O
,	,	punct	O
not	RB	neg	O
significant	JJ	amod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nsubjpass	O
in	IN	case	O
skeletal	JJ	amod	B-Organ
muscle	NN	nmod	I-Organ
was	VBD	auxpass	O
increased	VBN	parataxis	O
by	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
1	CD	dep	O
.	.	punct	O
7	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nmod	O
.	.	punct	O
2	CD	dep	O
versus	CC	cc	O
3	CD	conj	O
.	.	punct	O
8	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
mumol	NN	dep	O
/	:	punct	O
100	CD	nummod	O
g	NN	dep	O
/	SYM	punct	O
minute	NN	ROOT	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
012	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Both	CC	cc:preconj	O
basal	JJ	ROOT	O
(	-LRB-	punct	O
2	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
2	CD	nummod	O
mumol	NN	ROOT	O
/	:	punct	O
100	CD	nummod	O
g	NN	appos	O
/	SYM	punct	O
minute	NN	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
061	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
insulin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	conj	O
(	-LRB-	punct	O
8	CD	nummod	O
.	.	punct	O
5	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	nummod	O
.	.	punct	O
9	CD	nummod	O
mumol	NN	nsubj	O
/	:	punct	O
100	CD	nummod	O
g	NN	appos	O
/	SYM	punct	O
minute	NN	conj	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
055	CD	dep	O
)	-RRB-	punct	O
skeletal	JJ	amod	B-Multi-tissue_structure
arm	NN	compound	I-Multi-tissue_structure
muscle	NN	compound	I-Multi-tissue_structure
glucose	NN	compound	B-Simple_chemical
uptake	NN	compound	O
rates	NNS	conj	O
were	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
control	JJ	amod	O
subjects	NNS	nmod	O
than	IN	case	O
in	IN	case	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Whole	JJ	amod	O
body	NN	compound	B-Organism_subdivision
glucose	NN	compound	B-Simple_chemical
use	NN	nsubj	O
was	VBD	cop	O
55	CD	nummod	O
%	NN	nmod:npmod	O
lower	JJR	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
than	IN	case	O
in	IN	case	O
control	JJ	amod	B-Organism
subjects	NNS	nmod	I-Organism
(	-LRB-	punct	O
17	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
3	CD	dep	O
mumol	NN	dep	O
/	:	punct	O
kg	NN	dep	O
/	:	punct	O
minute	NN	conj	O
versus	CC	cc	O
38	CD	conj	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
3	CD	nummod	O
mumol	NN	compound	O
/	:	punct	O
kg	NN	appos	O
/	:	punct	O
minute	NN	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
002	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
consistent	JJ	advmod	O
with	IN	case	O
insulin	NN	compound	B-Gene_or_gene_product
resistance	NN	nmod	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	B-Gene_or_gene_product
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ccomp	O
major	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
of	IN	case	O
lymphomatous	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

Although	IN	mark	O
insulin	NN	compound	B-Gene_or_gene_product
sensitivity	NN	nsubjpass	O
of	IN	case	O
skeletal	JJ	amod	B-Organ
muscle	NN	nmod	I-Organ
was	VBD	auxpass	O
also	RB	advmod	O
reduced	VBN	advcl	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
,	,	punct	O
the	DT	det	O
net	JJ	amod	O
insulin	NN	compound	B-Gene_or_gene_product
effect	NN	nsubj	O
may	MD	aux	O
counteract	VB	ROOT	O
imbalance	NN	dobj	O
between	IN	case	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
of	IN	case	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
muscle	NN	conj	B-Organ
,	,	punct	O
offering	VBG	advcl	O
a	DT	det	O
potential	JJ	amod	O
means	NNS	dobj	O
to	TO	aux	O
circumvent	VB	xcomp	O
at	IN	case	O
least	JJS	nmod:npmod	O
some	DT	det	O
metabolic	JJ	amod	O
abnormalities	NNS	dobj	O
found	VBN	acl	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
1	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alkylpyrrolidine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
oxides	NNS	nmod	I-Simple_chemical
on	IN	case	O
energy	NN	compound	O
metabolism	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
a	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
1	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alkylpyrrolidine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
oxides	NNS	nmod	I-Simple_chemical
on	IN	case	O
ATP	NNP	npadvmod	B-Simple_chemical
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	B-Cell
ascites	VBZ	nmod	I-Cell
and	CC	cc	O
L1210	NN	compound	B-Cell
murine	JJ	amod	I-Cell
leukemia	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
on	IN	case	O
aerobic	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	nmod	O
,	,	punct	O
lactic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
formation	NN	conj	O
,	,	punct	O
content	NN	appos	O
of	IN	case	O
total	JJ	intj	O
(	-LRB-	punct	O
T	NN	compound	O
-	HYPH	punct	O
SH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
protein	NN	compound	O
thiol	NN	compound	O
groups	NNS	nmod	O
(	-LRB-	punct	O
NP	NN	compound	O
-	HYPH	punct	O
SH	NNP	appos	O
)	-RRB-	punct	O
,	,	punct	O
endogenous	JJ	amod	O
respiration	NN	conj	O
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
incubated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

1	LS	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Tetradecylpyrrolidine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
oxide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
TPNO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
active	JJ	amod	O
compounds	NNS	nmod	O
,	,	punct	O
immediately	RB	advmod	O
after	IN	case	O
addition	NN	appos	O
to	TO	case	O
the	DT	det	O
suspension	NN	nmod	O
of	IN	case	O
Ehrlich	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
an	DT	det	O
ice	NN	compound	O
bath	NN	nmod	O
,	,	punct	O
decreased	VBD	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
extent	NN	nmod	O
over	IN	case	O
the	DT	det	O
whole	JJ	amod	O
concentration	NN	compound	O
range	NN	nmod	O
.	.	punct	O

After	IN	case	O
2	CD	nummod	O
h	NN	compound	O
incubation	NN	nsubj	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
the	DT	det	O
drop	NN	dep	O
in	IN	case	O
the	DT	det	O
ATP	NN	compound	B-Simple_chemical
level	NN	nmod	O
was	VBD	cop	O
lower	JJR	ROOT	O
.	.	punct	O

The	DT	det	O
decrease	NN	nsubjpass	O
in	IN	case	O
ATP	NN	compound	B-Simple_chemical
level	NN	nmod	O
might	MD	aux	O
be	VB	auxpass	O
explained	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
the	DT	det	O
amine	NN	compound	B-Simple_chemical
oxide	NN	nmod	I-Simple_chemical
with	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
integrity	NN	nmod	O
.	.	punct	O

Transformation	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
cytokine	NN	compound	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
chemotactic	JJ	ROOT	O
for	IN	case	O
chicken	NN	compound	B-Organism
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
mononuclear	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
released	VBN	acl:relcl	O
from	IN	case	O
transformed	VBN	amod	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
(	-LRB-	punct	O
CEF	NN	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
platelet	NN	compound	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
family	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
the	DT	det	O
avian	JJ	amod	O
homolog	NN	conj	O
of	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
function	NN	nsubj	O
of	IN	case	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
unknown	JJ	advcl	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
protein	NN	nmod	O
on	IN	case	O
mitogenicity	NN	nmod	O
and	CC	cc	O
chemotaxis	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
its	PRP$	nmod:poss	O
expression	NN	conj	O
,	,	punct	O
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
and	CC	cc	O
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
chicken	NN	compound	B-Organism
peripheral	JJ	amod	B-Organism_substance
blood	NN	compound	I-Organism_substance
monocytes	NNS	nmod	I-Organism_substance
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
stimulated	VBN	conj	O
by	IN	case	O
incubation	NN	nmod	O
of	IN	case	O
the	DT	det	O
monocytes	NNS	nmod	B-Cell
with	IN	case	O
lipopolysaccharide	NN	nmod	B-Simple_chemical
or	CC	cc	O
phorbol	NN	compound	B-Simple_chemical
myristic	JJ	amod	I-Simple_chemical
acetate	NN	conj	I-Simple_chemical
.	.	punct	O

Boyden	NN	compound	O
double	JJ	amod	O
-	HYPH	punct	O
membrane	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
chemotaxis	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
chemotactic	JJ	ccomp	O
for	IN	case	O
chicken	NN	compound	B-Organism
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
mononuclear	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
for	IN	case	O
heterophils	NNS	conj	B-Cell
.	.	punct	O

Untransformed	JJ	amod	O
CEF	NN	nsubj	B-Cell
and	CC	cc	O
CEF	NN	conj	B-Cell
transformed	VBN	acl	O
with	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
also	RB	advmod	O
migrated	VBD	ROOT	O
to	TO	case	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
Boyden	NNP	compound	O
single	JJ	amod	O
-	HYPH	punct	O
membrane	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
slightly	RB	advmod	O
mitogenic	JJ	ROOT	O
for	IN	case	O
CEF	NN	nmod	B-Cell
,	,	punct	O
causing	VBG	advcl	O
a	DT	det	O
doubling	NN	dobj	O
of	IN	prep	O
[	-LRB-	punct	B-Simple_chemical
3H	NN	pobj	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
thymidine	NN	compound	I-Simple_chemical
uptake	NN	pobj	O
when	WRB	advmod	O
added	VBN	advcl	O
to	TO	case	O
serum	NN	npadvmod	B-Organism_substance
-	HYPH	punct	O
starved	VBN	amod	O
CEF	NN	nmod	B-Cell
.	.	punct	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	ROOT	O
associated	VBN	xcomp	O
not	RB	neg	O
only	RB	cc:preconj	O
with	IN	case	O
the	DT	det	O
cell	NN	nmod	B-Cell
and	CC	cc	O
in	IN	case	O
the	DT	det	O
culture	NN	compound	O
medium	NN	conj	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	intj	I-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
CEF	NN	nmod	B-Cell
but	CC	cc	O
also	RB	advmod	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	conj	I-Cellular_component
.	.	punct	O

The	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
role	NN	nsubjpass	O
of	IN	case	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ROOT	O
with	IN	case	O
chemotaxis	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
rather	RB	advmod	O
than	IN	mwe	O
with	IN	case	O
direct	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
mitogenicity	NN	nmod	O
.	.	punct	O

Vitamins	NNS	nsubj	B-Simple_chemical
regulate	VBP	ROOT	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
induce	VBP	conj	O
differentiation	NN	dobj	O
and	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Their	PRP$	nmod:poss	O
relevance	NN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
prevention	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
several	JJ	amod	O
hypotheses	NNS	nsubjpass	O
for	IN	case	O
human	JJ	amod	B-Organism
carcinogenesis	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
proposed	VBN	advcl	O
,	,	punct	O
the	DT	det	O
specific	JJ	amod	O
genetic	JJ	amod	O
changes	NNS	nsubjpass	O
that	WDT	nsubj	O
cause	VBP	acl:relcl	O
normal	JJ	amod	O
cells	NNS	dobj	B-Cell
to	TO	mark	O
become	VB	advcl	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
spite	NN	dep	O
of	IN	case	O
uncertainties	NNS	nmod	O
regarding	VBG	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
,	,	punct	O
several	JJ	amod	O
vitamins	NNS	appos	B-Simple_chemical
such	JJ	case	O
as	IN	mwe	O
beta	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carotene	NN	nmod	I-Simple_chemical
and	CC	cc	O
vitamins	NNS	compound	B-Simple_chemical
A	NN	conj	I-Simple_chemical
,	,	punct	O
C	NN	conj	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
E	NN	conj	B-Simple_chemical
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
reduce	VB	acl:relcl	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
animal	NN	dobj	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
models	NNS	conj	O
of	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
have	VBP	aux	O
led	VBN	ROOT	O
to	TO	case	O
a	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
the	DT	det	O
supplemental	JJ	amod	O
intake	NN	nsubj	O
of	IN	prep	O
these	DT	det	O
vitamins	NNS	pobj	B-Simple_chemical
may	MD	aux	O
reduce	VB	ccomp	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

This	DT	det	O
hypothesis	NN	nsubjpass	O
in	IN	case	O
humans	NNS	nmod	B-Organism
can	MD	aux	O
be	VB	auxpass	O
tested	VBN	ROOT	O
only	RB	advmod	O
by	IN	case	O
intervention	NN	compound	O
trials	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	acl:relcl	O
in	IN	prep	O
progress	NN	pobj	O
.	.	punct	O

Prospective	JJ	amod	O
and	CC	cc	O
retrospective	JJ	conj	O
case	NN	nmod:npmod	O
-	HYPH	punct	O
controlled	VBN	amod	O
experimental	JJ	amod	O
designs	NNS	nsubj	O
are	VBP	cop	O
not	RB	neg	O
suitable	JJ	ROOT	O
for	IN	mark	O
testing	VBG	advcl	O
the	DT	det	O
above	JJ	amod	O
hypothesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
fact	NN	nsubj	O
that	IN	mark	O
some	DT	det	O
vitamins	NNS	nsubj	B-Simple_chemical
induce	VBP	acl	O
cell	NN	compound	B-Cell
differentiation	NN	dobj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
culture	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
use	NN	nsubj	O
of	IN	case	O
these	DT	det	O
vitamins	NNS	nmod	B-Simple_chemical
in	IN	case	O
cancer	NN	compound	B-Cancer
prevention	NN	nmod	O
has	VBZ	ccomp	O
a	DT	det	O
cellular	JJ	amod	B-Cell
basis	NN	dobj	O
.	.	punct	O

In	IN	prep	O
addition	NN	pobj	O
to	TO	mark	O
having	VBG	pcomp	O
a	DT	det	O
direct	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
vitamins	NNS	nsubj	B-Simple_chemical
such	JJ	case	O
as	IN	mwe	O
alpha	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
tocopheryl	NN	dep	I-Simple_chemical
succinate	JJ	nmod	I-Simple_chemical
and	CC	cc	O
beta	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carotene	NN	conj	I-Simple_chemical
enhance	VBP	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
agents	NNS	nmod	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
differentiation	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Some	DT	det	O
vitamins	NNS	nsubj	B-Simple_chemical
like	IN	prep	O
beta	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carotene	NN	pobj	I-Simple_chemical
,	,	punct	O
retinoic	JJ	amod	B-Simple_chemical
acid	NN	conj	I-Simple_chemical
,	,	punct	O
alpha	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
tocopheryl	NN	conj	I-Simple_chemical
succinate	JJ	ROOT	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
vitamin	NN	compound	B-Simple_chemical
D	NN	nsubj	I-Simple_chemical
also	RB	advmod	O
regulate	VBP	conj	O
the	DT	det	O
expressions	NNS	dobj	O
of	IN	case	O
certain	JJ	amod	O
oncogenes	NNS	nmod	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
genes	NNS	conj	O
.	.	punct	O

These	DT	nsubj	O
are	VBP	aux	O
exciting	VBG	ROOT	O
new	JJ	amod	O
functions	NNS	dobj	O
of	IN	prep	O
vitamins	NNS	pobj	B-Simple_chemical
that	IN	mark	O
nobody	NN	nsubj	O
could	MD	aux	O
have	VB	aux	O
predicted	VBN	relcl	O
only	RB	advmod	O
a	DT	quantmod	O
few	JJ	nummod	O
years	NNS	npadvmod	O
ago	RB	advmod	O
.	.	punct	O

Increased	VBN	amod	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	compound	I-Gene_or_gene_product
messenger	NN	compound	O
RNA	NN	compound	O
expression	NN	ROOT	O
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
colon	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
of	IN	case	O
low	JJ	amod	O
and	CC	cc	O
high	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
murine	JJ	amod	B-Organism
nm23	NN	compound	B-Gene_or_gene_product
gene	NN	nsubj	O
suppresses	VBZ	dep	O
the	DT	det	O
metastatic	JJ	amod	O
behavior	NN	dobj	O
of	IN	case	O
malignant	JJ	amod	B-Cell
rodent	JJ	amod	I-Cell
tumor	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
reduced	VBD	amod	O
nm23	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
correlates	VBZ	conj	O
with	IN	case	O
increased	VBN	amod	O
likelihood	NN	nmod	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

More	RBR	advmod	O
recent	JJ	amod	O
data	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
human	JJ	amod	B-Organism
nm23	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
homologues	NNS	nmod	O
,	,	punct	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
have	VBP	aux	O
shown	VBN	conj	O
that	IN	mark	O
deletion	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
alleles	NNS	nmod	O
occurs	VBZ	ccomp	O
in	IN	case	O
some	DT	det	O
colon	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	nsubj	I-Gene_or_gene_product
encodes	VBZ	ccomp	O
for	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
colon	NN	compound	B-Cancer
carcinoma	NN	compound	I-Cancer
metastasis	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
total	JJ	amod	O
nm23	NN	compound	B-Gene_or_gene_product
messenger	NN	compound	O
RNA	NN	dep	O
(	-LRB-	punct	O
mRNA	NN	appos	O
)	-RRB-	punct	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	ccomp	O
to	TO	case	O
similar	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
of	IN	case	O
both	CC	cc:preconj	O
high	JJ	amod	O
and	CC	cc	O
low	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	dep	O
to	TO	mark	O
reconcile	VB	xcomp	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
findings	NNS	dobj	O
with	IN	case	O
the	DT	det	O
recent	JJ	amod	O
report	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
allelic	JJ	amod	O
deletion	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
purpose	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
for	IN	case	O
inactivation	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
candidate	NN	compound	O
metastasis	NN	compound	O
suppressor	NN	compound	O
genes	NNS	nmod	O
,	,	punct	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
,	,	punct	O
either	CC	cc:preconj	O
by	IN	case	O
mutation	NN	nmod	O
or	CC	cc	O
by	IN	case	O
loss	NN	conj	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
used	VBD	appos	O
ribonuclease	NN	compound	B-Gene_or_gene_product
protection	NN	compound	O
assays	NNS	dobj	O
to	TO	mark	O
analyze	VB	xcomp	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
tumors	NNS	dobj	I-Cancer
for	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
43	CD	nummod	O
samples	NNS	appos	B-Cancer
)	-RRB-	punct	O
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
41	CD	nummod	O
samples	NNS	appos	B-Cancer
)	-RRB-	punct	O
transcript	NN	compound	O
(	-LRB-	punct	O
mRNA	NN	appos	O
)	-RRB-	punct	O
expression	NN	dobj	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
mutations	NNS	nmod	O
that	WDT	nsubj	O
could	MD	aux	O
inactivate	VB	acl:relcl	O
potential	JJ	amod	O
suppressor	NN	compound	O
function	NN	dobj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
detected	VBD	ROOT	O
only	RB	advmod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
mRNA	NN	dobj	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
increased	VBD	ROOT	O
in	IN	case	O
33	CD	compound	O
of	IN	advmod	O
41	CD	nummod	O
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
expression	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
was	VBD	auxpass	O
elevated	JJ	conj	O
in	IN	case	O
28	CD	compound	O
of	IN	advmod	O
41	CD	nummod	O
colon	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
relative	JJ	case	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
matched	VBN	amod	O
normal	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

Increases	NNS	nsubj	O
in	IN	case	O
these	DT	det	O
mRNA	NN	compound	O
levels	NNS	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
of	IN	case	O
both	CC	cc:preconj	O
low	JJ	amod	O
and	CC	cc	O
high	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
,	,	punct	O
despite	IN	case	O
correlation	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
allelic	JJ	amod	O
deletions	NNS	nmod	O
with	IN	case	O
colon	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
,	,	punct	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
alleles	NNS	nmod	O
do	VBP	aux	O
not	RB	neg	O
directly	RB	advmod	O
mediate	VB	ccomp	O
metastasis	NN	compound	O
suppression	NN	dobj	O
in	IN	case	O
colon	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
leave	VBP	ROOT	O
unexplained	JJ	xcomp	O
the	DT	det	O
observation	NN	dobj	O
that	IN	mark	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
allelic	JJ	amod	O
deletion	NN	nsubj	O
correlates	VBZ	ccomp	O
with	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
colon	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

IMPLICATIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
findings	NNS	nsubj	O
also	RB	advmod	O
contrast	VBP	dep	O
with	IN	case	O
the	DT	det	O
demonstration	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
metastasis	NN	compound	O
suppressor	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
murine	JJ	amod	B-Organism
melanoma	NN	nmod	B-Cancer
and	CC	cc	O
with	IN	case	O
the	DT	det	O
correlation	NN	conj	O
of	IN	case	O
loss	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
may	MD	aux	O
be	VB	ROOT	O
that	IN	mark	O
metastasis	NN	compound	O
suppression	NN	nsubj	O
by	IN	case	O
the	DT	det	O
nm23	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
tissue	NN	nmod:npmod	B-Tissue
-	HYPH	punct	O
specific	JJ	amod	O
phenomenon	NN	ccomp	O
.	.	punct	O

E	NNP	compound	B-Gene_or_gene_product
mu	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
bcl	NN	compound	I-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
transgene	NN	nsubj	O
facilitates	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
pre	JJ	compound	B-Cell
-	HYPH	punct	I-Cell
B	NN	nmod	I-Cell
and	CC	cc	O
immunoglobulin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
secreting	NN	compound	O
cells	NNS	conj	B-Cell
but	CC	cc	O
not	RB	cc	O
T	NN	compound	B-Cell
cells	NNS	dep	I-Cell
.	.	punct	O

To	TO	mark	O
assess	VB	ROOT	O
the	DT	det	O
lymphoid	JJ	amod	B-Cell
tumorigenic	JJ	amod	O
potential	NN	dobj	O
of	IN	case	O
bcl	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
mice	NNS	dobj	B-Organism
of	IN	case	O
five	CD	nummod	O
independent	JJ	amod	O
strains	NNS	nmod	O
expressing	VBG	acl	O
a	DT	det	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
transgene	NN	dobj	O
in	IN	case	O
B	NN	nmod	B-Cell
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
T	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
monitored	VBN	conj	O
for	IN	case	O
disease	NN	nmod	O
up	IN	case	O
to	TO	case	O
12	CD	nummod	O
months	NNS	nmod	O
of	IN	case	O
age	NN	nmod	O
.	.	punct	O

Lymphoma	NN	compound	B-Cancer
prevalence	NN	nsubj	O
was	VBD	cop	O
minimal	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
T	NN	compound	B-Cell
lineage	NN	nmod	I-Cell
but	CC	cc	O
significant	JJ	conj	O
,	,	punct	O
although	IN	mark	O
low	JJ	advcl	O
(	-LRB-	punct	O
3	CD	compound	O
-	SYM	punct	O
15	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
B	NN	compound	B-Cell
lineage	NN	nmod	I-Cell
.	.	punct	O

The	DT	det	O
principal	JJ	amod	O
types	NNS	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
were	VBD	cop	O
plasmacytomas	NNS	compound	B-Cancer
secreting	VBG	compound	O
immunoglobulin	NN	ROOT	B-Gene_or_gene_product
and	CC	cc	O
novel	JJ	amod	O
lymphomas	NNS	conj	B-Cancer
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
markers	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
Sca	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
CD4	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Thy	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
CD34	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
CD45	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
B220	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
consistent	JJ	amod	O
with	IN	case	O
an	DT	det	O
origin	NN	nmod	O
very	RB	advmod	O
early	RB	amod	O
in	IN	case	O
B	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
lymphoid	JJ	amod	I-Cell
development	NN	nmod	O
.	.	punct	O

Rearrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
was	VBD	cop	O
common	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
plasmacytomas	NNS	nmod	B-Cancer
,	,	punct	O
implying	VBG	advcl	O
a	DT	det	O
synergistic	JJ	amod	O
role	NN	dobj	O
for	IN	prep	O
myc	NN	pobj	B-Gene_or_gene_product
and	CC	cc	O
bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
their	PRP$	nmod:poss	O
etiology	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	conj	O
in	IN	case	O
the	DT	det	O
lymphomas	NNS	nmod	B-Cancer
.	.	punct	O

Tumorigenic	JJ	amod	O
activity	NN	ROOT	O
of	IN	case	O
rho	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
from	IN	case	O
Aplysia	NN	compound	B-Organism
californica	NN	nmod	I-Organism
.	.	punct	O

rho	NN	ROOT	B-Gene_or_gene_product
genes	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ccomp	O
in	IN	case	O
both	CC	cc:preconj	O
lower	JJR	nmod	O
and	CC	cc	O
higher	JJR	conj	O
eucaryotes	NNS	dep	O
.	.	punct	O

They	PRP	nsubj	O
code	VBP	ROOT	O
for	IN	case	O
proteins	NNS	nmod	O
of	IN	case	O
21	CD	nummod	O
kDa	NN	nmod	O
,	,	punct	O
highly	RB	advmod	O
conserved	VBN	advcl	O
in	IN	case	O
evolution	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
belong	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
superfamily	NN	nmod	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
GTPases	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

Among	IN	case	O
the	DT	det	O
members	NNS	nmod	O
of	IN	case	O
this	DT	det	O
superfamily	NN	nmod	O
there	EX	expl	O
are	VBP	ROOT	O
proteins	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
function	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ras	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
proteins	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
vesicular	JJ	amod	B-Multi-tissue_structure
trafficking	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
family	NN	nmod	O
of	IN	case	O
rab	JJ	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
putative	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
rho	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
from	IN	case	O
Aplysia	NN	compound	B-Organism
californica	NN	nmod	I-Organism
as	IN	case	O
transforming	VBG	amod	O
GTPases	NNS	nmod	B-Gene_or_gene_product
utilizing	VBG	acl	O
the	DT	det	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	dobj	O
and	CC	cc	O
a	DT	det	O
Val	NN	compound	B-Organism
-	HYPH	punct	I-Organism
14	CD	nummod	I-Organism
mutant	JJ	conj	I-Organism
,	,	punct	O
equivalent	JJ	advcl	O
to	IN	case	O
the	DT	det	O
oncogenic	JJ	amod	O
Val	NN	compound	O
-	HYPH	punct	O
12	CD	nummod	O
mutation	NN	nmod	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
found	VBN	acl	O
in	IN	case	O
animal	NN	nmod	O
and	CC	cc	O
human	JJ	conj	B-Organism
tumors	NNS	dep	B-Cancer
.	.	punct	O

Over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
of	IN	case	O
either	CC	det	O
rho	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
confer	VB	xcomp	O
anchorage	NN	amod	O
-	HYPH	punct	O
and	CC	cc	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
introduced	VBN	advcl	O
into	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
selected	VBN	amod	O
clones	NNS	nsubj	O
generated	VBN	acl	O
from	IN	case	O
either	CC	det	O
gene	NN	nmod	O
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
tumors	NNS	dobj	B-Cancer
,	,	punct	O
although	IN	mark	O
those	DT	nsubj	O
carrying	VBG	acl	O
the	DT	det	O
mutated	VBN	amod	O
version	NN	dobj	O
were	VBD	cop	O
more	RBR	advmod	O
efficient	JJ	advcl	O
.	.	punct	O

Pathological	JJ	amod	O
analysis	NN	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
generated	VBN	amod	O
tumors	NNS	nsubj	B-Cancer
corresponded	VBD	ccomp	O
to	TO	case	O
well	RB	advmod	O
-	HYPH	punct	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	nmod	B-Cancer
with	IN	case	O
distinct	JJ	amod	O
and	CC	cc	O
intersecting	VBG	conj	O
bundles	NNS	nmod	B-Cell
and	CC	cc	O
spindle	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	ROOT	B-Cancer
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
appropriate	JJ	amod	O
conditions	NNS	nmod	O
rho	NN	ccomp	B-Gene_or_gene_product
genes	NNS	compound	O
function	VBP	dobj	O
as	IN	case	O
oncogenes	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
in	IN	case	O
fibroblast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Pancreatic	JJ	amod	B-Organ
somatostatin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
secreting	VBG	compound	O
gangliocytic	JJ	amod	B-Cancer
paraganglioma	NN	ROOT	I-Cancer
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
.	.	punct	O

Gangliocytic	JJ	amod	B-Cancer
paraganglioma	NN	nsubjpass	I-Cancer
(	-LRB-	punct	O
GPG	NN	appos	B-Cancer
)	-RRB-	punct	O
with	IN	case	O
local	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
pancreas	NN	nmod	B-Organ
of	IN	case	O
a	DT	det	O
74	CD	nummod	O
-	HYPH	punct	O
yr	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
female	NN	nmod	B-Organism
who	WP	nsubj	O
presented	VBD	acl:relcl	O
with	IN	prep	O
diarrhea	NNS	pobj	O
,	,	punct	O
steatorrhea	NNS	conj	O
,	,	punct	O
vomiting	NN	conj	O
,	,	punct	O
nausea	NN	conj	O
,	,	punct	O
and	CC	cc	O
abdominal	JJ	amod	B-Organism_subdivision
pain	NN	conj	O
.	.	punct	O

A	DT	det	O
Whipple	NNP	compound	O
procedure	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
complete	JJ	amod	O
resolution	NN	nmod	O
of	IN	case	O
these	DT	det	O
symptoms	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
return	NN	conj	O
of	IN	case	O
an	DT	det	O
elevated	JJ	amod	O
stomatostatin	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
to	TO	case	O
normal	JJ	nmod	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
description	NN	ROOT	O
of	IN	case	O
GPG	NN	nmod	B-Cancer
in	IN	case	O
this	DT	det	O
location	NN	nmod	O
and	CC	cc	O
the	DT	det	O
first	JJ	amod	O
endocrinologically	RB	advmod	O
active	JJ	amod	O
GPG	NN	conj	B-Cancer
.	.	punct	O

Stimulation	NN	ROOT	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
by	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
permeability	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
/	:	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
through	IN	case	O
cooperative	JJ	amod	O
mechanisms	NNS	nmod	O
involving	VBG	acl	O
the	DT	det	O
alphavbeta3	NN	compound	B-Gene_or_gene_product
integrin	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
osteopontin	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
thrombin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
several	JJ	amod	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
angiogenic	JJ	amod	O
cytokine	NN	compound	O
vascular	JJ	amod	B-Gene_or_gene_product
permeability	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
/	:	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VPF	NN	dep	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
likely	RB	advmod	O
regulates	VBZ	acl:relcl	O
endothelial	JJ	amod	B-Cell
cells	NNS	compound	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
migration	NN	dobj	O
.	.	punct	O

VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
induced	VBD	ROOT	O
dermal	JJ	amod	B-Cell
microvascular	JJ	amod	I-Cell
EC	NN	compound	I-Cell
expression	NN	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
alphav	JJ	dobj	B-Gene_or_gene_product
and	CC	cc	O
beta3	NN	compound	B-Gene_or_gene_product
integrin	NN	compound	I-Gene_or_gene_product
subunits	NNS	conj	I-Gene_or_gene_product
resulting	VBG	acl	O
in	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
alphavbeta3	NN	compound	B-Gene_or_gene_product
heterodimer	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
,	,	punct	O
and	CC	cc	O
VPF	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
induced	VBD	conj	O
mRNA	NN	dobj	O
encoding	NN	acl	O
osteopontin	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
OPN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
alphavbeta3	NN	compound	B-Gene_or_gene_product
ligand	NN	appos	O
.	.	punct	O

OPN	NNP	nsubj	B-Gene_or_gene_product
promoted	VBD	ROOT	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
;	:	punct	O
and	CC	cc	O
VPF	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
induction	NN	nsubjpass	O
of	IN	case	O
alphavbeta3	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
increased	VBN	amod	O
EC	NN	compound	B-Cell
migration	NN	nmod	O
toward	IN	case	O
OPN	NNP	nmod	B-Gene_or_gene_product
.	.	punct	O

Because	IN	mark	O
thrombin	NN	compound	B-Gene_or_gene_product
cleavage	NN	nsubj	O
of	IN	case	O
OPN	NN	compound	B-Gene_or_gene_product
results	VBZ	nmod	O
in	IN	case	O
substantial	JJ	amod	O
enhancement	NN	nmod	O
of	IN	case	O
OPN	NN	nmod:poss	B-Gene_or_gene_product
'	POS	punct	O
s	VBZ	compound	O
adhesive	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
because	IN	mark	O
VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
promotes	VBZ	conj	O
increased	VBD	amod	O
microvascular	JJ	amod	B-Tissue
permeability	NN	dobj	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
extrinsic	JJ	amod	O
coagulation	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
investigated	VBD	ROOT	O
whether	IN	mark	O
VPF	NNP	nsubj	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	conj	B-Gene_or_gene_product
facilitates	NNS	ccomp	O
thrombin	NN	compound	B-Gene_or_gene_product
cleavage	NN	dobj	O
of	IN	case	O
OPN	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
this	DT	det	O
hypothesis	NN	nmod	O
,	,	punct	O
co	NN	compound	O
-	HYPH	punct	O
injection	NN	nsubj	O
of	IN	case	O
VPF	NNP	nmod	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	dep	B-Gene_or_gene_product
together	RB	advmod	O
with	IN	case	O
OPN	NN	nmod	B-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
rapid	JJ	amod	O
cleavage	NN	nmod	O
of	IN	case	O
OPN	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
endogenous	JJ	amod	O
thrombin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
native	JJ	amod	O
OPN	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
thrombin	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
cleaved	VBN	amod	O
OPN	NN	appos	B-Gene_or_gene_product
stimulated	VBD	ROOT	O
a	DT	det	O
greater	JJR	amod	O
rate	NN	dobj	O
of	IN	case	O
EC	NN	compound	B-Cell
migration	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
additive	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
increased	VBN	amod	O
migration	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
v	NN	compound	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
cooperative	JJ	amod	O
mechanisms	NNS	dobj	O
for	IN	case	O
VPF	NNP	nmod	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
regulation	NN	conj	O
of	IN	case	O
EC	NN	compound	B-Cell
migration	NN	nmod	O
involving	VBG	acl	O
the	DT	det	O
alphavbeta3	NN	compound	B-Gene_or_gene_product
integrin	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
alphavbeta3	NN	compound	B-Gene_or_gene_product
ligand	NN	compound	O
OPN	NN	appos	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
thrombin	NN	compound	B-Gene_or_gene_product
cleavage	NN	conj	O
of	IN	case	O
OPN	NNP	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
also	RB	advmod	O
illustrate	VBP	ROOT	O
an	DT	det	O
operational	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
VPF	NNP	nmod	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
induction	NN	conj	O
of	IN	case	O
EC	NN	compound	B-Cell
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
VPF	NN	compound	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
enhancement	NN	conj	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
permeability	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
these	DT	det	O
distinct	JJ	amod	O
biological	JJ	amod	O
activities	NNS	nsubj	O
may	MD	aux	O
act	VB	ccomp	O
accordingly	RB	advmod	O
to	TO	mark	O
stimulate	VB	xcomp	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erb	NN	compound	I-Gene_or_gene_product
B2	NN	compound	I-Gene_or_gene_product
overexpression	NN	nsubj	O
decreases	VBZ	ROOT	O
the	DT	det	O
benefit	NN	dobj	O
of	IN	case	O
adjuvant	JJ	amod	O
tamoxifen	NN	nmod	B-Simple_chemical
in	IN	case	O
early	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
stage	NN	compound	I-Cancer
breast	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
without	IN	case	O
axillary	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
studied	VBD	dep	O
retrospectively	RB	advmod	O
the	DT	det	O
interaction	NN	dobj	O
between	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NN	compound	I-Gene_or_gene_product
overexpression	NN	nmod	O
and	CC	cc	O
adjuvant	JJ	amod	O
tomoxifen	NN	conj	B-Simple_chemical
in	IN	case	O
node	NN	nmod:npmod	B-Multi-tissue_structure
-	HYPH	punct	O
negative	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
enrolled	VBD	acl	O
in	IN	case	O
the	DT	det	O
Gruppo	NNP	compound	O
Universitario	NNP	nmod	O
Napoletano	NNP	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
GUN	NN	compound	O
-	:	punct	O
1	LS	nummod	O
)	-RRB-	punct	O
trial	NN	dep	O
.	.	punct	O

PATIENTS	NNS	nsubj	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	dep	I-Gene_or_gene_product
,	,	punct	O
evaluated	VBN	acl	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
in	IN	case	O
145	CD	compound	O
of	IN	advmod	O
173	CD	nummod	O
patients	NNS	nmod	B-Organism
randomly	RB	advmod	O
assigned	VBN	ROOT	O
to	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
year	NN	nmod	O
adjuvant	JJ	amod	O
tamoxifen	NN	dobj	B-Simple_chemical
or	CC	cc	O
no	DT	neg	O
further	JJ	amod	O
therapy	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
considered	VBN	conj	O
overexpressed	VBN	xcomp	O
if	IN	mark	O
greater	JJR	amod	O
than	IN	quantmod	O
10	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
showed	VBD	advcl	O
specific	JJ	amod	O
membrane	NN	compound	B-Cellular_component
staining	NN	dobj	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
each	DT	det	O
prognostic	JJ	amod	O
variable	NN	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
independent	JJ	amod	O
effect	NN	conj	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
Cox	NN	compound	O
model	NN	dobj	O
.	.	punct	O

Disease	NNP	compound	O
-	HYPH	punct	O
free	JJ	amod	O
(	-LRB-	punct	O
DFS	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
overall	RB	amod	O
(	-LRB-	punct	O
OAS	NN	appos	O
)	-RRB-	punct	O
survival	NN	dep	O
curves	NNS	nsubjpass	O
were	VBD	auxpass	O
estimated	VBN	ROOT	O
by	IN	agent	O
the	DT	det	O
Kaplan	NNP	compound	O
-	HYPH	punct	O
Meier	NNP	amod	O
method	NN	pobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
As	IN	prep	O
of	IN	prep	O
November	NNP	pobj	O
30	CD	nummod	O
,	,	punct	O
1994	CD	nummod	O
,	,	punct	O
the	DT	det	O
median	JJ	amod	O
follow	NN	compound	O
-	HYPH	punct	O
up	RP	cc	O
period	NN	nsubj	O
was	VBD	dep	O
12	CD	nummod	O
years	NNS	attr	O
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
overexpressed	VBN	ROOT	O
in	IN	case	O
43	CD	nummod	O
of	IN	case	O
145	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
29	CD	nummod	O
.	.	punct	O
7	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
directly	RB	advmod	O
correlated	VBD	acl:relcl	O
with	IN	case	O
tumor	NN	compound	B-Cancer
size	NN	nmod	O
and	CC	cc	O
inversely	RB	advmod	O
with	IN	case	O
estrogen	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
ER	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
level	NN	conj	O
.	.	punct	O

At	IN	case	O
univariate	JJ	amod	O
analysis	NN	nmod	O
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	nmod	I-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
either	CC	cc:preconj	O
DFS	NN	dobj	O
or	CC	cc	O
OAS	NN	conj	O
;	:	punct	O
tamoxifen	NN	nsubj	B-Simple_chemical
had	VBD	parataxis	O
a	DT	det	O
greater	JJR	amod	O
effect	NN	dobj	O
on	IN	mark	O
reducing	VBG	advcl	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
recurrence	NN	nmod	O
than	IN	case	O
of	IN	case	O
death	NN	nmod	O
.	.	punct	O

Addition	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	nmod	I-Gene_or_gene_product
to	IN	case	O
a	DT	det	O
multivariate	JJ	amod	O
Cox	NN	compound	O
model	NN	nmod	O
that	WDT	nsubj	O
contained	VBD	acl:relcl	O
menopausal	JJ	amod	O
status	NN	dobj	O
,	,	punct	O
tumor	NN	compound	B-Cancer
size	NN	conj	O
,	,	punct	O
nuclear	JJ	amod	B-Cellular_component
grade	NN	conj	O
,	,	punct	O
and	CC	cc	O
treatment	NN	nsubj	O
as	IN	case	O
covariates	NNS	nmod	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
the	DT	det	O
model	NN	nmod	O
for	IN	case	O
DSF	NNP	nmod	O
or	CC	cc	O
OAS	NNP	conj	O
,	,	punct	O
whereas	IN	mark	O
addition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
-	HYPH	punct	O
order	NN	compound	O
interaction	NN	nmod	O
between	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
tamoxifen	NN	conj	B-Simple_chemical
was	VBD	cop	O
statistically	RB	advmod	O
significant	JJ	advcl	O
both	CC	cc:preconj	O
for	IN	case	O
DFS	NN	nmod	O
and	CC	cc	O
OAS	NNP	conj	O
.	.	punct	O

The	DT	det	O
same	JJ	amod	O
result	NN	nsubjpass	O
was	VBD	auxpass	O
obtained	VBN	ROOT	O
when	WRB	advmod	O
the	DT	det	O
model	NN	nsubj	O
contained	VBD	advcl	O
ER	NN	compound	B-Gene_or_gene_product
status	NN	dobj	O
and	CC	cc	O
ER	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
tamoxifen	NN	compound	B-Simple_chemical
interaction	NN	conj	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
adjuvant	JJ	amod	O
tamoxifen	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
prolonged	VBD	ROOT	O
DFS	NN	dobj	O
and	CC	cc	O
OAS	NN	conj	O
in	IN	case	O
c	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
negative	JJ	amod	O
cases	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
it	PRP	nsubj	O
had	VBD	parataxis	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
DFS	NN	nmod	O
and	CC	cc	O
OAS	NN	conj	O
in	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
In	IN	case	O
early	JJ	amod	O
-	HYPH	punct	O
stage	NN	compound	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	nmod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
marker	NN	appos	O
of	IN	case	O
lack	NN	nmod	O
of	IN	case	O
efficacy	NN	nmod	O
of	IN	case	O
adjuvant	JJ	amod	O
tamoxifen	NN	nmod	B-Simple_chemical
.	.	punct	O

Gene	NN	compound	O
transfer	NN	nsubj	O
of	IN	case	O
naked	VBN	amod	O
DNA	NN	nmod	B-Cellular_component
encoding	VBG	acl	O
for	IN	case	O
three	CD	nummod	O
isoforms	NNS	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
stimulates	VBZ	ROOT	O
collateral	JJ	amod	B-Multi-tissue_structure
development	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
naturally	RB	advmod	O
secreted	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
specific	JJ	amod	O
mitogen	NN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
naked	VBD	amod	O
DNA	NN	nsubjpass	B-Cellular_component
encoding	VBG	acl	O
for	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
strategy	NN	nmod	O
of	IN	case	O
arterial	JJ	amod	B-Multi-tissue_structure
gene	NN	compound	O
therapy	NN	nmod	O
to	TO	mark	O
stimulate	VB	xcomp	O
collateral	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
development	NN	dobj	O
.	.	punct	O

Plasmid	NN	amod	B-Cellular_component
DNA	NN	nsubjpass	I-Cellular_component
encoding	VBG	acl	O
each	DT	dobj	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
principal	JJ	amod	O
human	JJ	amod	B-Organism
VEGF	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nmod	O
(	-LRB-	punct	O
phVEGF121	NN	dep	B-Gene_or_gene_product
,	,	punct	O
phVEGF165	NN	conj	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
phVEGF189	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
hydrogel	NN	compound	O
polymer	NN	nmod	O
coating	VBG	acl	O
of	IN	case	O
an	DT	det	O
angioplasty	JJ	amod	O
balloon	NN	nmod	O
and	CC	cc	O
delivered	VBN	conj	O
percutaneously	RB	advmod	O
to	IN	case	O
one	CD	nummod	O
iliac	JJ	compound	B-Multi-tissue_structure
artery	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
rabbits	NNS	nmod	B-Organism
with	IN	case	O
operatively	RB	advmod	O
induced	VBN	amod	O
hindlimb	JJ	compound	B-Organism_subdivision
ischemia	NN	nmod	O
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
animals	NNS	nsubj	O
transfected	VBN	acl	O
with	IN	case	O
LacZ	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
site	NN	nmod:npmod	O
-	:	punct	O
specific	JJ	amod	O
transfection	NN	conj	O
of	IN	case	O
phVEGF	NN	nmod	B-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
augmented	JJ	amod	O
collateral	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
development	NN	nmod	O
documented	VBN	acl	O
by	IN	case	O
serial	JJ	amod	O
angiography	NN	nmod	O
,	,	punct	O
and	CC	cc	O
improvement	NN	conj	O
in	IN	case	O
calf	NN	compound	B-Organism_subdivision
blood	NN	compound	B-Organism_substance
pressure	NN	compound	O
ratio	NN	nmod	O
(	-LRB-	punct	O
ischemic	JJ	dep	B-Organism_subdivision
to	TO	case	O
normal	JJ	amod	B-Organism_subdivision
limb	NN	nmod	I-Organism_subdivision
)	-RRB-	punct	O
,	,	punct	O
resting	VBG	amod	O
and	CC	cc	O
maximum	NN	conj	O
blood	NN	compound	B-Organism_substance
flow	NN	conj	O
,	,	punct	O
and	CC	cc	O
capillary	JJ	conj	B-Tissue
to	TO	prep	O
myocyte	VB	compound	B-Cell
ratio	NN	pobj	O
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
phVEGF121	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
phVEGF165	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
phVEGF189	NN	conj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
these	DT	det	O
isoforms	NNS	nsubj	O
are	VBP	cop	O
biologically	RB	advmod	O
equivalent	JJ	ccomp	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
fact	NN	nsubj	O
that	IN	mark	O
viral	JJ	amod	O
or	CC	cc	O
other	JJ	conj	O
adjunctive	JJ	amod	O
vectors	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
required	VBN	acl	O
further	RB	advmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
secreted	VBN	amod	O
gene	NN	compound	O
products	NNS	nsubj	O
may	MD	aux	O
have	VB	ccomp	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
utility	NN	dobj	O
even	RB	advmod	O
when	WRB	advmod	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
successfully	RB	advmod	O
transfected	VBN	amod	O
cells	NNS	nmod	B-Cell
remains	VBZ	advcl	O
low	JJ	xcomp	O
.	.	punct	O

Arterial	JJ	amod	B-Multi-tissue_structure
gene	NN	compound	O
transfer	NN	nsubj	O
of	IN	case	O
naked	VBN	amod	O
DNA	NN	nmod	B-Cellular_component
encoding	VBG	acl	O
for	IN	case	O
a	DT	det	O
secreted	VBN	amod	O
angiogenic	JJ	amod	O
cytokine	NN	nmod	O
,	,	punct	O
thus	RB	advmod	O
,	,	punct	O
represents	VBZ	ROOT	O
a	DT	det	O
potential	JJ	amod	O
alternative	NN	dobj	O
to	TO	case	O
recombinant	JJ	amod	O
protein	NN	compound	O
administration	NN	nmod	O
for	IN	mark	O
stimulating	VBG	acl	O
collateral	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
development	NN	dobj	O
.	.	punct	O

Comparison	NN	ROOT	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
manganese	JJ	amod	B-Simple_chemical
sulfate	NN	nmod	I-Simple_chemical
and	CC	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	conj	I-Simple_chemical
in	IN	case	O
Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
overexpressing	VBG	acl	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
oncogene	NN	dobj	O
.	.	punct	O

Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
cells	NNS	nsubjpass	I-Cell
are	VBP	auxpass	O
not	RB	neg	O
transformed	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	VBN	amod	O
carcinogens	NNS	compound	O
benzo	NN	nmod	B-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
a	DT	det	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
pyrene	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
BP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
or	CC	cc	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitro	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosoguanidine	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
MNNG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Upon	IN	case	O
retroviral	JJ	amod	B-Organism
transduction	NN	nmod	O
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-Organism
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
showed	VBD	ROOT	O
mildly	RB	advmod	O
altered	VBN	amod	O
morphology	NN	dobj	O
and	CC	cc	O
formed	VBN	conj	O
microcolonies	NNS	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
;	:	punct	O
furthermore	RB	advmod	O
,	,	punct	O
they	PRP	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
transformed	VBN	parataxis	O
by	IN	case	O
BP	NN	nmod	B-Simple_chemical
and	CC	cc	O
MNNG	NN	conj	B-Simple_chemical
to	TO	mark	O
form	VB	xcomp	O
large	JJ	amod	O
colonies	NNS	dobj	O
in	IN	case	O
agar	NN	nmod	O
(	-LRB-	punct	O
Hsiao	NNP	dep	O
et	FW	dep	O
al	FW	dep	O
.	.	punct	O
(	-LRB-	punct	O
1992	CD	dep	O
)	-RRB-	punct	O
Mol	NN	ROOT	O
.	.	punct	O
Carcinogenesis	NN	ROOT	O
,	,	punct	O
5	CD	appos	O
,	,	punct	O
140	CD	nummod	O
-	SYM	punct	O
154	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
to	IN	case	O
two	CD	nummod	O
additional	JJ	amod	O
chemicals	NNS	nmod	O
:	:	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	dep	I-Simple_chemical
and	CC	cc	O
MnSO4	NN	conj	B-Simple_chemical
.	.	punct	O

These	DT	det	O
chemicals	NNS	nsubj	O
differ	VBP	ROOT	O
from	IN	case	O
the	DT	det	O
direct	JJ	amod	O
-	HYPH	punct	O
acting	VBG	amod	O
mutagens	NNS	nmod	O
tested	VBN	acl	O
previously	RB	advmod	O
.	.	punct	O

5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Azacytidine	NNP	nsubj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
DNA	NN	compound	B-Cellular_component
methylation	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
induced	VBD	ROOT	O
growth	NN	dobj	O
of	IN	prep	O
large	JJ	amod	O
colonies	NNS	pobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	compound	O
cultures	NNS	nmod	O
of	IN	case	O
Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
or	CC	cc	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	conj	I-Gene_or_gene_product
cells	NNS	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
MnSO4	NN	nsubj	B-Simple_chemical
only	RB	advmod	O
induced	VBD	ROOT	O
transformation	NN	dobj	O
in	IN	case	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
cells	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	B-Cell
6	CD	nummod	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Transformants	NNS	nsubj	B-Cell
induced	VBN	acl	O
by	IN	agent	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	pobj	I-Simple_chemical
lost	VBD	ROOT	O
c	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
MnSO4	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
transformants	NNS	nsubj	B-Cell
showed	VBD	parataxis	O
a	DT	det	O
higher	JJR	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
cells	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
MnSO4	NN	compound	B-Simple_chemical
co	NN	compound	O
-	:	punct	O
operates	VBZ	ccomp	O
with	IN	case	O
overexpressed	VBN	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
in	IN	prep	O
inducing	VBG	pcomp	O
transformation	NN	dobj	O
,	,	punct	O
while	IN	mark	O
5	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	compound	I-Simple_chemical
transformation	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	advcl	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
overexpression	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
involve	VB	conj	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
transcriptional	JJ	amod	O
repression	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	B-Cell
transformation	NN	conj	O
by	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
55	CD	nummod	O
-	HYPH	punct	O
kilodalton	NN	compound	O
E1B	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
adenovirus	NN	compound	I-Organism
type	NN	nmod	I-Organism
5	CD	nummod	I-Organism
.	.	punct	O

The	DT	det	O
adenovirus	NN	compound	B-Organism
type	NN	compound	I-Organism
5	CD	nummod	I-Organism
55	CD	nummod	O
-	HYPH	punct	O
kDa	NN	compound	O
E1B	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
(	-LRB-	punct	O
E1B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
55kDa	NN	appos	O
)	-RRB-	punct	O
cooperates	VBZ	ROOT	O
with	IN	case	O
E1A	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
products	NNS	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	B-Cell
transformation	NN	dobj	O
.	.	punct	O

E1A	NN	compound	B-Gene_or_gene_product
proteins	NNS	nsubj	O
stimulate	VBP	ROOT	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
also	RB	advmod	O
cause	VBP	parataxis	O
rapid	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
by	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
independent	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
55kDa	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
is	VBZ	ccomp	O
to	TO	mark	O
protect	VB	xcomp	O
against	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	dep	O
and	CC	cc	O
inactivating	VBG	conj	O
p53	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
previously	RB	advmod	O
that	IN	mark	O
the	DT	det	O
55	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kDa	NN	amod	I-Gene_or_gene_product
polypeptide	NN	nsubj	O
abrogates	VBZ	ccomp	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transactivation	NN	dobj	O
and	CC	cc	O
that	IN	mark	O
mutants	NNS	nsubj	O
defective	JJ	amod	O
in	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
are	VBP	cop	O
unable	JJ	conj	O
to	TO	mark	O
cooperate	VB	xcomp	O
with	IN	case	O
E1A	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
transformation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
mapped	VBN	ROOT	O
phosphorylation	NN	compound	O
sites	NNS	dobj	O
near	IN	case	O
the	DT	det	O
carboxy	NN	compound	O
terminus	NN	nmod	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
55kDa	JJ	compound	O
protein	NN	nmod	O
at	IN	case	O
Ser	NN	compound	B-Amino_acid
-	HYPH	punct	I-Amino_acid
490	CD	nummod	I-Amino_acid
and	CC	cc	O
Ser	NNP	compound	B-Amino_acid
-	HYPH	punct	I-Amino_acid
491	CD	nmod	I-Amino_acid
,	,	punct	O
which	WDT	nsubj	O
lie	VBP	acl:relcl	O
within	IN	case	O
casein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
consensus	NN	compound	O
sequences	NNS	nmod	O
.	.	punct	O

Conversion	NN	nsubj	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
to	TO	case	O
alanine	NN	compound	B-Amino_acid
residues	NNS	nmod	O
greatly	RB	advmod	O
reduced	VBD	ROOT	O
transforming	NN	amod	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
although	IN	mark	O
the	DT	det	O
mutant	JJ	amod	O
55	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kDa	NN	compound	I-Gene_or_gene_product
protein	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
normal	JJ	amod	O
levels	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
somewhat	RB	advmod	O
defective	JJ	conj	O
for	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
transactivation	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
nearby	JJ	amod	O
residue	NN	nsubj	O
,	,	punct	O
Thr	NNP	compound	B-Amino_acid
-	HYPH	punct	I-Amino_acid
495	CD	appos	I-Amino_acid
,	,	punct	O
also	RB	advmod	O
appears	VBZ	ccomp	O
to	TO	mark	O
be	VB	auxpass	O
phosphorylated	VBN	xcomp	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
directly	RB	advmod	O
that	IN	mark	O
the	DT	det	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
55	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kDa	NN	compound	I-Gene_or_gene_product
protein	NN	nsubj	O
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
block	VB	xcomp	O
E1A	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
dependent	JJ	amod	O
apoptosis	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
cells	NNS	nsubj	B-Cell
infected	VBN	acl	O
by	IN	case	O
mutant	JJ	amod	B-Organism
pm490	NN	nmod	I-Organism
/	:	punct	I-Organism
1	CD	nummod	I-Organism
/	:	punct	I-Organism
5A	NN	appos	I-Organism
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
alanine	NN	compound	B-Amino_acid
residues	NNS	dobj	O
at	IN	case	O
all	DT	det	O
three	CD	nummod	O
phosphorylation	NN	compound	O
sites	NNS	nmod	O
,	,	punct	O
exhibited	VBD	advcl	O
extensive	JJ	amod	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	dobj	O
and	CC	cc	O
classic	JJ	amod	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
.	.	punct	O

The	DT	det	O
E1B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
55kDa	JJ	compound	O
product	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
exhibit	VB	xcomp	O
intrinsic	JJ	amod	O
transcriptional	JJ	amod	O
repression	NN	compound	O
activity	NN	dobj	O
when	WRB	advmod	O
localized	JJ	advcl	O
to	TO	case	O
promoters	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
by	IN	case	O
fusion	NN	nmod	O
with	IN	case	O
the	DT	det	O
GAL4	NN	compound	B-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
-	:	punct	O
binding	NN	compound	O
domain	NN	nmod	O
,	,	punct	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Such	JJ	amod	O
repression	NN	compound	O
activity	NN	nsubj	O
was	VBD	cop	O
totally	RB	advmod	O
absent	JJ	ROOT	O
with	IN	case	O
mutant	JJ	amod	O
pm490	NN	nmod	O
/	:	punct	O
1	CD	nummod	O
/	SYM	punct	O
5A	NN	appos	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
may	MD	aux	O
depend	VB	ccomp	O
on	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
repression	NN	compound	O
function	NN	nmod	O
of	IN	case	O
the	DT	det	O
55	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kDa	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
be	VB	cop	O
phosphorylation	NN	nmod	O
at	IN	case	O
the	DT	det	O
carboxy	NN	compound	O
terminus	NN	nmod	O
.	.	punct	O

Non	NNP	compound	O
-	HYPH	punct	O
invasive	JJ	amod	O
grading	NN	nsubj	O
of	IN	prep	O
primary	JJ	amod	O
brain	NN	pobj	B-Cancer
tumours	NNS	ROOT	I-Cancer
:	:	punct	O
results	NNS	dep	O
of	IN	case	O
a	DT	det	O
comparative	JJ	amod	O
study	NN	nmod	O
between	IN	case	O
SPET	NN	nmod	O
with	IN	case	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alpha	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
tyrosine	NN	nmod	I-Simple_chemical
and	CC	cc	O
PET	NN	conj	O
with	IN	case	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyglucose	NN	nmod	I-Simple_chemical
.	.	punct	O

Use	NN	nsubj	O
of	IN	case	O
iodine	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
123	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alpha	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
tyrosine	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
123I	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
allows	VBZ	ROOT	O
investigation	NN	dobj	O
of	IN	case	O
the	DT	det	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
transport	NN	compound	O
rate	NN	nmod	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
.	.	punct	O

It	PRP	nsubj	O
was	VBD	ROOT	O
the	DT	det	O
aim	NN	attr	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
to	TO	mark	O
compare	VB	advcl	O
the	DT	det	O
value	NN	dobj	O
of	IN	case	O
measurement	NN	nmod	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
measurement	NN	nmod	O
of	IN	case	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	compound	I-Simple_chemical
uptake	NN	nmod	O
for	IN	prep	O
the	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
invasive	JJ	amod	O
grading	NN	pobj	O
of	IN	prep	O
brain	NN	compound	B-Cancer
tumours	NNS	pobj	I-Cancer
.	.	punct	O

The	DT	det	O
study	NN	compound	O
population	NN	nsubj	O
comprised	VBD	ROOT	O
23	CD	nummod	O
patients	NNS	dobj	B-Organism
with	IN	case	O
histopathologically	RB	advmod	O
proven	JJ	amod	O
primary	JJ	amod	O
brain	NN	compound	B-Cancer
tumours	NNS	nmod	I-Cancer
;	:	punct	O
14	CD	nsubj	O
had	VBD	parataxis	O
high	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	compound	I-Cancer
gliomas	NN	dobj	I-Cancer
,	,	punct	O
and	CC	cc	O
nine	CD	nummod	O
low	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	compound	I-Cancer
brain	NN	compound	I-Cancer
neoplasms	NNS	conj	I-Cancer
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
metabolism	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
an	DT	det	O
ECAT	NN	compound	O
EXACT	NN	dep	O
47	CD	nummod	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	compound	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
camera	NN	dobj	O
and	CC	cc	O
fluorine	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
18	CD	nummod	I-Simple_chemical
fluorodeoxyglucose	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FDG	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
;	:	punct	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	compound	I-Simple_chemical
uptake	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	parataxis	O
with	IN	case	O
the	DT	det	O
triple	NN	npadvmod	O
-	HYPH	punct	O
headed	VBN	amod	O
single	JJ	amod	O
-	HYPH	punct	O
photon	NN	compound	O
emission	NN	compound	O
tomography	NN	compound	O
(	-LRB-	punct	O
SPET	NN	appos	O
)	-RRB-	punct	O
camera	NNS	nmod	O
,	,	punct	O
MULTISPECT	NN	appos	O
3	CD	nummod	O
.	.	punct	O

18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FDG	NN	nsubjpass	I-Simple_chemical
and	CC	cc	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	compound	I-Simple_chemical
uptake	NN	conj	O
was	VBD	auxpass	O
quantified	VBN	ROOT	O
as	IN	case	O
ratios	NNS	nmod	O
between	IN	prep	O
the	DT	det	O
uptake	NN	pobj	O
by	IN	prep	O
the	DT	det	O
tumour	NN	amod	B-Cancer
and	CC	cc	O
contralateral	JJ	conj	O
regions	NNS	pobj	O
of	IN	prep	O
reference	NN	pobj	O
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
metabolism	NN	nsubj	O
and	CC	cc	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
uptake	NN	conj	O
of	IN	case	O
the	DT	det	O
brain	NN	compound	B-Cancer
tumours	NNS	nmod	I-Cancer
correlated	VBD	ROOT	O
significantly	RB	advmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
71	CD	nummod	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	ROOT	O
0	CD	nummod	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Assuming	VBG	amod	O
discrimination	NN	compound	O
thresholds	NNS	ROOT	O
between	IN	prep	O
high	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	nmod	I-Cancer
and	CC	cc	O
low	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	conj	I-Cancer
tumours	NNS	pobj	I-Cancer
of	IN	prep	O
0	CD	pobj	O
.	.	punct	O
8	CD	nummod	O
for	IN	case	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
uptake	NN	ROOT	O
and	CC	cc	O
1	CD	conj	O
.	.	punct	O
8	CD	ccomp	O
for	IN	case	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	compound	I-Simple_chemical
uptake	NN	nmod	O
,	,	punct	O
the	DT	det	O
accuracy	NN	compound	O
values	NNS	nsubj	O
of	IN	case	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
PET	NN	dep	O
and	CC	cc	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	conj	I-Simple_chemical
SPET	NN	nmod	O
for	IN	mark	O
differentiating	VBG	acl	O
between	IN	case	O
high	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	nmod	I-Cancer
and	CC	cc	O
low	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	compound	I-Cancer
tumours	NNS	conj	I-Cancer
were	VBD	ROOT	O
21	CD	nummod	O
/	SYM	punct	O
23	CD	nummod	O
(	-LRB-	punct	O
91	CD	nummod	O
%	NN	attr	O
)	-RRB-	punct	O
and	CC	cc	O
19	CD	nummod	O
/	SYM	punct	O
23	CD	nummod	O
(	-LRB-	punct	O
83	CD	nummod	O
%	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
diagnostic	JJ	amod	O
performance	NN	nmod	O
was	VBD	ROOT	O
not	RB	neg	O
significant	JJ	acomp	O
on	IN	case	O
receiver	NN	compound	O
operating	VBG	amod	O
characteristic	JJ	amod	O
analysis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
>	NN	amod	O
0	CD	nummod	O
.	.	punct	O
4	LS	attr	O
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
no	DT	neg	O
major	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
PET	NN	compound	O
investigation	NN	nmod	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
the	DT	det	O
less	RBR	amod	O
expensive	JJ	amod	O
SPET	NN	compound	O
measurement	NN	conj	O
of	IN	case	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
uptake	NN	nmod	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
their	PRP$	poss	O
accuracy	NN	nmod	O
in	IN	mark	O
evaluating	VBG	acl	O
the	DT	det	O
malignancy	NN	compound	O
grade	NN	dobj	O
of	IN	prep	O
primary	JJ	amod	O
brain	NN	compound	B-Cancer
tumours	NNS	pobj	I-Cancer
.	.	punct	O

This	DT	nsubj	O
encourages	VBZ	ROOT	O
the	DT	det	O
performance	NN	dobj	O
of	IN	prep	O
further	JJ	amod	O
studies	NNS	pobj	O
to	TO	mark	O
analyse	VB	acl	O
the	DT	det	O
potential	JJ	amod	O
impact	NN	dobj	O
of	IN	case	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	compound	I-Simple_chemical
SPET	NN	nmod	O
on	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
management	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
brain	NN	compound	B-Cancer
tumours	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
Wilms	NN	amod	B-Cancer
tumor	NN	compound	I-Cancer
suppressor	NN	compound	O
gene	NN	compound	O
WT1	NN	nsubj	B-Gene_or_gene_product
induces	VBZ	ROOT	O
G1	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
myeloblastic	JJ	amod	B-Cell
leukemia	NN	compound	I-Cell
M1	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

WT1	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
isolated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
of	IN	case	O
Wilms	NN	amod	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
high	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
correlates	VBZ	ROOT	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
acute	JJ	amod	B-Cancer
leukemia	NN	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
addition	NN	compound	O
suppression	NN	nsubj	O
of	IN	case	O
WT1	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
by	IN	case	O
WT1	NN	compound	B-Gene_or_gene_product
anti	NN	amod	O
-	HYPH	punct	O
sense	NN	amod	O
oligonucleotide	NN	nmod	O
inhibits	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
leukemia	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
WT1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
their	PRP$	nmod:poss	O
proliferation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
elucidate	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
leukemic	JJ	amod	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
overexpressed	VBD	ROOT	O
exogenous	JJ	amod	O
WT1	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
murine	JJ	amod	B-Organism
M1	NN	compound	B-Cell
myeloblastic	JJ	amod	I-Cell
leukemia	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
using	VBG	acl	O
the	DT	det	O
isopropyl	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
beta	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
thiogalactoside	NN	nmod:npmod	I-Simple_chemical
(	-LRB-	punct	O
IPTG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
-	:	punct	O
controlled	VBN	amod	O
expression	NN	compound	O
system	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
induction	NN	nsubj	O
of	IN	case	O
one	CD	nummod	O
splicing	NN	compound	O
variant	NN	nmod	O
of	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
[	-LRB-	punct	O
WT1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
17AA	CD	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
+	CC	cc	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
KTS	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
]	-RRB-	punct	O
in	IN	case	O
M1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
induces	VBZ	ccomp	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
different	JJ	ccomp	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
type	NN	nmod	O
of	IN	case	O
leukemia	NN	compound	B-Cell
cell	NN	nmod	I-Cell
in	IN	case	O
which	WDT	nmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
.	.	punct	O

[	-LRB-	punct	O
Expression	NN	ROOT	O
of	IN	case	O
metastasis	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
]	-RRB-	punct	O
.	.	punct	O

For	IN	ROOT	O
the	DT	det	O
purpose	NN	pobj	O
of	IN	prep	O
investigating	VBG	pcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
for	IN	prep	O
determing	VBG	pcomp	O
the	DT	det	O
location	NN	dobj	O
of	IN	case	O
the	DT	det	O
positive	JJ	amod	O
sites	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
tumor	NN	compound	B-Cancer
metastasis	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	nsubjpass	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
and	CC	cc	O
the	DT	det	O
nonneoplastic	JJ	amod	B-Multi-tissue_structure
area	NN	conj	I-Multi-tissue_structure
surrounding	VBG	acl	O
the	DT	det	O
tumor	NN	dobj	B-Cancer
)	-RRB-	punct	O
was	VBD	auxpass	O
detected	VBN	conj	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
using	VBG	acl	O
digoxiginin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
labeled	VBN	amod	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
antisense	JJ	amod	O
complementary	JJ	amod	O
RNA	NN	compound	O
probe	NN	dobj	O
.	.	punct	O

The	DT	det	O
primary	JJ	amod	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
positive	JJ	amod	O
results	NNS	nsubj	O
of	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
are	VBP	cop	O
presence	NN	ccomp	O
of	IN	case	O
granules	NNS	nmod	B-Cellular_component
or	CC	cc	O
masses	NNS	conj	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	B-Organism_substance
;	:	punct	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
less	JJR	amod	O
expression	NN	dep	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
the	DT	det	O
higher	JJR	amod	O
metastatic	JJ	amod	O
rate	NN	appos	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
;	:	punct	O
(	-LRB-	punct	O
iii	LS	dep	O
)	-RRB-	punct	O
expression	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	compound	O
dose	NN	nmod	O
not	RB	neg	O
correlate	VBP	parataxis	O
with	IN	case	O
some	DT	det	O
other	JJ	amod	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	B-Cancer
size	NN	nmod	O
and	CC	cc	O
the	DT	det	O
background	NN	conj	O
of	IN	case	O
other	JJ	amod	O
liver	NN	compound	B-Organ
diseases	NNS	nmod	O
.	.	punct	O

CD56	NN	ROOT	B-Gene_or_gene_product
+	CC	cc	O
putative	JJ	amod	O
natural	JJ	amod	B-Cancer
killer	NN	compound	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	conj	I-Cancer
:	:	punct	O
production	NN	dep	O
of	IN	case	O
cytolytic	JJ	amod	O
effectors	NNS	nmod	O
and	CC	cc	O
related	JJ	amod	O
proteins	NNS	conj	O
mediating	VBG	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
?	.	punct	O

Apoptosis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
regulated	JJ	amod	O
form	NN	ROOT	O
of	IN	case	O
cell	NN	compound	B-Cell
death	NN	nmod	O
that	WDT	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
triggered	VBN	acl:relcl	O
by	IN	case	O
natural	JJ	amod	B-Cell
killer	NN	nmod	I-Cell
(	-LRB-	punct	O
NK	NN	appos	B-Cell
)	-RRB-	punct	O
or	CC	cc	O
cytotoxic	JJ	amod	B-Cell
T	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
which	WDT	nsubj	O
effect	NN	acl:relcl	O
target	NN	compound	O
cell	NN	compound	B-Cell
lysis	NN	dobj	O
by	IN	case	O
cytolytic	JJ	amod	O
effector	NN	nmod	O
and	CC	cc	O
related	JJ	amod	O
proteins	NNS	conj	O
through	IN	case	O
complex	JJ	amod	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signals	NNS	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
aimed	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
whether	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
selective	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cytolytic	JJ	amod	O
markers	NNS	nmod	O
in	IN	case	O
the	DT	det	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
and	CC	cc	O
whether	IN	mark	O
there	EX	expl	O
is	VBZ	conj	O
correlation	NN	nsubj	O
with	IN	case	O
zonal	JJ	amod	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
death	NN	nmod	O
in	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cytolytic	JJ	amod	O
effectors	NNS	compound	O
perforin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
granzyme	NN	compound	B-Gene_or_gene_product
B9	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
granule	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
protein	NN	compound	O
TIA1	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
24	CD	nummod	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
,	,	punct	O
18	CD	nummod	O
postthymic	JJ	amod	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	appos	I-Cancer
(	-LRB-	punct	O
one	CD	nummod	O
case	NN	compound	O
CD8	NN	dep	B-Gene_or_gene_product
+	CC	cc	O
CD56	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
and	CC	cc	O
three	CD	nummod	O
anaplastic	JJ	amod	B-Cancer
large	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	conj	I-Cancer
(	-LRB-	punct	O
ALCL	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
three	CD	nummod	O
T	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
lymphoblastic	JJ	amod	I-Cancer
lymphomas	NNS	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
20	CD	nummod	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	conj	I-Cancer
.	.	punct	O

Nineteen	NNP	nsubj	O
(	-LRB-	punct	O
79	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nsubj	I-Cancer
expressed	VBD	ROOT	O
perforin	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
all	DT	det	O
24	CD	nummod	O
cases	NNS	nsubj	O
expressed	VBD	conj	O
granzyme	NN	compound	B-Gene_or_gene_product
B9	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
TIA1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
only	JJ	amod	O
CD8	NN	nsubj	B-Gene_or_gene_product
+	CC	cc	O
CD56	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
postthymic	JJ	amod	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
lymphoma	NN	conj	O
also	RB	advmod	O
expressed	VBD	ROOT	O
all	DT	det	O
three	CD	nummod	O
cytolytic	JJ	amod	O
markers	NNS	dobj	O
,	,	punct	O
two	CD	nummod	O
CD8	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ALCL	NN	nsubj	O
expressed	VBD	parataxis	O
TIA1	NN	dobj	B-Gene_or_gene_product
;	:	punct	O
other	JJ	amod	O
postthymic	JJ	amod	B-Cancer
T	NN	compound	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
,	,	punct	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
lymphoblastic	JJ	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nsubj	I-Cancer
were	VBD	cop	O
consistently	RB	advmod	O
negative	JJ	parataxis	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
strong	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
percentage	NN	compound	O
perforin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
zonal	JJ	amod	B-Cell
tumor	NN	compound	I-Cell
cell	NN	compound	I-Cell
death	NN	conj	O
.	.	punct	O

Angioinvasion	NN	nsubj	O
,	,	punct	O
in	IN	prep	O
contrast	NN	pobj	O
,	,	punct	O
was	VBD	cop	O
present	JJ	ROOT	O
only	RB	advmod	O
in	IN	case	O
a	DT	det	O
proportion	NN	nmod	O
(	-LRB-	punct	O
37	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
these	DT	det	O
lymphomas	NNS	nmod	B-Cancer
despite	IN	case	O
the	DT	det	O
frequent	JJ	amod	O
presence	NN	nmod	O
of	IN	case	O
zonal	JJ	amod	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
death	NN	nmod	O
(	-LRB-	punct	O
71	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
cytolytic	JJ	amod	O
effector	NN	nsubj	O
and	CC	cc	O
related	JJ	amod	O
proteins	NNS	conj	O
produced	VBN	acl	O
by	IN	case	O
putative	JJ	amod	O
NK	NN	nmod	B-Cell
and	CC	cc	O
some	DT	det	O
CD8	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
CD56	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
postthymic	JJ	conj	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
lymphomas	NNS	dep	O
,	,	punct	O
probably	RB	advmod	O
in	IN	case	O
conjunction	NN	appos	O
with	IN	case	O
other	JJ	amod	O
mechanisms	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
effect	VB	ccomp	O
massive	JJ	amod	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
.	.	punct	O

The	DT	det	O
frequent	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
cytolytic	JJ	amod	O
effector	NN	compound	O
markers	NNS	nmod	O
in	IN	case	O
the	DT	dep	O
CD2	NN	nmod	B-Gene_or_gene_product
+	CC	cc	O
surface	NN	conj	O
CD3	NN	compound	B-Gene_or_gene_product
-	:	punct	O
CD56	NN	nmod	B-Gene_or_gene_product
+	CC	cc	O
putative	JJ	amod	O
NK	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
lymphomas	NNS	conj	O
lends	NNS	ROOT	O
further	RB	advmod	O
support	VBP	dobj	O
to	TO	case	O
their	PRP$	nmod:poss	O
probable	JJ	amod	O
NK	NN	compound	B-Cell
cell	NN	compound	I-Cell
origin	NN	nmod	O
.	.	punct	O

Prophylactic	JJ	amod	O
thyroidectomy	NN	nsubj	O
in	IN	case	O
MEN	NN	compound	B-Cancer
IIA	NN	nmod	I-Cancer
:	:	punct	O
does	VBZ	aux	O
the	DT	det	O
calcitonin	NN	compound	B-Gene_or_gene_product
level	NN	nsubj	O
correlate	VBP	ROOT	O
with	IN	case	O
tumor	NN	nmod	B-Cancer
spread	NN	acl	O
?	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
fate	NN	nsubjpass	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
multiple	JJ	amod	B-Cancer
endocrine	JJ	amod	I-Cancer
neoplasia	NN	nmod	I-Cancer
of	IN	case	I-Cancer
type	NN	compound	I-Cancer
II	CD	nummod	I-Cancer
A	NN	compound	I-Cancer
(	-LRB-	punct	O
MEN	NN	compound	B-Cancer
II	CD	nummod	I-Cancer
A	NN	nmod	I-Cancer
)	-RRB-	punct	O
is	VBZ	auxpass	O
determined	VBN	dep	O
by	IN	case	O
medullary	JJ	amod	B-Cancer
thyroid	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
which	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
in	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
.	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	B-Organ
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
a	DT	det	O
prophylactically	RB	advmod	O
thyroidectomized	VBN	amod	O
MEN	NN	compound	B-Cancer
II	CD	nummod	I-Cancer
A	NN	compound	I-Cancer
population	NN	dobj	O
to	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
the	DT	det	O
highly	RB	advmod	O
specific	JJ	amod	O
and	CC	cc	O
sensitive	JJ	conj	O
tumor	NN	compound	B-Cancer
marker	NN	compound	O
calcitonin	NN	nsubj	B-Gene_or_gene_product
correlates	VBZ	ccomp	O
with	IN	case	O
tumor	NN	nmod	B-Cancer
spread	NN	acl	O
.	.	punct	O

PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Fifteen	CD	nummod	O
patients	NNS	nsubjpass	B-Organism
with	IN	case	O
MEN	NN	compound	B-Cancer
II	CD	nummod	I-Cancer
A	NN	nmod	I-Cancer
(	-LRB-	punct	O
aged	JJ	amod	O
4	CD	compound	O
-	SYM	punct	O
24	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
who	WP	nsubj	O
had	VBD	aux	O
undergone	VBN	acl:relcl	O
prophylactic	JJ	amod	O
thyroidectomy	NN	dobj	O
since	IN	case	O
1990	CD	nmod	O
were	VBD	auxpass	O
included	VBN	dep	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
.	.	punct	O

Baseline	NN	npadvmod	O
and	CC	cc	O
pentagastrin	NN	conj	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
calcitonin	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
preoperatively	RB	advmod	O
determined	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
indication	NN	nsubjpass	O
for	IN	case	O
surgery	NN	nmod	O
was	VBD	auxpass	O
established	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
pathologic	JJ	amod	O
calcitonin	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
first	JJ	amod	O
seven	CD	nummod	O
patients	NNS	nmod	B-Organism
and	CC	cc	O
on	IN	case	O
the	DT	det	O
basis	NN	conj	O
of	IN	case	O
detected	VBN	amod	O
RET	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogene	NN	compound	O
mutation	NN	nmod	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
eight	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Bilateral	JJ	amod	O
central	JJ	amod	O
lymphadenectomy	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	B-Organism
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
thyroidectomy	NN	nmod	O
.	.	punct	O

RESULTS	NNS	dep	O
:	:	punct	O
Histology	NN	nsubj	O
demonstrated	VBD	ROOT	O
C	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
hyperplasia	NN	dobj	O
in	IN	case	O
five	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
aged	JJ	dep	O
4	CD	compound	O
-	SYM	punct	O
13	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
,	,	punct	O
unilateral	JJ	amod	O
medullary	JJ	compound	B-Cancer
microcarcinoma	NN	appos	I-Cancer
in	IN	case	O
six	CD	nummod	O
(	-LRB-	punct	O
aged	JJ	amod	O
9	CD	compound	O
-	SYM	punct	O
17	CD	nummod	O
years	NNS	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
bilateral	JJ	amod	O
medullary	JJ	compound	B-Cancer
microcarcinoma	NN	conj	I-Cancer
in	IN	case	O
three	CD	nummod	O
cases	NNS	nmod	O
(	-LRB-	punct	O
aged	JJ	amod	O
17	CD	compound	O
-	HYPH	punct	O
24	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

One	CD	nummod	O
9	CD	nummod	O
-	HYPH	punct	O
year	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
boy	NN	nsubj	B-Organism
with	IN	prep	O
bilateral	JJ	amod	O
microcarcinoma	NN	pobj	B-Cancer
already	RB	advmod	O
had	VBD	ROOT	O
a	DT	det	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	dobj	O
.	.	punct	O

The	DT	det	O
mean	JJ	amod	O
baseline	NN	compound	O
calcitonin	NN	compound	B-Gene_or_gene_product
level	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
histologic	JJ	amod	O
findings	NNS	nmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
71	CD	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
but	CC	cc	O
there	EX	expl	O
was	VBD	conj	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
pentagastrin	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
calcitonin	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
and	CC	cc	O
histology	NN	conj	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
21	CD	ROOT	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
47	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
In	IN	case	O
MEN	NN	compound	B-Cancer
II	CD	nummod	I-Cancer
A	NN	compound	I-Cancer
patients	NNS	dep	B-Organism
undergoing	VBG	acl	O
prophylactic	JJ	amod	O
thyroidectomy	NN	dobj	O
,	,	punct	O
baseline	NN	conj	O
but	CC	cc	O
not	RB	neg	O
stimulated	VBN	amod	O
calcitonin	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubj	O
already	RB	advmod	O
correlate	VBP	ROOT	O
with	IN	case	O
the	DT	det	O
histologic	JJ	amod	O
tumor	NN	compound	B-Cancer
stage	NN	nmod	O
at	IN	case	O
the	DT	det	O
stage	NN	nmod	O
of	IN	case	O
clinically	RB	advmod	O
occult	JJ	amod	O
C	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
hyperplasia	NN	nmod	O
or	CC	cc	O
medullary	JJ	compound	B-Cancer
microcarcinoma	NN	conj	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
biochemical	JJ	amod	O
screening	NN	nsubj	O
cannot	NN	advmod	O
reliably	RB	advmod	O
discriminate	VB	ROOT	O
the	DT	det	O
transition	NN	dobj	O
from	IN	case	O
C	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
hyperplasia	NN	nmod	O
to	TO	case	O
invasive	JJ	amod	O
microcarcinoma	NN	nmod	B-Cancer
.	.	punct	O

Individuals	NNS	nsubj	O
with	IN	case	O
MEN	NN	compound	B-Cancer
IIA	NN	nmod	I-Cancer
should	MD	aux	O
therefore	RB	advmod	O
undergo	VB	ROOT	O
early	JJ	amod	O
prophylactic	JJ	amod	O
thyroidectomy	NN	dobj	O
once	IN	mark	O
the	DT	det	O
diagnosis	NN	nsubjpass	O
is	VBZ	auxpass	O
confirmed	VBN	advcl	O
by	IN	case	O
molecular	JJ	amod	O
genetic	JJ	amod	O
testing	NN	nmod	O
.	.	punct	O

Induction	NN	ROOT	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
during	IN	case	O
reendothelialization	NN	nmod	O
after	IN	case	O
denuding	VBG	compound	O
injury	NN	nmod	O
.	.	punct	O

Ets	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	appos	O
,	,	punct	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
during	IN	case	O
reendothelialization	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
a	DT	det	O
confluent	JJ	amod	O
monolayer	NN	nsubjpass	B-Cell
of	IN	case	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
ECV304	NN	appos	B-Cell
,	,	punct	O
was	VBD	auxpass	O
denuded	VBN	advcl	O
,	,	punct	O
ECV304	NN	nsubj	B-Cell
at	IN	case	O
the	DT	det	O
wound	NN	compound	B-Pathological_formation
edge	NN	nmod	I-Pathological_formation
expressed	VBD	ROOT	O
Ets	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

An	DT	det	O
immunohistochemical	JJ	amod	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
Ets	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
accumulated	VBD	ccomp	O
in	IN	case	O
migrating	VBG	amod	B-Cell
cells	NNS	nmod	I-Cell
at	IN	case	O
the	DT	det	O
wound	NN	compound	B-Pathological_formation
edge	NN	nmod	I-Pathological_formation
and	CC	cc	O
returned	VBD	conj	O
to	TO	case	O
basal	JJ	amod	O
level	NN	nmod	O
when	WRB	advmod	O
reendothelialization	NN	nsubjpass	O
was	VBD	auxpass	O
accomplished	VBN	advcl	O
.	.	punct	O

This	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
reproduced	VBN	ROOT	O
in	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
denudation	NN	nmod	O
of	IN	case	O
rat	NN	compound	B-Organism
aortic	JJ	amod	B-Tissue
endothelium	NN	nmod	I-Tissue
by	IN	case	O
a	DT	det	O
balloon	NN	amod	O
catheter	NN	nmod	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
ECs	NNS	nmod	B-Cell
after	IN	case	O
denudation	NN	nmod	O
was	VBD	auxpass	O
regulated	VBN	ROOT	O
transcriptionally	RB	advmod	O
,	,	punct	O
and	CC	cc	O
humeral	JJ	amod	B-Gene_or_gene_product
factors	NNS	nsubj	I-Gene_or_gene_product
released	VBN	acl	O
from	IN	case	O
injured	JJ	amod	O
ECs	NNS	nmod	B-Cell
might	MD	aux	O
not	RB	neg	O
be	VB	cop	O
responsible	JJ	conj	O
.	.	punct	O

Mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
MAPK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
this	DT	det	O
induction	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
extracellular	JJ	amod	B-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	nsubjpass	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
2	CD	nummod	B-Gene_or_gene_product
(	-LRB-	punct	O
ERK1	NN	dep	B-Gene_or_gene_product
/	:	punct	O
2	CD	nummod	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Jun	NN	compound	I-Gene_or_gene_product
N	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
terminal	JJ	amod	I-Gene_or_gene_product
kinase	NN	appos	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
JNK1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
activated	VBN	advcl	O
after	IN	case	O
denudation	NN	nmod	O
,	,	punct	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
ERK1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
p38	NN	conj	B-Gene_or_gene_product
was	VBD	cop	O
more	RBR	advmod	O
rapid	JJ	ROOT	O
and	CC	cc	O
prominent	JJ	conj	O
.	.	punct	O

PD98059	NN	nsubj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
specific	JJ	amod	O
MAPK	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
ERK	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
MEK	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
inhibitor	NN	appos	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
ets	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
SB203580	NN	nsubj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
specific	JJ	amod	O
p38	NN	compound	B-Gene_or_gene_product
inhibitor	NN	appos	O
,	,	punct	O
almost	RB	advmod	O
completely	RB	advmod	O
abrogated	VBD	parataxis	O
its	PRP$	nmod:poss	O
induction	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Ets	NN	nsubjpass	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	auxpass	O
induced	VBN	ccomp	O
in	IN	case	O
ECs	NNS	nmod	B-Cell
after	IN	case	O
denudation	NN	nmod	O
through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
p38	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
relevant	JJ	ROOT	O
for	IN	case	O
reendothelialization	NN	nmod	O
by	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
certain	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

SV40	NN	compound	B-Organism
Tag	NN	compound	B-Gene_or_gene_product
transformation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
invasive	JJ	amod	O
trophoblast	NN	nmod	B-Cell
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
premalignant	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

I	PRP	ROOT	O
.	.	punct	O

Mechanisms	NNS	ROOT	O
responsible	JJ	amod	O
for	IN	prep	O
hyperinvasiveness	NN	pobj	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	prep	O
anti	VB	npadvmod	O
-	HYPH	punct	O
invasive	JJ	amod	O
action	NN	pobj	O
of	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Invasion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
uterus	NN	nmod	B-Organ
by	IN	case	O
first	JJ	amod	O
trimester	NN	compound	O
human	JJ	amod	B-Organism
placental	JJ	amod	B-Cell
extravillous	JJ	amod	I-Cell
trophoblast	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
EVT	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
depends	VBZ	ROOT	O
on	IN	case	O
mechanisms	NNS	nmod	O
shared	VBN	acl	O
by	IN	case	O
malignant	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
unlike	IN	case	O
tumor	NN	compound	B-Cancer
invasion	NN	nmod	O
,	,	punct	O
trophoblast	NN	compound	B-Cell
invasion	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
uterus	NN	nmod	B-Organ
is	VBZ	auxpass	O
stringently	RB	advmod	O
controlled	VBN	ROOT	O
in	FW	compound	O
situ	FW	advmod	O
by	IN	case	O
local	JJ	amod	O
molecules	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Since	IN	mark	O
EVT	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
possess	VBP	advcl	O
active	JJ	amod	O
invasion	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
genes	NNS	dobj	O
but	CC	cc	O
are	VBP	cop	O
nontumorigenic	JJ	conj	O
,	,	punct	O
our	PRP$	nmod:poss	O
objective	NN	nsubj	O
was	VBD	ROOT	O
to	TO	aux	O
induce	VB	xcomp	O
premalignant	JJ	dobj	O
and	CC	cc	O
then	RB	advmod	O
malignant	JJ	amod	O
phenotype	NN	conj	O
into	IN	case	O
a	DT	det	O
normal	JJ	amod	O
EVT	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
identify	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
SV40	NN	compound	B-Organism
Tag	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
into	IN	case	O
a	DT	det	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
first	JJ	amod	O
trimester	NN	compound	O
invasive	JJ	amod	O
EVT	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
HTR8	NN	appos	B-Cell
,	,	punct	O
established	VBN	acl	O
in	IN	case	O
our	PRP$	nmod:poss	O
laboratory	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
HTR8	NN	compound	B-Cell
line	NN	nsubj	I-Cell
has	VBZ	advcl	O
a	DT	det	O
limited	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
lifespan	NN	dobj	O
of	IN	case	O
12	CD	compound	O
-	SYM	punct	O
15	CD	nummod	O
passages	NNS	nmod	O
,	,	punct	O
SV40	NN	nmod:npmod	B-Organism
Tag	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
selected	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
extended	VBN	amod	O
lifespan	NN	nmod	O
.	.	punct	O

A	DT	det	O
long	RB	amod	O
-	HYPH	punct	O
lived	VBN	amod	O
line	NN	nsubjpass	B-Cell
,	,	punct	O
RSVT	NN	compound	B-Cell
-	:	punct	I-Cell
2	CD	appos	I-Cell
,	,	punct	O
was	VBD	auxpass	O
produced	VBN	ROOT	O
and	CC	cc	O
an	DT	det	O
immortalized	VBN	amod	O
subclone	NN	nsubjpass	O
,	,	punct	O
RSVT2	NN	compound	B-Cell
/	:	punct	I-Cell
C	NN	appos	I-Cell
,	,	punct	O
was	VBD	auxpass	O
further	RB	advmod	O
derived	VBN	conj	O
under	IN	case	O
a	DT	det	O
forced	VBN	amod	O
crisis	NN	compound	O
regimen	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
transformation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
alterations	NNS	dobj	O
in	IN	case	O
proliferative	JJ	amod	O
and	CC	cc	O
invasive	JJ	conj	O
abilities	NNS	nmod	O
,	,	punct	O
responses	NNS	dep	O
to	TO	case	O
the	DT	dep	O
invasion	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
-	HYPH	punct	O
regulating	VBG	dep	O
growth	NN	compound	O
factor	NN	compound	O
TGFbeta	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
for	IN	case	O
invasion	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
enzymes	NNS	nmod	O
or	CC	cc	O
enzyme	NN	compound	O
inhibitors	NNS	conj	O
.	.	punct	O

RSVT	NN	compound	B-Cell
-	:	punct	I-Cell
2	CD	dep	I-Cell
and	CC	cc	O
RSVT2	NN	conj	B-Cell
/	:	punct	I-Cell
C	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
were	VBD	cop	O
hyperproliferative	JJ	ROOT	O
and	CC	cc	O
hyperinvasive	JJ	conj	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
parental	JJ	amod	O
HTR8	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
.	.	punct	O

They	PRP	nsubj	O
were	VBD	cop	O
also	RB	advmod	O
variably	RB	advmod	O
resistant	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
proliferative	JJ	amod	O
and	CC	cc	O
anti	JJ	nmod:npmod	O
-	HYPH	punct	O
invasive	JJ	conj	O
signals	NNS	nmod	O
from	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Since	IN	mark	O
both	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nsubj	I-Cell
remained	VBD	advcl	O
non	JJ	amod	O
-	HYPH	punct	O
tumorigenic	JJ	dobj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
these	DT	det	O
properties	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
attained	VBD	ccomp	O
a	DT	det	O
premalignant	JJ	amod	O
phenotype	NN	dobj	O
.	.	punct	O

Both	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nsubj	I-Cell
showed	VBD	ROOT	O
reduced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	nmod	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteases	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TIMP	NNS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
while	IN	mark	O
TIMP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
plasminogen	NN	compound	B-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
inhibitor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
PAI	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
was	VBN	auxpass	O
also	RB	advmod	O
reduced	VBN	advcl	O
in	IN	case	O
RSVT2	NN	compound	B-Cell
/	:	punct	I-Cell
C	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
thus	RB	advmod	O
contributing	VBG	advcl	O
to	IN	case	O
their	PRP$	poss	O
hyperinvasiveness	NN	nmod	O
.	.	punct	O

Their	PRP$	poss	O
resistance	NN	nsubjpass	O
to	IN	case	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
invasive	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
failure	NN	nmod	O
of	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
upregulate	VB	acl	O
TIMPs	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
the	DT	det	O
TGFbeta	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
upregulation	NN	nmod	O
noted	VBN	acl	O
in	IN	case	O
parental	JJ	amod	O
HTR8	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
two	CD	nummod	O
type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
hexokinase	NN	compound	I-Gene_or_gene_product
RNA	NN	compound	O
transcripts	NNS	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

To	TO	mark	O
maintain	VB	ROOT	O
an	DT	det	O
elevated	JJ	amod	O
glycolytic	JJ	amod	O
rate	NN	dobj	O
,	,	punct	O
cancerous	JJ	amod	O
or	CC	cc	O
proliferating	VBG	conj	O
cells	NNS	nsubj	B-Cell
alter	VBP	parataxis	O
the	DT	det	O
expression	NN	compound	O
pattern	NN	dobj	O
of	IN	case	O
rate	NN	compound	O
limiting	VBG	amod	O
glycolytic	JJ	amod	B-Gene_or_gene_product
enzymes	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

Since	IN	mark	O
glucose	NN	compound	B-Simple_chemical
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
step	NN	advcl	O
in	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
hexokinase	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
HK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
first	JJ	amod	O
rate	NN	compound	O
limiting	VBG	amod	O
glycolytic	JJ	amod	B-Gene_or_gene_product
enzyme	NN	appos	I-Gene_or_gene_product
,	,	punct	O
can	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
key	JJ	amod	O
regulatory	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O

A	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
Km	NN	nsubjpass	O
,	,	punct	O
mitochondrial	JJ	amod	B-Cellular_component
type	NN	appos	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
HK	NN	appos	I-Gene_or_gene_product
is	VBZ	auxpass	O
described	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
form	NN	nmod	O
in	IN	case	O
hepatomas	NNS	nmod	B-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
recent	JJ	amod	O
identification	NN	nsubj	O
of	IN	case	O
a	DT	det	O
high	JJ	amod	O
-	HYPH	punct	O
Km	NN	compound	O
glucose	NN	nmod	B-Simple_chemical
phosphorylating	NN	acl	O
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
prompted	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
characterize	VB	xcomp	O
glucose	NN	dobj	B-Simple_chemical
phosphorylating	VBG	acl	O
enzymes	NNS	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
at	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

Highly	RB	advmod	O
sensitive	JJ	amod	O
reverse	NN	compound	O
-	HYPH	punct	O
transcription	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubj	O
identifies	VBZ	ROOT	O
an	DT	det	O
induction	NN	dobj	O
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
a	DT	det	O
type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	nmod	O
in	IN	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
irrespective	JJ	amod	O
of	IN	case	O
tissue	NN	compound	B-Tissue
origin	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
the	DT	det	O
identification	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
RNA	NN	compound	O
transcripts	NNS	nmod	O
of	IN	case	O
type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
HK	NN	nmod	I-Gene_or_gene_product
of	IN	case	O
approximately	RB	advmod	O
5	CD	nmod	O
.	.	punct	O
5	CD	ROOT	O
and	CC	cc	O
approximately	RB	advmod	O
4	CD	conj	O
.	.	punct	O
0	CD	nummod	O
kb	NN	ROOT	O
in	IN	case	O
these	DT	det	O
cancer	NN	compound	B-Cell
cells	NNS	compound	I-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
including	VBG	case	O
muscle	NN	npadvmod	B-Organ
-	HYPH	punct	O
derived	VBN	amod	O
L6	NN	compound	B-Cell
myoblast	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
under	IN	case	O
normal	JJ	amod	O
conditions	NNS	compound	O
muscle	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
express	VBP	ROOT	O
only	RB	advmod	O
a	DT	det	O
approximately	RB	advmod	O
5	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
kb	NN	compound	O
type	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	compound	O
transcript	NN	dobj	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
amount	NN	nsubjpass	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
HK	NN	compound	I-Gene_or_gene_product
RNA	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
expressed	VBN	xcomp	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

RNA	NN	compound	O
encoding	NN	compound	O
glucokinase	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	O
GK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
-	HYPH	punct	O
Km	NNP	compound	O
HK	NN	compound	B-Gene_or_gene_product
isozyme	NN	appos	O
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
only	RB	advmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
originating	VBG	acl	O
from	IN	case	O
liver	NN	nmod	B-Organ
and	CC	cc	O
pancreas	NN	conj	B-Organ
,	,	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
GK	NN	dobj	B-Gene_or_gene_product
under	IN	case	O
normal	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

Homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	ROOT	O
in	IN	case	O
hematopoiesis	NN	nmod	O
and	CC	cc	O
leukemogenesis	NN	conj	O
.	.	punct	O

Homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubj	O
have	VBP	ROOT	O
a	DT	det	O
strikingly	RB	advmod	O
conserved	VBN	amod	O
61	CD	nummod	O
-	HYPH	punct	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
sequence	NN	dobj	O
,	,	punct	O
encoding	VBG	advcl	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
binding	NN	compound	O
domain	NN	dobj	O
.	.	punct	O

Some	DT	det	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubjpass	O
,	,	punct	O
located	JJ	amod	O
in	IN	case	O
four	CD	nummod	O
clusters	NNS	nmod	O
are	VBP	auxpass	O
designated	VBN	ROOT	O
HOX	NN	compound	B-Gene_or_gene_product
A	NN	dobj	I-Gene_or_gene_product
through	IN	case	O
D	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
while	IN	mark	O
others	NNS	nsubjpass	O
are	VBP	auxpass	O
known	VBN	advcl	O
as	IN	case	O
divergent	JJ	amod	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
.	.	punct	O

Many	JJ	amod	O
researchers	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
express	VBP	ccomp	O
many	JJ	amod	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	dobj	O
.	.	punct	O

Induced	VBN	amod	O
over	IN	advmod	O
-	HYPH	punct	O
and	CC	advmod	O
under	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
their	PRP$	nmod:poss	O
affect	NN	dobj	O
on	IN	case	O
some	DT	det	O
aspects	NNS	nmod	O
of	IN	case	O
hematopoiesis	NN	nmod	O
and	CC	cc	O
leukemogenesis	NN	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
knock	NN	compound	O
-	HYPH	punct	O
out	RP	intj	O
mice	NNS	nsubjpass	B-Organism
of	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
by	IN	case	O
targeted	VBN	amod	O
disruption	NN	nmod	O
have	VBP	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
their	PRP$	nmod:poss	O
hematological	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

There	EX	expl	O
are	VBP	ROOT	O
examples	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
aberrant	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
homeobox	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
causing	VBG	acl	O
leukemias	NNS	dobj	B-Cancer
in	IN	case	O
humans	NNS	nmod	B-Organism
.	.	punct	O

In	IN	case	O
pre	JJ	compound	B-Cancer
-	HYPH	punct	I-Cancer
B	NNP	compound	I-Cancer
acute	JJ	amod	I-Cancer
lymphoblastic	JJ	amod	I-Cancer
leukemia	NN	compound	I-Cancer
(	-LRB-	punct	O
ALL	NN	appos	B-Cancer
)	-RRB-	punct	O
with	IN	case	O
t	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
;	:	punct	O
19	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nmod	O
,	,	punct	O
a	DT	det	O
fusion	NN	compound	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
created	VBN	ROOT	O
between	IN	case	O
E2A	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
a	DT	det	O
homeobox	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
PBX	NN	conj	B-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
ALL	NN	nmod	I-Cancer
with	IN	case	O
t	NN	compound	O
(	-LRB-	punct	O
10	CD	dep	O
;	:	punct	O
14	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nmod	O
,	,	punct	O
the	DT	det	O
HOX	NN	compound	B-Gene_or_gene_product
11	CD	nummod	I-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
deregulated	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	compound	I-Cancer
(	-LRB-	punct	O
AML	NN	appos	B-Cancer
)	-RRB-	punct	O
with	IN	case	O
t	NN	nmod	O
(	-LRB-	punct	O
7	CD	nummod	O
;	:	punct	O
11	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nmod	O
,	,	punct	O
the	DT	det	O
HOX	NN	compound	B-Gene_or_gene_product
A9	NN	compound	I-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
rearranged	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	compound	O
article	NN	nmod	O
,	,	punct	O
many	JJ	amod	O
functions	NNS	appos	O
of	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
both	CC	cc:preconj	O
at	IN	case	O
the	DT	det	O
early	JJ	amod	O
stem	NN	compound	B-Cell
cell	NN	compound	I-Cell
level	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
at	IN	case	O
the	DT	det	O
later	JJ	amod	O
stages	NNS	conj	O
of	IN	case	O
hematopoietic	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
leukemogenic	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
altered	JJ	amod	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Store	NNP	nmod:npmod	O
-	HYPH	punct	O
operated	VBN	amod	O
calcium	NN	compound	B-Simple_chemical
entry	NN	nsubj	O
promotes	VBZ	ROOT	O
shape	NN	compound	O
change	NN	dobj	O
in	IN	case	O
pulmonary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
expressing	VBG	acl	O
Trp1	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
Ca2	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
entry	NN	conj	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
produce	VB	xcomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
shape	NN	compound	O
change	NN	dobj	O
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
increased	VBN	amod	O
permeability	NN	nmod	O
,	,	punct	O
leukocyte	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
initiation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
conduit	NN	compound	B-Cell
-	HYPH	punct	I-Cell
vessel	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
mode	NN	nsubj	O
of	IN	case	O
Ca2	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
entry	NN	conj	O
regulating	VBG	acl	O
cell	NN	compound	B-Cell
shape	NN	dobj	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
store	NN	nmod:npmod	O
-	HYPH	punct	O
operated	VBN	amod	O
Ca2	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
channels	NNS	conj	O
(	-LRB-	punct	O
SOCs	NNS	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
promote	VB	xcomp	O
cell	NN	compound	B-Cell
shape	NN	compound	O
change	NN	dobj	O
necessary	JJ	amod	O
for	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
.	.	punct	O

SOC	NN	compound	O
activation	NN	nsubj	O
in	IN	case	O
rat	NN	compound	B-Organism
pulmonary	JJ	amod	B-Cell
arterial	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
increased	VBD	ROOT	O
free	JJ	amod	O
cytosolic	JJ	amod	B-Organism_substance
Ca2	NN	dobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
that	WDT	nsubj	O
was	VBD	cop	O
dependent	JJ	conj	O
on	IN	case	O
a	DT	det	O
membrane	NN	compound	B-Cellular_component
current	JJ	nmod	O
having	VBG	acl	O
a	DT	det	O
net	JJ	amod	O
inward	JJ	amod	O
component	NN	dobj	O
of	IN	prep	O
5	CD	pobj	O
.	.	punct	O
45	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
90	CD	nummod	O
pA	NN	npadvmod	O
/	:	punct	O
pF	NN	ROOT	O
at	IN	prt	O
-	HYPH	punct	O
80	CD	nummod	O
mV	NN	pobj	O
.	.	punct	O

Changes	NNS	nsubj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
shape	NN	nmod	O
accompanied	VBD	ROOT	O
SOC	NN	compound	O
activation	NN	dobj	O
and	CC	cc	O
were	VBD	cop	O
dependent	JJ	conj	O
on	IN	case	O
Ca2	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
entry	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
reconfiguration	NN	conj	O
of	IN	case	O
peripheral	JJ	amod	O
(	-LRB-	punct	O
cortical	JJ	dep	B-Multi-tissue_structure
)	-RRB-	punct	O
filamentous	JJ	amod	B-Gene_or_gene_product
actin	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
identity	NN	nsubj	O
of	IN	case	O
pulmonary	JJ	amod	O
endothelial	JJ	amod	B-Cell
SOCs	NNS	nmod	O
is	VBZ	cop	O
unknown	JJ	advcl	O
,	,	punct	O
but	CC	cc	O
mammalian	JJ	amod	O
homologues	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
Drosophila	FW	compound	B-Organism
melanogaster	FW	compound	I-Organism
transient	JJ	amod	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
potential	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
trp	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
proposed	VBN	conj	O
to	TO	mark	O
form	VB	xcomp	O
Ca2	NN	dobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
entry	NN	compound	O
channels	NNS	conj	O
in	IN	case	O
nonexcitable	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
we	PRP	nsubj	O
performed	VBD	ROOT	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	dobj	O
using	VBG	xcomp	O
Trp	NN	compound	B-Gene_or_gene_product
oligonucleotide	NN	compound	O
primers	NNS	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
rat	NN	amod	B-Organism
and	CC	cc	O
human	JJ	conj	B-Organism
pulmonary	JJ	amod	B-Cell
arterial	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Both	DT	det	O
cell	NN	compound	B-Cell
types	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
express	VB	xcomp	O
Trp1	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
neither	CC	cc:preconj	O
expressed	VBN	conj	O
Trp3	NN	dobj	B-Gene_or_gene_product
nor	CC	cc	O
Trp6	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
1	LS	dep	O
)	-RRB-	punct	O
Ca2	NN	nsubj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
entry	NN	conj	O
in	IN	case	O
pulmonary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
SOCs	NNS	nmod	O
produces	VBZ	ccomp	O
cell	NN	compound	B-Cell
shape	NN	compound	O
change	NN	dobj	O
that	WDT	nsubj	O
is	VBZ	cop	O
dependent	JJ	acl:relcl	O
on	IN	case	O
site	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
rearrangement	NN	nmod	O
of	IN	case	O
the	DT	det	O
microfilamentous	JJ	amod	B-Cellular_component
cytoskeleton	NN	nmod	I-Cellular_component
and	CC	cc	O
2	LS	conj	O
)	-RRB-	punct	O
Trp1	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
component	NN	conj	O
of	IN	case	O
pulmonary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
SOCs	NNS	nmod	O
.	.	punct	O

Glucose	NN	ROOT	B-Simple_chemical
and	CC	cc	O
lactate	NN	conj	B-Simple_chemical
metabolism	NN	conj	O
in	IN	case	O
C6	NN	compound	B-Cell
glioma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
:	:	punct	O
evidence	NN	dep	O
for	IN	case	O
the	DT	det	O
preferential	JJ	amod	O
utilization	NN	nmod	O
of	IN	case	O
lactate	NN	nmod	B-Simple_chemical
for	IN	case	O
cell	NN	compound	B-Cell
oxidative	JJ	amod	O
metabolism	NN	nmod	O
.	.	punct	O

13C	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
1H	NN	conj	B-Simple_chemical
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
spectroscopy	NN	dep	O
(	-LRB-	punct	O
NMR	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
metabolism	NN	dobj	O
of	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
lactate	NN	compound	I-Simple_chemical
and	CC	cc	O
D	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
in	IN	case	O
C6	NN	compound	B-Cell
glioma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
13C	NN	nummod	B-Simple_chemical
enrichment	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-Cell
metabolites	NNS	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
after	IN	case	O
a	DT	det	O
4	CD	nummod	O
-	HYPH	punct	O
h	NN	compound	O
incubation	NN	nmod	O
in	IN	case	O
media	NNS	nmod	O
containing	VBG	acl	O
5	CD	dobj	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
11	CD	nummod	O
mM	NN	amod	O
lactate	NN	conj	B-Simple_chemical
,	,	punct	O
each	DT	det	O
metabolite	NN	nsubjpass	O
being	VBG	auxpass	O
alternatively	RB	advmod	O
labelled	VBN	ROOT	O
with	IN	case	O
either	DT	cc:preconj	O
[	-LRB-	punct	B-Simple_chemical
1	CD	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
13C	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
D	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
or	CC	cc	O
[	-LRB-	punct	B-Simple_chemical
3	CD	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
13C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
L	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
lactate	NN	conj	I-Simple_chemical
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
exogenous	JJ	amod	O
lactate	NN	nsubj	B-Simple_chemical
was	VBD	cop	O
the	DT	det	O
major	JJ	amod	O
substrate	NN	ccomp	O
for	IN	case	O
oxidative	JJ	amod	O
metabolism	NN	nmod	O
.	.	punct	O

They	PRP	nsubj	O
were	VBD	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
concept	NN	nmod	O
of	IN	prep	O
the	DT	det	O
existence	NN	pobj	O
of	IN	prep	O
2	CD	nummod	O
pools	NNS	pobj	O
of	IN	prep	O
both	CC	cc:preconj	O
lactate	NN	pobj	B-Simple_chemical
and	CC	cc	O
pyruvate	VB	conj	B-Simple_chemical
,	,	punct	O
of	IN	case	O
which	WDT	nmod	O
1	CD	nummod	O
pool	NN	nsubjpass	O
was	VBD	auxpass	O
closely	RB	advmod	O
connected	VBN	relcl	O
with	IN	case	O
exogenous	JJ	amod	O
lactate	NN	nmod	B-Simple_chemical
and	CC	cc	O
oxidative	JJ	amod	O
metabolism	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
other	JJ	amod	O
pool	NN	nsubj	O
was	VBD	cop	O
closely	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
disconnected	VBD	conj	O
from	IN	case	O
oxidative	JJ	amod	O
metabolism	NN	nmod	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
basis	NN	nsubj	O
of	IN	case	O
this	DT	det	O
behaviour	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
related	JJ	ROOT	O
to	TO	case	O
different	JJ	amod	O
locations	NNS	nmod	O
for	IN	case	O
the	DT	det	O
lactate	NN	compound	B-Gene_or_gene_product
dehydrogenase	NN	compound	I-Gene_or_gene_product
isoenzymes	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
as	IN	mark	O
suggested	VBN	advcl	O
by	IN	case	O
their	PRP$	nmod:poss	O
immunohistochemical	JJ	amod	O
labelling	NN	nmod	O
.	.	punct	O

Tumors	NNS	ROOT	B-Cancer
of	IN	case	O
the	DT	det	O
retinal	JJ	amod	B-Tissue
pigment	NN	amod	I-Tissue
epithelium	NN	compound	I-Tissue
metastasize	NN	nmod	O
to	TO	case	O
inguinal	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
spleen	NN	conj	B-Organ
in	IN	case	O
tyrosinase	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
SV40	NN	compound	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
pigment	NN	amod	B-Tissue
epithelium	NN	nsubjpass	I-Tissue
of	IN	case	O
the	DT	det	O
retina	NN	nmod	B-Multi-tissue_structure
(	-LRB-	punct	O
RPE	NN	appos	B-Tissue
)	-RRB-	punct	O
is	VBZ	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
optic	JJ	amod	B-Multi-tissue_structure
cup	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
function	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
of	IN	prep	O
the	DT	det	O
eye	NN	pobj	B-Organ
.	.	punct	O

We	PRP	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
transgenic	JJ	amod	O
mouse	NN	compound	B-Organism
line	NN	dobj	O
that	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
SV40	NN	appos	B-Organism
)	-RRB-	punct	O
transforming	NN	amod	O
sequences	NNS	dobj	O
under	IN	case	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
1	CD	nmod	O
.	.	punct	O
4	CD	nummod	O
kb	NN	compound	O
tyrosinase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
promoter	NN	ROOT	O
,	,	punct	O
targeting	VBG	acl	O
expression	NN	dobj	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
Tag	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
RPE	NN	nmod	B-Tissue
.	.	punct	O

In	IN	case	O
transgenic	JJ	amod	O
embryos	NNS	nmod	B-Developing_anatomical_structure
,	,	punct	O
RPE	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
proliferated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
anterior	JJ	amod	B-Multi-tissue_structure
part	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
the	DT	det	O
eye	NN	nmod	B-Organ
and	CC	cc	O
near	IN	conj	O
the	DT	det	O
optic	JJ	amod	B-Multi-tissue_structure
nerve	NN	pobj	I-Multi-tissue_structure
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	B-Tissue
origin	NN	conj	O
.	.	punct	O

In	IN	case	O
3	CD	nummod	O
months	NNS	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
pigmented	VBN	amod	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
spleen	NN	nmod	B-Organ
and	CC	cc	O
inguinal	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
.	.	punct	O

In	IN	case	O
spleen	NN	nmod	B-Organ
,	,	punct	O
tyrosinase	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
TRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
SV40	NN	compound	B-Organism
Tag	NNS	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
expressed	VBN	ROOT	O
and	CC	cc	O
tyrosinase	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
enzymatically	RB	advmod	O
active	JJ	conj	O
.	.	punct	O

Pigmented	VBN	amod	O
regions	NNS	nsubj	O
were	VBD	cop	O
positive	JJ	ROOT	O
for	IN	case	O
an	DT	det	O
epithelial	JJ	amod	B-Tissue
marker	NN	nmod	O
,	,	punct	O
cytokeratin	NN	appos	B-Gene_or_gene_product
.	.	punct	O

Cell	NN	compound	B-Cell
lines	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
established	VBN	ROOT	O
from	IN	case	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
metastases	NNS	conj	O
and	CC	cc	O
kept	VBD	conj	O
in	IN	case	O
culture	NN	nmod	O
for	IN	case	O
more	JJR	amod	O
than	IN	quantmod	O
2	CD	nummod	O
months	NNS	nmod	O
.	.	punct	O

These	DT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
maintained	VBD	amod	O
expression	NN	conj	O
of	IN	case	O
tyrosinase	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
TRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
cytokeratin	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
SV40	NN	compound	B-Organism
Tag	NNS	conj	B-Gene_or_gene_product
.	.	punct	O

This	DT	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
RPE	NN	compound	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
metastasize	VBP	ccomp	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
spleen	NN	conj	B-Organ
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
metastasis	NN	nsubj	O
from	IN	case	O
TRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Tag	NN	compound	B-Gene_or_gene_product
RPE	NN	compound	O
tumors	NNS	nmod	O
towards	IN	case	O
spleen	NN	compound	B-Organ
and	CC	cc	O
lymph	NN	conj	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
serves	VBZ	ROOT	O
as	IN	case	O
potential	JJ	amod	O
tool	NN	nmod	O
to	TO	mark	O
investigate	VB	acl	O
biology	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
pigment	NN	amod	B-Tissue
epithelium	NN	nmod	I-Tissue
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
shark	NN	amod	B-Organism
cartilage	NN	npadvmod	B-Tissue
-	HYPH	punct	O
derived	VBN	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
on	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenesis	NN	nmod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activities	NNS	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
A	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nsubjpass	O
,	,	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	appos	I-Gene_or_gene_product
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	dep	O
from	IN	prep	O
the	DT	det	O
cartilage	NN	pobj	B-Tissue
of	IN	prep	O
the	DT	det	O
blue	JJ	amod	B-Organism
shark	NN	pobj	I-Organism
(	-LRB-	punct	O
Prionace	NN	compound	B-Organism
glauca	NN	appos	I-Organism
)	-RRB-	punct	O
.	.	punct	O

U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
two	CD	nummod	O
single	JJ	amod	O
peptides	NNS	nmod	O
with	IN	case	O
molecular	JJ	amod	O
mass	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
and	CC	cc	O
14	CD	conj	O
kDa	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

MATERIALS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	dep	I-Gene_or_gene_product
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
(	-LRB-	punct	O
HUVEC	NN	appos	B-Cell
)	-RRB-	punct	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
chicken	NN	compound	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
CAM	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
to	TO	mark	O
inhibiting	VBG	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
15	CD	intj	O
and	CC	cc	O
30	CD	conj	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
markedly	RB	advmod	O
inhibited	VBD	dep	O
HUVEC	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
,	,	punct	O
at	IN	case	O
15	CD	compound	O
-	HYPH	punct	O
50	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
decline	NN	dobj	O
in	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-	:	punct	O
thymidine	NN	compound	B-Simple_chemical
incorporation	NN	nmod	O
.	.	punct	O

30	CD	nummod	O
and	CC	cc	O
50	CD	conj	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
of	IN	prep	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	pobj	I-Gene_or_gene_product
,	,	punct	O
when	WRB	advmod	O
added	VBN	acl	O
to	TO	case	O
TNF	NN	compound	B-Gene_or_gene_product
alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
caused	VBD	ROOT	O
discontinuous	JJ	amod	O
and	CC	cc	O
disrupted	VBN	conj	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
200	CD	nummod	O
micrograms	NNS	compound	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
injected	VBN	ROOT	O
i	LS	dobj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
into	IN	case	O
mice	NNS	nmod	B-Organism
it	PRP	nsubj	O
suppressed	VBD	ROOT	O
sarcoma	NN	compound	B-Cell
-	:	punct	I-Cell
180	CD	nummod	I-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
B16	NN	compound	B-Cell
-	:	punct	I-Cell
F10	NN	compound	I-Cell
mouse	NN	compound	I-Cell
melanoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
metastasis	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
effects	NNS	nsubj	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
interference	NN	xcomp	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
HUVECs	NNS	nmod	B-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inhibition	NN	conj	O
of	IN	case	O
collagenolysis	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	conj	O
.	.	punct	O

